Citrus Sinensis ID: 003288
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 834 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.958 | 0.94 | 0.448 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.949 | 0.935 | 0.441 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.947 | 0.948 | 0.421 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.959 | 0.948 | 0.429 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.950 | 0.938 | 0.417 | 1e-180 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.930 | 0.914 | 0.426 | 1e-176 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.971 | 0.945 | 0.408 | 1e-172 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.922 | 0.982 | 0.406 | 1e-171 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.955 | 0.934 | 0.418 | 1e-171 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.956 | 0.947 | 0.405 | 1e-167 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/839 (44%), Positives = 527/839 (62%), Gaps = 40/839 (4%)
Query: 22 SLAADTVTPAS--FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVAN 78
S++A+T++ + I +VS FELGFF PG YLGI ++ I VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQLRDDGNLVIRDNS 136
RD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
+A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS G+F+++L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 LPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECVYWYEAYNRPSIM 255
P+I +N + SG W+G F F Y F +K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 256 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
L ++ SG + R W E + W++ + P C +Y CG C + P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 316 LES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+ QV + G C R L C GD F+ L ++K PD S+++ + +++C+ +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 373 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 429
++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+ A+ L +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETY---QDLLAFDINMN---ITTR 480
+I + + V+LL SF +F+ +RK +K + +ET L + D+ MN I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 481 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
+ E N D D LPL + AT NFS KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 541 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 601 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660
FD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVY 720
+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G Y
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 721 NAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM--LMRYINVALLCVQENAADRP 777
N+D NLLG W WK+ + ++IDP+I + ++R I + LLCVQE A DRP
Sbjct: 732 NSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
Query: 778 TMSDVISMINNEHLNLPSPKEPAF--TKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
TMS VI M+ +E +P PK P + + + +SS S E +VN +TVS++ R
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/833 (44%), Positives = 515/833 (61%), Gaps = 41/833 (4%)
Query: 27 TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGI ++ IP VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRDNSSGNATES 143
+N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPSPGNFTYRLDIHVLPKICT 202
+LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS G+F+ +L P+
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 203 FNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLN 260
+N SG W G F V + D++ F EN + VY Y L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFT-ENNQQVVYSYRVNKTNIYSILSLS 267
Query: 261 PSGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANTICSLDQKPMCECLEGF 314
+G + R W E + W +L+ P D Y CG YGYC ANT P+C C++GF
Sbjct: 268 STGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT------SPICNCIKGF 321
Query: 315 KL--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+ E + + C R L C D F+ L +++ PD + S+++ + L++C+ CL
Sbjct: 322 EPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381
Query: 373 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 429
K C+C A+AN++++ SGC++W G L D IRN+ GQ +Y+RV A L +K++
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKS 437
Query: 430 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGE 486
+I + + ++LL SF +F+ +RK + T + + D MN + +
Sbjct: 438 KKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT 497
Query: 487 ANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
+ + D + LPL ++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS
Sbjct: 498 SKENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLS 554
Query: 547 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK 606
S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LFD T+
Sbjct: 555 KMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRS 614
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG
Sbjct: 615 SNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFG 674
Query: 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SF 725
+E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G YN++
Sbjct: 675 REETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDL 734
Query: 726 NLLGHAWDLWKDDRVHDLIDPV---IMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 782
NLLG W WK+ + +++DP+ + E ++R I + LLCVQE A DRP MS V
Sbjct: 735 NLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSV 794
Query: 783 ISMINNEHLNLPSPKEPAFTKG-INVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
+ M+ +E +P PK P F G +++ S S++ + C+VN VT+S+I R
Sbjct: 795 MVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/839 (42%), Positives = 505/839 (60%), Gaps = 49/839 (5%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDR 81
++ DT+ +RDGE ++S+ +RF GFFS G S+ RY+GI + QI +VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISDNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSS 137
PI+D + ++ SN GNL + N T IWSTNVS + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 GNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVL 197
G + W+SFD+PTDT L M+LG+ K+ L+R L+SW+S DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKICTFNGSVKFTCSGHWDGAGFVSALSY-TDFLYKQFMMENKDECVYWYEAYNRPSIMT 256
P++ + G + G W G + +++ + N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 257 LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM--CECLEGF 314
+N +G + R W +W++ +SVP + C Y +CG N C C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 315 KLES------QVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCK 368
+ + + + G K +R+ C D F++L +K PD D S++ + L++CK
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASI--CSEKDGFVKLKRMKIPDTSDASVDMNITLKECK 370
Query: 369 AECLKNCSCRAYANS---NVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 422
CLKNCSC AYA++ + + + GCL W+G ++DAR + +GQ Y+RV +L
Sbjct: 371 QRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARW 428
Query: 423 ------GNKKLLWILVILVIPVVLLPS-FYVFYRRRRKCQEKETENVETYQDLLAFDINM 475
G +++L IL+ L+ V+LL + R RRK + + FD +
Sbjct: 429 NRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESF 488
Query: 476 NITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL 535
+DK+++ LPLF L +I AAT NFS Q KLG GGFGPVYKG L
Sbjct: 489 RFE-------------QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQ 535
Query: 536 NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKS
Sbjct: 536 NRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKS 595
Query: 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655
L+ F+F ++ L+W R+ I+ GIA+G+LYLHQ SR RIIHRDLKASNILLD +M PK
Sbjct: 596 LDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPK 655
Query: 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
ISDFG+AR+FGG++++G T ++VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++ KK
Sbjct: 656 ISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKK 715
Query: 716 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD 775
N+ ++ +S NL+GH WDLW++ ++ID ++ Q+ +M+ I + LLCVQENA+D
Sbjct: 716 NS-AFHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASD 774
Query: 776 RPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
R MS V+ M+ + NLP+PK PAFT + + SVNDVT S I R
Sbjct: 775 RVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/839 (42%), Positives = 517/839 (61%), Gaps = 39/839 (4%)
Query: 18 SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
+ VS + T + I + ++S SQ FELGFF+P S YLGI ++ IP VWV
Sbjct: 22 AFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWV 81
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRD 134
ANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L D+GN ++RD
Sbjct: 82 ANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD 140
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDI 194
+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS G F+ +L+
Sbjct: 141 SNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 195 HVLPKICTFNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYWYEAYNRP 252
P+ + SG W+G F V D++ F +K+E Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTA-SKEEVTYSYRINKTN 254
Query: 253 SIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLE 312
L LN +G + R W E + W +L+ P C Y CG C + P C C++
Sbjct: 255 LYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIK 314
Query: 313 GFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKA 369
GFK ++ + G C R L C D F L +K PD +++ + L+ CK
Sbjct: 315 GFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 370 ECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLL 428
CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R+ A++L +K++
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIK 432
Query: 429 WILVI---LVIPVVLLPSFYVFY---RRRRKCQEKETENVETY--QDLLAFDINMNITTR 480
+I + + ++LL SF +F+ R++++ +T NV+ QD L D+ ++
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492
Query: 481 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
T++ + KS+ LPL L ++ AT NFS KLG+GGFG VYKGRLL+G+E+
Sbjct: 493 TSK--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 541 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ L
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 601 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660
FD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVY 720
+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G Y
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724
Query: 721 NAD-SFNLLGHAWDLWKDDRVHDLIDPV---IMQDEISLPMLMRYINVALLCVQENAADR 776
N++ NLLG W WK+ +++DP+ + + ++R I + LLCVQE A DR
Sbjct: 725 NSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDR 784
Query: 777 PTMSDVISMINNEHLNLPSPKEPAFTKGIN-VKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
P MS V+ M+ +E +P PK P F G + ++ S S++ + C+VN +T+S+I R
Sbjct: 785 PVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 350/839 (41%), Positives = 519/839 (61%), Gaps = 46/839 (5%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GI + Q+ + +VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSSGNA 140
D + ++ S GNL + NGT IWST+V ++ P VA+L D GNLV+ D +G +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 TESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKI 200
W+SF++PT+TLL MK G+ ++ ++R ++SWRS DP GN TYR++ P++
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CTFNGSVKFTCSGHWDGAGFVSALSYTD-FLYKQFMMENKDECVYWYEAYNRPSIMTLKL 259
+ G + +G W G + T+ F++ + N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 260 NPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC--SLDQKPMCECLEGFKLE 317
N +G + R WN KW +S P+ C Y +CG N C + +K C CL G++ +
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 318 SQVN---QPGPIKCERSHSLE-CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
+ + + C R + C + F +L +K P+ V+++ + L++C+ CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 374 NCSCRAYANSNVKE---SSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL-------- 422
NCSC AYA++ + + GCL W+G+++D R + +GQ YLRV S+L
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 423 -GNKKLLWILVILV-IPVVLLPSFYVFYRRRR-KCQEKETENVETYQDLLAFDINMNITT 479
G K+L+ IL+ L+ + ++LL SF+ + R+RR + Q + +FD+ +
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 480 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 539
E DKS+ LPLF L++I AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 540 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 599
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKSL+ F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 600 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659
+F ++ L+W R+ II GI +G+LYLHQ SR RIIHRDLKASN+LLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 719
GLAR+FGG++++G+T ++VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
Query: 720 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM 779
Y +S NL+ H WD W++ ++ID ++ ++ +M+ +++ LLCVQEN++DRP M
Sbjct: 728 YE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDM 786
Query: 780 SDVISMINNEHLNLPSPKEPAFTKG--INVKNSSHSNSGTSEHCS--VNDVTVSLIYPR 834
S V+ M+ + ++LPSPK PAFT G N K S++ S S +NDVT++ + R
Sbjct: 787 SSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 348/816 (42%), Positives = 511/816 (62%), Gaps = 40/816 (4%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI 69
++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LGI + I
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEV---KNPVAQLR 125
D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS DPSP
Sbjct: 134 DTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 GNFTYRLDIHVLPKICTFNGS-VKFTCSGHWDGAGFVSALSY---TDFLYKQFMMENKDE 241
GN++ +D P+I + G+ + SG W+ A F + T++LY + DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 242 C--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 298
VY+ + PS++ K+ +G WNE KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 299 ICSLD-QKPMCECLEGFKLESQVN------QPGPIKCERSHSLECKSGDQFIELDEIKAP 351
IC + +C C+ G++ S N + P+KCER+ S+ D+F+ L +K P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTLKSVKLP 366
Query: 352 DFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 411
DF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++ G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ--FEAGGS 420
Query: 412 SVYLRVPASKLGN--KKLLWILVILVIPVVLLPSFYVFYRR--RRKCQEKETENVETYQD 467
S+++R+ S++G K + ++V +++ V+L+ F + R R+K T
Sbjct: 421 SLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTS 480
Query: 468 LLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQCKLGEGGF 526
++ D+ + T + G + + K+ + S LP+FSL +I AT +F + +LG GGF
Sbjct: 481 VVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGF 540
Query: 527 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586
GPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK+L
Sbjct: 541 GPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKML 600
Query: 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646
+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIHRDLK SN+
Sbjct: 601 VYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNV 660
Query: 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 706
LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KSDV+SFG+L
Sbjct: 661 LLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVL 720
Query: 707 MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVAL 766
+LE +S K+NT + +++ +L+G+AW L+ R +L+DP I + S +R I+VA+
Sbjct: 721 LLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREALRCIHVAM 779
Query: 767 LCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 802
LCVQ++AA+RP M+ V+ M+ ++ L +P++P FT
Sbjct: 780 LCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFT 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 607 bits (1565), Expect = e-172, Method: Compositional matrix adjust.
Identities = 351/860 (40%), Positives = 510/860 (59%), Gaps = 50/860 (5%)
Query: 7 LNIFCSLIFLL-SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR-YLGI 64
L +F +I + ++ + + + T + I + LVS FE+GFF ++ SR YLG+
Sbjct: 16 LLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGM 72
Query: 65 RFQQIPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVS--SEVKNPV 121
++++ D VWVANRD P+S+ L IS N NLVLL+ +N +W TN++ +E V
Sbjct: 73 WYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPVV 131
Query: 122 AQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSAD 181
A+L +GN V+RD+S+ +A+E YLWQSFDYPTDTLL +MKLG++ K L R+L+SWRS+D
Sbjct: 132 AELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSD 190
Query: 182 DPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKD 240
DPS GNF+Y+L+ LP+ + SG W+G F Y + +EN +
Sbjct: 191 DPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNE 250
Query: 241 ECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVP-DQYCGKYGYCGANTI 299
E Y + N L L G+ R W + W+ +S P D C Y CG
Sbjct: 251 EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAY 310
Query: 300 CSLDQKPMCECLEGF------KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 353
C ++ P+C C++GF + + +V G C R L C SGD F + ++K P+
Sbjct: 311 CDVNTSPVCNCIQGFNPRNIQQWDQRVWAGG---CIRRTQLSC-SGDGFTRMKKMKLPET 366
Query: 354 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--- 409
++++ + +++CK C+ +C+C A+AN++++ SGC++W L D IRN+
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNYATDA 422
Query: 410 --GQSVYLRVPASKLGNKKLL---WILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET 464
GQ +Y+R+ A+ + K+ I + + + V+LL + ++R++K + ++
Sbjct: 423 IDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIAN 482
Query: 465 YQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEG 524
Q +N + + E+ G+ K ++ LPL + ++ ATENFS KLG+G
Sbjct: 483 TQRNQNLPMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQG 537
Query: 525 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584
GFG VYKGRLL+G+E+AVKRLS S QG EF NE+ LIA+LQH NLV++LGCC+E EK
Sbjct: 538 GFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEK 597
Query: 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
+LI EY+ N SL+ +LF T++ LNW R I G+A+GLLYLHQ SRFRIIHRDLK S
Sbjct: 598 MLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVS 657
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
NILLDK+M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFG
Sbjct: 658 NILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFG 717
Query: 705 ILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDRVHDLIDPVIMQDEISLPML----- 758
+++LE +S KKN G YN D N LL + W WK+ R +++DPVI+ S P +
Sbjct: 718 VIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQE 777
Query: 759 -MRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT---KGINVKNSSHSN 814
++ I + LLCVQE A RP MS V+ M +E +P PK P + + SS
Sbjct: 778 VLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQ 837
Query: 815 SGTSEHCSVNDVTVSLIYPR 834
+E +VN T S+I R
Sbjct: 838 CDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 602 bits (1553), Expect = e-171, Method: Compositional matrix adjust.
Identities = 345/848 (40%), Positives = 505/848 (59%), Gaps = 79/848 (9%)
Query: 1 MEKIPCLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR 60
ME L++ +F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNV-----S 114
YLGI +++I VVWVANRD P+ D + L +S NG+L L N N IWS++
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQK 119
Query: 115 SEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYL 174
+ ++NP+ Q+ D GNLV+R+ SG+ + Y+WQS DYP D L MK G +F L R+L
Sbjct: 120 ASLRNPIVQILDTGNLVVRN--SGD-DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 175 SSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQ 233
+SWR+ DDPS GN+T ++D + +P+ SV +G W+G F + + +Y+
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 234 FMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 292
+ ++E Y Y+ N PS++T ++LNP+G + R W +N W+ S C +Y
Sbjct: 237 EYVFTEEEVYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYT 295
Query: 293 YCGANTICSLDQKPMCECLEGFKL---ESQVNQPGPIKCERSHSLECKSG-DQFIELDEI 348
CG+ C++++ P C CL+GF ++ V C R L+C G D F+++ ++
Sbjct: 296 LCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKL 355
Query: 349 KAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPIRN 407
K PD ++ M+L +CK CL+NC+C AY+ ++++ GC++W+GDLID R N
Sbjct: 356 KLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YN 413
Query: 408 FTGQSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQD 467
GQ +Y+ R E ET E+ +
Sbjct: 414 ENGQDLYV-----------------------------------RLASSEIETLQRESSR- 437
Query: 468 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 527
+++R K + +D LP L +++ AT FS KLG+GGFG
Sbjct: 438 ---------VSSR-----------KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 528 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587
PVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++ E++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
LD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFSFG+L+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 708 LETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVAL 766
LE +S ++N G N + NLLGHAW + +D+ +++ID + + + ++R I++ L
Sbjct: 658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGL 717
Query: 767 LCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDV 826
LCVQ++ DRP MS V+ ++ + + L P++P F N+ S + S E S N
Sbjct: 718 LCVQQDPKDRPNMS-VVVLMLSSEMLLLDPRQPGFFNERNLL-FSDTVSINLEIPSNNFQ 775
Query: 827 TVSLIYPR 834
T+S+I PR
Sbjct: 776 TMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1552), Expect = e-171, Method: Compositional matrix adjust.
Identities = 354/845 (41%), Positives = 518/845 (61%), Gaps = 48/845 (5%)
Query: 19 MKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVA 77
+ +S+ + T + I + +VS FELGFF S YLGI +++I VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPV-AQLRDDGNLVIRDNS 136
NRD P+S+ +L ISN NLV+L+ ++ +WSTN++ V++ V A+L D+GN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
N ++ +LWQSFD+PTDTLL MKLG D K L R+++SW+S+ DPS G+F ++L+
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 197 LPKICTFNGSVKFTCSGHWDG---AGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPS 253
LP+ F ++ SG WDG +G + + D +Y EN++E Y + + S
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNS 262
Query: 254 IMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEG 313
L +N G + +W +W+ + +P C YG CG C + P C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322
Query: 314 FK-LESQVNQPGPI--KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAE 370
F+ L Q G + +C R L C D+F L +K P +++R+ L++C+ +
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 371 CLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKL 427
C +C+C AYANS+++ SGC++W G+ R IRN+ GQ +++R+ A++ G ++
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFGERRT 437
Query: 428 LWILVILVI---PVVLLPSF--YVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTN 482
+ +I +I ++L+ SF Y F+++++K + + T Y+D + I N
Sbjct: 438 IRGKIIGLIIGISLMLVLSFIIYCFWKKKQK-RARATAAPIGYRDRIQELIITN------ 490
Query: 483 EYGEANGDGK---DKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 539
G G+ + +D LPL ++ ATENFS LG GGFG VYKGRLL+GQE
Sbjct: 491 --GVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQE 548
Query: 540 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 599
+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CC+ EKILI EY+ N SL+
Sbjct: 549 IAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSH 608
Query: 600 LFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
LF++T+ LNWQ R II GIA+GLLYLHQ SRF+IIHRDLKASN+LLDK+M PKISD
Sbjct: 609 LFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISD 668
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718
FG+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S K+N G
Sbjct: 669 FGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRG 728
Query: 719 VYNA-DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM-----LMRYINVALLCVQEN 772
+N+ NLLG+ W+ WK+ + +++D +I+ S+ + ++R I + LLCVQE
Sbjct: 729 FHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQER 788
Query: 773 AADRPTMSDVISMINNEHLNLPSPKEPAFTKG---INVKNSSHSNSGTSEHCSVNDVTVS 829
A DRP MS V+ M+ +E +P PK P + G ++ +SS S SE +VN +TVS
Sbjct: 789 AEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVS 848
Query: 830 LIYPR 834
+I R
Sbjct: 849 VINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1515), Expect = e-167, Method: Compositional matrix adjust.
Identities = 346/853 (40%), Positives = 493/853 (57%), Gaps = 55/853 (6%)
Query: 6 CLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIR 65
C N+ CS +++ T IR+G+ L+S + FELGFF+P S RY+GI
Sbjct: 21 CSNVSCS-----------TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 66 FQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQL 124
++ I P VVWVANR++P+ D+ L I+++GNLV++N N TIWSTNV E N VA L
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVL 129
Query: 125 RDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
G+LV+ +S + W+SF+ PTDT L M++ + R W+S DPS
Sbjct: 130 FKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 185 PGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGA---GFVSALSYTDFLY--KQFMMENK 239
PG ++ +D +I + G + SG W+ A G L +T+++Y K ++
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 240 DECVYW-YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 298
D VY+ Y A + + + P G + WN++ W+ L P C KY CG +
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYS 306
Query: 299 ICSLDQKPM----CECLEGFKLESQV---NQPGPIKCERSHSLECKSG------DQFIEL 345
+C D K C C++GF+ Q N+ C+R L C D F L
Sbjct: 307 VCD-DSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVL 365
Query: 346 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPI 405
IK PDF V L+ N E CK C ++CSC+AYA + GC++W DLID
Sbjct: 366 KGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFE 420
Query: 406 RNFTGQSVYLRVPASKLGNKK---LLWILVILVIPVVLLP-SFYVFYRRRRKCQEKETEN 461
R G S+ +R+ SKLG K LWI+V VI LL ++ ++ ++ +
Sbjct: 421 RG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAF---- 474
Query: 462 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 521
+ +D+ DI N ++ GD D LP+FS S+ +AT +F+ + KL
Sbjct: 475 LWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD---LPIFSFDSVASATGDFAEENKL 531
Query: 522 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581
G+GGFG VYKG G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCC+E
Sbjct: 532 GQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIED 591
Query: 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641
EK+L+ EYMPNKSL+ FLFD +K+ L+W+ R +I GIA+GLLYLH+ SR +IIHRDL
Sbjct: 592 NEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDL 651
Query: 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVF 701
KASNILLD +MNPKISDFG+AR+F + NT ++VGTYGYM+PEYA++G+FS KSDV+
Sbjct: 652 KASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVY 711
Query: 702 SFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 761
SFG+L+LE +S +KN D +L+G+AW LW + ++IDP++ +D + MR
Sbjct: 712 SFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIV-KDTRDVTEAMRC 770
Query: 762 INVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHC 821
I+V +LC Q++ RP M V+ M+ ++ LP P++P F +N + + G +
Sbjct: 771 IHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDG-HDVA 829
Query: 822 SVNDVTVSLIYPR 834
SVNDVT + I R
Sbjct: 830 SVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 834 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.947 | 0.985 | 0.471 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.923 | 0.712 | 0.485 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.931 | 0.947 | 0.478 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.950 | 0.948 | 0.485 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.950 | 0.954 | 0.468 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.962 | 0.976 | 0.471 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.941 | 0.957 | 0.470 | 0.0 | |
| 255555127 | 834 | S-locus-specific glycoprotein S6 precurs | 0.971 | 0.971 | 0.447 | 0.0 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.925 | 0.388 | 0.474 | 0.0 | |
| 359496546 | 866 | PREDICTED: receptor-like serine/threonin | 0.982 | 0.945 | 0.448 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/846 (47%), Positives = 536/846 (63%), Gaps = 56/846 (6%)
Query: 1 MEKIPCLNIFCSLIFLLSMK-VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS 59
ME +P IF S +F+ S+ +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN 119
RY+GI +++ P+ VVWVANR+ P++D+ VLTI N GNLVLL+Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
PVAQL D GNLV+RDN S TESY WQSFD P+DTLL MKLGW+ K ERYL +WRS
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 ADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENK 239
DPSPG+FTYRLDIH LP++ GSVK SG W+G F + +++ ++ N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 240 DECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTI 299
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 300 CSLDQKPMCECLEGFK------LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 353
C P+CECL+GFK L+ Q N G KCE +L+C+SG+ F++L +K PD
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQ-NFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDL 358
Query: 354 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVK---ESSGCLMWYGDLIDARRPIRNFTG 410
++ LN+ MNL++C+AEC KNCSC A+A +N+ + SGCLMW+G+LID R + G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418
Query: 411 QSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLA 470
Q +++RVPAS+L R ++ + +T V + LL
Sbjct: 419 QDIHIRVPASEL-----------------------EMARSSKRKKMLKTALVASMSALLG 455
Query: 471 FDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFSLASITAATENFSMQCKLGEGGFGPV 529
++ G D+ K+ PLF L +I AT NF+ +G GGFG V
Sbjct: 456 IFVS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSV 499
Query: 530 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589
YKG+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG C+ + E++LI E
Sbjct: 500 YKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYE 559
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
YMPNKSL+ F+FD + LL W+ R II GIA+GLLYLHQ S+ +I+HRDLK SN+LLD
Sbjct: 560 YMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLD 619
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
++ PKISDFGLAR+ G D + T++++GTYGYM+PEYA+DG FS+KSDVFS G+L+LE
Sbjct: 620 SNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLE 679
Query: 710 TLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLC 768
+S KKN G + D +LLGHAW +W + R +LID ++D L+R I V LLC
Sbjct: 680 IISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELID-TGLEDTSGKSQLLRCIQVGLLC 738
Query: 769 VQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTV 828
VQ+ DRP MS V+ M+ NE LP PK+P F I + S + S + S N+ +
Sbjct: 739 VQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFF--IERGSVSEATSRNEDSYSTNEANI 796
Query: 829 SLIYPR 834
+++ R
Sbjct: 797 TILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/826 (48%), Positives = 519/826 (62%), Gaps = 56/826 (6%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
AD++ I D E LVSS Q FELGFFSPG SK+RYLGI ++ P VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
D+ VLTI NNG LVLLNQ+ IWS N+S +NPVAQL + GNLV+RD S+ ++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 145 LWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN 204
+WQSFD P+DT+L MK+GW+ K L+R L+SW+S+DDPS G+F+Y DI+VLP +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGF 264
GS K SG W+G F + +YK + N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 265 VTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLESQVNQP- 323
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF +SQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 324 --GPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYA 381
C R L+C+ + F+++ +K PD ID + ++L +CK CL NCSC AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 382 NSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG------NKKLLWILVILV 435
+N S GCLMW GDLID R + +Y+R+ S+LG KKL+ ILVI
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 436 IPVVL---LPSFYVFYRRRRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGD 490
+L L ++ F+++R QE + EN+E
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESKKENLE--------------------------- 747
Query: 491 GKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 550
LPLF L +I AT NFS K+G GGFG VYKG L G VAVKRLS S
Sbjct: 748 ---------LPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798
Query: 551 QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN 610
QG++EFKNE +LIAKLQH+NLVRLLGCC++ E+IL+ EYMPNKSL+ F+FD ++ LL
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
W R I+ GIA+GLLYLHQ SRF+IIHRDLK SNILLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLG 729
+ TK+IVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +S +KN G + D NLLG
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLG 978
Query: 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789
HAW LW+ +R +L+D ++D ++R I V LLCVQ ADRP MS VI M+ NE
Sbjct: 979 HAWLLWEQNRALELMD-ACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNE 1037
Query: 790 HLNLPSPKEPA-FTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
LP PK P FT+ +V + + SG E S N VT+S++ R
Sbjct: 1038 GATLPQPKHPGFFTERSSV--DTDTMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1880), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/831 (47%), Positives = 527/831 (63%), Gaps = 54/831 (6%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GN VL++ N T+ WS+N ++ + +L+D GNLV+RD N
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 200 ICTFNGSVKFTCSGHWDGAGFVS--ALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF AL Y F+ ++ +E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFV-DDGEEVYYTYNLKNKSLITRI 261
Query: 258 KLNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 314
+N + F R WNE + W +VP YC Y CGA C + Q P+C+CLE F
Sbjct: 262 VMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTP 321
Query: 315 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+
Sbjct: 322 RSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQ 381
Query: 374 NCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI- 430
NCSC AY +N+KE SGC +W+GDLID IR F+ GQ +Y+R+ AS+ K I
Sbjct: 382 NCSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIK 437
Query: 431 ------LVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEY 484
L I V +LL ++Y+F R+ + EN +
Sbjct: 438 MTVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQI-------------------- 477
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
D K +D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K
Sbjct: 478 -----DSGPK-EDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKT 531
Query: 545 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 604
LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T
Sbjct: 532 LSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQT 591
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARM
Sbjct: 592 RGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARM 651
Query: 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD- 723
FGGD+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G + D
Sbjct: 652 FGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPDH 711
Query: 724 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783
S +L+GHAW LWKD + LI+ + ++MR IN++LLCVQ++ DRP+M+ V+
Sbjct: 712 SLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATVV 771
Query: 784 SMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
M+ E+ LP PKEP F KG S S+ T E S N++T SL+YPR
Sbjct: 772 WMLGGEN-TLPQPKEPGFFKGSGPFRPSSSSKNT-ELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/837 (48%), Positives = 540/837 (64%), Gaps = 44/837 (5%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDVN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ SYLWQSFDYP+DT+L MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 138 SG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 ICTFNGSVKFTCSGHWDGAGFV--SALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF +AL Y F+ +N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFV-DNGEEVYYTYNLKNKSLITRL 255
Query: 258 KLN-PSGFV-TRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF- 314
+N +GF+ R WNE S W+ VP YC Y CGA C + Q P+CECLE F
Sbjct: 256 VMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFT 315
Query: 315 --KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL
Sbjct: 316 PKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCL 375
Query: 373 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASK------LGN 424
+NCSC AY +++KE SGC +W+GDLID IR F GQ +Y+R+ AS+ L
Sbjct: 376 QNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSLIK 431
Query: 425 KKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET-YQDLLAF---DINMNITTR 480
++ L I V +LL ++Y+F K TE ++ Y LL + D + ++ +
Sbjct: 432 MEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLSEK 482
Query: 481 TNEYGEANGDGKDKS--KDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQ 538
T E N D D +D LPLF +I AT FS+ K+GEGGFGPVYKG L +GQ
Sbjct: 483 TGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQ 541
Query: 539 EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598
E+AVK LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPN+SL+
Sbjct: 542 EIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDS 601
Query: 599 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
F+FD T+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISD
Sbjct: 602 FIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISD 661
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 718
FGLARM GGD+ +GNT +++GTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 662 FGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRG 721
Query: 719 VYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 777
Y+ D S +L HAW LWKD + DLI+ + ++MR IN++LLCVQ + DRP
Sbjct: 722 FYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHPDDRP 781
Query: 778 TMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
+M+ V+ M+ E+ LP P EP F KG S S+S E S N+ T SL+YPR
Sbjct: 782 SMATVVWMLGGEN-TLPQPNEPGFFKGSGPFGPSSSSSNI-ELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1832), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/844 (46%), Positives = 538/844 (63%), Gaps = 51/844 (6%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
S++F LS+ S A +++ + DG+ LVSS FELGFFSPG S++RY+GI +++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
VVWVANR+ P++D++ +L ++GNL +N TNGTIWS+N+S NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTY 190
V+R + N E++LWQSFDYP D+ L MK G F L RYL+SW+S DPS G +T
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 191 RLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAY 249
+LD + LP+ GSV SG W+G F ++ + +Y + N++E Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 250 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCE 309
N + + L+P G + R W + + W + C ++ CGA+ +C+++ P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 310 CLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQ 366
CL+ F+ LE C R L+C +G+ FI+ IK PD N+ +NLE+
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 367 CKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 422
C+ CLKNCSC AYAN +V++ SGC++W+GDLID R+ N GQ +Y+R+ AS +
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKP 433
Query: 423 ----GNKKLLWILVILVIPVVL-------LPSFYVFYRRRRKCQEKETENVETYQDLLAF 471
G K++ I+VIPV L L F F R+ ++ Q NV T +
Sbjct: 434 VKSRGKKRVR----IIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE---- 485
Query: 472 DINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYK 531
RT E +++D LPLF LA++T AT FS+ KLG+GGFGPVYK
Sbjct: 486 ------QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYK 530
Query: 532 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591
G L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCC+E E++LI EYM
Sbjct: 531 GILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYM 590
Query: 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 651
PNKSL+ F+FD + LL+W R II GIA+GLLYLHQ SR RIIHRDLKASNILLD +
Sbjct: 591 PNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYE 650
Query: 652 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
MNPKISDFG+AR FGGDE NT +IVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +
Sbjct: 651 MNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 710
Query: 712 SSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQ 770
S +KN G +A+ NLLGHAW L K+ R DLID I+ D + ++R I VALLCVQ
Sbjct: 711 SGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIV-DTCIISEVLRSIEVALLCVQ 769
Query: 771 ENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSL 830
++ DRP MS V+ M++++ + LP PKEP F ++ N S S++ E SVN++T +L
Sbjct: 770 KSPEDRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDS-SSTIKHEISSVNELTSTL 827
Query: 831 IYPR 834
+ R
Sbjct: 828 LEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/834 (47%), Positives = 527/834 (63%), Gaps = 31/834 (3%)
Query: 19 MKVSLAA-DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
++VS A +T+ P ++DGE L+S+ FELGFFS G S+SRYLGI +++IP VVWV
Sbjct: 2 LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
NR+ P DN VL ++ G ++L N T G IWS+N S KNPV QL D GNL+++D +
Sbjct: 62 GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGN 121
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHV 196
GN ++ +WQSFD+P +TLL MKLGW+ L RYL+SW+S DDP+ GNF+ +D+
Sbjct: 122 -GNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 197 LPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAYNRPSIM 255
P++ G SG W+G F + + ++ + NK E Y YE N +
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 256 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
L ++ G + R W + + W FSVP C Y CGA C+++ P+C CLEGF
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300
Query: 316 LESQVNQPGPI---KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 372
+S + C R L C +GD F +L +K PD ++ M+L++C+ CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360
Query: 373 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLG-----NK 425
+NCSC AYANS+++ SGCL+W+ LID R+ FT GQ +Y+R+ AS+L K
Sbjct: 361 RNCSCLAYANSDIR-GSGCLLWFDHLIDMRK----FTEGGQDLYIRIAASELAKGKSHGK 415
Query: 426 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT--RTNE 483
++ I+ L+I + + + Y R+RK + + V + +F I+ I +
Sbjct: 416 RVAIIVSCLIIGMGMTALGSLLYTRKRK-RNILGQAVPLVLLVSSFAIHFYIISGLAKET 474
Query: 484 YGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 543
Y E GD K +D+ L F L +I AT NFS KLGEGGFGPVYKG LL+GQE+AVK
Sbjct: 475 YIENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVK 533
Query: 544 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 603
RLS SGQG KEFKNE++LIA+LQHRNLV+LLGCC+ EK+LI EYMPNKSL+ F+FD
Sbjct: 534 RLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDK 593
Query: 604 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
+ LL+W RII GIA+GLLYLHQ SR RIIHRDLKASNILLD DMNPKISDFGLAR
Sbjct: 594 KRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLAR 653
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD 723
FG D+ NTK++VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +S K+N G + D
Sbjct: 654 TFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLD 713
Query: 724 -SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 782
S NLLGHAW LW ++R +L D QDE S+ ++R I V LLCVQ DRP MS V
Sbjct: 714 HSLNLLGHAWRLWMEERALELFDK-FSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAV 772
Query: 783 ISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEH--CSVNDVTVSLIYPR 834
+ M+ +E +LP PK+P F ++ ++S TS+ S N+++ +LI PR
Sbjct: 773 VVMLGSES-SLPQPKQPGF---YTERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/829 (47%), Positives = 522/829 (62%), Gaps = 44/829 (5%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + + DG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDAN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPK 199
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS G+FT+ + P+
Sbjct: 138 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 ICTFNGSVKFTCSGHWDGAGFVSA--LSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTL 257
+ + GS ++ SG W+G GF L Y F+ ++ +E Y Y N+ I +
Sbjct: 197 LVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFV-DDGEEVYYTYNLKNKSLITRI 255
Query: 258 KLNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 314
+N S F R WNE + W +VP YC Y CGA C + Q P+CECLE F
Sbjct: 256 VMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQSPVCECLEKFTP 315
Query: 315 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 373
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C++ CL+
Sbjct: 316 KSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSICLE 375
Query: 374 NCSCRAYANSNVKESSGCLMWYGDLID-ARRPIRNFTGQSVYLRVPASKLGNKKLLWILV 432
NCSC AY +N+KE SGC +W+GDLID + P GQ +Y+R+ AS+ L ++
Sbjct: 376 NCSCMAYTATNIKERSGCAIWFGDLIDITQLPA---AGQEIYIRMNASESSECLSLVLMA 432
Query: 433 ------ILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGE 486
I V +LL ++Y+F R+ + L + + + E +
Sbjct: 433 VGIALSIFVACGILLVAYYIFKRKAK----------------LIGKVTLTAFSNREENDQ 476
Query: 487 ANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
+ K+ D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K S
Sbjct: 477 IDSGPKE---DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHS 533
Query: 547 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK 606
SGQG+ EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T+
Sbjct: 534 RSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRG 593
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARMFG
Sbjct: 594 ELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFG 653
Query: 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SF 725
GD+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G Y+ D S
Sbjct: 654 GDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDHSL 713
Query: 726 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785
+L+GHAW LWKD + DLI+ + ++MR IN++LLCVQ++ DRP+M+ V+ M
Sbjct: 714 SLIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHPDDRPSMATVVWM 773
Query: 786 INNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
+ E+ LP P EP F KG S S+S S N++T SL YPR
Sbjct: 774 LGCEN-TLPQPNEPGFFKGSGPFGPSSSSSNIELS-SNNEITTSLFYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/836 (44%), Positives = 535/836 (63%), Gaps = 26/836 (3%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
+F + + + + S ++DT+T + +G+ L+S+ Q+FELGFF+PG SK+ Y+GI ++
Sbjct: 15 LFFTFLSFYAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWYVGIWYKN 74
Query: 69 IPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
I D VWVANRD P+++++ + I N ++VL +Q N IWS+N + NPV QL D
Sbjct: 75 ISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSN-QIKATNPVMQLLDT 132
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGN 187
G+LV+R+ N YLWQSFDYPTDTLL DMKLGWD L RYLSSW+S DDP G+
Sbjct: 133 GDLVLRE---ANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKSKDDPGAGD 189
Query: 188 FTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECVYWY 246
++++LD H P+I +N K SG W+G F Y F + N+ E Y +
Sbjct: 190 YSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVTNQSEVFYSF 249
Query: 247 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 306
+ + L + SG + R W W+ + P C Y CG IC + P
Sbjct: 250 HISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPYGICDSNASP 309
Query: 307 MCECLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 363
+C+C+ GF+ L++ + G C R L+C + D+F+ L IK P+ +++ ++
Sbjct: 310 VCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPESSTSFVDRIIS 368
Query: 364 LEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL 422
L+ C+ CL+NCSC AYANS++ +GC++W+G+L+D R+ GQ +Y+R+ AS +
Sbjct: 369 LKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYTEG-GGQDLYVRLAASDI 427
Query: 423 GNKKLLWILVILV---IPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT 479
G+ K + L+I + I +LL F +RR ++++ E Q+LL ++ I++
Sbjct: 428 GDGKNVAALIIGISVGIGTLLLGLAACFIWKRRSVRKEQKGVQERSQNLLLNEVV--ISS 485
Query: 480 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 539
+ + GE + D + LPLF +I AT+NFS + KLG+GGFG VYKGRL+ GQ
Sbjct: 486 KRDYSGEKDKDELE------LPLFDFGTIATATDNFSDENKLGQGGFGCVYKGRLVEGQV 539
Query: 540 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 599
VAVKRLS S QG++EFKNE+ LIA+LQHRNLVRLLGCC+E EK+LI EYM ++SL+
Sbjct: 540 VAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYMEHRSLDSV 599
Query: 600 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659
+F++ K+ LLNWQ R I+ GIA+GLLY+HQ SRFRIIHRDLKASNILLD + NPKISDF
Sbjct: 600 IFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEWNPKISDF 659
Query: 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 719
G+AR+FGGD+ + +TK++VGTYGYMSPEYA+DG FS+KSDVFSFG+L+LE +S KN G
Sbjct: 660 GMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVLEIVSGNKNRGF 719
Query: 720 YNADS-FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 778
Y+++S NLLGHAW LWK+++ +++D + +L R I V LLCVQE A DRPT
Sbjct: 720 YHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVL-RCIQVGLLCVQERAEDRPT 778
Query: 779 MSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
MS V+ M+++E+ +P PK P F G N + S+ E +VN VTV+++ R
Sbjct: 779 MSSVVLMLSSENATMPHPKTPGFCLGRNPFETDSSSGKQDESYTVNQVTVTMLDAR 834
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/812 (47%), Positives = 533/812 (65%), Gaps = 40/812 (4%)
Query: 17 LSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVW 75
S+ V A DT+ +R + ++S+ FELGFFSPG S S ++GI +++I + VVW
Sbjct: 293 FSISVDAAPDTIFSGQMLRQTDTIISAGGNFELGFFSPGNSPSYFVGIWYKKISEQTVVW 352
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135
VANRD I+ ++ LTI+++GNLV+L+ T N+S +N A L D GNL++R
Sbjct: 353 VANRDYTITGSSPSLTINDDGNLVILD-GRVTYMVANISLG-QNVSATLLDSGNLILR-- 408
Query: 136 SSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIH 195
N + LWQSFDYP++ L MK+G++ K +SW++A+DP G + ++D
Sbjct: 409 ---NGNSNILWQSFDYPSNHFLPGMKIGYNRKTGEVWSFTSWKNAEDPGLGPVSLKMDPE 465
Query: 196 VLPKICTFNGSVKFTCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAYNRPSI 254
+ +N + ++ SG W+G F S D+++ E+ E + Y Y+ I
Sbjct: 466 THQFVIMWNSQMVWS-SGVWNGHAFSSVPEMRLDYIFNYSYFEDMSEAYFTYSLYDNSII 524
Query: 255 MTLKLNPSGFVTRQIWNENSNKWDELFSVPDQY-CGKYGYCGANTICSLDQKPMCECLEG 313
L ++ SG + + W + S W+ +S P + C Y YCG+ + C+ P+C+CL G
Sbjct: 525 SRLLIDVSGNIKQLTWLDRSG-WNLFWSQPQNFECDYYSYCGSFSSCNNQTTPICQCLYG 583
Query: 314 FKLES----QVNQPGPIKCERSHSLEC-------KSGDQFIELDEIKAPDFIDVSLNQRM 362
F+ S +NQ C R SL+C D+F+++ +K P + Q
Sbjct: 584 FRPNSAGDWMMNQFRD-GCVRKTSLQCDDLTSVNSEKDKFLKMANVKFPQSPQILETQ-- 640
Query: 363 NLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARR-PIRNFTGQSVYLRVPASK 421
++E CK CL CSC AYA++ CLMW L++ ++ ++ G+++YL++ AS+
Sbjct: 641 SIETCKMTCLNKCSCNAYAHN-----GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAASE 695
Query: 422 LGN----KKLLWILVILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDINMN 476
L N K W++ ++V+ V++L Y+ YR+ ++ Q++E + T QD+L ++ M
Sbjct: 696 LQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKRVQDRE--EMTTSQDILLYEFGMG 753
Query: 477 ITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLN 536
NE E N GKDK+KD+WLPLFS AS++AATE+FS + KLG+GGFGPVYKG L N
Sbjct: 754 SKATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFN 813
Query: 537 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596
GQE+AVKRLS SGQGL+E KNE +L+A+LQHRNLVRLLGCC+EQGEKILI EYMPNKSL
Sbjct: 814 GQEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSL 873
Query: 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656
+ FLFD K+ L+W RV IIEGIAQGLLYLH+YSR RIIHRDLKASNILLD DMNPKI
Sbjct: 874 DSFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKI 933
Query: 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716
SDFG+ARMFGG+E NT +IVGTYGYMSPEYAL+GLFS KSDVFSFG+LMLE LS KKN
Sbjct: 934 SDFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKN 993
Query: 717 TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR 776
TG YN+D+ NL+G+AW+LWK D +L+DP +++ + S ML+RYINV LLCV+E AADR
Sbjct: 994 TGFYNSDTLNLIGYAWELWKSDMAINLMDP-MLEGQSSQYMLLRYINVGLLCVEEIAADR 1052
Query: 777 PTMSDVISMINNEHLNLPSPKEPAFTKGINVK 808
PT+S+V+SM+ NE LPSPK PAF+ +++
Sbjct: 1053 PTLSEVVSMLTNELAVLPSPKHPAFSTASSLQ 1084
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/849 (44%), Positives = 521/849 (61%), Gaps = 30/849 (3%)
Query: 6 CLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIR 65
C N+ C L + ++ DT+T I +G+ LVS+ FELGFFSPG SK Y+GI
Sbjct: 28 CYNVLCFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGDFELGFFSPGDSK-WYVGIW 86
Query: 66 FQQIP-DAVVWVANRDRPISDNNA--VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVA 122
++ IP + VVWVANRD PI N++ V+ I + GN+V++++ WSTN S+ V NPVA
Sbjct: 87 YKNIPKERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDEDLHVFWSTNESTAV-NPVA 145
Query: 123 QLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADD 182
QL D GNLV+R++ + E+YLWQSFDY TDTLL MKLGWD K RYL+SW+S +D
Sbjct: 146 QLLDTGNLVVREDKDADP-ENYLWQSFDYLTDTLLPGMKLGWDQKTGSNRYLTSWKSKED 204
Query: 183 PSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMME-NKDE 241
PS G+++++LD P+I +N K SG W+G F F E N+D
Sbjct: 205 PSSGDYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGVPEMKSSSVFTFDFEWNQDG 264
Query: 242 CVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICS 301
Y YE N+ L ++ +G + R W E W+ + P C Y CG IC
Sbjct: 265 AYYSYELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLYWFAPKDQCDDYRECGPYGICD 324
Query: 302 LDQKPMCECLEGFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSL 358
+ P+C+C GF+ ++ + G C R +C +GD F+ L +K P+ +
Sbjct: 325 TNSSPVCKCPRGFEPKNPQAWNLRDGSDGCSRKTEFDCNNGDGFLALKRMKLPETGSSFV 384
Query: 359 NQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVP 418
++ M+L+ C+ C KNCSC YAN + GC++W DL+D R GQ +Y+RV
Sbjct: 385 DKSMSLKDCEMTCRKNCSCTGYANPEITSDKGCIIWTTDLLDMREYAEGEGGQDLYIRVA 444
Query: 419 ASKLGNK-------KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLA- 470
AS+LG++ K++ + I V VLL + Y +RK + ++ + L
Sbjct: 445 ASELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYLWKRKKMKIIVAHIVSKPGLSER 504
Query: 471 ---FDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 527
+ +N + +Y + + K+ + LPLF +I AT NFS KLG+GGFG
Sbjct: 505 SHDYILNEAVIPSKRDYTD-----EVKTDELELPLFDFGTIVLATNNFSDTNKLGQGGFG 559
Query: 528 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587
VYKG LL G+E+AVKRL+ SGQG++EF NE+ LIA+LQHRNLV+LLGCCVE EK+LI
Sbjct: 560 CVYKGMLLEGEEIAVKRLAKNSGQGIEEFMNEVRLIARLQHRNLVQLLGCCVEMEEKMLI 619
Query: 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
EYM N+SL+ LFD K LL+W R II G+A+GLLYLHQ SRFRIIHRDLKASN+L
Sbjct: 620 YEYMQNRSLDSILFDEKKSSLLDWGRRFNIICGVARGLLYLHQDSRFRIIHRDLKASNVL 679
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
LD +MNPKISDFG+AR+FG D+ + NTK++VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+
Sbjct: 680 LDGEMNPKISDFGMARIFGRDQTEANTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLV 739
Query: 708 LETLSSKKNTGVYNA-DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM-LMRYINVA 765
LE +S KKN G Y+ D NLLGHAW LW++ + +L+D + E P ++R I V
Sbjct: 740 LEIISGKKNRGFYHLNDEHNLLGHAWRLWREGKGLELMDSSV--SESCAPYDVLRCIQVG 797
Query: 766 LLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVND 825
LLCVQE+A DRP MS V+ M+++E LP PK P F G + + S+S E +VN
Sbjct: 798 LLCVQEHAEDRPVMSSVVLMLSSETATLPLPKNPGFCLGRKLVETDSSSSKQEETFTVNQ 857
Query: 826 VTVSLIYPR 834
VTV+++ R
Sbjct: 858 VTVTVMDAR 866
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 834 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.972 | 0.954 | 0.439 | 5e-179 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.961 | 0.946 | 0.439 | 5.7e-178 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.965 | 0.954 | 0.435 | 7.5e-176 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.442 | 0.471 | 0.522 | 2.9e-172 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.970 | 0.952 | 0.416 | 1.9e-163 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.931 | 0.953 | 0.417 | 5.1e-161 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.966 | 0.957 | 0.405 | 3.6e-153 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.393 | 0.407 | 0.523 | 1.2e-149 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.935 | 0.919 | 0.410 | 1.7e-144 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.960 | 0.965 | 0.387 | 7.5e-144 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1738 (616.9 bits), Expect = 5.0e-179, P = 5.0e-179
Identities = 374/851 (43%), Positives = 523/851 (61%)
Query: 10 FCSLIFLLSMKVSLAADTVTPASF--IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ 67
F + +L S++A+T++ + I +VS FELGFF PG YLGI ++
Sbjct: 14 FFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73
Query: 68 QIPDAV-VWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQL 124
I VWVANRD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAEL 132
Query: 125 RDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
D+GN V+RD S +A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS
Sbjct: 133 LDNGNFVLRD-SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 185 PGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQF-MMENKDECV 243
G+F+++L+ P+I +N + SG W+G F F Y F +K+E
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y + L ++ SG + R W E + W++ + P C +Y CG C +
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSN 311
Query: 304 QKPMCECLEGFKLES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQ 360
P+C C++GFK + QV + G C R L C GD F+ L ++K PD S+++
Sbjct: 312 TSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDR 371
Query: 361 RMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRV 417
+ +++C+ +CL++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+
Sbjct: 372 GIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRL 427
Query: 418 PASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEKETENVETY---QDLLAF 471
A+ L +K+ SF +F+ +RK +K + +ET L +
Sbjct: 428 AATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSR 485
Query: 472 DINMN---ITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
D+ MN I++R + E N D D LPL + AT NFS KLG+GGFG
Sbjct: 486 DLLMNEVVISSRRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGI 539
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI
Sbjct: 540 VYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIY 599
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILL
Sbjct: 600 EYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILL 659
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK M PKISDFG+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 660 DKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 719
Query: 709 ETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM--LMRYINVA 765
E +SSK+N G YN+D NLLG W WK+ + ++IDP+I + ++R I +
Sbjct: 720 EIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIG 779
Query: 766 LLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT--KGINVKNSSHSNSGTSEHCSV 823
LLCVQE A DRPTMS VI M+ +E +P PK P + + + +SS S E +V
Sbjct: 780 LLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTV 839
Query: 824 NDVTVSLIYPR 834
N +TVS++ R
Sbjct: 840 NQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1728 (613.3 bits), Expect = 5.7e-178, P = 5.7e-178
Identities = 374/851 (43%), Positives = 526/851 (61%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-D 71
+I L+ V + + T + I + ++S SQ FELGFF+P S YLGI ++ IP
Sbjct: 17 IILFLAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIR 76
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGN 129
VWVANRD P+S +N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN
Sbjct: 77 TYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGN 135
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPSPGNF 188
V+RD S N +LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS G+F
Sbjct: 136 FVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDF 194
Query: 189 TYRLDIHVLPKICTFNG-SVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDECVYW 245
+ +L P+ +N S+ + SG W G F V + D++ F EN + VY
Sbjct: 195 STKLRTSGFPEFYIYNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSFT-ENNQQVVYS 252
Query: 246 YEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANT 298
Y N+ +I + L L+ +G + R W E + W +L+ P D Y CG YGYC ANT
Sbjct: 253 YRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT 311
Query: 299 ICSLDQKPMCECLEGFKL--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDV 356
P+C C++GF+ E + + C R L C D F+ L +++ PD +
Sbjct: 312 ------SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTET 365
Query: 357 SLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSV 413
S+++ + L++C+ CLK C+C A+AN++++ SGC++W G L D IRN+ GQ +
Sbjct: 366 SVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDL 421
Query: 414 YLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEKETENVET-YQDLL 469
Y+RV A L +K+ SF +F+ +RK +K + ++T DL+
Sbjct: 422 YVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRK--QKRSITIQTPIVDLV 479
Query: 470 -AFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
+ D MN + + + + D + LPL ++ AT NFS KLG+GGFG
Sbjct: 480 RSQDSLMNELVKASRSYTSKENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGI 536
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI
Sbjct: 537 VYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 596
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LL
Sbjct: 597 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 656
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 657 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 716
Query: 709 ETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPV---IMQDEISLPMLMRYINV 764
E +S K+N G YN++ NLLG W WK+ + +++DP+ + E ++R I +
Sbjct: 717 EIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQI 776
Query: 765 ALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKG-INVKNSSHSNSGTSEHCSV 823
LLCVQE A DRP MS V+ M+ +E +P PK P F G +++ S S++ + C+V
Sbjct: 777 GLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTV 836
Query: 824 NDVTVSLIYPR 834
N VT+S+I R
Sbjct: 837 NQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1708 (606.3 bits), Expect = 7.5e-176, P = 7.5e-176
Identities = 371/852 (43%), Positives = 525/852 (61%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
IF LI L+ VS + T + I + ++S SQ FELGFF+P S YLGI ++
Sbjct: 13 IFLILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKI 72
Query: 69 IP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLR 125
IP VWVANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L
Sbjct: 73 IPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELL 131
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D+GN ++RD+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS
Sbjct: 132 DNGNFLLRDSNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSS 186
Query: 186 GNFTYRLDIHVLPK--ICTFNGSVKFTCSGHWDGAGF--VSALSYTDFLYKQFMMENKDE 241
G F+ +L+ P+ IC+ S+ + SG W+G F V D++ F +K+E
Sbjct: 187 GEFSTKLETSEFPEFYICS-KESILYR-SGPWNGMRFSSVPGTIQVDYMVYNFTA-SKEE 243
Query: 242 CVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC 300
Y Y N+ ++ + L LN +G + R W E + W +L+ P C Y CG C
Sbjct: 244 VTYSYRI-NKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYC 302
Query: 301 SLDQKPMCECLEGFK-LESQV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVS 357
+ P C C++GFK + Q + G C R L C D F L +K PD
Sbjct: 303 DSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATI 362
Query: 358 LNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLR 416
+++ + L+ CK CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R
Sbjct: 363 VDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVR 420
Query: 417 VPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRRKCQEK---ETENVETY--QDL 468
+ A++L +K+ SF +F+ +RK + +T NV+ QD
Sbjct: 421 LAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDS 480
Query: 469 LAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGP 528
L D+ + +R G + + K + + LPL L ++ AT NFS KLG+GGFG
Sbjct: 481 LINDV---VVSRR---GYTSKEKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGI 532
Query: 529 VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588
VYKGRLL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI
Sbjct: 533 VYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 592
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LL
Sbjct: 593 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 652
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
DK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+L
Sbjct: 653 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 712
Query: 709 ETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS--LPM--LMRYIN 763
E +S K+N G YN++ NLLG W WK+ +++DP+ + D +S P ++R I
Sbjct: 713 EIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINI-DSLSSKFPTHEILRCIQ 771
Query: 764 VALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGIN-VKNSSHSNSGTSEHCS 822
+ LLCVQE A DRP MS V+ M+ +E +P PK P F G + ++ S S++ + C+
Sbjct: 772 IGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECT 831
Query: 823 VNDVTVSLIYPR 834
VN +T+S+I R
Sbjct: 832 VNQITLSVIDAR 843
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 945 (337.7 bits), Expect = 2.9e-172, Sum P(2) = 2.9e-172
Identities = 195/373 (52%), Positives = 258/373 (69%)
Query: 463 ETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLG 522
E QDL + I T E + K + +D LP L +++ AT FS KLG
Sbjct: 414 ENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472
Query: 523 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582
+GGFGPVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532
Query: 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642
E++LI EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592
Query: 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFS 702
ASN+LLD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFS
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFS 652
Query: 703 FGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 761
FG+L+LE +S ++N G N + NLLGHAW + +D+ +++ID + + + ++R
Sbjct: 653 FGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRV 712
Query: 762 INVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHC 821
I++ LLCVQ++ DRP MS V+ M+++E L L P++P F N+ S + S E
Sbjct: 713 IHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLL-DPRQPGFFNERNLLFSD-TVSINLEIP 770
Query: 822 SVNDVTVSLIYPR 834
S N T+S+I PR
Sbjct: 771 SNNFQTMSVIDPR 783
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1591 (565.1 bits), Expect = 1.9e-163, P = 1.9e-163
Identities = 358/860 (41%), Positives = 529/860 (61%)
Query: 8 NIFCSL-IFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLG 63
+++ SL ++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LG
Sbjct: 8 SLYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 64 IRFQQIPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEV---KN 119
I + I D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
V + D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS
Sbjct: 128 RVVSIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 180 ADDPSPGNFTYRLDIHVLPKICTFNGS-VKFTCSGHWDGAGF--VSALSY-TDFLYKQFM 235
DPSPGN++ +D P+I + G+ + SG W+ A F + +S T++LY +
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 236 MENKDEC--VYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 292
DE VY+ + PS++ K+ +G WNE KW + S PD C +Y
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 293 YCGANTICSLD-QKPMCECLEGFKLESQVN-QPG-----PIKCERSHSLECKSGDQFIEL 345
CG IC + +C C+ G++ S N G P+KCER+ S+ D+F+ L
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTL 360
Query: 346 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPI 405
+K PDF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++
Sbjct: 361 KSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ-- 414
Query: 406 RNFTGQSVYLRVPASKLG-NKKXXXXXXXXXXXXXXXXSFY--VFYRRRRKCQEKET--- 459
G S+++R+ S++G N+K + + +R +RK
Sbjct: 415 FEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCG 474
Query: 460 ENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQ 518
+N +T ++ D+ + T + G + + K+ + S LP+FSL +I AT +F +
Sbjct: 475 KNTDT--SVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
E EK+L+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RDLK SN+LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 699 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPML 758
DV+SFG+L+LE +S K+NT + +++ +L+G+AW L+ R +L+DP I + S
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREA 771
Query: 759 MRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSG-- 816
+R I+VA+LCVQ++AA+RP M+ V+ M+ ++ L +P++P FT +NS N
Sbjct: 772 LRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTS--TRRNSIDVNFALD 829
Query: 817 TSEH--CSVNDVTVSLIYPR 834
+S+ S N++T +++ R
Sbjct: 830 SSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1568 (557.0 bits), Expect = 5.1e-161, P = 5.1e-161
Identities = 349/836 (41%), Positives = 498/836 (59%)
Query: 8 NIFCSLIFLLSMKVSLAAD--TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS---RYL 62
++F +FL+S +S+A D +TP F++DG+ L S Q F+LGFFS + + R+L
Sbjct: 6 SLFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFL 65
Query: 63 GIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWS-----TNVSSEV 117
G+ + + P AVVWVANR+ P+ + L +S+ G+L L + + +WS T S
Sbjct: 66 GLWYME-PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTA 124
Query: 118 KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSW 177
NP+ ++ GNL+ S + E+ LWQSFDYP +T+L MKLG +FK ++E LSSW
Sbjct: 125 NNPLLKISCSGNLI-----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSW 179
Query: 178 RSADDPSPGNFTYRLDIHVLPK-ICTFNGSVKFTCS-GHWDGAGFVSA--LSYTDFLYKQ 233
++ DPSPG+FT LD LP+ I NG ++ G W+G F A + + L+
Sbjct: 180 KTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDY 239
Query: 234 FMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGY 293
+ E Y + +R + L LN +G + R I ++ N+W + P+ C Y
Sbjct: 240 KFTSSAQEVNYSWTPRHR-IVSRLVLNNTGKLHRFIQSKQ-NQWILANTAPEDECDYYSI 297
Query: 294 CGANTICSLDQK--PMCECLEGFKLES--QVN-QPGPIKCERSHSLECKSGDQFIELDEI 348
CGA +C ++ K P C CL+GFK +S + N G C C+ D F++ +
Sbjct: 298 CGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGL 357
Query: 349 KAPD--FIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPI 405
K PD + M LE CK +C NCSC AYAN++++E GCL+W+GDL+D R
Sbjct: 358 KLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-Y 416
Query: 406 RNFTGQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETENVETY 465
+F GQ VY+R+ +K+ K V + C K+ ++ Y
Sbjct: 417 SSF-GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFA----CFRKKI--MKRY 469
Query: 466 QDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGG 525
+ GE G ++ +D LP+F +I+ AT++FS LG GG
Sbjct: 470 R------------------GENFRKGIEE-EDLDLPIFDRKTISIATDDFSYVNFLGRGG 510
Query: 526 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585
FGPVYKG+L +GQE+AVKRLS SGQG++EFKNE+ LIAKLQHRNLVRLLGCC++ E +
Sbjct: 511 FGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECM 570
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI EYMPNKSL+ F+FD + L+W+ R+ II G+A+G+LYLHQ SR RIIHRDLKA N
Sbjct: 571 LIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGN 630
Query: 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
+LLD DMNPKISDFGLA+ FGGD+ + +T ++VGTYGYM PEYA+DG FS+KSDVFSFG+
Sbjct: 631 VLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGV 690
Query: 706 LMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINV 764
L+LE ++ K N G +AD NLLGH W +W +DR ++ + +++ +P ++R I+V
Sbjct: 691 LVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHV 750
Query: 765 ALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEH 820
ALLCVQ+ DRPTM+ V+ M ++ +LP P +P F NV + S S S S++
Sbjct: 751 ALLCVQQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNRNVPDISSSLSLRSQN 805
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1494 (531.0 bits), Expect = 3.6e-153, P = 3.6e-153
Identities = 342/844 (40%), Positives = 483/844 (57%)
Query: 13 LIF-LLSMKVSLA-ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI- 69
LIF L VS + +++ T IR+G+ L+S + FELGFF+P S RY+GI ++ I
Sbjct: 15 LIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIE 74
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
P VVWVANR++P+ D+ L I+++GNLV++N N TIWSTNV E N VA L G+
Sbjct: 75 PQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGD 134
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFT 189
LV+ +S + W+SF+ PTDT L M++ + R W+S DPSPG ++
Sbjct: 135 LVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYS 191
Query: 190 YRLDIHVLPKICTFNGSVKFTCSGHWDGA---GFVSALSYTDFLY--KQFMMENKDECVY 244
+D +I + G + SG W+ A G L +T+++Y K ++D VY
Sbjct: 192 MGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVY 251
Query: 245 W-YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
+ Y A + + + P G + WN++ W+ L P C KY CG ++C D
Sbjct: 252 FTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCD-D 310
Query: 304 QKPM----CECLEGFKLESQV---NQPGPIKCERSHSLECKSG------DQFIELDEIKA 350
K C C++GF+ Q N+ C+R L C D F L IK
Sbjct: 311 SKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKV 370
Query: 351 PDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTG 410
PDF V L+ N E CK C ++CSC+AYA + GC++W DLID R G
Sbjct: 371 PDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERG--G 423
Query: 411 QSVYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETENVETYQDLLA 470
S+ +R+ SKLG K + K ++ + +D+
Sbjct: 424 NSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITV 483
Query: 471 FDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVY 530
DI N ++ GD D + D LP+FS S+ +AT +F+ + KLG+GGFG VY
Sbjct: 484 SDIIENRDYSSSPIKVLVGDQVD-TPD--LPIFSFDSVASATGDFAEENKLGQGGFGTVY 540
Query: 531 KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590
KG G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCC+E EK+L+ EY
Sbjct: 541 KGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEY 600
Query: 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650
MPNKSL+ FLFD +K+ L+W+ R +I GIA+GLLYLH+ SR +IIHRDLKASNILLD
Sbjct: 601 MPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDT 660
Query: 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
+MNPKISDFG+AR+F + NT ++VGTYGYM+PEYA++G+FS KSDV+SFG+L+LE
Sbjct: 661 EMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEI 720
Query: 711 LSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQ 770
+S +KN D +L+G+AW LW + ++IDP++ +D + MR I+V +LC Q
Sbjct: 721 VSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIV-KDTRDVTEAMRCIHVGMLCTQ 779
Query: 771 ENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSL 830
++ RP M V+ M+ ++ LP P++P F +N N + SVNDVT +
Sbjct: 780 DSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLN-SGDIELNFDGHDVASVNDVTFTT 838
Query: 831 IYPR 834
I R
Sbjct: 839 IVGR 842
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 1.2e-149, Sum P(2) = 1.2e-149
Identities = 176/336 (52%), Positives = 237/336 (70%)
Query: 500 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 559
L F + +I AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
++LI+KLQHRNLVR+LGCC+E+ EK+LI E+M NKSL+ FLFDS K+ ++W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
GIA+GLLYLH SR R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT+++VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHAWDLWKDD 738
T GYMSPEYA G+FS KSD++SFG+LMLE +S +K + Y + L+ +AW+ W +
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715
Query: 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKE 798
R DL+D + D + R I + LLCVQ ADRP ++++M+ +LPSPK+
Sbjct: 716 RGIDLLDQDLA-DSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQ 773
Query: 799 PAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
P F ++ S +++ +VN +T S+I R
Sbjct: 774 PTFAF-----HTRDDESLSNDLITVNGMTQSVILGR 804
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1412 (502.1 bits), Expect = 1.7e-144, P = 1.7e-144
Identities = 350/852 (41%), Positives = 495/852 (58%)
Query: 26 DTVTPASFIRDGEKLVSSSQR-FELGFFSPG-KSKSR-YLGIRFQQI-PDAVVWVANRDR 81
DT+ + LVSS + FE GFF+P K SR YLGI + I P VVWVANR
Sbjct: 26 DTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSRQYLGIWYHSISPRTVVWVANRVA 85
Query: 82 PISDNNAVLTISNNGNLVLLNQT--NGT-----IWSTNVSSEVKNP----VAQLRDDGNL 130
P + + LT++ G+L +L+ T NGT +WS+N +S P A L+D G+L
Sbjct: 86 PATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSSNTTSRA-GPRGGYSAVLQDTGSL 144
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNR--LERYL-SSWRSADDPSPGN 187
+R + LW SF +PTDT+L M++ R ER L +SW S DPSPG
Sbjct: 145 EVRSE------DGVLWDSFWHPTDTILSGMRITLQAPGRGPKERMLFTSWASETDPSPGR 198
Query: 188 FTYRLDIHVLPKICTF-NGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECV--- 243
+ LD + + +G+V + SG W+G F+ + + LY+ D +
Sbjct: 199 YALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIG-IPWRP-LYRSGFTPAIDPVLGNY 256
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC--S 301
Y Y A N S+ + P+G + ++S W+ ++ P C Y CG N C S
Sbjct: 257 YTYTATNT-SLQRFVVLPNGTDICYMVRKSSQDWELVWYQPSNECEYYATCGPNAKCTAS 315
Query: 302 LDQKPMCECLEGF--KLESQVNQPGPIK-CERSHSLECK---SGDQFIELDEIKAPDFID 355
D K C CL+GF KL+ Q N + C RS L C+ SGD F+ + IK PDF
Sbjct: 316 QDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWPDF-S 374
Query: 356 VSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ-SVY 414
++ + C+ CL NCSC AY + ++GCL W +LID ++ TG ++
Sbjct: 375 YWVSTVGDEPGCRTVCLNNCSCGAYVYT---ATTGCLAWGNELIDMHE-LQ--TGAYTLN 428
Query: 415 LRVPASKL-GNKKX--XXXXXXXXXXXXXXXSFYVFYRRRRKCQE-------KETENVET 464
L++PAS+L G+ ++++ R ++ + ++
Sbjct: 429 LKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRSRHSSTQS 488
Query: 465 YQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEG 524
Q+ DI+ +I R ++ E DGK L ++SL I AT NFS KLGEG
Sbjct: 489 QQNSAMLDISQSI--RFDDDVE---DGKSHE----LKVYSLDRIRTATSNFSDSNKLGEG 539
Query: 525 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584
GFGPVY G L G+EVAVKRL SGQGL+EFKNE++LIAKLQHRNLVRLLGCC+ + EK
Sbjct: 540 GFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEK 599
Query: 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
IL+ EYMPNKSL+ FLF+ K+RLL+W+ R IIEGIA+GLLYLH+ SR R++HRDLKAS
Sbjct: 600 ILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKAS 659
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
NILLD DM PKISDFG+ARMFGGD+ Q NT ++VGT+GYMSPEYA++G+FS+KSDV+ FG
Sbjct: 660 NILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFG 719
Query: 705 ILMLETLSSKKNTGVY-NADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYIN 763
+L+LE ++ K+ + + DS N+ G+AW W +D +LIDPVI + S+ ++R I+
Sbjct: 720 VLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVI-RASCSVRQVLRCIH 778
Query: 764 VALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT-KGINVKNSSHSNSGTSEHCS 822
+ALLCVQ++A +RP + VI M++N+ +LP+P+ P +G +++S S S H S
Sbjct: 779 IALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRS-H-S 836
Query: 823 VNDVTVSLIYPR 834
+ VT++ ++ R
Sbjct: 837 IGTVTMTQLHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 7.5e-144, P = 7.5e-144
Identities = 332/856 (38%), Positives = 480/856 (56%)
Query: 6 CLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIR 65
CL I + S+++ LA D +T +S RD E +VS+ F GFFSP S RY GI
Sbjct: 3 CLLILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIW 62
Query: 66 FQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVK-NPV-A 122
F IP VVWVAN + PI+D++ +++IS GNLV+++ WSTNV V N A
Sbjct: 63 FNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYA 122
Query: 123 QLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADD 182
+L + GNLV+ + N + LW+SF++P + L M L D K L SW+S D
Sbjct: 123 RLLNTGNLVLLGTT--NTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFD 180
Query: 183 PSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSA--LSYTDFLYKQFMMENKD 240
PSPG ++ L P++ + + SG W+G F+ + Y L++ + +
Sbjct: 181 PSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNR 240
Query: 241 ECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC 300
V A N + L+ G V ++ WN +W VP C Y CG C
Sbjct: 241 GSVSMSYAGNT-LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASC 299
Query: 301 SLD--QKPMCECLEGFKLESQVN-----------QPGPIKCE-RSHSLECKSGDQFIELD 346
+ P C C+ GFK +S + P++CE R ++ + D F+ +
Sbjct: 300 RFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQ 359
Query: 347 EIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIR 406
++K P S N + C CLKNCSC AY+ GCL+W G+L+D ++
Sbjct: 360 KMKVPHNPQRS---GANEQDCPESCLKNCSCTAYS---FDRGIGCLLWSGNLMD----MQ 409
Query: 407 NFTGQSV--YLRVPAS---KLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETEN 461
F+G V Y+R+ S K N+ + + + K +EK
Sbjct: 410 EFSGTGVVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNT 469
Query: 462 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 521
+ + A N N+Y K K+ LPLF + AT NFS+ KL
Sbjct: 470 RLLNERMEALSSNDVGAILVNQY---------KLKE--LPLFEFQVLAVATNNFSITNKL 518
Query: 522 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581
G+GGFG VYKGRL G ++AVKRLS SGQG++EF NE+++I+KLQHRNLVRLLG C+E
Sbjct: 519 GQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEG 578
Query: 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641
E++L+ E+MP L+ +LFD K+RLL+W+ R II+GI +GL+YLH+ SR +IIHRDL
Sbjct: 579 EERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDL 638
Query: 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVF 701
KASNILLD+++NPKISDFGLAR+F G+E + +T ++VGTYGYM+PEYA+ GLFS KSDVF
Sbjct: 639 KASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVF 698
Query: 702 SFGILMLETLSSKKNTGVYN-ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMR 760
S G+++LE +S ++N+ YN + NL +AW LW L+DPVI + E + R
Sbjct: 699 SLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFE-ECFENEIRR 757
Query: 761 YINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSH-SNSGTSE 819
++V LLCVQ++A DRP+++ VI M+++E+ NLP PK+PAF I + +S +SG S+
Sbjct: 758 CVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAF---IPRRGTSEVESSGQSD 814
Query: 820 -HCSVNDVTVSLIYPR 834
S+N+V+++ I R
Sbjct: 815 PRASINNVSLTKITGR 830
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4481 | 0.9580 | 0.94 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00027534001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (814 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 834 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-40 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-40 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 9e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PTZ00163 | 230 | PTZ00163, PTZ00163, hypothetical protein; Provisio | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 5e-56
Identities = 100/281 (35%), Positives = 144/281 (51%), Gaps = 35/281 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 574
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LG C E+ L+LEYM L +L F S +K L+ + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYGYMSPE 687
S+ + +HRDL A N L+ +D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
DG+F+ KSDV+SFG+L+ E TL + G+ N + L +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLP--K 228
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
P DE+ Y + L C Q + DRPT S+++ +
Sbjct: 229 PEYCPDEL-------Y-ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 96/281 (34%), Positives = 143/281 (50%), Gaps = 34/281 (12%)
Query: 516 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LLG C E+ ++++EYMP L +L + + L+ + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 687
S+ IHRDL A N L+ +++ KISDFGL+R D+ K +M+PE
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK---LPIRWMAPE 174
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
+G F+ KSDV+SFG+L+ E TL + G+ NA+ L + L K
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--------- 225
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
P E+ + L C E+ DRPT S+++ ++
Sbjct: 226 PPNCPPEL--------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 92/281 (32%), Positives = 141/281 (50%), Gaps = 35/281 (12%)
Query: 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LLG C E+ +++EYM L +L + L+ + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 687
IHRDL A N L+ +++ KISDFGL+R D+ + K +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK---LPIRWMAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
+G F+ KSDV+SFG+L+ E TL + G+ N + L + + L +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--------- 224
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
P E+ ++ L C E+ DRPT S+++ ++
Sbjct: 225 PPNCPPEL--------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 92/289 (31%), Positives = 138/289 (47%), Gaps = 48/289 (16%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 568
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
N+VRLLG C + ++ EYMP L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---YMS 685
S+ +HRDL A N L+ +++ KISDFGL+R D+ ++ G +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLI 744
PE DG F+ KSDV+SFG+L+ E + LG + ++ V +L+
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELL 217
Query: 745 D-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ P DE+ LM L C + DRPT S+++ +
Sbjct: 218 EDGYRLPRPENCPDELY--ELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 77/193 (39%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
++ L++EY SL L ++ K L+ +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 639 RDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSI 696
RDLK NILLD D K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 697 KSDVFSFGILMLE 709
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 71/199 (35%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
++ L++EY L +L ++ L+ +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS 695
IHRDLK NILLD++ KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 696 IKSDVFSFGILMLETLSSK 714
K DV+S G+++ E L+ K
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 572
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ + L++EY L L + RL +AR + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHSK- 116
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
I+HRDLK NILLD+D + K++DFGLAR E VGT YM+PE L
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 693 LFSIKSDVFSFGILMLE 709
+ D++S G+++ E
Sbjct: 172 GYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 576 GCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
G ++ + L LEY+ SL+ L +L R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLH---S 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
I+HRD+K +NIL+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 694 FSIKSDVFSFGILMLETLSSK 714
+ +D++S G ++E + K
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 53/115 (46%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
VVWVANR P++D++ L + ++GNLVL + +WS+N S + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
LV+ DNS LWQSFD+PTDTLL K G + R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 50/119 (42%), Positives = 69/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ G+ LVSS FELGFF Y I ++ VVWVANRD P S ++ LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152
++GNLV+ + + +WS+N + N V L DDGNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 570
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 628
+V+ +G +ILEY N SL K+ + + + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR-----QIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H+ +IHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+L C + E I I+ EYM SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE-- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
IHRDL A NIL+ +++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 83/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 LLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
G C + G + LI+EY+P+ SL +L + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-LLFSSQICKGMDYLGSQ 128
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYA 689
R IHRDL A NIL++ + KISDFGLA++ D + Y +PE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
FS SDV+SFG+ + E + + A+ ++G A R+ +L +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL-----L 239
Query: 750 QDEISLP----------MLMRYINVALLCVQENAADRPTMSDVISMINNEH 790
++ LP LM+ LC + DRP+ +D+I +++
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK------LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 66/191 (34%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+++ E +++E+ SL L ST + L Q + + + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSN---GIIH 121
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+KA+NILL D K+ DFGL+ +VGT +M+PE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 699 DVFSFGILMLE 709
D++S GI +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 51/120 (42%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLT 91
+ + G+ LVS + FELGFF+ Y I ++ VVWVANRD P+SD+ LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSDS-CTLT 59
Query: 92 ISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
+ ++GNLVL + +WS+N + N V L DDGNLVI D+ ++LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 625
L C +I E M SL FL + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
YL + IHRDL A NIL+ +D+ K++DFGLAR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE A G FS KSDV+SFGIL+ E +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 570
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 628
+V+ G ++GE ++LEYM SL L K++ V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
+S +D++S G+ +LE G + F G + +L+ +
Sbjct: 172 IQGESYSYAADIWSLGLTLLECA-----LGKF---PFLPPGQP-SFF------ELMQAIC 216
Query: 749 MQDEISLP------MLMRYINVALLCVQENAADRPT 778
SLP +I+ C+Q++ RP+
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 77/215 (35%), Positives = 112/215 (52%), Gaps = 29/215 (13%)
Query: 521 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIEG 620
LLG C ++ ++ EY+ + L+ FL D T K L+ + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 677
IA G+ YL S +HRDL A N L+ + + KISDFGL+R ++ D +Q +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 4e-31
Identities = 82/314 (26%), Positives = 133/314 (42%), Gaps = 21/314 (6%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 569
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+L ++G L++EY+ SL L +K L+ + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 630 QYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGD----ELQGNTKQIVGTYGYM 684
IIHRD+K NILLD+D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 685 SPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741
+PE L S SD++S GI + E L+ + + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTP 233
Query: 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAF 801
L P + + ++ + ++ +R + S +S HL L
Sbjct: 234 SLASP--LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 802 TKGINVKNSSHSNS 815
K + S
Sbjct: 292 LKPDDSAPLRLSLP 305
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ E +++EYM SL + R+ Q + + QGL YLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQI-AYVCREVLQGLEYLHS---QNV 137
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
IHRD+K+ NILL KD + K++DFG A + + +VGT +M+PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 697 KSDVFSFGILMLE 709
K D++S GI+ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 86/282 (30%), Positives = 122/282 (43%), Gaps = 44/282 (15%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
G C + +L++E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARM--FGGDELQGNT--KQIVGTYGYMSPEY 688
F +HRDL A N+LL KISDFG++R G D + T + + Y +PE
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
G FS KSDV+S+G+ + E S +K + A+ +L L + + I
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS 229
Query: 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
IM C + DRPT S++ S
Sbjct: 230 -IMLS----------------CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580
+G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640
++ EYM SL +L S + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 641 LKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDGLFSIKS 698
L A N+L+ +D+ K+SDFGLA+ + + Q G + +PE + FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 699 DVFSFGILMLETLS 712
DV+SFGIL+ E S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 83/280 (29%), Positives = 139/280 (49%), Gaps = 41/280 (14%)
Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLH 629
LG C+ ++ LI + MP L ++ + + LLNW IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ R++HRDL A N+L+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 690 LDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
L +++ KSDV+S+G+ + E T +K G+ + +LL K +R L P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGER---LPQPP 234
Query: 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
I I + M++ + C +A RPT ++I+ +
Sbjct: 235 IC--TIDVYMVL------VKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 77/210 (36%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 521 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 572
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYL 628
+LLG C+ + +I+E M L +L D+ +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 629 HQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYG 682
Q IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 70/284 (24%), Positives = 131/284 (46%), Gaps = 51/284 (17%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKR--------LLNW--QARVRIIEGIAQGLL 626
E+G+ +++EY L+ KK +L+W Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS-QKIKKQKKEGKPFPEEQILDWFVQ--------LCLALK 117
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
E + ++ KSD++S G ++ E + K + ++ L
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH---PFEGENLLELALK--------------- 214
Query: 747 VIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVISMI 786
I++ + P+ +Y N+ +Q++ +RP+++ ++
Sbjct: 215 -ILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
+ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 577 CCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C E I I+ E M SL +L R L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDG 692
IHRDL A N+L+ ++ K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 573
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQARVRIIEGI 621
G C E I++ EYM + LN FL DS L ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQIV 678
A G++YL + +HRDL N L+ D+ KI DFG++R ++ D + G+T +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 ---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
V++ +++E +P SL FL KK L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSI 696
RDL A N L+ ++ KISDFG++R G + KQI + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 697 KSDVFSFGILMLETLS 712
+SDV+S+GIL+ ET S
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 41/279 (14%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LGEG FG V +G+L + +VAVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 575 LGCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGL 625
+G C E ++IL +M + L+ FL S L Q ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNTKQIVGTYGY 683
YL S IHRDL A N +L +DM ++DFGL++ ++ GD QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVH 741
++ E D +++ KSDV++FG+ M E + + GV N + ++ L H +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG---------N 232
Query: 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS 780
L P DE+ M C + + DRPT +
Sbjct: 233 RLKQPEDCLDELYDLMYS--------CWRADPKDRPTFT 263
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 86/274 (31%), Positives = 136/274 (49%), Gaps = 27/274 (9%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLL 575
+G G FG V +GRL L G++ VA+K L S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
G V + ++I+ EYM N SL+ FL ++ K V ++ GIA G+ YL S
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
+HRDL A NIL++ ++ K+SDFGL+R E TK + +PE F
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 695 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754
+ SDV+SFGI+M E +S Y + WD+ D + + D + +
Sbjct: 186 TSASDVWSFGIVMWEVMS-------YGERPY------WDMSNQDVIKAVEDGYRLPPPMD 232
Query: 755 LPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
P + + L C Q++ +RPT S ++S ++
Sbjct: 233 CPSALYQL--MLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+ G + + +++EY S++ + T K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSN 118
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ IHRD+KA NILL+++ K++DFG++ ++GT +M+PE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 692 GLFSIKSDVFSFGILMLE 709
++ K+D++S GI +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---LNWQARVRIIEGIAQGLLY 627
++R +++G+ +++EY N L+ L + L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
D ++ KSDV++ G+++ E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 54/299 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 565
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYM-------------PNKSLNVFLFDSTKKRLLNWQ 612
++VRLLG ++++E M P N L T ++ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ 671
A IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLG 729
K ++ +M+PE DG+F+ KSDV+SFG+++ E TL+ + G+ N + +
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
Query: 730 HAWDLWKDDRVHDLID--PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
D DL + P + + LMR +C Q N RPT +++S +
Sbjct: 236 -------DGGHLDLPENCPDKLLE------LMR------MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
RL V E I I+ EYM N SL FL +L + + IA+G+ ++
Sbjct: 65 RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R IHRDL+A+NIL+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 70/245 (28%), Positives = 116/245 (47%), Gaps = 35/245 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
E+ L+ E+M + L+ +L ++ + + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLFSI 696
DL A N L+ ++ K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 697 KSDVFSFGILMLETLSSKK---------------NTG-------VYNADSFNLLGHAWDL 734
KSDV+SFG+LM E S K N G + + + L+ H W
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE 240
Query: 735 WKDDR 739
+DR
Sbjct: 241 RPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 568
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 569 RNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
N+VRL +G ++ EYM + L L DS + + Q + ++ + +GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH I+HRD+K SNIL++ D K++DFGLAR + T +++ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 687 EYAL-DGLFSIKSDVFSFGILMLETLSSK 714
E L + + D++S G ++ E K
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 521 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------------------LNWQAR 614
LLG C L+ EYM LN FL + + L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGN 673
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 563
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIE 619
+K H+N+VRL+G E+ + ++LE M L FL ++ + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLAR-MFGGDELQGNTK 675
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ +M PE LDG+F+ K+DV+SFG+L+ E S
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 79/270 (29%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640
Q ++ EYM N L +L +K L + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 641 LKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKS 698
L A N L+ +D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 699 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPML 758
DV+SFG+LM E S K ++ + + V ++ V + P L
Sbjct: 183 DVWSFGVLMWEVFSEGKM--------------PYERFSNSEV---VESVSAGYRLYRPKL 225
Query: 759 --MRYINVALLCVQENAADRPTMSDVISMI 786
+ C E DRP ++S +
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 45/288 (15%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 573
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 627
LLG C E +ILEY L FL + K L+ + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWK-----DDRV 740
+ FS KSDV+SFG+LM E + + G+ + + N L R+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ +M C N DRP+ S+++S +
Sbjct: 249 YK-----LMTR----------------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
+ +H+N++ LLG C ++G +++EY + +L FL R E
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 621 ---------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671
+A+G+ +L + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL- 728
T +M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248
Query: 729 -GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783
G+ + P E+ LMR C E + RPT ++
Sbjct: 249 EGYRME-----------KPQNCTQELY--HLMRD------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 572
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIE 619
LLG ++ +I Y + L+ FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQ 676
IA G+ +L S ++H+DL N+L+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 570
E +LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 571 LVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIA 622
+V+ G ++ + +EY SL DS K++ R+ +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YM+PE +SI SDV+S G+ +LE
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 77/205 (37%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 517 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 571 LVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+ GCC EQG K LI+EY+P SL +L K LN + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPE 687
H IHRDL A N+LLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 78/282 (27%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 516 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
LG C + +I E+M +L +L + ++ +N + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDG 692
IHRDL A N L+ ++ K++DFGL+R+ GD T + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 693 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDD----RVHDLIDP 746
FSIKSDV++FG+L+ E T G+ + + LL + + + + +V++
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE---- 236
Query: 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
LMR C Q N +DRP+ +++
Sbjct: 237 -----------LMRA------CWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 576
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ EK+ L+LEY P L F S + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---G 113
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
II+RDLK NILLD D + K++DFGLA+ + + T GT Y++PE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYG 171
Query: 696 IKSDVFSFGILMLETLS 712
D +S G+L+ E L+
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 72/194 (37%), Positives = 108/194 (55%), Gaps = 15/194 (7%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ G I ++E M +L FL + + L++ ++ +A+G+ YL +++H
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RDL A NIL+ +D K+SDFGLAR+ G N+K V + +PE FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKS 178
Query: 699 DVFSFGILMLETLS 712
DV+S+G+L+ E S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 88/281 (31%), Positives = 137/281 (48%), Gaps = 31/281 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ +I EYM SL FL ++L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEYA 689
R IHRDL+A+N+L+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAI 176
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
G F+IKSDV+SFGIL+ E ++ K G+ N+D + L + + + + P
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC-----PD 231
Query: 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ D + C +E A +RPT + S++++
Sbjct: 232 ELYD------------IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 79/206 (38%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 573 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+L E E I I+ EYM SL FL K L V + IA G+ Y+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E QG I T +PE
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
AL G F+IKSDV+SFGIL+ E L++K
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+L E+ I + EYM SL FL D + R L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPE 687
R IHRDL+++NIL+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 102/321 (31%), Positives = 149/321 (46%), Gaps = 56/321 (17%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 563
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLL 609
+ +H+N++ LLG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+++ V +A+G+ YL SR R IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 727
T +M+PE D +++ +SDV+SFGILM E TL G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 728 L--GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT------- 778
L GH D + H+L MLMR C RPT
Sbjct: 249 LREGHRMDK-PSNCTHELY------------MLMRE------CWHAVPTQRPTFKQLVEA 289
Query: 779 MSDVISMINNEHLNLPSPKEP 799
+ V++ ++ E+L+L P E
Sbjct: 290 LDKVLAAVSEEYLDLSMPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 35/267 (13%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
LG E+ + LE +P SL L + S + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD- 691
R +HRD+K +NIL+D + K++DFG+A+ K G+ +M+PE
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
G + + +D++S G +LE + K + ++K R +L P I D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--------VFKIGRSKEL--PPI-PD 225
Query: 752 EISLPMLMRYINVALLCVQENAADRPT 778
+S +I L C+Q + + RPT
Sbjct: 226 HLS-DEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 39/217 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQ 567
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEGI 621
H N++ LL + L+ E+M K ++ L + K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYM-LM--------T 111
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG--GDELQGNTKQIVG 679
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG ++ T Q+V
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV- 164
Query: 680 TYGYMSPEYALDGLFSIKS-----DVFSFGILMLETL 711
T Y +PE LF + D++S G + E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 79/297 (26%), Positives = 141/297 (47%), Gaps = 51/297 (17%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 573
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LG E L +E+M S++ L + + K+ ++ E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122
Query: 632 SRFRIIHRDLKASNILLDKD-MNPKISDFGLA-----RMFGGDELQGNTKQIVGTYGYMS 685
+IIHRD+K +N+L+D +I+DFG A + G E QG Q++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
PE + DV+S G +++E ++K +NA+ H ++K +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAE--KHSNHLALIFK---IASATT 228
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 802
+ + +S P L +V L C++ DRP +++ K P F
Sbjct: 229 APSIPEHLS-PGLR---DVTLRCLELQPEDRPPSRELL-------------KHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 635
+G+ L+ E+M +++ ++R L ++ ++ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 694
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 695 SIKSDVFSFGILMLETLS 712
S D++S G + E LS
Sbjct: 177 STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ V E L++ Y+ SL + S + L+ +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 688
+ IHRD+KA NILL +D + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 689 ALDGL-FSIKSDVFSFGILMLE 709
+ K+D++SFGI +E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-24
Identities = 27/65 (41%), Positives = 43/65 (66%)
Query: 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWY 395
C GD F+ L +K PD +++ + L++C+ CL NCSC AYA ++++ SGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 396 GDLID 400
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)
Query: 521 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 576 GCCVEQGEK--ILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 627
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-----IVGTYG 682
L R +HRDL NIL++ + KI DFGL ++ D+ ++ I
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKN 716
+ +PE + FS+ SDV+SFG+++ E + S K+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 561
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 613
++++L N+ RLLG C +I+EYM N LN FL + + L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
QG +M+ E L G F+ KSDV++FG+ + E L+
Sbjct: 189 QGRA---PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 571
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V L E+ I + E+M SL FL + K L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 688
R IHRDL+A+NIL+ ++ KI+DFGLAR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
AL G F+IKSDV+SFGIL+ E ++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
GC + + +EYMP S+ L L R + I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---SN 123
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYALDGL 693
I+HRD+K +NIL D N K+ DFG ++ G K + GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 694 FSIKSDVFSFGILMLETLSSK 714
+ K+DV+S G ++E L+ K
Sbjct: 184 YGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 573
+GEG F V + +E A+K L + Q +KE K E ++ +L H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
L ++ +LEY PN L ++ K L+ + I L YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---------------- 677
IIHRDLK NILLDKDM+ KI+DFG A++ + + K
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 678 --VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 84/272 (30%), Positives = 124/272 (45%), Gaps = 32/272 (11%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+LG G FG V G+ +VA+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQYSRFRII 637
+Q ++ EYM N L +L KR Q + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLF 694
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 695 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754
S KSDV++FG+LM E S K + ++ + K + L P + +++
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKM-------PYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 755 LPMLMRYINVALLCVQENAADRPTMSDVISMI 786
M C E A +RPT ++S I
Sbjct: 232 AIMYS--------CWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLL 575
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G G+ + +EYM SL+ L + R+ + +I + +GL YLH + +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL-KEVQGRI-PERILGKIAVAVLKGLTYLH--EKHK 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 696 IKSDVFSFGILMLE 709
+KSD++S G+ ++E
Sbjct: 178 VKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
E G + +E +P SL+ L N Q + + I +GL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 640 DLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSI 696
D+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 697 KSDVFSFGILMLETLSSK 714
+D++S G ++E + K
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQHRNLV 572
KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA----QGLLY 627
+LL K+ L+ EY + L +L + L+ +I+ I +GL Y
Sbjct: 62 KLLDVIH-TERKLYLVFEYC-DMDLKKYL--DKRPGPLS----PNLIKSIMYQLLRGLAY 113
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H + RI+HRDLK NIL+++D K++DFGLAR F G L+ T ++V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 688 YAL-DGLFSIKSDVFSFGILMLETLSSK 714
L +S D++S G + E ++ K
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 87/311 (27%), Positives = 148/311 (47%), Gaps = 53/311 (17%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + L+ + MP+ L ++ + + LLNW + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
F+ +SDV+S+G+ + E T K G+ + +LL ++ L P I
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---------EKGERLPQPPI 235
Query: 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN--------------NEHLNLP 794
++ + M+ C +A RP ++ + + ++ + LP
Sbjct: 236 CTIDVYMVMVK--------CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLP 287
Query: 795 SPKEPAFTKGI 805
SP + F + +
Sbjct: 288 SPNDSKFFQNL 298
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 570
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+ LG ++ + LEY+P S+ L + + ++ L+ + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IVGTYGYM 684
H +R IIHRD+K +NIL+D KISDFG+++ + L T + G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+PE ++ K+D++S G L++E L+ K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 75/245 (30%), Positives = 117/245 (47%), Gaps = 33/245 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------------------- 605
H ++++L G C + G +LI+EY SL FL +S K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+R L + I++G+ YL + +++HRDL A N+L+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNAD 723
++ + +M+ E D +++ +SDV+SFG+L+ E TL G+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 724 SFNLL 728
FNLL
Sbjct: 238 LFNLL 242
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
++ +++E +P FL KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 640 DLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
DL A N L+ ++ KISDFG++R G KQI + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 699 DVFSFGILMLETLS 712
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 73/214 (34%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLF--------------DSTKKRLLNWQARVRIIE 619
LLG ++ ++ EY+ L+ FL D T K L+ + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIV 678
IA G+ YL S F +H+DL A NIL+ + ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 563
NF ++ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIA 622
+L H N+++ L +E E ++LE L+ + K KRL+ + + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
L ++H RI+HRD+K +N+ + K+ D GL R F ++ VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YMSPE + ++ KSD++S G L+ E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 79/301 (26%), Positives = 142/301 (47%), Gaps = 36/301 (11%)
Query: 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMM 561
I + + ++ L EG FG ++ G L++ +EV VK + + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS-LNVFL-----FDSTKKRLLNWQARV 615
L+ L H+N++ +L C+E GE +L N L +FL ++ + L+ Q V
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE--LQG 672
+ IA G+ YLH+ +IH+D+ A N ++D+++ KI+D L+R +F D L
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW 732
N + V +M+ E ++ +S SDV+SFG+L+ E L + T D F + +
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEMAAYLK 233
Query: 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792
D ++ L P+ DE+ V C + +RP+ S ++ + + H
Sbjct: 234 DGYR------LAQPINCPDEL--------FAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279
Query: 793 L 793
L
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-23
Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 44/282 (15%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G + +++ EYM N SL+ FL + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 689
+HRDL A NIL++ ++ K+SDFGL+R+ D T T G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAPEAI 181
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID---- 745
F+ SDV+S+GI+M E +S Y + W++ D + + +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAIEEGYRL 228
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
P M +L LM L C Q++ +RP ++S+++
Sbjct: 229 PAPMDCPAALHQLM------LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 79/278 (28%), Positives = 116/278 (41%), Gaps = 35/278 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 629
G V +++ E P SL L L ++ + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYGYMSPEY 688
R IHRDL A NILL D KI DFGL R ++ + + + + +PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
FS SDV+ FG+ + E + Y + + L + L K D+ + ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLE--- 221
Query: 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ E NV L C N ADRPT + + +
Sbjct: 222 -RPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 81/286 (28%), Positives = 138/286 (48%), Gaps = 42/286 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR-----LLNWQARVRIIEGIAQGLLY 627
+L V + +I E+M SL FL + L+++ A+ IA+G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYM 684
+ Q + IHRDL+A+NIL+ + KI+DFGLAR+ +E +G I T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHD 742
+PE G F+IKSDV+SFGIL++E ++ + G+ N + L + + + +
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---- 226
Query: 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ P + N+ + C + +RPT + S++++
Sbjct: 227 -----------NCPEEL--YNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 83/283 (29%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ----ARVRIIEGIAQGLLYLHQY 631
G + ++I E+M N +L+ FL R + Q V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG---TYGYMSPEY 688
S +HRDL A NIL++ ++ K+SDFGL+R D +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH----DLI 744
F+ SDV+S+GI+M E +S Y + WD+ D ++ D
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WDMSNQDVINAIEQDYR 229
Query: 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
P M +L LM L C Q++ RP ++S ++
Sbjct: 230 LPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 573 RLLGCCVEQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ G ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ +HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173
Query: 692 GLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFGIL+ E S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 72/227 (31%), Positives = 128/227 (56%), Gaps = 25/227 (11%)
Query: 521 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 576 GCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLL 626
G C++ E ++IL +M + L+ FL S + L Q V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDEL-QGNTKQIVGTYGYM 684
YL S IHRDL A N +L+++MN ++DFGL+ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNT---GVYNADSFNLL 728
+ E D +++ KSDV+SFG+ M E ++++ T GV N++ ++ L
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWE-IATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 80/282 (28%), Positives = 141/282 (50%), Gaps = 44/282 (15%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G + ++I EYM N +L+ +L D + + V ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 689
+HRDL A NIL++ ++ K+SDFGL+R+ L+ + + T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID---- 745
F+ SDV+SFGI+M E +S + + WD+ + + + D
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS-------FGERPY------WDMSNHEVMKAINDGFRL 229
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
P M ++ LM L C Q++ A RP D++++++
Sbjct: 230 PAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 13/195 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
V K+ L+ E++ + L ++ DS+ L+ + + QG+ Y H + R
Sbjct: 66 V-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
++HRDLK N+L+D++ K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 695 SIKSDVFSFGILMLE 709
S D++S G + E
Sbjct: 178 STPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----------FDSTKKRLLNWQARVRI 617
H ++V+ G CVE I++ EYM + LN FL + + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G++YL + +HRDL N L+ +++ KI DFG++R ++ D + G+T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE + F+ +SDV+S G+++ E + K
Sbjct: 183 MLPI---RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 517 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
++ +LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL---------FDSTKKRL---LNWQARVRII 618
+VR G C E +++ EYM + LN FL + L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQI 677
IA G++YL + +HRDL N L+ + + KI DFG++R ++ D + + +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE L F+ +SD++SFG+++ E + K
Sbjct: 186 LPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V L + + +++E+ +L+ + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++IHRDLKA NILL D + K++DFG++ LQ +GT +M+PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ-KRDTFIGTPYWMAPEVVA 176
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 34/271 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + ++ + KK L + I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
IHRD+KA NILL + K++DFG A L VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
+ K DV+S GI +E L+ +K ++N ++ + L H + ++D P + ++
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSALYH---IAQND------SPTLSSND 238
Query: 753 ISLPMLMRYINVALLCVQENAADRPTMSDVI 783
S + N C+Q+ DRP+ +++
Sbjct: 239 WSD----YFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 520 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 574 LLGCCV-EQGEKI-LILEYMPNKSLNVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLH- 629
+ + + +++EY L + K+R + + RI+ + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 630 -QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
++HRDLK +NI LD + N K+ DFGLA++ G D K VGT YMSPE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQ 181
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ KSD++S G L+ E
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 514 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 571 LVR-----LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQG 624
++ L G + +++EY P L+ + K ++L+ Q RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L LH+ +I+HRDLK++NILL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
+PE +S KSD++S G L+ E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 83/293 (28%), Positives = 136/293 (46%), Gaps = 44/293 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EFKNEMM 561
KLGEG FG V+ ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 613
++++L+ N++RLL C+ +I EYM N LN FL + +++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL S +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 730
QG + V +MS E L G F+ SDV++FG+ + E L+ K ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 731 AWDLWKDD-RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 782
+ ++D R L P + D SL LM L C + NA +RP+ ++
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPD--SLYKLM------LSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 40/296 (13%)
Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 563
A E +M +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 564 AKLQHRNLVRLLGCCVEQGEKIL-ILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 615
+ ++VRLLG V QG+ L I+E M L +L ++ + + + +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 674
++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAW 732
K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N +
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
L K D D+ L LMR +C Q N RP+ ++IS I
Sbjct: 239 LLDKPDNCPDM-----------LFELMR------MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 48/280 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
+Q ++ E+M N L +L ++ L+ + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYALDGL 693
DL A N L+ K+SDFG+ R D + + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 694 FSIKSDVFSFGILMLETLS-------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
+S KSDV+SFG+LM E + K N V S R L P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS--------------RGFRLYRP 223
Query: 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ + M C E RPT ++++ I
Sbjct: 224 KLASMTVYEVMYS--------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 12/200 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 635
+++ LI E++ + L +L DS K V+ + I QG+L+ H R
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
++HRDLK N+L+D K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179
Query: 695 SIKSDVFSFGILMLETLSSK 714
S D++S G + E + K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIAQGLLYLH 629
LG C G + L+ + P SL + +RLLNW + IA+G+ YL
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
++ R++HR+L A NILL D +I+DFG+A + D+ + + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
L G ++ +SDV+S+G+ + E +S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 521 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 575 LGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQ 630
G C E G LI+E++P+ SL +L K +N + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT-YGYMSPEYA 689
Y +HRDL A N+L++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 41/198 (20%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 563
++ + KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 564 AKLQHRNLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
KL+H N+V L+ VE+ +K ++ YM D LL V
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----------DHDLSGLLE-NPSV 110
Query: 616 R--------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667
+ + + +G+ YLH+ I+HRD+KA+NIL+D KI+DFGLAR + G
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 668 DELQGNTKQIVGTYGYMS 685
GT Y +
Sbjct: 168 PPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 57/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKLQHRNLV 572
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+LL +L++EYMP+ L+ L D + L Q + + + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + Q V T Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 73/236 (30%), Positives = 121/236 (51%), Gaps = 30/236 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 568
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 569 RNLVRLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRL------LNWQARVR 616
N+++L+G + K ++IL +M + L+ FL S R+ L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS---RIGEEPFTLPLQTLVR 117
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNT 674
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL 728
++ +++ E D +++ SDV++FG+ M E T GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLLYLHQY 631
GC ++ EK L +EYMP S+ D K L + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYAL 690
I+HRD+K +NIL D N K+ DFG ++ + G + + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 691 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722
+ K+DV+S G ++E L+ K Y A
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 572
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
R++G C E +L++E LN FL S KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPE 687
+HRDL A N+LL KISDFGL++ G D+ + + G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR----SAGKWPLKWYAPE 168
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+GI M E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 84/300 (28%), Positives = 141/300 (47%), Gaps = 55/300 (18%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 568
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARV 615
N++ LLG C +G L +EY P+ +L FL S + L+ Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R G E+ K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179
Query: 676 QIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHA 731
+ +G +M+ E +++ SDV+S+G+L+ E +L G+ A+ + L
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 732 WDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+ L K DD V+DL M+ C +E +RP+ + ++ +N
Sbjct: 240 YRLEKPLNCDDEVYDL-----MRQ----------------CWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 570
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LL + + L+ E++ ++ L F+ D++ + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-21
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 35/271 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + ++ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
+IHRD+KA NILL + K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
+ K DV+S GI +E +++ ++N ++ + L H + P +
Sbjct: 190 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQNESPALQSGH 238
Query: 753 ISLPMLMRYINVALLCVQENAADRPTMSDVI 783
S + N C+Q+ DRPT S+V+
Sbjct: 239 WS----EYFRNFVDSCLQKIPQDRPT-SEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 572
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ G ++ + +I+EY S D K L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IHRD+KA+NILL ++ + K++DFG++ + NT VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 693 LFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 521 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
++ ++ +EY +L + K +L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
I+HRD+K NI L K K+ DFG++++ G + T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 695 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754
+ KSD+++ G ++ E L+ K+ ++A N L + + + PV+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR---TFDAT--NPLNLVVKIVQGNYT-----PVVSVYSSE 228
Query: 755 LPMLMRYINVALLCVQENAADRPTMSDVISM 785
L L+ +Q++ RPT +V+
Sbjct: 229 LISLVHS------LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 34/279 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 570
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ GC + + L++EY + + L + KK L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 691 ---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
+G + K DV+S GI +E +++ ++N ++ + L H + P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQNESPT 243
Query: 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ +E S + N C+Q+ DRPT +++ +
Sbjct: 244 LQSNEWS----DYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 569
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 622
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGT 680
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 681 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSSKK 715
+M+PE +S K D++S G ++LE + ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 565
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L H N+V LLG C G ++I EY L FL ++ L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQIVGTY 681
+ +L + IHRDL A N+LL KI DFGLAR D ++GN + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+LGEG FG V+ N VAVK L + + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQAR-----------VRIIEG 620
G C + I++ EYM + LN FL L++ Q R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 677
IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
+ +M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 577
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
C ++ +++E + FL T+ L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
HRDL A N L+ + KISDFG++R G G KQI + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 696 IKSDVFSFGILMLETLS 712
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 43/230 (18%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 561
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-----LFDSTKKR--------- 607
++++L+ N++RLLG CV++ +I EYM N LN F L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 608 --LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-M 664
+++ + + + IA G+ YL S +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 665 FGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ GD +QG + V +M+ E L G F+ SDV++FG+ + E L
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-20
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 332 HSLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES 388
L C D F++L ++K PD ++LE+C+ CL NCSC AYA +N S
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAITA--ISLEECREACLSNCSCTAYAYNNG--S 56
Query: 389 SGCLMWYGDLIDARRPIRNFTGQSVYLRVP 418
GCL+W G L + R + G ++YLR+
Sbjct: 57 GGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 93/331 (28%), Positives = 150/331 (45%), Gaps = 54/331 (16%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 617
++ LLG C + G +++EY +L +L FD+ K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLW 735
+M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG---- 252
Query: 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN-------- 787
H + P E L M+MR C + RPT ++ ++
Sbjct: 253 -----HRMDKPANCTHE--LYMIMRE------CWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 788 NEHLNLPSPKEPAFTKGINVKNSSHSNSGTS 818
+E+L+L P E ++ G SS S+ S
Sbjct: 300 DEYLDLSVPFE-QYSPGCPDSPSSCSSGDDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC- 577
+GEG +G VYK R GQ VA+K + +E K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CVEQGEKILILEYMPNKSLN--VFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 629
+ L++E S+ V KRL W A I+ +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH 130
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-- 687
+ ++IHRD+K NILL K+ K+ DFG++ D G +GT +M+PE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVI 185
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
D + +SDV+S GI +E
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ + L++ M L +++ + +A + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
++RDLK N+LLD N +ISD GLA G K GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 697 KSDVFSFGILMLETLSSK 714
D F+ G + E ++ +
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 73/240 (30%), Positives = 117/240 (48%), Gaps = 30/240 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 617
++ LLG C + G +I+EY +L +L +D + + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHAWD 733
+M+PE D +++ +SDV+SFG+LM E TL G+ + F LL GH D
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-20
Identities = 87/307 (28%), Positives = 147/307 (47%), Gaps = 53/307 (17%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + LI + MP L ++ + + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLA++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
+++ +SDV+S+G+ + E T SK G+ ++ ++L K +R L P I
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGER---LPQPPI 235
Query: 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN--------------NEHLNLP 794
++ + M+ C +A RP ++I + +E ++LP
Sbjct: 236 CTIDVYMIMVK--------CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 287
Query: 795 SPKEPAF 801
SP + F
Sbjct: 288 SPTDSNF 294
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 74/240 (30%), Positives = 117/240 (48%), Gaps = 30/240 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 570
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRI 617
++ LLG C + G +I+EY +L +L + L+++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHAWD 733
+M+PE D +++ +SDV+SFG+L+ E TL GV + F LL GH D
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 576
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
V + + + +EY +L L R+L+ + +GL YLH + I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFG------GDELQGNTKQIVGTYGYMSPEYAL 690
+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPEVIT 176
Query: 691 DGLFSIK---SDVFSFGILMLETLSSKK 715
G +D++S G ++LE + K+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEMMLI 563
KLGEG FG V+ E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLN-----WQAR 614
++L++ N++RLLG CV +I EYM N LN FL +ST N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G + V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 565
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 566 LQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVR-IIEGIA 622
L H N+V+L E E + EYM N++ L K + + ++ +R II I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFS-ESVIRSIIYQIL 109
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN---TKQIVG 679
QGL ++H++ F HRDLK N+L+ KI+DFGLAR E++ T V
Sbjct: 110 QGLAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYT-DYVS 160
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
T Y +PE L +S D+++ G +M E
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 575
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 GCCV-EQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 630
G C+ +G +++L YM + L F+ T K L+ + +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
F+ KSDV+SFG+L+ E ++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 571
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
VRL + + +L+ EYM +K L ++ + L+ + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYAL 690
R++HRDLK N+L++K K++DFGLAR FG + NT V T Y +P+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSSKK-NTGVYNADS----FNLLG 729
+S D++S G +M E ++ + G N D F ++G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 577
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
+E ++++EY P +L + +KR + I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 638 HRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
HRDLK NILLDK M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 697 KSDVFSFGILMLETLSSKK 715
KSD+++ G ++ E S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
G+ +++E+ P +++ + + + L Q +V I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 690
RDLKA N+LL D + K++DFG++ N K + +GT +M+PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 691 ---DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 186 TMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 572
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
R++G C E +L++E LN FL K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 688
+HRDL A N+LL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLN-VFLFDSTKKRLLN----WQARVRIIEGIAQG 624
N+++ L +E E ++LE L+ + + +KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 84/313 (26%), Positives = 151/313 (48%), Gaps = 50/313 (15%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 562
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 615
+ ++VRLLG + ++++E M + L +L ++ + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 674
++ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNAD--SFNLLGH 730
K ++ M+PE DG+F+ SD++SFG+++ E +L+ + G+ N F + G
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 731 AWDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
D + +RV DL M+ +C Q N RPT ++++++
Sbjct: 239 YLDQPDNCPERVTDL-----MR----------------MCWQFNPKMRPTFLEIVNLL-K 276
Query: 789 EHLNLPSPKEPAF 801
+ L+ PS E +F
Sbjct: 277 DDLH-PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 513 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 567 QHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQ 623
+H +V+ GC + EK L +EYMP S+ D K L R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYG 682
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722
+MSPE + K+DV+S ++E L+ K Y A
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA-------QG 624
V G + + + +++EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L YLH+ IHRD+K +NILL +D + K++DFG++ + + +GT +M
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWM 168
Query: 685 SPEYA---LDGLFSIKSDVFSFGILMLE 709
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 574
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 575 LGCC-VEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ RI+HRDLK NIL+ D KI+DFGLAR++ + T +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPEVL 178
Query: 690 LDGLFSIKSDVFSFGILMLE 709
L ++ D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 569
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 570 NLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LV L + E + L+++ + L L S K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H IIHRD+K NILLD+ + I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
+S+ D +S G+ E L K+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 567
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 568 HRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQG 624
H +V+ GC + E+ L +E+MP S+ D K L + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGY 683
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
MSPE + K+D++S G ++E L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 34/258 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 567
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQAR 614
H N++ LLG C +G + +EY P +L FL S L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 675 KQIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGH 730
K+ +G +M+ E +++ KSDV+SFG+L+ E +L G+ A+ + L
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 731 AWDLWK----DDRVHDLI 744
+ + K DD V++L+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-----NWQARVRIIEGIAQG 624
N+++ +E E ++LE L+ + K++ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
SPE + ++ KSD++S G L+ E + + + D NL + L K ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLCK--KIEQCD 224
Query: 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790
P + D S L + +N +C+ + RP ++ V + H
Sbjct: 225 YPPLPSDHYS-EELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 92/373 (24%), Positives = 157/373 (42%), Gaps = 54/373 (14%)
Query: 418 PASKLGNKKLLWILV---ILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDI 473
P ++ W + + V+ L +F +VF R R + K EN + +L FD
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 474 NMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSM--QCKLGEGGFGPVYK 531
SK S SIT S+ + + G G YK
Sbjct: 677 ---------------------SKVS-------KSITINDILSSLKEENVISRGKKGASYK 708
Query: 532 GRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590
G+ + NG + VK +++ + E + + KLQH N+V+L+G C + LI EY
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEY 764
Query: 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650
+ K+L+ L R L+W+ R +I GIA+ L +LH ++ +L I++D
Sbjct: 765 IEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
P + L + D I + Y++PE + KSD++ FG++++E
Sbjct: 819 KDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 711 LSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD-EISLPMLMRYINVALLCV 769
L+ K +++ A + D + IDP I D ++ ++ +N+AL C
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931
Query: 770 QENAADRPTMSDV 782
+ RP +DV
Sbjct: 932 ATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 568
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 569 RNLVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGL 625
N+V L+ +E +K L+ +Y + + F KR+ + V+ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMF--------GGDELQGN 673
YLH S + ++HRDLK +NIL+ + KI D GLAR+F D
Sbjct: 122 HYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
+V T Y +PE L K+ D+++ G + E L+ +
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 72/271 (26%), Positives = 132/271 (48%), Gaps = 34/271 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
GC +++ L++EY + ++ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 692
+IHRD+KA NILL + K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 693 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
+ K DV+S GI +E +++ ++N ++ + L H + ++D P + +E
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPTLQSNE 244
Query: 753 ISLPMLMRYINVALLCVQENAADRPTMSDVI 783
+ +++ C+Q+ +RP ++++
Sbjct: 245 WT-DSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYS 632
LG C++ + +E++P S++ L R V + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV----GTYGYMSPEY 688
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ + KSD++S G + E + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 630
LG C+ + L+ + MP L ++ ++ + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDL A N+L+ + KI+DFGLAR+ DE + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
F+ +SDV+S+G+ + E ++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 579
+G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 580 EQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
++ + L++E+ S+ L +TK L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL--- 690
++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 691 --DGLFSIKSDVFSFGILMLE 709
D + KSD++S GI +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 58/191 (30%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D + LN + + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 699 DVFSFGILMLE 709
D++S GI+++E
Sbjct: 199 DIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 559
L ++ S+ + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
++++ + +H N+V L + E +++EY+ SL D + ++ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
T +M+PE + K D++S GI+ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRNLVRLLGCC 578
LG G G V K + G +A K + + + K+ E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSRFRI 636
+ + + +E+M SL D K+ + +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYL--YNVHRI 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE G +++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 697 KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756
KSDV+S GI ++E K N D L DL+ ++ + LP
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIVQEPPPRLP 234
Query: 757 ------MLMRYINVALLCVQENAADRPTMSDVISM 785
L +++ C+ ++ +RPT + +M
Sbjct: 235 SSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ R G ++ + +I+EY+ S D K L I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 576
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKK-------RLLNWQARVRIIEGIAQGLLYLH 629
+ + L++ M L +++ ++ R + A+ I GL +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
Q RII+RDLK N+LLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL 169
Query: 690 LDGLFSIKSDVFSFGILMLETLSSK 714
+ D F+ G+ + E ++++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/204 (31%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG----IAQGLLYLHQYS 632
+ L+ EY+ + L + DS+ ++ R+I+ I +G+ Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSP----DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 633 RFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
R++HRDLK N+L+D+ N K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 692 GL-FSIKSDVFSFGILMLETLSSK 714
+S D++S G + E ++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRL 574
+GEG FG VY+G ++ VAVK N + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+G E I ++E P L +L K L+ + + ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
R +HRD+ A N+L+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 695 SIKSDVFSFGILMLETLS--SKKNTGVYNAD 723
+ SDV+ FG+ M E L K GV N D
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 77/250 (30%), Positives = 126/250 (50%), Gaps = 34/250 (13%)
Query: 521 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 575
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIA 622
G C +G L +EY P+ +L FL S L+ Q + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK-- 736
+M+ E +++ SDV+S+G+L+ E +L G+ A+ + L + L K
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 737 --DDRVHDLI 744
DD V+DL+
Sbjct: 235 NCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
++ +++EY L L D + + AR I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
II+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 696 IKSDVFSFGILMLETL 711
D +S GIL+ E L
Sbjct: 171 FSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 561
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN---KSLN--VFLFDSTKKRLLNWQARVR 616
++ +++H N++ L+ VE L+++ M + K ++ + L +S K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
I GL LH++ +HRDL +NI ++ KI+DFGLAR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 677 I------------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSK 714
V T Y +PE + + D++S G + E L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 570
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+LL + L +EY+P L + L AR + E + LH+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+ D +S G ++ E L
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 57/214 (26%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L ++ SI + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ +L++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 567
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 622
H N+V L +G L+ EY+ L + R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IV 678
Q + Y H IIHRD+K NIL+ + K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS 712
T Y +PE + D + DV++ G +M E L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 560
L S+ S+ + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCV 579
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 580 EQGEKILIL--EYMPN---KSL--NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
QG+K L L EY+P SL NV D AR+ I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLA------RMFGGDELQGNTKQIVGTYGYMSP 686
IIHRDLK NIL+D + + K++DFGL+ R ++ + K+IVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 515 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 564
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 622
KL H +V+ +E+ +I EY + L+ L T K L + ++ E
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFI 113
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
YMSPE + KSD++S G ++ E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 520 KLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNLV 572
++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 573 RLLGCCV-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
RL C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + R++HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D++S G + E K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 570
+ + K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+V E G +++EY L LF ++ ++L+W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
GL ++H +I+HRD+K+ NI L K+ M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y+SPE + ++ K+D++S G ++ E + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRNLVRLLG 576
++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 577 CCV-EQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
V + + I L++EY + L D+ Q + ++ + +GL YLH F
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS--LLDNMPTPFSESQVKC-LMLQLLRGLQYLH--ENF 128
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
IIHRDLK SN+LL KI+DFGLAR + G + T ++V T Y +PE L
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGCTT 185
Query: 695 SIKS-DVFSFGILMLETLSSK 714
+ D+++ G ++ E L+ K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 28/215 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 565
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 566 LQHRNLVRLLGCCVEQG-EKI-LILEYMPN--KSLNVFLFDSTKKRLLNWQARVR-IIEG 620
LQH N+V + V +KI +++EY+ + KSL ++ K+ L Q+ V+ ++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQ 114
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T Q+V T
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVT 169
Query: 681 YGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
Y +PE L +S D++S G + E L+ K
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V + + E +++E++ +L D +N + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+IHRD+K+ +ILL D K+SDFG + + K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISR 189
Query: 692 GLFSIKSDVFSFGILMLE 709
+ + D++S GI+++E
Sbjct: 190 LPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ +++E+ +++ + + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 690
RDLKA NIL D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 691 ---DGLFSIKSDVFSFGILMLE 709
D + K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 64/197 (32%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLG 576
LG G FG V R + A+K LS LK+ NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKK--RLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L++EY+P L F +K R AR + + L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD-- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L +
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 695 SIKSDVFSFGILMLETL 711
D ++ GIL+ E L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/195 (27%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 575
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G ++ +I+EY S+ + K + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 694
+IHRD+KA+NIL+ N K+ DFG+A + + + +T VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 695 SIKSDVFSFGILMLE 709
K+D++S GI + E
Sbjct: 180 DTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 31/203 (15%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
GE ++LE+M SL + T ++ L AR +I+ GIA YLH R
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR-QILSGIA----YLH---RR 187
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------ 688
I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLN 245
Query: 689 --ALDGLFSIKSDVFSFGILMLE 709
A DG D++S G+ +LE
Sbjct: 246 HGAYDGY---AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-16
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 212 SGHWDGAGF-----VSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVT 266
SG W+G F + LSY + + EN +E Y Y N L L+ G +
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNFT----ENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 267 RQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 315
R W NS W+ +S P C YG CG C ++ P C C++GF
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 45/283 (15%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 577
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 578 CVEQGEKILILEYMPNKSLNVF---LFDSTKKRLLNWQARVRIIEGIA----QGLLYLHQ 630
+G+ + +E M + SL+ F +++ K + I+ IA + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYGYMSPE- 687
+IIHRD+K SNILLD++ N K+ DFG++ +L + + G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 178
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
A DG + ++SDV+S GI + E TG + +N + D++ ++
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWNSVF--------DQLTQVV 224
Query: 745 --DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785
DP I+ + ++N LC+ ++ + RP +++
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 46/256 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++RL +Q +++EY+P L F + R N E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I++RDLK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168
Query: 689 ALDGLFSIKS-------DVFSFGILMLETLSSK-----KNT-GVYNA---------DSFN 726
I+S D ++ GIL+ E L N G+Y +
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222
Query: 727 LLGHAWDLWKDDRVHD 742
L +A DL K V D
Sbjct: 223 L--YAKDLIKKLLVVD 236
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVRIIEGIAQG 624
+ P SL F L + K + L+ ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L Y+H IIHRDLK SNI +++D KI DFGLAR DE+ G V T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRNLV 572
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 573 RLLGCCVEQGEK--------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L+ C + L+ E+ + L L S K ++++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKMLLNG 131
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYG 682
L Y+H R +I+HRD+KA+NIL+ KD K++DFGLAR F + + V T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 683 YMSPEYAL-DGLFSIKSDVFSFGILMLE 709
Y PE L + + D++ G +M E
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 576
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY ++ L + FDS + + + + + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFG 666
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 574
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 575 LGCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQY 631
+ ++ G L+ E M +N++ +KR L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 690
R I HRD+K NIL+ D K++DFG R G T+ I T Y +PE L
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLT 172
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
DG + K D+++ G + E LS
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 564
L+++ F + +G G +G VYKGR + ++A ++ + + +E K E+ ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 565 KL-QHRNLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
K HRN+ G +++ + L++E+ S+ L +TK L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
I +GL +LH + ++IHRD+K N+LL ++ K+ DFG++ D G
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 678 VGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLE 709
+GT +M+PE D + +SD++S GI +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
K+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ + L+ EY + LN R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 694
IHRD+K NIL+ K K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 695 SIKSDVFSFGILMLETLSS 713
DV++ G + E L+
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNLV 572
++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 573 RLLGCC----VEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
RL+ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I+HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D++S G + E K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ IHRD+KA+N+LL + K++DFG+A +++ N VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
F + ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 572 VRLLGCCV----------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
V L ++G L+ EYM + + + + + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQL 125
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+GL Y H+ + +HRD+K SNILL+ K++DFGLAR++ +E + T +++ T
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 714
Y PE L + + DV+S G ++ E + K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLL 575
+LG G +G V K R + G +AVKR+ + + Q K ++ + + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQGLLYLH 629
G +G+ + +E M + SL+ F K++ + + +I I + L YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-VGTYGYMSPEY 688
S+ +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173
Query: 689 ALDGL-----FSIKSDVFSFGILMLE 709
++ + +KSDV+S GI M+E
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 7e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 562
+ + KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 563 IAKL-QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619
+ +L H N+V+LL + +K L+ EYM V + +L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHKRYIMY 114
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-- 677
+ + L Y+H S +IHRDLK SNILL+ D K++DFGLAR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 678 ---VGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
V T Y +PE L S ++ G+ M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 44/281 (15%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G +++ EYM N +L+ FL + L + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS---------P 686
+H+ L A +L++ D+ KIS F + + Y MS P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
E FS SDV+SFGI+M E +S Y + WD+ D + + D
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS-------YGERPY------WDMSGQDVIKAVEDG 224
Query: 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+ + P L+ + L C Q+ +RP S + S+++
Sbjct: 225 FRLPAPRNCPNLLH--QLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V G + + + + +E+ SL ++ T L+ + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 690
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAV 180
Query: 691 --DGLFSIKSDVFSFGILMLE 709
G ++ D+++ GI +E
Sbjct: 181 ERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIAKLQHRN 570
+G G +G V G++VA+K++SN F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLN----VF-LFDSTKKRLLNWQARVRIIEGIAQ-- 623
++ LL IL + N V L ++ +++ ++ + + Q
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYF 108
Query: 624 ------GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-Q 676
GL YLH +IHRDLK SNIL++ + + KI DFGLAR DE + +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 677 IVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSK 714
V T Y +PE L +I D++S G + E L+ K
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 520 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-----RIIEGIAQGLLYL 628
E G ++++Y L + +N Q V +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL---------YKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPE 687
+I+HRD+K+ NI L KD K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+ ++ KSD+++ G ++ E + K
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 71/284 (25%), Positives = 130/284 (45%), Gaps = 42/284 (14%)
Query: 521 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLKEFKNEMMLIAK-LQ 567
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW-QARV-RIIEGIAQGL 625
H N+VR +E ++++ + L F+S K++ + + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
YLH+ R I+HRDL +NI+L +D I+DFGLA+ + +VGT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
PE + + K+DV++FG ++ + Y S N+L A + V + +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFY---STNMLSLATKI-----VEAVYE 231
Query: 746 PV---IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
P+ + ++++ ++ C+ +A RP + V +MI
Sbjct: 232 PLPEGMYSEDVTD-VITS-------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L+L M L ++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
RI++RDLK NILLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 694 FSIKSDVFSFGILMLETLSSK 714
++ D ++ G L+ E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 561
++ T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
L+ L+H N++ L + E I + + L+ L R L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTKQ 676
+GL Y+H ++HRDLK SNIL++++ + KI DFGLAR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 677 IVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + ++ D++S G + E L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 571
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLLYLHQ 630
V+L +G+ LIL+++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
II+RDLK NILLD++ + K++DFGL++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+ +D +SFG+LM E L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
LG G G VYK LL + +AVK + + + + K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ + E+M SL+V+ R + RI + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKILH 118
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 699 DVFSFGILMLE 709
DV+S GI +E
Sbjct: 175 DVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+L M L +++ ++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
+ + ++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ +++ D + G L+ E + +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 572 VRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLH 629
V G + + + + +EY SL +++ L + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ +HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
A+ D D +P A A+ +++ L G G V+ GQ V
Sbjct: 39 DSASES-DDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVL 96
Query: 545 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 604
Q G L E ML+ + H +++R+ V ++L P+ S +++ + +
Sbjct: 97 KIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTK 149
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+ R L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 664 -----MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 207 PVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 633
G C E +L++E+ P L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLA 662
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 520 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 633
G C+E +L+LE+ P L +L + Q V R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA---- 689
IH DL N L D++ KI D+GLA ++ +++PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 690 ---LDGLFSIKSDVFSFGILMLE 709
L + KS+++S G+ M E
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D +N + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 699 DVFSFGILMLE 709
D++S GI+++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D +N + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ +ILL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 699 DVFSFGILMLETLSSK 714
D++S GI+++E + +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHRN-LVRLL 575
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 576 GCCVEQGEK-------ILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIAQGL 625
VE E+ L+ EY+ + L F+ DS + R L + + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ H++ ++HRDLK N+L+DK KI+D GL R F ++ T +IV T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETL 711
+PE L +S D++S G + E
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+L M L +++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
R RI++RDLK NILLD + +ISD GLA + G+ ++G VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ ++ D + G L+ E + K
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 576 -----GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+E ++ ++ + LN + K + L+ + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLN----NIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
IIHRDLK SN+ +++D +I DFGLAR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 691 DGL-FSIKSDVFSFGILMLETLSSK 714
+ + ++ D++S G +M E L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++ + L + K+ LIL+Y+ L L+ + VR+ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVY--IAEI 114
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+L L + II+RD+K NILLD + + ++DFGL++ F +E + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+PE G D +S G+L E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I GL +LH+ II+RDLK N+LLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE + D ++ G+L+ E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-13
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 537 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCVEQGEKILILEYM 591
G EVA+K L + + + F+ E L A+L H N+V LL G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--- 648
P ++L L L R++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 649 DKDMNPKISDFGLARMFGG----DELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSF 703
+ K+ DFG+ + G D T +++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 704 GILMLETLSSK 714
G++ LE L+ +
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL-- 575
+G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 576 ---GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+E+ + ++ ++ LN + K + L +I I +GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IIHRDLK SN+ +++D KI DFGLAR DE+ G V T Y +PE L+
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNW 192
Query: 693 L-FSIKSDVFSFGILMLETLSSK 714
+ ++ D++S G +M E L+ +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 569
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNV--FLFDSTKKRLLNWQARVRIIEGI 621
N++ LL + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178
Query: 682 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
Y +PE L+ + ++ D++S G +M E L+ K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 570
++F +LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYL 628
+V G GE + +E+M SL+ L ++ + + +L +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL---GKVSI--AVLRGLAYL 119
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+S++SD++S G+ ++E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 51/147 (34%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ +K L +L D +N + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 537 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKILIL 588
GQ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 589 EYMPNKSLNVFLFDSTKKRL--LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646
E M V D +R+ L +Q + G+ +LH IIHRDLK SNI
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNI 149
Query: 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 706
++ D KI DFGLAR G + T +V Y Y +PE L + D++S G +
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 206
Query: 707 MLE 709
M E
Sbjct: 207 MGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 629
+ L++ M L +++ ++ R++++ A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 688
I++RD+K N+LLD N ++SD GLA + G Q GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEI 165
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
+ +S D F+ G + E ++ +
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 521 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKLQHRN 570
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLLNWQARVRIIEGIAQG 624
LV L C + ++EY L +VF ++ R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYG 682
L YLH+ +I++RDLK N+LLD + KI+DFGL + M GD T GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETL 711
+++PE + ++ D + G+L+ E L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 566
+ +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 567 QHRNLVRLLGC----CVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
+H N++ +L E + ++ E M L+ K + L+ + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---V 678
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T + V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
T Y +PE L+ K+ D++S G ++ E LS++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQ 623
NLV L+ + L+ E++ + L+ L +S ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
+ H ++ IIHRD+K NIL+ + K+ DFG AR V T Y
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWY 166
Query: 684 MSPEYAL-DGLFSIKSDVFSFGILMLETLS 712
+PE + D + D+++ G L+ E L+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 32/248 (12%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-----LHQ 630
+ ++ L+ +Y + ++ F K + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 631 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 685
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSSK----------KNTGVYNADS----FNLLGH 730
PE L K+ D+++ G + E L+S+ K + Y+ D FN++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 731 AWDL-WKD 737
D W+D
Sbjct: 244 PADKDWED 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 576 GCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ L+ EY+ + L ++ RL +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
Q R++HRDLK N+L+ + K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 521 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 578 CV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
E G +++ + L L + K L Q ++ IA L YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 696
+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 697 KSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728
KSDV++ G + E + K +NA N L
Sbjct: 182 KSDVWALGCCVYEMATLKH---AFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++ + L + K+ LIL+Y+ L F S ++R + ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
L +LH + II+RD+K NILLD + + ++DFGL++ F DE++ GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+P+ DG D +S G+LM E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V G GE + +E+M SL+ L K + +I + +GL YL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 691 DGLFSIKSDVFSFGILMLETLSSKKNTGVY 720
++++SD++S G+ ++E G Y
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMA-----IGRY 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 521 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 572
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 573 RLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L+ G+ LILEY+ L +F+ D+ L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE----------ISLAL 113
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGTYGY 683
+LHQ II+RDLK NILLD + K++DFGL + + + T GT Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
M+PE + D +S G LM + L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
IA GL +LH II+RDLK N++LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE + D ++FG+L+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L+L M L +++ +A E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
RI++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 694 FSIKSDVFSFGILMLETL 711
++ D + G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 566
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 567 QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIE 619
+H N+V LL + E + + EYM + L ++ RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR Q + ++V
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165
Query: 680 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 711
T Y P+ L +S D++ G + +E L
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 502 LFSLASITAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 560
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 561 MLIAKL-QHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
++ L H N+V+ G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 615 VR------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668
+ I+ G GL +LH RIIHRD+K +NILL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 669 ELQGNTKQIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLE 709
L+ NT VGT +M+PE D + + DV+S GI +E
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+AQG+ +L + IHRD+ A N+LL KI DFGLAR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716
V +M+PE D +++++SDV+S+GIL+ E S K+
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR--NLVRLL 575
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 632
G + + + +E M D KR+ ++ I + L YL +
Sbjct: 81 GYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-- 132
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ +IHRD+K SNILLD N K+ DFG++ R+ + + T+ G YM+PE +D
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRS-AGCAAYMAPE-RID 187
Query: 692 -----GLFSIKSDVFSFGILMLE 709
+ I++DV+S GI ++E
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
L+ EY+ +K L ++ D +++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFS 695
+HRDLK N+L+++ K++DFGLAR + + ++V T Y P+ L +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 696 IKSDVFSFGILMLETLSSK 714
+ D++ G + E S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 71/256 (27%), Positives = 115/256 (44%), Gaps = 40/256 (15%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 633
CC + +++ ++E++ L +F K R + +AR R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 691
II+RDLK N+LLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
L+ D ++ G+L+ E L GHA ++ + DL + I+ D
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC----------------GHA--PFEAENEDDLFE-AILND 211
Query: 752 EISLPMLMRYINVALL 767
E+ P + V +L
Sbjct: 212 EVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 521 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
+GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 VEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
G +++EY L + + +L W + + G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
R++HRD+K+ NI L ++ K+ DFG AR+ T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 694 FSIKSDVFSFGILMLE 709
++ KSD++S G ++ E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLNVFLF----DSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 630
+ ++ L+ +Y + ++ F + KK + ++ V+ ++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 631 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 685
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSSK 714
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 537 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCVEQG 582
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642
++ EYM NV + L AR+ + + + +GL Y+H + ++HRDLK
Sbjct: 90 SVYIVQEYMETDLANVL----EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141
Query: 643 ASNILLD-KDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPEYALDGLFSIKS-D 699
+N+ ++ +D+ KI DFGLAR+ +G + + T Y SP L K+ D
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 700 VFSFGILMLETLSSK 714
+++ G + E L+ K
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 29/174 (16%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSF-NLLGHAWDL 734
+ +M+PE D +++ +SDV+SFG+L+ E +L + GV + F L +
Sbjct: 239 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
P EI ML C N DRPT S+++ ++ +
Sbjct: 296 RA---------PEYATPEIYSIMLD--------CWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 521 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 576 GC-------CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
E E ++ E M + + + + + L + +V + + I +GL YL
Sbjct: 66 DILQPPHIDPFE--EIYVVTELMQSDLHKIIV---SPQPLSSDHVKVFLYQ-ILRGLKYL 119
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I+HRD+K N+L++ + KI DFGLAR+ DE + T+++V Y Y +PE
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 689 ALDGL--FSIKSDVFSFGILMLETLSSK 714
L G ++ D++S G + E L +
Sbjct: 176 -LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I GL +LH+ II+RDLK N+LLDKD + KI+DFG+ + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVK-----RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G GGFG VY R + G+ A+K R+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY----AAEIILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G+ + +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 559 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVR 616
E+ ++ + +V G GE + +E+M SL+ L + + +++L +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVS 109
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
I + +GL YL + + +I+HRD+K SNIL++ K+ DFG++ G +
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 161
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
VGT YMSPE +S++SD++S G+ ++E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-11
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQHRNLVRLL 575
+G+GG G VY + + VA+K++ + S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 576 GCCVEQGEKILILEYMPN------KSL--NVFLFDSTKKRL---LNWQARVRIIEGIAQG 624
C G+ + MP KSL +V+ +S K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE-----LQGNTK---- 675
+ Y+H S+ ++HRDLK NILL I D+G A +E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 676 -------QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 537 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILIL 588
G VAVK+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648
E M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 709 E 709
E
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
II+RDLK NILLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 695 SIKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ + L +L D+ + ++ + + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQ 623
++ + L + K+ LIL+Y+ + L+ +R + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
L +LH + I++RD+K NILLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSSKKNT 717
M+PE K+ D +S GIL+ E TL ++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 10/192 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNLVRLLGC 577
+GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
+G+ L+ EY+ L + + + N ++ I Q + +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL------EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 697
HRD+K N+L+ + K+ DFG AR + N + V T Y SPE L +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 698 SDVFSFGILMLE 709
D++S G ++ E
Sbjct: 182 VDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G GGFG VY G++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G + +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 516 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 569
+ +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N++ + + E ++ M S L + L A I++ + L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ----GNTKQIVGTYGYM 684
IHR +KAS+ILL D +S + M + Q K V ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 685 SPEYALDGL--FSIKSDVFSFGI 705
SPE L ++ KSD++S GI
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
II+RDLK NILLD + ++DFGL + G E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 33/93 (35%), Positives = 53/93 (56%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
Y++PE +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+G + +EYM SL+ + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG---- 692
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 693 --LFSIKSDVFSFGILMLE 709
++++SDV+S G+ +LE
Sbjct: 181 NPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 29/174 (16%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLW 735
+ +M+PE D +++ +SDV+SFG+L+ E +L + GV + F
Sbjct: 240 LK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------- 286
Query: 736 KDDRVHDLIDPVIMQ-DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
L D M+ E + P + R + L C Q + +RPT S ++ ++ +
Sbjct: 287 ----CQRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ + L ++ D L ++ + + + +GL Y+HQ R+ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQ--RY-I 124
Query: 637 IHRDLKASNILLDKDMNPKISDFGLAR 663
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 567
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN-----WQARVRIIEGIA 622
H V L G ++ L+LE++ F F KR N + A++ +I
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q L I++RDLK N+LLDKD K++DFG A++ + T + GT
Sbjct: 148 QSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETL 711
Y++PE L+ +D ++ GI + E L
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 677
+A+G+ +L + IHRDL A NILL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 710 TLSSK 714
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCC 578
G FG VY + G A+K L + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRL----LNWQARVRIIEGIAQGLLYLHQYSRF 634
+ L++EY+ + K L +W A+ I E + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG-- 117
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVG 169
Query: 695 SIK-SDVFSFGILMLETL 711
K SD +S G ++ E L
Sbjct: 170 DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H LV L C + ++EY+ L + +++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
PE + D ++ G+LM E ++ + F+++G + + D D +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDN--PDQNTEDYLF 214
Query: 746 PVIMQDEISLPMLM 759
VI++ +I +P +
Sbjct: 215 QVILEKQIRIPRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLL 575
LG+G FG V+ L Q A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
C + E + ++EY+ L +F S K L +A E I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLP-RATFYAAE-IICGLQFLHSKG-- 116
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDG 692
I++RDLK NILLD D + KI+DFG+ + M G T GT Y++PE L
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171
Query: 693 LFSIKSDVFSFGILMLETL 711
++ D +SFG+L+ E L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 578
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----VEQGEKI-LILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 632
V+ G+++ L+LE S+ + K+ + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY---- 688
+ IHRD+K +NILL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 199
Query: 689 -ALDGLFSIKSDVFSFGILMLE 709
LD + + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 521 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVR-IIEGIAQ 623
+ P+ SL+ F L K L+ + R++ ++ + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLK 129
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWY 181
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 521 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 570
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
LV+L G CV E I++ EY+ L+VFL L+W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNP-------KISDFGLARMFGGDELQGNTKQIVGTYGY 683
+++H ++ NIL+ + K+SD G+ E + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPW 170
Query: 684 MSPEYALDGLFSIKS--DVFSFGILMLE 709
++PE +G S+ D +SFG +LE
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 514 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 566
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H +V ++ ++ +LE++ L F R N A+ E +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAE-LVLAFE 132
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 687 EYALDGLFSIKSDVFSFGILMLETL 711
E D ++ G+L+ E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + +++E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TLSSK 714
+
Sbjct: 218 MIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 46/222 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 561
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 562 ---LIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL--FDSTKKRLLNWQAR 614
++A +V+L Q +K L ++EYMP L + +D +K W AR
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGN 673
E + L +H IHRD+K N+LLDK + K++DFG +M ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 674 TKQIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETL 711
T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
LG+G FG V L EV A+K L + M +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 633
CC + +++ ++EY+ L +F + R + + R R + L++LH++
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 691
+I+RDLK NILLD + + K++DFG+ + + G T GT Y++PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLSSK 714
+ D ++ G+LM E ++ +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 61/234 (26%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 572
+G G FG V+ R + +V A+K L NQ + E ++A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADADSPWIV 64
Query: 573 RLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG------IAQG 624
+L Q E+ L ++EYMP L +N R + IA+
Sbjct: 65 KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--------RMFGGDELQGNTKQ 676
+L L + IHRD+K NIL+D D + K++DFGL R + ++ +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 677 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
VGT Y++PE + ++ D +S G+++ E L
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLLG 576
LG+G FG V R +G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFR 635
+ ++EY+ L F +++R+ + + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK N++LDKD + KI+DFGL + G K GT Y++PE D +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 696 IKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728
D + G++M E + + YN D L
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-09
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 543 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE---YMPNK----S 595
KR+ S + + +NE++ + +L H N++++ E+IL E YM +
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 596 LNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652
L F++D K R L Q R I++ + + Y+H ++IHRD+K NI L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETL 711
+ DFG A F E + VGT SPE A DG I +D++S G+++L+ L
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
Query: 712 S 712
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLV 572
+G G +G V +G++VA+K++ + + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 573 RLLGCCVEQGEKILILEYMPNKSL--NVFL-FDSTKKRLLNWQARVRIIEG--------- 620
+ IL P + +V++ D + L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 621 ------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 672
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR E +
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 673 NTKQIVGTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 711
+ V T Y +PE +L ++ D++S G + E L
Sbjct: 167 FMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 678
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 714
T Y +PE L K+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQY 631
G CVE +L+ EY L +L R LL Q R+ IA G+ ++H++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKH 118
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+ +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 691 ---DGLFSIK----SDVFSFGILMLE 709
GL + + S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 644
++EY L F +++R+ + + R R I L YLH S +++RDLK
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLE 125
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
N++LDKD + KI+DFGL + G + K GT Y++PE D + D + G
Sbjct: 126 NLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 705 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756
++M E + + YN D H+ + +I+ +EI P
Sbjct: 184 VVMYEMMCGR--LPFYNQD-----------------HEKLFELILMEEIRFP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 24/136 (17%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
I L YLH +++RDLK N++LDKD + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740
Y++PE D + D + G++M E + + YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD----------------- 199
Query: 741 HDLIDPVIMQDEISLP 756
H+ + +I+ +EI P
Sbjct: 200 HEKLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 576
LG+G FG V L G+ AVK L + + M+ ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
II+RDLK N++LD+D + KI+DFG+ + +FG GT Y++PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 694 FSIKSDVFSFGILMLETL 711
++ D +SFG+L+ E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A+G+ +L + +HRDL A N+LL + KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 337 KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY 395
KS D F+ L K P F + ++ +LE+C ++CL NCSCR++ +N + GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNG--TKGCLLWS 57
Query: 396 -GDLIDARRPIRNFTGQSVYLRV 417
L DAR + G +Y ++
Sbjct: 58 ESSLGDAR--LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
IA GL +LH II+RDLK N++LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
Y++PE + D ++FG+L+ E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 629
LV L C L++EY+ L +F ++R L AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPE 687
+ II+RDLK N+LLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSK 714
+ D ++ G+LM E ++ +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK NILLD + ++DFGL + E G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 696 IKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 644
++EY L F +++R+ + R R I L YLH +++RD+K
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD---VVYRDIKLE 124
Query: 645 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
N++LDKD + KI+DFGL + D K GT Y++PE D + D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 705 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756
++M E + + YN D H+ + +I+ +EI P
Sbjct: 183 VVMYEMMCGR--LPFYNQD-----------------HERLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H LV L C + ++E++ L + +++L AR E I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNF 111
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
PE + D ++ G+LM E ++ + F+++G + + D D +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGMSDN--PDQNTEDYLF 214
Query: 746 PVIMQDEISLP 756
VI++ +I +P
Sbjct: 215 QVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF------KNEMMLIAKLQHRNLVR 573
+G+G FG VY+ R + + + A+K LS + KE +N ++ + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
L + L+ +YM L F + R +A+ I E + L +LH+Y
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD- 116
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
I++RDLK NILLD + + DFGL++ D NT GT Y++PE LD
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172
Query: 694 -FSIKSDVFSFGILMLE 709
++ D +S G+L+ E
Sbjct: 173 GYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 678
I+ GL +LH+ II+RDLK N++LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
GT Y++PE + D +++G+L+ E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 29/146 (19%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCC 578
L G VY ++ +K ++ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
G L++E++ ++L+ ++ + + I E +A+ L LHQ + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 639 RDLKASNILLDKDMNPKISDFGLARM 664
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 575
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +L+++ L F ++ +AR E IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I++RDLK NILLD + ++DFGL + G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 696 IKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 492 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 545
K+K+ D++L + + + E++ + +G G FG V R + Q+V A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 546 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNV 598
S +S F E ++A +V+L C Q +K L ++EYMP L
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVN 132
Query: 599 FL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656
+ +D +K + A V +L L +IHRD+K N+LLDK + K+
Sbjct: 133 LMSNYDVPEKWAKFYTAEV---------VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183
Query: 657 SDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 711
+DFG +M ++ +T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 184 ADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E + V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 681 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSK 714
Y +PE L + +I DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
A+ L L +F +I+RDLK NILLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
Y++PE L ++ D ++ G+L+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 51/217 (23%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRNLVRLLGC- 577
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLNVFLFDSTKKRLLNWQARVRI 617
C ++ EK + ++E++P N +L +FL +L ++Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLAR-MFGGDELQGNTK 675
+ + L Y+H S+F I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 676 QIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 711
I + Y +PE L ++ D++S G ++ E +
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 521 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
G CV E I++ EY+ SL+ +L K L+N ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 633 RFRIIHRDLKASNILL-----DKDMNP---KISDFGLA 662
+ H ++ A N+LL K NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 548 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 607
++ G K E+ ++ + HR ++ L+ K + MP ++F + +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180
Query: 608 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667
L + + I + + L YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 668 DELQGNTKQIVGTYGYM---SPEY-ALDGLFSIKSDVFSFGILMLE------TLSSKKNT 717
+T Q G G + SPE ALD + K+D++S G+++ E TL K+
Sbjct: 238 HP---DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 718 G 718
Sbjct: 294 S 294
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)
Query: 557 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 616
++E+ +A H +V+ + +LI+EY LN + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/275 (18%), Positives = 113/275 (41%), Gaps = 57/275 (20%)
Query: 529 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK- 584
+YKG N +EV ++ + +NE+ + ++ N++++ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 585 ---ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641
LILEY L L K++ L+++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149
Query: 642 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS---IKS 698
+ + L+ ++ KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 699 DVFSFGILMLETLSSK---KN---TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
D++S G+++ E + K +N +Y+ I+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDL-------------------------IINKN 238
Query: 753 ISLPMLM---RYI-NVALLCVQENAADRPTMSDVI 783
SL + + I + C ++ RP + +++
Sbjct: 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-07
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 574
K+G G FG V+ + QE + S +GLKE + ++I +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQY 631
+ + + + L ++E+ L+ + K + A V I + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 632 ----SRFRIIHRDLKASNILLD-------------KDMN----PKISDFGLARMFGGDEL 670
+ R++HRDLK NI L ++N KI DFGL++ G +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---I 194
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728
+ VGT Y SPE L S KSD+++ G ++ E S K T + A++F+ L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+A G+ +L + +HRDL A N+L+ + KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + L++ SDV+SFGIL+ E +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM---------FGG----DELQ 671
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
KQ+ GT Y++PE L + D ++ GI++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 567
++F + +G G FG V ++ + + + ++ N+ + LK F+ E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK-WEMLKRAETACFREERNVLVNGD 59
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+ + L ++ L+++Y L + L + RL AR I A+ +L
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI----AEMVLA 114
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 686
+H + +HRD+K N+LLD + + +++DFG +M +Q + VGT Y+SP
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 687 EY--ALD---GLFSIKSDVFSFGILMLETL 711
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVG 679
+A+ +L + + +HRD+K N+LLDK+ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 711
T Y+SPE A++ G + + D +S G+ M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 37/97 (38%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTY 681
+ L Y+H + F HRDLK NIL + D KI DFGLAR F V T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 682 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSSK 714
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 492 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 545
K+K+ D++L + + + E++ + +G G FG V R + ++V A+K L
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 546 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 600
S +S F E ++A +V+L + +++EYMP L +
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 134
Query: 601 --FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658
+D +K + A V +L L IHRD+K N+LLDK + K++D
Sbjct: 135 SNYDVPEKWARFYTAEV---------VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 711
FG + + VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 186 FGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 24/138 (17%)
Query: 586 LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639
L++EY P L L FD + +A+ +L +H + +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126
Query: 640 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY--ALDG----L 693
D+K N+L+D+ + K++DFG A +++ N+K VGT Y++PE ++G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 694 FSIKSDVFSFGILMLETL 711
+ ++ D +S G++ E +
Sbjct: 186 YGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 567
E+F + +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
++ + L ++ L+++Y L + L + RL AR + A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIA 114
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 686
+ + +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 687 EY--ALD---GLFSIKSDVFSFGILMLETL 711
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 559 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
E ++ + H ++++L G LIL P +++ + + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ + + YLH+ RIIHRD+KA NI ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT +PE + D++S GI++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 55/173 (31%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG--IAQGLLYLHQYSRFRIIHRDLKA 643
LI+E++P L L + + + +A+ +L + + IHRD+K
Sbjct: 78 LIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129
Query: 644 SNILLDKDMNPKISDFGLA-------------RMFGGDELQ------------------G 672
NIL+D+ + K+SDFGL+ ++ G +
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189
Query: 673 NTKQI--------------VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+ QI VGT Y++PE L + + D +S G +M E L
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLL 575
LG+G G V+ RL G+ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ L+++Y P L L K L AR E + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARM---------------------------FGGD 668
I++RDLK NILL + + +SDF L++ +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 669 ELQGNTKQIVGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETL 711
E + VGT Y++PE + DG ++ D ++ GIL+ E L
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 15/122 (12%)
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLL 626
+ N ++L +LI++Y+ + L FD KK L+ +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
LH++ IIH D+K N+L D+ + + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 686 PE 687
PE
Sbjct: 175 PE 176
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E F + + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 572 VRL--------LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRI 617
+ L L ++ + L++EY+ + L FD + V+
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
I +A L YLH++ IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 40/160 (25%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNL- 571
+G G FG V RL G A+K+L K+EM+ ++ H R++
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAHVRAERDIL 55
Query: 572 --------VRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
V+L Q E LI+EY+P + L K + R I E I
Sbjct: 56 AEADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI 111
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 ----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-05
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 793 LPSPKEPAFTKG-INVKNSSHSNSGTSEHCSVNDVTVSLIYPR 834
+P PK+P F G + S S++ E +VN VTVS+I R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 572
+G G FG V R ++ + A+K L NQ+ K E ++A+ + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+L ++ +++Y+P + L ++ L AR I E + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH- 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+ IHRD+K NIL+D+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI+E++P + L KK L + I A+ +L + + IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 646 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 676
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 677 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 630
+ +I +M S N L + + +A + I+ G +GL YLHQ
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLHQ 119
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-----QGNTKQIVGTY---- 681
IHR++KAS+IL IS GL + G L G ++V +
Sbjct: 120 NG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 682 ----GYMSPEYALDGL--FSIKSDVFSFGILMLE 709
++SPE L +++KSD++S GI E
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI+E++P + L KK L+ +A I + +HQ IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 646 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 676
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 677 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 59/242 (24%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V ++ + A+K L + + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
++ +++Y+P + L + + L + IA+ L + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--------IAELTLAIESVHKM 120
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFG---------------------------- 666
IHRD+K NIL+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 667 -----GDEL----QGNTKQ--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GD L Q TKQ +VGT Y++PE L ++ D +S G+++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 710 TL 711
L
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V R ++ + + A+K L + + K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
++ +++Y+P + L R+ + + IA+ + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122
Query: 637 IHRDLKASNILLDKDMNPKISDFGLARMF----------GGDELQGNT------------ 674
IHRD+K NIL+D+D + K++DFGL F GD ++ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 675 -----------------------KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
L++++ H +L + G CV E I++ E++ + L+V L + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNP--KISDFGLARMFGGDELQGNT 674
A L YL + ++H ++ A NILL + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 675 KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
++I +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 21/173 (12%)
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
+E L+ +L H ++ LL V G L+L P +++ + + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 618 IEGIAQGLL----YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 726
I GT +PE ++ D++S G+++ E V+ A F+
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE-------AAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|185490 PTZ00163, PTZ00163, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 10/83 (12%)
Query: 111 TNVSSEVKNPVAQLRD-------DGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLG 163
T++ S KNP + R D V DN+ N E+++ S D P D L+ D
Sbjct: 62 TSIFSGNKNPQKRERKNEEENQKDNTKVDNDNNMENEMENHIDDSIDDPMDDLMNDK--- 118
Query: 164 WDFKNRLERYLSSWRSADDPSPG 186
W+ N LE + + + DPS G
Sbjct: 119 WEHHNSLEDRIKEYYTLTDPSDG 141
|
Length = 230 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 834 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.83 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.25 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.99 | |
| PLN02236 | 344 | choline kinase | 96.96 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.73 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.4 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.18 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.68 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=449.18 Aligned_cols=288 Identities=42% Similarity=0.725 Sum_probs=254.0
Q ss_pred CCCcccHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeee
Q 003288 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578 (834)
Q Consensus 499 ~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 578 (834)
....|++.++..+|++|.-.++||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999998765443145699999999999999999999999
Q ss_pred eecC-eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 579 VEQG-EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 579 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775544 89999999999999999999999998899999999999999999999999
Q ss_pred ccccceecCCCcccCCcccc-cccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC-CCcccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN-ADSFNLLGHAWDLW 735 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~ 735 (834)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++..... .....+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111122 89999999999999999999999999999999999998877544 33445788888888
Q ss_pred cccccccccccccccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 736 KDDRVHDLIDPVIMQDEISL-PMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+++.+++|+.+....... .+..++..++.+|++.+|.+||+|.||+++|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88899999999985455554 6788899999999999999999999999999665
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=392.40 Aligned_cols=263 Identities=32% Similarity=0.514 Sum_probs=214.4
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-eeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 589 (834)
..+.+.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455567999999999999995444499999976432 22679999999999999999999999999988 7999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~ 668 (834)
|+++|+|..+++.. .+..+++..+++|+.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999664 56789999999999999999999999874 99999999999999997 9999999999876543
Q ss_pred cccCCcccccccccccCccccc--CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
. ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||...... .... .++..
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~------------~v~~~ 261 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVAS------------AVVVG 261 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHH------------HHHhc
Confidence 2 2233368999999999999 669999999999999999999999998754431 1110 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPS 795 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 795 (834)
.. +..+.......+..++.+||+.||.+||++.|++..|+.+......
T Consensus 262 ~~-Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GL-RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CC-CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11 2233333566788999999999999999999999999877554443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=373.55 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=209.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecC-CChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-eeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 590 (834)
+++.++.||+|..|+|||++++ +++.+|+|.+.. .++...+++.+|++++++.+||+||+++|+|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556789999999999999986 478899999954 35667789999999999999999999999999999 59999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++|+|+.++.. .+.+++..+.+|+.++++||.|||+ ++ ||||||||+|||++..|++||+|||.+..+-+.
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999843 3569999999999999999999996 55 999999999999999999999999999876443
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
..+..+||..|||||.+.+..|+.++||||||++++|+..|+.|+....+.. ....++++....
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-------------~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-------------LDIFELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-------------CCHHHHHHHHhc
Confidence 4566899999999999999999999999999999999999999987542111 111222222221
Q ss_pred --cCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 --QDEISL-PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 --~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+. ..+.++..++..||+.||.+||+++|++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222 367789999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=384.48 Aligned_cols=256 Identities=32% Similarity=0.495 Sum_probs=212.9
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.+.+.+.+.||+|.||.||.|.+.....||+|.++.. .-..+.|.+|+++|++|+|+|||+++|+|..++.++||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3455677899999999999999977779999999765 234478899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.+.
T Consensus 284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999965 34567899999999999999999999998 999999999999999999999999999965544432
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
. .....-+..|.|||.+..+.|+.|||||||||+||||+| |+.|++.... .++.+.++..- +
T Consensus 360 ~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------------~ev~~~le~Gy-R 422 (468)
T KOG0197|consen 360 A-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------------EEVLELLERGY-R 422 (468)
T ss_pred e-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------------HHHHHHHhccC-c
Confidence 2 223345779999999999999999999999999999999 6667553322 11222222221 2
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
-+.+..++.++.+++..||+.+|++|||++.+...|+.+
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 223344667889999999999999999999999999876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=383.38 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=213.3
Q ss_pred cCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|++|.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 77999999999653 3456678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+|++++|..++. +.+.+++.++..++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999983 5678999999999999999999999998 999999999999999999999999999988654
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.. ...+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...-. +..+...
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety~~Ik 231 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETYNKIK 231 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHHHHHH
Confidence 33 345689999999999999999999999999999999999999999753211 1111111
Q ss_pred c-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 M-QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ....+...+.+..+||.++|+.||.+|||+++|+..
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 112233456678999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=401.77 Aligned_cols=259 Identities=31% Similarity=0.459 Sum_probs=218.3
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
..+.+..+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|+++|..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445667789999999999999753 2457999999877655 789999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC-----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 585 ILILEYMPNKSLNVFLFDSTK-----------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
++|+|||..|+|.+||..... ...|+..+.+.|+.|||.||+||.++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999964321 233889999999999999999999997 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+||||++.....++......-.-+.+|||||.|..++||.+||||||||+|||+++ |+.|+.....+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------- 712 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------- 712 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---------
Confidence 99999999998877766665555567889999999999999999999999999999999 77776543322
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
++.+.+..... -+.+..++.+++.|++.||+.+|++||+++||...|+..
T Consensus 713 ------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 ------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11222222111 123444667899999999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=364.17 Aligned_cols=203 Identities=30% Similarity=0.535 Sum_probs=183.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..+|.+.++||+|+||+||+|++. ++..||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999986 4889999998655 5667788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC------CCceeeccccc
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD------MNPKISDFGLA 662 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~------~~~kl~DFGla 662 (834)
|||.+|+|..+|. +.+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999994 4447999999999999999999999998 9999999999999765 45899999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCC
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD 723 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~ 723 (834)
+.+.... ...+.+|++-|||||+++.++|+.|+|+||+|++||++++|+.||......
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9887543 345689999999999999999999999999999999999999999755443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=361.44 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChh-------hHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
.+.|.+.+.||+|+||.|-+|... +|+.||||++++..-. ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 567889999999999999999754 6999999999754211 12235799999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccc
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFG 660 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFG 660 (834)
.|+||||+++|.|-+++- ..+.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999883 4455777778889999999999999999 9999999999999765 679999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCC---CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
+|+..+.. ...+..+||+.|.|||++...-. ..+.|+||+||+||-+++|.+||...-.+.
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------- 388 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------- 388 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------------
Confidence 99987633 34567899999999999986543 357899999999999999999986422211
Q ss_pred ccccccccc-ccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 738 DRVHDLIDP-VIM-QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 738 ~~~~~li~~-~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+.+.+.. ... ....-....++..++|.+||..||++||++.|+++.
T Consensus 389 -sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 01111111 100 112223356788999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.39 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=209.8
Q ss_pred hcCccccceeccCCcEeEEEEE-ecCCcEEEEEEecC--CChhhHHHHHHHHHHHHhcCCCceeeEee-eeeecCe-eEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCVEQGE-KIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 586 (834)
...|+++++||+|.||.|||++ +.+|..+|.|.+.- .+.+..+....|+.+|++|+|||||++++ -+.++.+ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3568999999999999999997 45799999998863 35667788999999999999999999998 4555555 899
Q ss_pred EEEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcC-CCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 587 ILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYS-RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
|||+|..|+|..++...++ ++.++++.+++++.|+++||.++|++- +..|+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999976544 456999999999999999999999832 23599999999999999999999999999999
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
+..... .....+|||.||+||.+.+..|+.|+||||+||++|||..-++||...+ ..++-
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------------------~~~L~ 237 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------------------LLSLC 237 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------------------HHHHH
Confidence 865432 3445799999999999999999999999999999999999999986431 11111
Q ss_pred ccccccCC---CC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 745 DPVIMQDE---IS-LPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 745 ~~~~~~~~---~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
. .+.+.. ++ ...+..+..+|..|+..||..||+...++..+..
T Consensus 238 ~-KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 K-KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H-HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 111222 22 5567889999999999999999995555544433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=385.91 Aligned_cols=292 Identities=28% Similarity=0.378 Sum_probs=235.6
Q ss_pred cCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
....|.++||.|.||.|++|+++- ...||||.++... +....+|+.|+.||.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456778999999999999998863 3579999998764 55678999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
.|||+||+|+.||... .+++++.++.-++++||.||.||.+.+ +|||||.++|||++.+..+|++||||+|.+.+
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999654 356999999999999999999999998 99999999999999999999999999998755
Q ss_pred CcccC-CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 668 DELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
+.... .+..-.-+.+|.|||.+...+|+.++||||||++|||.++ |.+|+..... .++.+.+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------------QdVIkaIe 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------------QDVIKAIE 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------------HHHHHHHH
Confidence 43111 1222234679999999999999999999999999999888 8888653322 22222222
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCcc-ccccccCCCCCCCCCCcccccc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT-KGINVKNSSHSNSGTSEHCSVN 824 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 824 (834)
... +-+.+..+...+.+|++.|||.|-.+||.+.||+.+|++.+.+..+-+..+.. .+.++.-..++.++.....+++
T Consensus 849 ~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~~~~~~~f~sv~ 927 (996)
T KOG0196|consen 849 QGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRSGSDFTPFRSVG 927 (996)
T ss_pred hcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCCCCCCcccCCHH
Confidence 222 33445567788999999999999999999999999999997777666665433 3555554445556666655554
Q ss_pred c
Q 003288 825 D 825 (834)
Q Consensus 825 ~ 825 (834)
+
T Consensus 928 ~ 928 (996)
T KOG0196|consen 928 D 928 (996)
T ss_pred H
Confidence 3
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.44 Aligned_cols=240 Identities=26% Similarity=0.370 Sum_probs=202.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|+++++||+|+||+||.++..+ ++.+|+|.+++. .....+..++|..||.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 5789999999999999999998654 889999999764 233466788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||+.||.|..+| ++++.+++..+.-.+..|+.||.|||+++ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 55677999989999999999999999999 99999999999999999999999999985422
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. +..+..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------~~~~~I 237 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------KMYDKI 237 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------------------HHHHHH
Confidence 2 22445589999999999999999999999999999999999999998643321 111111
Q ss_pred cccC--CCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 748 IMQD--EISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 748 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.... ........+..+++...|+.||++|.
T Consensus 238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111 11122456788999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.55 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=206.3
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|+.+.++|+|+||.|||.+.++ |+.||||++....+ ...+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568888999999999999999875 99999999966533 344567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+..-|.++-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999988877652 3345889999999999999999999998 9999999999999999999999999999886421
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------cccccc-cc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWDLWK-DD 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~~~~~-~~ 738 (834)
...+.++.|.-|.|||.+.+ .+|....||||+||++.||++|.+-|....+.++ ..+.. ....+. ..
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23345788999999999987 7899999999999999999999998876554222 21111 111111 11
Q ss_pred ccccccccccccCC-C---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 RVHDLIDPVIMQDE-I---SLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ~~~~li~~~~~~~~-~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.++-+.-|.....+ . -+....-+++++..||+.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111110000 0 0112346889999999999999999988875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.57 Aligned_cols=266 Identities=26% Similarity=0.442 Sum_probs=216.5
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
+.+...+.++||+|-||.|.+.....+..||||+++..... ...+|..|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 45678889999999999999999877899999999876544 45899999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||++|+|.+|+..+.... +.-....+|+.||+.||+||.+.+ +|||||.++|+|+++++++||+|||+++.+...+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999996554332 455667789999999999999998 9999999999999999999999999999877666
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
+.......+-+.+|||||.+..++|+.++|||+||+++||+++ ...|+.....+ +.++..............+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~l--- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVVL--- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcceec---
Confidence 6655556677899999999999999999999999999999876 55666533222 2222222222211111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.-+...+++++..||..|-++||+++++...|.+.
T Consensus 767 ----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11222455788999999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.56 Aligned_cols=284 Identities=26% Similarity=0.384 Sum_probs=219.9
Q ss_pred CCCCCCCcccHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCcee
Q 003288 495 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLV 572 (834)
Q Consensus 495 ~~~~~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv 572 (834)
...+.+|.+-..++ .++..+.+.||+|.||.||+|++ .|+.||||+|...++. .+.+|.+|.+. |+|+||+
T Consensus 196 GSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred CCCCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhh
Confidence 34567888877776 56889999999999999999998 6899999999766554 45667777765 5999999
Q ss_pred eEeeeeeecC----eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-----cCCCceeeCCCCC
Q 003288 573 RLLGCCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-----YSRFRIIHRDLKA 643 (834)
Q Consensus 573 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dikp 643 (834)
.+++.-..+. +++||.+|.++|||.+||. ...++.+..++++..+|.||++||. ++++.|.|||||+
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 9999876553 7899999999999999993 3679999999999999999999994 5789999999999
Q ss_pred CcEEecCCCCceeeccccceecCCC--cccCCcccccccccccCcccccCC----CCC--ccCcchhhHHHHHHHHhCCC
Q 003288 644 SNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDG----LFS--IKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~----~~s--~~sDVwslGvvl~elltg~~ 715 (834)
.|||+..++.+.|+|+|||...... ......+..+||.+|||||++.+. .|. ..+||||||.|+||+..+..
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999987554 334455678999999999998654 232 45999999999999976432
Q ss_pred CCCCCCCCcccccccc-----cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 716 NTGVYNADSFNLLGHA-----WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 716 p~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.-+...+....+.... .+.+++.-..+.++|.+.....+.+.+..+.++++.||..+|.-|-|+--+-+.|.++
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 2111111111111111 1111111122334455545556778889999999999999999999999999999886
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=382.76 Aligned_cols=260 Identities=31% Similarity=0.498 Sum_probs=214.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC--Cc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++.+..+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|+.+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456778899999999999998653 43 4999999765 566778999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
++++|||++|+|..||.+.+. ...|...+++.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976422 356899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
||+.+...++........-+..|||||.+.++.|+.|+|||||||+|||++| |..|++.....+ ++..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~--------- 916 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLD--------- 916 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHH---------
Confidence 9997766555544444455679999999999999999999999999999999 667765332211 1110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..... +-+.+..+...+++++.+||+.+|++||++..+++.+..+.
T Consensus 917 ---~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 917 ---VLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---HHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11111 11223345667889999999999999999999999887763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=344.04 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=205.0
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--eeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E 589 (834)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999998765 8999999986654334778999999999999999999999855444 6899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCC-
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG- 667 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~- 667 (834)
|+++|+|.+++.+... .|++..+...+.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954432 6999999999999999999999998 999999999999999 79999999999987754
Q ss_pred CcccCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCC-CCCcccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVY-NADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
...........||+.|||||++..+. ...++|||||||++.||+||++||... .... .. ..+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-----~~---------~~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-----AL---------LLIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-----HH---------HHHhc
Confidence 12222344578999999999999643 345999999999999999999998642 1100 00 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
... .+.++........+++.+|++.||++|||++++++..-.
T Consensus 238 ~~~-~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 238 EDS-LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cCC-CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 000 113344455678999999999999999999999987643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=351.86 Aligned_cols=264 Identities=30% Similarity=0.468 Sum_probs=213.1
Q ss_pred HHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 506 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 506 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
.+.....+.+.+.+.||+|.||+||+|++. | .||||.+... .++..+.|++|+..+++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445556677888999999999999999984 3 5999998654 45678999999999999999999999999998887
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.+|.-+|++.+|+.+|+..+ ..++....+.|+.|||+||.|||.++ |||||||..||+|.+++++||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999996544 55889999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCcccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
.-..-.-........|...|||||+++. .+|+..+||||||+|+|||++|..|+.....+.. +- ..++-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--if------mVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IF------MVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--EE------Eeccc
Confidence 6544333334455678899999999975 4789999999999999999999999873222211 11 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.-. +.+ .........++.+|+..||..++++||.+.+|+.+|+..
T Consensus 609 ~l~--pd~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 609 YLM--PDL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccC--ccc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 000 000 011222345788999999999999999999999988876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.72 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=204.5
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
+.++|++.++||+|+||.||+|... .++.||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3578999999999999999999742 35679999997543 33456789999999999 8999999999887654
Q ss_pred -eeEEEEEecCCCchhhhhhccCC--------------------------------------------------------
Q 003288 583 -EKILILEYMPNKSLNVFLFDSTK-------------------------------------------------------- 605 (834)
Q Consensus 583 -~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999854211
Q ss_pred ---CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccccccccc
Q 003288 606 ---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (834)
Q Consensus 606 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 99999999999999999999999999986543322222223456788
Q ss_pred ccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHH
Q 003288 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 761 (834)
Q Consensus 683 y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l 761 (834)
|+|||++.+..++.++|||||||+||||++ |..|+........ . ......+.. ..........+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~----~~~~~~~~~----------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F----CQRLKDGTR----------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H----HHHHhcCCC----------CCCCCCCCHHH
Confidence 999999999999999999999999999997 8888764322110 0 000000000 01111234568
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 762 INVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+++.+||+.||.+||++.|++++|++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=351.10 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=210.8
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
...|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45677778999999999999975 46889999999776666677789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999998 4445999999999999999999999999 99999999999999999999999999998866543
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.....+||+.|||||+.....|..|.||||||++++||+-|++|+-...+- ..+ +. +..--.+.+
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAl---yL------Ia~ng~P~l-- 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RAL---YL------IATNGTPKL-- 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHH---HH------HhhcCCCCc--
Confidence 345679999999999999999999999999999999999999997532221 000 00 011111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+..+.+++.+||+.|+.+||+++|+++.
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1123345678999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=314.11 Aligned_cols=281 Identities=26% Similarity=0.350 Sum_probs=213.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|...++||+|.||.||+|++. +|+.||||+++.... .......+|++.|+.++|+||+.++++|.+.+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999864 599999999865432 224567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+. +|...+.+ +...+...++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 88888843 4557999999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccccccccccc---ccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDR---VHDLI 744 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~---~~~li 744 (834)
.... ..+-|.-|.|||.+.+. .|+...|+||.||++.||+-|.+-+....+-++ ..+-.+......+. +..+-
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 3222 23778999999998875 699999999999999999998877655443211 11111111111111 11111
Q ss_pred c-------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 003288 745 D-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTK 803 (834)
Q Consensus 745 ~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~ 803 (834)
| +.......-........+++..|+..||.+|++++|++++= .....|.|..|.-.+
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKLP 297 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhCc
Confidence 1 11111122333456779999999999999999999998773 234456555554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.23 Aligned_cols=252 Identities=27% Similarity=0.357 Sum_probs=208.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
..+|...+.||+|+|++|++|+.. .+++||||++.+. .+...+-...|-.+|.+| .||.|++|+-.|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 568999999999999999999865 5899999998654 223344567888999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+++|+|-++|. +.+.+++......+.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999994 4567999999999999999999999999 9999999999999999999999999999885
Q ss_pred CCccc---------CC--cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 667 GDELQ---------GN--TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 667 ~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
..... .. ....+||..|.+||++.++..+..+|+|+|||+||+|+.|++||-..++-. .
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--i-------- 295 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--I-------- 295 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--H--------
Confidence 43221 11 145899999999999999999999999999999999999999986433211 0
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
+.++++- ...+.....+.+.+|+.+.|..||++|++.+||-++-
T Consensus 296 ----FqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 ----FQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----HHHHHHh---cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0011110 1122223346778999999999999999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=332.76 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=209.4
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.+.|++.++||.|.-+.||+|+. +.++.||||++.-. .....+.+.+|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 57899999999999999999985 46899999998543 23347889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||.+|++.++++..-.. .+++..+..|++++++||.|||++| .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999654333 3899999999999999999999999 9999999999999999999999999877653321
Q ss_pred c-cC-CcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 670 L-QG-NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 670 ~-~~-~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
. .. ..+...||+.|||||+++. .-|+.|+||||||++..||.+|..||..+.+-..-+..- .+....+.-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL------qn~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL------QNDPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh------cCCCCCccc
Confidence 1 11 1256799999999999654 358999999999999999999999998776533211110 011111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+ ...........+.+++..||+.||.+|||++++++.
T Consensus 255 ~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 001 111122234478899999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.33 Aligned_cols=265 Identities=28% Similarity=0.469 Sum_probs=203.7
Q ss_pred hcCccccceeccCCcEeEEEEEecC-----------------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 573 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 573 (834)
.++|++.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999997532 3369999987643 345678999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCchhhhhhccC----------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 003288 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDST----------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637 (834)
Q Consensus 574 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 637 (834)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 1134788899999999999999999998 99
Q ss_pred eCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhC--CC
Q 003288 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS--KK 715 (834)
Q Consensus 638 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg--~~ 715 (834)
||||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443322223334567899999999988999999999999999999974 44
Q ss_pred CCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 716 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 716 p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
|+...... .............. .. . ...........+.+++.+||+.||++||++.||.+.|++
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~-~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQG-RQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhcc-cc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55432211 11111100000000 00 0 000111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.29 Aligned_cols=261 Identities=31% Similarity=0.423 Sum_probs=209.4
Q ss_pred HhcCccccceeccCCcEeEEEEEecC--C--cE-EEEEEecC---CChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 582 (834)
..++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|.+|+++|++++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34566777999999999999998753 2 23 89999874 34677899999999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
.+++|||+|.||+|+++|.... ..++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999995432 26999999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+.-.. +........-+..|+|||.+....|+.++|||||||++||+++ |..|+...... .+.
T Consensus 310 ~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------------~v~ 372 (474)
T KOG0194|consen 310 RAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------------EVK 372 (474)
T ss_pred cCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------------HHH
Confidence 86431 1111112245789999999999999999999999999999999 77776533221 111
Q ss_pred ccc-ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003288 742 DLI-DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 794 (834)
Q Consensus 742 ~li-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 794 (834)
..+ .... +...+......+..++.+||+.+|++||+|.++.+.|+.+.....
T Consensus 373 ~kI~~~~~-r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 373 AKIVKNGY-RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHhcCc-cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111 1111 112222345567788889999999999999999999988754443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.60 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=207.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHH--HHHHHHHHHhcC-CCceeeEeeeeeecC-eeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLLGCCVEQG-EKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 586 (834)
.++|.++++||.|.||.||+|+-. .|..||||++++.-.. +++ =.+|++.|++|+ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 578999999999999999999754 5889999999765332 333 368999999998 999999999999988 9999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||||+. +|.+++.++ .+.+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||...
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999965 888888554 778999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCcccCCcccccccccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--cc----cccccccccc-c
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NL----LGHAWDLWKD-D 738 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~----~~~~~~~~~~-~ 738 (834)
.. ...+.++.|.-|.|||++. .+.|+.+.|+||+|||++|+.+-++-|...++.+. .+ -...++.|.+ .
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 43 2345578899999999875 57899999999999999999999988765443111 11 1112222222 1
Q ss_pred ccccccccccc---cC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 RVHDLIDPVIM---QD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 ~~~~li~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+...+.-.+. .. ..-.....++.+++.+|++.||.+|||++|.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111 11 1112356789999999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.34 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=206.7
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 586 (834)
.+.|+.+++||+|.||.||||+. .+|+.||+|+++... +.......+|+.||++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 56788899999999999999985 469999999986543 55566778999999999999999999998877 68999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+|||++ +|.-++. ...-.+++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 6766663 33445999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc----c-cccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL----G-HAWDLWKDDR 739 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~----~-~~~~~~~~~~ 739 (834)
...... .+..+-|.-|.|||.+.+. .|+.+.|+||.||||.||+.|++.+....+.++ ..+ . .....|...+
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 655433 3446789999999999875 799999999999999999999998865443211 111 0 0111122111
Q ss_pred c--ccccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 V--HDLIDPVIMQDE----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~--~~li~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+ .....+...... ..........+|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 122222111000 011223567889999999999999999998653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.72 Aligned_cols=271 Identities=27% Similarity=0.399 Sum_probs=210.4
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeEeeeeeecC----eeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG----EKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 586 (834)
...++.++||+|+||.||||++ +++.||||++. .+..+.|++|-.|... |+|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678999999999999999 56999999996 4456778888888775 58999999999876655 8999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc------CCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY------SRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
|+||.+.|+|.++| +...++|.+..+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 455799999999999999999999964 35789999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCC-CC-----ccCcchhhHHHHHHHHhCCCCCCCCCCCcccc--ccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSSKKNTGVYNADSFNL--LGHAW 732 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDVwslGvvl~elltg~~p~~~~~~~~~~~--~~~~~ 732 (834)
+|..+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||+++..........++++ -....
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999998766666666689999999999997653 22 46899999999999999876543222211111 11111
Q ss_pred ccccccc-----cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 733 DLWKDDR-----VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 733 ~~~~~~~-----~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....-++ +++..+|.+.........+..+.+.+..||..||+.|.|+.=|.+.+.+...
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111122 2222333332222333556788999999999999999999999998877633
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.59 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=201.0
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCc
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
..++-||.|+-|.||.|++ .+++||||+++... ..+++-|++|+|+||+.+.|+|.....+|+|||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3457899999999999999 67899999986433 357888999999999999999999999999999999999
Q ss_pred hhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcc
Q 003288 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
|..+| +.++.+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||.++..... ....
T Consensus 199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 99999 45567888999999999999999999998 999999999999999999999999999876543 1233
Q ss_pred cccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCH
Q 003288 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~ 755 (834)
.+.||..|||||++.+.+.++|.|||||||||||||||..|+..-+. ..+.|. -+ .....-+.+.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAIIwG-----VG-------sNsL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAIIWG-----VG-------SNSLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---heeEEe-----cc-------CCcccccCcc
Confidence 47899999999999999999999999999999999999999643221 111111 00 1111223334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 756 PMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+...+.-|+++||+..|..||++++++..|+=.
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 4556677899999999999999999999999744
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=343.70 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=204.9
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC----Ch-hhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 583 (834)
...+|.+.+.||+|.||+|+.|+.. +++.||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3578999999999999999999764 5899999977553 12 33556778999999998 9999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeeccccc
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 662 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla 662 (834)
.++||||+.+|.|.+++.. .+.+.+.++.+++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999943 456888999999999999999999999 9999999999999999 99999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCC-CC-ccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||........ ..
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--~~----------- 233 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--YR----------- 233 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--HH-----------
Confidence 9873 1223455679999999999999987 86 789999999999999999999975221110 00
Q ss_pred ccccccccccCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 741 HDLIDPVIMQDEISLPM-LMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
. +... .-.+.... ..++..++.+||+.||.+|+++.+++
T Consensus 234 -k-i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 234 -K-IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -H-HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 0000 01111112 67889999999999999999999999
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.64 Aligned_cols=237 Identities=26% Similarity=0.356 Sum_probs=202.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
-++|++++.||.|+||.|.+++.+. |..+|+|++.+..- .+.+...+|..+|+.+.||.++++.+.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678899999999999999999764 78899999976532 3455678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||.++|.|..+| ++.+.++++.+...+.||+.||+|||+.+ |++|||||+|||||++|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999 45566999999999999999999999998 99999999999999999999999999997643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.+-..+|||.|+|||+++.+.|..++|-|||||++|||+.|.+||....+... ..+++...
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i--------------Y~KI~~~~ 257 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI--------------YEKILEGK 257 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH--------------HHHHHhCc
Confidence 35678999999999999999999999999999999999999999975443110 01111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCC
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADR 776 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
-.++......+.+|+...|+.|-.+|
T Consensus 258 ---v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 ---VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12333455678899999999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.57 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=210.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..|+.++.||+|.||.||||.+. .++.||+|++.-. .....+++++|+.+|..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999864 4888999998644 344578899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.+|++.+.| ..+..+.+..+.-|+.+++.||.|||.++ .+|||||+.|||+.++|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 44555688888899999999999999998 99999999999999999999999999998766544
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.. ...+||+.|||||++....|+.|+||||||++.+||++|.+|+....+.. +.-++.+.. .
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~-P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSA-P 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCC-C
Confidence 33 56899999999999998899999999999999999999999986544411 111221111 2
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.........+.+++..||..||+.||++.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22333566678999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=340.88 Aligned_cols=246 Identities=28% Similarity=0.422 Sum_probs=209.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. .+...+.+.+|++|++.++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999765 5789999998654 45567889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.+ +|..+|. ....++++.+..|+.++..||.|||+.. |+|||+||+|||++.++.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999993 4456999999999999999999999998 9999999999999999999999999999876532
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.....+.||+.|||||...+++|+..+|.||+||++||+.+|++||-.. .+.+++.....
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------si~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------SITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------------------HHHHHHHHHhc
Confidence 3445689999999999999999999999999999999999999998531 12222222221
Q ss_pred cC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QD-EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+ .........+.+++...|+.||.+|.+-.+++..
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11 1223556788999999999999999998888754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=335.05 Aligned_cols=244 Identities=19% Similarity=0.337 Sum_probs=198.1
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeEEEEEec
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 591 (834)
..||+|++|.||+|+. +|+.||||.++..... ..+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 7899999999754332 25778899999999999999999999877 34678999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++|+|.+++.. ...+++...++++.|++.||+|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999943 34688999999999999999999985 5 8899999999999999999999999998654321
Q ss_pred cCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ... . ++....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~----~--------i~~~~~ 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYD----L--------IINKNN 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHH----H--------HHhcCC
Confidence 22467899999999976 689999999999999999999999986433211 000 0 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++|||++||++.|+..
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111223455788999999999999999999999999865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.04 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 235689999996543 33456789999999999 89999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCC----------------------------------------------------------
Q 003288 584 KILILEYMPNKSLNVFLFDSTK---------------------------------------------------------- 605 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (834)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998853211
Q ss_pred --------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 606 --------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 606 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
...+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999998 999999999999999999999999999876443222
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......++..|+|||++.+..++.++|||||||++|||++ |..|+....... .. ......+ . .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~----~~~~~~~---------~-~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF----YKMIKEG---------Y-R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH----HHHHHhC---------c-c
Confidence 22222345678999999999999999999999999999998 777775332211 00 0001100 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.........++.+++.+||+.||++||++.||+++|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.01 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=209.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.-|.+.+.||+|+-|.|-+|++. +|+.+|||++.+. .......+.+|+.||+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999864 6999999999655 2334566789999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|-|.+++ .+++.+++.+.++++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 56677999999999999999999999998 999999999999999999999999999875433
Q ss_pred cccCCcccccccccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ...+.+|.+.|.|||++.+.+|. .++||||.|||||.||+|+.||+..+ +..++.+.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------------ir~LLlKV 224 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------------IRVLLLKV 224 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------------HHHHHHHH
Confidence 2 34567999999999999999985 78999999999999999999997322 22222222
Q ss_pred cccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ++ +++.....++.+|+.+|+..||.+|.|++||+++
T Consensus 225 ~-~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 Q-RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred H-cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1 22 2233455688999999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.43 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=201.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--------------hhHHHHHHHHHHHHhcCCCceeeEee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------QGLKEFKNEMMLIAKLQHRNLVRLLG 576 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~ 576 (834)
-++|++.+.||+|.||.|-+|+.. +++.||||++.+... -..+...+|+.+|++++|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 578999999999999999999864 588999999964311 12457889999999999999999999
Q ss_pred eeeec--CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCc
Q 003288 577 CCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (834)
Q Consensus 577 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~ 654 (834)
+..+. +.+|||+|||..|.+...- ..+..+.+.++.+++.++..||+|||.++ ||||||||+|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 98764 5889999999998875442 23333999999999999999999999999 9999999999999999999
Q ss_pred eeeccccceecCCC---cccCCcccccccccccCcccccCCC---C-CccCcchhhHHHHHHHHhCCCCCCCCCCCcccc
Q 003288 655 KISDFGLARMFGGD---ELQGNTKQIVGTYGYMSPEYALDGL---F-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 727 (834)
Q Consensus 655 kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~ 727 (834)
||+|||.+..+... .........+||+.|+|||.+.++. + +.+.||||+||+||.|+.|+.||-....-
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 99999999877332 1122233478999999999987732 3 57899999999999999999998532110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.-..+++...+ .-+...+..+.+.+||.++|+.||++|.++.+|..+.-
T Consensus 326 ----------~l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ----------ELFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----------HHHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 00112222222 22333345678899999999999999999999977653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=348.48 Aligned_cols=261 Identities=29% Similarity=0.418 Sum_probs=205.0
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
..++|++.++||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.+++.+ +|+||+++++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3568999999999999999998742 24579999997543 34456789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccC----------------------------------------------------------
Q 003288 583 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 604 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 604 (834)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred ---------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcc
Q 003288 605 ---------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 605 ---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
....+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1124788899999999999999999998 9999999999999999999999999998664332211222
Q ss_pred cccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCC
Q 003288 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~ 754 (834)
...++..|+|||++....++.++|||||||++|||++ |+.||........ ....+.... .....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--------------~~~~~~~~~-~~~~~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--------------FYKMVKRGY-QMSRP 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--------------HHHHHHccc-CccCC
Confidence 2345678999999999999999999999999999997 9999764322110 000000000 00011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 755 LPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.....++.+++.+||+.||.+||++.+|+++|++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.20 Aligned_cols=260 Identities=25% Similarity=0.313 Sum_probs=212.8
Q ss_pred HHHhcCccccceeccCCcEeEEEEEecCC-cEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeee-ee-----
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC-VE----- 580 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~----- 580 (834)
....-+++|.+.|.+|||+.||.|++..+ .+||+|++-..+++..+..++|+.+|++|+ |+|||.+++.. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456889999999999999999998776 999999987778899999999999999997 99999999932 21
Q ss_pred -cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 581 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 581 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
.-+++|+||||.+|.|-+++..+...+ |++.++++|+.++++|+++||... ++|||||||-+||||..+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 136789999999999999996554444 999999999999999999999985 67999999999999999999999999
Q ss_pred ccceecCCCccc-CCc------ccccccccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 003288 660 GLARMFGGDELQ-GNT------KQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729 (834)
Q Consensus 660 Gla~~~~~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~ 729 (834)
|.|...-..... ... -...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 998753221100 000 012468999999987 567899999999999999999999999974321
Q ss_pred cccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+++... .-+...++...+.+||..||+.||.+||++-+|++.+-++
T Consensus 264 -----------laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 -----------LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -----------eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 11222211 2233456888999999999999999999999999998765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=329.77 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=207.5
Q ss_pred cCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|.... .+.||+|.+.... ....+.|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999997643 2579999986543 345577999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 586 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854321 145889999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003288 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987644333233334566889999999999999999999999999999998 888875322211
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....+.... ..........++.+++.+||+.||.+||+++||++.|++
T Consensus 235 --------~~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 --------VIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111 111222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=334.79 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=205.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999876 4788999998754 33456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999843 345889999999999999999999863 3999999999999999999999999999765332
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc-ccc-ccc-------cc--cc-
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGH-AWD-------LW--KD- 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~-~~~-~~~-------~~--~~- 737 (834)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+.......... ... ... .. ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2234578999999999999999999999999999999999999986433211100 000 000 00 00
Q ss_pred ----------------ccccccccccc---ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 738 ----------------DRVHDLIDPVI---MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 738 ----------------~~~~~li~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
....++.+... ...........++.+++.+||+.||++|||++|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000 00001112345789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.08 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=204.1
Q ss_pred hcCccccceeccCCcEeEEEEEec----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999753 35689999987653 3445679999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998532 346899999999999999999999998 9999999999999999999999999876543
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.|+....... ... .....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~----~~~~~------- 224 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK----AVEDG------- 224 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHCC-------
Confidence 22111 1112345678999999999999999999999999999875 998875432211 000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ..+........+.+++.+||+.+|.+||+++++++.|++.
T Consensus 225 --~-~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --F-RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --C-CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 0111222345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=302.69 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=212.6
Q ss_pred HhcCccccceeccCCcEeEEEEE-ecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----ee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EK 584 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 584 (834)
..++|++.++||+|||+-||.++ ..+++.+|+|++.-...++.+..++|++.-++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 46799999999999999999998 4568899999998777778889999999999999999999999886544 48
Q ss_pred EEEEEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 585 ILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
|++++|...|+|.+.+..... +..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999998865444 447999999999999999999999986 479999999999999999999999999988
Q ss_pred ecCCCcccC-------CcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003288 664 MFGGDELQG-------NTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 664 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 733 (834)
...-..... .-..-.-|..|.|||.+. +...++++|||||||+||+|+.|.-||+..-...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 653211100 011234688999999885 4567899999999999999999999987532211
Q ss_pred cccccccc-cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRVH-DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~~-~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+. .+....+ .-+.....++.+.+++.+|++.||.+||++.+++..++..
T Consensus 249 ----gSlaLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 ----GSLALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CeEEEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 1112122 1122223677899999999999999999999999998865
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=342.84 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=206.3
Q ss_pred HhcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 582 (834)
..++|++.++||+|+||.||+|+... +..||||+++... ....+.|.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 46789999999999999999997531 3479999997543 334567999999999995 999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCC---------------------------------------------------------
Q 003288 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..++||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998854210
Q ss_pred ------------------------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec
Q 003288 606 ------------------------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (834)
Q Consensus 606 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~ 649 (834)
...+++.++.+++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 003288 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~ 728 (834)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H-
Confidence 999999999999987644322222233456788999999999999999999999999999997 8888753221110 0
Q ss_pred ccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 729 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
......+ . ...........+.+++.+||+.+|++||++.+|+++|++.
T Consensus 350 ---~~~~~~~---------~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSG---------Y-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcC---------C-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0000000 0 0011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.23 Aligned_cols=251 Identities=34% Similarity=0.536 Sum_probs=195.2
Q ss_pred cccceeccCCcEeEEEEEec-----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+.+++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35679999999999999876 2578999999654 34457899999999999999999999999998888999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.++|... ....+++..++.|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 3456899999999999999999999998 9999999999999999999999999998873332
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.............|+|||.+....++.++||||||+++|||++ |+.|+....... +.. .+ ....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~------------~~-~~~~ 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIE------------KL-KQGQ 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHH------------HH-HTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc------------cc-cccc
Confidence 2222333457789999999999999999999999999999999 667764332111 110 01 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
...........+.+++.+||+.+|++||+++++++.|
T Consensus 223 -~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111222345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.57 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=205.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
..++|+++++||+|+||.||+++-+ +|+.+|+|++++.. ....+..+.|-.+|....+|.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4689999999999999999999865 59999999998764 3445667889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||++||++..+| .+.+.|++..+...+.+++-|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 56678999999999999999999999999 9999999999999999999999999986431
Q ss_pred C----------------------CcccC-----------------------CcccccccccccCcccccCCCCCccCcch
Q 003288 667 G----------------------DELQG-----------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVF 701 (834)
Q Consensus 667 ~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVw 701 (834)
. .+... .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00000 01124799999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCcc--cccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-
Q 003288 702 SFGILMLETLSSKKNTGVYNADSF--NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT- 778 (834)
Q Consensus 702 slGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt- 778 (834)
|||||+||||.|.+||....+... .++.|.. .+ ..+...+...+..++|.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l-~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TL-KFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hc-cCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999987655322 2222210 01 111122233678899999998 9999975
Q ss_pred --HHHHHHH
Q 003288 779 --MSDVISM 785 (834)
Q Consensus 779 --~~evl~~ 785 (834)
++||-++
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 5555443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.06 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=207.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998643 478999999765444 567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 585 ILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
++||||+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 2345889999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~--- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE--- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH---
Confidence 99999999986543322222223456788999999999999999999999999999998 998875332211 000
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....+. ...........+.+++.+||+.||.+||++.||++.|++
T Consensus 236 -~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -CITQGR----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000000 001112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=327.31 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=201.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 68999999986432 2334567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887543 2345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-----------~~~~~~~~~~-- 220 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-----------EEVDRRVKED-- 220 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-----------HHHHHHhhcc--
Confidence 123357899999999999999999999999999999999999998643321100 0000000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
...........+.+++.+||+.||++||+ ++++++.
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11122233457889999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=337.80 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=204.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 48899999996532 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3346889999999999999999999998 99999999999999999999999999986533
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... . .... ....+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~----~i~~--~~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--E----NLKY--WKETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--H----HHHh--ccccccCCC
Confidence 233457899999999999999999999999999999999999998643322110 0 0000 000000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........++.+++.+||+.+|.+||+++|+++.
T Consensus 222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012234578899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=320.00 Aligned_cols=247 Identities=22% Similarity=0.391 Sum_probs=210.2
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+.+|++||..|+||||+.++.+|+..+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999975 67999999998654 456667789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||..+|.|.+++ ...+.|++.+...++.||..|+.|+|++. ++|||||.+|||||+++++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45567999999999999999999999998 99999999999999999999999999998765
Q ss_pred CcccCCcccccccccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ....++|++-|.+||++.+.+|. ...|-|||||+||.|+.|.-||+..+.. .++..
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------------------~lvrQ 264 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------------------RLVRQ 264 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------------------HHHHH
Confidence 43 34568999999999999999985 7799999999999999999998643321 11111
Q ss_pred ccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 747 VIMQDEI-SLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 747 ~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
+..+.+ .++......-||++||..+|++|.|+.+|....
T Consensus 265 -Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 265 -ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112221 222334567799999999999999999998875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.02 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=200.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999999865332
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~------------~i~~~~- 214 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--YE------------KILAGK- 214 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHhCC-
Confidence 2235789999999999999999999999999999999999999864322110 00 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
..........+.+++.+||+.||.+||+ ++|+++.
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0111122456789999999999999995 8887755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.23 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=210.5
Q ss_pred cCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 345699999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
||||+++++|.+++.... ....+++..+++++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1235899999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------H
Confidence 99999999986644332222333456789999999999999999999999999999998 8888754332110 0
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
......... .........+.+++.+||+.+|++||++++|+++|+.+..
T Consensus 236 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 001111110 0111234568899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.63 Aligned_cols=255 Identities=30% Similarity=0.437 Sum_probs=206.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999998778899999986543 34567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999998 999999999999999999999999999877532211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......+..|+|||++.+..++.++||||||++++||++ |+.|+....... ... .+.... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~-------------~~~~~~-~ 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ-------------QVDQGY-R 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH-------------HHHcCC-C
Confidence 1111233468999999999999999999999999999999 888875322110 000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..........+.+++.+|++.+|.+||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=337.02 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=201.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999875 58899999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999843 346889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .. +....
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~----~~--------i~~~~ 231 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--IY----EK--------ILAGR 231 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--HH----HH--------HhcCC
Confidence 2 223578999999999999999999999999999999999999985322110 00 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
+ ..+.....++.+++.+||+.||.+||+ +++++..
T Consensus 232 ~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 011112346789999999999999997 6777644
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.39 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=214.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecC--CChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe-eEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-KILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 587 (834)
.++|..++++|+|+||.++..+++ +++.+++|++.- ..+...+...+|+.++++++|||||.+.+.+.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999998765 477899998753 334445578999999999999999999999999998 9999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|+|++||+|.+.+...+ +..++++.+.+++.||+.|+.|||++. |+|||||+.||+++.+..+||.|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999996543 567999999999999999999999877 99999999999999999999999999999876
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. .++.+.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------------------~Li~ki 218 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------------------ELILKI 218 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------------------HHHHHH
Confidence 54 2455689999999999999999999999999999999999999998643322 222221
Q ss_pred cc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..+.+..+..++..++..|++.+|..||++.+++.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 245566678889999999999999999999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=328.07 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=208.9
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457889999999999999999742 24569999998776667788999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 586 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
+||||+++++|.+++.... +...+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985332 2235899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....... .. ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~----~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VI----EC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HH
Confidence 999999986643322222223445778999999999999999999999999999998 888875332211 00 00
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....... .........+.+++.+||+.+|.+||++.||++.|+++.
T Consensus 235 i~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 0001000 011122346899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=326.05 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=204.0
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
..++|++.++||+|+||.||+|... .+..||||.+.... .....+|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24679999986432 3345678999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 584 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678889999999999999999988 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+....... ... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~----~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLR----FV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HH
Confidence 99999986644332222222355788999999999999999999999999999999 677765322211 000 00
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..... ..........+.+++.+||+.+|++||++.|++++|++
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000 01111233568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.76 Aligned_cols=255 Identities=30% Similarity=0.445 Sum_probs=207.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46899999999999999999998888899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 3345888999999999999999999988 999999999999999999999999999876543221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||++....++.++||||||+++|||++ |+.|+....... .... .... . .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~----~~~~-----~-----~ 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSA----LQRG-----Y-----R 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHH----HHcC-----C-----C
Confidence 1122345678999999998899999999999999999998 888875432211 0000 0000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+........+.+++.+|++.+|++||+++++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111233568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.59 Aligned_cols=257 Identities=29% Similarity=0.446 Sum_probs=204.1
Q ss_pred cCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
+.|++.++||+|+||.||+|+. ..++.+++|.+... .....+.|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 24678999999753 34455789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC--------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 587 ILEYMPNKSLNVFLFDST--------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235788999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003288 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~--- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VI--- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 999999999987644332222333456778999999998889999999999999999998 887874322110 00
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
+.+.... ..........++.+++.+||+.+|.+||++.+|+++|..
T Consensus 237 ----------~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ----------EMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000 001111223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.15 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=211.2
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+..+|++.++||.|+||.||+|+..+++.+|+|.+........+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 35679999999999999999999888999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999643 3356899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. .....++..|+|||.+....++.++||||||+++++|++ |+.|+....... ... .+....
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~-------------~~~~~~- 221 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYD-------------QITAGY- 221 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH-------------HHHhCC-
Confidence 1 113345778999999999999999999999999999998 788875432111 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111122334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.64 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=205.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... ...||||.++... ....+.|.+|+.++++++|+||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998743 3579999987543 3455789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++..+.+++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236899999999999999999999988 9999999999999999999999999999875
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .. +.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~-------------~~~~ 222 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VI-------------KAVE 222 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HH-------------HHHH
Confidence 2221112222345678999999999999999999999999999998 888875322111 00 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ..+........+.+++.+||+.+|++||+++||+++|++.
T Consensus 223 ~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGY-RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0011122345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.61 Aligned_cols=267 Identities=29% Similarity=0.385 Sum_probs=204.3
Q ss_pred ccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 586 (834)
|++.+.||+|+||+||++.. .+++.||+|.++... ....+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 357789999987543 34567789999999999999999999988764 35789
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+|||+++++|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... .......++..|+|||.+.+..++.++||||||++++||++|..|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 33211 11122345667999999998899999999999999999999999875433221111111111111111122222
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ..+........+.+++.+||+.+|++||++++|+++|+..
T Consensus 239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 211 1112223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.52 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=202.1
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
++|++.+.||+|+||.||+++..++..+|+|.+... ....+.|.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468889999999999999999888889999988643 2334678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988532 235889999999999999999999998 999999999999999999999999999865432221
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ..... .... . .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i----~~~~--~--------~ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMI----SRGF--R--------L 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----HCCC--C--------C
Confidence 1122345668999999998899999999999999999999 888875432211 11100 0000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.........+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.31 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=196.2
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.||+|+||.||+++.. +|+.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 5889999998653 2334567789999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCc
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 9998884 3456899999999999999999999998 999999999999999999999999998753221 1123
Q ss_pred ccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCC
Q 003288 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. . +... .....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~----~--------~~~~---~~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----L--------ILME---EIRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HH----H--------HHcC---CCCCC
Confidence 346799999999999999999999999999999999999999853221110 00 0 0000 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 755 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.....++.+++.+||+.||++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22345688999999999999999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=376.96 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=207.8
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
...+...++||+|+||.||+|+. .+++.||||++...... ...|++++++++|||||+++++|.++...++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677788999999999999987 46899999998654322 13468899999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++. .++|.++.+++.||++||+|||+....+|+||||||+||+++.++..++. ||.+.....
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999983 28899999999999999999997655569999999999999999888876 665543221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.....+++.|+|||++.+..++.++|||||||++|||++|+.|+............+.............+++.+..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 11236789999999999999999999999999999999999998543332223333333223333334445554422
Q ss_pred C-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 D-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....++..++.+++.+||+.||++||+|+||+++|+++
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 1 33456677889999999999999999999999999986
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.84 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
..+|++.+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 333 48999987543 44567899999999999999999999998765 567
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998532 345889999999999999999999998 999999999999999999999999999976
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............++..|+|||++.+..++.++||||||+++|||++ |+.|+........ ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---------------~~~~ 224 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---------------SSIL 224 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---------------HHHH
Confidence 54332222222345678999999999999999999999999999998 8888754322110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ...........+.+++.+||+.+|.+||++.+++..|...
T Consensus 225 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 225 EKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred hCCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 0011112234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.19 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=202.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 47889999986532 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988876542 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccccc--------cc-cccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA--------WD-LWKDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~--------~~-~~~~~~ 739 (834)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......... .+... +. ......
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1223457899999999999989999999999999999999999998653321100 00000 00 000000
Q ss_pred ccccccccccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVIMQ-----DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00100000000 0001113456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.75 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec-C
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 582 (834)
.++|++.++||+|+||.||+|+.. .++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 468999999999999999999642 24789999987543 33456788999999999 899999999988654 5
Q ss_pred eeEEEEEecCCCchhhhhhccCC---------------------------------------------------------
Q 003288 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred -CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccccccccccc
Q 003288 606 -KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684 (834)
Q Consensus 606 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 684 (834)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999998 9999999999999999999999999998764332222233345677899
Q ss_pred CcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHH
Q 003288 685 SPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYIN 763 (834)
Q Consensus 685 aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~ 763 (834)
|||++.+..++.++|||||||+|+||++ |..|+........ + ....... . ..........++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~---------~-~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEG---------T-RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhcc---------C-CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 8888753221110 0 0000000 0 00111123457889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 764 VALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 764 li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
++.+||+.+|++||++.||+++|++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.06 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=202.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 4788999988654 33455779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999843 345889999999999999999999753 3999999999999999999999999998765322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc-cc-----c-ccccc--cccc-
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LG-----H-AWDLW--KDDR- 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~-~~-----~-~~~~~--~~~~- 739 (834)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... .. . ..... ....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1233568999999999999899999999999999999999999986433211100 00 0 00000 0000
Q ss_pred ----------------cccccccccccC--C-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 ----------------VHDLIDPVIMQD--E-ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ----------------~~~li~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+.+...... . .......++.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000000 0 001123568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=347.39 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=204.4
Q ss_pred CccccceeccCCcEeEEEEEec-C-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999754 3 5788999876555555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 592 PNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++|+|.+++... .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543 23446889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .. ..++....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~------------~~~~~~~~-- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IM------------QQVLYGKY-- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHhCCC--
Confidence 223345679999999999999999999999999999999999999985322110 00 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111223456889999999999999999999864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.19 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=207.9
Q ss_pred HhcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45679999999999999999997642 367999998754 334556789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhcc-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec
Q 003288 583 EKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~ 649 (834)
..+++|||+++++|..++... .....+++..+++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22356899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 003288 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~ 728 (834)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 999999999999987654433222233345678999999999999999999999999999998 8888653221110
Q ss_pred ccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 729 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.+.... ...........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 244 ------------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ------------FKLLKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ------------HHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 00000000 0111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.25 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=205.1
Q ss_pred HHhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
..-++|.++++||+|.||+|+++.++. ++.+|||.+++. .....+..+.|.+|+... +||.++.++.+++..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999998864 788999999876 345677888999999888 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+.||++..+ ...+.+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999995333 35567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
--. ....+.+.+||+.|||||++.+..|+...|.|||||+|||||.|+.||...++++. .
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------F 577 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------F 577 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------H
Confidence 321 22356779999999999999999999999999999999999999999975544321 1
Q ss_pred ccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003288 745 DPVIM-QDEISLPMLMRYINVALLCVQENAADRPTM 779 (834)
Q Consensus 745 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
+..+. ...++.-.+.+.+.++.++|..+|++|.-+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12111 112333456678899999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.71 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=200.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC--CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|+... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4679999999999999999998643 368999998543 23345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 346899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+...
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~------------~i~~~ 243 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQ------------KILEG 243 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHH------------HHhcC
Confidence 32 234579999999999999889999999999999999999999986432211 000 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.. ..+......+.+++.+||+.||++|+ +++++++.
T Consensus 244 ~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 II---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 01111234578899999999999995 89998775
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.77 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=197.0
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
+.||+|+||.||+|+.. +++.+|+|.+... ..+....|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 6889999988654 344567799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2345889999999999999999999998 99999999999999999999999999876543221111111
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISL 755 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~ 755 (834)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+........ ...+.... ......
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---------------~~~~~~~~-~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---------------REAIEQGV-RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---------------HHHHHcCC-CCCCcc
Confidence 233567999999999999999999999999999998 7777753222110 00000000 011112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 756 PMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.....+.+++.+||+.+|++||++.+|+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.09 Aligned_cols=252 Identities=30% Similarity=0.433 Sum_probs=202.5
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5688899999999999999988777789999986443 334678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998542 236899999999999999999999998 9999999999999999999999999998664332211
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .. ...... ..
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~----~~~~~~----------~~ 220 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VE----KVSQGL----------RL 220 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHhcCC----------CC
Confidence 112345678999999998889999999999999999998 8888754332110 00 000000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.55 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=202.2
Q ss_pred ccccceeccCCcEeEEEEEecC----CcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe-----
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 583 (834)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+..++.++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998643 367999998743 23446789999999999999999999999876554
Q ss_pred -eEEEEEecCCCchhhhhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 584 -KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 584 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++................+..|+|||.+....++.++||||||+++|||++ |..|+....... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~-------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDY-------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------
Confidence 99987654332222222345678999999998999999999999999999999 778875322111 1000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ...........+.+++.+||+.||++||++.||++.|++.
T Consensus 228 ----~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ----LRHGN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHcCC--CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 0111223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.54 Aligned_cols=242 Identities=23% Similarity=0.293 Sum_probs=196.1
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 5889999999653 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCc
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988884 3346899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCC
Q 003288 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. . +... .....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~----~--------~~~~---~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----L--------ILME---DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HH----H--------hccC---CccCC
Confidence 345799999999999999999999999999999999999999854322110 00 0 0000 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 755 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
......+.+++.+||+.||++|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22345678999999999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.74 Aligned_cols=239 Identities=21% Similarity=0.280 Sum_probs=192.6
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||.||+++.. +++.||+|.++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998643 234456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999843 345899999999999999999999998 9999999999999999999999999998542221 12334
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...+.. .......
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~------------~~~~~~---~~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MY------------RKILQE---PLRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HH------------HHHHcC---CCCCCCc
Confidence 679999999999999999999999999999999999999986422111 00 000000 0111122
Q ss_pred HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRPT---MSDVIS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt---~~evl~ 784 (834)
....+.+++.+||+.||.+||+ +.|++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 3456789999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.70 Aligned_cols=271 Identities=25% Similarity=0.411 Sum_probs=204.2
Q ss_pred cCccccceeccCCcEeEEEEEec-----CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 585 (834)
++|++.+.||+|+||.||++... +++.||+|.+........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999742 478999999987777777889999999999999999999998754 34688
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccC-CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc-cccccccccc
Q 003288 666 GGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-LWKDDRVHDL 743 (834)
Q Consensus 666 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~l 743 (834)
....... ......++..|+|||.+.+..++.++||||||++++||++|..++................ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332111 1111234456999999998899999999999999999999877643221110000000000 0000000111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ..+........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11110 1111122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.23 Aligned_cols=283 Identities=24% Similarity=0.333 Sum_probs=212.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChh--hHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 586 (834)
.+.|+.+++|++|.||.||+|+++ +++.||+|+++...+. .--.-.+|+.+|.+++|||||.+-.+..- -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467899999999999999999875 4788999999754322 12345789999999999999999888764 347999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||||+. +|..++... ...+...++.-+..|+++|++|||... |+|||||++|+|+...|.+||+|||+||.++
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999986 788888433 356889999999999999999999998 9999999999999999999999999999987
Q ss_pred CCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCC-Ccc----cccccc-cccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSF----NLLGHA-WDLWKDDR 739 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~-~~~----~~~~~~-~~~~~~~~ 739 (834)
... ...+..+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++.|..... +.. .++... ...|..-.
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 652 234456889999999999875 699999999999999999999988765433 111 111110 11111111
Q ss_pred cccccc-cccc-------cCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCcccc
Q 003288 740 VHDLID-PVIM-------QDEISLP-MLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKG 804 (834)
Q Consensus 740 ~~~li~-~~~~-------~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~~ 804 (834)
....+. -... +..+... ....-.+++...|..||.+|.|++|.++. +-..+.|.|..|..++.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPT 378 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCC
Confidence 111110 0000 0011111 23556789999999999999999999765 44457888887776553
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.89 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=198.9
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 58899999986443 23345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 88888743 2345789999999999999999999998 9999999999999999999999999998653322
Q ss_pred cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc-----cccccccc----cc
Q 003288 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG-----HAWDLWKD----DR 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~-----~~~~~~~~----~~ 739 (834)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .... .....+.. ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11233567999999998875 5689999999999999999999999864432111 0000 00000000 00
Q ss_pred cccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+...... .......++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111100000 00112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.94 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=206.1
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||.||+++.. ++..+|+|.+........+.|.+|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999642 35679999988777777788999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCC------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 586 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999864321 135889999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++|+........ .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~---- 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--I---- 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--H----
Confidence 99999999986643322222223345788999999999999999999999999999998 8888743221110 0
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....... ...........+.+++.+||+.||.+||++.||++.|++
T Consensus 235 --------~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 --------ECITQGR--ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --------HHHHcCc--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000000 001111233567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.03 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=200.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|+.. +++ .+++|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56888899999999999999864 344 47888875443 2345678889999999999999999998754 45788
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
............++..|+|||.+....++.++||||||+++|||++ |+.|+........ .+........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGERL---- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCcC----
Confidence 4332222334567789999999998999999999999999999998 8888754322110 0000000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.........+.+++.+||..+|++||++.|+++.|....
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 000112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.70 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=205.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.+|++.++||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888899999999999999865 4788999998654 334577899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998432 2345899999999999999999999998 999999999999999999999999999876543221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.. +.... ... .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~---------~~~-~ 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLE---------KGY-R 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHH---------CCC-C
Confidence 1112234668999999999999999999999999999998 8888753221110 00100 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+||+.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=316.64 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=208.3
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 6899999987542 3344567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++.... +...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885433 2345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+............ .+...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-------------~~~~~ 223 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-------------KIEQC 223 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-------------HHhcC
Confidence 321 112346888999999999888999999999999999999999997532221111110 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.............+.+++.+||+.+|++||++.+|++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 001111223346789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.65 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=202.8
Q ss_pred hcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|++|.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 5679999999999999999998753 5679999886443 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cceee
Q 003288 585 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~ 657 (834)
++||||+++++|.+++..... ...+++..+++++.||++||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999854321 235899999999999999999999998 99999999999998765 59999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||........ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~-------- 231 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--M-------- 231 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--H--------
Confidence 9999987643322222222334568999999999999999999999999999997 8888754322110 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
+.+.... ...........+.+++.+|++.+|++||++.+|++.|.
T Consensus 232 -----~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -----EFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----HHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000000 01111223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.86 Aligned_cols=242 Identities=22% Similarity=0.282 Sum_probs=195.2
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.||+|+||.||+++.. +|+.||+|.++.. .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 5899999998653 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCc
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988884 3346899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCC
Q 003288 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+.... ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~------------~~~~~~---~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE------------LILMEE---IRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HH------------HHhcCC---CCCC
Confidence 335789999999999999999999999999999999999999854322110 00 000000 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 755 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
......+.+++.+||+.||.+|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12345678999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=347.00 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=206.5
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC---
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--- 582 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 582 (834)
....++|++.++||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334679999999999999999999864 6899999998643 3455677899999999999999999988775432
Q ss_pred -----eeEEEEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 583 -----EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 583 -----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999986432 2356899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~------- 255 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMH------- 255 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH-------
Confidence 99999987654333333445679999999999999999999999999999999999999986432111 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+... ...........+.+++.+||+.||.+||++.+++++
T Consensus 256 -----~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -----KTLAGR--YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000000 011122334578899999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.81 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=203.8
Q ss_pred CccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999753 23578999886543 3445789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003288 587 ILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~N 645 (834)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 1235889999999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCc
Q 003288 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 724 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~ 724 (834)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222223355778999999998899999999999999999998 888875332211
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. + +.+.... ...........+.+++.+||+.+|++||++.|+++.|++.
T Consensus 238 ~------~---------~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 L------F---------NLLKTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred H------H---------HHHhCCC-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 0 0 0111100 0111112335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.44 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=203.8
Q ss_pred cCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.+|++.++||+|+||.||+|.... ++.||+|.++.... ...+.|.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998642 47899999975543 33567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 586 LILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
+++||+.+++|.+++.... ....+++..+.+++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999984221 1235888999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003288 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+....... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~--- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VI--- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 999999999887644332222333456789999999998899999999999999999998 777765322211 00
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.. +.+.. ...........+.+++.+||+.+|.+||++++|++.|+.
T Consensus 237 -~~--------i~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 -EM--------IRNRQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH--------HHcCC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00 00000 011122344568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.60 Aligned_cols=265 Identities=27% Similarity=0.421 Sum_probs=206.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC-----------------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 573 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 573 (834)
.++|++.++||+|+||.||+++..+ +..||+|.+.... ....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4688999999999999999987643 2458999987543 345678999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCchhhhhhccC--------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003288 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 574 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~N 645 (834)
+++++..+...+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985433 1236899999999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCCCCCCC
Q 003288 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNAD 723 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt--g~~p~~~~~~~ 723 (834)
|+++.++.++|+|||+++...............++..|+|||.+....++.++|||||||++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987654433333334556789999999998899999999999999999998 5556543221
Q ss_pred cccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 724 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..........+........ .........++.+++.+||+.||++||++.||++.|++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111110000000 01111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.17 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=196.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 588999999865432 233467889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 567666633 2345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc--ccc-----ccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--LGH-----AWDLWKDDRVH 741 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~--~~~-----~~~~~~~~~~~ 741 (834)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ... ....+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 12233567899999998865 458899999999999999999999986533211000 000 00000000000
Q ss_pred cccccc-cc-cCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 742 DLIDPV-IM-QDEIS-------LPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 742 ~li~~~-~~-~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+. .. ..... ......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 00000 011245779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.83 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 583 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 583 (834)
..++|++.+.||+|+||.||+|...+ ++.|++|++... .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999998765 688999998754 34456778999999999999999999998876 467
Q ss_pred eEEEEEecCCCchhhhhhccCCC-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeec
Q 003288 584 KILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 658 (834)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998554322 56899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+....... ... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAA----YLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHc
Confidence 999987644332222223345778999999998899999999999999999999 898875432211 110 0000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 738 ~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+ . ...........+.+++.+||+.+|++||++.+|++.|+...
T Consensus 235 ~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 G---------Y-RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C---------C-CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0 00011112356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.00 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=195.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999875 58999999986543 34457799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.... ...+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3567788899999999999999998 99999999999999999999999999987643221
Q ss_pred cCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
......||..|+|||++.. ...+.++|||||||++|||++|+.||............. ....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-----------~~~~ 290 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-----------AICM 290 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-----------HHhc
Confidence 1233578999999998743 234568999999999999999999987322211100000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. . ..........++.+++.+||+.||++||++.|+++.
T Consensus 291 ~-~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 S-Q-PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred c-C-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 111122334578899999999999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=326.50 Aligned_cols=242 Identities=26% Similarity=0.357 Sum_probs=194.5
Q ss_pred ceeccCCcEeEEEEEec----CCcEEEEEEecCC----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++||+|+||.||+++.. .++.||+|.++.. .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 5788999998643 223345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. +...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999884 3446788899999999999999999998 9999999999999999999999999987543221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+.....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~~------------~~~~~~~~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--TI------------DKILKGKL-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--HH------------HHHHcCCC--
Confidence 12234578999999999999899999999999999999999999986432211 00 00001100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.........+.+++.+||+.+|++|| +++++++.
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11112235678999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.95 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=202.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC---------------CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLL 575 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 575 (834)
.++|++.++||+|+||.||+++... ...||+|.++.. .....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4589999999999999999987532 235899998754 344556799999999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCchhhhhhccCC---------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003288 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTK---------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (834)
Q Consensus 576 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NI 646 (834)
+++......++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854221 124688999999999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhC--CCCCCCCCCCc
Q 003288 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS--KKNTGVYNADS 724 (834)
Q Consensus 647 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg--~~p~~~~~~~~ 724 (834)
+++.++.+||+|||++................++..|+|||++....++.++||||||++++||+++ ..|+.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999865433222222334557789999999999999999999999999999984 44554322111
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+......+.... ... ...........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 241 --~~~~~~~~~~~~~------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQG------RQI-YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcc------ccc-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1110000000000 000 001111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.92 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=197.1
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.|+++++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 5789999999653 23445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 345889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cCCcccccccccccCcccccCCCCCccCcchhhH
Q 003288 670 L---------------------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslG 704 (834)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 003288 705 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL--CVQENAADRPTMSDV 782 (834)
Q Consensus 705 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ev 782 (834)
|++|||++|+.||..............+ ...+ ..+.......++.+++.+ |+..++..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~------------~~~~-~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINW------------ENTL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcc------------cccc-CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999998654322111000000 0000 001111223456777777 556677779999999
Q ss_pred HHH
Q 003288 783 ISM 785 (834)
Q Consensus 783 l~~ 785 (834)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=319.24 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=206.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4688999999999999999997642 3689999986543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 585 ILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854322 234788999999999999999999988 9999999999999999999999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.|+........ .. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~----~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LK----FVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HH----HHh
Confidence 9999987654433223333456789999999998899999999999999999998 8888753222110 00 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
... ...........+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 000 001111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=296.39 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=207.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
-++|++.+.||+|.||.||.|+.+. +-.||+|++.+.. .+...++.+|++|-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4689999999999999999998754 6679999986542 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||...|.|...|.. .+...+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999853 24456888999999999999999999998 9999999999999999999999999987543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.......+||..|.|||...+..++...|+|++|++.||++.|.+||+.....+. ..++....
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et--------------YkrI~k~~ 238 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET--------------YKRIRKVD 238 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--------------HHHHHHcc
Confidence 2345568999999999999999999999999999999999999999974331110 01111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
-.++......+.++|..|+..+|.+|.+..|++..
T Consensus 239 ---~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 ---LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11123345578899999999999999999999764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.23 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=196.0
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----eeE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999865 5899999998643 2234467889999999999999999999886432 479
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+. ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 68888873 3345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-cCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------ccc
Q 003288 666 GGDEL-QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWD 733 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~~ 733 (834)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234578999999999876 6789999999999999999999999864332100 00000 000
Q ss_pred cccccccccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+........+.......... ......+.+++.+||+.||++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000000 0123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=312.62 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=206.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecC--CChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-----cCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-----QGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 583 (834)
...|..++.||+|+||.|..+... +|+.||||++.+ ......++-.+|+++|++++|+||+.+++.+.- -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456666789999999999999875 589999999973 344556778899999999999999999998865 347
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.|+|+|+| ..+|...+ +.++.|+......+++||++||.|+|+.+ ++||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 56888888 34445999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCC-Cccccccccccccccc---
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNLLGHAWDLWKDD--- 738 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~--- 738 (834)
...........+..+.|.-|.|||++.. ..|+...||||.||+|.||++|++-|...+. +...++........++
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8865433344466788999999998754 6799999999999999999999998875443 2222222211111111
Q ss_pred -----ccccccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 -----RVHDLIDPVIMQDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 -----~~~~li~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.....+........ .-.......++++.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111111 112334578899999999999999999999876
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=324.36 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=206.3
Q ss_pred hcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 568889999999999999999742 2457999998654 244567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
...++||||+++++|.+++..... ...+++.+++.++.||++||.|||+.+ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999864321 235788999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-- 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence 9999999999999987754332222333456678999999999999999999999999999998 6677643221110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
........ ...........+.+++.+||+.+|.+||++.||++.|+++
T Consensus 249 ----~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 249 ----FKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ----HHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 00000000 0011122345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=317.37 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=199.0
Q ss_pred ccccceeccCCcEeEEEEEecCC-c--EEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------Ce
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLNG-Q--EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 583 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 583 (834)
|.+.++||+|+||.||+|+.... + .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987543 2 5899988653 345567899999999999999999999987532 24
Q ss_pred eEEEEEecCCCchhhhhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 584 KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
.+++|||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2345899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++.+.............+++.|+|||.+....++.++||||||+++|||++ |+.|+...... ... .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~----~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIY----DYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHcCC
Confidence 9987644322222223346778999999999999999999999999999999 77787532211 110 0111110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. .........+.+++.+||+.+|.+||++.++++.|++.
T Consensus 232 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 11112334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.53 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=204.9
Q ss_pred hcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+++.. ..+.+|+|.++.. .....+++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 2357999999754 234556788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
...++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 235889999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.....+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 9999999999999986643222222222234578999999999999999999999999999998 7777653221110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.+.... ...........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 252 -------------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 -------------FKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -------------HHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 00000000 0111122345778899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.09 Aligned_cols=251 Identities=29% Similarity=0.424 Sum_probs=201.2
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.+|++.+.||+|+||.||+++...+..+|+|.+.... ...+.|.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4588889999999999999998777789999986432 234578899999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 99999998533 236899999999999999999999998 999999999999999999999999999865432211
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .... ..... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~---------~~~~~-----~~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVES---------VSAGY-----RL 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHH---------HHcCC-----cC
Confidence 1111234568999999999999999999999999999999 788875432211 0000 00000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.........+.+++.+||+.+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122455789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.44 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=190.4
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4788999998653 223345566677777654 899999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999998653222 22
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .. .+... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~------------~i~~~---~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FD------------SILND---RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHcC---CCCC
Confidence 3346789999999999999999999999999999999999999864332110 00 00000 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMS-DVIS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 784 (834)
.......+.+++.+||+.||++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 122334678899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=321.05 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=204.2
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24579999886443 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 584 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
.++||||+++|+|.+++..... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999954221 234567888999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+. ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~------ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK------ 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------
Confidence 99999986644332222223345778999999999999999999999999999998 677764322111 000
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.+... ..........+.+++.+||+.+|++||++.++++.|++.
T Consensus 233 ------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ------FVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ------HHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0000000 001112235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=333.47 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=204.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|+++|.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3567888999999999999999853 24689999997543 333467899999999997 999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccC----------------------------------------------------------
Q 003288 583 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 604 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 604 (834)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003288 605 -------------------------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (834)
Q Consensus 605 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NIL 647 (834)
....+++..+++++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124677888999999999999999988 999999999999
Q ss_pred ecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccc
Q 003288 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~ 726 (834)
+++++.+||+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986533221112223356789999999999899999999999999999998 7888753221110
Q ss_pred ccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 727 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ...+.... ...........+.+++.+||+.+|.+||+++||++.|++.
T Consensus 351 ~-------------~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 F-------------YNAIKRGY-RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H-------------HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 00000000 0011112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.48 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=203.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-----------------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 573 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 573 (834)
.++|++.++||+|+||.||+++.. +...+|+|.+... .....+.|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 2346899998754 3445678999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCchhhhhhccCC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003288 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 574 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~N 645 (834)
+++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854321 134788899999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCCCCCCC
Q 003288 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNAD 723 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt--g~~p~~~~~~~ 723 (834)
||+++++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999987644322222223345678999999888899999999999999999998 55666433221
Q ss_pred cccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 724 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
. .............. .. ..+........+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~--~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q--VIENTGEFFRDQGR-QV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHhhccc-cc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 11100000000000 00 001111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.42 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=203.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 58999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998533 56899999999999999999999988 999999999999999999999999999876433
Q ss_pred c---------------------------ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 669 E---------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 669 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112234578999999999999999999999999999999999999986443
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVISM 785 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 785 (834)
..... .. +.... ..+ ..+........+.+++..|++ +|.+||+ ++|+++.
T Consensus 235 ~~~~~------~~-----i~~~~-~~~-~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETY------NK-----IINWK-ESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHH------HH-----HhccC-Ccc-cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21100 00 00000 000 001111134567889999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=334.28 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=199.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 5889999999643 2334566889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999998765321
Q ss_pred cccC------------------------------------CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 003288 669 ELQG------------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 669 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt 712 (834)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003288 713 SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISM 785 (834)
Q Consensus 713 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 785 (834)
|..||........ ... ... . ...+ ..+........+.+++.+|+. +|.+|++ ++|+++.
T Consensus 235 G~~Pf~~~~~~~~--~~~---i~~-~------~~~~-~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET--YRK---IIN-W------KETL-QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH--HHH---HHc-C------CCcc-CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999864332110 000 000 0 0000 000111223467788999996 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.24 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=203.6
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|+..+...||+|.++... ...+.|.+|+.++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999988777789999997533 23467899999999999999999999875 45679999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998542 2345789999999999999999999998 999999999999999999999999999876443221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||+..+..++.++||||||+++|||++ |..|+....... ... . +.... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~----~---------~~~~~-~ 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD----Q---------VERGY-R 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHH----H---------HhcCC-C
Confidence 1122346778999999998999999999999999999999 777765322111 000 0 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.33 Aligned_cols=254 Identities=31% Similarity=0.478 Sum_probs=203.4
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457899999999999999999988888999999975433 3467999999999999999999999875 45688999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 2345899999999999999999999998 999999999999999999999999999876443211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .+.... .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~-------------~~~~~~-~ 221 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLE-------------QVERGY-R 221 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHH-------------HHHcCC-C
Confidence 1122345678999999998899999999999999999999 788875322111 000 000000 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+........+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.73 Aligned_cols=271 Identities=26% Similarity=0.400 Sum_probs=203.6
Q ss_pred cCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Cee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 584 (834)
+.|+++++||+|+||.||+++. .+++.||+|.++... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247889999987553 44457899999999999999999999998875 568
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|...........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433211 112234567789999999988999999999999999999998765322111000000000000000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ..+........+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 1111222456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.68 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=194.2
Q ss_pred cCccccceeccCCcEeEEEEEec--CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc---CCCceeeEeeeeee-----
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE----- 580 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 580 (834)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46789999886432 22334566787777766 69999999998852
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 5888887432 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWDLWKDD 738 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~ 738 (834)
+++..... .......|++.|+|||.+....++.++|||||||++|||++|++||........ .+.... ......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEE 231 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChh
Confidence 99876433 223345789999999999999999999999999999999999999865432110 000000 000000
Q ss_pred ccc-------cccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 RVH-------DLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ~~~-------~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ........ ...........+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 00001112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.29 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=197.9
Q ss_pred CccccceeccCCcEeEEEEEec----CCcEEEEEEecCC----ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
+|++.++||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++.++ +|+||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999998753 5789999998643 223346688999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+......... .... ..+
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~--------~~~ 223 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVS--------RRI 223 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHH--------HHH
Confidence 533221 122345799999999999865 4789999999999999999999998643221100 0000 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
... ...........+.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LKC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hcC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 1111122345678999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.07 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=208.1
Q ss_pred cCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++. .+++.+|||.+... .....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 47899999987643 2334568899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 3456899999999999999999999998 99999999999999999999999999887643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... ......++..|+|||.+.+..++.++||||||+++|||++|..|+............ .+.....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~-- 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDY-- 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------hhhcCCC--
Confidence 321 122346888999999999989999999999999999999999997532221111100 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.+|++||||.+|++++++.
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 --PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111122455788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.63 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=209.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999886 6899999988532 2334678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|..++.... ....+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999885432 3455899999999999999999999998 99999999999999999999999999886543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............ .+...
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~ 223 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KIEKC 223 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh-------------hhhcC
Confidence 221 122346788999999999989999999999999999999999997533211111100 00000
Q ss_pred cccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 748 IMQDEIS-LPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 748 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ..+.. ......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 224 ~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 D-YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C-CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 01111 13345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.93 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=194.7
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.||+|+||.||+++.. +++.||+|.++.. .......+.+|++++..++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998653 2234567788999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
+|..++. +...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9998873 34468999999999999999999997 66 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.. . +.+... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~-------------~~i~~~--~~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--F-------------ELILME--EIRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--H-------------HHHhcC--CCCC
Confidence 2345799999999999999999999999999999999999999854322110 0 000000 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112345678999999999999996 89999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.93 Aligned_cols=271 Identities=28% Similarity=0.415 Sum_probs=206.5
Q ss_pred cCccccceeccCCcEeEEEEEec-----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeee--cCee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 584 (834)
+.|++.+.||+|+||.||+++.. .++.+|||.++..... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998533 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... ........++..|+|||.+....++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 753221 1111123455679999999988999999999999999999999988653222111110000000000111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ..........++.+++.+||+.+|.+||++.||+++|+++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 1111122336788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.07 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=200.8
Q ss_pred cCccccceeccCCcEeEEEEEecC-C--cEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 587 (834)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 3 34788888743 344567899999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCc
Q 003288 588 LEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~ 654 (834)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred eeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003288 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~---- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYE---- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----
Confidence 99999998643211 01111233567999999999999999999999999999997 888875432211 000
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ...........+.+++.+||+.+|.+||++.++++.|++.
T Consensus 230 ---------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 ---------KLPQGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred ---------HHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000000 0111122345688999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.37 Aligned_cols=202 Identities=25% Similarity=0.351 Sum_probs=175.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++.. +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 48899999996532 234467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------------CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCC
Q 003288 669 ELQ---------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~ 715 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003288 716 NTGVY 720 (834)
Q Consensus 716 p~~~~ 720 (834)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.52 Aligned_cols=247 Identities=30% Similarity=0.416 Sum_probs=195.6
Q ss_pred eeccCCcEeEEEEEec---CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999653 57889999986443 345678999999999999999999999875 45678999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC-C
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-N 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 673 (834)
+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999984 3346899999999999999999999998 9999999999999999999999999998764432211 1
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+....... .. +.+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~-------------~~i~~~~-~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VT-------------QMIESGE-RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------------HHHHCCC-CCC
Confidence 122234678999999988889999999999999999998 888886432211 00 0011100 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 753 ISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.......++.+++.+||+.||.+||++.+|.+.|++-
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1122345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.97 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=201.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.++||+|+||.||+|+.. +++ .||+|.++.. .....+.+.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467889999999999999999753 444 4899998654 34456788999999999999999999999875 4577
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998532 346899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---------------~~~~ 224 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---------------PDLL 224 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---------------HHHH
Confidence 53322111222345678999999999999999999999999999998 8888753221110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ..+........+.+++.+||+.||++||++.++++.|+..
T Consensus 225 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 225 EKGE-RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HCCC-cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0000 0111122345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=333.72 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=197.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++.. +++.||||.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999999643211
Q ss_pred ccc------------C---------------------------------CcccccccccccCcccccCCCCCccCcchhh
Q 003288 669 ELQ------------G---------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSF 703 (834)
Q Consensus 669 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwsl 703 (834)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHH
Q 003288 704 GILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR---PTMS 780 (834)
Q Consensus 704 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 780 (834)
||++|||++|+.||........ ... ..... ..+ .-+.......++.+++.+||+ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~~---i~~~~-------~~~-~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET--YRK---IINWR-------ETL-YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH--HHH---HHccC-------Ccc-CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999864332110 000 00000 000 000011123467889999997 66665 5999
Q ss_pred HHHHH
Q 003288 781 DVISM 785 (834)
Q Consensus 781 evl~~ 785 (834)
|++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=333.36 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=195.0
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.|+++++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999865 57899999986532 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999843 346888999999999999999999998 9999999999999999999999999976431100
Q ss_pred ---------------------------------------------ccCCcccccccccccCcccccCCCCCccCcchhhH
Q 003288 670 ---------------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslG 704 (834)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011234789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 003288 705 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSD 781 (834)
Q Consensus 705 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e 781 (834)
|++|||++|+.||....+....... .. ....+ ..+.......++.+++.+|+ .+|.+|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i-----~~-------~~~~~-~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKV-----IN-------WQTSL-HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHH-----Hc-------cCCCc-CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999998643321110000 00 00000 00111122345667777765 59999997 777
Q ss_pred HHHH
Q 003288 782 VISM 785 (834)
Q Consensus 782 vl~~ 785 (834)
+++.
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.63 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=202.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999864 5889999999765555566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998842 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+....+...... ...... ..+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------~~~~~~---~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MSKSNF---QPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------eecCCC---CCCC
Confidence 122346888999999884 44578899999999999999999998753222111000 000000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
. .........+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.30 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=193.8
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHH---HhcCCCceeeEeeeeeecCeeEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|++++ ..++||||+++++++.+....++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999875 58899999996432 23345667776665 456799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 345899999999999999999999998 99999999999999999999999999875322
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.|+........ .. .+....
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~------------~i~~~~ 217 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FD------------SIVNDE 217 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHhCC
Confidence 1 1223346789999999999999999999999999999999999999864322110 00 000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
..........+.+++.+||+.||.+|| ++.++++.
T Consensus 218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011112345678899999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.17 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=210.6
Q ss_pred HhcCccccceeccCCcEeEEEEEecC---Cc--EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
..+..+..++||.|-||.||+|.+.+ |+ .||||..+.. ..+..+.|..|+.+|++++||||++++|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34556667899999999999998643 33 5899999873 55667899999999999999999999999976 478
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++|||.++-|.|..+|. .++..|+.......+.||..||+|||+.. +|||||..+|||+...--+||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999994 34556889999999999999999999998 99999999999999999999999999999
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
+..+.+.... ...-+..|||||.+.-.+|+.++|||-|||.+||+++ |.+||..-... ++.-.
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~ 604 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGH 604 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEE
Confidence 8776554433 3456789999999999999999999999999999988 88887532221 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+...- +.+.+..+...++.++.+||..+|.+||++.|+...|+.+
T Consensus 605 iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 605 IENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 11100 2344556677889999999999999999999999888554
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.05 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=204.9
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999742 24579999987553 34456799999999999 79999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998532 2234899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ ..+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--------------~~~ 255 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--------------FYK 255 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--------------HHH
Confidence 6643321111222355778999999999999999999999999999998 8888753221110 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ..........++.+++.+||+.+|++||++.|+++.|++.
T Consensus 256 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGY-RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 010000 0011112235788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=334.71 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=197.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.+|+++++||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 48899999986432 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 346888999999999999999999998 999999999999999999999999997533110
Q ss_pred c-----------------------------------------ccCCcccccccccccCcccccCCCCCccCcchhhHHHH
Q 003288 669 E-----------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707 (834)
Q Consensus 669 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl 707 (834)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 003288 708 LETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP---TMSDVIS 784 (834)
Q Consensus 708 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~ 784 (834)
|||++|+.||.............. +. ... ..+........+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~---~~---------~~~-~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVIN---WE---------TTL-HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhc---cC---------ccc-cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999865433211000000 00 000 00011112345667777766 5999999 8898886
Q ss_pred H
Q 003288 785 M 785 (834)
Q Consensus 785 ~ 785 (834)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.91 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 46789999987543 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003288 585 ILILEYMPNKSLNVFLFDST-------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~N 645 (834)
++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1234788999999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCc
Q 003288 646 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 724 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~ 724 (834)
|++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543322222222344678999999998999999999999999999997 777764222111
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.. ....... . .........++.+++.+||+.+|.+||++.|+++.|++
T Consensus 241 --~~----~~~~~~~--------~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VI----YYVRDGN--------V--LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHhcCC--------C--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 0000010 0 00111234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.25 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=202.3
Q ss_pred cCccccceeccCCcEeEEEEEecC-C---cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
..|++.+.||+|+||.||+|+... + ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998753 3 36999998754 345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998432 346899999999999999999999998 99999999999999999999999999886643
Q ss_pred CcccCCccc-c--cccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccc
Q 003288 668 DELQGNTKQ-I--VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 668 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
......... . ..+..|+|||.+....++.++||||||+++|||++ |..|+....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~------------- 223 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINA------------- 223 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHH-------------
Confidence 221111111 1 12457999999999999999999999999999886 888875332111 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ..+........+.+++.+||+.+|.+||++.+|+++|++.
T Consensus 224 i~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 224 IEQDY-RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHcCC-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 0011112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.21 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=193.9
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4789999998753 233456678899998877 899999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988873 3346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc---ccccccccccccccccccccccccc
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF---NLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~---~ 221 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK---Q 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcC---C
Confidence 2346789999999999999999999999999999999999999853221110 000000000 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPT------MSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 785 (834)
..++......+.+++.+||+.||++||+ +.++++.
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1122233456789999999999999998 4666443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.58 Aligned_cols=260 Identities=18% Similarity=0.210 Sum_probs=195.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|++.++||+|+||.||++... .++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 468999999999999999999875 58899999753 24568899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 95 67877773 2345889999999999999999999998 9999999999999999999999999997543221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-----ccccccc--------ccc--
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-----NLLGHAW--------DLW-- 735 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-----~~~~~~~--------~~~-- 735 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+........ ..+.... ...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999999999999999999999999999987532211000 0000000 000
Q ss_pred ccccccccc----cccc--ccCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLI----DPVI--MQDEIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li----~~~~--~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......... .... ...... ......+.+++.+||+.||.+|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 0000 000000 1223478899999999999999999999853
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.50 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=195.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCC-CceeeEeeeeeecCeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 588 (834)
+|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 4778999998653 23445678889999999976 45888999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999998753221
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~------------~i~~~-- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQ------------SIMEH-- 216 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHcC--
Confidence 1 123345789999999999999999999999999999999999999864322110 00 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
...........+.+++.+||+.||.+||+. +++.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001111234567899999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.81 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=205.1
Q ss_pred hcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|.+.++||+|+||.||+++.. ....+|+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468889999999999999999742 2457999998754 334567789999999999 699999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
...+++|||+++++|.+++.... ....+++.++.+++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986432 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999987643322222222334568999999999999999999999999999999 7777753321110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. ....... ...........+.+++.+||+.+|++||++.|+++.|++..
T Consensus 246 ~----~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 F----KLLREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred H----HHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 0000000 00111223346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.09 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=204.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC-C---cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|+..+.||+|+||.||+|+... + ..+|+|.++.. .....+.+.+|++++.+++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998753 3 36999998654 34456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999843 2346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCc-ccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDELQGNT-KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
........ .....+..|+|||++....++.++|||||||++|||++ |+.|+....... .. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~-------------~~i 223 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VM-------------KAI 223 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH-------------HHH
Confidence 32211111 11223567999999998899999999999999999997 999975332211 00 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ..+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 NDGF-RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 1111122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.47 Aligned_cols=253 Identities=19% Similarity=0.307 Sum_probs=200.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999875 58899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccCCcccccccccccCccccc------CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .. ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~---~i~~~~~~-- 227 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YN---NIMNFQRF-- 227 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HH---HHHcCCCc--
Confidence 221 223357899999999986 45678999999999999999999999864322110 00 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+ ..+........+.+++..|++ +|.+||+++++++.
T Consensus 228 -----~-~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -----L-KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----c-CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 001111234567889999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.87 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=194.3
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||||.++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998653 234456678899999876 799999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99998884 3345889999999999999999999998 9999999999999999999999999987643221 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~------------~i~~~~~---~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FE------------SILHDDV---LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HH------------HHHcCCC---CC
Confidence 2345789999999999999999999999999999999999999864332111 00 0000000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRP-------TMSDVISM 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 785 (834)
+......+.+++.+||+.||++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111235678999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.42 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=204.7
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788999999999999999987 488999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999998 99999999999999999999999999987632211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
....+..|+|||.+....++.++||||||++++||++ |..|+........ ... .. ... .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~----~~---------~~~-~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPH----VE---------KGY-R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHH----Hh---------cCC-C
Confidence 2234668999999998899999999999999999997 8888754322110 000 00 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..........+.+++.+||+.+|++||+++|++++|++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=321.82 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=205.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC--------CcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
..+|++.+.||+|+||.||+++... +..||+|.++.. .....+++.+|+.++.++ +|+||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3578999999999999999997421 236899988754 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
...+++|||+++++|.+++.... ....+++.+++.++.|+++||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986432 2245888999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 9999999999999987644322222222344578999999999999999999999999999998 7777653221110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....... . ...........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 246 ----~~~~~~~---------~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 ----FKLLKEG---------H-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHcC---------C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0000000 0 001112234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=308.03 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=204.6
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|++|.||+++.. +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 5889999998643 345567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+++++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 2456899999999999999999999998 99999999999999999999999999987654321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||++.+..++.++||||||++++||++|+.|+....... .. ....... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~------------~~~~~~~--~ 218 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LI------------LKIIRGV--F 218 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHcCC--C
Confidence 1233467889999999999999999999999999999999999986433211 00 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.59 Aligned_cols=254 Identities=31% Similarity=0.441 Sum_probs=204.1
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 56889999999999999999998889999999987543 23467899999999999999999999864 55789999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 3346899999999999999999999998 999999999999999999999999999876532211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||++....++.++||||||++++||++ |+.|+....... ... . +.... .
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~---------~~~~~-~ 221 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ----N---------LERGY-R 221 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH----H---------HHcCC-C
Confidence 1122345678999999998899999999999999999999 898885332111 000 0 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+.......++.+++.+||+.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111233568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.34 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=192.7
Q ss_pred ceeccCCcEeEEEEEecC---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999997643 4579999986543 334457899999999999999999999999999999999999999
Q ss_pred chhhhhhccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 595 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234677788899999999999999998 9999999999999999999999999997654332222
Q ss_pred CcccccccccccCcccccCC-------CCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 673 NTKQIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
......++..|+|||++... .++.++||||||+++|||++ |+.|+........ .... .. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---VR-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---hh-cccCCCC
Confidence 22334678899999988642 35789999999999999996 9989864332211 0000 00 0001111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
++ .........+.+++..|+ .+|++||+++||+..|.
T Consensus 232 ~~-----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KP-----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC-----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 111122345778899998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.82 Aligned_cols=240 Identities=22% Similarity=0.334 Sum_probs=189.8
Q ss_pred ceeccCCcEeEEEEEecC-------------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 519 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
+.||+|+||.||+|+... ...|++|.+........+.|.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997532 2358999887665666678899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-------ceeec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-------PKISD 658 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-------~kl~D 658 (834)
+||||+++++|+.++.. +...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2345899999999999999999999998 999999999999987664 89999
Q ss_pred cccceecCCCcccCCcccccccccccCccccc-CCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
||++...... ....++..|+|||.+. ...++.++|||||||++|||++ |..|+.........
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---------- 219 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---------- 219 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----------
Confidence 9998754321 2245788999999887 4678999999999999999985 77665432211100
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
...... .....+....+.+++.+||+.||.+||++.++++.|+
T Consensus 220 -----~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 -----RFYEGQ---CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----HHHhcC---ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000000 0111122356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.06 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=195.3
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+++.. +++.||+|.++.. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 5889999999753 233456688999999998 799999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 99988873 3356899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc---ccccccccccccccccccccccccc
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF---NLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ .+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------VILEKQI-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------HHHcCCC--
Confidence 2346789999999999999999999999999999999999999864322110 00000000 0111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPT------MSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 785 (834)
.........+.+++.+||+.||.+||+ ++++++.
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 112223456889999999999999997 6777643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.27 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=200.8
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
..++|++.++||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3578999999999999999999875 5889999998642 22334567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCcccccccccccCcccccCC----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
..... ......||+.|+|||++... .++.++|||||||++|||++|+.||........ . ..
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~------------~~ 258 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y------------SK 258 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--H------------HH
Confidence 33211 12345799999999998653 478999999999999999999999864332110 0 00
Q ss_pred cccccc-ccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 743 LIDPVI-MQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 743 li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
+..... ...+........+.+++.+||+.+|.+ ||++.|+++.
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000000 000111123457789999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.64 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=200.9
Q ss_pred hcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec-C
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 582 (834)
.++|++.++||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 346789999997543 33456788999999999 789999999988654 4
Q ss_pred eeEEEEEecCCCchhhhhhccCC---------------------------------------------------------
Q 003288 583 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998853210
Q ss_pred -------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccccc
Q 003288 606 -------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678 (834)
Q Consensus 606 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 678 (834)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788889999999999999999998 9999999999999999999999999998753322211222234
Q ss_pred ccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHH
Q 003288 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM 757 (834)
Q Consensus 679 gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~ 757 (834)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... ....... ........
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~----------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC----RRLKEGT----------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHH----HHHhccC----------CCCCCCCC
Confidence 5678999999999999999999999999999997 888865322110 000 0000000 00001112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 758 LMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 758 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+.+++..||+.+|++||++.||++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.05 Aligned_cols=250 Identities=35% Similarity=0.523 Sum_probs=203.8
Q ss_pred ceeccCCcEeEEEEEecC----CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||++.... +..|++|.++..... ..+.+.+|++++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 788999999765443 367899999999999999999999999999999999999999
Q ss_pred CchhhhhhccCC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 594 KSLNVFLFDSTK------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
++|.+++..... ...+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865422 367999999999999999999999998 99999999999999999999999999988755
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
...........++..|+|||.+....++.++||||||++++||++ |..|+....... .. ..... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~~--------~ 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VL----EYLRK--------G 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHc--------C
Confidence 432223344567889999999998899999999999999999999 588876432211 00 00000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
. ...........+.+++.+||+.+|.+||++.|+++.|+
T Consensus 224 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 Y--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C--CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 01112222467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.36 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=199.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 6889999998654 344556799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996553 3678889999999999999999998 999999999999999999999999999865432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++|+.|+............. .......+... .
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~~~~~~~-~ 218 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-------QLLQCIVDEDP-P 218 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-------HHHHHHhccCC-C
Confidence 1233578999999999999999999999999999999999999986432211110000 00000000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........++.+++.+||+.+|.+||+++|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111233567899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=307.29 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=198.2
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchh
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 597 (834)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876543 34457899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccc
Q 003288 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988432 345889999999999999999999998 999999999999999999999999999765332211 11122
Q ss_pred cccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
.++..|+|||++....++.++||||||+++|||++ |..|+....... ... ..... . .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~----~~~~~-----~-----~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--ARE----QVEKG-----Y-----RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHHcC-----C-----CCCCCCC
Confidence 44678999999998899999999999999999998 888875332111 000 00000 0 0011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 757 MLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.01 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=196.0
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 588 (834)
+|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999876 47799999987532 23345677788888887 5899999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999999754322
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~------------~i~~~~- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ------------SIMEHN- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HH------------HHHhCC-
Confidence 1 122345789999999999999999999999999999999999999864332111 00 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
...+.....++.+++.+||+.+|.+|++. .++.+
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 01112234567899999999999999984 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.37 Aligned_cols=252 Identities=26% Similarity=0.320 Sum_probs=201.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888543 2345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+...+...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~---------~~~~~~~~~-- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--RE---------EVERRVKED-- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HH---------HHHHHhhhc--
Confidence 1 1234789999999999999999999999999999999999999864322110 00 000001100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
...........+.+++.+||+.||.+|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112223455788999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.00 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=203.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
..+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3578889999999999999998642 3479999986543 3446789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++..+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999998532 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccC-CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
...... ......++..|+|||.+.+..++.++||||||++++|+++ |+.|+........ .. ...+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~----~~~~~-----~ 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IK----AIEEG-----Y 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HH----HHhCC-----C
Confidence 432111 1111233568999999999899999999999999999887 9988754322110 00 00000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....+..+.+++.+|++.+|.+||++.++++.|++.
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011112345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.65 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=195.9
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||+||+++.. +++.||+|.+.... ....+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 58899999986432 22346778899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcc
Q 003288 597 NVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 597 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98875432 3456899999999999999999999998 99999999999999999999999999987644322 223
Q ss_pred cccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCH
Q 003288 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~ 755 (834)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . .......... .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~--------~~~~~~~~~~---~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K--------ELKQRILNDS---VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--H--------HHHHhhcccC---CCCcc
Confidence 357899999999999999999999999999999999999998643221100 0 0000001100 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 756 PMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.....+.+++.+||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2445688999999999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.44 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=196.0
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----eeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 586 (834)
-.|+..+++|.|+||.||+|.+.+ ++.||||+.-...+. -.+|+++|+++.|||||+|+-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357777999999999999998754 689999998544322 136899999999999999998886543 3458
Q ss_pred EEEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeecccccee
Q 003288 587 ILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 664 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~ 664 (834)
|||||+. +|..++... ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999986 777777532 23456788888889999999999999988 9999999999999976 8999999999998
Q ss_pred cCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCC-cccccccccccccccccc-
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVH- 741 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~- 741 (834)
+...+-. ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|...+.. ....+.........+++.
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8554322 335668899999999875 6999999999999999999999988764432 111111111111111111
Q ss_pred ------cccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 ------DLIDPVIMQDE----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ------~li~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+...+.+.... .......+..+++.++|+.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11112221111 233345678899999999999999999998865
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.61 Aligned_cols=249 Identities=30% Similarity=0.401 Sum_probs=199.3
Q ss_pred ceeccCCcEeEEEEEecC--C--cEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|++|.||+|.+.+ + ..||||.++.... ...+.|.+|+.++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3699999977655 667889999999999999999999999988 889999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc-cC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 672 (834)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..... ..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 56899999999999999999999998 99999999999999999999999999987744221 11
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......++..|+|||.+....++.++||||||++++||++ |+.|+....... ..... .. ... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~----~~------~~~---~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKI----DK------EGE---RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----Hh------cCC---cC
Confidence 1223456789999999999999999999999999999998 999875322111 00000 00 000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.........+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.06 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=201.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc--EEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+.. ++. .+++|.++.. .....+.|.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999864 344 4688877653 344567889999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1235889999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++..... .......++..|+|||++....++.++|||||||+++||++ |..|+........ ..
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~--- 234 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE--- 234 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HH---
Confidence 999999998643211 11111234668999999988889999999999999999998 8888753322110 00
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. +.... ...........+.+++.+||+.+|++||++.+++++|+++
T Consensus 235 -~---------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -K---------LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -H---------HhcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00000 0011112234678999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.78 Aligned_cols=236 Identities=23% Similarity=0.340 Sum_probs=190.1
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||||.+... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998643 233456778888888877 699999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 346899999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .. ..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~----~i--------~~~~~---~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE----AI--------LNDEV---VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH----HH--------hcCCC---CC
Confidence 3345789999999999999999999999999999999999999864332110 00 00 00000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTM 779 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
.......+.+++.+||+.||.+||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11233567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.67 Aligned_cols=240 Identities=24% Similarity=0.328 Sum_probs=191.0
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 58899999986532 23445667788888765 899999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999988843 345889999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~----~~~~~------~~-----~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFE----SIRVD------TP-----HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhC------CC-----CC
Confidence 234678999999999999999999999999999999999999986433211 000 00000 00 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMS-DVI 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 783 (834)
......++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112334678899999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.35 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=194.5
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+++.. +++.||||.++.. .....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 4789999999753 233456678899999888 799999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99998874 3346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. . +.... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~----~--------i~~~~---~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQ----S--------ILEDE---VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HH----H--------HHcCC---CCC
Confidence 2345789999999999999999999999999999999999999864332110 00 0 00000 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTM-----SDVISM 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 785 (834)
.......+.+++.+||+.||++||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11234567899999999999999999 888654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.01 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=201.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58999999886432 1234678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345889999999999999999999998 9999999999999999999999999998664
Q ss_pred CCcccC-CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . . ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~---------~~~~ 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--I---F---------KIAT 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--H---H---------HHhc
Confidence 322111 11335678899999999999999999999999999999999999753221100 0 0 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... ...........+.+++.+||+.+|.+||++.|+++.
T Consensus 222 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPT-NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCC-CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 111222334567899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.83 Aligned_cols=238 Identities=26% Similarity=0.310 Sum_probs=191.5
Q ss_pred ceeccCCcEeEEEEEe----cCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 519 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 357899999996532 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999884 3346899999999999999999999998 9999999999999999999999999988653321 1
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
......|++.|+|||.+.+..++.++|||||||++|||++|+.|+....... ... .+.... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~------------~i~~~~---~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMT------------MILKAK---LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHH------------HHHcCC---CC
Confidence 2234578999999999999889999999999999999999999986432111 000 000000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003288 753 ISLPMLMRYINVALLCVQENAADRPTMSD 781 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
........+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11123356789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.20 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=194.8
Q ss_pred eeccCCcEeEEEEEec---CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCc
Q 003288 520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
.||+|+||.||+|.+. .+..||+|.+.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35579999987653 334567999999999999999999999875 457899999999999
Q ss_pred hhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc-CCc
Q 003288 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-GNT 674 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 674 (834)
|.+++.. ....+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..+...... ...
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999843 2346899999999999999999999998 999999999999999999999999999865433211 111
Q ss_pred ccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
....++..|+|||.+....++.++||||||+++|||++ |+.|+........ ...+.... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---------------~~~~~~~~-~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---------------MSFIEQGK-RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---------------HHHHHCCC-CCCC
Confidence 11233578999999998889999999999999999996 8888753322110 00000000 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
......++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 222346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.61 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=199.1
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchh
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 597 (834)
++||+|+||.||++...+++.||+|.++..... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccc
Q 003288 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
+++... ...+++..+..++.+++.+|+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998432 335789999999999999999999998 999999999999999999999999999865432222121223
Q ss_pred cccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..+..|+|||.+.+..++.++||||||++++||++ |..|+........ ...+.... .......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---------------~~~~~~~~-~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---------------RERIESGY-RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---------------HHHHhcCC-CCCCCcc
Confidence 34667999999998899999999999999999999 7777654322110 00000000 0111122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 757 MLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....+.+++.+|++.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.26 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=204.7
Q ss_pred HHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEec--CCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeE
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 585 (834)
......|+++++||+||.+.||++...+.+.+|+|++. ..+.+..+.|.+|+..|.+|+ |.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34467899999999999999999998888889999764 446677889999999999994 999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||= ..+|..+|... ...++.-.+..+..||+.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999975 56899998432 233342377789999999999999999 99999999999994 568999999999998
Q ss_pred CCCcccCCcccccccccccCcccccCCC-----------CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGL-----------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
..+...-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||+.+....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~---------- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI---------- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH----------
Confidence 8777666667789999999999986432 4578999999999999999999987433110
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.++..+.++.-.-.-...+..-++++++..||+.||++||+..|+++.
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112233333210000111112238999999999999999999999865
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.90 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=202.3
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688999999999999999998777789999886543 33467899999999999999999999875 45688999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999998543 2345789999999999999999999998 999999999999999999999999999876433211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... .... .... . .
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~~---------~-~ 221 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQ----VERG---------Y-R 221 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcC---------C-C
Confidence 1122345778999999998999999999999999999999 888875322111 0000 0000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..........+.+++.+||+.+|.+||++++|++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=314.08 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=204.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 5889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999832 34789999999999999999999998 99999999999999999999999999886543221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........... ..... .+.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-----~~~~~------~~~~-- 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNG------TPEL-- 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-----HhcCC------CCCC--
Confidence 12234688999999999988899999999999999999999999864332111000 00000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+++.+||+.+|.+||++.|+++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1111233567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.48 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=200.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCc-eeeEeeeeeecC-----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQG----- 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 582 (834)
...|..+++||+|.||+||+|+.. +|+.||+|+++-..+ .......+|+.+|++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777789999999999999865 589999999865433 23355689999999999999 999999999877
Q ss_pred -eeEEEEEecCCCchhhhhhccCCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 583 -EKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 583 -~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
..++||||++ .+|..++....+. ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 4888888544332 45777889999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-----ccccc-ccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-----NLLGH-AWD 733 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-----~~~~~-~~~ 733 (834)
+|+.+.-... .....++|.-|.|||++.+. .|+...||||+||++.||++++.-|....+... ..+.. ..+
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9997653321 13345789999999999887 799999999999999999998887765443111 01100 011
Q ss_pred cccccccccccccccccC----CCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LWKDDRVHDLIDPVIMQD----EISL---PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~----~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.|.......-.+...... .... .......+++.+||+.+|.+|.+++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111000001000000 0000 011367889999999999999999999876
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.57 Aligned_cols=256 Identities=31% Similarity=0.480 Sum_probs=206.0
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..++|++.++||+|+||.||+|...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999998888899999987543 3457789999999999999999999999988999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2346899999999999999999999998 99999999999999999999999999987653221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. .......+..|+|||.+.+..++.++||||||++++||++ |+.|+....... .... +....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~-------------~~~~~- 221 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQ-------------VERGY- 221 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------------HHcCC-
Confidence 1 1112234568999999998899999999999999999998 888874322110 0000 00000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...........+.+++.+|++.+|.+||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111124568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.55 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=199.1
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
...++|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999876 4789999998642 2233456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999842 24788999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCC----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
..... .......||+.|+|||++... .++.++|||||||++|||++|+.||........ ..
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------------~~ 257 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------------YS 257 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--------------HH
Confidence 43221 112345799999999998754 378999999999999999999999864322110 00
Q ss_pred ccccccc-ccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 742 DLIDPVI-MQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
.+++... ...+........+.+++..|++.++.+ ||++.|+++.
T Consensus 258 ~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000 000111123456778889999865544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.79 Aligned_cols=241 Identities=24% Similarity=0.319 Sum_probs=191.3
Q ss_pred ceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+|+... ++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7899999986532 23345667788888765 899999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998843 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ... .... ..+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~----~i~~------~~~-----~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQ----SIRM------DNP-----CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHh------CCC-----CC
Confidence 234578999999999999999999999999999999999999986432211 000 0000 000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMS-DVIS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 784 (834)
.......+.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112334678999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=342.90 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=203.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+|+.. +++.||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 4889999998653 2334567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 589 EYMPNKSLNVFLFDSTK--------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
||+++++|.+++..... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 234567788999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcc----------------cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 661 LARMFGGDEL----------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 661 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987622110 001123569999999999999999999999999999999999999985422111
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 789 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 789 (834)
.... ..+..+.. ..........+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~~~------------~~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYR------------DVILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh------------hhccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000 00000000 000112234678899999999999995 677788877665
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.29 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=203.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999998754 889999999877777788899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998887432 345899999999999999999999988 9999999999999999999999999987643221
Q ss_pred cCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.......++..|+|||++. ...++.++|||||||++|||++|+.|+........ ... . . ....
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----~-~-----~~~~ 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLK----I-A-----KSEP 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHH----H-h-----cCCC
Confidence 1123356788999999984 34578899999999999999999999754322110 000 0 0 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+. ..........+.+++.+||+.+|++||+++|+++.
T Consensus 233 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PT---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cc---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 01112234567899999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.62 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=207.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+.++..+||-|.||.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+..+|||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4456777899999999999999865 567999999754 34568999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.+|+|.++|..- .+..++.-.++.++.||+.||+||..++ +|||||.++|+|+.++..+|++||||++++..+.+
T Consensus 345 M~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999643 3445777788899999999999999998 99999999999999999999999999999876654
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.... ...-+..|.|||-+....|+.|+|||+|||+||||.| |--|+...+ +.+++.+++.+.
T Consensus 421 TAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgy---------- 483 (1157)
T KOG4278|consen 421 TAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGY---------- 483 (1157)
T ss_pred eccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccc----------
Confidence 3221 1233678999999999999999999999999999998 555543211 112222222221
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.....-+...+++|+++||+.+|.+||++.|+.+.++..
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1122233556789999999999999999999998887543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=301.88 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=208.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+-|.++++||+|+||.|||+.++ .|+.+|||++.- +...+++..|+.||++.+.+++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45778899999999999999876 499999999864 346788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
..|+..+++. .+++.|.+.++..++...++||+|||... -||||||+.||||+.+|.+||+|||.|-.+....
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 9999999984 45567999999999999999999999987 8999999999999999999999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
...+.+.||+.|||||++..--|+.++||||||++..||.-|++|+....+-.--+ .-+.-...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------MIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------MIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------eccCCCCC
Confidence 23456899999999999999999999999999999999999999976433211000 00111111
Q ss_pred CC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 752 EI--SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 752 ~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+ +...+.++-+++++||-..|++|-|+-++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22 23356789999999999999999999988765
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=311.09 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=201.1
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+.|++.++||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|+|++++++++..+...++||||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 346788999999999999998764 7788999997766667788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99999988743 2346899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.......++..|+|||++. ...++.++|||||||++|||++|++|+........ ... . ... ..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~----~-~~~-----~~~ 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLK----I-AKS-----EPP 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHH----H-hhc-----CCC
Confidence 1223356889999999984 44578899999999999999999999754322110 000 0 000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+ .........+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111234578899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=330.35 Aligned_cols=194 Identities=24% Similarity=0.316 Sum_probs=167.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|.+.+.||+|+||.||++.... ++.||||... ...+.+|+++|++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998764 7889999642 23457899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++.. ....+++.+++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 678777743 2346899999999999999999999998 99999999999999999999999999987644322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~ 717 (834)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999987654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.07 Aligned_cols=248 Identities=31% Similarity=0.455 Sum_probs=195.8
Q ss_pred ceeccCCcEeEEEEEecC----CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 35578999999999999999999999875 4568999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC-
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG- 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 672 (834)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999533 36899999999999999999999998 9999999999999999999999999998764332111
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ..... .... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~----~~~~----------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAML----ESGE----------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH----HcCC----------cC
Confidence 1111233568999999999999999999999999999998 899876433211 11100 0000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.34 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=199.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeee-ecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~ 590 (834)
.++|++.+.||+|+||.||++.. .++.+|+|.++... ..+.|.+|+.++++++|+|++++++++. +++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788999999999999999977 47889999986543 3467899999999999999999999765 45678999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+++++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998542 2335889999999999999999999998 9999999999999999999999999988653321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+....... ... ....+ .
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~----~~~~~---------~- 216 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKG---------Y- 216 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcC---------C-
Confidence 12334568999999999899999999999999999998 888875322111 000 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...........+.+++.+|++.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.35 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=199.0
Q ss_pred hcCccccceeccCCcEeEEEEEec---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..+|++.++||+|+||.||++... .++.||+|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 468999999999999999999753 3578999988643 23468999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|++. ++|.+++ .....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 5777777 33456899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccc--------ccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW--------DLWKDDR 739 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~--------~~~~~~~ 739 (834)
..........||+.|+|||++....++.++|||||||++|||++|+.|+........ ..+.... .......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 333333456799999999999999999999999999999999999999854332110 0000000 0000000
Q ss_pred --ccc---ccccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 --VHD---LIDPVIMQDEIS-------LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 --~~~---li~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+ ...... +.... ......+.+++.+||+.||++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVL-RPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccc-cCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000 00000 0123467789999999999999999999866
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.69 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+..+ ++.+++|.++.... .+++.+|++++++++|+||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678999999999999999998765 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 2356899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+............ .....+ .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~---~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----------PNKPPP---T 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----------ccCCCC---C
Confidence 223345788999999999999999999999999999999999998643221110000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.+|++||+++||++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0111223456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.28 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=201.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+++.. +++.+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999865 4788999988654 334456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999843 35688999999999999999999974 5 999999999999999999999999998765322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-cccccccccccc----------
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDD---------- 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~---------- 738 (834)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ............
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 123357889999999998888999999999999999999999997533221110 000000000000
Q ss_pred -------ccccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 -------RVHDLIDPVIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 -------~~~~li~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...++.+....... ........+.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000 001134468899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.68 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 5789999999999999999999877888999988654 3345678999999999999999999999887 7789999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 999999998543 3345788999999999999999999988 99999999999999999999999999987643221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......++..|+|||++....++.++||||||++++|+++ |+.|+....... ... ...... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~----~~~~~~----------~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERGY----------R 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhCCC----------C
Confidence 11222345678999999998899999999999999999999 888875332111 000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+........+.+++.+|++.+|++||++.++.++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.67 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=189.6
Q ss_pred ceeccCCcEeEEEEEecC---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
++||+|+||.||+|.... ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3568899876443 334567899999999999999999999999999999999999999
Q ss_pred chhhhhhccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 595 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.+++..... ....++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567888999999999999999998 9999999999999999999999999987543322211
Q ss_pred CcccccccccccCcccccC-------CCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 673 NTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+....+.. .... ... .....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~---~~~-~~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQ---VVR-EQDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHH---Hhh-ccCccCC
Confidence 2223355778999998743 456889999999999999999 677765332111 0000 000 0001111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.+ .........+.+++..|+ .||++||+++||++.|.
T Consensus 232 ~~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 112223345667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.87 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=202.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 468889999999999999999865 5889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999884 3346899999999999999999999998 9999999999999999999999999988664321
Q ss_pred cCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+...... . .... ...+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~-----~~~~---~~~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-M-----TKSN---FQPPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-h-----hccC---CCCCc
Confidence 1223457899999999874 45688999999999999999999998753322110000 0 0000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. .. .......+.+++.+||+.+|++||++++|+++
T Consensus 231 ~-~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 L-KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c-cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 00 01123467899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.45 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=188.9
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHH-HHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+++.. +|+.+|+|++... .....+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999864 5899999998643 2233445556655 46778999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99988873 3456899999999999999999999998 999999999999999999999999998753221 112
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..++...+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~------------~~~~~~~~---~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MY------------DNILHKPL---VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HH------------HHHHcCCc---cC
Confidence 334678999999999999999999999999999999999999986432211 00 00000000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
.......+.+++.+|++.+|.+||++++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112345678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.45 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=195.0
Q ss_pred ceeccCCcEeEEEEEecC-Cc--EEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 5788988753 344567899999999999 899999999999999999999999999
Q ss_pred CchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 594 KSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1235789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
++...... ........+..|+|||++....++.++||||||++++||++ |..||....... ... .
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~----~----- 223 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE----K----- 223 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHH----H-----
Confidence 98632211 11111233567999999998899999999999999999997 888875322111 000 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ...........+.+++.+||+.+|.+||++.++++.|+++
T Consensus 224 ----~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 224 ----LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----HhCCC-CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00000 0011112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=318.49 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=194.4
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999754 233456788999999988 699999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988873 3346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccccccccccccccccccccccCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~---~~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------ILEK---PIR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------HHhC---CCC
Confidence 2346789999999999999999999999999999999999999864322111 000000000 0000 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003288 753 ISLPMLMRYINVALLCVQENAADRPTM------SDVISM 785 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 785 (834)
.+......+.+++.+||+.||.+||++ +++++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 122234567899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.13 Aligned_cols=237 Identities=23% Similarity=0.299 Sum_probs=187.3
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHH-HHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58999999986432 222344555544 56778999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 99998884 3446889999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..++.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~------------~~i~~~~~---~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MY------------DNILNKPL---RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HH------------HHHHcCCC---CC
Confidence 334578999999999999999999999999999999999999986432111 00 00000000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
.......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.20 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=201.4
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.+|++.+.||+|+||.||++...+++.+|+|.+.... .....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688889999999999999988778899999986443 234678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988432 345789999999999999999999998 9999999999999999999999999998664332211
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+....... .... .... .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~--~~~~~~----- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVET----INAG--FRLYKP----- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH----HhCC--CCCCCC-----
Confidence 112234678999999998899999999999999999998 888875322111 0000 0000 000001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
......+.+++.+||+.+|++||++.|+++.|.
T Consensus 224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.49 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=193.1
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||.||+++.. +|+.||+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9887543 2335889999999999999999999998 9999999999999999999999999998764322 1223
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... . . ....+...+ . .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-~----~-----~~~~~~~~~-~-~~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-E----L-----KRRTLEDEV-K-FEHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-H----H-----HHHhhcccc-c-ccccc
Confidence 468999999999999899999999999999999999999986432211000 0 0 000000000 0 00112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
...++.+++.+||+.||++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345678999999999999999998876444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.05 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=202.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC-Cc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
..+|++.+.||+|+||.||+|...+ ++ .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578889999999999999998643 32 58999886554 3456788999999999999999999999887 7889
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998532 335899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............++..|+|||.+....++.++||||||++++||++ |+.|+........ .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---------------~~~~ 224 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---------------PDLL 224 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---------------HHHH
Confidence 53322111112234568999999988899999999999999999998 9998764322111 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ...........+.+++.+||..+|++||++.++++.|++.
T Consensus 225 ~~~~-~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 225 EKGE-RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred hCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000 0011111234678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.32 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=208.3
Q ss_pred cccceeccCCcEeEEEEEe-cCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRL-LNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~-~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
...++||+|+||+||||.+ ++| -+||||++... ..+..+++..|+.+|.+++|||++||+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999975 334 36899988544 4556789999999999999999999999998876 889999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+.|.|.++++. .+..+..+..+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 3455888999999999999999999987 9999999999999999999999999999987766
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+ .+.+++....
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------------eI~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------------EIPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---------------HhhHHHhccc
Confidence 5555555566789999999999999999999999999999999 77886543322 1222222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+-..++.....++.++.+||..|+..||+++++...+.+..
T Consensus 918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11223345667899999999999999999999999886653
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.65 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=203.7
Q ss_pred cCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999864 2467999988665443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCC------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 586 LILEYMPNKSLNVFLFDSTKK------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644322 25899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|++........ .......++..|+|||.+.+..++.++||||||++++||++ |..|+....... ... .....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLN----RLQAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHH----HHHcC
Confidence 99875432221 12233456788999999988889999999999999999999 677764322111 000 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.. ...........+.+++.+||+.+|.+||++.|++++|.+
T Consensus 235 ~~---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KL---------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred Cc---------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 001111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.01 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=187.6
Q ss_pred eeccCCcEeEEEEEecC-------------------------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeE
Q 003288 520 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 574 (834)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555556788999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC--
Q 003288 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-- 652 (834)
Q Consensus 575 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-- 652 (834)
++++.+....++||||+++++|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998843 2346889999999999999999999998 99999999999997654
Q ss_pred -----CceeeccccceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHH-hCCCCCCCCCCCcc
Q 003288 653 -----NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SSKKNTGVYNADSF 725 (834)
Q Consensus 653 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~ell-tg~~p~~~~~~~~~ 725 (834)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643221 12356788999998875 56899999999999999995 68888753322110
Q ss_pred cccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 726 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
. ...... .....+....+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~---------------~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E---------------RFYEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---------------HHHHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000000 0011112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=331.38 Aligned_cols=264 Identities=18% Similarity=0.276 Sum_probs=191.8
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--------
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-------- 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 581 (834)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 58899999885432 2345799999999999999999886532
Q ss_pred CeeEEEEEecCCCchhhhhhc-cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-Cceeecc
Q 003288 582 GEKILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDF 659 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DF 659 (834)
...++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 146789999986 56555533 234456899999999999999999999998 99999999999998665 6999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKD 737 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 737 (834)
|+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||........ ..+.........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998764322 12235789999999998764 689999999999999999999999864332110 000000000000
Q ss_pred -------cccccccccccc----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 738 -------DRVHDLIDPVIM----QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 738 -------~~~~~li~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....++..+... ...+......++.+++.+||+.||.+|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000000 000111123578899999999999999999999854
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=309.64 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=200.2
Q ss_pred ccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHH--HHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLK--EFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
|++.+.||+|+||.||+++... ++.+|+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999865 668999999776544332 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. +...+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999995 4456899999999999999999999998 99999999999999999999999999986511 12
Q ss_pred CCcccccccccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......++..|+|||++. +..++.++||||||+++++|++|..|+.......... ...+........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-----------~~~~~~~~~~~~ 221 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-----------IIEKILKRPLPS 221 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-----------HHHHHHHTHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-----------hhhhcccccccc
Confidence 2334467899999999998 8889999999999999999999999976431100000 000000000000
Q ss_pred -CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 751 -DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 751 -~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.34 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEec--CCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++-++||+|.|+.|++... ..|+.+|+|++. +....+.+++.+|+.|-+.|+||||++|.+...+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 57889999999999999998754 468889988763 223447788999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~ 665 (834)
|+|.|+.|-.-|- .+-..++..+-..+.||+++|.|+|.++ |||||+||+|+||-+. --+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999966552 2245678888899999999999999998 9999999999999543 35899999999988
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
+.... .....|||+|||||++...+|+..+|||+.||+||-|+.|.+||...+.... . +.++.+. .|
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl--y----e~I~~g~----yd 230 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--Y----EQIKAGA----YD 230 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH--H----HHHhccc----cC
Confidence 74332 2346899999999999999999999999999999999999999865332111 0 0000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..+.=....++..+++++||..||.+|.|+.|.++
T Consensus 231 --~-~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 --Y-PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --C-CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 11111223457789999999999999999888764
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.92 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=201.0
Q ss_pred CccccceeccCCcEeEEEEEecCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999886432 22346689999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 245789999999999999999999998 99999999999999999999999999886532
Q ss_pred Cc----ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 668 DE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 668 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.. .........++..|+|||++.+..++.++||||||++++||++|+.|+........... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY--------IGAHRG- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH--------hhhccC-
Confidence 11 11122345688999999999998999999999999999999999999864321110000 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ...........+.+++.+||+.+|.+||++.|+++
T Consensus 226 ~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 L-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01112223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.10 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=204.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 578999999999999999999864 6899999999766555667789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999832 35789999999999999999999998 99999999999999999999999999987543321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+........... ..... .+ .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~---~ 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TP---E 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CC---C
Confidence 12234688899999999999999999999999999999999999854332111000 00000 00 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.29 Aligned_cols=251 Identities=32% Similarity=0.494 Sum_probs=198.4
Q ss_pred ceeccCCcEeEEEEEecC-------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+.||+|+||.||+|+..+ ++.+|||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 34567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-----Cceeecccc
Q 003288 591 MPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-----NPKISDFGL 661 (834)
Q Consensus 591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-----~~kl~DFGl 661 (834)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234789999999999999999999988 99999999999999877 899999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~-- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQH----VTAG-- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHH----HhcC--
Confidence 986644332222233455788999999999999999999999999999998 888875322111 1000 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
. ...........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 230 -----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -----G---RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----C---ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001112234577899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.01 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=198.6
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec------
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ------ 581 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 581 (834)
.+.+.|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999875 47889999986543 3446788999999998 799999999998753
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999998542 3346889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+........... ...
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----Hhc
Confidence 98653321 1223457899999999986 34678899999999999999999999853322110000 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .. ..........+.+++.+||+.+|.+||++.|+++
T Consensus 231 -~~-----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -NP-----AP----RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CC-----CC----CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00 0011122346789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.39 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||++... +++.+|+|.+........+.|.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567999999999999999999875 5889999999877667778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999998432 345899999999999999999999998 9999999999999999999999999987653321
Q ss_pred cCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+........ .. ..... ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~-----~~ 225 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KILKS-----EP 225 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HHhcC-----CC
Confidence 1223356889999999875 34578899999999999999999999864322110 00 00000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.+ .........+.+++.+||+.+|.+||++.+|++.
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111233467899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.76 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=200.0
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3455555678999999999999865 477899999987766677889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~ 668 (834)
|+++++|.+++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999854322212278888999999999999999998 999999999999986 678999999999865432
Q ss_pred cccCCcccccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......++..|+|||++.... ++.++||||||+++|||++|+.|+.......... +... ...
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-------~~~~-----~~~ 228 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-------FKVG-----MFK 228 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-------hhhh-----hhc
Confidence 21 122345789999999987644 7899999999999999999999975322111000 0000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ..........++.+++.+||+.+|.+||++.|++..
T Consensus 229 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 I--HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred c--CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 111222334568899999999999999999999753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=323.83 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=201.0
Q ss_pred HHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 506 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
..+....++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 334445689999999999999999999876 4788999998642 223345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998842 34788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCC----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||........ . ......
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~---~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y---SKIMNH 262 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--H---HHHHcC
Confidence 987643321 112345799999999998754 378999999999999999999999864322100 0 000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 003288 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISMI 786 (834)
Q Consensus 738 ~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 786 (834)
... + ..+........+.+++.+||+.++.+ ||+++|+++..
T Consensus 263 ~~~-------~-~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNS-------L-TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCc-------c-cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 0 00111123456788999999844433 78999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=319.89 Aligned_cols=241 Identities=24% Similarity=0.296 Sum_probs=188.0
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHH-HHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+++.. +++.||+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999876 47789999986432 12233444444 456778999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998843 345788888899999999999999998 999999999999999999999999999754221 122
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~------------~i~~~~~---~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD------------NILNKPL---QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHH------------HHHhCCc---CC
Confidence 334679999999999999999999999999999999999999986432211 000 0000000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......+.+++.+||+.||.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1123456789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.91 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=186.7
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHH-HHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99988873 3345888999999999999999999998 9999999999999999999999999987532211 22
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ... .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~------------~i~~~~---~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MYD------------NILHKP---LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HHH------------HHhcCC---CCC
Confidence 334578999999999999999999999999999999999999986432111 000 000000 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
.......+.+++.+||+.||.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222345688999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.06 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=196.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccc---------------------------------CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCC
Q 003288 669 ELQ---------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~ 715 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003288 716 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISM 785 (834)
Q Consensus 716 p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 785 (834)
||........ .. ..... ...+ ..+...+...++.+++.+++. +|.+|++ +.|+++.
T Consensus 235 Pf~~~~~~~~--~~----~i~~~------~~~~-~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET--YR----KVMNW------KETL-VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH--HH----HHHcC------CCce-ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9864332111 00 00000 0000 000011133467778888764 9999985 5666544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.50 Aligned_cols=250 Identities=21% Similarity=0.338 Sum_probs=202.3
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++++.++...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999875 5889999998543 3445678889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999887432 3445789999999999999999999998 99999999999999999999999999987643221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......+++.|+|||++.+..++.++||||||+++|+|++|+.|+........ .. .. .... ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~---~~-~~~~----------~~ 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--IL---KV-CQGS----------YK 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HH---HH-hcCC----------CC
Confidence 12335688999999999998999999999999999999999999864321110 00 00 0000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+++.+||+.||.+||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112234567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.63 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999986 46899999999765555667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999883 235899999999999999999999998 99999999999999999999999999886543321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+........... ... .. .+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-----~~~-~~-----~~~~-- 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IAT-NG-----TPEL-- 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHh-cC-----Cccc--
Confidence 12234688899999999998999999999999999999999999864332111000 000 00 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+++.+||+.||.+||++.++++.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111223467889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=319.17 Aligned_cols=198 Identities=27% Similarity=0.370 Sum_probs=171.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-C-----CceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 585 (834)
-+|++.+.||+|.||.|.++.+. +++.||||++++... ...+-..|+.+|..|+ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 38999999999999999999764 589999999987643 3455688999999997 4 47999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC--Cceeeccccce
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLAR 663 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~--~~kl~DFGla~ 663 (834)
||+|.++ .+|.++|... +-..++...+..|+.||+.||.+||+.+ |||+||||+||||.+.. .+||+|||.|+
T Consensus 265 iVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999884 5899999654 3345899999999999999999999998 99999999999996543 69999999999
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
...... .....+..|.|||++.+.+|+.+.|+||||||+.||++|.+-|...+
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 764432 25678889999999999999999999999999999999987665443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=317.20 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=192.3
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 588 (834)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999865 5889999998653 2334566788999998885 577888999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999884 3345899999999999999999999998 999999999999999999999999998754322
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ... .+....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~------------~i~~~~- 217 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQ------------SIMEHN- 217 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCC-
Confidence 1 12234568999999999999999999999999999999999999986433211 000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
..........+.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01111223467889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=315.41 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=197.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999875 57889999986443 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 77777643 2345889999999999999999999998 99999999999999999999999999986533221
Q ss_pred cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------ccccccccc-
Q 003288 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWDLWKDDR- 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~~~~~~~~- 739 (834)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... .|..+....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 4688999999999999999999999865432111 00000 000000000
Q ss_pred cccccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 VHDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~~~li~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....-.+..... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=324.04 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=197.4
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----eeE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999864 6899999998653 2334567899999999999999999999998776 789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46766663 3456899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc----
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV---- 740 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 740 (834)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ .............
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 43221 122234678899999998874 579999999999999999999999865432110 0000000000000
Q ss_pred ------ccccccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 ------HDLIDPVIMQD-------EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ------~~li~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+....... ........++.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 1111224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.95 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=190.4
Q ss_pred ceeccCCcEeEEEEEecC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997632 235888988665556667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC--------ceeeccccc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PKISDFGLA 662 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~--------~kl~DFGla 662 (834)
+++|+|..++... +..+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998533 336899999999999999999999998 999999999999987765 589999988
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCC-CCCCCCCCCccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.........
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------------- 215 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------------- 215 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------------
Confidence 65432 223467889999999987 45799999999999999999985 444322111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
..... ..........++.+++.+||+.+|++||+++++++.|+
T Consensus 216 -~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 -QFYED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 01111222356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.27 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=202.3
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998643 2468999887654 4566789999999999999999999998875 56789
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 335899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
...... .....++..|+|||.+....++.++||||||++++||++ |..||........ ... .....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~------ 225 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGR----IENGE------ 225 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH----HHcCC------
Confidence 432211 112334568999999988889999999999999999996 9998754332110 000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+|+..+|.+||++.++++.|++.
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.13 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=203.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 58899999986543 44557789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 26899999999999999999999998 9999999999999999999999999998875432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+... .. . ......+.+
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~----~-----~~~~~~~~~-- 218 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LF----L-----IPKNNPPSL-- 218 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HH----H-----hhhcCCCCC--
Confidence 122335678899999999998899999999999999999999999864332110 00 0 000000111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........+.+++.+||+.+|++||+++++++.
T Consensus 219 --~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 --EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001134568899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.42 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=201.9
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeee---
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV--- 579 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 579 (834)
+..+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445556889999999999999999999875 47899999886532 2346688999999999 6999999999884
Q ss_pred --ecCeeEEEEEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 580 --EQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 580 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999987532 23456889999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~ 731 (834)
+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ ...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~-- 240 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK-- 240 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh--
Confidence 99999987643321 1223468999999998853 4578899999999999999999999764332110 000
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ... ..+.+ .........+.+++.+||+.+|++||++.||++.
T Consensus 241 --~-~~~-----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 --I-PRN-----PPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --c-ccc-----CCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000 00000 0011123468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.01 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=196.2
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 582 (834)
..++|++.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 5889999998643 3344567889999999999999999999986543
Q ss_pred -eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 583 -EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 583 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 479999999764 544442 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-c---cccc-----
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-L---LGHA----- 731 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~---~~~~----- 731 (834)
++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... . . ....
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97643221 22335789999999999999999999999999999999999999864332100 0 0 0000
Q ss_pred -------ccc------cccccccccccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 -------WDL------WKDDRVHDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 -------~~~------~~~~~~~~li~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... .......++....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000000000000 00111123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.92 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=198.3
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 58899999986432 23356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588888755444567899999999999999999999998 9999999999999999999999999998654321
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--cc-------ccccccccc-cc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LL-------GHAWDLWKD-DR 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~-------~~~~~~~~~-~~ 739 (834)
.......+++.|+|||.+.+. .++.++||||||++++||++|+.|+......... .. ...|..... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 111223568899999988754 5789999999999999999999988643221000 00 000000000 00
Q ss_pred cccccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......... ..........++.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00001113456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.51 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=210.7
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChh---hHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 585 (834)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 35689999999999999999998775 999999999765432 4568899999999998 999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC----CCceeecccc
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGL 661 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGl 661 (834)
+|||++.+|.|.+.+... .+++.++..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998554 3999999999999999999999998 9999999999999543 4799999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||........... ....+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~------i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA------ILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH------HHcCCC-
Confidence 998765 3345678999999999999999999999999999999999999999976543221110 000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..+.-......+.+++..|+..||.+|+|+.++++.
T Consensus 256 -----~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 01 112223345678899999999999999999999985
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.45 Aligned_cols=253 Identities=29% Similarity=0.386 Sum_probs=209.0
Q ss_pred cCccccceeccCCcEeEEEEEecC--Cc--EEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
++..+.|+||+|.||.|++|.+.. |+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445567899999999999998753 44 5899999766544 67899999999999999999999999988 788999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||.++.|+|.+.|++ ..+..|-...+..++.|||.||.||..+. +|||||.++|+||-....+||+||||.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 56667888899999999999999999998 99999999999999999999999999998865
Q ss_pred C-cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 668 D-ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 668 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
. +.........-...|.|||.+....|+.++|||+|||+||||++ |..||-... ...+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------g~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------GIQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------HHHHHHhcc
Confidence 4 33344445566789999999999999999999999999999999 556653211 122233333
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..- .-+-...+.+.+++++..||..+|.+||++..|++.+
T Consensus 330 ~~e-rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGE-RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccc-cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 211 2223445678999999999999999999999998554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.79 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=198.8
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
|++.++||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999865 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999988542 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ......+... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----------~~~~~~~~~~--~ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----------EEVERLVKEV--Q 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----------HHHHhhhhhh--h
Confidence 112347899999999999999999999999999999999999998643211000 0000010000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPT-----MSDVIS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
..........+.+++.+||+.||++||+ ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111223446789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.63 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=201.2
Q ss_pred CccccceeccCCcEeEEEEEecC--CcEEEEEEecCC----------ChhhHHHHHHHHHHHHh-cCCCceeeEeeeeee
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE 580 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 580 (834)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999987532 23345667889988875 799999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeec
Q 003288 581 QGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISD 658 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~D 658 (834)
++..+++|||+++++|.+++... .....+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 234568999999999999999999996 55 99999999999999999999999
Q ss_pred cccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~--------- 223 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LAT--------- 223 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHH---------
Confidence 99998765432 2334578899999999999889999999999999999999999975322110 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....... ...........+.+++.+||+.||++||++.||.++++
T Consensus 224 ---~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 ---KIVEAVY-EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HHhhccC-CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000000 00001122356889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.14 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=192.2
Q ss_pred ceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCeeEEEEEecC
Q 003288 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~~ 592 (834)
+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357999998543 34456788999999999999999999998764 556889999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc-
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 671 (834)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998532 234678888999999999999999988 999999999999999999999999999865432211
Q ss_pred -CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCC-CCCCCCCCcccccccccccccccccccccccccc
Q 003288 672 -GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 672 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.......++..|+|||.+....++.++||||||+++|||++|+. |+..... ....... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~------------~~~~-- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL------------LQGR-- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH------------hcCC--
Confidence 11123355778999999998899999999999999999999654 4432211 1111000 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.+|++||++.||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.57 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=199.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh---------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... +..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4678889999999999999864 578999998864322 223678899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 346889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 664 MFGGDELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 664 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~---~------~ 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI---F------K 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH---H------H
Confidence 77532111 11123457889999999999899999999999999999999999986422110 00 0 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ...........+.+++.+||+.||.+||++.||++
T Consensus 224 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENA-----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccC-----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 11112233467889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.79 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=210.3
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..-|.+.+.||+|.|..|-+|++ ..|..||||++.+. +......+.+|++-|+.++|||||+||++......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45577889999999999999975 47999999999765 3444567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~ 667 (834)
|.-.+|+|.+||.++..+ +++....+.+.||+.|+.|+|+.. +|||||||+||.+- .-|-+||.|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999766554 899999999999999999999998 99999999998875 567899999999988765
Q ss_pred CcccCCcccccccccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.+ .....+|...|-|||++.+..|+ ++.||||||||||-|++|++||...++.+. +..++|
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImD- 233 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMD- 233 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhc-
Confidence 43 34457999999999999999997 578999999999999999999975433211 111121
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+...+.....++.+||..||+.||++|.+.+||+..
T Consensus 234 --CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 --CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1344556677899999999999999999999999865
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.16 Aligned_cols=193 Identities=25% Similarity=0.333 Sum_probs=164.6
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++.+....++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999875 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. ++|.+++.. ....+++.++..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577777743 3346899999999999999999999998 999999999999999999999999999753221
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~ 717 (834)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223357899999999999999999999999999999999865543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.48 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=205.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999875 4788999999876666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988432 246899999999999999999999998 9999999999999999999999999987654321
Q ss_pred cCCcccccccccccCcccccCC---CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+........... .... . ..+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~---~-~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKS---N-FPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc---c-CCCc
Confidence 112234678899999999777 889999999999999999999999754322110000 0000 0 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.+|.+||++++|+.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=315.73 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=205.4
Q ss_pred eeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhh
Q 003288 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 598 (834)
+||+|.||+||.|++.+ ...+|||.+...+....+-+.+|+.+-++++|.|||+++|.+.+++.+-+.||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999865 45799999988877788889999999999999999999999999999999999999999999
Q ss_pred hhhccCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCCCcccCCcc
Q 003288 599 FLFDSTKKRLL--NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 599 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
+|.. +=+++ ++..+-...+||++||.|||++. |||||||-+|||++. .|.+||+|||.++.+.. ....+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9943 33455 77888889999999999999998 999999999999965 68899999999987743 345567
Q ss_pred cccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 676 QIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
...||..|||||++..++ |..++|||||||++.||.||++||-......-- .++-+ ..-..+++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVG-------myKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVG-------MYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhc-------ceecCCCC
Confidence 789999999999998764 889999999999999999999998533221100 00000 00014566
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.+...+...+|++|+.+||.+||++++++..
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 77778899999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.74 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=192.5
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc---CCCceeeEeeeeeec-----C
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQ-----G 582 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 582 (834)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999876 58899999986432 22234556777777765 699999999988642 4
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+.+ +|..++... ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 787777432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc----cccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH----AWDLWK 736 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~----~~~~~~ 736 (834)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||........ ..... ....+.
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8764322 12235678999999999999999999999999999999999999854332110 00000 000000
Q ss_pred cc-cc-ccccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 737 DD-RV-HDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 737 ~~-~~-~~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .. .....+... ...........+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00 000000000 00011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=300.75 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=204.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|+..+.||.|+||.||.++.. +++.+++|.+... .....+++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999998764 5889999987543 345667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.... ...+++.++..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 356899999999999999999999998 99999999999999999999999999987644331
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+........ . ..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~------------~~~~~~~~-- 218 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL--V------------VKIVQGNY-- 218 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH--H------------HHHHcCCC--
Confidence 22345689999999999988899999999999999999999998754221110 0 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..........+.+++.+||+.+|.+||+++++++.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011122345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.37 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=199.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.+.||+|+||.||+|+.. +++ .+|+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 343 57999886543 33345789999999999999999999998754 567
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998432 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ . .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~----- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--P----DLLEKGE----- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHCCC-----
Confidence 54322222223445778999999999999999999999999999997 8888753221110 0 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++..||..+|++||+++++++.|+..
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 -----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0001111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.64 Aligned_cols=238 Identities=26% Similarity=0.451 Sum_probs=189.2
Q ss_pred ceeccCCcEeEEEEEecCCc-----------EEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 519 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999876432 5788887654433 6789999999999999999999999988 788999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-------Cceeeccc
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-------NPKISDFG 660 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-------~~kl~DFG 660 (834)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 26899999999999999999999988 99999999999999888 79999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCC--CCCccCcchhhHHHHHHHHhC-CCCCCCCCCCcccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......... ..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~------~~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------RFYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH------HHHh-
Confidence 9986533 1223567789999999876 789999999999999999995 5555432211100 0000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 738 ~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
. ......+....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------D----QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------c----CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.71 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=201.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777789999999999999865 47889999986443 34567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999873 245889999999999999999999998 99999999999999999999999999986643221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++||||||++++||++|+.|+....+..... .+.... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------------~~~~~~-~ 218 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---------------LIPKNS-P 218 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---------------hhhcCC-C
Confidence 1223467889999999999999999999999999999999999975322211000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|.+||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11112234568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.24 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=194.6
Q ss_pred ccceeccC--CcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
++++||+| +|++||+++.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78899999764 6899999998654 2344567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc-
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL- 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~- 670 (834)
++++|.+++.... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234899999999999999999999998 99999999999999999999999987554321110
Q ss_pred ----cCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc--c-cccccccc-----
Q 003288 671 ----QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--L-GHAWDLWK----- 736 (834)
Q Consensus 671 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~--~-~~~~~~~~----- 736 (834)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 011122356778999999976 468999999999999999999999986432211000 0 00000000
Q ss_pred -------------cccccc--c---cccc---cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 -------------DDRVHD--L---IDPV---IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 -------------~~~~~~--l---i~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...... . ..+. ....+........+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000000 0 0000 00001122334578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.77 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=201.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 6899999988654 344567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999885443344789999999999999999999974 5 999999999999999999999999998765322
Q ss_pred ccCCcccccccccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ .. .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~---------~~~~~ 222 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FA---------QLSAI 222 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HH---------HHHHH
Confidence 12234678899999998554 358899999999999999999999853221110 00 00001
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... ...........+.+++.+||+.+|.+||++.+++..
T Consensus 223 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1100 112222355678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=301.35 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=205.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.+.||.|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+..+...++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 57889999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865444456899999999999999999999998 99999999999999999999999999987654322
Q ss_pred c--CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 Q--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .......++..|+|||++... .++.++||||||++++||++|+.|+........ .. ..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQN------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcC------CCCC
Confidence 2 122345688999999998877 789999999999999999999999864332110 00 00000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.............+.+++.+||+.||++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1000001123467889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.22 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=203.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999875 58899999986543 45567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998832 35888999999999999999999988 99999999999999999999999999987644321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ..+.... .
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------~~~~~~~-~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------FLIPKNN-P 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------hhhhcCC-C
Confidence 122346788999999999889999999999999999999999997643221100 0000000 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233455678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=337.33 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=197.8
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 585 (834)
..++|+++++||+|+||.||+++... ++.+|+|.+... .......|..|+.++++++|||||++++++.+. ..++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 35789999999999999999998754 678999988643 344567899999999999999999999988654 4689
Q ss_pred EEEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCC----CceeeCCCCCCcEEecCC---------
Q 003288 586 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR----FRIIHRDLKASNILLDKD--------- 651 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dikp~NILl~~~--------- 651 (834)
+||||+++++|..+|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999985432 23569999999999999999999998542 249999999999999642
Q ss_pred --------CCceeeccccceecCCCcccCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 652 --------MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 652 --------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998764332 2234578999999999854 458899999999999999999999985322
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... .++. ..... +.+ ........+.+|+..||+.+|.+||++.|++.
T Consensus 248 ~~~-qli~----~lk~~-------p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS-QLIS----ELKRG-------PDL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH-HHHH----HHhcC-------CCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 110 0000 00000 000 00112356889999999999999999999984
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.99 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=195.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .....+.|.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 4889999998642 2334566889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2345889999999999999999999998 999999999999999999999999999765432
Q ss_pred cccCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .. ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~~---~i~~~~~~~~- 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHKEHFQ- 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--HH---HHHcCCCccc-
Confidence 21 11223468999999999863 4578899999999999999999999854321110 00 0000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENA--ADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~ 785 (834)
+ ..........+.+++.+|+..++ ..||+++++++.
T Consensus 229 ----~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----F--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----C--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00011133456778888775433 347899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=330.96 Aligned_cols=265 Identities=21% Similarity=0.278 Sum_probs=192.5
Q ss_pred HHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC------ceeeEeeeeee
Q 003288 508 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCCVE 580 (834)
Q Consensus 508 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~ 580 (834)
+....++|++.++||+|+||.||+|... .++.||||+++... ...+.+..|+.+++.++|. +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999875 47889999996532 2344567788888877654 58889888876
Q ss_pred c-CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCC------
Q 003288 581 Q-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM------ 652 (834)
Q Consensus 581 ~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~------ 652 (834)
. .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4788999988 6677777743 34689999999999999999999974 7 99999999999998765
Q ss_pred ----------CceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 653 ----------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 653 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999876432 122346899999999999999999999999999999999999999865432
Q ss_pred Ccc-ccccccc----cccc----cccccccc----------ccc----cccC--CCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 723 DSF-NLLGHAW----DLWK----DDRVHDLI----------DPV----IMQD--EISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 723 ~~~-~~~~~~~----~~~~----~~~~~~li----------~~~----~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
... ..+.... ..+. .....++. ++. +... .........+.+|+.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111 1100000 0000 00000000 000 0000 00011234678999999999999999
Q ss_pred CHHHHHHH
Q 003288 778 TMSDVISM 785 (834)
Q Consensus 778 t~~evl~~ 785 (834)
|++|++++
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.18 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=199.5
Q ss_pred ccccceeccCCcEeEEEEEec----CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
|.+.++||+|+||.||+|... .++.||||.+... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999998654 3445678899999999999999999999886542
Q ss_pred eeEEEEEecCCCchhhhhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 583 EKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
..++++||+.+++|..++.... ....+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998874322 2235789999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++...............+++.|++||.+....++.++||||||+++|||++ |++|+....... .... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~----~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNY----LIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHH----HHcC
Confidence 99987644332222223455678999999999999999999999999999999 778765332211 0000 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ...........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0001112345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.18 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=206.7
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
-+.|++++.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-+||+.++||.++.|+..++.+...|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3567888999999999999999865 5789999997653 34456678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||||+||+|...+. .+..+.++++.+...+..++-||+|||-.| ||+|||||+||||.++|++-|+||.|+.....
T Consensus 156 meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999988874 355677999999999999999999999999 99999999999999999999999999765411
Q ss_pred -----------------------------C---c-c---------------------cCCcccccccccccCcccccCCC
Q 003288 668 -----------------------------D---E-L---------------------QGNTKQIVGTYGYMSPEYALDGL 693 (834)
Q Consensus 668 -----------------------------~---~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 693 (834)
. . . .......+||-.|+|||++.+.-
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 01123458999999999999999
Q ss_pred CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCC
Q 003288 694 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENA 773 (834)
Q Consensus 694 ~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP 773 (834)
.+.+.|.|+|||+||||+.|..||-..+... .+..++...+ .-+-....+..+.+||++.|..||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~l-~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQPL-KFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCCC-cCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999986544321 1122222222 111122445678999999999999
Q ss_pred CCCCC----HHHHHHH
Q 003288 774 ADRPT----MSDVISM 785 (834)
Q Consensus 774 ~~RPt----~~evl~~ 785 (834)
++|.. +.||-+.
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 7777553
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.24 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=198.6
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.|+..++||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++.+++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999875 58899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888543 2346899999999999999999999998 9999999999999999999999999997653321
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .... ..+...
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~--------~~~~~~--- 220 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVD--------RRVLET--- 220 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH--------Hhhhcc---
Confidence 122347899999999999999999999999999999999999998643221100 0000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
...........+.+++..||+.||++||+ +.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00111223346788999999999999999 5666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.70 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=203.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999865 58899999876543 4456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+. + ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998743 34689999999999999999999974 5 999999999999999999999999998754322
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
......++..|+|||++.+..++.++|||||||++|||++|+.|+.......... .......+.+...+
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~ 226 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-------DDPMGILDLLQQIV 226 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-------hhhhHHHHHHHHHh
Confidence 1224578999999999988899999999999999999999999987533211000 00000001111100
Q ss_pred cc--CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 749 MQ--DEI-SLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 749 ~~--~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.. ... .......+.+++.+||+.||.+||++.|++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 011 112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=310.99 Aligned_cols=197 Identities=26% Similarity=0.427 Sum_probs=160.5
Q ss_pred cceeccCCcEeEEEEEec---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEEEEEecC
Q 003288 518 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMP 592 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 592 (834)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 46789999986542 23457889999999999999999998864 456789999986
Q ss_pred CCchhhhhhccC------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe----cCCCCceeeccccc
Q 003288 593 NKSLNVFLFDST------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLA 662 (834)
Q Consensus 593 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla 662 (834)
+ +|..++.... +...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6766653221 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred eecCCCcc-cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCC
Q 003288 663 RMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVY 720 (834)
Q Consensus 663 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~ 720 (834)
+.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87654321 1122346789999999998774 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.49 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=200.5
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 68999999886433 33567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999887643
Q ss_pred CcccCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+........ . ........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~---~~~~~~~~------- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V---FKIGRSKE------- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H---HHHHhccc-------
Confidence 32 223456889999999988776 89999999999999999999999864331110 0 00000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.+|.+||++.+++.
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01112223456788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=300.65 Aligned_cols=251 Identities=33% Similarity=0.531 Sum_probs=200.3
Q ss_pred ccccceeccCCcEeEEEEEecC-----CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
+++.+.||.|+||.||+++..+ +..||+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999853221 12899999999999999999999998 999999999999999999999999999877544
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
...... ...+++.|+|||.+....++.++||||||++++||++ |..|+....... ... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~----~~~~~~-------- 221 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLE----YLKKGY-------- 221 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCC--------
Confidence 222111 2336789999999988889999999999999999998 677765322111 000 000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
...........+.+++.+|++.+|++|||+.|+++.|
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011111345788899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.88 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 58899999886432 2334668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999988763 2345899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccc-cc-------cccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLG-HA-------WDLWKDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~-~~-------~~~~~~~~ 739 (834)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+......... ... .. ...+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 56889999999999999999999998643321110 000 00 00000000
Q ss_pred c-ccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 V-HDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~-~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.. ..... ......+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000 00000 112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.72 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=198.0
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
++|++.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++.+++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999975 67889999986532 346789999999999999999999998764 4789999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998543 2345889999999999999999999988 9999999999999999999999999987643221
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.|+........ . .. +.... ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~----~~---------~~~~~-~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--K----EC---------VEKGY-RM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--H----HH---------HhCCC-CC
Confidence 12234568999999998899999999999999999998 8888754322110 0 00 00000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.........+.+++.+||+.+|.+||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.45 Aligned_cols=255 Identities=19% Similarity=0.236 Sum_probs=196.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++.. +++.||+|.+... .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4788999998642 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999532 345889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .. ......
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~----- 224 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHE----- 224 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--HH---HHHcCC-----
Confidence 21 11233579999999999875 5678999999999999999999999864322110 00 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
..............++.+++.+|++.++.+ |++++++++.
T Consensus 225 --~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 --ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000001112456788899988865544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.46 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=200.6
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 589 (834)
+|++.+.||+|++|.||+++.. +++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999865 4788999998643 23455678999999999999999999998764 446789999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++.++..++.|++.|+++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998542 3446899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.......+++.|+|||++.+..++.++||||||++++||++|+.|+...+.... .. .+....+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~---------~~~~~~~- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VY---------RIIEGKL- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HH---------HHHhcCC-
Confidence 122345688999999999999999999999999999999999998753221110 00 0000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+|++.+|.+||++.++++.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.15 Aligned_cols=246 Identities=32% Similarity=0.462 Sum_probs=200.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecC---CChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
+.|+-++.||.|+||.||-|++. +.+.||||+++- .+.+.++++..|+..|.+++|||++.+-|+|..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34666789999999999999864 577899999853 34566889999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|||- |+-.+++.-+ ++++.+-++..|+.+.++||+|||+.+ .||||||+.||||.+.|.+||+|||.|....+
T Consensus 106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 9994 5777777433 356889999999999999999999998 99999999999999999999999999976533
Q ss_pred cccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.+.++|||.|||||++. .+.|+-|+||||||++..||.-.++|.-..+. +...+.. .+--.
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYHI------AQNes 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHI------AQNES 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHHH------HhcCC
Confidence 45579999999999985 57899999999999999999999988542221 1111110 00001
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
|.+ ...+.+..+.+++..||+.-|.+|||.+++++.
T Consensus 243 PtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 245677889999999999999999998887654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=301.25 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=194.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Cee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 584 (834)
.+|++.+.||+|+||.||+|... .++.||+|.+... ..+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999875 5889999988543 123456789999999999999999999988753 567
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 335889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCc-ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
+.... .........++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--------------~~~~ 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--------------IFKI 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--------------HHHH
Confidence 54321 11122335688999999999998999999999999999999999999863321100 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... ............+..++ .||..+|++||+++||++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 01111222234455565 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=303.47 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=189.3
Q ss_pred ceeccCCcEeEEEEEecCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 519 CKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
++||+|+||.||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677765443 345678999999999999999999999999999999999999999
Q ss_pred chhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 595 SLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
+|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999864322 234677788899999999999999988 99999999999999999999999999864322222222
Q ss_pred cccccccccccCcccccC-------CCCCccCcchhhHHHHHHHHhC-CCCCCCCCCCcccccccccccccccccccccc
Q 003288 674 TKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... ..... .. .+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~---~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNH---VI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH---HH-hhcccccCC
Confidence 234567889999998753 2457899999999999999975 5565432211 11110 00 111122222
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
+.+ .......+.+++..|| .+|.+||+++||++.|.
T Consensus 232 ~~~-----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL-----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc-----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222 1223456778889999 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.44 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=195.2
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998764 778999998542 2223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999532 345889999999999999999999998 999999999999999999999999999765332
Q ss_pred cccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .. ....... ..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~~--~~ 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHKE--RF 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--HH---HHhCCCc--cc
Confidence 21 1223357999999999986 34688999999999999999999999864322110 00 0000000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
.. ..........+.+++.+|+..++.+ ||+++|+++.
T Consensus 228 ---~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0001122456778888888654443 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.77 Aligned_cols=263 Identities=24% Similarity=0.280 Sum_probs=196.6
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 581 (834)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3578999999999999999999864 5889999998653 333456788999999999999999999988643
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 5555552 24788999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-cccc---------
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGH--------- 730 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~--------- 730 (834)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ . .+..
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654321 22335789999999999999999999999999999999999999864331100 0 0000
Q ss_pred -----ccccc-c-ccccc-----cccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 -----AWDLW-K-DDRVH-----DLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 -----~~~~~-~-~~~~~-----~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+ . ..... ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0 00000 00000000 000111123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.79 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=198.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
-++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357999999999999999999875 57899999986443 2334567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 5888877432 345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-c--------ccccccccccc-
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-L--------LGHAWDLWKDD- 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~--------~~~~~~~~~~~- 738 (834)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......... . ....|..+...
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 112234568899999988654 5788999999999999999999998644321110 0 00001000000
Q ss_pred ccccccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 RVHDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 ~~~~li~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.......+..... .........+.+++.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000000 0011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=286.06 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=200.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|.-.+.||+|..+.|-+..++ .|+++|+|++.... .+-.+.-..|+.||+++ -||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 467777889999999999887654 58899999884221 12234557899999998 699999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...++|+|.|+.|.|.++| ...-.+++++..+|+.|+.+|++|||.++ ||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 45567999999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
++.+.... .....+|||+|+|||.+.-. -|+...|.|++||++|.|+.|.+||.....- + ....+
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----l--MLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----L--MLRMI 240 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH----H--HHHHH
Confidence 99876543 34568999999999998532 4778899999999999999999998522110 0 00000
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.++.. + . ..+.=.+.+....++|.+||+.||.+|.|++|+++.
T Consensus 241 meGky-q-----F-~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKY-Q-----F-RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhccc-c-----c-CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 01100 0 0 111112345678899999999999999999998764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.48 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=201.9
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999876 4789999988643 23345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..++. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988876652 2345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc-c-------cccccccc-c
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G-------HAWDLWKD-D 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~-~-------~~~~~~~~-~ 738 (834)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ... . .....+.. .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678899999999888 889999999999999999999998864322110 000 0 00000000 0
Q ss_pred -----ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 -----RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 -----~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.................++.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000000111122567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.09 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=202.9
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999876 58899999987653 34567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568899999999999999999999 77 9999999999999999999999999987653221
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+.............. .......
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~-- 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL---------QYIVNEP-- 220 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH---------HHHhcCC--
Confidence 1 125688899999999999999999999999999999999999864321111110000 0000000
Q ss_pred cCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLP-MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....... ....+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111111 45568899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.22 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=196.9
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Cee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 584 (834)
.+|++.++||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999875 4889999987532 123456789999999999999999999988764 467
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+++|||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999843 234788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-------------~~~ 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I-------------FKI 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H-------------HHH
Confidence 5432111 122335688999999999988899999999999999999999999853221100 0 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... ............+.+++.+|+. +|++||+++||++.
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 0111223344567888999984 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=308.07 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=200.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+.|.....||+|+||.||++... +++.||||.+........+.+.+|+.++.+++|+||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34444568999999999999864 58899999987666666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999999873 234889999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ... . ....+....
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----~-----~~~~~~~~~--- 238 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR----R-----IRDNLPPRV--- 238 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----H-----HHhcCCCcc---
Confidence 12233568899999999998899999999999999999999999975322111 000 0 000011111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+++.+|++.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111233467889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=307.05 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=199.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999876 48899999885432 2245678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..+... ...+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--cccccccccc-------cccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWDLW-------KDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~-------~~~~ 739 (834)
.......++..|+|||++.+ ..++.++||||||++++||++|++|+........ .+........ ....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 12233467889999999875 4578899999999999999999988754322100 0000000000 0000
Q ss_pred c-cccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 V-HDLIDPVIMQ----DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~-~~li~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.... ..........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000 0001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=316.23 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=196.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------C
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 582 (834)
.++|++.++||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 578999999999999999999865 4889999998653 234456788999999999999999999987543 3
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999976 5655552 23788899999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-cccc-------ccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGH-------AWD 733 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~-------~~~ 733 (834)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.... . .+.. ...
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8654321 22335789999999999999999999999999999999999999864332110 0 0000 000
Q ss_pred cc--------------ccccccccccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LW--------------KDDRVHDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~--------------~~~~~~~li~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ......++....... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000000000000 00111123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=304.74 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=201.8
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec-
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ- 581 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 581 (834)
..++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3455556889999999999999999999874 58899999986532 2345678899999999 899999999998754
Q ss_pred ----CeeEEEEEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 582 ----GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 582 ----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999988532 23456899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCC-----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~ 731 (834)
+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+........ +.
T Consensus 170 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~--- 243 (291)
T cd06639 170 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LF--- 243 (291)
T ss_pred eecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HH---
Confidence 999998865432211 1234678899999987643 368999999999999999999999764322110 00
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. .......+ .........+.+++.+||+.+|++||++.|+++.
T Consensus 244 -~~-~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 -KI-PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HH-hcCCCCCC--------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00000000 0011233468899999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.64 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=201.1
Q ss_pred CccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
+|+..+.||+|++|.||+++. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 468899999986432 2245789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-Cceeeccccceec
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 665 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~ 665 (834)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346889999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 666 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+........... ..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------~~~~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----------IFKI 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------HHHH
Confidence 543211 112335688999999999888899999999999999999999999753321110000 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ..............+.+++.+|++.+|.+||++.|+++
T Consensus 224 ~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 AS-ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hc-cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 00011222334567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.95 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=205.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.++|+..||.|+||.||||..++ +-..|.|.+...+++..++|.-|++||....||+||+|++.|..++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4567888999999999999998765 344677888777888899999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.||-.+.++.. -+..|.+.++.-+++|+++||.|||++. |||||||+.|||++-+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-- 183 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--
Confidence 999999998743 3457999999999999999999999998 999999999999999999999999998754322
Q ss_pred cCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
......+.|||.|||||+.. +.+|+.++||||||++|.||..+.+|....++-. . +.++..
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-V-------------llKiaK 249 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-V-------------LLKIAK 249 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-H-------------HHHHhh
Confidence 12334579999999999864 5789999999999999999999998854222100 0 001111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+..+.-..+......+.+++..||..||..||++.++++.
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1110001123456789999999999999999999998764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.45 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=204.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++++......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999764 5789999998765555567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999842 34789999999999999999999998 99999999999999999999999999876543322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||.+....++.++||||||+++|||++|+.||........... ....+. + .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~------~---~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------P---E 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCC------C---C
Confidence 22334688899999999988899999999999999999999999864332111000 000000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111233467899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.88 Aligned_cols=263 Identities=25% Similarity=0.310 Sum_probs=195.0
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 581 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 581 (834)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999864 57899999986532 23445678999999999999999999987543
Q ss_pred -CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 582 -GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 582 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
...++++|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999987 778887763 345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccc---cc---
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLG---HA--- 731 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~---~~--- 731 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . ... ..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99865432 233578999999999877 5689999999999999999999999854321100 0 000 00
Q ss_pred -ccccccccccccccc--ccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 -WDLWKDDRVHDLIDP--VIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 -~~~~~~~~~~~li~~--~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
............+.. ..... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 00000 0000112346799999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.31 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=198.5
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC----------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 582 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 582 (834)
+|.+.+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999764 58899999875321 112356889999999999999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998433 46899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+...............++..|+|||.+.... ++.++||||||++++||++|..|+........ ...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLGN-KRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhhc-ccc
Confidence 8654322222223456889999999987654 78999999999999999999999753221100 000000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ... ...........+.+++.+||+.+|.+||++.+|++.
T Consensus 230 ~----~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 A----PPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred C----CcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 000 111112234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.05 Aligned_cols=196 Identities=27% Similarity=0.433 Sum_probs=159.6
Q ss_pred ceeccCCcEeEEEEEecC---CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5789999986543 23467889999999999999999998854 4578999999875
Q ss_pred Cchhhhhhcc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe----cCCCCceeeccccce
Q 003288 594 KSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (834)
Q Consensus 594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~ 663 (834)
+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 565555321 12235889999999999999999999998 9999999999999 566789999999998
Q ss_pred ecCCCccc-CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 003288 664 MFGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVY 720 (834)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~ 720 (834)
.+...... .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 12234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=307.22 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=201.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+++.. .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999875 47899999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999998742111
Q ss_pred cc-------------cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 669 EL-------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 669 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
.. ........++..|+|||.+....++.++||||||+++|||++|+.|+....... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~----~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFG----QV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HH
Confidence 00 001112457889999999998899999999999999999999999975322111 000 00
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... .... ..........+.+++.+||+.+|++||++.++.+.|+.-
T Consensus 229 ~~~---~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 229 ISD---DIEW-----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred Hhc---ccCC-----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 000 0000 000112345678999999999999999988787777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.29 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=201.9
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.++||+|+||.||+++.. +++.||+|.+... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999865 5889999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++.++++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988432 2335789999999999999999999998 99999999999999999999999999987643321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+++.|+|||++.+..++.++||||||++++||++|+.|+........ ....+... .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--------------~~~~~~~~--~ 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--------------VLKIIRGS--Y 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--------------HHHHhcCC--C
Confidence 12234678899999999999999999999999999999999999753221110 00000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|.+||++.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=301.85 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=200.6
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC------
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 582 (834)
++++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999875 578899999865543 346799999999999 7999999999997654
Q ss_pred eeEEEEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 583 EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885432 2456899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+....... .......++..|+|||.+.. ..++.++||||||++++||++|+.|+........ .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~--------- 227 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-L--------- 227 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-H---------
Confidence 88654322 12233568899999998753 3467899999999999999999999853221110 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.++.................+.+++.+||..||++|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 ----FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000000001111224457889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.49 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=206.3
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.+.||+|++|.||+++... ++.|++|++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 89999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998533 568999999999999999999999 88 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc-cccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... .+....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------~~~~~~- 219 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ------------AICDGP- 219 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH------------HHhcCC-
Confidence 22 124567899999999999999999999999999999999999986543210 00000 000000
Q ss_pred ccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLP-MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....... ....+.+++.+||+.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111222 44678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.29 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=201.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|.+.+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 688999999875544 3678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345789999999999999999999998 99999999999999999999999999987654322
Q ss_pred cCC--cccccccccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGN--TKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
... .....++..|+|||++.... ++.++||||||++++||++|+.|+........ .. ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~---~~~------~~~~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IM---FHV------GAGHK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HH---HHH------hcCCC
Confidence 111 22356788999999998766 88999999999999999999999864321110 00 000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.+ +........+.+++.+||+.+|.+||++.|++.
T Consensus 225 ~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001 011112456778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.86 Aligned_cols=240 Identities=23% Similarity=0.272 Sum_probs=185.5
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc---CCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
||+|+||.||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 48899999986432 12233455677777665 699999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99998884 3456899999999999999999999998 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCC
Q 003288 674 TKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ . ....... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~----~~i~~~~------~~~~~-- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--Y----RNIAFGK------VRFPK-- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--H----HHHHcCC------CCCCC--
Confidence 3346799999999998765 479999999999999999999999854321110 0 0000000 00101
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 003288 753 ISLPMLMRYINVALLCVQENAADRP----TMSDVIS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~ 784 (834)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234678899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.71 Aligned_cols=262 Identities=26% Similarity=0.335 Sum_probs=198.3
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-----hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 588999999965432 2345678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999984322 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc--------cc-c
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL--------WK-D 737 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~-~ 737 (834)
... ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++....... ........ +. .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence 321 1222356788999998865 467899999999999999999977765332211 00000000 00 0
Q ss_pred ccccccccccc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 738 DRVHDLIDPVI----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 738 ~~~~~li~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........... ............+.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0000112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.60 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee-
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE- 580 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 580 (834)
.+..+..+.+.|++.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34444556789999999999999999999874 57899999885543 3446788999999999 79999999999853
Q ss_pred -----cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 581 -----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 581 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
....+++|||+++++|.+++... +...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988542 2345788889999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 730 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~ 730 (834)
|+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.|+....+.....
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 99999987653221 1223356889999999876 3568889999999999999999999985432211000
Q ss_pred ccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 731 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....... ...........+.+++.+||+.||.+||++.|+++
T Consensus 237 -----------~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -----------LIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000 00111123457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=304.99 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=194.9
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.++||+|+||.||+|+.. +|+.+|+|+++... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 677766432 345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc----------ccccccccc-
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG----------HAWDLWKDD- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~- 738 (834)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........+.. ..+......
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 112234578899999998765 4789999999999999999999885432221100000 000000000
Q ss_pred cc--ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 RV--HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ~~--~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ....................+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000000111123457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.60 Aligned_cols=264 Identities=24% Similarity=0.274 Sum_probs=195.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
+++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 578999999999999999999864 588999999865432 233467889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 566666532 2245788889999999999999999998 9999999999999999999999999997643321
Q ss_pred ccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc---c--------
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK---D-------- 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~-------- 737 (834)
. ......+++.|+|||++.+. .++.++||||||+++|||++|+.|+......... +...+.... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHHHHHHcCCCChhhhhhhhh
Confidence 1 12234568899999998764 5788999999999999999999998643321110 000000000 0
Q ss_pred -ccc-ccccc----cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 738 -DRV-HDLID----PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 738 -~~~-~~li~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ..... ..+............+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000 000000000112356788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=299.30 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=201.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 588 (834)
++|++.++||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999875 57889999987543 34567799999999999999999999998654 3689999
Q ss_pred EecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23455889999999999999999999998 99999999999999999999999999876532
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ...........+ ..
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~- 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPEL-KD- 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchhh-cc-
Confidence 21 123457889999999999999999999999999999999999987542210000000 000000000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.+|.+|||+.||++.
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 --EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 001112245678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=306.30 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=198.4
Q ss_pred cccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
....+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999875 58899999986655555677899999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCc
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..... ..
T Consensus 104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9998873 245889999999999999999999998 99999999999999999999999999876543321 12
Q ss_pred ccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCC
Q 003288 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~ 754 (834)
....++..|+|||++.+..++.++||||||++++||++|+.|+........ .. ...... .... ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~-----~~~~---~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MK----RLRDSP-----PPKL---KNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhccC-----CCCc---ccc
Confidence 335688999999999998999999999999999999999999864322110 00 000000 0000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 755 LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+.+++.+||+.+|.+||+++++++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1123457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.34 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=199.2
Q ss_pred CccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 588 (834)
.|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986 46889999998654 3445677889999999997 999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998832 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+......... . . ......+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~----~-----~~~~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--M----L-----IPKSKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--h----c-----cccCCCCC
Confidence 31 12334688899999988754 5789999999999999999999998643221100 0 0 00000011
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.. ......+.+++.+||+.||++||++.|++++
T Consensus 222 ~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LED----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 100 0134568899999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.03 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=200.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5889999998643 334567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+.+++.|++++|+|||+.+ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345899999999999999999999998 99999999999998654 57999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......++..|+|||.+....++.++||||||+++|+|++|+.|+........ .. ......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~------------~~~~~~-- 217 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VL------------KIMSGT-- 217 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HH------------HHHhcC--
Confidence 12235688899999999988899999999999999999999999754322110 00 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.+|.+|||++|+++.
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011112234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.04 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=201.5
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 588 (834)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5789999998643 34456778999999999999999999998764 34678999
Q ss_pred EecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
||+++++|.+++.... ....+++..++.++.||++||+|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999985432 2456899999999999999999999332 223999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... ......++..|+|||.+....++.++||||||+++++|++|+.|+....... ... .....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~~------- 225 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LAS----KIKEG------- 225 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHH----HHhcC-------
Confidence 54332 1233468999999999999899999999999999999999999986433111 000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ...........+.+++.+|++.+|++||++.+|+++
T Consensus 226 --~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 --K-FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --C-CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 111222344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.86 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=199.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 58899999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.....+++.|+|||.+.+...+.++||||||++++||++|+.|+....... .. ......
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~------------~~~~~~-- 213 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IY------------EKILEG-- 213 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH------------HHHhcC--
Confidence 233568899999999988889999999999999999999999975432110 00 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
...........+.+++.+||+.+|.+|| +++|+++
T Consensus 214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0111122245788999999999999999 6677654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.51 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=201.2
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998764 89999999875432 25567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23456899999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 669 ELQ---------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 669 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123467889999999999899999999999999999999999985432
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT----MSDVIS 784 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 784 (834)
.... ......... ...........+.+++.+||+.+|++||+ ++|++.
T Consensus 237 ~~~~--------------~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET--------------FSNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH--------------HHHHhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 001111110 00111114567899999999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.69 Aligned_cols=265 Identities=24% Similarity=0.340 Sum_probs=200.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999875 58899999987543 34457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885432 56899999999999999999999998 99999999999999999999999999987654321
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-cccc-------ccccccc-cc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGH-------AWDLWKD-DR 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~-------~~~~~~~-~~ 739 (834)
.......++..|+|||.+.+. .++.++||||||++++||++|++++........ . .... .+..... ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 122335688999999998654 468999999999999999999777653322100 0 0000 0000000 00
Q ss_pred ccccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 VHDLIDPVIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~~~li~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+..+.... ..........+.+++.+||+.+|.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111223678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.31 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=195.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 588999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+.+ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 898887533 236889999999999999999999998 99999999999999999999999999875432211
Q ss_pred cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc---cccc------
Q 003288 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK---DDRV------ 740 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~------ 740 (834)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .....+.... ....
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346789999998875 4588999999999999999999999854331100 0000000000 0000
Q ss_pred ---cc----ccc-cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 ---HD----LID-PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ---~~----li~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ... ..+............+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000 000000001111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.35 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=197.1
Q ss_pred CccccceeccCCcEeEEEEEecC---CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 585 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 585 (834)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999997633 34456778999999999999999999999988 7899
Q ss_pred EEEEecCCCchhhhhhcc-CC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC----CCCceeecc
Q 003288 586 LILEYMPNKSLNVFLFDS-TK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDF 659 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~-~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DF 659 (834)
+||||+++ +|.+++... .. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++ ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 555555322 22 236889999999999999999999998 999999999999999 999999999
Q ss_pred ccceecCCCcc-cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccc-------cc
Q 003288 660 GLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL-------GH 730 (834)
Q Consensus 660 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~-------~~ 730 (834)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|++|+........... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122345678899999988764 578999999999999999999999865443220000 00
Q ss_pred cccccc------------cccccc---ccc-cccccCC----CCH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 AWDLWK------------DDRVHD---LID-PVIMQDE----ISL--PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 ~~~~~~------------~~~~~~---li~-~~~~~~~----~~~--~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+. ...... ... ....... ... ....++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000000 000 0000000 000 233468899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=299.37 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=192.9
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHH-HHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58999999986542 2334455666665 556689999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 590 YMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787777442 2345689999999999999999999987 6 99999999999999999999999999986543
Q ss_pred CcccCCcccccccccccCcccccC----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+......... ....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~ 220 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-------------LKQV 220 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-------------HHHH
Confidence 21 1122467889999998865 45688999999999999999999997532211000 0011
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.... ...........+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEEPS-PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HhcCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10000 00001113456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=297.04 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=200.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+-|++.++||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677889999999999999864 57899999886433 34457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999883 235889999999999999999999998 99999999999999999999999999987643321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++|||||||++|||++|..|+........ . ..+.... .
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~-------------~~~~~~~-~ 218 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--L-------------FLIPKNN-P 218 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--H-------------HHHhcCC-C
Confidence 12234678899999999988899999999999999999999999753221100 0 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11112234567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.26 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=204.5
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..+.|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3667888899999999999999886 588999999976544 56788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999995432 36899999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+..... ........
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~ 234 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--------------LITTKGIP 234 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------HHHhcCCC
Confidence 1 1223457889999999998899999999999999999999999976432211000 00000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000111133568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=289.76 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=204.3
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999875 588999999977665567889999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999984432 46899999999999999999999988 99999999999999999999999999987654322
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
.....++..|+|||.+....++.++||||||+++++|++|+.|+........... ........ . .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~-----~---~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IATNGPPG-----L---R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HHhcCCCC-----c---C
Confidence 3345788999999999988899999999999999999999999764321110000 00000000 0 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 753 ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........+.+++.+||+.||++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011124568899999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.14 Aligned_cols=247 Identities=24% Similarity=0.298 Sum_probs=201.1
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
+|++.+.||.|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999876 48899999986532 2456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 256899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......++..|+|||.+....++.++||||||+++|+|++|+.|+........... ...... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~~~--~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI------------RAKQET--A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH------------HHHhcc--c
Confidence 12235678899999999988899999999999999999999999864432111000 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTM--SDVI 783 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 783 (834)
...........+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=297.79 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=199.0
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5889999998765555667789999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999999843 45889999999999999999999998 99999999999999999999999998876543221 1
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....|+..|+|||.+.+..++.++||||||++++||++|+.|+....... ... ... ....+.. ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~~----~~~-----~~~~~~~---~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AMK----RIR-----DNLPPKL---KN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HHH----HHH-----hcCCCCC---cc
Confidence 223468899999999998899999999999999999999999975322110 000 000 0000000 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.93 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=205.1
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 588 (834)
+|.+.+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999886 58899999986554 25578899999999999999999999999988 8899999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++... ..+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998533 37899999999999999999999988 999999999999999999999999999887554
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
..........++..|+|||.+....++.++||||||+++++|++|+.|+........ ..+. +.....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~---------~~~~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYK---------IGSSGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHh---------ccccCC
Confidence 321123345788999999999988899999999999999999999999865431110 0000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+|++.+|.+||++.|++.
T Consensus 222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122223567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=299.52 Aligned_cols=248 Identities=31% Similarity=0.446 Sum_probs=196.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.|++.++||+|+||.||+|+.. +++.||+|.+... .....+++.+|+++++.++||||+++++++.++...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888999999999999999875 5889999988643 234456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 466665532 2345899999999999999999999998 99999999999999999999999999876532
Q ss_pred CcccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ . ..... ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~---~~~~~-~~----- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQ-ND----- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--H---HHHhc-CC-----
Confidence 2 2346788999999874 45688999999999999999999999753321110 0 00000 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.+ ..........+.+++.+||+.+|++||++.+|+.+.
T Consensus 231 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 SP----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CC----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 001112345789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=297.38 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=196.0
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999875 58899999886432 23346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 5788887443 3356899999999999999999999998 9999999999999999999999999987654321
Q ss_pred cCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc-------ccccccc---
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH-------AWDLWKD--- 737 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~-------~~~~~~~--- 737 (834)
.......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........ ..... .+.....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1122235688999999887654 68899999999999999999999864332110 00000 0000000
Q ss_pred --cccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 738 --DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 738 --~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........... ..........+.+++.+||+.||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0001112346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.68 Aligned_cols=263 Identities=24% Similarity=0.286 Sum_probs=197.8
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 581 (834)
..++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999865 6889999998643 334456778899999999999999999988643
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 77776632 2888999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc------------
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL------------ 728 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~------------ 728 (834)
++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||...+.... ..+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987644321 2234678899999999999999999999999999999999999864331100 000
Q ss_pred ---ccccccc-------ccccccccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 729 ---GHAWDLW-------KDDRVHDLIDPVIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 729 ---~~~~~~~-------~~~~~~~li~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+ ......++....+.. ..........+.+++.+||+.||++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000001111111100 00011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.33 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=197.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 587 (834)
++|++.+.||+|+||.||+|+.. +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999876 48899999986432 22334678899999999999999999999877 889999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+.+ +|.+++... ...+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 888887432 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccc-------cccccc--
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLG-------HAWDLW-- 735 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~-------~~~~~~-- 735 (834)
.. .......+++.|+|||.+.+. .++.++||||||++++||++|+.|+........ . +.. ..|..+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999998764 468999999999999999999999864332110 0 000 000000
Q ss_pred ----cccccccccccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 736 ----KDDRVHDLIDPVIMQDEISLP-MLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 736 ----~~~~~~~li~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
............+ ....... ....+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000 1111111 2456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=296.11 Aligned_cols=262 Identities=26% Similarity=0.382 Sum_probs=198.8
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+|++.++||.|++|.||+|+.. +++.||||.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 588999999875432 23466788999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++ +|.+++........+++..+.+++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78888755444456899999999999999999999998 99999999999999999999999999976543211
Q ss_pred CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccc-------cccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLG-------HAWDLWKDDRVH 741 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~-------~~~~~~~~~~~~ 741 (834)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ . ... ..+..+. ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCc
Confidence 11234568899999988664 578999999999999999999999864332110 0 000 0000000 000
Q ss_pred ccccccccc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 742 DLIDPVIMQ------DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ...... ..........+.+++.+|++.||.+||++.|+++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EY-KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hh-cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000000 0011122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.10 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=195.0
Q ss_pred eccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999998754 8899999986532 23457799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345899999999999999999999988 9999999999999999999999999998765432 2223
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..++..|+|||.+....++.++|+||||+++|||++|+.|+.....+...... ...+... .......
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~-~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN------------DILKGNG-KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH------------HHhccCC-CCCCCcc
Confidence 46788999999998888999999999999999999999998654321111100 0010000 1111122
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRPT-----MSDVIS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
....+.+++.+||+.+|.+||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2567899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=291.72 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=199.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999875 4789999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-ceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2335799999999999999999999998 999999999999998864 6999999998764332
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......|++.|+|||++....++.++||||||++++||++|+.|+........ . ........
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~---------~~~~~~~~- 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----V---------LKICQGYF- 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----H---------HHHhcccC-
Confidence 1 12234688899999999988999999999999999999999999753221110 0 00000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+|++.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112233568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.08 Aligned_cols=270 Identities=22% Similarity=0.333 Sum_probs=199.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----ee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 584 (834)
+++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999864 5899999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++|+||+++ +|..++ ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 776666 2345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccc---cc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD---DR 739 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 739 (834)
....... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...+... ........... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 6432211 12233578899999998755 568999999999999999999999985422100 00000000000 00
Q ss_pred cccccc--------cccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccC
Q 003288 740 VHDLID--------PVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM--INNEHL 791 (834)
Q Consensus 740 ~~~li~--------~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 791 (834)
...+.. ......... .....++.+++.+||+.+|++||++.|+++. ++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 000000001 1124568899999999999999999999987 655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.87 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=195.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 586 (834)
.++|++.++||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 58999999986432 22234567899999999999999999998765 46899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 787777432 256899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc--------ccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG--------HAWDLWK 736 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~--------~~~~~~~ 736 (834)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ..+. ..+..+.
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 432 11122345788999999865 5678999999999999999999999864332111 0000 0000000
Q ss_pred ccccccccc-cccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 DDRVHDLID-PVIMQDEI---SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~~~~~~li~-~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......... +....... .......+.+++.+||+.||++||+++|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00000000 01124567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=333.45 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=203.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
+-++.....||.|.||.||.+... +|.-.|+|.++.. .........+|+.++..|+|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 445666779999999999999754 5888999977543 3344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|||++|+|.+.+. .++..++........|++.|++|||+++ ||||||||.||+|+.+|.+|+.|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999983 3444566666678899999999999999 999999999999999999999999999988654
Q ss_pred c--ccCCcccccccccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 669 E--LQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 669 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
. .........||+.|||||++.+.. ...++||||+|||+.||+||++||..++.+ +.++-++. .-
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~---------~g 1457 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVA---------AG 1457 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHh---------cc
Confidence 2 333445679999999999998755 346899999999999999999999755432 11111110 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
- .+.++.....+-.+++.+||+.||++|.++.|+++.=
T Consensus 1458 h-----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 H-----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred C-----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 0 1222333556678999999999999999998887653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.89 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=206.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
...|.+.+.||+|.|+.|.+|++. .+..||||.+.+.. ....+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 567899999999999999999865 58999999997653 334566899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+|.+.+++.. ...+.+..+..++.|+.+|++|||+++ |+|||||++||||+++.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999944 344566888899999999999999998 999999999999999999999999999987643
Q ss_pred cccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
......+|++.|.|||++.+..| .+.+|+||+|++||-|++|..||+...- ..+-++.
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------k~Lr~rv 267 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------KELRPRV 267 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------ccccchh
Confidence 33455799999999999999887 4789999999999999999999863211 1111111
Q ss_pred cc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IM-QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+. +..++.....++.++++++|-.+|.+|++++++-+.
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 10 112333345578899999999999999999998765
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.20 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=186.8
Q ss_pred eeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHh---cCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAK---LQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++.. .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999886432 1222334455544443 479999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999884 3346899999999999999999999998 9999999999999999999999999997654321
Q ss_pred CcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.....|+..|+|||.+.. ..++.++|||||||+++||++|+.||.............. .... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~-----~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TLTV-----NV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------hhcC-----Cc
Confidence 123468999999998864 5689999999999999999999999864322111100000 0000 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 752 EISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
........++.+++.+||+.||.+|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12223345788999999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.28 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=195.7
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
|++.++||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999865 68999999986443 233467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+ ++|.+++.... ...+++..+.+++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68988874322 246899999999999999999999988 99999999999999999999999999976543211
Q ss_pred CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc-------ccccccc-ccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH-------AWDLWKD-DRV 740 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~-------~~~~~~~-~~~ 740 (834)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ..... .+..... ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999988664 578999999999999999999999864332110 00000 0000000 000
Q ss_pred cccccccc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 HDLIDPVI--MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ~~li~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ ............+.+++.+||+.+|.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 000011122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.69 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=193.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999875 58899999885432 223345678999999999999999999987654
Q ss_pred --eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 583 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
..++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 35999999975 67776632 2335899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc--CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccc----
Q 003288 661 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW---- 732 (834)
Q Consensus 661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~---- 732 (834)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876433211 122234678899999988664 478899999999999999999988754332110 0000000
Q ss_pred -ccccccccccccccc-cccC-------C-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 733 -DLWKDDRVHDLIDPV-IMQD-------E-ISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 733 -~~~~~~~~~~li~~~-~~~~-------~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......+..+.. .... . ........+.+++.+||+.||.+||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000000 0000 0 00011245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.65 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=194.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCe-----
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE----- 583 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 583 (834)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.++++++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58899999876432 223467889999999995 6999999999987665
Q ss_pred eEEEEEecCCCchhhhhhccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccc
Q 003288 584 KILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFG 660 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFG 660 (834)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78887754322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--ccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLGHAWDLWKD 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~ 737 (834)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+......... +... ......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-LGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-hCCCCh
Confidence 9986543211 1122356788999998865 45789999999999999999999988643321100 0000 000000
Q ss_pred cc---cccccc----ccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 738 DR---VHDLID----PVIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 738 ~~---~~~li~----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ...... +.... .........++.+++.+||+.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000 00000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=307.99 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=193.4
Q ss_pred cccceeccCCcEeEEEEEec-CCcEEEEEEec----CCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe--eEEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE--KILIL 588 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 588 (834)
...++||+|+|-+||||.+. +|.+||=-.++ ...+...++|..|+.+|+.|+|+||++++.+..+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999764 36666533322 1245567899999999999999999999999987665 78999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~ 667 (834)
|.+..|+|..|+.+ .+.++.+.+.+|++||++||.|||++. ++|||||||-+||+|+.+ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999954 445788999999999999999999985 689999999999999764 8899999999998754
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .+.+.|||.|||||+.. ..|++..||||||+.++||+|+..|+.--.. ..+.++... +.
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~---------SG 259 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVT---------SG 259 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHH---------cC
Confidence 32 33479999999999777 8899999999999999999999999642111 111111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
++...+..-...++.++|.+||.. .++|||+.|+++.
T Consensus 260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111222222245788999999998 9999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=306.71 Aligned_cols=202 Identities=29% Similarity=0.463 Sum_probs=176.4
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------eeEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKIL 586 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 586 (834)
+...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||++++.-++.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445578999999999999954 69999999997643 334566789999999999999999999866543 5689
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec--CCCC--ceeeccccc
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMN--PKISDFGLA 662 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~--~~~~--~kl~DFGla 662 (834)
|||||.+|+|...|...+....|++.+.+.++..+..||.|||+++ |+||||||.||++- ++|+ .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888899999999999999999999999988 99999999999993 3343 799999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
+.+..+. ......||..|++||.+.. +.|+...|.|||||++||++||..||.....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9886554 5566899999999999985 8899999999999999999999999976543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.16 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=194.3
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|+..++||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999875 48899999986432 345567899999999996 9999999999999999999999
Q ss_pred ecCCCchhhhhhc--cCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+.. +|.++... ......+++..+.+++.|+++||+|||+. + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 44443211 12235689999999999999999999975 6 9999999999999999999999999997654
Q ss_pred CCcccCCcccccccccccCcccccCC---CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
... ......++..|+|||.+... .++.++||||||+++|||++|+.|+....... ........ .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~----- 226 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF----DQLTQVVK-G----- 226 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH----HHHhhhcC-C-----
Confidence 321 11223678899999998776 68999999999999999999999986432100 00000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+.+ ...........+.+++.+||+.+|++||++.+|++.
T Consensus 227 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPIL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 111112345578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.66 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=202.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|+|++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998432 56899999999999999999999998 99999999999999999999999999987754332
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
. .....++..|+|||...+..++.++||||||+++++|++|+.|+........ .+.. .... .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~---------~~~~--~ 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRI---------VQDD--H 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHH---------hccC--C
Confidence 1 2335678899999999888889999999999999999999999753321100 0000 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223457889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.79 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=203.8
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.++||+|+||.||+++.. +++.+|+|.+... .......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999764 5789999998653 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999985432 2356899999999999999999999998 999999999999999999999999999876544
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+......... ..+....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---------------~~~~~~~- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---------------YKVQRGK- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHhcCC-
Confidence 122346788999999999999999999999999999999999998643321100 0000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112223445678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.64 Aligned_cols=260 Identities=18% Similarity=0.230 Sum_probs=183.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCC----cEEEEEEecCCChhhH-----------HHHHHHHHHHHhcCCCceeeEee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLLG 576 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 576 (834)
.++|.+.++||+|+||.||+|+..++ ..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999987543 4566665332221110 11223344555678999999999
Q ss_pred eeeecC----eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 577 CCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 577 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
++.... ..++++|++.. ++.+.+. .....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776544 34677777643 4555542 2223578888999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCcc-----cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc
Q 003288 653 NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 727 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~ 727 (834)
.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+++||++|+.||........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-L 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-H
Confidence 999999999987643211 1122234799999999999999999999999999999999999999875422111 0
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.... +.+-...+..... . .......+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~----~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAA----KCDFIKRLHEGKI-K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHh----HHHHHHHhhhhhh-c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000 0000011111111 0 0112356889999999999999999999998763
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=296.30 Aligned_cols=249 Identities=31% Similarity=0.428 Sum_probs=196.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
+.|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778889999999999999865 5889999998643 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+ +|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 676666432 345899999999999999999999998 99999999999999999999999999875432
Q ss_pred cccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.....++..|+|||++. .+.++.++|||||||++|||++|+.|+........ . ..+..
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~------------~~~~~ 238 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L------------YHIAQ 238 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H------------HHHHh
Confidence 22346788999999874 45788999999999999999999998753221100 0 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
... ...........+.+++.+||+.+|.+||++.+|++.+-.
T Consensus 239 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 239 NES-PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ccC-CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 000 001111234568899999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.03 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=197.4
Q ss_pred ccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEEEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 589 (834)
|++.++||+|++|.||+|+..+ ++.+|+|.+.... ....+.+.+|++++++++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6778999999999999998764 8899999997653 34456788999999999999999999999988 78999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887432 246899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc--------cccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG--------HAWDLWKDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~--------~~~~~~~~~~ 739 (834)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ..+. ..+.....-.
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1 11223456788999998765 4678999999999999999999999864432110 0000 0000000000
Q ss_pred ccccccccc-----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVI-----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......... ........+...+.+++.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 000001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=287.83 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=197.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Cee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 584 (834)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 5889999987432 234456889999999999999999999998764 457
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++++||+++++|.+++.. ...+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998842 335789999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
....... .......++..|+|||.+.+..++.++|||||||+++||++|+.|+....... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------------AIFKI 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------------HHHHH
Confidence 5432111 11223568899999999998889999999999999999999999985321110 00011
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ...........+.+++.+|++ +|..||+..+++.
T Consensus 222 ~~~~~-~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQPT-KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCCC-CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 10000 112233345678899999998 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=286.15 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=204.8
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|++.+.||+|+||.||++... +++.+++|++.... ....+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999875 58899999987543 35667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999985432 2367899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.......+++.|+|||.+....++.++||||+|+++++|++|+.|+....... ... ......
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~------------~~~~~~-- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL------------KILKGQ-- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH------------HHhcCC--
Confidence 12233578899999999999899999999999999999999999975433111 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.+|.+||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=291.92 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=197.0
Q ss_pred eccCCcEeEEEEEecC-CcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865433 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc------
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL------ 670 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~------ 670 (834)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998532 36899999999999999999999998 99999999999999999999999999876533211
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
........++..|+|||.+.....+.++||||||++++||++|+.|+........ .. .+..... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~------------~~~~~~~-~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQ------------NILNGKI-E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHhcCCc-C
Confidence 1122335678899999999988899999999999999999999999864332110 00 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+........+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00011124577899999999999999999777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.36 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=197.1
Q ss_pred cceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
..+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 368999999999999874 6889999998765555667899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 988732 34789999999999999999999998 9999999999999999999999999987654322 11233
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..++..|+|||.+....++.++||||||+++|||++|+.|+........ .. . ........+ . ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~----~-----~~~~~~~~~-~--~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MK----M-----IRDNLPPKL-K--NLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H-----HHhhCCccc-C--Cccc
Confidence 5688999999999888899999999999999999999999753221110 00 0 000000110 0 0111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.25 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.|+.-++||+|+||.||-.+.. +|+-+|.|.+.+. ..++.....+|-.+|.+++.+.||.+-.+++..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356777789999999999988754 5899999988543 234455678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+..|.||+|.-+|++... ..++++.+...+.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987644 67999999999999999999999998 99999999999999999999999999998865
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.+. ....+||.+|||||++.+..|+...|.|||||+||||+.|+-||...... ...+-++.+
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---------------vk~eEvdrr 401 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---------------VKREEVDRR 401 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---------------hhHHHHHHH
Confidence 542 23358999999999999999999999999999999999999998643321 111122222
Q ss_pred cc--cCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003288 748 IM--QDEISLPMLMRYINVALLCVQENAADRPT 778 (834)
Q Consensus 748 ~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
.. ..+++...++++..+....|+.||++|..
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 22 22345556778888999999999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=296.90 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=193.4
Q ss_pred cceeccC--CcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 518 QCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 518 ~~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.+.||+| +||+||++++. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 89999999875 6899999998643 33456788999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc-
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 671 (834)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999885432 235889999999999999999999998 999999999999999999999999865433211100
Q ss_pred ----CCcccccccccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc--cc-ccccccc------
Q 003288 672 ----GNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--LG-HAWDLWK------ 736 (834)
Q Consensus 672 ----~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~--~~-~~~~~~~------ 736 (834)
.......++..|+|||++.+. .++.++|||||||+++||++|+.|+.......... .. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 001112345679999999764 47899999999999999999999986433211000 00 0000000
Q ss_pred -----------------ccccc-----cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 -----------------DDRVH-----DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 -----------------~~~~~-----~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.... .+....+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0000011 112223456688999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=290.78 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=191.6
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999854322 46899999999999999999999998 999999999999999999999999998765432 12223
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ..+....... .......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~--~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----------EELKRRTLEM--AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----------HHHHhccccc--cccCCcc
Confidence 46788999999998888999999999999999999999998643321000 0000000000 1111222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRP-----TMSDVIS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.+++.+||+.+|.+|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 345678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=322.09 Aligned_cols=263 Identities=30% Similarity=0.447 Sum_probs=208.2
Q ss_pred HHHhcCccccceeccCCcEeEEEEEecC--------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeee
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 578 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 578 (834)
+...++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3445666777899999999999997531 4579999997653 34678899999999999 799999999999
Q ss_pred eecCeeEEEEEecCCCchhhhhhccC-------C----C--ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCc
Q 003288 579 VEQGEKILILEYMPNKSLNVFLFDST-------K----K--RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 579 ~~~~~~~lv~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~N 645 (834)
..++..++|+||+..|+|..+|+..+ . . ..++..+++.++.|||.|++||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999996554 0 0 24889999999999999999999998 9999999999
Q ss_pred EEecCCCCceeeccccceecCCCcccCCc-ccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCC
Q 003288 646 ILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNAD 723 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~ 723 (834)
||+.++..+||+|||+|+........... ....-+..|||||.+....|+.|+|||||||+||||+| |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976554333211 11114567999999999999999999999999999999 66665421100
Q ss_pred cccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 724 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+ ++..+.+. +...+..+..+++++++.||+.+|++||++.|+++.++..
T Consensus 529 -~~l----~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 -EEL----LEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HHH----HHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 000 11111111 1222334467888999999999999999999999999884
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.64 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=199.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 584 (834)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 58999999986542 2345678889999999999999999998763 3468
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888873 3345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc----cc----cc
Q 003288 665 FGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL----GH----AW 732 (834)
Q Consensus 665 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~----~~----~~ 732 (834)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ... .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 6433211 11223578899999998865 4689999999999999999999999854332100 000 00 00
Q ss_pred ccccccccccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........++......... ......+.+++.+||+.+|.+||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111111111100011111 1235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.76 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=198.8
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 588999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 777777432 256899999999999999999999998 9999999999999999999999999998775543
Q ss_pred CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc-c-------cccccccc---c
Q 003288 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G-------HAWDLWKD---D 738 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~-~-------~~~~~~~~---~ 738 (834)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...+.... ... . ..+..... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112234578899999998876 789999999999999999999988854332110 000 0 00000000 0
Q ss_pred cccccccccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 RVHDLIDPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ~~~~li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......... ...........++.+++.+||+.||.+||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000 000111234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=294.80 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=193.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+|+... ++.||||.++... .....++..|+.++.+.+ |+||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678899999999999999999865 8899999997543 334456777887777775 999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++ +|..++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 666665332 23689999999999999999999974 6 99999999999999999999999999876543
Q ss_pred CcccCCcccccccccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
... .....++..|+|||.+.... ++.++||||||+++|||++|+.|+....... .... ..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~------------~~ 231 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT------------KI 231 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH------------HH
Confidence 221 12235778999999987654 7899999999999999999999985422211 0000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.......+.......++.+++.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 232 LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000111234568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=316.79 Aligned_cols=269 Identities=22% Similarity=0.312 Sum_probs=187.1
Q ss_pred HhcCccccceeccCCcEeEEEEEecC--CcEEEEE------------------EecCCChhhHHHHHHHHHHHHhcCCCc
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLKEFKNEMMLIAKLQHRN 570 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~n 570 (834)
..++|+++++||+|+||.||++.... +...++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999986532 2222222 111 12234567889999999999999
Q ss_pred eeeEeeeeeecCeeEEEEEecCCCchhhhhhccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 571 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
|+++++++.+.+..++|+|++.. +|..++..... .......++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999854 66666543211 122345677889999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC-CCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p-~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876543221 22235799999999999999999999999999999999998754 33221111000
Q ss_pred ccccccc---cccc------ccccccccc-cccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 728 LGHAWDL---WKDD------RVHDLIDPV-IMQDEIS-------LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 728 ~~~~~~~---~~~~------~~~~li~~~-~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+...... ...+ ...+.++.. ....... ......+.+++.+||+.||++||++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 0000 000000000 0000000 0112356778999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.75 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=197.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec--CeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ--GEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 585 (834)
.++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 578999999999999999999875 5789999988542 334456678899999999 999999999998654 3689
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588888732 26889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc---CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccc--------c
Q 003288 666 GGDELQ---GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------W 732 (834)
Q Consensus 666 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~ 732 (834)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.|+........ ...... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 443221 12234568999999998765 4678999999999999999999999864332110 000000 0
Q ss_pred cccccccccccccccccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLIDPVIMQ-----DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+......++++..... ..........+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000011100000 00011134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=298.27 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=197.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Ce
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 583 (834)
.++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999998653 233456678899999999999999999988654 35
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877773 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc-ccccc--------cccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLG--------HAWD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~-~~~~~--------~~~~ 733 (834)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.|+...+... ..... ..+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764332 12233467889999998865 468999999999999999999999985432110 00000 0000
Q ss_pred cccccccccccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LWKDDRVHDLIDPVIMQD-----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+....... ........++.+++.+||+.+|++||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000010000000000 0011234568899999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=292.17 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=194.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999886432 2344678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~ 668 (834)
|++ ++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777766322 2234678888899999999999999998 999999999999985 557999999999765432
Q ss_pred cccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--cccc---c-cccccccc-cc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLG---H-AWDLWKDD-RV 740 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~---~-~~~~~~~~-~~ 740 (834)
. .......+++.|+|||++.+. .++.++||||||+++|||++|+.|+........ .... . ....|... .+
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1 112234678899999988764 578999999999999999999999864332110 0000 0 00000000 00
Q ss_pred cccc--ccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 HDLI--DPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ~~li--~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... .+..... ........++.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000 0011224567899999999999999999999863
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=287.46 Aligned_cols=245 Identities=23% Similarity=0.279 Sum_probs=189.7
Q ss_pred ceeccCCcEeEEEEEec-CCcEEEEEEecCCCh---hhHHHHHHHHHHHH-hcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIA-KLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.||+|+||.||+|... +++.||+|.++.... .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 588999999865432 22334455555444 45899999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 346899999999999999999999998 99999999999999999999999999876432
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....++..|+|||.+.+..++.++||||||++++||++|..|+........ +........ . . ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~----~--~-~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRI----N--W-PEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhccc----C--C-CCcc
Confidence 2234678899999999888899999999999999999999999864322110 000000000 0 0 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11234578899999999999999988776666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=294.58 Aligned_cols=264 Identities=22% Similarity=0.244 Sum_probs=195.5
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
.+.+.+|.|+++.|++++. +++.||||+++.. .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666655 6899999998654 445667899999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc---
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--- 670 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~--- 670 (834)
++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999985432 335889999999999999999999998 99999999999999999999999999876532211
Q ss_pred --cCCcccccccccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc----cccccc-----
Q 003288 671 --QGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA----WDLWKD----- 737 (834)
Q Consensus 671 --~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~----~~~~~~----- 737 (834)
........++..|+|||++... .++.++|||||||++|||++|+.||........ ..... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhh
Confidence 1112334577889999998763 588999999999999999999999864332110 00000 000000
Q ss_pred --ccccc----cccccc---ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 738 --DRVHD----LIDPVI---MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 738 --~~~~~----li~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ..++.. ............+.+++.+||+.||++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000000 0112223345678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=286.40 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=191.4
Q ss_pred HHHHHhcCcccccee--ccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 507 SITAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 507 ~i~~~~~~y~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
+.....++|++.+.+ |+|+||.||+++.. +++.+|+|.+....... .|+.....+ +|+||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445678887776 99999999999864 57889999986432111 122222223 7999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-Cceeecccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGL 661 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGl 661 (834)
..++||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999843 237899999999999999999999998 99999999999999998 999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++..... ....++..|+|||++.+..++.++||||||++++||++|+.|+.....+....... .
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----------~ 220 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL----------L 220 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH----------H
Confidence 8865432 22467889999999999999999999999999999999999986433222111100 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 784 (834)
..... ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 221 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 KRQQK---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Hhhcc---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 01111234567899999999999999996 688874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=290.53 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=191.1
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeec--CeeEEEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 589 (834)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999865 58899999986542 222234457888999885 99999999999987 88999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++ +|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 77777643 2346899999999999999999999998 999999999999999 999999999998764322
Q ss_pred ccCCcccccccccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc----ccccc----cccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL----GHAWD----LWKDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~----~~~~~----~~~~~~ 739 (834)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.|+...+.... ... ..... ......
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 12345788999999764 45678999999999999999999999864332110 000 00000 000000
Q ss_pred cccccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 740 VHDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 740 ~~~li~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+..... .........+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001123568899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=292.21 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 587 (834)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 6899999998653 2344567889999999998 99999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc------------------CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 003288 668 DELQ------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729 (834)
Q Consensus 668 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~ 729 (834)
.... .......++..|+|||.+....++.++||||||++++|+++|+.|+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-
Confidence 3221 12233567889999999998889999999999999999999999976432110 00
Q ss_pred cccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM----SDVIS 784 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 784 (834)
...... ...........+.+++.+||+.+|.+||++ +++++
T Consensus 232 -----------~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -----------QKILKL---EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----------HHHHhc---CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000000 111122234568899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.19 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=196.0
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999876 48899999986432 233456788999999999999999999987655
Q ss_pred ------eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 583 ------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 583 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 56565532 2346899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc----
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH---- 730 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~---- 730 (834)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++|+........ ..+..
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999987643321 11122346778999998865 4578999999999999999999998864322100 00000
Q ss_pred ----ccccccccccccccc------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 731 ----AWDLWKDDRVHDLID------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 731 ----~~~~~~~~~~~~li~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+............+ ... ... .......+.+++..||+.+|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRL-REE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccch-hhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000000 000 000 0012356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=291.02 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=199.9
Q ss_pred CccccceeccCCcEeEEEEEec----CCcEEEEEEecCCC----hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998742 56889999986432 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345889999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCcccCCcccccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+..... .......++..|+|||.+.+.. .+.++||||||++++||++|..|+........ ... . ...
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~-----~----~~~ 223 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSE-----I----SRR 223 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHH-----H----HHH
Confidence 543321 1122346889999999987665 78899999999999999999999753221100 000 0 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ...........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 224 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 ILKS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHcc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0000 0111122335678899999999999999999998887664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=282.25 Aligned_cols=269 Identities=24% Similarity=0.340 Sum_probs=218.6
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEee
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 576 (834)
..+++.....+++...++-+|.||.||.|.+. +.+.|.+|.++.. ++-+...+..|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 35566667788998899999999999999654 3456788887654 3445678899999999999999999999
Q ss_pred eeeec-CeeEEEEEecCCCchhhhhh-----ccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC
Q 003288 577 CCVEQ-GEKILILEYMPNKSLNVFLF-----DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 650 (834)
Q Consensus 577 ~~~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~ 650 (834)
++.++ ...+.+|.++.-|+|..||. +....+.++..+...++.|++.|++|||+++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98765 46788999999999999997 4455567888899999999999999999998 999999999999999
Q ss_pred CCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccc
Q 003288 651 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLG 729 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~ 729 (834)
..++||+|=.++|.+-+.++......-..+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999998877666655555566889999999999999999999999999999999 788876444322110
Q ss_pred cccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
. +.|...... +.+++.++..++.-||...|++||+++|++.-|.+...
T Consensus 510 ----y--------lkdGyRlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 510 ----Y--------LKDGYRLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ----H--------HhccceecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1 111111122 23355678899999999999999999999999987543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=271.92 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=194.7
Q ss_pred CccccceeccCCcEeEEEEEecC-CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+.+..||.|..|.|++.+... |..+|||.+.+. ..+..+++...+.++.+-+ +|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 44556789999999999998764 889999999765 4456678888888887775 89999999999999999999998
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.- .++.++. .-++.+++..+-++...+.+||.||.++. .|+|||+||+|||+|+.|++||+|||++-.+-...
T Consensus 173 Ms~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 173 MST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 843 3444442 23345888888899999999999999876 69999999999999999999999999997764322
Q ss_pred cCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
..+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+..-+.+- ..+. ++++..
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~lt------------kvln~e 311 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLT------------KVLNEE 311 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHH------------HHHhcC
Confidence 2334578899999999864 468999999999999999999999987533321 1111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...-+.....+..+.+++..||+.|+.+||...++++.
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 00001111255678999999999999999999999865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=286.10 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=194.0
Q ss_pred ccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhc---CCCceeeEeeeeeecCe-----
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGE----- 583 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 583 (834)
|++.++||+|+||.||+|+... ++.+|+|.++... ......+.+|+.++.++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5778999999999999999864 8999999986432 22234567788877766 59999999999988776
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888774322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccccc----cccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGHA----WDLWKD 737 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~~----~~~~~~ 737 (834)
.+..... .....++..|+|||.+.+..++.++||||||+++|||++|++|+........ . ..... ...+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 7643321 1223578899999999999999999999999999999999888764332110 0 00000 000000
Q ss_pred ccc--ccccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 738 DRV--HDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 738 ~~~--~~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ......... ...........+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 00111223457789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=291.95 Aligned_cols=249 Identities=31% Similarity=0.410 Sum_probs=195.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344777789999999999999875 4788999988632 334456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 5777766432 345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
. ....++..|+|||.+. ...++.++|||||||++|||++|+.|+......... ....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------------~~~~ 227 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--------------YHIA 227 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--------------HHHh
Confidence 2 2346788999999874 356788999999999999999999987533211100 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.... ...........+.+++.+||+.+|.+||++.+|++.--
T Consensus 228 ~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 228 QNES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred hcCC-CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0000 00111123456789999999999999999999997743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=285.74 Aligned_cols=242 Identities=25% Similarity=0.312 Sum_probs=186.2
Q ss_pred eeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHH---HhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++ ....||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 48899999886532 12222344454443 34579999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|..++. +...+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998884 3456999999999999999999999998 9999999999999999999999999987653321
Q ss_pred CcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.|+............. ..... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~-----~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------MTLTM-----AV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---------Hhhcc-----CC
Confidence 2234789999999998754 68999999999999999999999986432211100000 00000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 752 EISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.........+.+++.+|++.+|.+|| ++.++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11112345788999999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=316.17 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=189.9
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee------
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------ 580 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 580 (834)
.+...+|+.++.||+||||.|||++.+ ||+.||||++.-. +......+.+|++.|++|+|||||+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 455678999999999999999999875 7999999998644 34456678999999999999999999842100
Q ss_pred ------------------------------------------------------------------------c-------
Q 003288 581 ------------------------------------------------------------------------Q------- 581 (834)
Q Consensus 581 ------------------------------------------------------------------------~------- 581 (834)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHH
Q 003288 582 ----------------------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627 (834)
Q Consensus 582 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 627 (834)
..+|+=||||+..+|++++.+..-. -.....++++.+|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence 1135668888888888887432211 1366788999999999999
Q ss_pred HHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC----C------------CcccCCcccccccccccCcccccC
Q 003288 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG----G------------DELQGNTKQIVGTYGYMSPEYALD 691 (834)
Q Consensus 628 LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~ 691 (834)
+|+.+ ||||||||.||+|+++..+||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 0 011112345789999999999976
Q ss_pred C---CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc-CCCCHHHHHHHHHHHHH
Q 003288 692 G---LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ-DEISLPMLMRYINVALL 767 (834)
Q Consensus 692 ~---~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~-~~~~~~~~~~l~~li~~ 767 (834)
. +|+.|+|+|||||||+||+. ||+...+.. ..+..+-+..++. ..+..+....-..+|++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-------------SILTNLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHH-------------HHHHhcccCCCCCCcccccccchHHHHHHHH
Confidence 5 49999999999999999984 343211110 0011111222211 12233445566789999
Q ss_pred ccccCCCCCCCHHHHHH
Q 003288 768 CVQENAADRPTMSDVIS 784 (834)
Q Consensus 768 cl~~dP~~RPt~~evl~ 784 (834)
|++.||++|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999964
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=287.48 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=195.0
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEec
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999976 478899999865432 22334567999999998 999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+++|.+++.... ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 788888874332 346899999999999999999999998 9999999999999999999999999998664322
Q ss_pred CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-----cccc-cccccccc-ccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-----LLGH-AWDLWKDD-RVHDL 743 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-----~~~~-~~~~~~~~-~~~~l 743 (834)
......++..|+|||++.. ..++.++||||||++++||++|+.|+......... .... ....+.+. .....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 1223467889999998754 55789999999999999999999888544321100 0000 00000000 00000
Q ss_pred cccccc---cC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIM---QD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+...+. .. .........+.+++.+||+.+|.+||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00 0001113578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=288.58 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=195.6
Q ss_pred CccccceeccCCcEeEEEEEe----cCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|+||.||+++. .+|+.||+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999986532 22346788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+........ ... ..+
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~----------~~~ 222 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAE----------ISR 222 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHH----------HHH
Confidence 6433221 12235688999999998753 467899999999999999999999753221100 000 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.+... ..+........+.+++.+||+.+|++|| ++.+++..
T Consensus 223 ~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 RILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred Hhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00000 1111222345678999999999999997 66766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=295.17 Aligned_cols=265 Identities=25% Similarity=0.337 Sum_probs=201.5
Q ss_pred CccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-----eeE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 585 (834)
+|++.+.||+|++|.||+|+... ++.+|||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999998754 8899999987643 445578899999999999999999999988775 789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
++|||+++ +|.+++. ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7888873 2337899999999999999999999998 999999999999999999999999999976
Q ss_pred CCCcc-cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccc--------ccc
Q 003288 666 GGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------WDL 734 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~~~ 734 (834)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||........ ..+... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 1122345678899999999887 789999999999999999999999864432110 000000 000
Q ss_pred ccccccccccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+........ ........+.+++.+||+.+|.+||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000111110000000 111134578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=289.57 Aligned_cols=244 Identities=30% Similarity=0.445 Sum_probs=191.5
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
|...++||+|+||.||+|+.. +++.|++|.+... .....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 5889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|.+++.. ....+++.++..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 466666632 2345899999999999999999999998 99999999999999999999999999864321
Q ss_pred cCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.....++..|+|||++. ...++.++||||||+++|||++|.+|+........ . ..... ... +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~---~~~~~-~~~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQ-NDS-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--H---HHHHh-cCC-----CC
Confidence 22356888999999984 45688999999999999999999998753321110 0 00000 000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+++.+||+.+|.+||++.+++..
T Consensus 240 ----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123457889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=297.66 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=194.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 5899999998643 2233466889999999999999999999987543
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 666554 234889999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccc--------c
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------W 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~ 732 (834)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...... .
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 764321 223467889999999876 4688999999999999999999999864331100 000000 0
Q ss_pred ccccccccccccc--cccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003288 733 DLWKDDRVHDLID--PVIMQDEI---SLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 789 (834)
Q Consensus 733 ~~~~~~~~~~li~--~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 789 (834)
..+........+. +....... .......+.+++.+||+.||++||++.|++.. ++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000000 00000000 01123467899999999999999999999855 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=291.93 Aligned_cols=267 Identities=26% Similarity=0.354 Sum_probs=193.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|++.++||+|+||.||+|+.. +++.+|||++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999875 58899999885432 222356788999999999999999999875443
Q ss_pred --eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 583 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
..++|+||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56555532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc---------CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc
Q 003288 661 LARMFGGDELQ---------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG 729 (834)
Q Consensus 661 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~ 729 (834)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|++|+........ ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99866432211 111234678889999988654 588999999999999999999999864332110 0000
Q ss_pred --------ccccccccccccc--ccccccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 730 --------HAWDLWKDDRVHD--LIDPVIMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 730 --------~~~~~~~~~~~~~--li~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+..+....... ......... .........+.+++.+||+.+|.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000 000000000 000112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=292.84 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCeeE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKI 585 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 585 (834)
..+++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35788999999999999999999865 6889999988542 23345678899999999999999999999876 45789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+ +++|..++. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568888773 335788888899999999999999998 999999999999999999999999998754
Q ss_pred CCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc----c----cccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL----G----HAWDLW 735 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~----~----~~~~~~ 735 (834)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ ..+ . ......
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 123467889999998766 5689999999999999999999998854332100 000 0 000000
Q ss_pred cccccccccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+++........... .....+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000111110000011111 123578899999999999999999999766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=275.18 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=200.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|..+++||+|.||+|.+.+.+ .++.+|+|++++.- ......-..|-++|+..+||.+..|-..++..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478899999999999999999865 58899999998653 23334456788999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||..||.|.-+| .+.+.+++......-..|..||.|||+++ ||.||||.+|.|||.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 9999999998888 45667888888888899999999999998 999999999999999999999999999742
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
-.....++..+|||.|+|||++....|....|.|.+||++|||++|+.||...+.+. +.+++-..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------LFeLIl~e 383 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------LFELILME 383 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------HHHHHHhh
Confidence 122345677899999999999999999999999999999999999999986433221 11111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.-.++.....+...++...|..||++|. .++||.+
T Consensus 384 --d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 384 --DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred --hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 0112223345667788888999999996 3555543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.64 Aligned_cols=266 Identities=22% Similarity=0.275 Sum_probs=194.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec---------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--------- 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 581 (834)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999875 5889999998766666677889999999999999999999876544
Q ss_pred -----CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCce
Q 003288 582 -----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (834)
Q Consensus 582 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~k 655 (834)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58887773 235889999999999999999999998 99999999999997 456789
Q ss_pred eeccccceecCCCcc-cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccc
Q 003288 656 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW 732 (834)
Q Consensus 656 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~ 732 (834)
|+|||+++.+..... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||....+... .......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643211 111223457889999998754 5688999999999999999999999864332110 0000000
Q ss_pred ccccc---ccc----ccccccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKD---DRV----HDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~---~~~----~~li~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ... ............. ......++.+++.+||+.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 000 0000000000000 01123567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=296.41 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=195.2
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++|+||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999864 5889999998543 2334567889999999999999999999987654
Q ss_pred --eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 583 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 678888773 245899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc-------
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH------- 730 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~------- 730 (834)
++...... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+........ .....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99865332 223467889999999876 4588999999999999999999999864322100 00000
Q ss_pred cccccccccccccccc--ccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 731 AWDLWKDDRVHDLIDP--VIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~li~~--~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+........+.. ..... .........+.+++.+|++.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 00000 001122345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=269.79 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=199.4
Q ss_pred ceeccCCcEeEEEEE-ecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
+.||+|+++.|-... +.+|+++|||++.+.......+..+|++++.+.+ |+||++|+++|+++..+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999998775 5689999999999988888899999999999995 99999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeeccccceecCCCc----
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMFGGDE---- 669 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~~~~~~---- 669 (834)
..+| .+...+++.++.++.++|+.||.|||.++ |.||||||+|||...... +||+||.|..-+....
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9998 45567999999999999999999999999 999999999999965544 8999999876542211
Q ss_pred -ccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc---
Q 003288 670 -LQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV--- 740 (834)
Q Consensus 670 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 740 (834)
........+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||-..-.... -|..+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence 112223468999999999863 34689999999999999999999999864322111 1122221
Q ss_pred -ccccccccccCCC--CH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 -HDLIDPVIMQDEI--SL----PMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 -~~li~~~~~~~~~--~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.+...+..+.+ +. ..+.+..+++...+..++.+|.++.+++.
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111212222 21 23557788999999999999999999887
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=274.32 Aligned_cols=271 Identities=25% Similarity=0.332 Sum_probs=198.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC-----CcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 583 (834)
-..|+..+.||+|.||.||||.-.+ .+.+|||+++.... ..-....+|+.+++.++|||++.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4678999999999999999995432 33799999975532 223566899999999999999999999987 778
Q ss_pred eEEEEEecCCCchhhhhhc--cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC----CCceee
Q 003288 584 KILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKIS 657 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~----~~~kl~ 657 (834)
.++++||.+. +|..+|+. ..+.+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 55555543 234467999999999999999999999997 9999999999999877 899999
Q ss_pred ccccceecCCCcccC-CcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCC-----ccc----
Q 003288 658 DFGLARMFGGDELQG-NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-----SFN---- 726 (834)
Q Consensus 658 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~-----~~~---- 726 (834)
|||+++.+...-..- ....++-|.-|.|||.+.+. .|+.+.|||+.||++.||++-++.|.-.... .++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986543222 33456789999999999875 6899999999999999999988776432211 111
Q ss_pred -----ccc----cccccccccccc-cccccccc--cCCCCHH--------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 727 -----LLG----HAWDLWKDDRVH-DLIDPVIM--QDEISLP--------MLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 727 -----~~~----~~~~~~~~~~~~-~li~~~~~--~~~~~~~--------~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
++. ..|..++.-.-. .++..... ....+.. ......+++.++|+.||.+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 010 011111110000 11111100 0111011 011367899999999999999999998764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.42 Aligned_cols=268 Identities=24% Similarity=0.304 Sum_probs=197.4
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
..++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667899999999999999999999864 68899999986532 23356788999999999999999999988643
Q ss_pred ------CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 582 ------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 582 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
...++++|++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467788876 778888773 235899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc-c---
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G--- 729 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~-~--- 729 (834)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+........ ... .
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998864321 223467889999998876 5688999999999999999999999854322110 000 0
Q ss_pred ----cccccccccccccccc--cccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 730 ----HAWDLWKDDRVHDLID--PVIMQDEI---SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 730 ----~~~~~~~~~~~~~li~--~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..............+. +....... .......+.+++.+|++.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 00000000 00124467899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=291.31 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=194.9
Q ss_pred hcCccc-cceeccCCcEeEEEEEec-CCcEEEEEEecCCChhh--------------HHHHHHHHHHHHhcCCCceeeEe
Q 003288 512 TENFSM-QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLL 575 (834)
Q Consensus 512 ~~~y~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 575 (834)
.++|.. .+.||+|+||.||+|+.. .++.||||.++...... ...+.+|++++.+++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 467999999999999865 58899999986432211 12578899999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 576 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
+++..+...++||||+. ++|.+++. ....+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58888873 3345899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcc------------cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 656 ISDFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 656 l~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
|+|||+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652110 1111223567889999998764 468999999999999999999999865432
Q ss_pred Cccccccccccc--------cccc---cccccccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 723 DSFNLLGHAWDL--------WKDD---RVHDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 723 ~~~~~~~~~~~~--------~~~~---~~~~li~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... ....... |... ....-....... ..........+.+++.+||+.+|++||+++|++..
T Consensus 240 ~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111 0000000 0000 000000000000 00011124568899999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=291.29 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=192.0
Q ss_pred CccccceeccCCcEeEEEEEecC---CcEEEEEEecCC--ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec----Ce
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ----GE 583 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 583 (834)
+|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 678999998643 223356788999999999 599999999875433 35
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 58888873 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc--CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc--------cc
Q 003288 664 MFGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG--------HA 731 (834)
Q Consensus 664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~--------~~ 731 (834)
.+...... .......|+..|+|||.+.+ ..++.++||||||+++++|++|+.|+...+.... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76432211 11233578999999998765 4689999999999999999999998864332100 0000 00
Q ss_pred ccccccccccccccc-----ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 WDLWKDDRVHDLIDP-----VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ~~~~~~~~~~~li~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+........+.. ..............+.+++.+||+.||++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 000000011123568899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=280.99 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=194.0
Q ss_pred CccccceeccCCcEeEEEEEecC-CcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998654 444556655432 222344577899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++++|.+++... .....+++.++..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456899999999999999999999998 999999999999975 569999999998764
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ... ......
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~------------~~~~~~ 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVV------------LRIVEG 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH------------HHHHcC
Confidence 3221 222346788999999998888999999999999999999999987532110 000 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ...........+.+++.+||+.+|.+||++.|+++
T Consensus 221 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 11112234457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.54 Aligned_cols=262 Identities=27% Similarity=0.344 Sum_probs=197.5
Q ss_pred ccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
|++.+.||+|++|.||+|+... ++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998764 8999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999885432 46899999999999999999999998 99999999999999999999999999987643321
Q ss_pred CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccc-------ccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLL-------GHAWDLWKDDRVH 741 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~-------~~~~~~~~~~~~~ 741 (834)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ ... ...|..+..-...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223457789999998776 889999999999999999999988754331100 000 0000000000000
Q ss_pred cccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 742 DLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+..-+..... .........+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.79 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=196.5
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe----
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 583 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 583 (834)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999875 4789999998643 23345667889999999999999999998876554
Q ss_pred --eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 584 --KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 584 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888742 45899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-cccc---c----
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGH---A---- 731 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~---~---- 731 (834)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ . +... .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9865332 233467889999998865 3678999999999999999999999864322110 0 0000 0
Q ss_pred cccccccccccccccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+........+......... .......+.+++.+||+.+|++|||+.||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000000000000 01124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=312.93 Aligned_cols=146 Identities=29% Similarity=0.434 Sum_probs=131.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|.+.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999876 58899999986532 33457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
|||+.+++|.+++.. ...+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999843 345889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=284.58 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=195.1
Q ss_pred cceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
.++||+|.||+||-|++. +|+.||||.+.+. ......++.+|+.||++++||.||.+--.|+..+..++|||.+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999875 6999999998654 3445578999999999999999999999999999999999999776
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccccceecCCCccc
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 671 (834)
-|.-+| ...++.|++..-..++.||+.||.|||.++ |+|+||||+||||.+. -++||+|||.|+.++...+
T Consensus 649 MLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 665555 334556888888899999999999999999 9999999999999654 4699999999999976654
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.+.++||+.|+|||++..+-|...-|+||.||++|--++|..||....+...++. +...+-.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ----------------NAaFMyP 784 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ----------------NAAFMYP 784 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh----------------ccccccC
Confidence 3457999999999999999999999999999999999999999864332211111 1111111
Q ss_pred CCC-HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 752 EIS-LPMLMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 752 ~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
+.+ .+.....+++|...||..-.+|-+...-+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 111 22345678889999999888888766544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.27 Aligned_cols=236 Identities=26% Similarity=0.348 Sum_probs=191.7
Q ss_pred eccCCcEeEEEEEec-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 2456889999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccc
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999843 335899999999999999999999988 9999999999999999999999999998764332 12334
Q ss_pred ccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
..++..|+|||.+.+...+.++|+||||+++|||++|+.|+...+... .. ..+... .......
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~------------~~~~~~---~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IY------------EKILKD---PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HH------------HHHhcC---CCCCCCC
Confidence 567889999999998889999999999999999999999985432210 00 000000 0111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 003288 757 MLMRYINVALLCVQENAADRPTMSD 781 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.95 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=199.7
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC--C-----hhhHHHHHHHHHHHHhcCCCceeeEeeeee-ecC
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--S-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQG 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 582 (834)
.++|-++.+||+|||+.||||.+ ...+.||||+-.-. - +.-.+...+|..|-+.|.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788889999999999999964 45778999975321 1 112345678999999999999999999986 456
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeecc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDF 659 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DF 659 (834)
.+|-|+|||+|.+|+-+| ...+.++++++..|+.||..||.||.+.. ++|||-||||.||||.. -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 789999999999999999 45567999999999999999999999874 67999999999999954 477999999
Q ss_pred ccceecCCCccc-----CCcccccccccccCcccccC----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccc
Q 003288 660 GLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 730 (834)
Q Consensus 660 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~ 730 (834)
||++.+..+.+. ..++...||.-|++||.+.- .+++.|.||||.||++|..+.|++||+...... .++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq- 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ- 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh-
Confidence 999998765443 23566789999999998853 357899999999999999999999998543221 1111
Q ss_pred ccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 731 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 731 ~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
+. .++...-...+..+....+...+|++||+..-++|....++.
T Consensus 696 ------eN---TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ------EN---TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------hh---chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 111111111222233455778899999999999998877764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=292.72 Aligned_cols=261 Identities=22% Similarity=0.374 Sum_probs=210.5
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee-
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE- 580 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 580 (834)
.+..+...++.|++.++||.|.+|.||+++.. +++.+|+|++.... ...+++..|..+|+.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34445556889999999999999999999854 68889999886543 3446778899999988 69999999999864
Q ss_pred ----cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 581 ----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 581 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
+++++||||||.+|+..+++..-. +..+.|..+..|+..+++||.+||... ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 468999999999999999997655 777999999999999999999999987 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~ 731 (834)
.|||++..+.... .......||+.|||||++.. ..|+.++|+||||++..||.-|.+|+....+....+
T Consensus 165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---- 238 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 238 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence 9999998875433 34456799999999999954 357889999999999999999999976443321100
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+.....+.-.-......++.++|..||..|-.+||++.+++++
T Consensus 239 ----------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 ----------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00000000111234467899999999999999999999988754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=270.05 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=194.9
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+.+-+..||.|+||+|+|-.++ .|+..|||+++... +...+++..|.+...+- +.||||+++|++..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999875 59999999997554 35667888888876665 789999999999999999999999
Q ss_pred cCCCchhhhhh--ccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLF--DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|. .||+.+-. ...++..++++.+-+|..-..+||.||...- +|||||+||+||||+..|.+||+|||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 45554421 1234456889988999999999999998764 6999999999999999999999999998765322
Q ss_pred cccCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
. ..+.-.|-..|||||.+.. .-|+.++||||||++|+|+.||+.|+...+....++.. . ..++. +
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~----V-v~gdp-----p 288 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ----V-VIGDP-----P 288 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH----H-HcCCC-----C
Confidence 1 1223467789999999864 34899999999999999999999997654431111110 0 01111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+....-..+....+..++..|+..|-++||...++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 121222234466788999999999999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.53 Aligned_cols=220 Identities=20% Similarity=0.120 Sum_probs=175.7
Q ss_pred CCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhhhhhc
Q 003288 524 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 602 (834)
Q Consensus 524 G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 602 (834)
|.+|.||+++.. +++.+|+|+++... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 58899999997543 234455566667899999999999999999999999999999998843
Q ss_pred cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccccccccc
Q 003288 603 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 235899999999999999999999998 999999999999999999999999988765432 122345678
Q ss_pred ccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHH
Q 003288 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 762 (834)
Q Consensus 683 y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~ 762 (834)
|+|||.+....++.++||||+|+++|||++|+.|+........ ... ....+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THT-----TLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccc-----ccCCcccCCHHHH
Confidence 9999999888899999999999999999999987542211100 000 0011112345678
Q ss_pred HHHHHccccCCCCCCCHH
Q 003288 763 NVALLCVQENAADRPTMS 780 (834)
Q Consensus 763 ~li~~cl~~dP~~RPt~~ 780 (834)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=286.45 Aligned_cols=240 Identities=23% Similarity=0.287 Sum_probs=194.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++.|++...+|.|+|+.|-..... +++..++|++.+... +-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 678999999999999999888754 588999999976522 224567666665 79999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe-cCCCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~~~~ 668 (834)
.+.++-|.+.+. ..+... .++..|+.+|+.|+.|||.++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999988877763 222233 777889999999999999998 9999999999999 69999999999999876544
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
....+-|..|.|||+.....|++++|+||||++||+||+|+.|+..-..+ .+ ++ .++
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e-------------i~----~~i 526 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE-------------IH----TRI 526 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH-------------HH----Hhh
Confidence 22346688999999999999999999999999999999999998643222 00 11 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.....+...+....+|+.+||+.||.+||+|.++...
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1233334456678999999999999999999999754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=258.33 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=193.2
Q ss_pred hcCcccc-ceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 584 (834)
+++|++. ++||-|-.|.|-....+ +++++|+|++... ....+|+++--.. .|||||.+++++.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 6677765 58999999999888664 5889999998644 3346788776665 69999999999864 3467
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeecccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGl 661 (834)
.+|||.|+||.|...+.++ ....+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999999888543 3456999999999999999999999998 999999999999964 45699999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||..... ..+ .
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~ai-------------s 272 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAI-------------S 272 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccC-------------C
Confidence 986432 3344556889999999999999999999999999999999999999853221 111 0
Q ss_pred cccccccccC--CCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQD--EIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~--~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.-.+.++... .++ ...++...++|+.+|..+|++|.|+.|+...
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0111111111 111 1235678899999999999999999999765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=270.28 Aligned_cols=241 Identities=23% Similarity=0.315 Sum_probs=193.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
..+|..+.+||+|+||.|.+|.-+. .+.+|||++++.. ....+--+.|-++|+.. +-|.+++++.+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578889999999999999997653 5679999997642 23334446777888777 56889999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+.+|+|--++ ++-+.+-+..+...+..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999997777 34455778888899999999999999999 9999999999999999999999999998531
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
- ....++..+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.. ..+.+.
T Consensus 502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--------------~aI~eh 565 (683)
T KOG0696|consen 502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--------------QAIMEH 565 (683)
T ss_pred c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--------------HHHHHc
Confidence 1 123456789999999999999999999999999999999999999999865543321 011111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.-.++...+.+...+....|..+|.+|.
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1123334455667788888899999995
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.67 Aligned_cols=263 Identities=21% Similarity=0.248 Sum_probs=198.8
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcC-C-Cc----eeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-RN----LVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~~~~~~~~~~ 584 (834)
+++|.+..++|+|.||.|-+..+.. +..||||+++... .-.+..+-|+++|+++. + |+ +|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7899999999999999999987643 6889999997543 33455678999999993 2 33 78888999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC--------------
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------------- 650 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-------------- 650 (834)
|+|+|.+ |-|+.++|.. .+...++...+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 5589999843 24456889999999999999999999998 999999999999831
Q ss_pred ------CCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 651 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 651 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
+..+||+|||.|...... ...++.|..|.|||++.+-.++.++||||+||||+|+.+|..-|..-+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 345899999999865433 256789999999999999999999999999999999999998776543211
Q ss_pred c-cc----ccc----------ccccccccc-----------ccccc---ccccccCCCCHHHHHHHHHHHHHccccCCCC
Q 003288 725 F-NL----LGH----------AWDLWKDDR-----------VHDLI---DPVIMQDEISLPMLMRYINVALLCVQENAAD 775 (834)
Q Consensus 725 ~-~~----~~~----------~~~~~~~~~-----------~~~li---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
. .. +.. ..+....++ ..... ++.-.......++..++.+|+..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 1 00 000 000000000 00011 1110111233456678999999999999999
Q ss_pred CCCHHHHHHH
Q 003288 776 RPTMSDVISM 785 (834)
Q Consensus 776 RPt~~evl~~ 785 (834)
|+|+.|++..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=259.35 Aligned_cols=267 Identities=23% Similarity=0.371 Sum_probs=195.3
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecC--CChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--------c
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------Q 581 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 581 (834)
..|+-..+||+|.||.||+|+..+ |+.||+|++-- ..+..-....+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667899999999999998754 77889986532 222233455789999999999999999998863 2
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
..+++||.+|+. +|..+|. .....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999976 6777773 23345889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcc--cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCC-ccccc--------c
Q 003288 662 ARMFGGDEL--QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLL--------G 729 (834)
Q Consensus 662 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~-~~~~~--------~ 729 (834)
++.+..... .......+-|.-|.+||.+.+ ..|+.+.|||.-||++.||.++.+.+...... ...++ .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987754322 222334567999999998876 46899999999999999999998876543321 11111 2
Q ss_pred cccccccccccccccccc-cccCCCC--HH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 730 HAWDLWKDDRVHDLIDPV-IMQDEIS--LP------MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~-~~~~~~~--~~------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..|....+-.+.+.+... +.+.... .+ ...+..+++.+++..||.+|+++.+++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 233332222222222111 1111100 01 12257789999999999999999998765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=236.82 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=192.6
Q ss_pred CccccceeccCCcEeEEEEEecC-CcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+|.-.++||+|.+|+||||+..+ ++.||+|+++-. ++.......+|+-+|+.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556899999999999998764 778999988643 333456778999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.. +|..+. ..-.+.++.+.+..++.|+++||.++|+++ +.|||+||+|.||+.+|++||+|||+++.++-...
T Consensus 83 cdq-dlkkyf--dslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF--DSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH--HhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 666664 233456889999999999999999999998 99999999999999999999999999998865431
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc--cccccccccc---ccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG--HAWDLWKDDR---VHDLI 744 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~---~~~li 744 (834)
. .+..+-|.-|.+|.++.+. .|+...|+||-||++.|+.....|.-...+...++.. +......++. +.++-
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 1 2223568899999999875 5899999999999999999855553322221111110 0111111111 11222
Q ss_pred ccccc---cC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 745 DPVIM---QD-----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 745 ~~~~~---~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
|-... .. .+-+.....=.+++.+.+.-+|.+|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 21110 00 1112222344677888888999999999988653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=261.73 Aligned_cols=237 Identities=28% Similarity=0.351 Sum_probs=192.0
Q ss_pred CcEeEEEEEecC-CcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhhhhhc
Q 003288 525 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 602 (834)
Q Consensus 525 ~fg~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 602 (834)
+||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998864 8999999997665444 68899999999999999999999999999999999999999999999843
Q ss_pred cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCccccccccc
Q 003288 603 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22889999999999999999999998 9999999999999999999999999998765432 2334567889
Q ss_pred ccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH-HHHHH
Q 003288 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP-MLMRY 761 (834)
Q Consensus 683 y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~-~~~~l 761 (834)
|+|||.+....++.++||||||+++++|++|..|+....... .. .+.+............ ...++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~-------------~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-EL-------------FKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH-------------HHHHhccCCCCccccccCCHHH
Confidence 999999998889999999999999999999999875421110 00 0000000000000000 34578
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 003288 762 INVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=295.03 Aligned_cols=262 Identities=19% Similarity=0.209 Sum_probs=168.4
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-----CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeee------ee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CV 579 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 579 (834)
..++|++.++||+|+||.||+|++.+ ++.||||++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998754 689999998643221 111111 1122222222222211 24
Q ss_pred ecCeeEEEEEecCCCchhhhhhccCCC-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 580 EQGEKILILEYMPNKSLNVFLFDSTKK-----------------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 580 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
++...++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999988532210 01123445679999999999999998 9999999
Q ss_pred CCcEEecC-CCCceeeccccceecCCCcccCCcccccccccccCcccccCC----------------------CCCccCc
Q 003288 643 ASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG----------------------LFSIKSD 699 (834)
Q Consensus 643 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD 699 (834)
|+|||+++ ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5789999999998654322 1223446789999999966432 2345679
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCcccccc---ccccccccccccccccccccc-----CCCCHHHHHHHHHHHHHcccc
Q 003288 700 VFSFGILMLETLSSKKNTGVYNADSFNLLG---HAWDLWKDDRVHDLIDPVIMQ-----DEISLPMLMRYINVALLCVQE 771 (834)
Q Consensus 700 VwslGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~~~~-----~~~~~~~~~~l~~li~~cl~~ 771 (834)
||||||+||||+++..+...........+. .....| ...+.+.... ............+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW-----RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHH-----HHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876653311000000000 000000 0001110000 000011122355899999999
Q ss_pred CCCCCCCHHHHHHH
Q 003288 772 NAADRPTMSDVISM 785 (834)
Q Consensus 772 dP~~RPt~~evl~~ 785 (834)
||++|||++|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=297.41 Aligned_cols=260 Identities=22% Similarity=0.237 Sum_probs=205.8
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 580 (834)
...+....++|.++++||+|+||.|..++.+. ++.||+|++.+. ......-|..|-.+|..-+.+=|+.++-+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45556667899999999999999999999864 788999999762 34455678999999999999999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
+.++|+|||||+||+|-.++.+ ...+++..+...+..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999943 336899999999999999999999999 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCccccc----C-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
.+-.+..+.. ......+|||.|++||++. + +.|+..+|.||+||++|||+.|..||....-.+. ....+
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-----Y~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-----YGKIM 294 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-----HHHHh
Confidence 9987764432 2334579999999999985 3 5789999999999999999999999864332110 00011
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 785 (834)
.... .+ .-+.....+....+||.+.+ -+|+.|.. ++++-.+
T Consensus 295 ~hk~-------~l-~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKE-------SL-SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhh-------hc-CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1100 01 11111224556778888766 57888887 7777654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=282.62 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=180.9
Q ss_pred hcCccccceeccCCcEeEEEEEe-----------------cCCcEEEEEEecCCChhhHHHH--------------HHHH
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKEF--------------KNEM 560 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~E~ 560 (834)
.++|++.++||+|+||.||+|.. ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 67899999999999999999964 2356799999865443333333 3477
Q ss_pred HHHHhcCCCce-----eeEeeeeee--------cCeeEEEEEecCCCchhhhhhccCC---------------------C
Q 003288 561 MLIAKLQHRNL-----VRLLGCCVE--------QGEKILILEYMPNKSLNVFLFDSTK---------------------K 606 (834)
Q Consensus 561 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~ 606 (834)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 677787753 3568999999999999999864211 1
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCc
Q 003288 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686 (834)
Q Consensus 607 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 686 (834)
..+++..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23567788999999999999999998 99999999999999999999999999976543211 111223457899999
Q ss_pred ccccCCC--------------------C--CccCcchhhHHHHHHHHhCCC-CCCCCCC--Ccccccccccccccccccc
Q 003288 687 EYALDGL--------------------F--SIKSDVFSFGILMLETLSSKK-NTGVYNA--DSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 687 E~~~~~~--------------------~--s~~sDVwslGvvl~elltg~~-p~~~~~~--~~~~~~~~~~~~~~~~~~~ 741 (834)
|.+.... + ..+.||||+||+++||+++.. |+..... ............|+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 134799999999999999875 4432110 0000000000011000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENA---ADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 785 (834)
. . .............+++.++|..+| .+|+|++|++++
T Consensus 460 ~-----~-~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 K-----Y-DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred C-----C-CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 0 001112234567889999998766 689999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=285.48 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=190.7
Q ss_pred ccccceeccCCcEe-EEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEecC
Q 003288 515 FSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 y~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
|.-.+.+|.|.-|+ ||+|.. +|++||||++-. +..+-..+|+..|+.- +|||||++++.-.+++..|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34446789999985 799988 789999999853 3344567899999988 69999999999999999999999995
Q ss_pred CCchhhhhhccCCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---C--CCceeeccccceecC
Q 003288 593 NKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---D--MNPKISDFGLARMFG 666 (834)
Q Consensus 593 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~--~~~kl~DFGla~~~~ 666 (834)
.+|++++...... ........+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999653111 11111455788999999999999988 999999999999976 2 569999999999986
Q ss_pred CCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhC-CCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
..... .......||-+|+|||++....-+.++|||||||++|+.++| .+||+..-..+-+++...... .. +
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L------~~-L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL------VH-L 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce------ee-e
Confidence 65332 224567899999999999999889999999999999999996 899986444333333221111 00 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....++ +..+||.+|++.+|..||++.+|+.
T Consensus 736 -------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111111 6789999999999999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.95 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=198.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
-++|.++++||+|+|.+|..+++. +.+.+|+|++++. +.+.++-.+.|-.+..+. +||.+|.+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467899999999999999999875 4778999998754 344555667788888776 79999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|.||.++|+|--++ ++++.|+++.+......|..||.|||+++ ||.||||.+|||||.+|++||.|+|+.+.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999986554 66677999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. -..++..+||+.|+|||++.+..|....|.|+|||+++||+.|+.||..-..+.... -.++.+.+++-.
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~-------ntedylfqvile 473 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM-------NTEDYLFQVILE 473 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc-------chhHHHHHHHhh
Confidence 21 234567899999999999999999999999999999999999999997533221110 011112222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
. +-.++...+.+...++..-|..||++|.
T Consensus 474 k--qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 K--QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred h--cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 1123344455677788888999999985
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=232.96 Aligned_cols=110 Identities=48% Similarity=0.786 Sum_probs=82.5
Q ss_pred CCeeEEeecCCCCCCCC--CceEEEeeCCcEEEEcCCCCeEEEE-ecCCCC-ccceEEEecCCcEEEEeCCCCCCCCcee
Q 003288 70 PDAVVWVANRDRPISDN--NAVLTISNNGNLVLLNQTNGTIWST-NVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYL 145 (834)
Q Consensus 70 ~~t~vW~ANr~~p~~~~--~~~l~~~~~G~Lvl~~~~~~~vWst-~~~~~~-~~~~a~LldsGNlVl~~~~~~~~~~~~l 145 (834)
++||||+|||++|+... .++|.|+.||+|+|.|..++++|+| ++.+.+ ....|+|+|+|||||+|.. +++|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEE
Confidence 47999999999999543 4789999999999999999999999 556554 5788999999999999964 4899
Q ss_pred eeecCCCChhhhhhcccccccccccceeeEEecCCCCCC
Q 003288 146 WQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184 (834)
Q Consensus 146 WqSFd~PTDtlLpg~~l~~~~~t~~~~~l~Sw~s~~dps 184 (834)
||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888878899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=266.00 Aligned_cols=211 Identities=23% Similarity=0.347 Sum_probs=176.7
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
+....-|..++.||-|+||+|.+++-. +...+|+|.+++.+ .......+.|-.||+.-..+=||+|+-.|.+++.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 334456888899999999999999644 46679999997654 23445578899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
|+||+|++||++-.+| .+-+.+.+..+...+..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-
T Consensus 705 YFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 9999999999998888 34567888888888999999999999999 99999999999999999999999999864
Q ss_pred cC---------CCccc-------------------------------CCcccccccccccCcccccCCCCCccCcchhhH
Q 003288 665 FG---------GDELQ-------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 665 ~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslG 704 (834)
+. ..+.. ......+||+.|+|||++...-|+..+|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 41 00000 001125799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcc
Q 003288 705 ILMLETLSSKKNTGVYNADSF 725 (834)
Q Consensus 705 vvl~elltg~~p~~~~~~~~~ 725 (834)
||||||+.|+.||-...+.+.
T Consensus 859 vil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcc
Confidence 999999999999976655433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-30 Score=268.87 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=202.0
Q ss_pred cCccccceeccCCcEeEEEEEecCCc-EEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.+++++..||-|+||.|-+++..... .+|+|.+++. +....+....|-.||...+.|.||+++-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999875433 3788887654 3445567788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|-|-||.|-..| +.++.++......++..+++|++|||.++ ||.|||||+|.+|+.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999 44566888888889999999999999999 999999999999999999999999999988654
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc-ccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .+-..+||+.|.|||++.++-.+.++|.||||++++||++|.+||...++-. .+++ .+-++
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid-- 636 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGID-- 636 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhh--
Confidence 3 4556899999999999999999999999999999999999999997544321 1111 11111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
.-..+........+++++....+|.+|.. +.+|.++
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11222333445678888888999999975 6777665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=237.52 Aligned_cols=258 Identities=20% Similarity=0.318 Sum_probs=195.6
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecC--eeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 587 (834)
.++|++.+++|+|.++.||.|.. .++++++||+++.. ..+.+++|++||..|. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999974 46889999999753 4467899999999997 999999999988754 56799
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~ 666 (834)
+||+.+.+...+- ..|+..++...+.++++||.|+|+.| |.|||+||.|++||. ...++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876554 34778888899999999999999999 999999999999985 4569999999999887
Q ss_pred CCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc--------------
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-------------- 731 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~-------------- 731 (834)
..... +..+.+..|.-||.+.+ ..|+..-|+|||||+|.+|+..+.||-...+...+++.-+
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 65432 22456678889999876 4688999999999999999999999865444333332111
Q ss_pred cccccccccccccccccc-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 732 WDLWKDDRVHDLIDPVIM-------QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+..-...+...++..... ..+-..-...+.++++.+.|..|..+|||++|...
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000011111111111100 00101112357889999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=233.15 Aligned_cols=209 Identities=28% Similarity=0.391 Sum_probs=170.8
Q ss_pred HHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 508 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 508 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
++...+...-.+.||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+- .+|.+|+++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3445566666789999999999888764 6999999999654 345567788888887665 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhc-cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 585 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
++.||.|. .||+.+-.+ ..++..+++..+-+|+..+.+||.|||++- .+||||+||+||||+.+|++|++|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 477766433 235567899999999999999999999865 69999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccC----CCCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
.+.+.. ..+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 764321 1122467789999998853 3689999999999999999999999875443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=234.69 Aligned_cols=210 Identities=37% Similarity=0.611 Sum_probs=183.9
Q ss_pred eccCCcEeEEEEEecC-CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhh
Q 003288 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 598 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 598 (834)
||+|.+|.||+++... ++.+++|.+...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765433 45789999999999999999999999999999999999999999999
Q ss_pred hhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCCCcccCCcccc
Q 003288 599 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQI 677 (834)
Q Consensus 599 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 984322 45889999999999999999999998 999999999999999 89999999999987644321 12334
Q ss_pred cccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHH
Q 003288 678 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~ 756 (834)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 678899999999887 888999999999999998
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 757 MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=243.71 Aligned_cols=266 Identities=21% Similarity=0.281 Sum_probs=193.9
Q ss_pred cccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----CeeEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEKILI 587 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 587 (834)
+-.+.||.|+||.||.+.++ +|+.||+|++.+.-. ...+.+.+|+++|..++|.|++..++...-. ++.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999999865 699999999865432 3457788999999999999999988775533 256777
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
.|.|. .+|..++ .....|+...+.-+++||++||.|||+.+ |.||||||.|.|++++-.+||+|||+++....
T Consensus 136 TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88774 3666666 34456888888889999999999999998 99999999999999999999999999997655
Q ss_pred CcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCC-ccccccccccccc--------c
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWK--------D 737 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~--------~ 737 (834)
++.... ...+-|..|.|||++++. +|+.+.||||.||++.||+..+.-|...++. ..+++........ +
T Consensus 209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 443333 345678999999999875 6999999999999999999888777654432 2222221111100 1
Q ss_pred cccccccccccccCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 738 DRVHDLIDPVIMQDE--------ISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 738 ~~~~~li~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+....+++....... .......+...+..+++..||.+|.+..+.+..+...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 111111111111110 1112234566788889999999999999998876443
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=214.78 Aligned_cols=109 Identities=34% Similarity=0.774 Sum_probs=105.0
Q ss_pred eecCCCCCcceeeccccc-ccceeeeeeecCceEEEEEEeeCCCceeeEEeCCCCcEEEEEEecCCCceEEEEeeeCCCC
Q 003288 210 TCSGHWDGAGFVSALSYT-DFLYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYC 288 (834)
Q Consensus 210 ~~~g~w~g~~~~~~~~~~-~~~~~~~~~~n~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 288 (834)
||+|+|||..|.++|++. ..++.+.|+.+.+|.+|+|.+.+.+.++|++||.+|++++|.|++..+.|.+.|.+|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999997 7789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccCCCCCCccccccCcccCC
Q 003288 289 GKYGYCGANTICSLDQKPMCECLEGFKLES 318 (834)
Q Consensus 289 d~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 318 (834)
|+|+.||+||+|+.+..|.|.||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988899999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=256.49 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=168.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcC---CCceeeEeeeee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCV 579 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 579 (834)
...|+.++.+|.|+||.|+.+.++. ..+|+||.+.+.. +...-..-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468999999999999999998865 5679999886542 111223467999999997 999999999999
Q ss_pred ecCeeEEEEEec-CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeec
Q 003288 580 EQGEKILILEYM-PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (834)
Q Consensus 580 ~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 658 (834)
+++.+||+||-. ++.+|.++| ..+..+++.+...|+.|++-|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999976 466888888 45667999999999999999999999999 99999999999999999999999
Q ss_pred cccceecCCCcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCC
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~ 717 (834)
||.+...... .....+||..|.|||++.+.+| ...-|||++|++||.++....|+
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999876443 3456799999999999999888 46689999999999999877664
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=210.30 Aligned_cols=115 Identities=43% Similarity=0.728 Sum_probs=102.2
Q ss_pred cccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEE
Q 003288 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst 111 (834)
++|++|++|+|++|.|++|||.+......|.+|||.+.+.++||.||++.|. ...+.|.|+.||+|+|.|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5789999999999999999999976655899999988778899999999994 457889999999999999999999999
Q ss_pred ecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCC
Q 003288 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (834)
Q Consensus 112 ~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~P 152 (834)
++++.....+|+|+|+|||||++.++ ++||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEEcCCCCC
Confidence 98763456788999999999998753 7899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=248.79 Aligned_cols=273 Identities=20% Similarity=0.236 Sum_probs=206.5
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcC------CCceeeEee
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ------HRNLVRLLG 576 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~ 576 (834)
.+.-.+....+|.+....|+|-|++|..|.+.. |++||||++.+.. .-.+.=+.|++||++|+ .-|+++|+-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 333344557899999999999999999998653 8899999997652 33345578999999996 347999999
Q ss_pred eeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-Cce
Q 003288 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPK 655 (834)
Q Consensus 577 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~k 655 (834)
.|...+++|||+|-+ ..+|.++|....+.-.|....+...+.|+.-||..|..-+ |+|.||||+|||+++.. .+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999977 5689999988878888999999999999999999999988 99999999999998765 589
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCC-cccc-------
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNL------- 727 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~-~~~~------- 727 (834)
|||||.|-..+..+. ..+.-+..|.|||++.+-+|+...|+||.||.||||.||+..|...... ...+
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 999999987655432 2234566899999999999999999999999999999999766432221 1111
Q ss_pred ----------------------cccccccccccc---ccccccc------cccc-CCC---CHHHHHHHHHHHHHccccC
Q 003288 728 ----------------------LGHAWDLWKDDR---VHDLIDP------VIMQ-DEI---SLPMLMRYINVALLCVQEN 772 (834)
Q Consensus 728 ----------------------~~~~~~~~~~~~---~~~li~~------~~~~-~~~---~~~~~~~l~~li~~cl~~d 772 (834)
+....+...+.. +...+.| .+.. ..+ .......+.+|+.+|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 110011111111 1111111 1111 111 2334568899999999999
Q ss_pred CCCCCCHHHHHHH
Q 003288 773 AADRPTMSDVISM 785 (834)
Q Consensus 773 P~~RPt~~evl~~ 785 (834)
|++|.|..+.++.
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=230.51 Aligned_cols=198 Identities=34% Similarity=0.489 Sum_probs=172.7
Q ss_pred ccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 889999999766554 67889999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++..... .+++..+..++.++++++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999853321 1789999999999999999999997 99999999999999999999999999987754321 1
Q ss_pred CcccccccccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 003288 673 NTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwslGvvl~elltg~~p~~ 718 (834)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22345678899999998 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.82 Aligned_cols=132 Identities=27% Similarity=0.354 Sum_probs=108.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----C---CceeeEeeeeeec-
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLLGCCVEQ- 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~- 581 (834)
..+|.++++||.|.|++||++.+. +.+.||+|+.+.. ..-.+....|+++|++++ | .+||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999865 4678999998643 344566789999999984 3 3699999999754
Q ss_pred ---CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 ---GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
.+.|||+|++.. +|..+|.. ...+.++...+.+|+.||+.||.|||.++ .|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 589999999954 55555532 34456899999999999999999999987 69999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-27 Score=257.27 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=203.2
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..++|+++.++|.|.+|.|||+++. .++..|+|.++-......+-.++|+.+++..+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4678999999999999999999875 488899999987777777888899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||.+|+|++.- .....+++.++..+++..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+....
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999875 34567899999999999999999999998 8999999999999999999999999998775432
Q ss_pred ccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCC-Ccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
...+...||+.|||||+.. .+-|..++|||++|+...|+---++|.-...+ ....+.+ ....+
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----------kS~~q 233 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----------KSGFQ 233 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----------ccCCC
Confidence 3445679999999999874 45689999999999999999776666321111 0000000 01111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.- -.-.....+.+-++++.|+..+|++||+++.++.
T Consensus 234 pp~--lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPT--LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCc--ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 1112234556788999999999999999876543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=224.97 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=187.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeee-eeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC-CVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 588 (834)
.+.|.|.+.||+|.||.+-+++++. .+.+++|.+.... ...++|.+|...--.| .|.||+.-+++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999864 6779999886543 3467899998776666 58999987765 56667788999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec--CCCCceeeccccceecC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFG 666 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~ 666 (834)
||++.|+|.+-+. ...+.+.-..+++.|++.|+.|||+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988773 345778888899999999999999998 99999999999993 34479999999988654
Q ss_pred CCcccCCcccccccccccCcccccCC-----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.. .....-+..|.+||..... .....+|||.||+++|.+++|+.|+.......... +.|..|..+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNP 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCc
Confidence 32 1223445689999987532 23578999999999999999999997433222221 223333333322
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+-+ ......+++.++.++-+..+|++|--..++-++
T Consensus 248 ~~P~-------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPK-------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCch-------hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2111 112344567788899999999999555554444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-26 Score=227.91 Aligned_cols=260 Identities=26% Similarity=0.283 Sum_probs=189.8
Q ss_pred cCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------Ce
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 583 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 583 (834)
.+|.-++.+|.|.- .|..+-+ -.++.||+|++... .....++..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46666778888887 5555532 25889999987543 233456678899999999999999999998633 36
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.|+|||+|. .+|...+. -.++-+.+.+|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999995 47777764 23677888999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCC-Ccccc----ccc--------
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNL----LGH-------- 730 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~-~~~~~----~~~-------- 730 (834)
..... -..+.++.|..|.|||++.+..+.+.+||||.||++.||+.|+--|...+. +.+.. ++.
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 65433 234557889999999999998899999999999999999999876542221 11100 000
Q ss_pred ----cccccc------ccccccccccccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 ----AWDLWK------DDRVHDLIDPVIMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 ----~~~~~~------~~~~~~li~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+..... .-...+++...+... +.+.-....+.+++.+||-.||++|.++++++..
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 001111111111111 1112234567889999999999999999999876
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=198.16 Aligned_cols=113 Identities=45% Similarity=0.772 Sum_probs=100.0
Q ss_pred cccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEE
Q 003288 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst 111 (834)
+.|..|++|+|++|.|++|||.+... ..+.+|||+..++++||+|||+.|+.. ++.|.|..||+|+|.|.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 57888999999999999999998654 689999998776889999999999876 4889999999999999999999999
Q ss_pred ecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCC
Q 003288 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (834)
Q Consensus 112 ~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~ 151 (834)
++.......+|+|+|+|||||++..+ ++|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEeCCCCC
Confidence 98734455688999999999998754 799999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=226.99 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=197.0
Q ss_pred HHHhcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
....+.|..+++||.|.|++||++.+.+ .+.||+|.+...+ ....+.+|+++|..+ -+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445778899999999999999997643 5789999986543 345688999999999 58999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeeccccc
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 662 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla 662 (834)
..+|+||++...-.++.. .++..++...+..+++||+++|++| ||||||||+|+|.+.. +.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 999999999998888873 3678889999999999999999999 9999999999999754 56789999999
Q ss_pred eecCCC-------c------cc-----------------------------CCcccccccccccCcccccC-CCCCccCc
Q 003288 663 RMFGGD-------E------LQ-----------------------------GNTKQIVGTYGYMSPEYALD-GLFSIKSD 699 (834)
Q Consensus 663 ~~~~~~-------~------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~sD 699 (834)
...... . .. .......||++|.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 832100 0 00 00112479999999999875 46789999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCccccccc---------------cc--ccccccccc----------cc-cccccc--
Q 003288 700 VFSFGILMLETLSSKKNTGVYNADSFNLLGH---------------AW--DLWKDDRVH----------DL-IDPVIM-- 749 (834)
Q Consensus 700 VwslGvvl~elltg~~p~~~~~~~~~~~~~~---------------~~--~~~~~~~~~----------~l-i~~~~~-- 749 (834)
|||.||+++.+++++.||-....+...+... .. ..|...++. .+ +.....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999986544332211100 00 011111110 01 000000
Q ss_pred -----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 -----QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+++++.+|+..||.+|.|+++.++.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001112234478999999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=266.74 Aligned_cols=197 Identities=19% Similarity=0.242 Sum_probs=139.2
Q ss_pred hcCC-CceeeEeeee-------eecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003288 565 KLQH-RNLVRLLGCC-------VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 565 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 636 (834)
.++| +||+++++++ .+...+++++|++ +++|.++|.. ....+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5778888877 2334567888987 5699999953 2355999999999999999999999998 9
Q ss_pred eeCCCCCCcEEecC-------------------CCCceeeccccceecCCCcc--------------cCCcccccccccc
Q 003288 637 IHRDLKASNILLDK-------------------DMNPKISDFGLARMFGGDEL--------------QGNTKQIVGTYGY 683 (834)
Q Consensus 637 vH~Dikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 683 (834)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45567777777764321000 0001123578899
Q ss_pred cCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHH
Q 003288 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYIN 763 (834)
Q Consensus 684 ~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~ 763 (834)
||||++.+..++.++|||||||+||||++|.+|+...... .. ... .....+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~----~~~----~~~~~~~------~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MS----SLR----HRVLPPQ------ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HH----HHH----HhhcChh------hhhcCHHHHH
Confidence 9999999999999999999999999999988775321100 00 000 0000010 0112334567
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 003288 764 VALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 764 li~~cl~~dP~~RPt~~evl~~ 785 (834)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=220.96 Aligned_cols=176 Identities=20% Similarity=0.246 Sum_probs=136.4
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec--CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceee-Eeeeeee
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCVE 580 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 580 (834)
....++|++.++||+|+||+||+|++. +++.+|||++... .....+.|.+|+++|++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 344678999999999999999999865 4777899987533 2234567999999999999999985 4432
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCcEEecCCCCceeecc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDF 659 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DF 659 (834)
+..++||||+++++|.... ... ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4679999999999996321 111 1467889999999999998 999999 999999999999999999
Q ss_pred ccceecCCCcccC------CcccccccccccCcccccCCC------CCccCcch
Q 003288 660 GLARMFGGDELQG------NTKQIVGTYGYMSPEYALDGL------FSIKSDVF 701 (834)
Q Consensus 660 Gla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~s~~sDVw 701 (834)
|+++.+....... ......+++.|+|||.+.... .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999875432111 123567888999999986543 23446766
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=204.92 Aligned_cols=166 Identities=19% Similarity=0.131 Sum_probs=124.2
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|.+++.. .+..+++.+++.++.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888843 2456999999999999999999999875 999999999999999 99998764322
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC-C
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD-E 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~-~ 752 (834)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+.. . ... ..+..... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~-~----~~~-----~~~~~~~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI-L----LNG-----MPADDPRDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH-H----HHH-----hccCCccccc
Confidence 26889999999999999999999999999999999999997533211100000 0 000 00000000 1
Q ss_pred CCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 753 ISLPMLM--RYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 753 ~~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... .+.+++.+||+.+|.+||++.|+++.+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 1111222 689999999999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=210.39 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=192.0
Q ss_pred CccccceeccCCcEeEEEEEecCC--cEEEEEEecCCChhhHHHHHHHHHHHHhcCC----CceeeEeeee-eecCeeEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-VEQGEKIL 586 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 586 (834)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987653 4788888765433333378889999999973 6888999888 47778899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-----CCceeecccc
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGL 661 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGl 661 (834)
||+.+ +.+|.++..... .+.++...++.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 779988764443 567999999999999999999999999 9999999999999755 4699999999
Q ss_pred ce--ecCCCcc-----cCC-cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003288 662 AR--MFGGDEL-----QGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 662 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 733 (834)
++ .+..... ... .....||..|.+++...+...+.+.|+||++.++.|++.|..|+........ ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~---- 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KS---- 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HH----
Confidence 99 4322211 111 2235699999999999999999999999999999999999999754332110 00
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
............. ...... ..+.++...+-..+..++|....+...|.....
T Consensus 248 ~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR---FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHhhhhcccc---ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 0000000000000 011122 234444444445899999999999999876533
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=197.15 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=189.1
Q ss_pred CccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+..+.-+|.+...|..|+|++. |..+++|++.-. .....++|..|.-.|+-+.||||+.++|.|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445568999999999999994 555677776433 3334467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee--ccccceecCCCc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS--DFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~--DFGla~~~~~~~ 669 (834)
+.|+|...|+.. ..-..+..++.+++.+||+|++|||+..+ -|.---|.+..|++|++.+++|. |--++.
T Consensus 270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee------
Confidence 999999999643 33457888999999999999999999873 13344689999999999998875 211111
Q ss_pred ccCCcccccccccccCcccccCCCCC---ccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
+.....-.+.||+||.++.++-+ .++|+|||+++||||.|...||....+-+... ++.-.
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kiale 404 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALE 404 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhc
Confidence 11112346799999999887654 57999999999999999999987655432211 00001
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+ +..+++-....+.+++.-|+..||.+||.+..|+-+|++.
T Consensus 405 gl-rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GL-RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cc-cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11 2233334455678899999999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-20 Score=201.16 Aligned_cols=260 Identities=29% Similarity=0.393 Sum_probs=197.6
Q ss_pred ccccceeccCCcEeEEEEEecCCcEEEEEEecCCChh---hHHHHHHHHHHHHhcCCC-ceeeEeeeeeecCeeEEEEEe
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 590 (834)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999886 78999998655332 467899999999999988 799999999777778999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
+.++++.+++........+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976633221136889999999999999999999998 99999999999999998 79999999998665443
Q ss_pred ccC----CcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCC--ccccccccccccccccc
Q 003288 670 LQG----NTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNAD--SFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 670 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 740 (834)
... ......|+..|+|||.+.. ..++...|+|++|++++++++|..|+...... ......... ....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH----hcCC
Confidence 221 3456789999999999988 57889999999999999999999996543321 001111000 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ...... ...........+.+++..++..+|..|.++.+....
T Consensus 233 ~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-cccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000001223467888999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=225.08 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=187.7
Q ss_pred ccceeccCCcEeEEEEEec-CCcEEEEEEec----C-CChh-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----N-QSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..+.+|.|++|.|+..... ..+..+.|.+. . .... ....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999988777543 23334444332 1 1111 12226678888888999999988888877776666699
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++ +|..++. ....+...++-.++.|+++|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9988883 3346888899999999999999999999 9999999999999999999999999998875544
Q ss_pred cc--CCcccccccccccCcccccCCCCCcc-CcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQ--GNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......+|...|+|||.+....|+.. .||||.|+++..|++|+.||-........+...... .. ...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-------~~-~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-------DQ-RNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-------cc-ccc
Confidence 33 45566889999999999999999865 899999999999999999987544332221000000 00 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+......+...++..||+.+|.+|.|+++|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000112223344577889999999999999999999764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=185.79 Aligned_cols=203 Identities=23% Similarity=0.332 Sum_probs=169.9
Q ss_pred hcCccccceeccCCcEeEEEEE-ecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.-+|.+.++||+|.||.++.|+ +.+++.||||.-...++. -++..|.+..+.| ..++|...+-+..++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 5689999999999999999997 458999999986544322 4567788888888 56999999988888888899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-----CCceeecccccee
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGLARM 664 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGla~~ 664 (834)
.+ |-+|.++.. . =++.++.+.++.++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD-~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFD-L-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHH-H-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 668877652 1 2345899999999999999999999998 9999999999999643 3489999999998
Q ss_pred cCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 665 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
+...... ...+...||.+||+=....+...+.+.|.=|||-|+++.|-|..||.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 8654332 234567899999999999999999999999999999999999999976543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=188.77 Aligned_cols=171 Identities=16% Similarity=0.177 Sum_probs=134.5
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChh---hHHH------HHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKE------FKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
...+|.+.++||.|+||.||.... +++.+|||.+.+.... ..+. |.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368999999999999999999755 6778999999754322 2223 68999999999999999998886643
Q ss_pred --------CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 582 --------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 582 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
...+++|||++|.+|.++.. ++. ....+++.+|..||..+ ++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999987741 222 24569999999999998 99999999999999988
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHH
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ell 711 (834)
++|+|||........... ..+.....|..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754221100 11344556778999999999987764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=178.37 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=189.4
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 589 (834)
..+|.++++||.|+||.+|.|.. .+|.+||||.-+.... .-++.-|.++...++| ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 57899999999999999999974 5699999998754432 3456788999999975 678888888888899999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~ 666 (834)
.+ +-+|.++..--. +.++.+.++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 668887763222 34788899999999999999999998 9999999999999644 458999999999875
Q ss_pred CCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
..... .......||.+|.+-....+...+.+.|.=|+|.+|..+.-|..||.......... .++.+.+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q---KyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ---KYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH---HHHHHHHhhcC
Confidence 43221 22345789999999888888888999999999999999999999987544322110 11111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..+.. +.. -.+.++...+.-|-...-++-|...-+.++.
T Consensus 243 ~~ie~-LC~-----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 243 TPIEV-LCK-----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCHHH-HhC-----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11100 001 1123555566667777777778766555544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=183.35 Aligned_cols=139 Identities=18% Similarity=0.166 Sum_probs=108.4
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChh--h-------HHH-----------------HHHHHHHHHhcCCCce
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 571 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 571 (834)
.+.||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 0 112 2359999999988776
Q ss_pred eeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeCCCCCCcEEecC
Q 003288 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLKASNILLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dikp~NILl~~ 650 (834)
.....+. ....++||||++++++...+. ....++..++..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4333222 223489999999987765432 234688999999999999999999 6777 99999999999998
Q ss_pred CCCceeeccccceec
Q 003288 651 DMNPKISDFGLARMF 665 (834)
Q Consensus 651 ~~~~kl~DFGla~~~ 665 (834)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-21 Score=217.09 Aligned_cols=252 Identities=20% Similarity=0.225 Sum_probs=182.7
Q ss_pred CccccceeccCCcEeEEEEEecCCcEEEEEEecCCC-hhhHHHHHHHHHHHH--hcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLKEFKNEMMLIA--KLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+...+.||++.|=+|.++++++|. |+||++-+.. ....+.|+++++-++ .++|||.+.+.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999998887 9999986654 345566665554444 45899999988877777777888888
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC-CCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~-~~~ 669 (834)
..+ +|.+.| ..+..|...+...|+.|++.||..+|..+ |+|+|||.+||||+.-.-+.|+||-.-+... .++
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 677776 45566888889999999999999999999 9999999999999999999999998765432 112
Q ss_pred ccCCccc----ccccccccCcccccCC-----------CCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003288 670 LQGNTKQ----IVGTYGYMSPEYALDG-----------LFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 670 ~~~~~~~----~~gt~~y~aPE~~~~~-----------~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 733 (834)
....... ...-..|+|||.+... ..+.+.||||+||+++||++ |+++|...+ +..+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRS- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhc-
Confidence 2222222 2334479999988542 15678999999999999998 567765321 111100
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
........++.. + +...+.++++.|++.||++|.+++++++.-.+.
T Consensus 250 -~~~~~~e~~Le~------I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 -GNADDPEQLLEK------I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -cCccCHHHHHHh------C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 000011111111 1 112578999999999999999999999885554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=177.10 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=111.5
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChh--------------------------hHHHHHHHHHHHHhcCCCce
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL 571 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 571 (834)
.+.||+|+||.||+|+..+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999878999999998754211 01234679999999999987
Q ss_pred eeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecC
Q 003288 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~ 650 (834)
.....+... ..++||||++++++..... ....++..+...++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544333222 3489999999886543321 22357788999999999999999999 87 99999999999999
Q ss_pred CCCceeeccccceecCC
Q 003288 651 DMNPKISDFGLARMFGG 667 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~~ 667 (834)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=167.29 Aligned_cols=184 Identities=18% Similarity=0.134 Sum_probs=138.6
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEEecCCChh----hHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEec
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++++ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 6788888877654321 1235889999999995 5889999886 4568999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC-CCCcEEecCCCCceeeccccceecCCCcc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++.+|...+. . ....++.|++++|.++|..+ |+|||| ||+|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865431 0 12357889999999999999 999999 79999999999999999999986543221
Q ss_pred c------CC-----cccccccccccCcccccCC-CCC-ccCcchhhHHHHHHHHhCCCCCC
Q 003288 671 Q------GN-----TKQIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSSKKNTG 718 (834)
Q Consensus 671 ~------~~-----~~~~~gt~~y~aPE~~~~~-~~s-~~sDVwslGvvl~elltg~~p~~ 718 (834)
. .. ......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 0112357777777754332 333 55788999999999999988754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=191.10 Aligned_cols=216 Identities=25% Similarity=0.356 Sum_probs=162.5
Q ss_pred HHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 563 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...++++|++||+|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999965 3445899999999999999999999876 13999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCC-------CCCccCcchhhHHHHHHHHhCCC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDVwslGvvl~elltg~~ 715 (834)
+.|+++|....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111111222345689999998763 14678999999999999999999
Q ss_pred CCCCCCCCcc--cccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 716 NTGVYNADSF--NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 716 p~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
||........ .++... +. .......+.+.... +....+..++..||..+|.+||++++|...++...
T Consensus 157 ~~~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRV----KK-GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHH----Hh-cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9876433221 111111 11 01111222221111 22336889999999999999999999999987763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=178.24 Aligned_cols=234 Identities=19% Similarity=0.249 Sum_probs=151.8
Q ss_pred cCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCC----------CceeeEeeee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGCC 578 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 578 (834)
..+...+.||.|+++.||.+++.+ ++++|+|.+... .....+++++|......+.+ -.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 355667899999999999999865 899999987432 23357788888766655432 1222222221
Q ss_pred e---------ec---C-----eeEEEEEecCCCchhhhhh---ccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 003288 579 V---------EQ---G-----EKILILEYMPNKSLNVFLF---DSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637 (834)
Q Consensus 579 ~---------~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 637 (834)
. .. . ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.+ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 236677776 557777652 2222 233555666778899999999999999 99
Q ss_pred eCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccC--------CCCCccCcchhhHHHHHH
Q 003288 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLE 709 (834)
Q Consensus 638 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwslGvvl~e 709 (834)
|+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999988765432211 234578999997643 247889999999999999
Q ss_pred HHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 003288 710 TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR 776 (834)
Q Consensus 710 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
|.++..|++...+...... . -..+. +..+.+..+|..+|+.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------------------~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------------------D--FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------------------G--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------------------c--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999875433211000 1 12333 566778899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=203.95 Aligned_cols=200 Identities=22% Similarity=0.244 Sum_probs=160.5
Q ss_pred HHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCee
Q 003288 508 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 508 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 584 (834)
.....+.|.|.+.||+|+||+||+|...+|+.||+|.-+....- +|---.+++.+|+ -+-|..+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34457889999999999999999999888999999987654321 1111122333333 23455566666667788
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-------CCCCceee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-------KDMNPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-------~~~~~kl~ 657 (834)
+||+||.+.|+|.+++. ..+.++|..+..++.|+++.++.||..+ |||+||||+|+||. ...-++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999994 5667999999999999999999999998 99999999999993 23458999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p 716 (834)
|||-+-.+..-......+..++|-.+--+|...+..++..+|.|.|+.+++-||.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999876433222345567889999999999999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.1e-19 Score=195.21 Aligned_cols=225 Identities=25% Similarity=0.328 Sum_probs=179.6
Q ss_pred eeccCCcEeEEEEE----ecCCcEEEEEEecCCChhh--HHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEecC
Q 003288 520 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
++|+|.||.|++++ .+.++.+|+|.+++..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999764 3347788999886543221 124567888999996 9999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccC
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.|...+ .+...+++.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99998777 34445677777788889999999999999 99999999999999999999999999987543321
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~ 752 (834)
.+||..|||||++. .....+|-||||++++||++|..||.. +....++.. ...
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------------~~~~~Il~~---~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------------DTMKRILKA---ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------------HHHHHHhhh---ccC
Confidence 28999999999988 567889999999999999999999863 001111111 224
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 003288 753 ISLPMLMRYINVALLCVQENAADRPTM 779 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
.+.+....+.+++..++..+|..|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 455566778889999999999999755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=167.04 Aligned_cols=135 Identities=22% Similarity=0.288 Sum_probs=105.7
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-----CCCceeeEeeeeeecC---e-eEEE
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCVEQG---E-KILI 587 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv 587 (834)
-.+.||+|+||.||. +++....+||++........+.+.+|+.++..+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 443333479988765445567899999999999 5799999999998874 3 3378
Q ss_pred EEe--cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHH-HHHHhcCCCceeeCCCCCCcEEecC----CCCceeeccc
Q 003288 588 LEY--MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL-LYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDFG 660 (834)
Q Consensus 588 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFG 660 (834)
+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 558999999943 225544 35678888777 9999998 999999999999974 3479999944
Q ss_pred cc
Q 003288 661 LA 662 (834)
Q Consensus 661 la 662 (834)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-17 Score=166.09 Aligned_cols=152 Identities=18% Similarity=0.165 Sum_probs=116.8
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEE--ecCCcEEEEEEecCCChh------------------------hHHHHHH
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKN 558 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~ 558 (834)
+.++......|.+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+..
T Consensus 20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 34444445568999999999999999998 567999999998643210 1123578
Q ss_pred HHHHHHhcCCC--ceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003288 559 EMMLIAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 559 E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 636 (834)
|+.++.++.+. .+.+++++ ...++||||+++.+|..... ....+...+...++.||+.++++||+.+ .|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 99999999753 34444443 23589999999988876542 2234556677899999999999999986 49
Q ss_pred eeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 637 IHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 637 vH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+||||||+||+++ +++++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999987643
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=134.82 Aligned_cols=66 Identities=50% Similarity=1.105 Sum_probs=59.6
Q ss_pred cCCCCeeEEeeeccCCCcccccccccCChHHHHHHHhhcCCceeeecccccCCcceeeeccccccc
Q 003288 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDA 401 (834)
Q Consensus 336 C~~~~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~~~l~~~ 401 (834)
|+.+|+|+++++|++|++....++.++++++|++.|++||||+||+|.+++++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 556799999999999999777766779999999999999999999998777889999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=158.56 Aligned_cols=147 Identities=19% Similarity=0.201 Sum_probs=115.1
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh----------------------hhHHHHHHHHHH
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMML 562 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~ 562 (834)
+.++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 3344455555888899999999999999988899999998754221 011236788999
Q ss_pred HHhcCCCc--eeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCC
Q 003288 563 IAKLQHRN--LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640 (834)
Q Consensus 563 l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 640 (834)
+..+.|++ +++.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|+|
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 99998874 444443 245589999999999976541 1345678899999999999988 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCC
Q 003288 641 LKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 641 ikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=160.77 Aligned_cols=134 Identities=20% Similarity=0.295 Sum_probs=113.5
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|+.++..++|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 778899998653321 1124578899999999999988777777777888999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988422 12 77899999999999999998 99999999999999 78999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.2e-17 Score=178.38 Aligned_cols=175 Identities=26% Similarity=0.339 Sum_probs=132.5
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++.|++|...+|.++|.+.......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777778899999999999999999 66 999999999999999999999999998
Q ss_pred eecCCCc----ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccc
Q 003288 663 RMFGGDE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 663 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
....... .........||..||+||.+.+..|+.|+||||||++|+||+. -...++. .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------~ 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------I 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------H
Confidence 8765443 1223456789999999999999999999999999999999997 2222110 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003288 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 782 (834)
Q Consensus 738 ~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 782 (834)
....++-+..+ . +........-+.++.+++...|.+||++.++
T Consensus 467 ~t~~d~r~g~i-p-~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGII-P-PEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCC-C-hHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 00111111111 1 0111112234678899999999999954443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.6e-16 Score=156.22 Aligned_cols=130 Identities=23% Similarity=0.369 Sum_probs=106.6
Q ss_pred eeccCCcEeEEEEEecCCcEEEEEEecCCC---h-----hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQS---G-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.||+|+||.||+|.. ++..+++|...... . ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999864321 1 12356789999999999887655555556667789999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++++|.+++.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 078999999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-16 Score=178.34 Aligned_cols=136 Identities=21% Similarity=0.337 Sum_probs=111.7
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEe-cCC-C------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
..|...++||+|+||.||+|.+... .+++|+. .+. . ....+.+.+|++++.+++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456678999999999999987544 4444432 211 1 11235688999999999999998888888777788
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 35679999999999999998 9999999999999 678999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=157.85 Aligned_cols=197 Identities=18% Similarity=0.277 Sum_probs=134.1
Q ss_pred CCCceeeEeeeeee---------------------------cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHH
Q 003288 567 QHRNLVRLLGCCVE---------------------------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 619 (834)
Q Consensus 567 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 619 (834)
+|||||++.++|.+ ....|+||.-.+. +|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 59999999987643 2246788876643 78888743 2345666778999
Q ss_pred HHHHHHHHHHhcCCCceeeCCCCCCcEEec--CC--CCceeeccccceecCCC--c--ccCCcccccccccccCcccccC
Q 003288 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLD--KD--MNPKISDFGLARMFGGD--E--LQGNTKQIVGTYGYMSPEYALD 691 (834)
Q Consensus 620 ~ia~~L~~LH~~~~~~ivH~Dikp~NILl~--~~--~~~kl~DFGla~~~~~~--~--~~~~~~~~~gt~~y~aPE~~~~ 691 (834)
|+++|+.|||+++ |.|||+|++||||. ++ -.+.|+|||.+-.-... + +....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 34789999987543221 1 1111123457778999998865
Q ss_pred CC--C----CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHH
Q 003288 692 GL--F----SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVA 765 (834)
Q Consensus 692 ~~--~----s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li 765 (834)
.+ . -.|+|.|+.|.+.||++....||.....-...... +.+..+. ..+......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLP----------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLP----------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCC----------CCcccCChHHHHHH
Confidence 32 1 26899999999999999998887542211111100 1111111 11222334678899
Q ss_pred HHccccCCCCCCCHHHHHHHH
Q 003288 766 LLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 766 ~~cl~~dP~~RPt~~evl~~L 786 (834)
...|+.||++|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.3e-16 Score=178.67 Aligned_cols=210 Identities=23% Similarity=0.257 Sum_probs=142.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|..++.|..|++|.||..+++. .+.+|+|+=++. - . +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-i---lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-I---LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-h---hhc---cccccCCccee------------------
Confidence 4678899999999999999998864 567787432211 0 0 000 11111222222
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC--
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-- 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~-- 668 (834)
|+-...+. .-+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222331 1122332 2378999999998 999999999999999999999999998864211
Q ss_pred -----------cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003288 669 -----------ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 669 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
...-..++++||+.|+|||++..+-|....|.|++|+++||.+-|+.||..+.+++..
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf----------- 267 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF----------- 267 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----------
Confidence 1112345679999999999999999999999999999999999999998765443321
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003288 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 778 (834)
Q Consensus 738 ~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
..++...+...+-......++.+++.+.|+.+|..|--
T Consensus 268 ---g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 268 ---GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ---hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 11111111112222333456788899999999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=138.31 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=115.2
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeEeeeeeecCeeEEEEEecCCC
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899999865543 5678999999999976 58999999888888899999999988
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
.+..+ +......++.+++++|++||......++|+||+|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566678899999999999987545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=145.26 Aligned_cols=137 Identities=20% Similarity=0.257 Sum_probs=99.2
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChh--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 571 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 571 (834)
.+.||+|+||.||+|...+++.||||.+...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 135666666664432 4
Q ss_pred eeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecC
Q 003288 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~ 650 (834)
.+.+++ ...++||||++++.+......... . ..+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999544221111000 1 15677899999999999999 77 99999999999999
Q ss_pred CCCceeeccccceecC
Q 003288 651 DMNPKISDFGLARMFG 666 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~ 666 (834)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=7e-14 Score=144.85 Aligned_cols=135 Identities=23% Similarity=0.279 Sum_probs=105.0
Q ss_pred ceec-cCCcEeEEEEEecCCcEEEEEEecCCC-------------hhhHHHHHHHHHHHHhcCCCce--eeEeeeeeecC
Q 003288 519 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCVEQG 582 (834)
Q Consensus 519 ~~LG-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 582 (834)
..|| .|+.|+||++.. .+..++||++.... ......+.+|+.++.+++|+++ ++.+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 888999999877 47789999885311 1223567899999999998875 67777654432
Q ss_pred ----eeEEEEEecCC-CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 583 ----EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 583 ----~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
..++|||++++ .+|.+++.. ..++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888732 234433 3678999999999999 9999999999999998999999
Q ss_pred ccccceec
Q 003288 658 DFGLARMF 665 (834)
Q Consensus 658 DFGla~~~ 665 (834)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.3e-15 Score=172.12 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=189.7
Q ss_pred hcCccccceeccCCcEeEEEEEecC--CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 586 (834)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4467777889999999998876533 4456777665442 333444556777777776 9999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCceeeCCCCCCcEEecCCC-Cceeecccccee
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARM 664 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~ 664 (834)
+.||..++++.+.+... .....+....-..+.|+..++.|+| ..+ +.||||||+|.++++.+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998877311 1113555667788999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-CcccCCcccccc-cccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 665 FGG-DELQGNTKQIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 665 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............+ ......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-----KSNKGR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-----cccccc
Confidence 876 444445556678 9999999999885 44678999999999999999999987544332221111 111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .............++..+++..+|..|.+.+++..
T Consensus 250 ~-------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 F-------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c-------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00001111234567778888899999999888754
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=115.05 Aligned_cols=71 Identities=21% Similarity=0.353 Sum_probs=60.9
Q ss_pred cCCCCeeEEeeeccCCCcccccccccCChHHHHHHHhh---cCCceeeecccccCCcceeeecccc-ccccCCCCCCCCc
Q 003288 336 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK---NCSCRAYANSNVKESSGCLMWYGDL-IDARRPIRNFTGQ 411 (834)
Q Consensus 336 C~~~~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~---nCsC~ay~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~~ 411 (834)
|...++|+++.+|++|++.. ++++||++.|++ ||||+||+|.+. ++||++|+++| ++++++ ...+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~--~~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKE--FSHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhc--cCCCc
Confidence 45567899999999999854 689999999999 999999999753 46999999999 999877 44588
Q ss_pred eEEEe
Q 003288 412 SVYLR 416 (834)
Q Consensus 412 slylr 416 (834)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 89987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=146.89 Aligned_cols=141 Identities=23% Similarity=0.279 Sum_probs=102.1
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhH----------------------------------------HHHHH
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------KEFKN 558 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~ 558 (834)
+.||.|++|.||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421110 02455
Q ss_pred HHHHHHhcC----CCceeeEeeeee-ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003288 559 EMMLIAKLQ----HRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ-GLLYLHQYS 632 (834)
Q Consensus 559 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~~ 632 (834)
|+..+.+++ |.+-+.+-.++. ..+..++||||++|++|.++...... .. .+.+++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666653 333333333332 24567999999999999887632111 11 23456666666 467889888
Q ss_pred CCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
++|+|+||.||+++.++.++|+|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.4e-12 Score=110.49 Aligned_cols=80 Identities=41% Similarity=0.861 Sum_probs=64.6
Q ss_pred CcccCCC---CeeEEeeeccCCCcccccccccCChHHHHHHHhhcCCceeeecccccCCcceeeeccccccccCCCCCCC
Q 003288 333 SLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT 409 (834)
Q Consensus 333 ~l~C~~~---~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~~~l~~~~~~~~~~~ 409 (834)
+++|+.. ++|+.+.++++|++.... .++++++|++.|++||+|+||+|.+ ++++|++|.+.+.+.+.. ...
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~--~~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSL--SSG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEee--cCC
Confidence 4567554 699999999999885443 6789999999999999999999974 478999999999887654 333
Q ss_pred CceEEEecc
Q 003288 410 GQSVYLRVP 418 (834)
Q Consensus 410 ~~slylrl~ 418 (834)
+..+|+|++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 577999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=143.77 Aligned_cols=250 Identities=24% Similarity=0.286 Sum_probs=182.4
Q ss_pred cCccccceecc--CCcEeEEEEEe---cCCcEEEEEEecC--CChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 513 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 513 ~~y~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
..|.+.+.+|. |.+|.||+++. .++..+|+|+-+. ..+.....=.+|+...+++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677789999 99999999986 3578899997432 2223323335666666666 599999988889999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHH----HHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeecc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDF 659 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DF 659 (834)
++-.|++. .+|..+.. .....++...++....+... ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 67777763 34445777888888888888 999999998 9999999999999999 88999999
Q ss_pred ccceecCCCcccCCc---ccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 660 GLARMFGGDELQGNT---KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 660 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|+...++........ .+..|...|++||... +.++.++|||++|.++.|...+....-..... .|...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence 999998776533222 3346788999999554 67789999999999999999876653221111 111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. . .+.++-..-..++..++.+|++.+|..|++.+.+...
T Consensus 340 ~~---~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 340 QG---Y------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cc---c------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11 1 1222222223455558899999999999998877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.5e-11 Score=119.20 Aligned_cols=130 Identities=23% Similarity=0.188 Sum_probs=98.3
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCcee-eEeeeeeecCeeEEEEEecCCCchh
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLN 597 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL~ 597 (834)
+.|+.|.++.||+++. .++.+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 6789999999999987 478899999765432 223567899999999765544 455443 33468999999998875
Q ss_pred hhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 598 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 0 11245678999999999987 33469999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.1e-12 Score=127.57 Aligned_cols=202 Identities=21% Similarity=0.230 Sum_probs=138.4
Q ss_pred HHhcCCCceeeEeeeeeec-----CeeEEEEEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003288 563 IAKLQHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 563 l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 636 (834)
|-++.|.|||+++.|..+. ....++.|||+.|+|..+|.+..+ +..+......+|+.||+.||.|||+.. ++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 4455799999999987643 357899999999999999976443 345788888899999999999999974 679
Q ss_pred eeCCCCCCcEEecCCCCceeeccccceecCC---CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhC
Q 003288 637 IHRDLKASNILLDKDMNPKISDFGLARMFGG---DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS 713 (834)
Q Consensus 637 vH~Dikp~NILl~~~~~~kl~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg 713 (834)
+|+++.-+-|++..++-+|+.- +....... ...........+-++|.|||+=.....+.++|||+||...+||.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999888777642 11111110 0011122234567899999987777788899999999999999876
Q ss_pred CCC-CCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 714 KKN-TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 714 ~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..- ....... ..+......+. .-+...-..++.+|++..|..||+|++++...
T Consensus 279 Eiq~tnseS~~-----------~~ee~ia~~i~---------~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKV-----------EVEENIANVII---------GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCccee-----------ehhhhhhhhee---------eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 542 1111000 00011111100 00011124567889999999999999987553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.1e-11 Score=134.99 Aligned_cols=145 Identities=19% Similarity=0.233 Sum_probs=96.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChh----------------------------------hHH--
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ----------------------------------GLK-- 554 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~~-- 554 (834)
...|+. +.||+|++|.||+|++++ |+.||||+.++.-.+ ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999998754211 011
Q ss_pred ----HHHHHHHHHHhcC----CCceeeEeeeeee-cCeeEEEEEecCCCchhhhhhccCCC---ccCCHHHHHHHHHHHH
Q 003288 555 ----EFKNEMMLIAKLQ----HRNLVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIA 622 (834)
Q Consensus 555 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia 622 (834)
+|.+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 2344555555542 4444444444433 45778999999999998753111111 11222222223333
Q ss_pred HHHHHHHhcCCCceeeCCCCCCcEEecCCC----CceeeccccceecCC
Q 003288 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFGLARMFGG 667 (834)
Q Consensus 623 ~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFGla~~~~~ 667 (834)
++..+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999888 999999999988754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-10 Score=128.01 Aligned_cols=168 Identities=18% Similarity=0.219 Sum_probs=129.2
Q ss_pred ecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHH
Q 003288 534 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQA 613 (834)
Q Consensus 534 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~ 613 (834)
..++.+|.|+..+.......+...+-++.|+.++||||++++.....++..|+|+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688899988877666445667788899999999999999999999999999999873 56656522 33566
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCC
Q 003288 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693 (834)
Q Consensus 614 ~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 693 (834)
+...+.||+.||.|||+.+ .++|++|....|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 7778999999999999777 599999999999999999999999998875432211 111222233566676554332
Q ss_pred CCccCcchhhHHHHHHHHhCCC
Q 003288 694 FSIKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 694 ~s~~sDVwslGvvl~elltg~~ 715 (834)
...|.|.||++++|++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 45699999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.8e-10 Score=110.00 Aligned_cols=137 Identities=15% Similarity=0.124 Sum_probs=99.8
Q ss_pred ceeccCCcEeEEEEEecC-------CcEEEEEEecCC-------------C---------hhhHHHHH----HHHHHHHh
Q 003288 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQ-------------S---------GQGLKEFK----NEMMLIAK 565 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~-------------~---------~~~~~~~~----~E~~~l~~ 565 (834)
..||.|--+.||.|...+ +..+|||+.+.. + ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997643 478999986421 0 01122333 89999999
Q ss_pred cCC--CceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeCCCC
Q 003288 566 LQH--RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLK 642 (834)
Q Consensus 566 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dik 642 (834)
+.. -++.+.+++ ...++||||+.+..+..-. .+...++.++...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 954 456666654 5678999999875442211 1112345566678889999999999 7777 9999999
Q ss_pred CCcEEecCCCCceeeccccceecC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-10 Score=113.22 Aligned_cols=142 Identities=18% Similarity=0.267 Sum_probs=111.3
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCC--CceeeEeeeeeecC---eeEEEEEecC
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG---EKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~E~~~ 592 (834)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887678999999765432 235678999999999976 34577777766542 5689999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 632 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 632 (834)
+.++...+.. ..++..+...++.+++++|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 34677788888899999999998531
Q ss_pred -------------CCceeeCCCCCCcEEecC--CCCceeecccccee
Q 003288 633 -------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARM 664 (834)
Q Consensus 633 -------------~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~ 664 (834)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=102.03 Aligned_cols=143 Identities=24% Similarity=0.327 Sum_probs=106.0
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEE-ecCCCh-------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQSG-------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
....|-+|+-+.|+++.. .|+.++||. +.+... -..++-++|+++|.+++--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 678877874 333211 12456788999999997666654444566666778999
Q ss_pred EecCC-CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeecccccee
Q 003288 589 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARM 664 (834)
Q Consensus 589 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~ 664 (834)
||+++ -++.+++........ ..+....++..|-+.+.-||..+ |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477777754333322 22333678889999999999998 999999999999966553 58999999863
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.6e-09 Score=101.04 Aligned_cols=131 Identities=22% Similarity=0.343 Sum_probs=100.9
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEE-ecCCC--hh-----hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQS--GQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~-l~~~~--~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+++|+-+.+|.+.+. |..+++|. +++.. ++ ....-.+|++++.+++--.|.--+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999663 44567774 33321 11 123457899999999766665555556677788999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2567788888889999999 99999999999997765 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.6e-10 Score=124.59 Aligned_cols=247 Identities=19% Similarity=0.193 Sum_probs=174.9
Q ss_pred HhcCccccceeccCCcEeEEEEEe--cCCcEEEEEEecCCChhhHHH--HHHHHHHHHhc-CCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 585 (834)
...+|..+..||.|.|+.|++... .++..|++|.+.+.......+ -..|+.+...+ .|.++++.+..+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788899999999999998753 357789999886654332222 24566666666 6899999888888777888
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeecccccee
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 664 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~ 664 (834)
+=-||++++++...+ .-...+.+..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 889999999987766 33345788889999999999999999988 9999999999999876 8899999999864
Q ss_pred cCCCcccCCccccccccccc--CcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+.-.. ......-+++ +|+......+-.++|++|||.-+.|.+++..-..... ....
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------------~~~~ 474 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------------QSLT 474 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------------ccee
Confidence 22111 1112233444 5555566778899999999999999998865432100 0000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
+....... ... ....+..+...++..++..||.+.++..+.+-
T Consensus 475 i~~~~~p~--~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 475 IRSGDTPN--LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eecccccC--CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00010100 011 11445566677888999999999888766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.5e-08 Score=97.53 Aligned_cols=126 Identities=25% Similarity=0.304 Sum_probs=85.0
Q ss_pred eEEEEEecCCcEEEEEEecCCC--------------h------------hhHHHHHHHHHHHHhcCCC--ceeeEeeeee
Q 003288 528 PVYKGRLLNGQEVAVKRLSNQS--------------G------------QGLKEFKNEMMLIAKLQHR--NLVRLLGCCV 579 (834)
Q Consensus 528 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 579 (834)
.||.|...+|..+|||..+... . ......++|++.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999874210 0 0123467899999999765 45666654
Q ss_pred ecCeeEEEEEecC--CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHH-HHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 580 EQGEKILILEYMP--NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-LHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 580 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
...++||||++ +..+..+.... ++.++...++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 65665443111 1234556788888886665 46777 9999999999999988 9999
Q ss_pred eccccceecC
Q 003288 657 SDFGLARMFG 666 (834)
Q Consensus 657 ~DFGla~~~~ 666 (834)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-09 Score=127.09 Aligned_cols=251 Identities=18% Similarity=0.200 Sum_probs=167.7
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
...+.+.+.+-+-+|.++.++.++-. .|...++|..... .....+....+-.++-..+||-+++...-+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34577888889999999999987532 2333334433211 1111222233333333334566666655555677889
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
|+++|..+++|...|+... ..+.+.....+..+.++++|||... +.|+|++|.|+|+..++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988885432 3444444556667888999999987 899999999999999999999999844332
Q ss_pred CC-------------------------Cccc----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 003288 666 GG-------------------------DELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (834)
Q Consensus 666 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p 716 (834)
+. .... .......+|+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112345789999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003288 717 TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS 780 (834)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
+....+... +..++...+...........+..+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~--------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI--------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh--------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 865433211 11111122212222333344566777788889999997665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.2e-08 Score=104.73 Aligned_cols=169 Identities=20% Similarity=0.289 Sum_probs=128.4
Q ss_pred cEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeEEEEEecCC-Cchhhh
Q 003288 526 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYMPN-KSLNVF 599 (834)
Q Consensus 526 fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~ 599 (834)
-.+.||+.. .+|..|++|+++.........-..-+++++++.|+|+|++.+++.. +..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788864 4799999999954433333233455788999999999999998873 4478999999985 577666
Q ss_pred hhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 600 LFDST------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 600 l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
-+... .....++..++.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 2345778999999999999999999999 88899999999999999999999888776543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p 716 (834)
+.. |-+.. -.+-|.=.||.+++.|.+|...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2456888999999999998655
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.6e-08 Score=100.53 Aligned_cols=140 Identities=18% Similarity=0.132 Sum_probs=101.1
Q ss_pred eeccCCcEeEEEEEecCCcEEEEEEecCCChh-hHH----------HHHHHHHHHHhcCCCc--eeeEeeeeee-----c
Q 003288 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLK----------EFKNEMMLIAKLQHRN--LVRLLGCCVE-----Q 581 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~ 581 (834)
.+-.-....|++... +|+.+.||+....... ..+ .+.+|...+.++...+ .++.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667665 6889999977443211 112 3789999999995444 3455666543 2
Q ss_pred CeeEEEEEecCCC-chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-------CCC
Q 003288 582 GEKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMN 653 (834)
Q Consensus 582 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-------~~~ 653 (834)
...++|+|++++. +|.+++.... ....+......++.+++..+.-||..+ |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 8988874321 233456677789999999999999999 999999999999975 467
Q ss_pred ceeecccccee
Q 003288 654 PKISDFGLARM 664 (834)
Q Consensus 654 ~kl~DFGla~~ 664 (834)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.8e-07 Score=94.78 Aligned_cols=148 Identities=20% Similarity=0.218 Sum_probs=104.7
Q ss_pred ccHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC----------------------hhhHHHHHHHH
Q 003288 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLKEFKNEM 560 (834)
Q Consensus 503 ~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~E~ 560 (834)
+.+..+.....=..+..+||-|--+.||.|..+.|.++|||.-+... .......++|.
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 34444444344456678999999999999999999999999642111 01133457899
Q ss_pred HHHHhcCCC--ceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 003288 561 MLIAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638 (834)
Q Consensus 561 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 638 (834)
++|.+|.-. .+.+.++. +...+||||+++-.|...- ++.+..-.++..|++-+.-+-..| |||
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVH 225 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVH 225 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccc
Confidence 999999655 66676654 5567999999997775432 123333344555555555555666 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceec
Q 003288 639 RDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 639 ~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+++-||+++++|.+.++||-.+...
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccC
Confidence 999999999999999999999766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3e-06 Score=90.07 Aligned_cols=263 Identities=15% Similarity=0.137 Sum_probs=156.3
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeee------eeecC-eeEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC------CVEQG-EKILI 587 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv 587 (834)
...+.||+|+-+.+|..-. -.-.+-|+..........+. +..|.+. .||-+-.=+.+ .-+++ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456899999999996422 12234577765544433332 2233333 45543321111 11222 25677
Q ss_pred EEecCCCchhhhhhc----cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 588 LEYMPNKSLNVFLFD----STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
|..+++.-=-..++. ++.....+|.-.++++..++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 877766522222222 223345789999999999999999999999 9999999999999999999999865443
Q ss_pred ecCCCcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhC-CCCCCCCCC--Ccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSS-KKNTGVYNA--DSFNLLGHAWDLW 735 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg-~~p~~~~~~--~~~~~~~~~~~~~ 735 (834)
...+. ....-.+|...|.+||.-. +..-+...|-|.||+++++++.| ++|+..... +...-.+. .+
T Consensus 166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~I 239 (637)
T COG4248 166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DI 239 (637)
T ss_pred eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hh
Confidence 32111 1223357889999999754 23345779999999999999987 888754221 11010000 01
Q ss_pred cccccccccc--cccccCC--CCHHH-HHHHHHHHHHccccC--CCCCCCHHHHHHHHhcccCC
Q 003288 736 KDDRVHDLID--PVIMQDE--ISLPM-LMRYINVALLCVQEN--AADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 736 ~~~~~~~li~--~~~~~~~--~~~~~-~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~ 792 (834)
..+.+...-+ ......+ ..... ...+.-+..+|+..- +.-||+++-.+..|.....+
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1111111111 1111111 22222 235566777887543 56899999999888665433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=85.95 Aligned_cols=138 Identities=16% Similarity=0.200 Sum_probs=103.9
Q ss_pred eccCCcEeEEEEEecCCcEEEEEEecCC------ChhhHHHHHHHHHHHHhcCCCc--eeeEeeeee-ec----CeeEEE
Q 003288 521 LGEGGFGPVYKGRLLNGQEVAVKRLSNQ------SGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCV-EQ----GEKILI 587 (834)
Q Consensus 521 LG~G~fg~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv 587 (834)
-|+||-+-|+...+ +|+.+-+|+-.+. .+.+...|.+|...|.++...+ +.+.+ ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46788888998776 5567899976421 1446788999999999996433 44555 332 21 246899
Q ss_pred EEecCC-CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC--ceeecccccee
Q 003288 588 LEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARM 664 (834)
Q Consensus 588 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~ 664 (834)
+|-+++ .+|.+++.... ....+......++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 58888874321 224577778899999999999999999 999999999999986667 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=89.27 Aligned_cols=107 Identities=24% Similarity=0.273 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeEeeeeeecC----eeEEEEEecCCC-chhhhhhccCCCccCCHHHHHHHHHHHHHHH
Q 003288 553 LKEFKNEMMLIAKLQHR--NLVRLLGCCVEQG----EKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625 (834)
Q Consensus 553 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 625 (834)
.....+|...+..++.. ...+.+++..... ..++|+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 34678899988888543 3466777766533 458999999874 89998843222 56667789999999999
Q ss_pred HHHHhcCCCceeeCCCCCCcEEecCCC---Cceeeccccceec
Q 003288 626 LYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 665 (834)
Q Consensus 626 ~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~ 665 (834)
+-||..+ |+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-06 Score=99.24 Aligned_cols=141 Identities=17% Similarity=0.226 Sum_probs=95.2
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhh------------------------------HH----------HHHH
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG------------------------------LK----------EFKN 558 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~------------------------------~~----------~~~~ 558 (834)
+.|+.++-|.||+|++++|+.||||+.++.-.+. .+ +|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999975432110 11 1344
Q ss_pred HHHHHHhcC----CCceeeEeeeee-ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHH-HHHHHhcC
Q 003288 559 EMMLIAKLQ----HRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG-LLYLHQYS 632 (834)
Q Consensus 559 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~ 632 (834)
|+.-+.+++ +..-+++=.++. ..+..+|+|||++|..+.+...... ..++.+. ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 555555552 222233333343 3567899999999999988853222 3344333 33333332 22222344
Q ss_pred CCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+.|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.8e-07 Score=105.61 Aligned_cols=153 Identities=19% Similarity=0.304 Sum_probs=102.6
Q ss_pred HHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc-c------CCcccccccccccCccccc
Q 003288 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-Q------GNTKQIVGTYGYMSPEYAL 690 (834)
Q Consensus 618 ~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-~------~~~~~~~gt~~y~aPE~~~ 690 (834)
+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........ . ....-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999876 699999999999999999999999998876544211 1 0111123456899999999
Q ss_pred CCCCCccCcchhhHHHHHHHHhCCCC-CCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHcc
Q 003288 691 DGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCV 769 (834)
Q Consensus 691 ~~~~s~~sDVwslGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl 769 (834)
....+.++|+||+|+++|.+..|..+ +............ ....+.. ...++.....++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----------~~~~~~~--~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----------RNLLNAG--AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----------hcccccc--cccccccCcHHHHHHHHHHh
Confidence 98889999999999999999954443 3322211100000 0000000 11112233456677778899
Q ss_pred ccCCCCCCCHHHHHHH
Q 003288 770 QENAADRPTMSDVISM 785 (834)
Q Consensus 770 ~~dP~~RPt~~evl~~ 785 (834)
..++..||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999987776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=80.43 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=94.9
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHH---------HHHHHHHHhcCCC---ceeeEeeee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQHR---NLVRLLGCC 578 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l~~~~ 578 (834)
...+|.+.+++-......|.+-.. +|+.+++|..++......+.| .+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 357888888888888888887766 688999998876543322222 3344444555332 223322222
Q ss_pred e-----ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 579 V-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 579 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
. .....+++|||++|..|.++.. ++. .++..+.+++.-||+.| +.|+|..|.|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2 2235679999999988866541 222 24566778899999999 9999999999999865 4
Q ss_pred ceeecccccee
Q 003288 654 PKISDFGLARM 664 (834)
Q Consensus 654 ~kl~DFGla~~ 664 (834)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=73.03 Aligned_cols=72 Identities=38% Similarity=0.771 Sum_probs=54.0
Q ss_pred CeeEEeeeccCCCcccccccccCChHHHHHHHhh-cCCceeeecccccCCcceeeec-cccccccCCCCCCCCceEEEe
Q 003288 340 DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY-GDLIDARRPIRNFTGQSVYLR 416 (834)
Q Consensus 340 ~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~-nCsC~ay~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~~slylr 416 (834)
..|.++.++.+++..... ....++++|++.|++ +|+|.||.|.. .+++|.+|. +.+.+... ....+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~--~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARL--FPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCcccccee--cccCCceeEEe
Confidence 569999999998664432 346799999999999 99999999974 567999999 66655542 23445555554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-05 Score=83.21 Aligned_cols=139 Identities=18% Similarity=0.191 Sum_probs=85.9
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEeeeeeecCeeEEEEEecCCCc-
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEYMPNKS- 595 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 595 (834)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567889876533 2345688999999986443 4677877777777889999999863
Q ss_pred hhhhhh--------------------ccCCCccCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCceeeCCCC
Q 003288 596 LNVFLF--------------------DSTKKRLLNWQARV-RIIE----------GIAQ-GLLYLHQY-SRFRIIHRDLK 642 (834)
Q Consensus 596 L~~~l~--------------------~~~~~~~l~~~~~~-~i~~----------~ia~-~L~~LH~~-~~~~ivH~Dik 642 (834)
+...+. +............. .+.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 00000001111100 0000 0001 11222211 23457999999
Q ss_pred CCcEEecCCCCceeeccccce
Q 003288 643 ASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~ 663 (834)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.15 E-value=8e-06 Score=74.25 Aligned_cols=88 Identities=26% Similarity=0.340 Sum_probs=61.7
Q ss_pred eEEEeeCCcEEEEcCC-CCeEEEEecCCCCc-cceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 89 VLTISNNGNLVLLNQT-NGTIWSTNVSSEVK-NPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 89 ~l~~~~~G~Lvl~~~~-~~~vWst~~~~~~~-~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
++.+..||+||+.+.. +.+||++++..... ...+.|.++|||||++.++ .++|+|= +
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~--t-------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDG-----RVVWSSN--T-------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCC-----CEEEEec--c--------------
Confidence 3555689999999765 58999999864432 3567899999999998753 6788861 1
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
....|.+.+.++.+|...++-.++ .+.|.+.
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 112456788888888877654444 4667653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.8e-05 Score=79.28 Aligned_cols=144 Identities=22% Similarity=0.231 Sum_probs=85.9
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC--ceeeEeeeeee---cCeeEEEEEecC
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCVE---QGEKILILEYMP 592 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~E~~~ 592 (834)
++.|+.|..+.||+....+ ..+++|..... .....+.+|+.++..+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 69999997654 4556778899999888533 35566664432 234689999999
Q ss_pred CCchhh----------------hh---hcc-CCCccCCH-H--------HHHHH------------HHHHHH-HHHHHHh
Q 003288 593 NKSLNV----------------FL---FDS-TKKRLLNW-Q--------ARVRI------------IEGIAQ-GLLYLHQ 630 (834)
Q Consensus 593 ~gsL~~----------------~l---~~~-~~~~~l~~-~--------~~~~i------------~~~ia~-~L~~LH~ 630 (834)
+..+.. .+ +.. ........ . ..... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 011 01000110 0 00000 111222 2333332
Q ss_pred ----cCCCceeeCCCCCCcEEec-CCCCceeecccccee
Q 003288 631 ----YSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 664 (834)
Q Consensus 631 ----~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~ 664 (834)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7e-07 Score=99.49 Aligned_cols=188 Identities=16% Similarity=0.123 Sum_probs=136.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 590 (834)
+.-+.....+++|+.++++|.+..-.+....+.+... ....-++++|.+++||| .++.++-+..+....+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 4445555678999999999987644444445555332 33456788999999999 67777777777788999999
Q ss_pred cCCC-chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 591 MPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+..+ +-..-. ....-.+..-+...+...-++++++||+.. -+|+| ||+..+ +..|..||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9876 221111 011112333444566677788999999875 58998 777766 678999999988765443
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~ 717 (834)
..+...+++.++|||+.....+..+.|+|++|+--.++--|-+|.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 345578999999999999999999999999998777777666654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.2e-05 Score=79.88 Aligned_cols=140 Identities=14% Similarity=0.131 Sum_probs=86.3
Q ss_pred eeccCCc-EeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEEecCCCchh
Q 003288 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLN 597 (834)
Q Consensus 520 ~LG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 597 (834)
.|-.|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 688998764 4788889876543 345678999998884 444567788777666789999999998876
Q ss_pred hhhh-------------------ccCC-CccCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 003288 598 VFLF-------------------DSTK-KRLLN--WQARVRIIE--------------------GIAQGLLYLHQ----Y 631 (834)
Q Consensus 598 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~~LH~----~ 631 (834)
.... .... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0000 00000 000000000 01111222211 1
Q ss_pred CCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 632 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23459999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.6e-05 Score=78.98 Aligned_cols=105 Identities=22% Similarity=0.232 Sum_probs=83.5
Q ss_pred HHHHHHHHhcCC-CceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003288 557 KNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635 (834)
Q Consensus 557 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 635 (834)
.+|..+++.+++ +++++++|+|- .++|.||...+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 69999999994 3689999987765422000011124689999999999999999999876556
Q ss_pred eeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 636 IIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 636 ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.4e-05 Score=75.90 Aligned_cols=153 Identities=19% Similarity=0.219 Sum_probs=100.3
Q ss_pred ccHHHHHHHhcCccccce---eccCCcEeEEEEEecCCcEEEEEEecCCChhh-------------------HH-----H
Q 003288 503 FSLASITAATENFSMQCK---LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------LK-----E 555 (834)
Q Consensus 503 ~~~~~i~~~~~~y~~~~~---LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------~~-----~ 555 (834)
..+..+.....+..+.+. |+.|--+.||+|...++..+|||+++...... .+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345555555666655554 55677778999988789999999985432111 00 1
Q ss_pred HHHHHHHHHhcC--CCceeeEeeeeeecCeeEEEEEecCCCch-hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC
Q 003288 556 FKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632 (834)
Q Consensus 556 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 632 (834)
-..|+.-|.++. +-.+.+-+++. .-.|||||+....+ .-.| +...+...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 134666666663 33344444432 34799999965421 1111 1122333356777888888888888733
Q ss_pred CCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 633 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
.+||+||+.-|||+. ++.+.|+||+-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.7e-05 Score=87.14 Aligned_cols=141 Identities=20% Similarity=0.245 Sum_probs=91.8
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhh-------------------------------HH------HHHHHHH
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------LK------EFKNEMM 561 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------~~------~~~~E~~ 561 (834)
+.||.-+.|.||+|++++|+.||||+-++.-++. .+ +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865432111 01 2444554
Q ss_pred HHHhc----CCCc---eeeEeeeee-ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHH-HHhcC
Q 003288 562 LIAKL----QHRN---LVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-LHQYS 632 (834)
Q Consensus 562 ~l~~l----~h~n---iv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~ 632 (834)
-..+. .|-+ -|.+-.++. .....+|+||||+|..+.+...-.. ..++...+. ..+.++... |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~---~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDIL---NKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHH---HHHHHHHHHHHHhcC
Confidence 44433 3545 122223332 3457899999999998877753322 235555443 333333222 12234
Q ss_pred CCceeeCCCCCCcEEecC----CCCceeeccccceecCC
Q 003288 633 RFRIIHRDLKASNILLDK----DMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dikp~NILl~~----~~~~kl~DFGla~~~~~ 667 (834)
++|+|=.|.||++.. +..+.+-|||+...+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999887643
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.4e-05 Score=71.34 Aligned_cols=88 Identities=24% Similarity=0.278 Sum_probs=61.5
Q ss_pred EEEee-CCcEEEEcCC-CCeEEEEecCCC-CccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 90 LTISN-NGNLVLLNQT-NGTIWSTNVSSE-VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 90 l~~~~-~G~Lvl~~~~-~~~vWst~~~~~-~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
+.... ||+||+.+.. +.+||++|+... .....+.|.++|||||++.++ .++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG-----TVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC-----cEEEEeccc---------------
Confidence 44555 8999999765 589999998642 344567899999999998754 678885311
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+.+.+.+.|+.+|...++-.+ ..+.|.+..
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 1245678888888877766544 355676643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0002 Score=88.05 Aligned_cols=79 Identities=18% Similarity=0.397 Sum_probs=58.6
Q ss_pred cceeccCCcEeEEEEEecCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhcC-CCce--eeEeeeeeec---CeeEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCVEQ---GEKILI 587 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 587 (834)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999877553 467888764432 123356889999999995 6665 7888887764 467899
Q ss_pred EEecCCCch
Q 003288 588 LEYMPNKSL 596 (834)
Q Consensus 588 ~E~~~~gsL 596 (834)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00018 Score=71.82 Aligned_cols=128 Identities=18% Similarity=0.253 Sum_probs=91.3
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCC----------------hhhHHHHHHHHHHHHhcC------CCceeeEe
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLL 575 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 575 (834)
...||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999996 5667778899886554 223566677777766665 78899999
Q ss_pred eeeeecCeeEEEEEecCC--C----chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec
Q 003288 576 GCCVEQGEKILILEYMPN--K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (834)
Q Consensus 576 ~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~ 649 (834)
|+.+++...-+|+|.+.+ | +|.+++ +...++. ...+.+ -+-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 2 566666 2333544 333333 34445666665 99999999999995
Q ss_pred CCC----Cceeec
Q 003288 650 KDM----NPKISD 658 (834)
Q Consensus 650 ~~~----~~kl~D 658 (834)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00018 Score=65.11 Aligned_cols=100 Identities=25% Similarity=0.399 Sum_probs=64.6
Q ss_pred CeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEee-cCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCC
Q 003288 38 EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVA-NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSE 116 (834)
Q Consensus 38 ~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~A-Nr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~ 116 (834)
+.+.+.+|.+.|-|-..|+ |-|.- -..++||.. +...... ..+.|.|..||||||.|..+.++|++.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEEc--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4555555888888887774 44432 235679999 4343332 3678999999999999999999999942 2
Q ss_pred CccceEEEec--CCcEEEEeCCCCCCCCceeeeecCCCC
Q 003288 117 VKNPVAQLRD--DGNLVIRDNSSGNATESYLWQSFDYPT 153 (834)
Q Consensus 117 ~~~~~a~Lld--sGNlVl~~~~~~~~~~~~lWqSFd~PT 153 (834)
.........+ .||++ .... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 2344455666 89998 6542 257898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00019 Score=74.52 Aligned_cols=73 Identities=12% Similarity=0.181 Sum_probs=47.5
Q ss_pred ceeccCCcE-eEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC---ceeeEeeeeeecC---eeEEEEEec
Q 003288 519 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQG---EKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~~ 591 (834)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 48875 345778875542 2345788999999988532 3444454433322 347899999
Q ss_pred CCCchh
Q 003288 592 PNKSLN 597 (834)
Q Consensus 592 ~~gsL~ 597 (834)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00044 Score=74.32 Aligned_cols=78 Identities=15% Similarity=0.137 Sum_probs=57.9
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC---CceeeEeeeeeec---CeeEEEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQ---GEKILILE 589 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~E 589 (834)
.-.+.||.|..+.||+....++ .+++|..+... ....|.+|+..|+.+.. ..+.++++++.+. +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346899999999999876555 46777754311 23578899999999853 3678888877543 56899999
Q ss_pred ecCCCch
Q 003288 590 YMPNKSL 596 (834)
Q Consensus 590 ~~~~gsL 596 (834)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00015 Score=69.26 Aligned_cols=129 Identities=19% Similarity=0.285 Sum_probs=90.1
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCcee-eEeeeeeecCeeEEEEEecCCC
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~g 594 (834)
...+.|++|.+|.||++.+ .|.++|+|.-+.. .....+..|+++|..++-.++- +++.|-.+ ++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 4457899999999999988 4568899986543 4457889999999999877764 45555332 3559999998
Q ss_pred chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC-CCcEEecCCCCceeecccccee
Q 003288 595 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik-p~NILl~~~~~~kl~DFGla~~ 664 (834)
.|.+.-... +- +-+..++..---|...+ |-|..|. |..++|-.+..+.|+||..|..
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 886664211 12 22334444444455555 9999986 5555555556999999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00037 Score=72.26 Aligned_cols=140 Identities=19% Similarity=0.251 Sum_probs=82.5
Q ss_pred ceeccCCcEeEEEEEecC--CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecCCCc
Q 003288 519 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
+.|..|-...+|+....+ ++.+++|........ .....+|+.++..+...++ +++++... -.++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888888999988754 678999977543222 1233578889998854333 44544332 248999999877
Q ss_pred hhhh-------h----------hccCCC--------ccCC-HHHHHHHHH----------------------HHHHHHHH
Q 003288 596 LNVF-------L----------FDSTKK--------RLLN-WQARVRIIE----------------------GIAQGLLY 627 (834)
Q Consensus 596 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~~ 627 (834)
+... + +..... .... ++.+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6322 0 110000 0111 122111111 11111111
Q ss_pred H----Hhc-CCCceeeCCCCCCcEEecC-CCCceeeccccce
Q 003288 628 L----HQY-SRFRIIHRDLKASNILLDK-DMNPKISDFGLAR 663 (834)
Q Consensus 628 L----H~~-~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~ 663 (834)
| ... ....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 111 2345999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00059 Score=67.54 Aligned_cols=125 Identities=24% Similarity=0.397 Sum_probs=90.8
Q ss_pred cCccccceeccCCc-EeEEEEEecCCcEEEEEEecCC------------C--h-------hhHHHHHHHHHHHHhcC---
Q 003288 513 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSNQ------------S--G-------QGLKEFKNEMMLIAKLQ--- 567 (834)
Q Consensus 513 ~~y~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~l~~~------------~--~-------~~~~~~~~E~~~l~~l~--- 567 (834)
.+++.++.||.|.- |.|||+++ +|+.+|+|.++.- . + .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 7889999994210 0 0 12235788999888885
Q ss_pred CCce--eeEeeeeeecC------------------eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHH
Q 003288 568 HRNL--VRLLGCCVEQG------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627 (834)
Q Consensus 568 h~ni--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 627 (834)
+.++ |+.+||..-.. ...+|.||.+... .+ ..+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4455 89999874221 1246777664422 11 22345677888899
Q ss_pred HHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 628 LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999975 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0004 Score=73.08 Aligned_cols=139 Identities=14% Similarity=0.097 Sum_probs=80.5
Q ss_pred eeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecCCCchhh
Q 003288 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKSLNV 598 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 598 (834)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456677788998874 577888987654332211235789999999864433 34444332 368999999877643
Q ss_pred h-----------------hhccC-CCccCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCceeeCCCCCCc
Q 003288 599 F-----------------LFDST-KKRLLNWQAR-VRIIEG---------IAQGLLYLHQY-----SRFRIIHRDLKASN 645 (834)
Q Consensus 599 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~~LH~~-----~~~~ivH~Dikp~N 645 (834)
- |+... ....++.... .....+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 0111222111 111111 11112222211 12358999999999
Q ss_pred EEecCCCCceeecccccee
Q 003288 646 ILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~ 664 (834)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0013 Score=72.84 Aligned_cols=74 Identities=14% Similarity=0.201 Sum_probs=54.5
Q ss_pred ceeccCCcEeEEEEEecCC-cEEEEEEecCC-----C--hhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCeeEEE
Q 003288 519 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 587 (834)
+.||.|.+..||++...+| +.++||.-... . +-..+.+..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998777 58999985321 1 224566778888888873 2456777766 44567899
Q ss_pred EEecCCC
Q 003288 588 LEYMPNK 594 (834)
Q Consensus 588 ~E~~~~g 594 (834)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0021 Score=69.11 Aligned_cols=142 Identities=18% Similarity=0.188 Sum_probs=86.2
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEeee------eeecCeeEEEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 589 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E 589 (834)
.+.|..|....+|+.... +..+++|+.... ..+....|+.++..+++.. +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456788888899998764 457888987642 2355677888888885433 4454432 123445689999
Q ss_pred ecCCCchhh----hh----------hccCC--------CccCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 003288 590 YMPNKSLNV----FL----------FDSTK--------KRLLNWQARV----------RIIEGIAQGLLYLHQY----SR 633 (834)
Q Consensus 590 ~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~~L~~LH~~----~~ 633 (834)
|++|..+.. .. +.... .....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 10000 0111221110 0111233444555431 12
Q ss_pred CceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 634 FRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 634 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0016 Score=70.29 Aligned_cols=140 Identities=26% Similarity=0.334 Sum_probs=84.3
Q ss_pred ceeccCCcEeEEEEEecC-------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~ 590 (834)
+.|..|--..+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899987654 57899999765432 23445788888888854333 355555432 368999
Q ss_pred cCCCchhhhh-----------------hccCCCc------cCC--HHHHHH--------------------------HHH
Q 003288 591 MPNKSLNVFL-----------------FDSTKKR------LLN--WQARVR--------------------------IIE 619 (834)
Q Consensus 591 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 619 (834)
++|..+.... +...... ..+ +..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 1110000 000 111111 111
Q ss_pred HHHHHHHHHHh------cCCCceeeCCCCCCcEEecCC----CCceeeccccce
Q 003288 620 GIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKD----MNPKISDFGLAR 663 (834)
Q Consensus 620 ~ia~~L~~LH~------~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~ 663 (834)
.+.+.+..|.. .....++|+|+.+.|||++++ +.++|+||+.+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134569999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0015 Score=78.50 Aligned_cols=199 Identities=18% Similarity=0.193 Sum_probs=136.3
Q ss_pred HHHHHHHHHHHhcCCCceeeEeeeeeecCeeE----EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH
Q 003288 554 KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629 (834)
Q Consensus 554 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 629 (834)
.....|...+.+++|+|+++++.|-.+....- +..|++..-++...+ ..-..++......+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34456777888899999999999877654332 445677777777766 33345788888889999999999999
Q ss_pred hcCCCceeeCCCCCC---cEEecCCCCceee--ccccceecCCCcccCCcccccccccccCcccccCCCCCc--cCcchh
Q 003288 630 QYSRFRIIHRDLKAS---NILLDKDMNPKIS--DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFS 702 (834)
Q Consensus 630 ~~~~~~ivH~Dikp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDVws 702 (834)
+.. ..|.-+..+ +.-.+.++...+. ||+.++.+...... ....-+..+.+||......++. ..|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 985 555555544 4555666677777 88888766543211 1123455778888777665544 479999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003288 703 FGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 782 (834)
Q Consensus 703 lGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 782 (834)
+|..+..+..|..+...... ...+++.. ....+.+...+|+..++++|++..++
T Consensus 378 lgll~~~~~~~~~i~~~~~~-----------------~~~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV-----------------PVSLLDVL---------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccc-----------------hhhhhccc---------cchhhhhhhhhhcchhhhhccchhhh
Confidence 99999999988766432110 00111100 00145667789999999999999999
Q ss_pred HHHHh
Q 003288 783 ISMIN 787 (834)
Q Consensus 783 l~~L~ 787 (834)
+.+.-
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 88753
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00074 Score=50.02 Aligned_cols=45 Identities=38% Similarity=0.685 Sum_probs=33.8
Q ss_pred cCCCCCCCCCCccccccccCCCCCCCCC-CccccccceeeccccCC
Q 003288 790 HLNLPSPKEPAFTKGINVKNSSHSNSGT-SEHCSVNDVTVSLIYPR 834 (834)
Q Consensus 790 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 834 (834)
...||.||+|+|+.++.......+.+.+ ...+++|++|+|.|++|
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4689999999999876655333222222 37889999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0058 Score=67.14 Aligned_cols=141 Identities=18% Similarity=0.251 Sum_probs=83.7
Q ss_pred ceeccCCcEeEEEEEecC-----CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecC
Q 003288 519 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~ 592 (834)
+.|-.|-.-.+|+....+ ++.|++|..........++ .+|..+++.+...++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456557777899987532 3679999886654433333 779999999865444 3556655332 5899998
Q ss_pred CCchhhh-----------------hhccC-C--CccCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 003288 593 NKSLNVF-----------------LFDST-K--KRLLNWQARVRIIEGI-----------------AQGLLYL----HQ- 630 (834)
Q Consensus 593 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------a~~L~~L----H~- 630 (834)
+.+|... ++... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776422 01100 0 0011223332332211 1112222 21
Q ss_pred cCCCceeeCCCCCCcEEecC-CCCceeecccccee
Q 003288 631 YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 664 (834)
Q Consensus 631 ~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~ 664 (834)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346999999999999986 46899999988763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.011 Score=64.43 Aligned_cols=141 Identities=19% Similarity=0.215 Sum_probs=77.6
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEee------eeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E~ 590 (834)
+.|+.|....+|+....+| .+++|++.... .+....|+.++..|.... +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567777788999876555 68899876222 233445666666663222 333332 11234567899999
Q ss_pred cCCCchhh-----h------h---hccCC--------CccC-CHHHHHH------------HH-HHHHHHHHHHHhc---
Q 003288 591 MPNKSLNV-----F------L---FDSTK--------KRLL-NWQARVR------------II-EGIAQGLLYLHQY--- 631 (834)
Q Consensus 591 ~~~gsL~~-----~------l---~~~~~--------~~~l-~~~~~~~------------i~-~~ia~~L~~LH~~--- 631 (834)
++|..+.. . | +.... ...+ .|..... .+ ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 1 11000 0011 1111111 11 1111222333211
Q ss_pred -CCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 632 -SRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 632 -~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
-...+||+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12359999999999999976556899999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0086 Score=64.08 Aligned_cols=138 Identities=19% Similarity=0.272 Sum_probs=85.4
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEEecC--CChhhHHHHHHHHHHHHhcCC--CceeeEeeeeeecC--eeEEEEEe
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG--EKILILEY 590 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~ 590 (834)
+.+.+..|..-.+|.... .++++++. ... ..........+|+.+|+.+.- .-+.+.+++|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 344453343334555444 37788888 331 223344556788888888743 33456677777766 67999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHH-HHHHHHHHHHHh---------------------------------------
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQ--------------------------------------- 630 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~--------------------------------------- 630 (834)
.++..+...+.... .. -+.+ ..+++.|+-||+
T Consensus 107 veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 98854433221100 00 0111 244444444443
Q ss_pred -----------c-----CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 631 -----------Y-----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----------~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+ ++..++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1 345699999999999999988899999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0017 Score=67.90 Aligned_cols=145 Identities=14% Similarity=0.160 Sum_probs=99.1
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC-----------------Chhh-----HHHHHHHHH
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----------------SGQG-----LKEFKNEMM 561 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~-----------------~~~~-----~~~~~~E~~ 561 (834)
.+.++..-..-+.+.++||-|--+-||.+...+|++.++|.-+-. .... .-...+|..
T Consensus 83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 83 ALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred HHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 344444434457788999999999999999989999999953110 0000 112356888
Q ss_pred HHHhcCC--CceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeC
Q 003288 562 LIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 639 (834)
Q Consensus 562 ~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 639 (834)
.|+.|.. =-+.+.+++ +..++|||++.+-.|...-+ ..+.. .+...+..-+.-|..+| +||+
T Consensus 163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G---lIHg 226 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG---LIHG 226 (465)
T ss_pred HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC---ceec
Confidence 8888843 224455544 45689999999888755431 12222 34444555556677777 9999
Q ss_pred CCCCCcEEecCCCCceeecccccee
Q 003288 640 DLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 640 Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
|..-=||+++++..++++||--...
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999975443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.022 Score=61.56 Aligned_cols=143 Identities=20% Similarity=0.217 Sum_probs=82.6
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEeeee------eecCeeEEEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCC------VEQGEKILILE 589 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~E 589 (834)
.+.++.|.-..+|+....++ .+++|+..... ..+....|++++..|.... +.+.+... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876444 67789875432 1234456777777774322 34444321 22456789999
Q ss_pred ecCCCchhhh--------------hhccCCC---------ccCCHHHHH------------HHHHHHHHHHHHHHh----
Q 003288 590 YMPNKSLNVF--------------LFDSTKK---------RLLNWQARV------------RIIEGIAQGLLYLHQ---- 630 (834)
Q Consensus 590 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~L~~LH~---- 630 (834)
|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 1110000 001111110 011123344555543
Q ss_pred cCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 631 ~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.-...++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.015 Score=61.80 Aligned_cols=31 Identities=29% Similarity=0.538 Sum_probs=25.8
Q ss_pred CceeeCCCCCCcEEecCCCC-ceeecccccee
Q 003288 634 FRIIHRDLKASNILLDKDMN-PKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dikp~NILl~~~~~-~kl~DFGla~~ 664 (834)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.009 Score=63.49 Aligned_cols=75 Identities=17% Similarity=0.222 Sum_probs=49.7
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCeeEEEEEecC
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. -..+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678989999999987 578899999875 334467888999998884 3457788888887778899999998
Q ss_pred CC
Q 003288 593 NK 594 (834)
Q Consensus 593 ~g 594 (834)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0017 Score=53.70 Aligned_cols=35 Identities=26% Similarity=0.592 Sum_probs=30.1
Q ss_pred cCChHHHHHHHhhcCCceeeecccccCCcceeeeccc
Q 003288 361 RMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 397 (834)
Q Consensus 361 ~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~~~ 397 (834)
..+.++|++.|+.+|+|.||.|. .+...|+++.+.
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~--~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYN--TKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEE--CCCCeEEcccCC
Confidence 46899999999999999999997 346789998764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.028 Score=60.09 Aligned_cols=143 Identities=18% Similarity=0.207 Sum_probs=97.1
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCC-------C-----------------h-hhHH-HHHHHHHHHHhcCCC
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-------S-----------------G-QGLK-EFKNEMMLIAKLQHR 569 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~-------~-----------------~-~~~~-~~~~E~~~l~~l~h~ 569 (834)
.+...|..|--+.||.+.-.+|..+|||+++.. . + .-.+ -...|++-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344578899999999999989999999987421 0 0 0000 124577778877654
Q ss_pred ceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec
Q 003288 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (834)
Q Consensus 570 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~ 649 (834)
.|..---... ...+|||+|+.... +-.-.-+...++...+..+-.|+++-|.-|.+.+ ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4321111111 23479999996322 2111223445777788888899999999999888 599999999999985
Q ss_pred CCCCceeeccccceecC
Q 003288 650 KDMNPKISDFGLARMFG 666 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~ 666 (834)
+|.+.|+|-+-+....
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 4689999988776543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0084 Score=60.97 Aligned_cols=123 Identities=20% Similarity=0.257 Sum_probs=61.2
Q ss_pred CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecCCCchhhhh---------------
Q 003288 537 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKSLNVFL--------------- 600 (834)
Q Consensus 537 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~l--------------- 600 (834)
.+.|+||+.....+ ..-.-.+|..+++.+...++ .++++++..+ .|+||+++..|..--
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 46788888866633 33455789999998865444 4566654333 577999776653311
Q ss_pred --hc--c--CCCccCCHHHHHHH----------------------HHHHHHHHHHHH----hc-CCCceeeCCCCCCcEE
Q 003288 601 --FD--S--TKKRLLNWQARVRI----------------------IEGIAQGLLYLH----QY-SRFRIIHRDLKASNIL 647 (834)
Q Consensus 601 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~~L~~LH----~~-~~~~ivH~Dikp~NIL 647 (834)
+. . .....-.+..+.++ ...+.+-+..+. .. ....++|+|+.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 00000011111111 011111122221 11 1235899999999999
Q ss_pred e-cCCCCceeecccccee
Q 003288 648 L-DKDMNPKISDFGLARM 664 (834)
Q Consensus 648 l-~~~~~~kl~DFGla~~ 664 (834)
+ +.++.++|+||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.036 Score=60.60 Aligned_cols=141 Identities=16% Similarity=0.258 Sum_probs=81.3
Q ss_pred ceeccCCcEeEEEEEecC----CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~ 593 (834)
+.|..|---.+|+....+ +..|++|+.....+... .-.+|..+++.+...++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456557777889886543 23789998865543322 23679999999866555 45666553 22 58999987
Q ss_pred Cchhhh-------h----------hccC-C-Cc-cCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 003288 594 KSLNVF-------L----------FDST-K-KR-LLNWQARVRIIEGI----------------------AQGLLYLH-- 629 (834)
Q Consensus 594 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~L~~LH-- 629 (834)
..|..- + +... . .. .--+..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1100 0 00 11122222222211 11111111
Q ss_pred --h-cCCCceeeCCCCCCcEEecC-CCCceeecccccee
Q 003288 630 --Q-YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 664 (834)
Q Consensus 630 --~-~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~ 664 (834)
. .....++|+|+.+.|||+++ ++.++++||+.|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11235899999999999975 57899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.068 Score=59.17 Aligned_cols=73 Identities=10% Similarity=0.058 Sum_probs=50.5
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCC-----C--hhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCeeEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 587 (834)
.+.||.|....||+... .++.++||+-... . +....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 4567999976421 1 113334445566776653 247788888876 446788
Q ss_pred EEecCC
Q 003288 588 LEYMPN 593 (834)
Q Consensus 588 ~E~~~~ 593 (834)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.091 Score=57.15 Aligned_cols=79 Identities=15% Similarity=0.167 Sum_probs=50.6
Q ss_pred eeccCCcEeEEEEEecCC-cEEEEEEecC-------CChhhHHHHHHHHHHHHhcC--CC-ceeeEeeeeeecCeeEEEE
Q 003288 520 KLGEGGFGPVYKGRLLNG-QEVAVKRLSN-------QSGQGLKEFKNEMMLIAKLQ--HR-NLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 588 (834)
.||.|....||++...+| +.|+||.-.. .-+-..++..-|...|.... -| .+.+++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998654 6899997532 11223445556777776653 24 3445543 3556677999
Q ss_pred EecCC-Cchhhhh
Q 003288 589 EYMPN-KSLNVFL 600 (834)
Q Consensus 589 E~~~~-gsL~~~l 600 (834)
|+++. ..|+..|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 834 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 834 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-132 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-131 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-117 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-92 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-80 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-63 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-61 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-61 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-58 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-57 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-57 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-56 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-56 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-56 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-53 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-50 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-50 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-50 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-50 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-49 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-47 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 7e-47 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-46 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-46 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-46 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-46 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-46 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-46 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-46 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-46 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-46 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 6e-46 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-46 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-46 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 9e-46 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-45 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-45 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-45 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-45 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-45 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-45 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-45 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-45 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-45 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-45 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-44 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-44 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-44 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-44 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-44 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-44 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 6e-44 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-43 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-43 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-43 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-43 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-43 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-43 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-43 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-43 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-43 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-42 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-42 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-42 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-42 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-41 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-41 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-40 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-40 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-40 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 9e-40 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-39 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-39 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-38 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-38 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-37 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-35 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-34 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-34 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-34 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-33 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-32 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-32 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-31 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-31 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-31 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-31 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-30 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-30 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-30 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-29 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-29 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-28 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-28 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-28 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-28 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-28 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-28 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-28 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-28 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-27 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-27 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-27 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-26 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-26 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-26 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-26 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-26 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-26 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-26 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-26 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-25 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-25 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-25 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-25 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-25 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-25 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-25 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-25 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-24 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-24 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-24 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-24 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-23 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-23 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-23 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-22 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 9e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-20 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-17 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 9e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-16 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-16 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-16 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 8e-16 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-15 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-14 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-13 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 2e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-12 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 2e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-12 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-11 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 3e-11 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 5e-06 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-11 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 7e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-11 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 9e-11 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 7e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-10 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 2e-10 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 7e-10 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-10 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-09 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 2e-08 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 1e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 5e-08 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 1e-04 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 1e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-05 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 7e-07 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 1e-04 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 8e-07 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 3e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 5e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-05 | |
| 2hz6_A | 369 | Endoplasmic reticulum to nucleus signalling 1 isof | 7e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-132
Identities = 101/299 (33%), Positives = 154/299 (51%), Gaps = 19/299 (6%)
Query: 500 LPLFSLASITAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 549
FS + T NF + K+GEGGFG VYKG + N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 550 GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL 609
+ ++F E+ ++AK QH NLV LLG + + L+ YMPN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729
T +IVGT YM+PE L G + KSD++SFG+++LE ++ + + LL
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLD 245
Query: 730 HAWDLWKDDR-VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
++ +++ + D ID + ++ + +VA C+ E RP + V ++
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-131
Identities = 115/298 (38%), Positives = 175/298 (58%), Gaps = 7/298 (2%)
Query: 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFK 557
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG + +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVR 616
E+ +I+ HRNL+RL G C+ E++L+ YM N S+ L + + + L+W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 676
I G A+GL YLH + +IIHRD+KA+NILLD++ + DFGLA++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 194
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT---GVYNADSFNLLGHAWD 733
+ GT G+++PEY G S K+DVF +G+++LE ++ ++ + N D LL
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791
L K+ ++ L+D +Q + + I VALLC Q + +RP MS+V+ M+ + L
Sbjct: 255 LLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-117
Identities = 102/286 (35%), Positives = 169/286 (59%), Gaps = 6/286 (2%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVRIIEGI 621
++ +H +LV L+G C E+ E ILI +YM N +L L+ S + ++W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN-ADSFNLLGHAWDLWKDDRV 740
GY+ PEY + G + KSDV+SFG+++ E L ++ + NL A + + ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
++DP + D+I L ++ + A+ C+ ++ DRP+M DV+ +
Sbjct: 266 EQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 4e-92
Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 32/310 (10%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 563 IAKLQHRNLVRLLGCCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
+ ++H N+++ +G + LI + SL+ FL K +++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 619 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671
E +A+GL YLH+ + I HRD+K+ N+LL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 672 GNTKQIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 726
G+T VGT YM+PE + ++ D+++ G+++ E S +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245
Query: 727 LLGHAWDLWKDDR--------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 778
+L ++ + VH PV+ + C +A R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 779 MSDVISMINN 788
V I
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 3e-80
Identities = 72/334 (21%), Positives = 129/334 (38%), Gaps = 41/334 (12%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 563 IAKLQHRNLVRLLGCCVE-----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 617
+ ++H N+ R + + E +L++EY PN SL +L +W + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 618 IEGIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG---- 667
+ +GL YLH + + I HRDL + N+L+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 668 --DELQGNTKQIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSSKKNT 717
E VGT YM+PE L+G ++ + D+++ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 718 GVYNADSFNLLGHAWDLWKDDRVHDLID--------PVIMQDEISLPMLMRYI-NVALLC 768
+ + ++ D+ P + + +R + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 769 VQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 802
++A R T + + K + T
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-64
Identities = 74/295 (25%), Positives = 137/295 (46%), Gaps = 28/295 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V +G + ++ EY+ SL L S + L+ + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 691 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
D + KSDV+SFG+++ E + ++ W + ++ V +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ------------------PWGNLNPAQVVAAVGFK 254
Query: 751 D---EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN-EHLNLPSPKEPAF 801
EI + + + C RP+ + ++ ++ +P P
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-63
Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 27/289 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+ L++EY SL L + + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 633 RFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
+S K DVFS+GI++ E ++ +K ++ W + R P ++++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR------PPLIKN 228
Query: 752 -EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEP 799
+ LM C ++ + RP+M +++ ++ + P EP
Sbjct: 229 LPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-61
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 44/300 (14%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+ I EY+ +L + W RV + IA G+ YLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQ------------GNTKQIVGTYGYMSP 686
RDL + N L+ ++ N ++DFGLAR+ ++ Q +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
E + K DVFSFGI++ E + +A + +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIG---------------RVNADPDYLPRTM-----D 231
Query: 747 VIMQDEISLPMLM------RYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 800
+ L + + + C + RP+ + + ++L
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-60
Identities = 77/283 (27%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
+G GGFG VY+ G EVAVK Q ++ + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G C+++ L++E+ LN L + + V IA+G+ YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 636 IIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
IIHRDLK+SNIL+ + + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-LWKDDRVHDLIDP 746
+FS SDV+S+G+L+ E L+ + + + L A+
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLA------L 233
Query: 747 VIMQD-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
I LM C + RP+ ++++ +
Sbjct: 234 PIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-58
Identities = 70/295 (23%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 564
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
L H N+V+L G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ Y+ I+HRDL++ NI L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 680 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSK---KNTGVYNADSFNLLGHAWDL 734
+ +M+PE A + ++ K+D +SF +++ L+ + N++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---- 244
Query: 735 WKDDRVHDLIDPVIMQD-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ R P I +D L ++ LC + RP S ++ ++
Sbjct: 245 -EGLR------PTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 30/284 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
++ +G I + ++ SL L + + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 687
S IIHRDLK++NI L +D KI DFGLA +Q+ G+ +M+PE
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
+S +SDV++FGI++ E ++ + + + N D + +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSL------- 243
Query: 747 VIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMINN 788
D + R + C+++ +RP+ +++ I
Sbjct: 244 --SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-57
Identities = 56/287 (19%), Positives = 114/287 (39%), Gaps = 40/287 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 570
+ + KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 571 LVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++ +LG C I +MP SL L + T + + V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H I L + ++++D+DM +IS + F + + +++PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 689 ALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
AL +D++SF +L+ E ++ + + D ++
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPFADLSNMEIG 220
Query: 745 DPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
V ++ I + + +C+ E+ A RP ++ ++
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 7e-57
Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 32/301 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 569
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 570 NLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
N++ + + LI Y SL +L + L+ + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 626 LYLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 678
+LH I HRDLK+ NIL+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 679 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS---FNLLG 729
GT YM+PE + D+++FG+++ E + G+ ++++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 730 H--AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+ +++ + D P I S P L + C +N + R T + +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 788 N 788
Sbjct: 299 K 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-56
Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
C+ +I ++L + D K +L+ +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 638 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---VGTYGYMSPE------- 687
H+DLK+ N+ D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
FS SDVF+ G + E + + W + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELH-----AREWPFKTQPAEAIIWQMGTGMK------ 260
Query: 746 PVIMQDEISLPM--LMRYINVALLCVQENAADRPTMSDVISMINN 788
P + Q + + ++ + C +RPT + ++ M+
Sbjct: 261 PNLSQIGMGKEISDILLF------CWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-56
Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 34/301 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 570
+ M ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 571 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
++ + ++ LI +Y N SL +L K L+ ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVG 679
+LH I HRDLK+ NIL+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 680 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSKKNTGV---YNADSFNLLG 729
T YM PE LD I +D++SFG+++ E + G+ Y +L+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 730 H--AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+++ ++ + P S L + + C N A R T V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 788 N 788
Sbjct: 328 K 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-53
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 34/297 (11%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 574
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 575 LGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 631 YSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGY 683
I HRDLK+ NIL+ K+ I+D GLA D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 684 MSPEYALDGL-------FSIKSDVFSFGILMLETLSSKKNTGV---YNADSFNLLGH--A 731
M+PE LD ++D+++ G++ E G+ Y ++L+ +
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ + + P I S L + C N A R T + ++
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 677
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 124 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWK 736
+ + +PE + FS+ SDV+SFG+++ E + + + A+ ++G+
Sbjct: 181 I---FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 737 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ +L+ P DEI M+M C N RP+ D+ ++
Sbjct: 238 VFHLIELLKNNGRLPRPDGCPDEIY--MIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-50
Identities = 88/326 (26%), Positives = 147/326 (45%), Gaps = 44/326 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
+V+ G G + L++EY+P+ L FL RLL + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+G+ YL SR R +HRDL A NIL++ + + KI+DFGLA++ D+ +V
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREP 189
Query: 682 G-----YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736
G + +PE D +FS +SDV+SFG+++ E + + +A+ ++G D+
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 737 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789
R+ +L++ P E+ LM LC + DRP+ S + ++
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVH--ELM------KLCWAPSPQDRPSFSALGPQLDML 301
Query: 790 HLNLPSPKEPAFTKGINVKNSSHSNS 815
+ AFT K+ S S S
Sbjct: 302 WSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-50
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 44/289 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 570
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+VRL+G C ++ +++E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEY 688
IHRDL A N L+ + KISDFG++R G +Q+ + +PE
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLID- 745
G +S +SDV+SFGIL+ ET S + + N + ++
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TREFVEK 330
Query: 746 ------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
P + D + M C RP+ S + + +
Sbjct: 331 GGRLPCPELCPDAVFRLMEQ--------CWAYEPGQRPSFSTIYQELQS 371
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-50
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 568 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 621
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 677
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 155 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWK 736
+ + +PE + FS+ SDV+SFG+++ E + + + A+ ++G+
Sbjct: 212 I---FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 737 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ +L+ P DEI M+M C N RP+ D+ ++
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIY--MIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 567 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
H ++++ GCC + G L++EY+P SL +L + + + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGT 680
+ YLH ++ IHRDL A N+LLD D KI DFGLA+ ++ + V
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740
+ +PE + F SDV+SFG+ + E L+ ++ L+G A R+
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 741 HDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+L++ P E+ LM C + A+ RPT ++I ++
Sbjct: 261 TELLERGERLPRPDKCPAEVY--HLM------KNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-49
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 567 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEG 620
H N+V+ G C E G LI+E++P+ SL +L + K+ L +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQ 676
I +G+ YL + +HRDL A N+L++ + KI DFGL + D+ ++ +
Sbjct: 135 ICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736
V + +PE + F I SDV+SFG+ + E L+ + A ++G
Sbjct: 192 PV---FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 737 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
R+ + + P DE+ LM C + ++R + ++I
Sbjct: 249 VTRLVNTLKEGKRLPCPPNCPDEVY--QLM------RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-47
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 55/310 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQA 613
QH ++V+ G C + I++ EYM + LN FL K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 670
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLL 728
G+T + +M PE + F+ +SDV+SFG+++ E + K + N + +
Sbjct: 192 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 729 GHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
L + V+D +M C Q R + ++
Sbjct: 249 TQGRVLERPRVCPKEVYD-----VMLG----------------CWQREPQQRLNIKEIYK 287
Query: 785 MINNEHLNLP 794
+++ P
Sbjct: 288 ILHALGKATP 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 84/326 (25%), Positives = 141/326 (43%), Gaps = 51/326 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 566
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 567 QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDS---TKKRLLNWQARVRI 617
H ++ +L+G + K +IL +M + L+ FL S L Q VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAW 732
K V +++ E D L+++ SDV++FG+ M E T G+ NA+ +N L
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 733 DLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
L + + V+D +M C + RP+ + + + N
Sbjct: 257 RLKQPPECMEEVYD-----LMYQ----------------CWSADPKQRPSFTCLRMELEN 295
Query: 789 EHLNLPSPKEPAFTKGINVKNSSHSN 814
+L IN++ + H +
Sbjct: 296 ILGHLSVLSTSQDPLYINIERAHHHH 321
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L+ +L T++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+IHRDL A N L+ ++ K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV+SFG+LM E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 57/297 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHA 731
M+ E L +++ +SDV+S+G+ + E ++ SK G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232
Query: 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
++ L P I ++ M+M C +A RP ++I +
Sbjct: 233 ------EKGERLPQPPICTIDVY--MIM------RKCWMIDADSRPKFRELIIEFSK 275
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 573 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + I EYM SL +L S + +L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 685
+HRDL A N+L+ +D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE + FS KSDV+SFGIL+ E S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 56/305 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQ 612
LQH N+V LLG + +I Y + L+ FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--E 669
V ++ IA G+ YL S ++H+DL N+L+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 727
L GN+ + +M+PE + G FSI SD++S+G+++ E + + G N D +
Sbjct: 186 LLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 728 LGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783
+ + L V+ L M+ C E + RP D+
Sbjct: 243 IRNRQVLPCPDDCPAWVYAL-------------MIE--------CWNEFPSRRPRFKDIH 281
Query: 784 SMINN 788
S +
Sbjct: 282 SRLRA 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 50/305 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 566
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 567 QHRNLVRLLGCCVEQG-----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRII 618
H N++RLLG C+E + ++IL +M L+ +L S T + + Q ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 733
V +++ E D +++ KSDV++FG+ M E T GV N + ++ L H
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 734 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789
L + D +++ IM C + + DRPT S + +
Sbjct: 268 LKQPEDCLDELYE-----IMYS----------------CWRTDPLDRPTFSVLRLQLEKL 306
Query: 790 HLNLP 794
+LP
Sbjct: 307 LESLP 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 54/303 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQAR 614
QH+++VR G C E +++ EYM + LN FL + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + +A G++YL + +HRDL N L+ + + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLG 729
G T + +M PE L F+ +SDV+SFG+++ E T + + N ++ + +
Sbjct: 218 GRTMLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 730 HAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785
+L + V+ + M C Q R ++ DV +
Sbjct: 275 QGRELERPRACPPEVYAI-------------MRG--------CWQREPQQRHSIKDVHAR 313
Query: 786 INN 788
+
Sbjct: 314 LQA 316
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-46
Identities = 83/329 (25%), Positives = 139/329 (42%), Gaps = 73/329 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 620
+ +H+N++ LLG C + G +I+EY +L +L + R+ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYN 721
+ T G +M+PE D +++ +SDV+SFG+LM E TL G+
Sbjct: 212 YYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 722 ADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 777
+ F LL + K + ++ + M C + RP
Sbjct: 266 EELFKLLKEGHRMDKPANCTNELYMM-------------MRD--------CWHAVPSQRP 304
Query: 778 TMSDVISMI--------NNEHLNLPSPKE 798
T ++ + N E+L+L P E
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ IHRDL A N L+D+D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV++FGILM E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 50/300 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
E +M +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------FDSTKKRLLNWQARVRII 618
++VRLLG + ++I+E M L +L ++ + +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHA 731
V +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N + G
Sbjct: 202 LPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 732 WDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789
D + D + +L M M C Q N RP+ ++IS I E
Sbjct: 259 LDKPDNCPDMLFEL-------------MRM--------CWQYNPKMRPSFLEIISSIKEE 297
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-46
Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 55/314 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 621
H+N+VR +G ++ + +++E M L FL ++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 733
V +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 207 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 734 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--- 786
+ V+ + M C Q DRP + ++ I
Sbjct: 264 MDPPKNCPGPVYRI-------------MTQ--------CWQHQPEDRPNFAIILERIEYC 302
Query: 787 --NNEHLNLPSPKE 798
+ + +N P E
Sbjct: 303 TQDPDVINTALPIE 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
FS KSD+++FG+LM E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-46
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 692 GLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
FS KSDV+SFGIL+ E S + + D + ++ + + P
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGC 411
Query: 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ +M+ C +AA RPT + + +
Sbjct: 412 PPAVY--DVMKN------CWHLDAATRPTFLQLREQLEH 442
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-46
Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYA 689
+ IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWK----DDRVHDL 743
FSIKSDV++FG+L+ E + + G+ + + LL + + + ++V++L
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244
Query: 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
M C Q N +DRP+ +++
Sbjct: 245 -------------MRA--------CWQWNPSDRPSFAEIHQAFET 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 520 KLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 575 LGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+G + + L YM + L F+ +R + + +A+G+ YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E + + + + E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPVKWTALES 199
Query: 689 ALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK----DDRVHD 742
F+ KSDV+SFG+L+ E T + + D + L L + D ++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259
Query: 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--------NNEHLNLP 794
+ M C + + A RPT ++ + + ++ LP
Sbjct: 260 V-------------MQQ--------CWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 79/314 (25%), Positives = 127/314 (40%), Gaps = 55/314 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 621
H+N+VR +G ++ + ++LE M L FL ++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 733
V +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 248 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 734 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--- 786
+ V+ + M C Q DRP + ++ I
Sbjct: 305 MDPPKNCPGPVYRI-------------MTQ--------CWQHQPEDRPNFAIILERIEYC 343
Query: 787 --NNEHLNLPSPKE 798
+ + +N P E
Sbjct: 344 TQDPDVINTALPIE 357
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-45
Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L ++ ++ + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+ IHR+L A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 692 GLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
FSIKSDV++FG+L+ E + + G+ + + LL ++ + + P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPEGC 444
Query: 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+++ LM C Q N +DRP+ +++
Sbjct: 445 PEKVY--ELM------RACWQWNPSDRPSFAEIHQAF 473
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL ++ I I EYM N SL FL + L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + K + + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 82/305 (26%), Positives = 137/305 (44%), Gaps = 61/305 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 614
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 675 KQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 727
G +M+ E +++ SDV+S+G+L+ E +L G+ A+ +
Sbjct: 200 M------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 728 LGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783
L + L K DD V+D +M+ C +E +RP+ + ++
Sbjct: 254 LPQGYRLEKPLNCDDEVYD-----LMRQ----------------CWREKPYERPSFAQIL 292
Query: 784 SMINN 788
+N
Sbjct: 293 VSLNR 297
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 83/379 (21%), Positives = 154/379 (40%), Gaps = 77/379 (20%)
Query: 446 VFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFS 504
+ RR+ + + ++ + L+ ++ T T + + + W P
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-EYELPEDPKWEFPR-- 80
Query: 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKE 555
+ ++ LGEG FG V + VAVK L + + + L +
Sbjct: 81 --------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 556 FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------F 601
+EM ++ + +H+N++ LLG C + G +I+EY +L +L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 602 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ + + ++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 662 AR-MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSS 713
AR + D + T G +M+PE D +++ +SDV+SFG+LM E TL
Sbjct: 250 ARDINNIDYYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 714 KKNTGVYNADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCV 769
G+ + F LL + K + ++ + M C
Sbjct: 304 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMM-------------MRD--------CW 342
Query: 770 QENAADRPTMSDVISMINN 788
+ RPT ++ ++
Sbjct: 343 HAVPSQRPTFKQLVEDLDR 361
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ L +L YM + L F+ + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPE 687
+ +HRDL A N +LD+ K++DFGLAR D + G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWK----DDRVH 741
F+ KSDV+SFG+L+ E ++ V D L L + D ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262
Query: 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793
++ M C A RP+ S+++S I+
Sbjct: 263 EV-----MLK----------------CWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 566
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
H ++VRLLG C ++ + +Y+P SL + + LLNW IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL ++HR+L A N+LL +++DFG+A + D+ KQ++ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEA 177
Query: 683 -----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+ E G ++ +SDV+S+G+ + E ++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G +++ EYM N SL+ FL T V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 683
L S +HRDL A N+L+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE FS SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-45
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 70/316 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 604
+ H ++++L G C + G +LI+EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+R L + I+QG+ YL + +++HRDL A NIL+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 664 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKN 716
++ D ++ G +M+ E D +++ +SDV+SFG+L+ E TL
Sbjct: 200 VYEEDSYVKRSQ------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 717 TGVYNADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQEN 772
G+ FNLL + + + ++ +M C ++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYR-----LMLQ----------------CWKQE 292
Query: 773 AADRPTMSDVISMINN 788
RP +D+ +
Sbjct: 293 PDKRPVFADISKDLEK 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-44
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 690
+ IHRDL+A+NIL+ + KI+DFGLAR+ +E + K + + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAIN 358
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL++E ++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H N++RL G + ++I EYM N +L+ FL K + V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 682
YL + +HRDL A NIL++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE F+ SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 85/328 (25%), Positives = 145/328 (44%), Gaps = 71/328 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 622
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHA 731
M+ E L +++ +SDV+S+G+ + E ++ SK G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232
Query: 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI----- 786
++ L P I ++ M+M + C +A RP ++I
Sbjct: 233 ------EKGERLPQPPICTIDVY--MIM------VKCWMIDADSRPKFRELIIEFSKMAR 278
Query: 787 ---------NNEHLNLPSPKEPAFTKGI 805
+E ++LPSP + F + +
Sbjct: 279 DPQRYLVIQGDERMHLPSPTDSNFYRAL 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-44
Identities = 74/291 (25%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ L +L YM + L F+ + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E T +M+ E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN---KTGAKLPVKWMALES 267
Query: 689 ALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK----DDRVHD 742
F+ KSDV+SFG+L+ E T + V D L L + D +++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327
Query: 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793
+ ML C A RP+ S+++S I+
Sbjct: 328 V-------------MLK--------CWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 75/301 (24%), Positives = 116/301 (38%), Gaps = 54/301 (17%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 573 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
RL+G C Q E +++ +E L+ FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 685
+HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLI 744
PE FS +SDV+S+G+ M E LS G + K V I
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFI 226
Query: 745 D-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 797
+ P E+ LM C DRP V + + +L S
Sbjct: 227 EQGKRMECPPECPPELY--ALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 798 E 798
E
Sbjct: 279 E 279
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-44
Identities = 82/324 (25%), Positives = 137/324 (42%), Gaps = 66/324 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 620
+ +H+N++ LLG C + G +I+EY +L +L L E
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYN 721
+ T G +M+PE D +++ +SDV+SFG+L+ E TL GV
Sbjct: 246 YYKKTTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 722 ADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 777
+ F LL + K + ++ + M C + RP
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMM-------------MRD--------CWHAVPSQRP 338
Query: 778 TMSDVISMINNEHLNLPSPKEPAF 801
T ++ ++ + L S +E +
Sbjct: 339 TFKQLVEDLDRI-VALTSNQEMGY 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-44
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 604
+ N+V+LLG C L+ EYM LN FL S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 605 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
L+ ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 664 MFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ D + GN + +M PE ++ +SDV+++G+++ E S
Sbjct: 224 IYSADYYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 565
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 566 L-QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG--- 620
+ H N+V LLG C + G + +I+E+ +L+ +L + + A + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 621 ----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE 669
+A+G+ +L + + IHRDL A NILL + KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 670 LQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 204 YVRKGD------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-43
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 693 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
F+IKSDV+SFGIL+ E T G+ N + + + +R + + P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 407
Query: 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ + LM C ++ +RPT + + + +
Sbjct: 408 ESLH--DLM------CQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-43
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 693 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
F+IKSDV+SFGIL+ E T G+ N + + + +R + + P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 490
Query: 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ + LM C ++ +RPT + + + +
Sbjct: 491 ESLH--DLM------CQCWRKEPEERPTFEYLQAFLED 520
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 63/302 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 564
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
KL H++LV G CV E IL+ E++ SL+ +L K +N ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQ 676
+ +L +IH ++ A NILL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 677 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLL 728
+ PE + ++ +D +SFG + E S + + +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 729 --GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
H K + +L + C+ RP+ +I +
Sbjct: 232 EDRHQLPAPKAAELANL-------------INN--------CMDYEPDHRPSFRAIIRDL 270
Query: 787 NN 788
N+
Sbjct: 271 NS 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-43
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G + +++ EYM N SL+ FL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 683
L S +HRDL A NIL++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
SPE F+ SDV+S+GI++ E +S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ FG+ M E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
L H N+V LLG C G ++I EY L FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 668
+A+G+ +L + IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 669 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 520 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 574
+LG G FG V KG + VAVK L E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+G C + E L++E LN +L + R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEYA 689
+HRDL A N+LL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L HRNL+RL G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YG 682
YL R IHRDL A N+LL KI DFGL R ++ ++ +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E+ I I+E P L +L K L V I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L +HRD+ NIL+ K+ DFGL+R ++ T+ + +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMS 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ F + M E LS
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTKKRLLNWQA 613
L QH N+V LLG C G ++I EY L FL + + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQG 672
+ +AQG+ +L + IHRD+ A N+LL KI DFGLAR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 673 NTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 49/290 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 572 VRLLGCCVEQGEKI----------------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
V GC + +E+ +L ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ E I +G+ Y+H ++I+RDLK SNI L KI DFGL D G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735
+ GT YMSPE + + D+++ G+++ E L A++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------TAFET- 224
Query: 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785
+ + I+ D + + + DRP S+++
Sbjct: 225 --SKFFTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRT 268
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 8e-42
Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 48/300 (16%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL+G C + + ++E L+ FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 688
+HR+L A N+LL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLID-- 745
FS +SDV+S+G+ M E LS G + K V I+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQG 555
Query: 746 -----PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 800
P E+ LM C DRP V + + +L S E
Sbjct: 556 KRMECPPECPPELY--ALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVRLLGCCVEQGEKI------------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
+VR +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-- 676
IA+ + +LH ++HRDLK SNI D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 677 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
VGT YMSPE +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-41
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 43/234 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 565
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 620
L H N+V LLG C G LI EY L +L +K +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 621 ----------------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 663
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 664 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 222 IMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 31/267 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 633 RFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
+ DV++FG+ MLE T Y ++ +A +++ RV + P
Sbjct: 205 K-YDESVDVYAFGMCMLEMA-----TSEY---PYSECQNAAQIYR--RVTSGVKPASFDK 253
Query: 752 EISLPMLMRYINVALLCVQENAADRPT 778
P + I C+++N +R +
Sbjct: 254 VAI-PEVKEIIE---GCIRQNKDERYS 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 685
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 686 PEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743
PE F+ SDV+ FG+ M E K GV N D + + L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERL 611
Query: 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
P + LM C + + RP +++ + ++
Sbjct: 612 PMPPNCPPTLY--SLM------TKCWAYDPSRRPRFTELKAQLST 648
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 64/280 (22%), Positives = 124/280 (44%), Gaps = 33/280 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+ E G ++++Y L + ++ K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+I+HRD+K+ NI L KD ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
+ ++ KSD+++ G ++ E + K + A S L + K I+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNL-----VLK-----------II 238
Query: 750 QDEISLPMLMRY----INVALLCVQENAADRPTMSDVISM 785
P+ + Y ++ + N DRP+++ ++
Sbjct: 239 SGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 68/305 (22%), Positives = 129/305 (42%), Gaps = 31/305 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 568
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLLY 627
N+++ +E E ++LE L+ + K++ L + V + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+H R++HRD+K +N+ + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
+ ++ KSD++S G L+ E + + + D NL + + D P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDY------PP 257
Query: 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINV 807
+ D S + + +C+ + RP ++ V ++ +
Sbjct: 258 LPSDHYSEEL----RQLVNMCINPDPEKRPDVTYV--------YDVAKRMHACTASSLEH 305
Query: 808 KNSSH 812
+ H
Sbjct: 306 HHHHH 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIA 564
S++ +S+ ++G GG V++ Q A+K L Q L ++NE+ +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 565 KLQHRNL--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
KLQ + +RL + +++E N LN +L KK + W+ + + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNML 137
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+ + +HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 683 YMSPE-----------YALDGLFSIKSDVFSFGILMLETLSSK 714
YM PE S KSDV+S G ++ K
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+F LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 571 LVRLLGCCVEQGEKI-------------LILEYMPNKSLNVFLFD--STKKRLLNWQARV 615
+VR +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF---------- 665
R+ I + L Y+H IIHRDLK NI +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 666 --GGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
N +GT Y++ E G ++ K D++S GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 571 L--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+RL + +++E N LN +L KK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSSK 714
S KSDV+S G ++ K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-38
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL 575
++G GG V++ Q A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
+ +++E N LN +L KK + W+ + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-------- 687
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSSK 714
S KSDV+S G ++ K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQYSRFRIIH 638
E G + +E +P SL+ L S L + + + + I +GL YLH +I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 639 RDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE---YALDGLF 694
RD+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-Y 202
Query: 695 SIKSDVFSFGILMLETLSSK 714
+D++S G ++E + K
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 32/277 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QH 568
++F +LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
VRL E G L E SL ++ L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD-TLLALAHL 173
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H ++H D+K +NI L K+ DFGL G + G YM+PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
L G + +DVFS G+ +LE + + + + + L P
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLR------------QGYLPPE 272
Query: 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785
+S + +V ++ ++ + R T ++++
Sbjct: 273 FTAGLSSEL----RSVLVMMLEPDPKLRATAEALLAL 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLL 626
N+VR +++ L ++EY L + TK+R + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 627 YLHQ--YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H+ ++HRDLK +N+ LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE ++ KSD++S G L+ E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 55/318 (17%)
Query: 508 ITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 566
+ +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 567 QHRNLVRLLGCCVEQGEK----ILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEG 620
H N++RL+ C+ + L+L + +L + L Q ++ G
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTK 675
I +GL +H HRDLK +NILL + P + D G + G +
Sbjct: 143 ICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 676 QI--VGTYGYMSPE------YALDGLFSIKSDVFSFGILM--LETLSSKKNTGVYNADSF 725
T Y +PE + + ++DV+S G ++ + + DS
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 726 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSD 781
L +Q+++S+P R+ + + + RP +
Sbjct: 257 AL--------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296
Query: 782 VISMINNEHLNLPSPKEP 799
++S + E L P+P +
Sbjct: 297 LLSQL--EALQPPAPGQH 312
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
LG+GGF ++ + A K + +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
E + + ++LE +SL +K L +AR + I G YLH+ R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 696 IKSDVFSFGILM 707
+ DV+S G +M
Sbjct: 194 FEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 568
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+++V G E + + ++LE +SL +K L +AR + I G Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH+ R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 211
Query: 688 YALDGLFSIKSDVFSFGILM 707
S + DV+S G +M
Sbjct: 212 VLSKKGHSFEVDVWSIGCIM 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
E L++EY+ +L+ ++ L+ + I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
I+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 696 IKSDVFSFGILMLETLSSKKNTGV--YNADS 724
+D++S GI++ E L G +N ++
Sbjct: 191 ECTDIYSIGIVLYEML-----VGEPPFNGET 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ Q ++G G FG V++ + G + AVK++ + + E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLH 629
+V L G E + +E + SL + + L + R G +GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLH 167
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQ---IVGTYGYMS 685
RI+H D+KA N+LL D + + DFG A D L + I GT +M+
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSK 714
PE + K D++S +ML L+
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V L + E +++EY+ SL D + ++ + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
++IHRD+K+ NILL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K D++S GI+ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 568
E+F + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+++ L E + L+LE N +N +L + K +AR + I G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLY 127
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y+SPE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
A ++SDV+S G + L
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLL 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 563
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RI 617
+ V G +G+ + +E M + SL+ F K++++ + +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
I + L +LH S+ +IHRD+K SN+L++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 678 VGTYGYMSPE----YALDGLFSIKSDVFSFGILMLE 709
G YM+PE +S+KSD++S GI M+E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V + + E +++E++ +L D + LN + + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+IHRD+K+ +ILL D K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 691 DGLFSIKSDVFSFGILMLE 709
L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 567
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLL 626
H ++VR E ++ EY SL + ++ + +A ++ + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLARMFGG 667
Y+H ++H D+K SNI + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 668 DELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
+ + G +++ E + K+D+F+ + ++
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + + +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LLG G+ +++E+ P +++ + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 687
RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 688 --YALDGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 486 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKR 544
E D + + + ++F +LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 545 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 603
+ + E+ ++ + +V G GE + +E+M SL+ L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--- 122
Query: 604 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
K + Q ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
+ N+ VGT YMSPE +S++SD++S G+ ++E
Sbjct: 181 QL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 567
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N++RL G + LILEY P ++ L + + I +A L Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSY 124
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
+ K D++S G+L E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ G + + +++EY S++ + K L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R IHRD+KA NILL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ ++ +D++S GI +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 192 KQSAYDSKADIWSLGITAIE 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
+ GG G +Y +NG+ V +K L + + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 CCVEQGEKI-----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+++EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+++ DLK NI+L ++ K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 692 GLFSIKSDVFSFGILMLETL 711
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALT 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
LG GG V+ R L + ++VAVK L + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 576 --GCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
G + +++EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYAL 690
+ IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 691 DGLFSIKSDVFSFGILMLETLSSKKNTGV--YNADS 724
+SDV+S G ++ E L TG + DS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVL-----TGEPPFTGDS 223
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 18/211 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 575
+G GG G VY+ + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
G+ + + + L L ++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 695
HRD+K NIL+ D + DFG+A ++L VGT YM+PE + +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHAT 213
Query: 696 IKSDVFSFGILMLETLSSKKNTGV--YNADS 724
++D+++ ++ E L TG Y D
Sbjct: 214 YRADIYALTCVLYECL-----TGSPPYQGDQ 239
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLS 712
P+ + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 569
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQ 623
+V+ G +G+ + +E M + S + F K + +I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
L +L +IIHRD+K SNILLD+ N K+ DFG++ + G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 684 MSPE----YALDGLFSIKSDVFSFGILMLE 709
M+PE A + ++SDV+S GI + E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 20/233 (8%)
Query: 485 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 543
G + GK + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 544 RL-SNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 601
++ + + + K ++ +++ +V+ G + + + +E M +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KL 113
Query: 602 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ + + ++ I + L YL + +IHRD+K SNILLD+ K+ DFG+
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 662 ARMFGGDELQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
+ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 172 SGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILM 707
P+ + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 572
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 573 RLLGCCVEQGEKI--LILEYMPNKSLNVFLFD---STKKRLLNWQARVRIIEGIAQGLLY 627
R C E+ + + +E L + L + +++ GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 628 LHQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLARMFGGDEL-QGNTKQIVGTY 681
LH I+HRDLK NIL+ + ISDFGL + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 682 GYMSPEY---ALDGLFSIKSDVFSFGILMLETLS 712
G+++PE + D+FS G + +S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 54/326 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
L EGGF VY+ + + +G+E A+KRL + + + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 578 CVEQGEK-------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
E+ L+L + L FL + L+ ++I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI----------VGT 680
+ IIHRDLK N+LL K+ DFG A + Q T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 681 YGYMSPE-YALDGLFSI--KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 737
Y +PE L F I K D+++ G ++ + + L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC-----FRQHPFEDGAKLR-------- 260
Query: 738 DRVHDLIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVI----SMINNE 789
I+ + S+P ++ +Q N +R ++++V+ +
Sbjct: 261 ----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
Query: 790 HLNLPSPKEPAFTKGINVKNSSHSNS 815
++N SP + +++ S
Sbjct: 311 NVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 555
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 556 FKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLL 609
FKNE+ +I +++ + G E +I EYM N S+ L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ II+ + Y+H + I HRD+K SNIL+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 711
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-31
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 571
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 572 VRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
V +L +EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 626 LYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
YLH+ RIIHRDLK NI+L + + KI D G A+ EL + VGT
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188
Query: 683 YMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE +++ D +SFG L
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 567
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 625
H N++R+ ++ L+LE+ P L + R ++ +E +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE K D++ G+L E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 503 FSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMM 561
L+++ F + +G G +G VYKGR + GQ A+K + + +G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 562 LIAKL-QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
++ K HRN+ G +++ L++E+ S+ + ++ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 133 Y-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 675 KQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
+GT +M+PE D + KSD++S GI +E
Sbjct: 189 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 16/218 (7%)
Query: 504 SLASITAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKN 558
++S + + +G+G V R G+ V V+R L S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 559 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
E+ + H N+V + E ++ +M S L + +N A I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT---- 674
+G+ + L Y+H +HR +KAS+IL+ D +S +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 675 -KQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLE 709
K V ++SPE L + KSD++S GI E
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N ++ GC + + L++EY + + L + KK L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + +IHRD+KA NILL + K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
+G + K DV+S GI +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 67/308 (21%), Positives = 103/308 (33%), Gaps = 81/308 (26%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCC 578
LG G G V G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 579 VEQGEK--ILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
E ++ + LE N +L + D K + ++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 632 SRFRIIHRDLKASNILLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKQ 676
+IIHRDLK NIL+ +++ ISDFGL + + + N
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSSKK-------------N 716
GT G+ +PE + D+FS G + LS K
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 717 TGVYNADSFNLLGHAWDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAA 774
G+++ D + DLI ++ +
Sbjct: 252 RGIFSLDEM-----KCLHDRSLIAEATDLIS-------------------QMIDH--DPL 285
Query: 775 DRPTMSDV 782
RPT V
Sbjct: 286 KRPTAMKV 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 570
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE--GIA------ 622
+V V + E L+++ + S+ D K + + + +++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 623 -QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL-ARMFGGDELQGNTKQ--IV 678
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ N + V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 679 GTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
GT +M+PE + K+D++SFGI +E
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 34/190 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L H N+V+LL + + L+ E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ QGL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T ++
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 678 VGTYGYMSPE 687
V T Y +PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 40/302 (13%), Positives = 84/302 (27%), Gaps = 64/302 (21%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 568
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 569 --------RNLVRLLGCC-----VEQGEKILILEY---MPNKSLNVFLF------DSTKK 606
+LV+ + +L P N+ F S+
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 667 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721
G + + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-----CADL- 315
Query: 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSD 781
DD + I + ++P +R + L + DR
Sbjct: 316 ------------PNTDDAALGGSEW-IFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQ 360
Query: 782 VI 783
+
Sbjct: 361 AM 362
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 34/189 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 618
+L H N+V L+ + L+ E+M L DS K L +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQ------ 127
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ +G+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T ++V
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 679 GTYGYMSPE 687
T Y +P+
Sbjct: 182 -TLWYRAPD 189
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L+H+N+VRL + L+ E+ S N L K L +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQ----- 109
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ +GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + ++
Sbjct: 110 ---LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 678 VGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKK 715
V T Y P+ L+S D++S G + E ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 33/228 (14%), Positives = 65/228 (28%), Gaps = 24/228 (10%)
Query: 507 SITAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEM 560
++ + LGEG F VY+ N Q+ +K + M
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 561 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRI 617
+ ++ + Q +L+ E +L ++ +K +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILL-----------DKDMNPKISDFGLARMFG 666
+ + + +H IIH D+K N +L D + D G +
Sbjct: 179 MR-MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
T G+ E + ++ + D F + L
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 25/246 (10%), Positives = 57/246 (23%), Gaps = 43/246 (17%)
Query: 501 PLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 556
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 557 KNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILEYMPN-----------KSLNVFL---- 600
A+L + + + ++ P N L
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 601 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
F + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 705
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 706 LMLETL 711
+
Sbjct: 282 SIYRVW 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y+H++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 626
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y+H+++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 561
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARV 615
L+ +L H N++ LL + L+ ++M K ++ L S K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ F G + T
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 676 QIVGTYGYMSPE 687
Q+V T Y +PE
Sbjct: 172 QVV-TRWYRAPE 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 34/189 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 618
+L+H N+V+L + +L+ E++ L T K L Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
+ G+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T +IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 679 GTYGYMSPE 687
T Y +P+
Sbjct: 163 -TLWYRAPD 170
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+++L ++ L++E L FD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
YLH+++ I+HRDLK N+LL +KD KI DFGL+ +F + K+ +GT Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L + K DV+S G+++
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 33/194 (17%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 563
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYM----------PNKSLNVFLFDSTKKRLLNWQA 613
+L+H N+VRL + + L+ E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 674 TKQIVGTYGYMSPE 687
+ ++V T Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYL 628
++RL + + L++E LF+ K+ A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
P+ L+GL+ + D +S G++M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 575
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 G-CCVEQGEKI-LILEYMPNKSLNVFLFDS-TKKRLLNWQAR---VRIIEGIAQGLLYLH 629
E+ +K+ +++EY + DS +KR QA ++I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 690 L-----DGLFSIKSDVFSFGI 705
G K D++S G+
Sbjct: 184 NGLDTFSGF---KVDIWSAGV 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQ 567
++ + Q LG+G FG V + + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 625
H N+++L ++G L+ E L FD ++KR A RII + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 626 LYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Y+H+ I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE L G + K DV+S G+++
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 569
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW------QARVRIIEGIAQ 623
N++++ + +++E L + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
L Y H ++H+DLK NIL KI DFGLA +F DE GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILM 707
YM+PE + K D++S G++M
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 566
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEG 620
+H N+V L + L+ EY+ + K L +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ-------- 108
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL Y H+ +++HRDLK N+L+++ K++DFGLAR + ++V T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 681 YGYMSPE 687
Y P+
Sbjct: 164 LWYRPPD 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 52/253 (20%), Positives = 91/253 (35%), Gaps = 37/253 (14%)
Query: 546 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 605
S + ++ + +N V L + + ++ ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 606 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665
+ I IA+ + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 666 GGDELQGNTKQI----------VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LLYSF 273
Query: 716 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL---CVQEN 772
+T +RV + D + + L +Y ++ + +
Sbjct: 274 STQ------------------MERVRIITD--VRNLKFPLLFTQKYPQEHMMVQDMLSPS 313
Query: 773 AADRPTMSDVISM 785
+RP +D+I
Sbjct: 314 PTERPEATDIIEN 326
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 43/310 (13%), Positives = 87/310 (28%), Gaps = 77/310 (24%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 567
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 568 ----------------HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVF---LFD-STKK 606
+ ++R+ L +L F L S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 607 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 667 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKK 715
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW---- 307
Query: 716 NTGVYNADSFNLLGHAWDL-WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAA 774
DL D + I + ++P +R + L
Sbjct: 308 -CA--------------DLPITKDAALGGSEW-IFRSCKNIPQPVRALLEGFLRY--PKE 349
Query: 775 DRPTMSDVIS 784
DR +
Sbjct: 350 DRLLPLQAME 359
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
L+ L ++ E +LILE++ LFD + + ++ + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 629 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H++ I+H D+K NI+ K + KI DFGLA DE K T + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E +D+++ G+L
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
S LG G FG V+K G ++A K + + + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+L + + +L++EY+ LFD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 631 YSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
I+H DLK NIL ++D KI DFGLAR + E K GT +++PE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 689 ALDGLFSIKSDVFSFGILM 707
S +D++S G++
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 617
+L+H NLV LL + L+ EY + + + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ----- 110
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 677
Q + + H++ IHRD+K NIL+ K K+ DFG AR+ ++
Sbjct: 111 ---TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 678 VGTYGYMSPE 687
T Y SPE
Sbjct: 164 A-TRWYRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 59/194 (30%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 563
+ + KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPN--KSL---NVFLFDSTKKRLLNWQARVRII 618
+LQHRN++ L LI EY N K N + K L +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQ------ 140
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN 673
+ G+ + H R +HRDLK N+LL KI DFGLAR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 674 TKQIVGTYGYMSPE 687
T +I+ T Y PE
Sbjct: 195 THEII-TLWYRPPE 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 557
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 558 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV 615
NE+ L+ L H N+++L ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQG 672
I++ I G+ YLH+++ I+HRD+K NILL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
+ +GT Y++PE L ++ K DV+S G++M
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGI 705
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 565
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ------ARVRIIE 619
L+H ++V LL G ++ E+M L KR A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQ 676
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
VGT +M+PE + DV+ G+++
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
V+L Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YLH IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E + SD+++ G ++ + ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 565
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIE 619
L+H NLV LL C ++ L+ E++ + + L ++ L +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ------- 132
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
I G+ + H + IIHRD+K NIL+ + K+ DFG AR + ++
Sbjct: 133 -IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 680 TYGYMSPE 687
T Y +PE
Sbjct: 187 TRWYRAPE 194
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 577
+G+G F V R +L G+EVA+K + + L++ E+ ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 578 CVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+E + + LI+EY + FD R+ +AR I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 688
RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY 190
Query: 689 ALDGLFSIKSDVFSFGILM 707
DG + DV+S G+++
Sbjct: 191 --DGP---EVDVWSLGVIL 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+++ + +LG G FG V++ G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
LV L + E ++I E+M LF+ + + ++ V + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 629 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H+ + +H DLK NI+ K N K+ DFGL + + K GT + +P
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E A +D++S G+L
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGI 705
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L + K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 626
N+VRL E+ L+ + + L F+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 684 MSPE 687
+SPE
Sbjct: 174 LSPE 177
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 495 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 545
++D+ LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 546 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD- 602
S + Q L+E E+ ++ K+ H N+++L L+ + M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 603 -STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661
+ K L + R +I+ + + + LH+ I+HRDLK NILLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 662 ARMFGGDELQGNTKQIVGTYGYMSPE 687
+ E +++ GT Y++PE
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPE 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L DK++ K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+++ M +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
+++H N++ L + + +LILE + LFD +K L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH RI H DLK NI+L + K+ DFG+A K I G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
+V L L+++ + LFD + A +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ I+HRDLK N+L +++ I+DFGL++M + GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE +S D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 60/249 (24%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 565
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV---------- 615
L H N+ RL ++ L++E L D + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 616 -------------------------------RIIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 645 NILL--DKDMNPKISDFGLARMFGGDELQGNT--KQIVGTYGYMSPE--YALDGLFSIKS 698
N L +K K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 699 DVFSFGILM 707
D +S G+L+
Sbjct: 258 DAWSAGVLL 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 562
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 620
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)
Query: 519 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNL 571
CK+G G +G VYK + + ++ A+K++ S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 572 VRLLGCCVEQGEKI--LILEYM--------------PNKSLNVFLFDSTKKRLLNWQARV 615
+ L + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFG--GDE 669
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 670 LQGNTKQIVGTYGYMSPE 687
L +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
++ L E ++I E++ +F+ +T LN + V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 629 HQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H ++ I H D++ NI+ + KI +FG AR + + + Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLKE-FKNEMML 562
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 563 IAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIE 619
+ ++ H +++ L+ L+ + M L FD + K L + R I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ + + +LH I+HRDLK NILLD +M ++SDFG + E +++ G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 680 TYGYMSPE 687
T GY++PE
Sbjct: 262 TPGYLAPE 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 43/200 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 564
+ K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 565 KLQHRNLVRLLGCCVEQGEKI--------LILEYMPN------KSLNVFLFDSTKKRLLN 610
L+H N+V L+ C + L+ ++ + ++ V S KR++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG---G 667
+ GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 668 DELQGNTKQIVGTYGYMSPE 687
+ T ++V T Y PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 570
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 571 LVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 622
+V L G+K L+LEY+P +++ + K+ + ++ + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQ-LL 151
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTY 681
+ L Y+H I HRD+K N+LLD K+ DFG A++ + N I Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206
Query: 682 GYMSPE 687
Y +PE
Sbjct: 207 -YRAPE 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 564
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 623
++QH N++ L + + ILILE + LFD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 624 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
G+ YLH I H DLK NI+L KI DFGLA K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILM 707
T +++PE +++D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 562
+ + M LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 620
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 677
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 302 CGTPTYLAPE 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 563
AT + ++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 564 AKLQ---HRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLL 609
+L+ H N+VRL+ C L+ E++ + + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
Q +GL +LH I+HRDLK NIL+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 626
N+VRL E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 627 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
+SPE +S D+++ G+++
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKEFKNEMML 562
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 563 ------IA---KLQHRNLVRLLGCCVEQGEK---ILILEYMPNKSLNVFLFD-STKKRLL 609
IA KL H N+V+L+ ++ + ++ E + + + T K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGD 668
QAR + + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 669 ELQGNTKQIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 705
L NT VGT +M+PE +L I DV++ G+
Sbjct: 192 ALLSNT---VGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 564
+S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 565 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
+++H N++++L QG L++E + L++F F RL A I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ YL IIHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 685 SPE------YALDGLFSIKSDVFSFGILM 707
+PE Y G + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 564
+ + ++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 565 KLQHRNLVRLLGCCV----EQGEKI-LILEYMPN--KSL-----NVFLFDSTKKRLLNWQ 612
+H N+VRL C ++ K+ L+ E++ + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666
+ +GL +LH + R++HRDLK NIL+ K++DFGLAR++
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ +++EY+ L FD R+ +AR R+ + I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 187 Y--AGP---EVDIWSCGVIL 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 58/187 (31%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 569
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 570 NLVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGI 621
N+VRL GEK L+L+Y+P +++ + K+ L ++ + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGT 680
+ L Y+H F I HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 220
Query: 681 YGYMSPE 687
Y Y +PE
Sbjct: 221 Y-YRAPE 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 578
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 637
E+ L+ E M S+ K+R N +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 638 HRDLKASNILL---DKDMNPKISDFGLARMF-----GGDELQGNTKQIVGTYGYMSPE 687
HRDLK NIL ++ KI DF L G+ YM+PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 566
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 567 QHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIA 622
++RLL +LILE LFD + + L AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELAR-SFFWQVL 159
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+ + + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 682 GYMSPEYAL----DGLFSIKSDVFSFGIL 706
Y PE+ G + V+S GIL
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGIL 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 505 LASITAA--TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNE 559
+A+IT TE + + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRII 618
+ L+H N+VRL E+G LI + + L F+ + + I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTK 675
+ I + +L+ HQ ++HR+LK N+LL K K++DFGLA G+ Q
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWF 171
Query: 676 QIVGTYGYMSPE 687
GT GY+SPE
Sbjct: 172 GFAGTPGYLSPE 183
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMMLIAKLQHR 569
LG+GGFG V+ G L + +VA+K + + S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
++RLL Q +L+LE P + ++F + + K L +R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
++HRD+K NIL+D K+ DFG + + GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209
Query: 689 ALDGLFS-IKSDVFSFGIL 706
+ + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR-NLVRLL 575
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 632
E ILILEY + F L +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 633 RFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H DLK NILL + KI DFG++R G ++I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 690 LDGLFSIKSDVFSFGILM 707
+ +D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ I +++EY+ L FD RL ++R R+ + I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 192 Y--AGP---EVDIWSSGVIL 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 576
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
+ I +++EY + LFD KKR+ + R R + I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 687
+I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKL 183
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + DV+S GI++
Sbjct: 184 Y--AGP---EVDVWSCGIVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 629
++ L + ++ E M L D +++ + + ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 630 QYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
++HRDLK SNIL D+ NP +I DFG A+ + G T +++
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFVA 188
Query: 686 PE 687
PE
Sbjct: 189 PE 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKL 566
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 567 QHRNLVRLLGCCVEQGEK-------ILILEYMP---------NKSLNVFLFDSTKKRLLN 610
H N+V+L GE+ +++EY+P V K L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL- 135
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDE 669
+Q + + + LH S + HRD+K N+L+++ K+ DFG A+ E
Sbjct: 136 FQ--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 670 LQGNTKQIVGTYGYMSPE 687
N I Y Y +PE
Sbjct: 187 P--NVAYICSRY-YRAPE 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 628
+++L E L+LE + L FD K A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 629 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE + + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LG G G V + GQ+ A+K L + + + E+ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
++ I HRD+K N+L +KD K++DFG A+ + L + T Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAP 198
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 578 CVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+Q L++E + L F+ KK+ + I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 637 IHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
+HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNG 185
Query: 694 FSIKSDVFSFGILM 707
+ D++S G+++
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 6e-22
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH R RI++RDLK NILLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
+ ++ D ++ G L+ E +
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMI 379
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-22
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 564
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 565 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+V + +K+ IL+ M L S R E I
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE-IIL 303
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL ++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 356
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETL 711
M+PE G+ S D FS G ++ + L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLL 626
R +V L E + L++ M + +++ + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
+LHQ II+RDLK N+LLD D N +ISD GLA + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 687 EYALDGLFSIKSDVFSFGILMLETL 711
E L + D F+ G+ + E +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 578
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636
+ +I+EY L ++ R +AR + + G+ Y H +I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 637 IHRDLKASNILLDKD--MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 688
HRDLK N LLD KI DFG ++ K VGT Y++PE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY 194
Query: 689 ALDGLFSIKSDVFSFGI 705
DG +DV+S G+
Sbjct: 195 --DGK---IADVWSCGV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 577
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 43/197 (21%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRL 574
G ++ L ++VA+ + Q L+E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
L + +++ E++ SL A +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 694
+ S + + D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179
Query: 695 SIKSDVFSFGILMLETL 711
+ + D+ G + L
Sbjct: 180 NPQDDIRGIGASLYALL 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 41/199 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + ++ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 562 LIAKLQHRNLVRLLGCCV----EQGEKI-LILEYMPN------KSLNVFLFDSTKKRLLN 610
++ +L H ++V++L + E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 671 QGNTKQIVGTYGYMSPEYA 689
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 16/240 (6%)
Query: 478 TTRTNEYGEANGDGKDKSKDSWLPLFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRL-L 535
+ E+ + K+K+ +L + S A + F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 536 NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592
+G A+K L Q LK+ NE ++ + LV+L + +++EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652
+ F R AR + I YLH +I+RDLK N+L+D+
Sbjct: 125 GGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+++DFG A+ ++G T + GT ++PE L ++ D ++ G+L+ E +
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+HQ +HRD+K NIL+D + + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 688 YALDGLFSIKS-----DVFSFGILMLETL 711
D +S G+ M E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 51/247 (20%), Positives = 103/247 (41%), Gaps = 57/247 (23%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 569
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 570 NLVRLLGCCVEQGEKI--------------------------------------LILEYM 591
N+++L+ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 592 PNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649
P +L+ L F + + + + I + + + + ++H I HRD+K N+L++
Sbjct: 121 P-DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 650 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 707
KD K+ DFG A+ + + I + Y +PE L ++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 708 LETLSSK 714
E + K
Sbjct: 233 GELILGK 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 19/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
R + +L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+H+ +HRD+K NILLD+ + +++DFG D + VGT Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 688 -------YALDGLFSIKSDVFSFGILMLETL 711
G + + D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
++F + LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++R+ G + + +I++Y+ L F +R N A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
++ D +SFGIL+ E L+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 562 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 612
L+ + H+N++ LL +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672
+ G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 182
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + D++S G +M E +
Sbjct: 183 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 8e-18
Identities = 60/275 (21%), Positives = 95/275 (34%), Gaps = 81/275 (29%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-----------LKE 555
+ + LG G FG V + + VAVK L + L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 556 F----------------KNEMMLIAKL-QHRNLVRLLGCCVEQGE--KILILEYMPNKSL 596
+M+I + + NL L + K + K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 597 NVFLFDSTKKRL------------------------------------LNWQARVRIIEG 620
+ K+RL L + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQI 677
+A+G+ +L + + IHRDL A NILL + KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 560
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 561 MLIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMPN------KSLNVFLFDSTKKRLL 609
L+ H N++ L K+ L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ I GL LH+ ++HRDL NILL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
N V Y +PE + F+ D++S G +M E + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 569
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 570 NLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
N++ L + + L+ E++ N + L ++ R + E I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 628 LHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
H S I+HRD+K N+++D + ++ D+GLA Q ++ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 687 EYALDGLFSIKS-DVFSFGILMLETLSSKK 715
E +D S D++S G ++ + K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 562 LIAKLQHRNLVRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
L+ + H+N++ LL E + L++E M L + L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ + + G+ +LH S IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L + D++S G +M E + K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 568
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V+L + +++EYMP L + + + AR E + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 687
H IHRD+K N+LLDK + K++DFG + + VGT Y+SPE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240
Query: 688 ---YALDGLFSIKSDVFSFGILMLETL 711
DG + + D +S G+ + E L
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 568
++F + +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVRLLGCCVEQ-GEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
LV L Q E + ++++ + L ++ I E + L
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YL RIIHRD+K NILLD+ + I+DF +A M + + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 687 EYALDGLFSIKS---DVFSFGILMLETL 711
E + S D +S G+ E L
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
+ + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 569 RNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARVRIIE 619
N++ LL + L++ +M K + + + + L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 679
+ +GL Y+H ++HRDLK N+ +++D KI DFGLAR + V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 185
Query: 680 TYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
T Y +PE L ++ D++S G +M E L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH S +++RDLK N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE D + D + G++M E +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 29/252 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H LV L C + ++ ++EY+ L +++L AR E I+ L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
YLH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
+PE + D ++ G+LM E + G F+++G + + ++ D +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMM-----AG---RSPFDIVGSSDNPDQNTE--DYL 227
Query: 745 DPVIMQDEISLP 756
VI++ +I +P
Sbjct: 228 FQVILEKQIRIP 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 41/202 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 562 LIAKLQHRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLLN 610
++ +L+ ++RL + ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 671 QGNTKQIVGTYGYMSPEYALDG 692
+ L
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 562 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
++ + +H N++ + +EQ + + ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 674 T-KQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
+ V T Y +PE L+ ++ D++S G ++ E LS++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 64/303 (21%), Positives = 123/303 (40%), Gaps = 29/303 (9%)
Query: 462 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 521
+ Y D ++ T G +++ + AS + ++F + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 522 GEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLG 576
G G + V RL + A++ + + ++ H LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 577 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
C + ++ ++EY+ L +++L AR E I+ L YLH+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RG 173
Query: 636 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 693
II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++PE
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGED 229
Query: 694 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753
+ D ++ G+LM E + G F+++G + + ++ L VI++ +I
Sbjct: 230 YGFSVDWWALGVLMFEMM-----AG---RSPFDIVGSSDNPDQNTE-DYLFQ-VILEKQI 279
Query: 754 SLP 756
+P
Sbjct: 280 RIP 282
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.8 bits (193), Expect = 8e-16
Identities = 34/199 (17%), Positives = 60/199 (30%), Gaps = 46/199 (23%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 562
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 563 IAKLQ---------HRNLVRLLGCCVEQGE--KILILEYM----PNKSLNVFL------- 600
+L + L QG +L+ + S N
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 601 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647
+ + +L + I+ + L R HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 648 LDKDMNPKISDFGLARMFG 666
L K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 567
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H L + C + E + ++EY+ L + + +A E I GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
+LH I++RDLK NILLDKD + KI+DFG+ + M G T GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE L ++ D +SFG+L+ E L
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 568
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 685
LH +++RD+K N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE D + D + G++M E +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 571 LVRLL--------------GCCVEQGEKILILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
+V++ G E ++ EYM L RL +Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQG 672
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 673 NT-KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSK 714
+ + T Y SP L ++ D+++ G + E L+ K
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H LV L + +K+ +L+Y+ L F ++ L +AR E IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
YLH + I++RDLK NILLD + ++DFGL + + T GT Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + D + G ++ E L
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-15
Identities = 71/399 (17%), Positives = 136/399 (34%), Gaps = 23/399 (5%)
Query: 325 PIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSN 384
P C H+ +D + + N ++ S
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 385 VKESSGCLM---WYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLWILVILVIPVVLL 441
K+ + + R ++ + ++ + L
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 442 PSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLP 501
+ + + +E E NV + + + + G+ ++K+ ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 502 LFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNE 559
+ + +F+ LG+G FG V E+ AVK L + +
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 560 MM----LIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
M+ L + L +L C + +++ ++EY+ L R A
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAV 445
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 672
E IA GL +L II+RDLK N++LD + + KI+DFG+ + ++ G
Sbjct: 446 FYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---- 497
Query: 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
TK GT Y++PE + D ++FG+L+ E L
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
L +L C + +++ ++EY+ L R A E IA GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAE-IAIGLF 135
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 684
+L II+RDLK N++LD + + KI+DFG+ + ++ G TK GT Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 188
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + D ++FG+L+ E L
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF---------KNE 559
F + LG+G FG V+ + ++G + A+K L K K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 560 MMLIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 618
++ ++ H +V+L + K+ LIL+++ L F S + + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 133
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQ 676
E +A L +LH II+RDLK NILLD++ + K++DFGL++ + +
Sbjct: 134 E-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYS 185
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT YM+PE + +D +SFG+LM E L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 569 RNLVRLL-----GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
N++ LL ++ L++ +M L + K L ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQML 138
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190
Query: 683 YMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
Y +PE L+ ++ D++S G +M E ++ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 26/156 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 577
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 578 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 630 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLA 662
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQS-GQGLKEF---KNEMMLIA 564
E F + LG+GG+G V++ R + G A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
+++H +V L+ + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTY 681
L +LHQ II+RDLK NI+L+ + K++DFGL + + G T GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETL 711
YM+PE + + D +S G LM + L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 567
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 568 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H L +L CC + +++ ++E++ L +R +AR E I L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--RMFGGDELQGNTKQIVGTYGYM 684
+LH II+RDLK N+LLD + + K++DFG+ + G T GT Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE + L+ D ++ G+L+ E L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 562 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 612
L+ ++H N++ LL +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 672
I +GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 673 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 714
V T Y +PE L+ ++ D++S G +M E L+ +
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 562 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 613
++ +H N++ + E ++ +I E M ++ ++ + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 614 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673
+ + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ DE +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 674 TKQIVGTYGYMSPEY 688
+ G M E+
Sbjct: 169 NSEPTGQQSGMV-EF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 561
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 562 LIAKLQ-HRNLVRLLGCCV-EQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARV 615
++ +L H N+V LL + + L+ +YM + + + + K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ + + YLH S ++HRD+K SNILL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 676 QIVGTYGYMSPEYALDGL 693
+ + + L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-13
Identities = 20/126 (15%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ +T + G+ L + VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNLVLYD--------HSTSVWASNTGIL-GK 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ ++GN V+ + ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDY 151
W + Y
Sbjct: 103 WSTGTY 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF-----------K 557
ENF + LG G +G V+ R ++G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 558 NEMMLIAKLQHRN-LVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARV 615
E ++ ++ LV L + K+ LIL+Y+ L F S ++R + ++
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQI 163
Query: 616 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ E I L +LH+ II+RD+K NILLD + + ++DFGL++ F DE +
Sbjct: 164 YVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY 218
Query: 676 QIVGTYGYMSPEYALDGLFSIKSDV--FSFGILMLETL 711
GT YM+P+ G V +S G+LM E L
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAKLQH 568
KLG G F V+ + ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 569 RNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624
++++LL +G ++ E + ++L + + + + +I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP------KISDFGLARMFGGDELQGNTKQIV 678
L Y+H R IIH D+K N+L++ +P KI+D G A + + +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
T Y SPE L + +D++S L+ E
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-12
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 19/123 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
++++ + + G L + L G VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNFVLYDSGK--------PVWASNTGGL--G 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ NNGNLV+ +Q+N IW T + + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQS 148
W +
Sbjct: 103 WAT 105
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 625
++ ++LE + SL LFD + + Q + +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGNTKQ---- 676
Y+H + +I+RD+K N L+ + N I DF LA+ + + TK+
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPY 171
Query: 677 -----IVGTYGYMS 685
+ GT YMS
Sbjct: 172 REHKSLTGTARYMS 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 570
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+ + C E ++++E + SL LF+ ++ + + + + + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123
Query: 631 YSRFRIIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQGNT-------KQIVGT 680
+ IHRD+K N L+ I DFGLA+ + + + + K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGT 178
Query: 681 YGYMS 685
Y S
Sbjct: 179 ARYAS 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 32/201 (15%), Positives = 77/201 (38%), Gaps = 34/201 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 557
+ ++ G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 558 -----NEMMLIAKLQHRNLVRLLGCCVEQGE-KILILEYMPNKSLNVFLFDSTKKRLLNW 611
N+ + + +G V Q + + L+L + +SL D + K +L+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158
Query: 612 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMF--GG 667
++ +++ + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 668 DEL---QGNTKQIVGTYGYMS 685
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 40/187 (21%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 569
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
+ + E +L+++ + SL L D ++ + + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-SVKTVAMAAKQMLARVQSIH 123
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGN------TKQIV 678
+ S +++RD+K N L+ + + + DFG+ + + D + K +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 679 GTYGYMS 685
GT YMS
Sbjct: 180 GTARYMS 186
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + L + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK-- 48
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
+ VL + N+GNLV+ + + IW++N + + N L+ D N+VI D +S NA
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD-NSNNA---- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-06
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 1/69 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+++ + I N+ NLVL + N +W++ + + V ++++DGNLVI S
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDY 151
+ Q+ +Y
Sbjct: 75 NTNRQNGNY 83
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 569
+ + +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 570 -----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQ 623
+V L + + L+ E + S N++ L +T R ++ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTY 681
LL+L IIH DLK NILL KI DFG + G + Q + +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY----QYIQSR 222
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLE 709
Y SPE L + + D++S G +++E
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 7e-11
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + L + + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNLVKYQ--------NGRQIWASNTDR--RG 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ ++GNLV+ + N +W + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 39/201 (19%), Positives = 77/201 (38%), Gaps = 48/201 (23%)
Query: 520 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
+G+GGFG +Y + + + VK + +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 574 LL-------------GCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRL-------LNW 611
G + G+ +I++ L ++++ KR L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 612 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGGDE 669
+ + I+E Y+H++ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 670 L-----QGNTKQIVGTYGYMS 685
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 9e-11
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+W N N + +G LV++ N T+W + V+ + + V L+ D N+VI
Sbjct: 50 PIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 133 RDNSSGNATESYLWQS 148
++ LW +
Sbjct: 108 YGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-08
Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 73 VVWVANRDRPISDNNA-VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
++ + + + + NLVL + N IW+TN A L+ DG LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 132 IRDNSSGNATESYLWQS 148
+ N + +WQS
Sbjct: 75 VITNEN-----VTVWQS 86
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLV-RLL 575
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 635
VE +L+++ + SL LF+ ++ L+ + + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 636 IIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQG------NTKQIVGTYGYMS 685
+HRD+K N L+ I DFGLA+ + D K + GT Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-10
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L ++ R+ + +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNLVLYDVDK--------PIWATNTGGL--D 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
L++ ++GNLV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 7e-10
Identities = 20/112 (17%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRD 80
+ + + + +L + + +L W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN---------LVLYGGKYGWQSNTH 50
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+ + L +++ G L++ + TIWS+ SS+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 7/71 (9%)
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSS 137
D ++ N L + + NLVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 GNATESYLWQS 148
+W S
Sbjct: 74 KT-----IWSS 79
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 39/203 (19%), Positives = 73/203 (35%), Gaps = 55/203 (27%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IAKLQHRN 570
K+G GGFG +Y ++ A VK ++G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 571 LVRLLG----------CCVEQGEKILILEYMPNKSLNVFLFDSTKK-----------RLL 609
+ LG + + +++E + L + R+L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRML 161
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGG 667
+ ++E Y+H+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 162 D------VLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 668 DEL-----QGNTKQIVGTYGYMS 685
+ + K GT + S
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTS 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR------N 570
+G+G FG V K Q VA+K + N+ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
++ +L + + E + S+N++ L K + + + I Q L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 630 QYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
+ RIIH DLK NILL + K+ DFG + + + + + Y +PE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQSRFYRAPE 269
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
L + + D++S G ++ E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 8/65 (12%)
Query: 84 SDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATES 143
+ + LT+++ G LV+ N T+W + S N A + DG LV+ S
Sbjct: 47 NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------- 99
Query: 144 YLWQS 148
+++
Sbjct: 100 -VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 11/76 (14%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+VW + + + + ++G L + + T++ +N + + V L+ +G V+
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
Query: 133 RDNSSGNATESYLWQS 148
+ +W +
Sbjct: 104 YGPA--------VWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-06
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)
Query: 83 ISDNNAVLTISNNGNLVL-LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141
++ + L + ++ NLVL +W + S ++ +L G L I D+
Sbjct: 21 LATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT-- 78
Query: 142 ESYLWQS 148
++ S
Sbjct: 79 ---VFVS 82
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 5e-08
Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 10/79 (12%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
D VW N + NG + +L N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSGNATESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 23/122 (18%), Positives = 36/122 (29%), Gaps = 11/122 (9%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTY 190
I LW S +++ + S Y
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 191 RL 192
RL
Sbjct: 153 RL 154
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 17/89 (19%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
Q D + + + + L++ + NLVL + + +WSTN + + A L+
Sbjct: 130 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQ 188
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTD 154
+G + + N + +W S + +
Sbjct: 189 PNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 87/668 (13%), Positives = 170/668 (25%), Gaps = 213/668 (31%)
Query: 156 LLQDMKLGWDFKNRLE--RYLSSWRSADD----PSPGNFTYRLDIHVLPKICTFNGSV-- 207
+D K+ + + + S D + T RL + + +
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL----FWTLLSKQEEMVQ 80
Query: 208 KFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYW--YEAYNRPSIMTLKLNPSGFV 265
KF ++Y FL E + + Y ++ V
Sbjct: 81 KFVEEVL--------RINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 266 TRQIWNENSNKWDELFSV-PDQY---CGKYGYCG----ANTICSLDQKPMCECLEGFKLE 317
+R + L + P + G G G A +C K C
Sbjct: 132 SRLQPYLKLRQA--LLELRPAKNVLIDGVLG-SGKTWVALDVCL-SYKVQC--------- 178
Query: 318 SQVNQPGPI------KCERSHSLECKSGDQFIELDEIKAPDF---IDVSLNQRMNLEQCK 368
I C ++ ++D P++ D S N ++ + +
Sbjct: 179 ---KMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTSRSDHSSNIKLRIHSIQ 231
Query: 369 AECLKNCSCRAYANS-----NVKESS-------GCLMWYGDLIDAR-RPIRNFTGQSVYL 415
AE + + Y N NV+ + C + L+ R + + +F +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI----LLTTRFKQVTDFLSAATTT 287
Query: 416 RVPASKLGN-------KKLL--WI----------------LVILVIPVVL--LPSFYVFY 448
+ K LL ++ + +I + + + +
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 449 RR---------RRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKD 497
+ + E + + L F + +I T
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL---------------- 391
Query: 498 SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK 557
L L I + + +K L+ Q KE
Sbjct: 392 --LSLIWFDVIKSDVMVVVNKL----------HKYSLVEKQP--------------KEST 425
Query: 558 NEMMLIA---KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 614
+ I K++ N L + ++ Y K+ FDS
Sbjct: 426 ISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKT-----FDSDDLIPPYLDQ- 471
Query: 615 VRIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGD 668
Y + + R + LD + KI A G
Sbjct: 472 ------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 669 ELQGNTKQIVGTY-GYMSPEYALDGLFS-IKSDVFSFGILMLET--LSSK---------- 714
L NT Q + Y Y+ D + + + + F + +E + SK
Sbjct: 520 IL--NTLQQLKFYKPYICDN---DPKYERLVNAILDF-LPKIEENLICSKYTDLLRIALM 573
Query: 715 -KNTGVYN 721
++ ++
Sbjct: 574 AEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 7e-05
Identities = 62/457 (13%), Positives = 131/457 (28%), Gaps = 165/457 (36%)
Query: 397 DLIDARRPIRNFTGQSV--YLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKC 454
D+ D + I + + + + + G +L W L
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTL----------------------- 71
Query: 455 QEKETENVETY-QDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATE 513
K+ E V+ + +++L + Y +L ++ I
Sbjct: 72 LSKQEEMVQKFVEEVLRIN-----------YK-------------FL----MSPIKTEQR 103
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 573
SM ++ + RL N +V K + Q + + ++ +L+ V
Sbjct: 104 QPSMMTRMYIE-----QRDRLYNDNQVFAKY-NVSRLQPYLKLRQALL---ELRPAKNVL 154
Query: 574 L---LGCCVEQGEKILILE---------YMPNKS--LNVFLFDSTKKRLL---------- 609
+ LG G+ + L+ M K LN+ +S + L
Sbjct: 155 IDGVLGS----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 610 -NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG- 667
NW +R I + + R + + + ++L + + + F
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-N----VQNAKAWNAFNLS 265
Query: 668 -------------DELQGNTKQ---IVGTYGYMSPEYALDGLFS--IKSDVFS------- 702
D L T + ++P+ L +
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLT 324
Query: 703 ---FGILML-ETLSSKKNTGVYNADSFNLLGHAWDLWKD---DRVHDLIDPVIMQDEISL 755
+ ++ E++ T WD WK D++ +I E SL
Sbjct: 325 TNPRRLSIIAESIRDGLAT--------------WDNWKHVNCDKLTTII-------ESSL 363
Query: 756 ----PMLMR--YINVALLCVQENAADRPTMSDVISMI 786
P R + +++ +A + ++S+I
Sbjct: 364 NVLEPAEYRKMFDRLSVF--PPSA---HIPTILLSLI 395
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.8 bits (120), Expect = 7e-07
Identities = 13/69 (18%), Positives = 26/69 (37%), Gaps = 8/69 (11%)
Query: 84 SDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATES 143
+GNLV+ N +W ++ + V +L+ +G++ I D
Sbjct: 193 GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP------ 245
Query: 144 YLWQSFDYP 152
+W F +
Sbjct: 246 -VWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.9 bits (102), Expect = 1e-04
Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDR 81
+ + + G+ L+S +QRF+L G L I+ A VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIS------DNNAVLTISNNGNLVLLNQTNGTIW-----STNVSSEVKNPVAQLRDDGNL 130
P S + A L L + + +W + + + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VIRDNSSG-NATESYLWQSFDYPTDTLLQDMKLGWDF 166
V+ D+ + N T + + L +L
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGV 159
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 8e-07
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+S +A + + NLVL N + +N + +L + G L I +S
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 143 SY 144
Y
Sbjct: 75 VY 76
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGT---IWSTNVSSEVKNPVAQLRDD 127
+A + +N + L ++N G L + + + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSGNATESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 46/226 (20%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 569
+ + LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 570 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 622
V + G + E + N F + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 663
L +LH ++ H DLK NIL +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
F + IV T Y PE L+ ++ DV+S G ++ E
Sbjct: 190 TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 56/284 (19%), Positives = 98/284 (34%), Gaps = 82/284 (28%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRN 570
KLG G F V+ + + VA+K + + + +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 571 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
+V+LL G ++ E + L ++ S + L + +II+ + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 627 YLHQYSRFRIIHRDLKASNILL-------------------------------------- 648
YLH ++ RIIH D+K NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 649 -----------DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 697
+ + KI+D G A + + T Y S E + ++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTP 273
Query: 698 SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741
+D++S + E TG Y F H+ + + D H
Sbjct: 274 ADIWSTACMAFELA-----TGDY---LFE--PHSGEEYTRDEDH 307
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 50/230 (21%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 569
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 570 ----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQG 624
N+V+ G + LI E + +++ + + + I +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 625 LLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------------KISDF 659
L YL + + H DLK NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
G A F D I+ T Y +PE L+ + + SD++SFG ++ E
Sbjct: 207 GCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 48/227 (21%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 569
+ + LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 570 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 622
V++L G ++ E + L+ + ++ I
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 663
+ + +LH ++ H DLK NIL + K+ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
+ + +V T Y +PE L L +S DV+S G +++E
Sbjct: 185 TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 11/92 (11%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRD 134
+ + + + + +G +V ++ +G + W N +S V + +G +
Sbjct: 163 ASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVA-FYVWQREGLRKVMH 221
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166
+ T YL +
Sbjct: 222 INVAVETLRYLTFMSGEVGRITKWKYPFPKET 253
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 834 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.72 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.55 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.53 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.49 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.21 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.01 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.45 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.29 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 91.45 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 83.38 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.75 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=450.08 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=216.4
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467899999999999999999864 37789999998887778889999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 586 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
+|||||++|+|.++|.... ....++|.++++|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996532 2356999999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +.. .
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~----~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----C 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH----H
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----H
Confidence 999999997755443333445679999999999999999999999999999999999 899986433211 110 0
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+. ..+.+...+.++.+++.+||+.||++||||+||++.|+++.
T Consensus 243 i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01110 01112234467889999999999999999999999998863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=451.86 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=208.9
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999864 47889999998888888899999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCC------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 586 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
+|||||++|+|.++|..... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999965432 246999999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~--- 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AID--- 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHH---
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHH---
Confidence 99999999997755544444455789999999999999999999999999999999999 899986433211 110
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+. ..+.+.....++.+++.+||+.||++||||+||+++|+.+.
T Consensus 272 -~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 -CITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp -HHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 000000 11112233467889999999999999999999999999873
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=444.38 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=213.1
Q ss_pred cCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
..+++.++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 46789999997543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 586 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
+|||||++|+|.++|..... ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 246899999999999999999999998 99999999999999999
Q ss_pred CceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003288 653 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 731 (834)
++||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||....... +..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~-- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVE-- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHH--
Confidence 999999999997755544444556789999999999999999999999999999999998 888986433211 111
Q ss_pred cccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 732 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 732 ~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+. ..+.+...+..+.+++.+||+.||++||||+||++.|+..
T Consensus 259 --~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --MIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011110 1112233456788999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=436.78 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=205.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.+++++.++||+|+||+||+|++. ..||||+++.. ..+..+.|.+|+.+|++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999999874 36999998643 45567889999999999999999999998865 56899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||++|+|.++|.. ....+++.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999954 3346999999999999999999999998 9999999999999999999999999998765444
Q ss_pred ccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ +.. ....+ ...+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~----~~~~~----~~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIF----MVGRG----YASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH----HHHTT----CCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHH----HHhcC----CCCC
Confidence 3344556789999999999864 4689999999999999999999999864332110 000 00000 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
.+ .......+..+.+++.+||+.||++||||.||++.|+.+...+
T Consensus 258 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 258 DL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred Cc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11 1122234467889999999999999999999999998764333
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=431.72 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=203.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|+++++||+|+||.||+|+.. +|+.||||++... .....+.|.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 5899999999654 44557789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||++|+|.++|.. .+...+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999953 23456789999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +.. .++....
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~------------~i~~~~~- 242 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVL------------KIISGSF- 242 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH------------HHHHTCC-
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH------------HHHcCCC-
Confidence 12345689999999999999999999999999999999999999986433211 100 0011000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.......++.+|+.+||+.||++|||++|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122233457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=430.74 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=209.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999875 5899999999765555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999843 35899999999999999999999998 9999999999999999999999999999875432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... ... .+... ..+ .
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~----~i~~~-----~~~---~ 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MIRDN-----LPP---R 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHS-----SCC---C
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----HHHcC-----CCC---C
Confidence 22345789999999999999999999999999999999999999986432211 110 00000 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........++.+|+.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112234578899999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=426.61 Aligned_cols=271 Identities=24% Similarity=0.290 Sum_probs=203.9
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----eeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 588 (834)
++|.+.++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688899999999999999998 6899999999654322 223345666667889999999999998764 579999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
|||++|+|.++|.. ..++++.+++++.|+++||+|||++. +++||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 35899999999999999999999871 2349999999999999999999999999999
Q ss_pred ecCCCcc--cCCcccccccccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 664 MFGGDEL--QGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
....... .......+||+.|||||++.+. .++.++|||||||+||||+||++|+..................
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 8754322 2223446899999999999764 4678999999999999999999887654332221111100000
Q ss_pred cccc-----cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 736 KDDR-----VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 736 ~~~~-----~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ....+++.+.......+....+.+++.+||+.||++||||.||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0000 11112222222222345567889999999999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=434.32 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=216.5
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCC-CceeeEee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQH-RNLVRLLG 576 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~ 576 (834)
....+...++|++.++||+|+||.||+|++.. ++.||||+++... ....++|.+|+++|.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34445567899999999999999999998643 3689999997653 3456789999999999965 89999999
Q ss_pred eeeec-CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 577 CCVEQ-GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 577 ~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
+|.+. +..++|||||++|+|.++|..... ...+++.+++.++.|||+||+|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99765 568999999999999999965322 345899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 721 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~ 721 (834)
|+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998765444334456789999999999999999999999999999999998 899986433
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... + ...+.... +...+.....++.+++.+||+.||++|||+.||+++|+++
T Consensus 293 ~~~~-~-------------~~~i~~g~-~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 293 IDEE-F-------------CRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CSHH-H-------------HHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-H-------------HHHHHcCC-CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2110 0 00111000 1112222345788999999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=427.10 Aligned_cols=256 Identities=22% Similarity=0.244 Sum_probs=205.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.|++.++||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999975 589999999975422 24799999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecCCCc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
|++|+|.++|.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 346999999999999999999999998 99999999999999987 69999999999875432
Q ss_pred ccC---CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
... .....+||+.|||||++.+..|+.++|||||||+||||++|++||........ ... +...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~------------i~~~ 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLK------------IASE 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHH------------HHHS
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH------------HHcC
Confidence 211 22346899999999999999999999999999999999999999864332211 000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
..............+.+++.+||+.||++|||+.|+++.|.....+
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0000112223345788999999999999999999999998765433
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=423.63 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=209.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 5899999999643 2344678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999943 356999999999999999999999998 999999999999999999999999999988655
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... +.. .++...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~------------~i~~~~- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFA------------KIIKLE- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHHTC-
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHcCC-
Confidence 44445566899999999999999999999999999999999999999986432211 100 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
..+......++.+|+.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011112345688999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=413.51 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=197.0
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 587 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 587 (834)
|++.++||+|+||.||+|++. +++.||||++... .....+.|.+|+.+|++++|||||++++++.+ +...++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999875 4889999998643 44556789999999999999999999999875 3468999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~ 666 (834)
||||++|+|.+++.. ...+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999953 356899999999999999999999875 35999999999999974 7899999999998643
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+. .....+. .+
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~----~~i~~~~-----~~ 248 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIY----RRVTSGV-----KP 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHH----HHHTTTC-----CC
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHH----HHHHcCC-----CC
Confidence 22 3345789999999998865 69999999999999999999999985322211 000 0001110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ........++.+++.+||+.||++|||++|+++
T Consensus 249 ~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 011112346789999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=432.11 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=209.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999875 5899999999766655667789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999843 34899999999999999999999998 9999999999999999999999999999875432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ... .+. ....+.+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~----~i~-----~~~~~~~-- 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MIR-----DNLPPRL-- 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHH-----HSCCCCC--
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----HHH-----cCCCCCC--
Confidence 23345789999999999999999999999999999999999999986432211 110 000 0000111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+.+|+.+||+.||++|||++|+++.
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111234578899999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=404.87 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=190.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999875 5899999999654 2334577999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6789888843 356999999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... +.. ..... .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~----~i~~~--------~ 228 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK----NISNG--------V 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHT--------C
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcC--------C
Confidence 2 2345689999999999998876 579999999999999999999986432211 100 00000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+...+.++.+++.+||+.||++|||++|+++.
T Consensus 229 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111234567899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=412.25 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=196.0
Q ss_pred cCccccceeccCCcEeEEEEEec----CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
++|+++++||+|+||+||+|+.. .++.||||++++.. ......+.+|+.+|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46889999996542 2234468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999943 346999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... ... .+...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~------------~i~~~ 241 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMT------------MILKA 241 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHHC
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHH------------HHHcC
Confidence 322 22345689999999999999999999999999999999999999986433211 100 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
. ...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 242 ~---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 K---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 0111223456889999999999999998 466664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=402.86 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=189.6
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--------
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-------- 582 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 582 (834)
++|++++.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999875 58999999986543 445678999999999999999999999987654
Q ss_pred ----eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeec
Q 003288 583 ----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (834)
Q Consensus 583 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 658 (834)
..++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965544455677788999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCcccC----------CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccc
Q 003288 659 FGLARMFGGDELQG----------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728 (834)
Q Consensus 659 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~ 728 (834)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||..... ....+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHHH
Confidence 99999875432211 1234579999999999999999999999999999999996 5431100 00000
Q ss_pred ccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 729 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 729 ~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+..... .+........+.+++.+||+.||++|||+.|+++
T Consensus 238 ------------~~~~~~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 ------------TDVRNLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ------------HHHHTTCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HHHhcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 0011122345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=395.38 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=202.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee------cC
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QG 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 582 (834)
.++|+++++||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999875 5999999999654 23455778999999999999999999998764 35
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..|+|||||+ |+|.+++. +.+.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67988883 4457999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCc--ccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------
Q 003288 663 RMFGGDE--LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH-------- 730 (834)
Q Consensus 663 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~-------- 730 (834)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...+.... ..+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764332 22234457999999999998875 569999999999999999999999965432111 10000
Q ss_pred ccccccccccccccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 AWDLWKDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 ~~~~~~~~~~~~li~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+...........+........... ....++.+|+.+||+.||++|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000000000111111 123567899999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=390.47 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=171.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec----CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 585 (834)
..++|++.++||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|..+ +||||+++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3678999999999999999999753 46789999986543 345678999999998 6999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeecccccee
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 664 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~ 664 (834)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999982 3899999999999999999999998 9999999999999877 7999999999987
Q ss_pred cCCCccc--------------------------CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCC
Q 003288 665 FGGDELQ--------------------------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 665 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~ 717 (834)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6432111 112335799999999999876 5899999999999999999999998
Q ss_pred CCCC
Q 003288 718 GVYN 721 (834)
Q Consensus 718 ~~~~ 721 (834)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 5433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=383.56 Aligned_cols=279 Identities=36% Similarity=0.631 Sum_probs=234.2
Q ss_pred HHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 507 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
++...+++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34446789999999999999999999988899999999987777778899999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 587 ILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999864432 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc-cccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~li 744 (834)
.............||+.|+|||++.+..++.++||||||+++|||++|+.|+....+.. .....+.............+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 54333333344678999999999999999999999999999999999999987544322 22222222223334444555
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
++.+ ...........+.+++.+||+.||++||++.||++.|+..
T Consensus 270 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 270 DPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Chhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5544 4456677888999999999999999999999999999876
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=375.61 Aligned_cols=234 Identities=18% Similarity=0.212 Sum_probs=181.5
Q ss_pred hhccccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCC----CceEEEeeCC
Q 003288 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDN----NAVLTISNNG 96 (834)
Q Consensus 21 ~~~~~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~----~~~l~~~~~G 96 (834)
++++.|+|++||+|++|++|+|++|+|+||||+++ ++|+ |+ ..+ +||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 46788999999999999999999999999999543 6788 77 445 99999999999885 7899999999
Q ss_pred cEEE--EcCCCCeEEEEecCCC-----CccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhcccccccccc
Q 003288 97 NLVL--LNQTNGTIWSTNVSSE-----VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNR 169 (834)
Q Consensus 97 ~Lvl--~~~~~~~vWst~~~~~-----~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~t~ 169 (834)
+||| .|++|.+||+|+++.. ..+.+|+|+|+|||||+| + .+|||| |||||||||||+|.+.++|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-----~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-----LALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-----EEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-----ceeeCc--ccccccccccccccccccC
Confidence 9999 8888999999997642 245789999999999998 2 689999 9999999999999998887
Q ss_pred cceeeEEecCCCCCCCcceEEeeccCCCceEEEEc-CCeeeeecCCCCCcceeecccccccceeeeeeecCceEEEEEEe
Q 003288 170 LERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN-GSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEA 248 (834)
Q Consensus 170 ~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~-~~~~~~~~g~w~g~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~ 248 (834)
.. | ++.+||++|.|++.++++|. +++++ ++.+||++|.|++.... ..+.. .-.+.+.++.. ..+.++.
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~--l~l~~-dGnLvl~d~~~-~~vWsS~ 221 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVR--AVFQG-DGNLVVYGAGN-AVLWHSH 221 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCE--EEECT-TSCEEEECTTS-CEEEECS
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEE--EEEcC-CCeEEEEeCCC-cEEEEec
Confidence 65 6 67899999999999999984 34454 56899999999764311 11111 11222333322 2222333
Q ss_pred eCCCceeeEEeCCCCcEEEEEEecCCCceEEEEeeeC
Q 003288 249 YNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPD 285 (834)
Q Consensus 249 ~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~ 285 (834)
......+|++|+.||++++|.| ...|..++..|.
T Consensus 222 t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 222 TGGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 3333458999999999999998 245665555443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.47 Aligned_cols=289 Identities=39% Similarity=0.651 Sum_probs=237.7
Q ss_pred CCCcccHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhcCCCceeeEeee
Q 003288 499 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGC 577 (834)
Q Consensus 499 ~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 577 (834)
.+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3556888999999999999999999999999999988899999999975432 223468999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 578 CVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 578 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
+.+....++||||+++++|.+++..... ...+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999965443 345999999999999999999999992222999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC---CCcccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN---ADSFNLLGHAWD 733 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~---~~~~~~~~~~~~ 733 (834)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... ........+...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987653322 22334569999999999999999999999999999999999999985321 122222333333
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.........+.+..+ ...........+.+++.+||+.||.+|||++||+++|++.
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTC-TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhh-ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 344444555555554 4566777888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=404.39 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=209.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+++.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.++...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 5899999999877777778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC--CCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~ 668 (834)
|++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 3356999999999999999999999998 9999999999999854 89999999999987543
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ .. ....... . +
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~----~i~~~~~-~-~---- 375 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR----NVKSCDW-N-M---- 375 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HHHTTCC-C-C----
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH----HHHhCCC-C-C----
Confidence 2 23456899999999999999999999999999999999999999864332211 00 0000000 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+|+.+||+.||.+|||+.|++++
T Consensus 376 -~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001123567899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=401.00 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=199.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHH---HHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
-++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+ ..++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999875 58999999996421 1122233 3446667777999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
|+||||++||+|..+|.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999953 356999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
+.... ....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+. ...
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-----------~~i 406 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMT 406 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-----------HHH
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----------Hhh
Confidence 75432 345689999999999975 57999999999999999999999999643221110000 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
... ........+.++.+|+.+||+.||++|++ ++||.++
T Consensus 407 ~~~---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 407 LTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHC---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCC---CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 000 11122233457889999999999999998 6887653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=361.89 Aligned_cols=282 Identities=35% Similarity=0.537 Sum_probs=229.3
Q ss_pred CCCcccHHHHHHHhcCcccc------ceeccCCcEeEEEEEecCCcEEEEEEecCC----ChhhHHHHHHHHHHHHhcCC
Q 003288 499 WLPLFSLASITAATENFSMQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH 568 (834)
Q Consensus 499 ~~~~~~~~~i~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h 568 (834)
..+.|++.++..++++|... ++||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35668899999999988877 8999999999999987 6889999998643 23456789999999999999
Q ss_pred CceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 569 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~ 728 (834)
++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........ .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987654332223344678999999998765 588999999999999999999999865433211 1
Q ss_pred ccccccc--cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 729 GHAWDLW--KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 729 ~~~~~~~--~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... ....+.+.+++.+ ..........+.+++.+||+.||.+||++++|+++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0000000 0111222233322 234566778899999999999999999999999999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.73 Aligned_cols=264 Identities=27% Similarity=0.435 Sum_probs=206.4
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..++|++.++||+|+||.||+|+. +++.||||++.... ....+.|.+|+.++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 357899999999999999999987 68899999986543 445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965444445999999999999999999999885 24999999999999999999999999999865432
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. +....
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~-------------~~~~~ 255 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AA-------------VGFKC 255 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HH-------------HHHSC
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-------------HHhcC
Confidence 2 1233467999999999999999999999999999999999999998643321110 00 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
............+.+++.+||+.||.+||+++|+++.|+......
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 011122233456889999999999999999999999999875433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.57 Aligned_cols=262 Identities=24% Similarity=0.423 Sum_probs=214.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999875 5899999999877778888999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999543 345899999999999999999999998 99999999999999999999999999987644322
Q ss_pred cC------------CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccc
Q 003288 671 QG------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 671 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 1114579999999999999999999999999999999999999876543322111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.....+. .........+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 236 -~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 236 -VRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -HHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hhccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0011111 11112234578899999999999999999999999887443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=374.50 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=213.5
Q ss_pred hcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999863 3567999999765 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999997765443334444567889999999999999999999999999999999 8888764322111
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ..+.... ...........+.+++.+||+.||.+||++.|+++.|+++
T Consensus 315 ~-------------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 F-------------KLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp H-------------HHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------------HHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0000000 1111223345788999999999999999999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.68 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=209.3
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----eeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 587 (834)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 578999999999999999999874 8999999996543 33455677999999999999999999998755 36999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc----------CCCceeeCCCCCCcEEecCCCCceee
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY----------SRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
|||+++|+|.+++.. ..+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999943 3489999999999999999999998 7 9999999999999999999999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCC-----CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccc-ccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL-GHA 731 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~-~~~ 731 (834)
|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||........... ...
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999887655444444456899999999999863 556789999999999999999999865433211110 000
Q ss_pred cccccccccc-----cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 732 WDLWKDDRVH-----DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 732 ~~~~~~~~~~-----~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.......... ....+.+............+.+++.+||+.||++|||+.||++.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000000 111111111111234556799999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=359.27 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=208.2
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 57899999999999999999986 46899999999766555677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........... +.......
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------------~~~~~~~~ 235 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--------------IATNGTPE 235 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------HHHHCSCC
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhCCCCC
Confidence 23346799999999999999999999999999999999999999864332110000 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11112234568899999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=364.76 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=208.9
Q ss_pred hcCccccceeccCCcEeEEEEEec----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|++. .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999874 3456999999765 44556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 3346999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ .. .+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~-------------~~ 267 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--IS-------------SV 267 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH-------------HH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HH-------------HH
Confidence 43211 12223456788999999999999999999999999999999 9999854322110 00 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.... ...........+.+++.+||+.||.+||+++||++.|+.+.
T Consensus 268 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 268 EEGY-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC-CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000 11122233457889999999999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=375.22 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=210.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. +++.||||.++... ....+.|.+|+.++++++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 578999999999999999999986 68999999997543 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999953 2345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.........+++.|+|||.+....++.++|||||||++|||++ |..|+........ .+.+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---------------~~~~~~~~ 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---------------REFVEKGG 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---------------HHHHHTTC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHHcCC
Confidence 2222223356788999999999999999999999999999998 8888764332110 00010000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+........+.+++.+||+.||++|||+++|++.|+.+
T Consensus 333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0111122345688999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=357.91 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=214.4
Q ss_pred CcccHHHHHHHhcC----------ccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC
Q 003288 501 PLFSLASITAATEN----------FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR 569 (834)
Q Consensus 501 ~~~~~~~i~~~~~~----------y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ 569 (834)
+.++..++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44677777776654 777889999999999999986 6999999999876666778899999999999999
Q ss_pred ceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec
Q 003288 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 649 (834)
Q Consensus 570 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~ 649 (834)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999983 245899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 003288 650 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~ 729 (834)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999987654321 2234679999999999999999999999999999999999999986432211 000
Q ss_pred cccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. .....+.+ .........+.+++.+||+.||++||+++|+++.
T Consensus 252 ----~~-----~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 ----RL-----RDSPPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HH-----HHSSCCCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HH-----hcCCCCCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000000 1111234568899999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.34 Aligned_cols=276 Identities=26% Similarity=0.403 Sum_probs=209.6
Q ss_pred hcCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Cee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 584 (834)
.++|++.++||+|+||.||++++ .+++.||||++........+.|.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 57899999999999999999984 25889999999887777788999999999999999999999998654 468
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999543 335899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc-ccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 742 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.............. ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543211 222334577889999999999999999999999999999999988754221110000000 00000000001
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
.+.... ..+........+.+++.+||+.||++|||++|+++.|+++...+
T Consensus 244 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111110 11222334467889999999999999999999999998874443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.74 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=206.4
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 46999999998654 4455678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCcccccccccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||........ .. .+...
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~------------~i~~~- 229 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RE------------RVLRG- 229 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH------------HHHHC-
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHhC-
Confidence 2 23456899999999999988875 789999999999999999999864332110 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+......+.+++.+||+.||.+|||++|+++.
T Consensus 230 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 --KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011112234567899999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=372.05 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=199.5
Q ss_pred hcCccccceeccCCcEeEEEEEec----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|++. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 4678999999764 34556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... . .+.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~-------------~~~i 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--V-------------IKAV 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--H-------------HHHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--H-------------HHHH
Confidence 43211 11222345778999999999999999999999999999998 999985432211 0 0111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.... ...........+.+++.+||+.||++||++.||+++|+++..
T Consensus 264 ~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 264 DEGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HTTE-ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC-CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111 111122334578899999999999999999999999988643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=369.40 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=214.8
Q ss_pred ccHHHHHHHhcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeE
Q 003288 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 574 (834)
Q Consensus 503 ~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 574 (834)
+.........++|++.++||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34555566688999999999999999999974 236789999997643 34567899999999999 79999999
Q ss_pred eeeeeecC-eeEEEEEecCCCchhhhhhccCC------------------------------------------------
Q 003288 575 LGCCVEQG-EKILILEYMPNKSLNVFLFDSTK------------------------------------------------ 605 (834)
Q Consensus 575 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------ 605 (834)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999965432
Q ss_pred ---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 606 ---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 606 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
........||+.|+|||++.+..++.++||||||+++|||++ |+.|+......... ...+....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--------------~~~~~~~~- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--------------CRRLKEGT- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--------------HHHHHHTC-
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--------------HHHHHcCC-
Confidence 333445678999999999999999999999999999999998 99998643321100 00000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+||+++||+++|+++
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111122345688999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.18 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=202.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.++||+|+||.||+|++. +++ +||+|.+... .....+.|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999864 344 4688888543 3345678999999999999999999999998754 78
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+........ ...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~ 232 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---------------SSIL 232 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------------HHHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---------------HHHH
Confidence 65544333444567889999999999999999999999999999999 9999864332211 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.... ...........+.+++.+||+.||.+||+++||+++|+...
T Consensus 233 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 233 EKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HTTC-CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HcCC-CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 11112223457889999999999999999999999997753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=367.91 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=215.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 580 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 580 (834)
..++|++.++||+|+||.||+|+.. .++.||||+++.. .....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3578999999999999999999852 2357999999764 344567899999999999 99999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NIL 647 (834)
++..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999965432 245999999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccc
Q 003288 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~ 726 (834)
+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987765443344445677899999999999999999999999999999999 8888764322110
Q ss_pred ccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 727 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
. +.+.... ...........+.+++.+||+.||++||+++||++.|+++....
T Consensus 303 -~-------------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 303 -F-------------KLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -H-------------HHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -H-------------HHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0 0000000 01111223456889999999999999999999999999874433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=358.35 Aligned_cols=254 Identities=26% Similarity=0.320 Sum_probs=204.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 68999999986443 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999983 3456999999999999999999999998 9999999999999999999999999998764433
Q ss_pred ccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............. ... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~--------~~ 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEK--------KT 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTT--------CT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hcc--------cc
Confidence 3333445689999999999988776 788999999999999999999986543321111110 000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||++|||++|+++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000112234567899999999999999999999765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.37 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=210.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+++.+|+.++++++||||+++++++.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468999999999999999999998899999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999843 3346899999999999999999999998 999999999999999999999999999876443211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ ... .. ... .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~~----~~---------~~~-~ 225 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VED----IS---------TGF-R 225 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH----HH---------TTC-C
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HHH----Hh---------cCc-c
Confidence 2223456788999999999999999999999999999999 8888864332110 000 00 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+||+.||.+||+++|+++.|+++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111112245688999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.78 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=213.2
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 578999999999999999999862 3578999999754 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 003288 585 ILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp 643 (834)
++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999965432 234899999999999999999999998 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCC
Q 003288 644 SNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNA 722 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~ 722 (834)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755433333344567889999999999999999999999999999999 9999864332
Q ss_pred CcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 723 DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ....... ...........+.+++.+||+.||.+||++.|+++.|+++
T Consensus 259 ~~~~------~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERLF------NLLKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGHH------HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH------HHhhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2110 0000000 1111222345788999999999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.13 Aligned_cols=262 Identities=27% Similarity=0.346 Sum_probs=201.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeEeeeeeec----CeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQ----GEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 585 (834)
.++|++.++||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999988 7899999999643 34556667777776 7999999999997653 4589
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
+||||+++|+|.+++. ...+++..+++++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346899999999999999999999 666 9999999999999999999999
Q ss_pred ccccceecCCCccc--CCcccccccccccCcccccCC------CCCccCcchhhHHHHHHHHhC----------CCCCCC
Q 003288 658 DFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKNTGV 719 (834)
Q Consensus 658 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwslGvvl~elltg----------~~p~~~ 719 (834)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.|+..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876443221 122335799999999999876 455799999999999999999 555533
Q ss_pred CCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 720 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.......... .... .......+.+............+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFED-MRKV----VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHH-HHHH----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhh-hhHH----HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211110000 0000 000011111111112334667899999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.43 Aligned_cols=276 Identities=25% Similarity=0.372 Sum_probs=213.9
Q ss_pred hcCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeee--ecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 584 (834)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999984 358899999998877777888999999999999999999999887 45568
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998542 235899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 665 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+........................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 754322 1122335678889999999999999999999999999999999998753222111100000000000001111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
+.... ...........+.+++.+||+.||.+||+++|+++.|+......
T Consensus 257 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111 11223334567899999999999999999999999999874433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.73 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=213.9
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
....++|++.+.||+|+||.||+|+.. +++.||||.++.. .....+.|.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344689999999999999999999874 3478999999765 344567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCC
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 640 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 640 (834)
+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999965321 256899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCC
Q 003288 641 LKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGV 719 (834)
Q Consensus 641 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~ 719 (834)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654433333344578899999999999999999999999999999999 8888864
Q ss_pred CCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 720 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...... .. ....... ..........+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 280 ~~~~~~--~~----~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEV--IY----YVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHH--HH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHH--HH----HHhCCCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 322110 00 0000100 01112234578899999999999999999999999998743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=346.75 Aligned_cols=255 Identities=29% Similarity=0.397 Sum_probs=210.1
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|+..++..||+|+++.... ..+++.+|+.++.+++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 578999999999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998543 345899999999999999999999998 999999999999999999999999999876543321
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........... .... . .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~--~--------~ 223 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK------VSQG--H--------R 223 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------HHTT--C--------C
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH------HHcC--C--------C
Confidence 1223456778999999999899999999999999999999 9999864332211000 0000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 001111234688999999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.37 Aligned_cols=266 Identities=25% Similarity=0.428 Sum_probs=206.8
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|+. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46899999999999999999988 5789999998643 345789999999999999999999998873 589999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-ceeeccccceecCCCcc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-~kl~DFGla~~~~~~~~ 670 (834)
++++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976555456889999999999999999999932223999999999999998887 799999999765332
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+............. . .... .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~-~~~~----------~ 222 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---V-HNGT----------R 222 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---H-HTTC----------C
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---H-hcCC----------C
Confidence 223468999999999999999999999999999999999999986433221111100 0 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAF 801 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~ 801 (834)
..........+.+++.+||+.||.+||+++|++++|+.+....+.+..|..
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 111112234678999999999999999999999999988666666555543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=366.76 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=210.1
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999843 4678999999654 445566899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cceee
Q 003288 585 ILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~ 657 (834)
++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 2245899999999999999999999998 99999999999999555 59999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..|+........ .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~-------- 296 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--L-------- 296 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--H--------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H--------
Confidence 9999986543333333444678999999999999999999999999999999998 8888864332110 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+.+.... ...........+.+++.+||+.||.+||++.||++.|+...
T Consensus 297 -----~~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 297 -----EFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0000000 01112223456889999999999999999999999997764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.41 Aligned_cols=272 Identities=20% Similarity=0.281 Sum_probs=214.7
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--eeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 587 (834)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4689999999999999999998764 8999999997543 334677889999999999999999999988765 77999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe----cCCCCceeeccccce
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~ 663 (834)
|||+++++|.+++........+++.+++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ecCCCcccCCcccccccccccCccccc--------CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--cccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~~~~ 733 (834)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 775432 223457899999999986 57889999999999999999999999864332111 00000000
Q ss_pred cccccc----------cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDR----------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~----------~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...... .....................+.+++.+||+.||++||+++|+++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000000 00000011112244566777899999999999999999999999999775
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=360.13 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=210.1
Q ss_pred HhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3578999999999999999999862 35689999997542 33457899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCCC--------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKK--------------------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
..++||||+++|+|.+++...... ..+++..++.++.||++||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 721 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~ 721 (834)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333223344567889999999999999999999999999999998 999986433
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.... ....+.... ...........+.+++.+||+.||.+||++.||++.|+.....
T Consensus 280 ~~~~--------------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDAN--------------FYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHH--------------HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHH--------------HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2110 000000000 1111222345788999999999999999999999999987443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.74 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=205.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 5899999999653 233456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+....
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~------------~i~~~~ 221 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE------------LILMEE 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH------------HHHHCC
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HH------------HHHcCC
Confidence 21 223456899999999999999999999999999999999999999864322110 00 000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
..........+.+++.+||+.||++|| +++|+++.
T Consensus 222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011122345788999999999999999 89999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=356.74 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=195.1
Q ss_pred HhcCccccceeccCCcEeEEEEEecCC----cEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
..++|++.+.||+|+||.||+|+.... ..||||.++.. .....+.+.+|+.++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 357899999999999999999987543 27999998754 345578899999999999999999999999877655
Q ss_pred ------EEEEEecCCCchhhhhhccCC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 585 ------ILILEYMPNKSLNVFLFDSTK---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 585 ------~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999854322 225899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN----- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH-----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH-----
Confidence 999999987755443333344567889999999999999999999999999999999 8888764332211 00
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.+.... ...........+.+++.+||+.||.+||++.++++.|+++.
T Consensus 251 -------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 251 -------YLIGGN--RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp -------HHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHhcCC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000 01112223457889999999999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=348.66 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=207.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+++..+++.||||++..... ..+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 578999999999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ...+++.+++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999542 345899999999999999999999998 999999999999999999999999999876443211
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ .. .+.... .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~-------------~~~~~~-~ 239 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE-------------HIAQGL-R 239 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH-------------HHHTTC-C
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HH-------------HHhccc-C
Confidence 1223456788999999999999999999999999999998 9999864332111 00 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+||+.||.+||+++|+++.|.++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111111235688999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.98 Aligned_cols=261 Identities=27% Similarity=0.382 Sum_probs=213.0
Q ss_pred hcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 57899999999999999999985 246789999997553 34567899999999999 99999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCC---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 584 KILILEYMPNKSLNVFLFDSTK---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
.++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999965432 225899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999987755433333344567889999999999999999999999999999999 8888764332110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+.... ...........+.+++.+||+.||.+||++.|++++|++..
T Consensus 257 ------------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 ------------FYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ------------HHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------HHHHhccCC-CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 000000000 11111223457889999999999999999999999998863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.02 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=205.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999865 5889999998543 345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... .....
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~-~~~~~---- 232 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQD-SVPNV---- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSS-CCCCH----
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhc-cCCCc----
Confidence 321 2233457999999999999999999999999999999999999998643321110 000000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+|| +++++.+.|+..
T Consensus 233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0001112235688999999999999998 999999999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.26 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=197.3
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+|+. .++.||||.++... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 58999999986542 23357889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC--------CCCceeecc
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------DMNPKISDF 659 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~--------~~~~kl~DF 659 (834)
|||+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346899999999999999999999987666899999999999986 678999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
|+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.|+..........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------ 224 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------------ 224 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 9998654332 223578999999999999999999999999999999999999986433211100
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....... ...........+.+++.+||+.||.+||++.|+++.|++
T Consensus 225 --~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 --GVAMNKL-ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --HHHTSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --hhhcCCC-CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0000000 111122234578899999999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=358.92 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC-Cc----EEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.++||+|+||.||+|+... ++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4689999999999999999998643 44 38888875432 333456788999999999999999999886 56789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998532 356899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.|+.......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~----- 234 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD------LLEKGE----- 234 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH------HHHTTC-----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH------HHHcCC-----
Confidence 65544444455678889999999999999999999999999999999 999986533221100 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...........+.+++.+||+.||.+||+++|+++.|+....
T Consensus 235 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001111122356789999999999999999999999988743
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=373.63 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=209.9
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..++|++.++||+|+||.||+|+..+++.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 467899999999999999999999888999999997643 35688999999999999999999999986 5678999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999532 2235789999999999999999999998 99999999999999999999999999987643321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......+|..|+|||++....++.++|||||||+||||++ |+.|+....... ... .+....
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~-------------~i~~~~- 402 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR-------------ALERGY- 402 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH-------------HHHHTC-
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------HHHcCC-
Confidence 1 1122356789999999999999999999999999999999 999986432211 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..+........+.+++.+||+.||++|||+++|++.|+...
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01112223457889999999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=374.38 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=211.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|++.. ++.||||.++... ...++|.+|+.+|++++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 5679999999999999999999865 8899999997543 3467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999643 3345899999999999999999999998 99999999999999999999999999997654322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......++..|+|||++....++.++|||||||+||||++ |+.|+........ .+.+....
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---------------~~~~~~~~- 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEKDY- 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---------------HHHHHTTC-
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHHcCC-
Confidence 1 2223456789999999999999999999999999999999 8888764332110 01111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+||++.+|++.|+..
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111223345788999999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.56 Aligned_cols=260 Identities=26% Similarity=0.439 Sum_probs=211.5
Q ss_pred hcCccccceeccCCcEeEEEEEec--------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 578999999999999999999863 4678999999754 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965432 234899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence 9999999999999998765433333344567889999999999899999999999999999999 8888754322110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.. ..... . ...........+.+++.+||+.||.+||++.|+++.|+++.
T Consensus 269 ~~----~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 FK----LLKEG---------H-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH----HHHHT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcC---------C-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00000 0 01112223456889999999999999999999999998873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.06 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=204.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 578999999999999999999876 589999999865432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC----Cceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 660 (834)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999983 3456999999999999999999999998 99999999999998877 79999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .. .+.....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~----~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NITAVSY 235 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HHHTTCC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhcCC
Confidence 998765432 23346799999999999999999999999999999999999999864322110 00 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~-~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 -D-FDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -C-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -C-CCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0112346789999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=367.77 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=205.3
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-eeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+. .++.||||.++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 57899999999999999999988 47899999997653 4578999999999999999999999987765 78999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999643 2334789999999999999999999998 999999999999999999999999999864322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .. ....+ .
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~----~i~~~---------~- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----RVEKG---------Y- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HH----HHHTT---------C-
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHHcC---------C-
Confidence 122356889999999999999999999999999999998 9999864332211 00 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111223346788999999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.20 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=201.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC-------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------- 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 582 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999986 68999999996543 345678999999999999999999999986654
Q ss_pred --------------------------------------------------eeEEEEEecCCCchhhhhhccCCCccCCHH
Q 003288 583 --------------------------------------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQ 612 (834)
Q Consensus 583 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 612 (834)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766665667788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc----------CCccccccccc
Q 003288 613 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ----------GNTKQIVGTYG 682 (834)
Q Consensus 613 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 682 (834)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987554211 12234579999
Q ss_pred ccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHH
Q 003288 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 762 (834)
Q Consensus 683 y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~ 762 (834)
|+|||++.+..++.++||||||+++|||++|..|+... .... ....... ...........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~------------~~~~~~~--~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRII------------TDVRNLK--FPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHH------------HHHHTTC--CCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHH------------HHhhccC--CCcccccCChhHH
Confidence 99999999999999999999999999999986653210 0000 0000000 0001122345678
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 003288 763 NVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 763 ~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+++.+||+.||++||+++|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=357.21 Aligned_cols=269 Identities=28% Similarity=0.383 Sum_probs=209.3
Q ss_pred ccccceeccCCcEeEEEEEec-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 586 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 586 (834)
|++.++||+|+||.||++... +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999988643 57899999997653 45567899999999999999999999999884 57899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 24899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 22334567889999999999999999999999999999999999875422111111111100111111111221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
... ...........+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 266 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 112233345678999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=371.09 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=205.2
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..++|++.++||+|+||.||+|+...+..||||+++... ...+.|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 357899999999999999999999888889999997543 345789999999999999999999999876 678999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987654321
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ... .+....
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~-------------~i~~~~- 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD-------------QVERGY- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH-------------HHHTTC-
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------HHHcCC-
Confidence 1 1223456789999999999999999999999999999999 888875432211 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
..+........+.+++.+||+.||++|||+++|++.|+.....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1111223345788999999999999999999999999987433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.55 Aligned_cols=272 Identities=26% Similarity=0.391 Sum_probs=207.7
Q ss_pred hcCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--Ce
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 583 (834)
.+.|++.++||+|+||.||++++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999983 358899999997543 34567899999999999999999999999877 66
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998543 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 664 MFGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.........................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 87543221 22334568889999999999999999999999999999999998753211100000000000000000111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ...........+.+++.+||+.||.+|||++|+++.|+++
T Consensus 255 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111111 1122233446788999999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=348.29 Aligned_cols=248 Identities=20% Similarity=0.287 Sum_probs=205.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999876 4889999998654 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC--CCCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~ 668 (834)
+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999843 3346899999999999999999999998 999999999999987 789999999999887543
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||....... ... .+....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~------------~i~~~~- 219 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIE------------NIMNAE- 219 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH------------HHHHTC-
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHH------------HHHcCC-
Confidence 2 2334678999999999999889999999999999999999999986433211 000 000000
Q ss_pred ccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISL----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ....++.+++.+||+.||.+|||+.|+++.
T Consensus 220 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 220 --YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011 123568899999999999999999999984
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.63 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=195.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--------------------------hhHHHHHHHHHHHH
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 564 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 564 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999875 588999999865421 12356899999999
Q ss_pred hcCCCceeeEeeeeee--cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 565 KLQHRNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 565 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56889999999999998875 3356999999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGV 719 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwslGvvl~elltg~~p~~~ 719 (834)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654321 223457999999999998765 47889999999999999999999864
Q ss_pred CCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 720 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... .. ..... .. ..+........+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~--~~----~~~~~--------~~-~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCL--HS----KIKSQ--------AL-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHH--HH----HHHHC--------CC-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHH--HH----HHhcc--------cC-CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321100 00 00000 00 00111123356889999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=357.23 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=210.1
Q ss_pred HhcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||+|+... .+.||+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 46789999999999999999998643 2479999997653 34567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCC-----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC
Q 003288 583 EKILILEYMPNKSLNVFLFDSTK-----------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 651 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~ 651 (834)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999864321 345799999999999999999999998 9999999999999999
Q ss_pred CCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccc
Q 003288 652 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGH 730 (834)
Q Consensus 652 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~ 730 (834)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 9999999999987644332222334567889999999999999999999999999999998 8888754322110
Q ss_pred ccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 731 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 731 ~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+.... ...........+.+++.+||+.||.+||++.||++.|++.
T Consensus 276 ---------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ---------FYKLVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---------HHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHHHhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 000110000 0111111235688999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.37 Aligned_cols=264 Identities=25% Similarity=0.325 Sum_probs=201.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 57899999999999999999999889999999986542 2335778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++ +|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 77777643 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-cccc--------cccccccc-
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGH--------AWDLWKDD- 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~--------~~~~~~~~- 738 (834)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.. .+......
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 12233578999999999876 56899999999999999999999998654432210 0000 00000000
Q ss_pred ----ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 ----RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ----~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......... ..........++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKP-WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCC-HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCc-HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 00001112346789999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=351.27 Aligned_cols=257 Identities=19% Similarity=0.225 Sum_probs=207.5
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+. .+++.||||.+..... .+.+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 4689999999865432 24688999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-----ceeecccccee
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-----~kl~DFGla~~ 664 (834)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 356999999999999999999999998 999999999999998887 99999999997
Q ss_pred cCCCcccC-----CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 665 FGGDELQG-----NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 665 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~---------- 229 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY---------- 229 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH----------
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH----------
Confidence 64432211 124568999999999999999999999999999999999999998754322110000
Q ss_pred cccccccccccCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 740 VHDLIDPVIMQDEISLP----MLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..+..... ....+ ...++.+++..||+.||.+||++.+|++.|++..
T Consensus 230 -~~i~~~~~---~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 230 -QKIGDTKR---ATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -HHHHHHHH---HSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHhhhc---cCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 00000000 00000 0127899999999999999999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=358.08 Aligned_cols=270 Identities=20% Similarity=0.251 Sum_probs=206.1
Q ss_pred hcCccccceeccC--CcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+| +||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5789999999999 99999999986 5899999999654 34556788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 2345899999999999999999999998 9999999999999999999999999987652
Q ss_pred CCc-----ccCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccc--cccccc-
Q 003288 667 GDE-----LQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH--AWDLWK- 736 (834)
Q Consensus 667 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~- 736 (834)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1112233578999999999987 679999999999999999999999986543321110000 000000
Q ss_pred -----cc-------------cccccccc--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 -----DD-------------RVHDLIDP--------VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 -----~~-------------~~~~li~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ...+.+.. .....+........+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 000001122234578999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.38 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=195.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. ..||||.++.. .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 578999999999999999999863 46999998644 345567899999999999999999999965 5567899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999843 3456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.........||+.|+|||.+. ...++.++||||||+++|||++|+.||........ ... ........ +
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~~~~----~ 245 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIE----MVGRGSLS----P 245 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHH----HHHHTSCC----C
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHH----HhcccccC----c
Confidence 333344567999999999986 66788999999999999999999999864332111 000 00000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+ ..........+.+++.+||+.||.+||++.|++++|+++
T Consensus 246 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 246 DL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00 111122345789999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.97 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEecC-C-------cEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+... + +.||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998653 3 4799999987777778899999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC--------ce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PK 655 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~--------~k 655 (834)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999542 334899999999999999999999998 999999999999998887 99
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+......... .. .
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~----~ 230 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQ----F 230 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HH----H
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HH----H
Confidence 999999875432 233568899999999987 77999999999999999999965543221111000 00 0
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. . ...........+.+++.+||+.||++|||++|+++.|+++
T Consensus 231 ~~---------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 231 YE---------D---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HH---------T---TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred hh---------c---cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 00 0 0001111123578899999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=349.05 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=204.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 589999999865422 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC----Cceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 660 (834)
++||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999984 3456899999999999999999999998 99999999999998887 79999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~----~~~~- 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANV----SAVN- 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHH----HHTC-
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH----HhcC-
Confidence 998775332 22345799999999999999999999999999999999999999854322110 0000 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..... .......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YE-FEDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-CCHHH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-cCccc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000 00123467899999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=352.26 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=202.0
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 468999999986431 22345789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+ +|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888743 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .+.+..
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~ 222 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNS 222 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHc
Confidence 32 2234579999999999988876 7899999999999999999999864322111 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ...........+.+++.+||+.||.+|||++|+++.
T Consensus 223 ~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 C--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 001112234567899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.90 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=211.8
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
....++|++.+.||+|+||.||+|+.. .++.||||.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 334688999999999999999999764 36789999997543 34556799999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCc
Q 003288 582 GEKILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~ 654 (834)
+..++||||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999985422 1245789999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003288 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~---- 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR---- 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HH----
Confidence 9999999987644333233334567889999999999999999999999999999999 7888754322110 00
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...... . ..........+.+++.+||+.||.+||++.|+++.|++.
T Consensus 252 ~~~~~~--------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVMEGG--------L--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHTTC--------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCC--------c--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 000000 0 011122345688999999999999999999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.77 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=200.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 5889999998644 33445788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..+. .....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444443 22356999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc---ccccc---ccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL---WKDDR---VHD 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~---~~~ 742 (834)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ ........ ..... ..+
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcc
Confidence 2223457899999999998765 89999999999999999999888533222110 00000000 00000 000
Q ss_pred ccc--------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LID--------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+ ...............+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000011112334578899999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=343.69 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=195.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... +..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 5789999999999999999998743 457999998764 3445678999999999999999999999974 567899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998532 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... ......+|+.|+|||.+....++.++||||||+++|||++ |..||........ .. ......
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~----~i~~~~------ 234 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE------ 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTC------
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH----HHHcCC------
Confidence 43221 2233456789999999999999999999999999999997 8888864332111 00 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||++||++.|+++.|+++
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.96 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=197.5
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCC--CceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 5689999999999999999999988999999998643 44556789999999999976 9999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999853 356899999999999999999999998 99999999999997 57899999999987755
Q ss_pred CcccCCcccccccccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------- 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------- 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----------
Confidence 433333445689999999999865 67899999999999999999999998632211000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+++.. ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ---~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 ---LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhcCCc-ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011111111 111111123467899999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.12 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=200.5
Q ss_pred HHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc--CCCceeeEeeeeeec----Ce
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQ----GE 583 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 583 (834)
...++|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++.+. ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34678999999999999999999884 8999999986432 23445566666554 899999999999887 68
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc--------CCCceeeCCCCCCcEEecCCCCce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------SRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence 8999999999999999943 3589999999999999999999988 6 99999999999999999999
Q ss_pred eeccccceecCCCcccC--CcccccccccccCcccccCCCCCcc------CcchhhHHHHHHHHhCCCCCCCCCCCcccc
Q 003288 656 ISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSSKKNTGVYNADSFNL 727 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDVwslGvvl~elltg~~p~~~~~~~~~~~ 727 (834)
|+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|..|+..........
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998764432211 1234579999999999988777665 999999999999999955543221111100
Q ss_pred ccc-----ccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 728 LGH-----AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 728 ~~~-----~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ...............+..............+.+++.+||+.||.+||++.||++.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 000 000000000001111111111112356678999999999999999999999999998863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=352.68 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=203.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 5899999998532 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeecccc
Q 003288 586 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGL 661 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGl 661 (834)
+||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FE----GIIKGKYK 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HH----HHHHTCCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HH----HHHcCCCC
Confidence 988754322 2234579999999999999999999999999999999999999986422110 00 00000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+.. . ......+.+++.+||+.||++||++.|+++.
T Consensus 251 --~~~~~-~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQ-W----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHH-H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccc-c----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 0123568899999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.18 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=199.8
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 585 (834)
..++|++.++||+|+||.||+++.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999875 4899999999653 233456788999999998 7999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999853 345899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~------------~~i~~ 238 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--F------------EAILN 238 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H------------HHHHH
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--H------------HHHHc
Confidence 3221 223456899999999999999999999999999999999999999864332110 0 00011
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
.. ..........+.+++.+||+.||.+||++ +|+++
T Consensus 239 ~~---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DE---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 10 01112234567899999999999999998 77765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.20 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=207.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +++.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 5889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC--CCCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~ 668 (834)
+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999843 3346899999999999999999999998 999999999999974 577999999999987543
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..... ..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i----~~~~~------~~ 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNV----KRCDW------EF 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH----HHCCC------CC
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHH----HhCCC------CC
Confidence 2 2234579999999999999999999999999999999999999986433211 00000 00000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||.+|||+.|+++.
T Consensus 270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011111234568899999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.71 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=199.6
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999997899999999965432 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888743 2346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--ccc----cccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLG----HAWDLWKDDRVHDL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~~----~~~~~~~~~~~~~l 743 (834)
.......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... ... .....+........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 122335789999999998764 5899999999999999999999998653321100 000 00000000000000
Q ss_pred cccccc------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIM------QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.++... ...........+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000111234567899999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.96 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=201.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999876 47889999997542 23345678999999887 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999853 345899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc-ccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD-LID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-li~ 745 (834)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+.+ +..
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~------~~~~~~~~i~~ 276 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------TEDYLFQVILE 276 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C------CHHHHHHHHHH
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh------hHHHHHHHHhc
Confidence 22 12344578999999999999999999999999999999999999998643221100000 0000000 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
. ...........+.+++.+||+.||++||++ +||++
T Consensus 277 ~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 277 K---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp C---CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred c---ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1 111222344578899999999999999985 56654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=340.96 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=209.4
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+++..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468999999999999999999998889999999976533 3468899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998543 345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ..... . .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~i~~~-----~-----~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE----DISTG-----F-----R 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHTT-----C-----C
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHH----HHhcC-----C-----c
Confidence 11223456789999999998999999999999999999999 888876432211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..........+.+++.+||+.||.+||+++|+++.|+++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112345688999999999999999999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=349.02 Aligned_cols=267 Identities=27% Similarity=0.395 Sum_probs=213.1
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLG 576 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 576 (834)
........++|++.+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445578999999999999999999974 246889999997653 34567899999999999 7999999999
Q ss_pred eeeecC-eeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCC
Q 003288 577 CCVEQG-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 577 ~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 642 (834)
++.+.+ ..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988765 58999999999999999965432 223889999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCC
Q 003288 643 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 721 (834)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~ 721 (834)
|+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433233344577899999999999999999999999999999998 998876433
Q ss_pred CCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 722 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... .. ....... ...........+.+++.+||+.||.+||++.||++.|+.+
T Consensus 256 ~~~~-~~----~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEE-FC----RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHH-HH----HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHH-HH----HHhccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2110 00 0000000 0111122345688999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=348.36 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=200.3
Q ss_pred HhcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-- 582 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 582 (834)
..++|.+.+.||+|+||.||+|+... ++.||||.++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 46789999999999999999997642 458999998644 3455678999999999999999999999998765
Q ss_pred ---eeEEEEEecCCCchhhhhhcc---CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 583 ---EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 583 ---~~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
..++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 359999999999999998533 23456999999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........ .. ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD----YL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH----HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH----HH
Confidence 99999987654433333344567889999999999999999999999999999999 8888754332111 00 00
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 794 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 794 (834)
.... ...........+.+++.+||+.||.+||++.++++.|+++...+|
T Consensus 263 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0000 011112233568899999999999999999999999998754443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.21 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=204.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999999875 5899999999654 3445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~ 665 (834)
||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999884 3456899999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ....... ..
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~----~i~~~~~-~~-- 249 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYA----QIKAGAY-DY-- 249 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTCC-CC--
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHhCCC-CC--
Confidence 5332 2234679999999999999999999999999999999999999986432211 000 0000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||++||++.|+++.
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000011224568899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=354.21 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=204.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999875 48899999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ..+
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~------------~~~ 232 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV------------HTF 232 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH------------HHH
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH------------HHH
Confidence 32 2345689999999999874 45899999999999999999999998643322111000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVIS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 784 (834)
... ...........+.+++.+||+.||.+||+ +++|.+
T Consensus 233 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 01112223457889999999999999998 777765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.68 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=210.6
Q ss_pred hcCccccc-eeccCCcEeEEEEEec---CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+ .||+|+||.||+|... +++.||||.++.. .....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999854 5778999999765 345677899999999999999999999999 5567899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999843 3456899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ .. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~i~~~~----- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK----- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHhcCC-----
Confidence 4322 122233456889999999998899999999999999999998 9999864332110 00 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPS 795 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 795 (834)
...........+.+++.+||+.||++||++.|+++.|+........
T Consensus 231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 0111223345788999999999999999999999999887444333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.83 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=200.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.++||+|+||.||+|+.. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999864 344 4688887543 3446788999999999999999999999998754 78
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---------------~~~~ 232 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---------------SSIL 232 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------------HHHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---------------HHHH
Confidence 55433333344567889999999999999999999999999999999 9999864332211 0111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.... ...........+.+++.+||+.||.+||++.|+++.|++..
T Consensus 233 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 233 EKGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HTTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1100 11112223456889999999999999999999999998874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.68 Aligned_cols=263 Identities=17% Similarity=0.235 Sum_probs=209.5
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56899999999999999999986 468999999986543 234678899999999 79999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-----ceeecccccee
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-----~kl~DFGla~~ 664 (834)
|+ +++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999543 345899999999999999999999998 999999999999987776 99999999998
Q ss_pred cCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccc
Q 003288 665 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDD 738 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 738 (834)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GEK 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----HHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH----Hhh
Confidence 7543221 123456799999999999999999999999999999999999999875432211 000000 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.. ... ...........+.+++.+||+.||++||++++|++.|+++...
T Consensus 237 ~~----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 237 KQ----STP--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HH----HSC--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cc----Ccc--HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 00 000 0000111235788999999999999999999999999887443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=346.73 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=204.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+++.. +|+.||+|.++... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999875 58999999996532 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999953 345899999999999999999999998 99999999999999999999999999987543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..++...
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~------------~~i~~~~ 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY------------EKILNAE 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH------------HHHHHCC
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH------------HHHHhCC
Confidence 2 234689999999999999999999999999999999999999986432211 00 0011110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
. .........+.+++.+||+.||++|| +++|+++.
T Consensus 220 ~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0 11122345688999999999999999 88998853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.44 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=204.3
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
..++|++.++||+|+||.||++... +|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999864 68999999986543 34567789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec---CCCCceeecccccee
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~ 664 (834)
|||+++|+|.+.+.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998853 345899999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ....+.. .
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~~-~-- 231 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ----QIKAGAY-D-- 231 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTCC-C--
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhCCC-C--
Confidence 654321 22346799999999999999999999999999999999999999854322110 00 0000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ..+........+.+++.+||+.||++|||+.|+++.
T Consensus 232 ---~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ---F-PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---C-CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---C-CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 001111234568899999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.60 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=198.1
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcC--CCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999998643 4456688999999999996 59999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999854 346889999999999999999999998 99999999999995 57999999999987754
Q ss_pred CcccCCcccccccccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---------- 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------- 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----------
Confidence 433333345689999999999865 46889999999999999999999998632211000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+..++++.. ...........+.+++.+||+.||.+||++.|+++.
T Consensus 277 ---~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 ---LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhCccc-cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111111 001111113467899999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.25 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=196.4
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 583 (834)
.++|++.++||+|+||.||+++. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999986 46889999999754 33456788999999999999999999999887654
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999853 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 664 MFGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 664 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~--- 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDP--- 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCC---
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCC---
Confidence 7644321 12233457899999999999999999999999999999999999998643321110 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS-DVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L~~~ 789 (834)
..+.. ........+.+++.+||+.||.+||++. ++.+.|.+.
T Consensus 237 -~~~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 -IPPSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -CCHHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00000 0011235688999999999999999655 455566554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.65 Aligned_cols=257 Identities=31% Similarity=0.430 Sum_probs=207.9
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|+..+++.||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 57899999999999999999998888899999996543 34578999999999999999999999876 45689999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998432 1235899999999999999999999998 999999999999999999999999999877543221
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ... ..... . .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~-----~-----~ 228 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ----NLERG-----Y-----R 228 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTT-----C-----C
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHH----HHhcc-----c-----C
Confidence 1223456789999999998899999999999999999999 888875432211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..........+.+++.+||+.||++||++.++++.|++...
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 01112234578899999999999999999999999988643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.35 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=193.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+..|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999986 6899999998653 233445566666666666 899999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67888887543 345999999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..++..... +........ .+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~~~----~~~ 272 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQGYL----PPE 272 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTTCC----CHH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhccCC----Ccc
Confidence 32 2234568999999998876 789999999999999999999766432110 001111100 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .......+.+++.+||+.||++|||++|+++
T Consensus 273 ~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 F-----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 1112357889999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=351.87 Aligned_cols=267 Identities=17% Similarity=0.212 Sum_probs=200.1
Q ss_pred hcCccccceeccCCcEeEEEEEec----CCcEEEEEEecCCChh-----------hHHHHHHHHHHHHhcCCCceeeEee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLLG 576 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 576 (834)
.++|++.++||+|+||.||+|+.. .+..+|||.+...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5678999998755322 1234678889999999999999999
Q ss_pred eeee----cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC
Q 003288 577 CCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 652 (834)
Q Consensus 577 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~ 652 (834)
++.+ ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 337999999999999999999999998 99999999999999887
Q ss_pred --CceeeccccceecCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc
Q 003288 653 --NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF 725 (834)
Q Consensus 653 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~ 725 (834)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999877433211 112345799999999999999999999999999999999999999853222111
Q ss_pred cccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 726 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...... ......+...+............+.+++.+||+.||++||++++|++.|++...
T Consensus 269 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAK------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHH------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHH------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110000 000000000000000001233478899999999999999999999999988633
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.73 Aligned_cols=254 Identities=26% Similarity=0.510 Sum_probs=202.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChh-------hHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999874 6899999998643321 1267899999999999999999999987654
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC-----ceeec
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISD 658 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~-----~kl~D 658 (834)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999888854 3456999999999999999999999985 24999999999999988776 99999
Q ss_pred cccceecCCCcccCCcccccccccccCcccc--cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..............
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----- 242 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----- 242 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-----
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-----
Confidence 999985432 23346789999999998 455678999999999999999999999865433221111100
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..... ...........+.+++.+||+.||.+||+++|+++.|++
T Consensus 243 -------~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 -------REEGL-RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------hccCC-CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00000 111222334578899999999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.48 Aligned_cols=262 Identities=21% Similarity=0.246 Sum_probs=206.8
Q ss_pred HhcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 585 (834)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999987 4689999999977777778889999999999999999999999873 34789
Q ss_pred EEEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 586 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999986432 3456999999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCccc-------CCcccccccccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 665 FGGDELQ-------GNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 665 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
....... .......||+.|+|||.+.... ++.++||||||+++|||++|+.|+..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------- 256 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------- 256 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-------
Confidence 5321110 0112345799999999987654 6899999999999999999999975311110000
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+.... ..+........+.+++.+||+.||.+||+++|+++.|+.+
T Consensus 257 ------~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 257 ------ALAVQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ------HHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------hHHhhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00000000 1111122345788999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.57 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=202.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|++.+.||+|+||.||+|+... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999998653 236999999754 3445668999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999854 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccc
Q 003288 666 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. +.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~-------------~~ 262 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM-------------KA 262 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH-------------HH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HH-------------HH
Confidence 543211 11223356789999999999999999999999999999999 999985432211 00 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
+.... ...........+.+++.+||+.||.+||++.++++.|+++..
T Consensus 263 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 263 INDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHTTC-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHCCC-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000 011122234568899999999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=353.42 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=203.1
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCee
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 584 (834)
...++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45689999999999999999999985 58899999996532 23456788899999987 999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999853 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ...
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~----~i~-------- 231 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----SIR-------- 231 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHH--------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHH--------
Confidence 43221 22345689999999999999999999999999999999999999986432211 000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS-DVI 783 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 783 (834)
.. ...........+.+++.+||+.||++||++. |++
T Consensus 232 ~~---~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MD---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred hC---CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 0011112345688999999999999999997 665
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.10 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=211.7
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..++|++.+.||+|+||.||+|+... ++.||+|.+... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 36789999999999999999999865 888999999754 3456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 3356899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........ .+.+....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---------------~~~~~~~~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEKDY 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---------------HHHHHTTC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHhccC
Confidence 2 12233467889999999999999999999999999999999 8888764332111 00010000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+||++.|+++.|+..
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111222345788999999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.59 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=205.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999875 5899999998643 23456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ....+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999983 3456899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.|+............ +.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~-------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT-------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-----HHTTCT--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----hhhccc--------
Confidence 2233345678999999999988765 78899999999999999999998654332111110 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00001123456789999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.30 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=203.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999976 4889999999654 344567789999999988 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999853 345899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc-cccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH-DLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~li~ 745 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...... .+..
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~~~~i~~ 233 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------TEDYLFQVILE 233 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------CHHHHHHHHHH
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc------cHHHHHHHHHc
Confidence 221 2234568999999999999999999999999999999999999998643211100000 000000 0001
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
.. ..........+.+++.+||+.||.+||++ .|+++
T Consensus 234 ~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 234 KQ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CC---CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 10 11222334578899999999999999995 56654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=373.20 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=209.0
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..++|++.++||+|+||.||+|++..++.||||+++... ...++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 357899999999999999999999888889999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......++..|+|||++....++.++|||||||+||||++ |+.|+....... ... .+....
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~-------------~i~~~~- 481 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD-------------QVERGY- 481 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHH-------------HHHTTC-
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------HHHcCC-
Confidence 1 1223456789999999999999999999999999999999 888875432211 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...........+.+++.+||+.||++||++++|+++|+...
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112233457889999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.31 Aligned_cols=246 Identities=20% Similarity=0.262 Sum_probs=204.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 58999999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998542 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+....
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~------------~~i~~~~ 254 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IY------------EKIVSGK 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------------HHHHHCC
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HH------------HHHHcCC
Confidence 2 234689999999999999999999999999999999999999986432211 00 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
..........+.+++.+||+.||.+||+ ++||++.
T Consensus 255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0111223456889999999999999998 8888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.89 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=194.6
Q ss_pred hcCccccceeccCCcEeEEEEEe----cCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999987 468999999997542 2345668899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999843 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ..+
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~------------~~i 233 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TI------------DKI 233 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH------------HHH
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HH------------HHH
Confidence 643221 12334579999999999999999999999999999999999999986432211 00 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.... ..........+.+++.+||+.||.+|| ++.|+++.
T Consensus 234 ~~~~---~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKCK---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHTC---CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhCC---CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0000 011122345688999999999999999 77888764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.92 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=189.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 578999999999999999999986 47899999997543 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeeccccceecCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~~~ 667 (834)
+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999984 3456899999999999999999999998 999999999999975 88999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......... . ....... ..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~----~i~~~~~-~~---- 270 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-R----RILNCEY-YF---- 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-H----HHHTTCC-CC----
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-H----HHHhCCC-cc----
Confidence 22 2234678999999999999999999999999999999999999986433221100 0 0000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........+.+++.+||+.||++||++.|+++.
T Consensus 271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112234568899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.64 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=183.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999874 68999999986432 22357789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999853 3356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ . .......
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~------------~~~~~~~ 228 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L------------NKVVLAD 228 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H------------HHHhhcc
Confidence 321 12235789999999999999999999999999999999999999864332110 0 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.||++||+++++++
T Consensus 229 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 ---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111123356789999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.38 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=205.0
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec--CeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 587 (834)
.++|++.++||+|+||.||+|+. +++.||||+++.. .....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46899999999999999999998 5889999999754 345567899999999999999999999999887 788999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++... ....+++.+++.++.||++||+|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999542 2335899999999999999999999874 3499999999999999999999999988764322
Q ss_pred CcccCCcccccccccccCcccccCCCCCc---cCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.|+......... ....
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------------~~~~ 224 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--------------MKVA 224 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH--------------HHHH
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH--------------HHHH
Confidence 2347899999999998765554 799999999999999999998643321110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... ...........+.+++.+||+.||++|||++|+++.|+++
T Consensus 225 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 225 LEGL-RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0000 1111222345688999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.00 Aligned_cols=261 Identities=27% Similarity=0.376 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeee-ecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 585 (834)
..+|++.++||+|+||.||+|+..+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999998643 235899998764 3445678999999999999999999999865 456789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++.. ....+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999953 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCCCCCCccccccccccccccccccc
Q 003288 666 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|. +|+........ .... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~----~~~---- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYL----LQG---- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHH----HTT----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHH----hcC----
Confidence 543321 1223356788999999999999999999999999999999955 45433222111 0000 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
. ...........+.+++.+||+.||.+||+++|+++.|+++...+
T Consensus 249 ----~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 ----R--RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----C--CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00111112346889999999999999999999999999875443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.83 Aligned_cols=268 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999864 6899999999753 345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999985422 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+............. ......
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~------ 255 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDY------ 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCS------
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccC------
Confidence 3321 2233578999999999999999999999999999999999999985432211111100 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 797 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~ 797 (834)
...........+.+++.+||+.||.+||++++|++.|+++....++|+
T Consensus 256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 000111234568899999999999999999999999998865555443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.92 Aligned_cols=270 Identities=16% Similarity=0.206 Sum_probs=205.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCCChhhH-----------HHHHHHHHHHHhcCCCceeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRL 574 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 574 (834)
.++|++.++||+|+||.||+|++.. ++.||||.+........ ..+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 5689999999999999999998764 47899999876543211 123456667777889999999
Q ss_pred eeeeeec----CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-
Q 003288 575 LGCCVEQ----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD- 649 (834)
Q Consensus 575 ~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~- 649 (834)
++++.+. ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998875 4589999999 9999999854 3356999999999999999999999998 99999999999999
Q ss_pred -CCCCceeeccccceecCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCC
Q 003288 650 -KDMNPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD 723 (834)
Q Consensus 650 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~ 723 (834)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999877543211 1123356999999999999999999999999999999999999998742221
Q ss_pred cccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 724 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
... ....... ....+..++++.+... ....++.+++..||+.+|.+||++.+|++.|++.....
T Consensus 268 ~~~-~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKY-VRDSKIR-YRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHH-HHHHHHH-HHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH-HHHHHHH-hhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 110 0000000 0011222222222111 12356889999999999999999999999998764433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.06 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=193.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 578999999999999999999986 689999999965432 336688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC--ceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999843 345899999999999999999999998 999999999999987765 999999999753222
Q ss_pred cccCCcccccccccccCcccccCCCCCcc-CcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ... ...+....
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~---------~~~~~~~~ 238 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKT---------IQRILSVK 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHH---------HHHHHTTC
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHH---------HHHHhcCC
Confidence 12334579999999999988888766 89999999999999999998643321110 000 00000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ..+........+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 Y-SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C-CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C-CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 001111223567899999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=350.26 Aligned_cols=247 Identities=27% Similarity=0.323 Sum_probs=196.9
Q ss_pred ccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCCCc
Q 003288 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
..+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999874 589999999987766677889999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe--cCCCCceeeccccceecCCCcccCC
Q 003288 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9998853 2345899999999999999999999998 9999999999999 5678899999999998754322
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCC
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~ 753 (834)
.....||+.|+|||++....++.++|||||||++|||++|+.||........ .... ..... .... ..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i----~~~~~-~~~~------~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNI----LACRW-DLED------EE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH----HHTCC-CSCS------GG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----HhccC-CCCh------hh
Confidence 2334799999999999999999999999999999999999999864332110 0000 00000 0000 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 754 SLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......+.+++.+||+.||.+||++.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112356889999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.85 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=206.0
Q ss_pred cCccccceeccCCcEeEEEEEecC----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee-EE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK-IL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 586 (834)
-.|.+.++||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677999999999999998643 2379999997643 34567899999999999999999999999876655 99
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+.+++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999954 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCC-CCCCcccccccccccccccccccc
Q 003288 667 GDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 667 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.. ..... .. ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~-------------~~ 240 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LT-------------HF 240 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HH-------------HH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HH-------------HH
Confidence 4321 1223345788999999999999999999999999999999996665432 21111 00 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
+.... ...........+.+++.+||+.||.+|||++++++.|+++...+
T Consensus 241 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 241 LAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhcCC-CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 00000 01111223356889999999999999999999999998875443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.52 Aligned_cols=261 Identities=20% Similarity=0.229 Sum_probs=202.0
Q ss_pred HHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 508 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 508 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
+....++|++.++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455789999999999999999999874 5789999998543 344567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccC-------------------------------------CCccCCHHHHHHHHHHHHHH
Q 003288 582 GEKILILEYMPNKSLNVFLFDST-------------------------------------KKRLLNWQARVRIIEGIAQG 624 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 624 (834)
+..++||||+++|+|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 12234677888999999999
Q ss_pred HHHHHhcCCCceeeCCCCCCcEEecCCC--CceeeccccceecCCCcc--cCCcccccccccccCcccccC--CCCCccC
Q 003288 625 LLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALD--GLFSIKS 698 (834)
Q Consensus 625 L~~LH~~~~~~ivH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~s 698 (834)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987643211 112344679999999999875 6789999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc-cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 699 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM-QDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 699 DVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
||||||+++|||++|+.||........ . ..++..... ..+........+.+++.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~--~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT--I------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH--H------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH--H------------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999864332110 0 000000000 0000111345788999999999999999
Q ss_pred CHHHHHHH
Q 003288 778 TMSDVISM 785 (834)
Q Consensus 778 t~~evl~~ 785 (834)
++.|+++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=350.01 Aligned_cols=272 Identities=26% Similarity=0.415 Sum_probs=210.3
Q ss_pred hcCccccceeccCCcEeEEEEEe-----cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--ee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 584 (834)
.++|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 358899999998877777889999999999999999999999987654 78
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999543 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc-ccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 742 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.............. ........+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543221 112234567889999999988899999999999999999999988653211100000000 00000000111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ..+........+.+++.+||+.||++||++.||++.|+.+
T Consensus 275 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 1112223346788999999999999999999999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=361.77 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=207.5
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 580 (834)
+.++....++|++.++||+|+||.||+|+... ++.||||++++.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445557899999999999999999999865 7889999996432 1223348899999999999999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
++..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999954 2356999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~------ 291 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG------ 291 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH------
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HH------
Confidence 9987644322 1223468999999999987 56789999999999999999999999864332111 00
Q ss_pred ccccccccccc--ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 736 KDDRVHDLIDP--VIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
.++.. .+............+.+++.+||+.+|++ ||+++|+++.
T Consensus 292 ------~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 292 ------KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ------HHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ------hhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 00000001113456789999999888888 9999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.71 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=205.1
Q ss_pred hcCccccceeccCCcEeEEEEEe------cCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999984 24678999999654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceee
Q 003288 585 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~ 657 (834)
++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 245899999999999999999999998 999999999999984 4569999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLE----FVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHH----HHh
Confidence 9999986644333333344578899999999999999999999999999999998 888876432211 000 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ...........+.+++.+||+.||.+||++.||++.|+...
T Consensus 260 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 000 01111223456889999999999999999999999998763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=350.38 Aligned_cols=252 Identities=15% Similarity=0.152 Sum_probs=205.1
Q ss_pred HhcCccccceeccCCcEeEEEEE------ecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 581 (834)
..++|++.++||+|+||.||+|+ ...++.||||+++... ..++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35789999999999999999994 3468899999997653 456778888888886 99999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---------
Q 003288 582 GEKILILEYMPNKSLNVFLFDST--KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------- 650 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~--------- 650 (834)
+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996432 3456999999999999999999999998 999999999999998
Q ss_pred --CCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccc
Q 003288 651 --DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 728 (834)
Q Consensus 651 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~ 728 (834)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999999999998764332223344567999999999999999999999999999999999999997532211100
Q ss_pred ccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcc
Q 003288 729 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR-PTMSDVISMINNE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~ 789 (834)
+...+ ... .....+.+++..|++.+|.+| |+++++.+.|++.
T Consensus 295 ---------------~~~~~-~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 ---------------PEGLF-RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------ECSCC-TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------echhc-ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111 111 124457788999999999999 7888888888775
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.57 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=196.2
Q ss_pred cCccccceeccCCcEeEEEEEecC--C--cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee-cCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 586 (834)
..|++.++||+|+||.||+|+..+ + ..||||.++.. .....+.|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998642 2 36899998654 34566889999999999999999999998764 457899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999953 3345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccC--CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccc
Q 003288 667 GDELQG--NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 667 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+........ ... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~----~~~~~---- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY----LLQGR---- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHH----HHTTC----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHH----HHcCC----
Confidence 432211 2233467889999999999999999999999999999999 5666653322111 000 00000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 794 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 794 (834)
...........+.+++.+||+.||++||+++|+++.|+.+...+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001111223568899999999999999999999999998754444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=352.31 Aligned_cols=272 Identities=20% Similarity=0.286 Sum_probs=213.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC--eeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 587 (834)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999998764 8999999997543 334677889999999999999999999998765 77999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe----cCCCCceeeccccce
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~ 663 (834)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966555555999999999999999999999998 9999999999999 777889999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccC--------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--cccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~~~~ 733 (834)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 765432 2233579999999999865 5678899999999999999999999864332111 11000000
Q ss_pred ccccccc----------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 734 LWKDDRV----------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 734 ~~~~~~~----------~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... .+..................+.+++.+||+.||++||++.|+++.++.+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 0000000 0000011112234566777899999999999999999999999998775
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.60 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=202.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... +..||+|.+... .....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 5789999999999999999998643 346999999765 34556789999999999999999999999765 45689
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999542 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ .. ......
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~----~~~~~~------ 231 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG----VLEKGD------ 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH----HHHHTC------
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH----HHhcCC------
Confidence 43221 1233456889999999998999999999999999999998 9999864322211 00 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||++||++.|+++.|+.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011112335688999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.44 Aligned_cols=267 Identities=27% Similarity=0.361 Sum_probs=189.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 58999999986543 2344678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|++ ++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988885432 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccc--------ccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG--------HAWDLWK 736 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~--------~~~~~~~ 736 (834)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+. ..+....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 332 12234578999999999876 4689999999999999999999999865432111 0000 0000000
Q ss_pred c-ccccccc--------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 D-DRVHDLI--------DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~-~~~~~li--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ......+ ...+ ...........+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVL-QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHH-GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhh-cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000 0000 000111223568899999999999999999999763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.18 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=193.6
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeee--------e
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCV--------E 580 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 580 (834)
...+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3568999999999999999999875 68999999997777777788999999999996 999999999984 3
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
....++||||+. |+|.+++........+++.+++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345799999996 789888865445567999999999999999999999874 249999999999999999999999999
Q ss_pred cceecCCCcccC----------CcccccccccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc
Q 003288 661 LARMFGGDELQG----------NTKQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 727 (834)
Q Consensus 661 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~ 727 (834)
+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+....... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--I 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--h
Confidence 998765432111 11234689999999998 56778999999999999999999999985322111 0
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
.. ... ...........+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus 262 ~~----------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 VN----------------GKY-SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------C-CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hc----------------Ccc-cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 000 00001111234678999999999999999999999998875433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.42 Aligned_cols=266 Identities=22% Similarity=0.252 Sum_probs=199.3
Q ss_pred hcCcccc-ceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.+.|++. ++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999864 6899999999776666678899999999995 7999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~~ 665 (834)
||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 45899999999999999999999998 999999999999988776 999999999865
Q ss_pred CCCcc-----cCCcccccccccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 666 GGDEL-----QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 666 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||..................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223569999999999875 56889999999999999999999998754332110000000000
Q ss_pred cccccccccccccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+.+... ...... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000000 001111 123568899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.13 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=203.6
Q ss_pred HhcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 585 (834)
..++|++.++||+|+||.||+++... ++.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999864 7889999996532 23456788999999988 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999853 245899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+..
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~------------~~i~~ 235 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF------------QSIME 235 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------------HHHHH
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HH------------HHHHh
Confidence 3221 22345689999999999999999999999999999999999999986432211 00 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
.. ..........+.+++.+||+.||.+||+ ++|+++.
T Consensus 236 ~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 10 0111223457889999999999999995 5777654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=359.00 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=205.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999876 68999999996432 22356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999998654
Q ss_pred CcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ... .+.+.
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~------------~i~~~ 231 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFK------------KICDG 231 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHH------------HHHTT
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHH------------HHhcC
Confidence 32 2334579999999999998776 689999999999999999999986432211 000 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. .........+.+++.+||+.||.+|||++|+++.
T Consensus 232 ~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IF---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cc---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00 0111123467899999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.11 Aligned_cols=246 Identities=21% Similarity=0.310 Sum_probs=203.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+... ++.+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 5689999999999999999998764 778999999776556678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceecCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~~ 667 (834)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998853 345899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.|+........ .. .+...
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~------------~~~~~- 222 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--ML------------KIREG- 222 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH------------HHHHC-
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HH------------HHHhC-
Confidence 32 22345789999999988654 89999999999999999999999864332110 00 00000
Q ss_pred cccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... .....+.+++.+||+.||.+||++.|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 --TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111 12357889999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=343.97 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=205.5
Q ss_pred HHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHh--cCCCceeeEeeeeeecC----
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG---- 582 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 582 (834)
....++|++.+.||+|+||.||+|+. +++.||||.+... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44568999999999999999999988 6899999999643 34677889999988 78999999999998876
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeCCCCCCcEEecCCCCc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNP 654 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dikp~NILl~~~~~~ 654 (834)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999943 35899999999999999999999 666 9999999999999999999
Q ss_pred eeeccccceecCCCccc--CCcccccccccccCcccccCC------CCCccCcchhhHHHHHHHHhC----------CCC
Q 003288 655 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKN 716 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDVwslGvvl~elltg----------~~p 716 (834)
||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543211 123345799999999998775 234789999999999999999 445
Q ss_pred CCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 717 TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+........... ...... ......+.+............+.+++.+||+.||++||+++||+++|+++
T Consensus 267 ~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVE-EMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHH-HHHHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHH-HHHHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 432221110000 000000 01111111111112335667899999999999999999999999999886
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=359.52 Aligned_cols=258 Identities=20% Similarity=0.234 Sum_probs=206.2
Q ss_pred HHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 506 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
..+....++|++.++||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445789999999999999999999986 48899999986421 11234578999999999999999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccc
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999843 34899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
++....... ......+||+.|+|||++.... ++.++|||||||++|||++|+.||........ .
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~--------- 282 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y--------- 282 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---------
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--H---------
Confidence 987654321 1223468999999999998765 78999999999999999999999864332110 0
Q ss_pred ccccccccccc-ccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003288 738 DRVHDLIDPVI-MQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 785 (834)
Q Consensus 738 ~~~~~li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
..++.... ...+........+.+++.+||+.+|.+ ||+++||+++
T Consensus 283 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 ---SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00110000 000111123456889999999999988 9999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.28 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=196.6
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHH--HHhcCCCceeeEeeeeee-----cCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML--IAKLQHRNLVRLLGCCVE-----QGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 584 (834)
.++|++.++||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 78999999996443 3344445444 445899999999986543 2367
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc---------CCCceeeCCCCCCcEEecCCCCce
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------SRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
++||||+++|+|.+++.. ...++..+..++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999943 2358899999999999999999998 7 99999999999999999999
Q ss_pred eeccccceecCCCcc------cCCcccccccccccCcccccC-------CCCCccCcchhhHHHHHHHHhCCCCCCCCCC
Q 003288 656 ISDFGLARMFGGDEL------QGNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 722 (834)
Q Consensus 656 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwslGvvl~elltg~~p~~~~~~ 722 (834)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987754321 112234579999999999987 4567889999999999999999877543322
Q ss_pred Cccccccccccccccc---ccc-----ccccccccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 723 DSFNLLGHAWDLWKDD---RVH-----DLIDPVIMQ-DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~---~~~-----~li~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
................ ... ....+.+.. ..........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1110000000000000 000 000111100 0112335667999999999999999999999999998873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.36 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=204.3
Q ss_pred hcCccccc-eeccCCcEeEEEEEec---CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 56788888 9999999999999643 36789999997543 33467899999999999999999999998 667889
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999954 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccc
Q 003288 666 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ . ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~-------------~~ 232 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T-------------AM 232 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H-------------HH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H-------------HH
Confidence 543221 11223456789999999998889999999999999999999 9999864332110 0 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+.... ...........+.+++.+||+.||.+||++.+|++.|++..
T Consensus 233 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 233 LEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000 11112233457889999999999999999999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=372.67 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=202.0
Q ss_pred cCccccc-eeccCCcEeEEEEEec---CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4555555 8999999999999864 45679999997653 3467889999999999999999999999876 568999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999843 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 668 DEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 668 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
... ........+|+.|+|||++....++.++|||||||+||||++ |+.|+........ . +.+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~-------------~~i~ 553 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--M-------------AFIE 553 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--H-------------HHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--H-------------HHHH
Confidence 321 111222345789999999999999999999999999999998 9999864332211 0 0010
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ...........+.+++.+||+.||++||++.+|++.|+...
T Consensus 554 ~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 554 QGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 000 11122234467889999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.18 Aligned_cols=264 Identities=25% Similarity=0.301 Sum_probs=199.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999985 48999999986543 3345778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998874 3345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccccc--------cccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA--------WDLWKDDR 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~--------~~~~~~~~ 739 (834)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+......... ..... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999876 67899999999999999999999998654332110 00000 00000000
Q ss_pred c-ccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 V-HDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~-~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. .....+.. ..... ......+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDP-EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCC-SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCc-cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000 00000 1223467899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.43 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=202.1
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 58899999986542 11344678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 582 GEKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 582 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
+..++||||+.+| +|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999984 3346999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 998765432 2334679999999999988877 78999999999999999999998531110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... .........+.+++.+||+.||++||+++|+++.
T Consensus 237 ----~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----Hhhcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011123468899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=346.70 Aligned_cols=208 Identities=27% Similarity=0.333 Sum_probs=180.0
Q ss_pred ccHHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----CCceeeEee
Q 003288 503 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLLG 576 (834)
Q Consensus 503 ~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 576 (834)
+++.......++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++++++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344444445789999999999999999999874 5889999999643 445567888999999997 999999999
Q ss_pred eeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC------
Q 003288 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------ 650 (834)
Q Consensus 577 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~------ 650 (834)
++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 99999998543 2335899999999999999999999998 999999999999975
Q ss_pred -------------------CCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHH
Q 003288 651 -------------------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 651 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ell 711 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999865432 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 003288 712 SSKKNTGVYN 721 (834)
Q Consensus 712 tg~~p~~~~~ 721 (834)
+|+.||....
T Consensus 254 ~g~~pf~~~~ 263 (360)
T 3llt_A 254 TGSLLFRTHE 263 (360)
T ss_dssp HSSCSCCCSS
T ss_pred HCCCCCCCCc
Confidence 9999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.43 Aligned_cols=248 Identities=32% Similarity=0.455 Sum_probs=200.1
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999986 468999999986432 33457899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||++ |+|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5777776432 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.|+........ . .......
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~---~~~~~~~------ 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQNE------ 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHHHSC------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H---HHHHhcC------
Confidence 2 2357899999999984 56789999999999999999999999854322110 0 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.+.. ........+.+++.+||+.||++|||++++++..
T Consensus 270 ~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 SPAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0001 1112235678999999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.43 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=199.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999875 5889999998654 233457899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999853 245899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .... .....
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~-----~~~~~- 253 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---G---AHIN-----QAIPR- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---H---HHHH-----SCCCC-
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---H---HHhc-----cCCCC-
Confidence 321 122345789999999999999999999999999999999999999864322100 0 0000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccc
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNEH 790 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 790 (834)
...........+.+++.+||+.||++|| +++++++.|+...
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0011112234678899999999999999 9999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.70 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=204.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.++||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 4889999998643 3445678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~~ 665 (834)
||+++++|.+.+.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 345899999999999999999999998 999999999999987665 999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. ....... ..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~~~~-~~-- 226 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA----QIKAGAY-DY-- 226 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC-CC--
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HH----HHHhccc-cC--
Confidence 5432 22335789999999999999999999999999999999999999854322110 00 0000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||++||+++|+++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111223568899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.80 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=204.3
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee---------
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------- 580 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 580 (834)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3578999999999999999999986 68999999997554 346789999999999999999998864
Q ss_pred -------cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 581 -------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 581 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44589999999999999999543 2346899999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 733 (834)
+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|..|+.... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHH
Confidence 9999999998775432 2233578999999999999999999999999999999999988753110 0000
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.+.. ..........+.+++.+||+.||.+||++.|+++.|....
T Consensus 230 --------~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 --------DLRD-----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------HHHT-----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------Hhhc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0000 1111122345789999999999999999999999998873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=363.15 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=194.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 5899999999643 333456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++++|..++.. ...+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999843 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+...
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~------------~i~~~ 364 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE------------LILME 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH------------HHHHC
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH------------HHHhC
Confidence 221 223446899999999999999999999999999999999999999864322110 00 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
...........+.+++.+||+.||.+|| +++|+++.
T Consensus 365 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 ---EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0011122345688999999999999999 99999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.89 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=204.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999876 589999999865422 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC----Cceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 660 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999943 356899999999999999999999998 99999999999999888 79999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ... .....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----i~~~~- 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----ITSVS- 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----HHTTC-
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHH----HHhcc-
Confidence 998765432 22345789999999999999999999999999999999999999864322110 000 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -YDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 01123468899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.56 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=200.5
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+... ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 5789999999999999999998754 7789999985432 22356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999865433
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. .+...
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~------------~~~~~- 222 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YK------------RISRV- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH------------HHHHT-
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HH------------HHHhC-
Confidence 2 22345789999999999999999999999999999999999999864322110 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||.+||+++|+++.
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 011112234567899999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.80 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=204.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcE--EEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+.. +++. +|||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999865 4554 499998653 334556789999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC
Q 003288 587 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 653 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~ 653 (834)
||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999996432 2346899999999999999999999998 999999999999999999
Q ss_pred ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003288 654 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~--- 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE--- 252 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH---
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HH---
Confidence 999999999743221 12233466889999999998899999999999999999998 9999864332110 00
Q ss_pred ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
..... . ...........+.+++.+||+.||.+||+++|+++.|++....
T Consensus 253 -~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 -KLPQG---------Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HGGGT---------C-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HhhcC---------C-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0 0111122345688999999999999999999999999886443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=353.14 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=168.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Ce
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 583 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999875 4788999999753 344567899999999999999999999999876 57
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||++ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 59999884 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccc--------------------CCcccccccccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 003288 664 MFGGDELQ--------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTG 718 (834)
Q Consensus 664 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwslGvvl~elltg~~p~~ 718 (834)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87543211 123456899999999986 56679999999999999999999766654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.82 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=198.0
Q ss_pred HhcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhcC---CCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 581 (834)
..++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 468999999986322 112345677777777764 99999999999876
Q ss_pred C-----eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 582 G-----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 582 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
. ..++||||+. ++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5999988543 2334899999999999999999999998 999999999999999999999
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccccccccc
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~ 735 (834)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+.......
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998664322 234568899999999999999999999999999999999999998654321110 000000000
Q ss_pred cccccc---cccccccc-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVH---DLIDPVIM-QDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~---~li~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...... .+...... .... .......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00000000 0000 11223578899999999999999999999763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.55 Aligned_cols=260 Identities=18% Similarity=0.234 Sum_probs=206.0
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 580 (834)
+.+.....++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455789999999999999999999985 58999999996532 2233458899999999999999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
.+..++||||+++|+|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999543 236899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCccccc-------CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 733 (834)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ .
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~----- 279 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--Y----- 279 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H-----
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--H-----
Confidence 9987654321 1123458999999999987 45789999999999999999999999864332110 0
Q ss_pred ccccccccccccc--ccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 003288 734 LWKDDRVHDLIDP--VIMQDEISLPMLMRYINVALLCVQENAADR---PTMSDVISM 785 (834)
Q Consensus 734 ~~~~~~~~~li~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 785 (834)
..++.. .+...........++.+++.+||+ +|.+| |+++|++++
T Consensus 280 -------~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 -------GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -------HHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -------HHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000 000000111234578899999999 99998 689999765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=334.91 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=201.7
Q ss_pred HhcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeee-eecCeeEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILIL 588 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 588 (834)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999986 4688999998754322 24578899999999988877666655 5667889999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~ 665 (834)
||+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345899999999999999999999998 9999999999999 78999999999999987
Q ss_pred CCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 666 GGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 666 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----------~ 227 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----------Y 227 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-----------H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-----------h
Confidence 544321 123356899999999999999999999999999999999999999865332211000 0
Q ss_pred ccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 741 HDLIDPVIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 741 ~~li~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..+..... ... ........+.+++.+||+.||++||++++|++.|++...
T Consensus 228 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 228 ERISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhhcccc-cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00000000 000 001123578899999999999999999999999988643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.61 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=204.9
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeee-eecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 589 (834)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999986 5689999999865432 24688999999999988876666555 56677899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~ 666 (834)
|+ +++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 345899999999999999999999998 9999999999999 588999999999999875
Q ss_pred CCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccccc
Q 003288 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRV 740 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 740 (834)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------- 228 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----------- 228 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH-----------
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh-----------
Confidence 44321 122456799999999999999999999999999999999999999875332111 0000
Q ss_pred ccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 741 HDLIDPVIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 741 ~~li~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.+..... ... ........+.+++.+||+.||.+||++++|++.|++...
T Consensus 229 -~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 229 -RISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -HHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hhccccc-CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0000000 000 001123568899999999999999999999999988744
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=333.43 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=199.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 578999999999999999999886 6899999998753 334567788999999999 999999999999999999999
Q ss_pred EEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---------------
Q 003288 588 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--------------- 651 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~--------------- 651 (834)
|||+++++|.+++..... ...+++.++..++.||++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999954322 256899999999999999999999998 9999999999999844
Q ss_pred ----CCceeeccccceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc
Q 003288 652 ----MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 726 (834)
Q Consensus 652 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~ 726 (834)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23589999999999876 567899999999999999999876532110
Q ss_pred ccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 727 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+........ ..........+.+++.+||+.||++||++.|+++.
T Consensus 237 -----~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -----WHEIRQGRL----------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHTTCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHcCCC----------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 000011100 11111234568899999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=341.97 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=205.8
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|.+.+.||+|+||.||+++..+ ++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999998764 788999998643 345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......... ......
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~--------- 256 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKN--------- 256 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHT---------
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcC---------
Confidence 22 1223457899999999999999999999999999999999999998643221100 000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||++||+++|+++.
T Consensus 257 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111223467889999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=350.77 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=192.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecC--ee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EK 584 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 584 (834)
..++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4679999999999999999999874 5899999998643 3455677889999999997 999999999997554 68
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||++ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 588888843 36899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------ccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 665 FGGDE-------------------LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 665 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64311 0112234689999999999986 678999999999999999999999986543211
Q ss_pred c-ccccccccccccccc--------------------------ccccc---cccccCCCCHHHHHHHHHHHHHccccCCC
Q 003288 725 F-NLLGHAWDLWKDDRV--------------------------HDLID---PVIMQDEISLPMLMRYINVALLCVQENAA 774 (834)
Q Consensus 725 ~-~~~~~~~~~~~~~~~--------------------------~~li~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 774 (834)
. ..+............ ..... ..+............+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 0 000000000000000 00000 00000000012235688999999999999
Q ss_pred CCCCHHHHHHH
Q 003288 775 DRPTMSDVISM 785 (834)
Q Consensus 775 ~RPt~~evl~~ 785 (834)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.45 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=197.5
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-CeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 590 (834)
.++|++.+.||+|+||.||+++. .++.||||.++... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 57899999999999999999987 58899999997543 457899999999999999999999997654 478999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998532 2234889999999999999999999998 999999999999999999999999999865432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ . ...... .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~----~~~~~~---------~- 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKG---------Y- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--H----HHHTTT---------C-
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcC---------C-
Confidence 122357889999999999999999999999999999998 9998864322110 0 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.67 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=197.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 468999999999999999999875 58899999986543 3356789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceec
Q 003288 590 YMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 665 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~ 665 (834)
|+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999885432 3356899999999999999999999998 9999999999999 45678999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||............ ... .
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~----~~~--------~ 241 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----TYK--------E 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHC--------C
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh----ccC--------C
Confidence 4432 223457899999999875 56899999999999999999999998643321110000 000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... .....+....+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNY--AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC--CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc--ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000112356789999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.91 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=206.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.+.|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999864 58899999986543 3456889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999983 346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. ..... .
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~-----~----- 235 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LF----LIPKN-----N----- 235 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHS-----C-----
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HH----HhhcC-----C-----
Confidence 2 22345789999999999999999999999999999999999999864322110 00 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011112233568899999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.19 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=156.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Ce
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 583 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 5899999999653 344567899999999999999999999998543 56
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999984 68888883 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-------------------------CCcccccccccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCC
Q 003288 664 MFGGDELQ-------------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKK 715 (834)
Q Consensus 664 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDVwslGvvl~elltg~~ 715 (834)
........ ......+||+.|+|||++ ....++.++|||||||+||||++|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 76432110 123346789999999986 55679999999999999999999543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.95 Aligned_cols=255 Identities=21% Similarity=0.249 Sum_probs=180.8
Q ss_pred cCcccc---ceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQ---CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~---~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 587 (834)
++|++. ++||+|+||.||+++.. +++.||||++... ....+.+|+.++++++ ||||+++++++.++...++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 345543 78999999999999875 5899999999643 3467789999999997 99999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cceeecccccee
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARM 664 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~ 664 (834)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999854 356999999999999999999999998 99999999999997765 799999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~l 743 (834)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............+...
T Consensus 159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-- 234 (325)
T 3kn6_A 159 KPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-- 234 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--
T ss_pred cCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--
Confidence 64432 123345789999999999999999999999999999999999999865332110 0000000000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ...........+.+++.+||+.||.+||+++|+++.
T Consensus 235 ----~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 ----F-EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ----C-CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ----C-CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 000001134578899999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=355.77 Aligned_cols=262 Identities=24% Similarity=0.254 Sum_probs=195.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------C
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 582 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999865 5889999999754 445567889999999999999999999998654 3
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||++++ |...+. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 444542 23899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------ccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWD 733 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~~ 733 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..+.. .+.
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764322 23446899999999999999999999999999999999999999865432110 00000 000
Q ss_pred cc--------------cccccccccccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LW--------------KDDRVHDLIDPVIMQDE--ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~--------------~~~~~~~li~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ............+.... ........+.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000000000000 011125678999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=334.82 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=205.7
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|.+.+.||+|+||.||+++... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 5789999999999999999999864 788999998643 344567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... .... ...
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~--------~~~ 231 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIK--------KNE 231 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH--------TTC
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHh--------hcc
Confidence 221 223457899999999999999999999999999999999999998643321100 0000 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.||++||+++|+++.
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111223567899999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.10 Aligned_cols=253 Identities=17% Similarity=0.214 Sum_probs=191.5
Q ss_pred hcCcccc-ceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 584 (834)
.++|.+. ++||+|+||.||+++.. +++.||||++... ..+.+|+.++.++ +||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999875 5889999999643 4567888887554 89999999999876 5678
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeecccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGl 661 (834)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999542 2346899999999999999999999998 999999999999997 78899999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~- 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY- 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC-
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc-
Confidence 98764322 233467899999999999999999999999999999999999998643321110 000000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 285 -----~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -----EF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----CC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000111234568899999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.35 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=191.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHH-HHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999976 47899999996542 2334556777776 467899999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999843 345889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..++..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~------------~~i~~~ 254 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--Y------------DNILNK 254 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--H------------HHHHHS
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--H------------HHHHhc
Confidence 221 233456899999999999999999999999999999999999999864322110 0 001111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSD 781 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
.+ .........+.+++.+||+.||.+||++.+
T Consensus 255 ~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 00 111123356889999999999999999853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.98 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=200.2
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecC
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 592 (834)
+|....+||+|+||.||+|+.. +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4444568999999999999864 588999999987766667889999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-CCCceeeccccceecCCCccc
Q 003288 593 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 671 (834)
+++|.+++........+++..+..++.||++||+|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999966544456788999999999999999999998 999999999999987 8999999999998764322
Q ss_pred CCcccccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.|+............. . ....
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~--~~~~----- 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-------G--MFKV----- 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-------H--HHCC-----
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-------c--cccc-----
Confidence 1223457899999999997654 8899999999999999999999985322211000000 0 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11122233457889999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.48 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=191.1
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcCCCceeeEeeeeee
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 580 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 580 (834)
...++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34689999999999999999999875 47899999986431 122335889999999999999999999975
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cceee
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 657 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~kl~ 657 (834)
.+..++||||+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999999883 3456999999999999999999999998 99999999999997544 59999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ +.. .
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----Q 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHH----H
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHH----H
Confidence 999998764332 2344689999999999863 6788999999999999999999999864322110 000 0
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....... .. +.. .......+.+++.+||+.||++||+++|+++.
T Consensus 357 i~~~~~~-~~-~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN-FI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC-CC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC-CC-chh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 00 000 01123568899999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.44 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=194.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhh-HHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|++.++||+|+||.||+|+.. +++.||||++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999876 68899999996543221 22456799999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 5888887532 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccccccccccccccccc---
Q 003288 671 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDLID--- 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~li~--- 745 (834)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12234578999999999876 5689999999999999999999999865432211 00000000000000000000
Q ss_pred ------cccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 ------PVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+..... .........+.+++.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 0001123567899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.12 Aligned_cols=264 Identities=16% Similarity=0.181 Sum_probs=205.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC---------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceee---------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 573 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 573 (834)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998764 789999998754 46789999999999999988
Q ss_pred ------Eeeeeee-cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003288 574 ------LLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (834)
Q Consensus 574 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NI 646 (834)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667766 67889999999 99999999543 2356999999999999999999999998 99999999999
Q ss_pred EecCCC--CceeeccccceecCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 003288 647 LLDKDM--NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 719 (834)
Q Consensus 647 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~ 719 (834)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876533211 122345899999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 720 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
............... ......+..... ........+.+++.+||+.||++||++++|++.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTEDIMKQKQKF--VDKPGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHHHHHHHHHH--HHSCCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhc--cCChhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 432211111100000 000111111110 001123568899999999999999999999999988743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=371.39 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=197.3
Q ss_pred ceeccCCcEeEEEEEec---CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.+|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 48999999999999653 36789999997543 345688999999999999999999999986 4568899999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc-cC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 672 (834)
|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999943 346899999999999999999999998 99999999999999999999999999987754322 12
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+........ .+.+.... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---------------~~~i~~~~-~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---------------TAMLEKGE-RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---------------HHHHHTTC-CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------------HHHHHcCC-CC
Confidence 2233456889999999999999999999999999999998 9999864332110 00110000 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.........+.+++.+||+.||++||++.+|++.|++.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223346788999999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=348.76 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=205.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999876 5889999998755 34556789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+++++|.+++... ..+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999543 3589999999999999999999996 7 999999999999999999999999998755321
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccc----------c-------
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH----------A------- 731 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~----------~------- 731 (834)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............. .
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2234578999999999999999999999999999999999999986543221110000 0
Q ss_pred -------cccccccccccccccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 -------WDLWKDDRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 -------~~~~~~~~~~~li~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.++.... ...........+.+++.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000011110000 001111234568899999999999999999999874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.13 Aligned_cols=217 Identities=13% Similarity=0.139 Sum_probs=168.0
Q ss_pred ccccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEc
Q 003288 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (834)
Q Consensus 23 ~~~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~ 102 (834)
++.|+|++||+|++|++| ++|.|+|||+.+++ +.+|.. +|+||+|||+.| ..+.|+|+.||||||.|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 667999999999999999 59999999998775 334432 799999999998 46889999999999999
Q ss_pred CCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhh-hhhccccccc-cccc-----ceeeE
Q 003288 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTL-LQDMKLGWDF-KNRL-----ERYLS 175 (834)
Q Consensus 103 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtl-Lpg~~l~~~~-~t~~-----~~~l~ 175 (834)
++|.+||+|++........|+|+|+|||||++ .++||||||||||+ ||+| |.+. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998654445689999999999984 27999999999877 5554 4444 4444 56777
Q ss_pred EecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCCCCCcceeecccccccceeeeeeecCceEEEEEEeeCCCcee
Q 003288 176 SWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGAGFVSALSYTDFLYKQFMMENKDECVYWYEAYNRPSIM 255 (834)
Q Consensus 176 Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w~g~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~ 255 (834)
| .+||++|.|++.++++| ++++++++.+||++++|++. +...+++......+.+..+.++..++|...+ ...+
T Consensus 143 s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~-~~~~ 215 (236)
T 1dlp_A 143 A---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRY 215 (236)
T ss_dssp S---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCS-SSCC
T ss_pred c---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCC-CCCE
Confidence 4 78999999999999998 67888888899999999753 4444555422222223234445454444333 3468
Q ss_pred eEEeCCCCcEEEEE
Q 003288 256 TLKLNPSGFVTRQI 269 (834)
Q Consensus 256 rl~L~~~G~l~~~~ 269 (834)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=346.08 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=202.6
Q ss_pred hcCccccceeccCCcEeEEEEEe----cCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecC
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 582 (834)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368999999986432 22345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~-------- 275 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EIS-------- 275 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHH--------
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHH--------
Confidence 87643322 12334679999999999986 357899999999999999999999986433211100 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISMI 786 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 786 (834)
..+... ...........+.+++.+||+.||.+|| +++|+++..
T Consensus 276 ~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 276 RRILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHhcc---CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000000 1112223345678999999999999999 999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.96 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=202.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 568999999999999999999875 6899999999866555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceecCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~~ 667 (834)
+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998843 245899999999999999999999998 9999999999999 7889999999999976432
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... ... ....... .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~i~~~~~-~----- 225 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFE----KIKEGYY-E----- 225 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHCCC-C-----
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcCCC-C-----
Confidence 2 2334578999999999999999999999999999999999999986432211 000 0000000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ...........+.+++.+||+.||++||+++|+++.
T Consensus 226 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 F-ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp C-CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011112234578899999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.64 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=200.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999986 589999999865321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC----Cceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 660 (834)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 345899999999999999999999998 99999999999998877 79999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
++....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. .......
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LT----NISAVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHTTCC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HH----HhHhccc
Confidence 998764432 22345689999999999999999999999999999999999999864322110 00 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... .......+.+++.+||+.||++||++.|+++
T Consensus 229 --~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 --DFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000000 0112346889999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.78 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=206.4
Q ss_pred ccHHHHHHHhcCcccc-ceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc-CCCceeeEeee
Q 003288 503 FSLASITAATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGC 577 (834)
Q Consensus 503 ~~~~~i~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 577 (834)
..+.......+.|.+. ++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344555567788887 89999999999999876 58999999987542 33467899999999999 56999999999
Q ss_pred eeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCc
Q 003288 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNP 654 (834)
Q Consensus 578 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~ 654 (834)
+.+....++||||+++++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998432 3356899999999999999999999998 999999999999987 7899
Q ss_pred eeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........... .
T Consensus 174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i--- 245 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN--I--- 245 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H---
T ss_pred EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH--H---
Confidence 999999998765332 22345799999999999999999999999999999999999999864332111000 0
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... .... ...........+.+++.+||+.||.+|||++|+++.
T Consensus 246 ------~~~-~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 ------SQV-NVDY-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------HHT-CCCC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------Hhc-cccc-CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0000 111112234568899999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.07 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=204.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 586 (834)
.++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 5899999999653 34556789999999999999999999998854 568899
Q ss_pred EEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 587 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999986 2349999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ... .......
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~----~i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG----KIREGKF--- 233 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTCC---
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHH----HHhhccc---
Confidence 764321 11233578999999999999999999999999999999999999986433211 000 0000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..........+.+++.+||+.||.+||++.||++.+..
T Consensus 234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01122234578899999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=359.22 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=207.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 58999999996432 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999985432 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+...
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-----------~~i~~~i~~~ 404 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----------EEVERLVKEV 404 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-----------HHHHHHHHHC
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-----------HHHHHHhhcc
Confidence 32 223458999999999999999999999999999999999999998643321100 0000000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
...........+.+++.+||+.||.+|| +++||++.
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112223346788999999999999999 78888754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.96 Aligned_cols=252 Identities=18% Similarity=0.263 Sum_probs=199.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.+.||+|+||.||+++.. +++.||||++..... .+.+|++++.++ +||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 578999999999999999999875 588999999975533 235688888888 79999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-C---Cceeeccccceec
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-M---NPKISDFGLARMF 665 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~---~~kl~DFGla~~~ 665 (834)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+..+ + .+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999843 356899999999999999999999998 9999999999998443 3 4999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+ ......+...
T Consensus 171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGKFS---- 241 (342)
T ss_dssp BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHHCCCC----
T ss_pred cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHccCCcc----
Confidence 5432 123346789999999999988899999999999999999999999864322111000 0000000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 242 --~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 --L-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --C-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --c-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 011112234578899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.44 Aligned_cols=257 Identities=26% Similarity=0.361 Sum_probs=197.5
Q ss_pred hcCccccceeccCCcEeEEEEEec--CCc--EEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--NGQ--EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.++||+|+||.||+|++. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 233 6899998654 3345678999999999999999999999988765 8
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998543 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~------------ 236 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHK------------ 236 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH------------
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHH------------
Confidence 7543221 12233567889999999998889999999999999999999 999986433211 0000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+..... ...........+.+++.+||+.||.+||++.++++.|++.
T Consensus 237 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 237 IDKEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp HHTSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHccCC-CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 000000 0111122345788999999999999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.41 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=203.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999876 47889999985432 22356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ . ..+....
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~------------~~~~~~~ 228 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--H------------RRIVNVD 228 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H------------HHHHTTC
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--H------------HHHhccc
Confidence 22 2345789999999999999999999999999999999999999864332110 0 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.||.+||+++|+++
T Consensus 229 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0111123356789999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.47 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=192.7
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh--hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
...++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34678999999999999999999865 688999999965432 335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-----CCCCceeecccc
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-----KDMNPKISDFGL 661 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-----~~~~~kl~DFGl 661 (834)
||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 99888843 345899999999999999999999998 99999999999994 455699999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc-ccccccccccc-
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHAWDLWKDD- 738 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~- 738 (834)
++.+.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.......... +..........
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764332 122345789999999999875 58999999999999999999999986543211100 00000000000
Q ss_pred ------------ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 ------------RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ------------~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.....+ ...........+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTL-KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCH-HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccH-hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000 00000112356789999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.63 Aligned_cols=242 Identities=14% Similarity=0.168 Sum_probs=189.5
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecC---CChhhHHHHHHHHH---HHHhcCCCceeeEe-------ee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN---QSGQGLKEFKNEMM---LIAKLQHRNLVRLL-------GC 577 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 577 (834)
.++|++.+.||+|+||.||+|+. .+|+.||||++.. ......+.|.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999996 4589999999863 34456688999994 55555899999998 55
Q ss_pred eeecC-----------------eeEEEEEecCCCchhhhhhccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003288 578 CVEQG-----------------EKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 578 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 636 (834)
+.+.+ ..++||||+ +|+|.+++.... ....+++..++.|+.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54443 278999999 689999985421 1223456888899999999999999998 9
Q ss_pred eeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCC-----------CCCccCcchhhHH
Q 003288 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGI 705 (834)
Q Consensus 637 vH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDVwslGv 705 (834)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 706 LMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 706 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
++|||++|+.||........ . ..+. ... . .....+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~--~------------~~~~-~~~--~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG--S------------EWIF-RSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC--S------------GGGG-SSC--C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc--h------------hhhh-hhc--c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864322110 0 0000 000 1 12356889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=336.76 Aligned_cols=267 Identities=23% Similarity=0.355 Sum_probs=200.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeee--------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 580 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 580 (834)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999974 68999999985443 2334678899999999999999999999987
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
.+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 66666633 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcc--cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc------
Q 003288 661 LARMFGGDEL--QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH------ 730 (834)
Q Consensus 661 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~------ 730 (834)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+........ ..+..
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987753221 122344678999999999876 4689999999999999999999999875432111 00000
Q ss_pred --ccccccccccccccccccccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 --AWDLWKDDRVHDLIDPVIMQDEISLP-------MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 --~~~~~~~~~~~~li~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+.........+.+.... ....... ....+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000000000000 0011111 12457899999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.96 Aligned_cols=254 Identities=10% Similarity=0.080 Sum_probs=183.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhc--CCCceeeEe-------eee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL--QHRNLVRLL-------GCC 578 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 578 (834)
..+|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999975 68999999997654 23456788886655555 599988755 344
Q ss_pred eec-----------------CeeEEEEEecCCCchhhhhhccCCCccCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 003288 579 VEQ-----------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR------VRIIEGIAQGLLYLHQYSRFR 635 (834)
Q Consensus 579 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 635 (834)
... ...++||||++ ++|.+++... ...+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 33799999999 8999999643 223455566 788899999999999998
Q ss_pred eeeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhC
Q 003288 636 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSS 713 (834)
Q Consensus 636 ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg 713 (834)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876432 113467799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 714 KKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 714 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.||............ ............ ...........+.+++.+||+.||++||++.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK-------RPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC-------BCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh-------hhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998754332111100 000000000000 00111123457889999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=338.30 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=204.6
Q ss_pred HHHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhc-CCCceeeEe
Q 003288 506 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLL 575 (834)
Q Consensus 506 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~ 575 (834)
.......++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445678999999999999999999985 69999999986543 12246788999999999 799999999
Q ss_pred eeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCce
Q 003288 576 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655 (834)
Q Consensus 576 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~k 655 (834)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999853 345899999999999999999999998 99999999999999999999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccC------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~ 729 (834)
|+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLR 315 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHH
Confidence 99999998775432 2234679999999999863 358899999999999999999999985422110 000
Q ss_pred cccccccccccccccccccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... ..... .....+.+++.+||+.||++||++.|+++
T Consensus 316 ----~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 ----MIMEGQ-----------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHHHTC-----------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHhCC-----------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 00011 12346889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=340.90 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=199.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4689999999999999999998764 8999999985443 334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998863 2345899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--ccc-------ccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLG-------HAWDLWKDD 738 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~~-------~~~~~~~~~ 738 (834)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......... ... .....+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 21 22345789999999999875 7899999999999999999999998654321110 000 000000000
Q ss_pred -ccccccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 -RVHDLIDPVIMQDE----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 -~~~~li~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.......+.+.... ........+.+++.+||+.||.+|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000001110000 001234578999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=355.70 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=206.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999985 58999999996432 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 446999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ..+...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~--------~~i~~~ 408 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELK--------QRVLEQ 408 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHH--------HHHHHC
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHH--------HHHhhc
Confidence 4321 233458999999999999999999999999999999999999998643221100 0000 000111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
. ..........+.+++.+||+.||.+||++ ++|++
T Consensus 409 ~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 A---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 11122334578899999999999999975 56654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=336.77 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=198.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 578999999999999999999986 4889999999877666778999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999988542 345899999999999999999999998 9999999999999999999999999976432111
Q ss_pred cCCcccccccccccCcccc-----cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.......||+.|+|||++ ....++.++||||||+++|||++|+.|+........ .. .... ....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~~~-~~~~---- 240 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL---KIAK-SDPP---- 240 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHHH-SCCC----
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH---HHhc-cCCc----
Confidence 112235789999999998 467789999999999999999999999864332110 00 0000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||.+|||+.|+++
T Consensus 241 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 ----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00111223456889999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.19 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=198.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 584 (834)
.+.|.+.++||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456888899999999999999875 5788999998643 34567789999999999999999999999875 3468
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCceeeccccce
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLAR 663 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~ 663 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999943 245899999999999999999999875 2499999999999997 78999999999997
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.|+......... . .......
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~----~~~~~~~---- 246 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-Y----RRVTSGV---- 246 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-H----HHHTTTC----
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-H----HHHhccC----
Confidence 54332 233457899999999876 45899999999999999999999998643221110 0 0000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+ ..........+.+++.+||+.||.+||+++|+++.
T Consensus 247 -~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 -KP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CC----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -Cc----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 00111122468899999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.70 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=195.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999976 68999999986432 23456889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.|+....... .. .... .
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~---------~ 225 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LF----KKIR---------G 225 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHH---------H
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH----HHhh---------c
Confidence 32 1234578999999999988765 689999999999999999999985422111 00 0000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..........+.+++.+||+.||.+||+++|+++.
T Consensus 226 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 GV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 01111223567899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.40 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=198.8
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC----hhhHHHHHHHHHHHHhcCCCceeeEeeeee--ecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 584 (834)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999875 58899999996532 234678999999999999999999999984 45688
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||++++ |.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 66665432 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.|+....... .. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~i~~~---- 228 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LF----ENIGKG---- 228 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHC----
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HH----HHHhcC----
Confidence 75433333334567899999999987644 4789999999999999999999986432111 00 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||.+||+++|+++.
T Consensus 229 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 -------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111234567899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=336.76 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=187.2
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
...++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34679999999999999999999864 58899999986543 34457789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcc-----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 588 LEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
|||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998531 13456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcc---cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccc
Q 003288 663 RMFGGDEL---QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 663 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
........ ........||+.|+|||.+.. ..++.++||||||+++|||++|+.|+........... ... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~-~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQ-N 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHT-S
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----Hhc-c
Confidence 86643211 112234578999999999876 5689999999999999999999999865433211100 000 0
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ................+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCT-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcc-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 0000011111122356889999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.29 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=199.4
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcC--CCceeeEeeeeee
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVE 580 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 580 (834)
+..+....++|++.+.||+|+||.||+++..+++.||||.+... .....+.+.+|+.++.+++ |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33344457889999999999999999999888999999998643 3456688999999999997 5999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
++..++||| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 668899999853 346899999999999999999999998 999999999999965 899999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~ 729 (834)
+++.+.............||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--- 248 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 248 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---
Confidence 9987654433333344578999999999875 46888999999999999999999998543211100
Q ss_pred cccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 730 ~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+++.. ...........+.+++.+||+.||.+||++.|+++.
T Consensus 249 ----------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 ----------LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----------HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------HHHHHhccc-ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 001111110 011111123468899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=341.40 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=201.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC--------CCceeeEeeeee---
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCV--- 579 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 579 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999643 445678899999999996 788999999987
Q ss_pred -ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCC-----
Q 003288 580 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 652 (834)
Q Consensus 580 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~----- 652 (834)
+....++||||+. ++|.+.+... ....+++..+..++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 5568899999995 4555554332 234689999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CceeeccccceecCCCcccCCcccccccccccCccc
Q 003288 653 --------------------------------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688 (834)
Q Consensus 653 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 688 (834)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233578999999999
Q ss_pred ccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc----ccccc------------------ccccc-cccccccc
Q 003288 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL----LGHAW------------------DLWKD-DRVHDLID 745 (834)
Q Consensus 689 ~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~----~~~~~------------------~~~~~-~~~~~li~ 745 (834)
+.+..++.++|||||||++|||++|+.||.......... +.... ..+.. .....+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997544322100 00000 00000 00000000
Q ss_pred --------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 --------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 --------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...............+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000111334566778999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.26 Aligned_cols=258 Identities=20% Similarity=0.303 Sum_probs=200.3
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeee--cCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE--QGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 587 (834)
.++|++.++||+|+||.||+|+. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999986 468999999997543 467899999999997 9999999999988 5678999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~ 666 (834)
|||+++++|.+++. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999872 3889999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccc--------ccccc-
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA--------WDLWK- 736 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~- 736 (834)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+.........+.... .....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4322 234578999999999887 6789999999999999999999999854322111110000 00000
Q ss_pred -----cccc--------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 -----DDRV--------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 -----~~~~--------~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... ........ ...........+.+++.+||+.||.+|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFV-HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGC-CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhc-cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00000000 111112235678999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.63 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=203.9
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChh-----------------hHHHHHHHHHHHHhcCCCceeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL 574 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 574 (834)
.++|++.+.||+|+||.||+|+. +++.||||.+...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643211 12789999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCchhhh------hhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEE
Q 003288 575 LGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNIL 647 (834)
Q Consensus 575 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NIL 647 (834)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225679999999999999999999999 87 999999999999
Q ss_pred ecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCC-CCCc-cCcchhhHHHHHHHHhCCCCCCCCCCCcc
Q 003288 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSSKKNTGVYNADSF 725 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDVwslGvvl~elltg~~p~~~~~~~~~ 725 (834)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.|+........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876443 23345789999999999887 6766 99999999999999999999875433110
Q ss_pred ccccccccc-cccc-ccccccccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 726 NLLGHAWDL-WKDD-RVHDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 726 ~~~~~~~~~-~~~~-~~~~li~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........ .... .......+... ...........+.+++.+||+.||.+||+++|+++.
T Consensus 261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0000 00000000000 000112234578899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=338.18 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=195.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 5899999998543 3445678899999999999999999999997653
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899999843 35899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------cc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AW 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~ 732 (834)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||........ ..+.. ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 875432 234578999999999887 6799999999999999999999999864432110 00000 00
Q ss_pred cccccccccccccc--cccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLIDP--VIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~~--~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........+.. .... ..........+.+++.+||+.||.+|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000000 0000 01111234578899999999999999999999884
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=337.86 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=196.5
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChh-----hHHHHHHHHHHHHhcCCCceeeEeeeeeecCe
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 583 (834)
...++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999875 4899999998643221 23468899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++ +|..++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78887743 3346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc----cccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH----AWDLWK 736 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~----~~~~~~ 736 (834)
.+.... .......+|+.|+|||++.+. .++.++|||||||++|||++|.+|+........ .+... ....|.
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 764332 122345789999999998764 589999999999999999999998764432110 00000 000000
Q ss_pred c-cccccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 737 D-DRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 737 ~-~~~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ....+.+.... ..... ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKS-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCC-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccc-cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000000 00011 1223578999999999999999999999876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=331.04 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=199.7
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..++|++.+.||+|+||.||+|+.. +|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4678999999999999999999876 48999999997543 34678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999853 2346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.......... .. .... .+.
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~-~~~~-----~~~-- 244 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----MI-PTNP-----PPT-- 244 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HH-HHSC-----CCC--
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HH-hcCC-----Ccc--
Confidence 1 2234578999999999999999999999999999999999999986432211000 00 0000 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.||.+||++.++++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011122356889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.05 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=187.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-h-hhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-G-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.++||+|+||.||+++.. +++.||||+++... . ...+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 578999999999999999999874 68899999997542 2 22344555566678889999999999999999999999
Q ss_pred EecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 589 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 589 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||+++ +|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99984 887776432 2345699999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCcccCCcccccccccccCcccc----cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||.+ ....++.++||||||+++|||++|+.|+........... .
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~ 225 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-------------Q 225 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-------------H
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-------------H
Confidence 432 22334789999999996 566789999999999999999999999864322111110 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 226 VVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHSCC-CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhccCC-CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 00111123456889999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=366.30 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=204.5
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 585 (834)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3578999999999999999999875 4788999999643 223456788899999988 7999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999543 45899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.... . ..++.
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~------------~~i~~ 556 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--F------------QSIME 556 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H------------HHHHS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--H------------HHHHh
Confidence 3322 224457899999999999999999999999999999999999999864332111 0 00111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
.. ..+......++.+|+.+||+.||++||++ +||++
T Consensus 557 ~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SC---CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CC---CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 10 11122344578899999999999999997 77764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=343.55 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=197.3
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe------eE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------KI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 585 (834)
..+|++.++||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999988778999988644322 2369999999999999999999976543 78
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCceeecccccee
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 664 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~ 664 (834)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998766555433344567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccc----------
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW---------- 732 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~---------- 732 (834)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..+....
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 644321 2345789999999998765 589999999999999999999999865432111 0000000
Q ss_pred --ccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 --DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 --~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+............. ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPF-SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcH-HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000000 000111234578999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.20 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=192.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999865 5889999999653 3445678899999999999999999999997665
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777763 24889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccccc-------cc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGHA-------WD 733 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~~~-------~~ 733 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . +.... +.
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8764321 22345789999999999999999999999999999999999999865432110 0 00000 00
Q ss_pred c--------------ccccccccccccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 L--------------WKDDRVHDLIDPVIMQDE--ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~--------------~~~~~~~~li~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. +.......+......... ........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 000000000000000000 011235678999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.96 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=203.1
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---------hhhHHHHHHHHHHHHhcC-CCceeeEeeeee
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCV 579 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 579 (834)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999875 58899999986542 123567889999999995 999999999999
Q ss_pred ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 580 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 580 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
+....++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999853 346899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCcccCCcccccccccccCccccc------CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 733 (834)
|++....... ......+++.|+|||++. ...++.++||||||+++|||++|+.|+........ ..
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~---- 239 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LR---- 239 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HH----
Confidence 9998765432 223457899999999885 45688999999999999999999999854322110 00
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ . ..+........+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQ------F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCC------C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcc------c-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000000 0 00111223457889999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=353.71 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 568999999999999999999876 68999999986432 34567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeecccccee
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~ 664 (834)
|||+.+++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998843 346899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||....... .... .......
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~----i~~~~~~--- 245 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKK----VEKGKYT--- 245 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHCCCC---
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHH----HHcCCCC---
Confidence 64432 2344679999999998876 68999999999999999999999986433211 1000 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ..+........+.+++.+||+.||.+|||+.|+++.
T Consensus 246 -~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 -F---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -C---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -C---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 000011234568899999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.59 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=195.4
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 581 (834)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3578999999999999999999875 47899999986432 12234688999999999999999999998765
Q ss_pred CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeec
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISD 658 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~D 658 (834)
. .++||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999883 3456899999999999999999999998 999999999999987665 99999
Q ss_pred cccceecCCCcccCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+........ +.. ..
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~----~~ 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QI 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHH----HH
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHH----HH
Confidence 99998764332 123457899999999874 56789999999999999999999999864332110 000 00
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ... +.. .......+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~-~~~-~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKY-NFI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCC-CCC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCcc-ccC-chh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 000 000 0112356889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=337.85 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=184.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------C
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 582 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 5889999999653 344567889999999999999999999998654 5
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899888732 46999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccc--------c
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------W 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~ 732 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ..+... +
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 234678999999999887 6789999999999999999999999865432110 000000 0
Q ss_pred ccccccccccccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+........... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000000000001111 123568899999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=338.98 Aligned_cols=271 Identities=23% Similarity=0.278 Sum_probs=199.1
Q ss_pred cHHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC-----------hhhHHHHHHHHHHHHhcCCCcee
Q 003288 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-----------GQGLKEFKNEMMLIAKLQHRNLV 572 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 572 (834)
...++....++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3566777889999999999999999999998889999999985422 22347899999999999999999
Q ss_pred eEeeeeeec-----CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003288 573 RLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (834)
Q Consensus 573 ~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NIL 647 (834)
++++++... ...++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 36799999998 577777743 3446899999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccccceecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc
Q 003288 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~ 726 (834)
++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|+........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999998543322 2234578999999999877 6789999999999999999999999865332110
Q ss_pred ccccccccc-----------cccccccccccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 727 LLGHAWDLW-----------KDDRVHDLIDPVIMQD------EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 727 ~~~~~~~~~-----------~~~~~~~li~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........ ......+.+....... .........+.+++.+||+.||.+|||++|+++.
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000000 0000000000000000 0011123568899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.55 Aligned_cols=199 Identities=23% Similarity=0.289 Sum_probs=173.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc------CCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 584 (834)
..+|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 568999999999999999999875 4889999999753 34456788899999888 467999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC--ceeeccccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLA 662 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla 662 (834)
++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6888888543 2345899999999999999999999998 999999999999999987 999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 865432 234578999999999999999999999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=339.08 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=199.4
Q ss_pred HhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
..++|++.+.||+|+||.||+|+... .+|+|.++.. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 36789999999999999999998743 5999998643 2333456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999943 2346899999999999999999999998 99999999999998 679999999998765322
Q ss_pred c---ccCCcccccccccccCcccccC---------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003288 669 E---LQGNTKQIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 669 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
. .........|++.|+|||.+.. ..++.++||||||+++|||++|+.|+........ .. ...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~ 256 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IW----QMG 256 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HH----HHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----Hhc
Confidence 1 1122334568999999999874 4578899999999999999999999864332111 00 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 792 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.. ..+.. ........+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 257 ~~-----~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TG-----MKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TT-----CCCCC----CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cC-----CCCCC----CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00111 0111223578999999999999999999999999987443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=352.15 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=197.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 567999999999999999999976 58899999986542 334577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~ 665 (834)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999888433 45899999999999999999999998 9999999999999764 45999999999877
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||........ .. ....... ....
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~~-~~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LR----KVEKGKY-TFDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC-CCCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCCC-CCCc
Confidence 5432 233457999999999876 5699999999999999999999999864332111 00 0000000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 259 ~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PE------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hh------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 01123568899999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.57 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=195.8
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeee-----------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----------- 579 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 579 (834)
.++|++.+.||+|+||.||+|+... ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999864 8999999998777777889999999999999999999998873
Q ss_pred ---ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCce
Q 003288 580 ---EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (834)
Q Consensus 580 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~k 655 (834)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 69999883 345899999999999999999999998 99999999999997 567999
Q ss_pred eeccccceecCCCcc-cCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccc
Q 003288 656 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW 732 (834)
Q Consensus 656 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~ 732 (834)
|+|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||........ ..+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643211 122334567999999998865 6789999999999999999999999865432110 0000000
Q ss_pred cccccccccc-------ccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHD-------LIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~-------li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+ .+.......... ......+.+++.+||+.||.+||+++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 000000000001 1124578899999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=351.84 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=201.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 6899999998543 2234678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec---CCCCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~ 665 (834)
||+++++|.+.+... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999888443 45899999999999999999999998 99999999999995 4567999999999866
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .... ........
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~----i~~~~~~~--- 241 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKR----VETGKYAF--- 241 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHTCCCS---
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhCCCCC---
Confidence 4332 2334579999999999875 59999999999999999999999986432211 0000 00000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000011224568899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=347.98 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=204.2
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++| +++..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 4689999998865432 2457899999999987 556666677778888999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---cCCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl---~~~~~~kl~DFGla~~~~ 666 (834)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345999999999999999999999998 9999999999999 688999999999999875
Q ss_pred CCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||........... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~i~~~~~~ 234 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEKISEKKVA 234 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHHHhhcccc
Confidence 43321 122356899999999999999999999999999999999999999875433211000 0000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.... .....++.+++..||+.+|++||++.+|+++|+.+
T Consensus 235 ~~~~~l~------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 235 TSIEALC------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp SCHHHHH------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHHHh------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000000 11235789999999999999999999999998765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=351.63 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=199.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-------------hhHHHHHHHHHHHHhcCCCceeeEeee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLLGC 577 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 577 (834)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 678999999999999999999876 478999999865321 335778999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC---Cc
Q 003288 578 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NP 654 (834)
Q Consensus 578 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~---~~ 654 (834)
+.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999998843 345899999999999999999999998 99999999999998776 69
Q ss_pred eeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
||+|||+++.+.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---- 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IKK---- 258 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH----
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----
Confidence 999999998775432 233457999999999887 5689999999999999999999999864332110 000
Q ss_pred ccccccccccccccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ..... .....+.+++.+||+.||.+|||++|+++.
T Consensus 259 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGK-----------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCC-----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCC-----------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 00011 123568899999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.52 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=197.0
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee------
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE------ 580 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------ 580 (834)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 345789999999999999999999874 68999999986543 3346789999999999 89999999999987
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46789999999999999998543 2356899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.|+........ . ....
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L---FLIP 247 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHH
T ss_pred CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H---HHhh
Confidence 998764321 1223457899999999987 56789999999999999999999999854322110 0 0000
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. .. .+.. ........+.+++.+||+.||.+||++.|+++.
T Consensus 248 ~-~~-----~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 R-NP-----APRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-SC-----CCCC----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-Cc-----cccC----CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 0000 111223568899999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.26 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=201.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Cee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 584 (834)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999875 58889999997543 34457899999999999999999999998765 368
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||++ ++|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 588888843 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccccc-
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRV- 740 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~- 740 (834)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 6543221 12344689999999998765 4589999999999999999999999865432211 000000000000000
Q ss_pred -------ccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 741 -------HDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 741 -------~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.............. ......+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000111 1123568899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.87 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=204.0
Q ss_pred hcCccccceeccCCcEeEEEEEe--cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc------eeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999654 345677899999999997664 9999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-------------
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------------- 650 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~------------- 650 (834)
.++||||+ +++|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988543 2345889999999999999999999998 999999999999987
Q ss_pred ------CCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 651 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 651 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875332 234578999999999999999999999999999999999999987543221
Q ss_pred cc-ccccc--------cccccccc------------------cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 725 FN-LLGHA--------WDLWKDDR------------------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 725 ~~-~~~~~--------~~~~~~~~------------------~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.. .+... ........ ......+..............+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 10 00000 00000000 00000000001122334567899999999999999999
Q ss_pred CHHHHHHH
Q 003288 778 TMSDVISM 785 (834)
Q Consensus 778 t~~evl~~ 785 (834)
|++|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=343.93 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=193.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------ee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 584 (834)
..+|++.++||+|+||.||+|++. +++.||||++..... .+.+|+++|++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999985 589999999865432 2347999999999999999999986432 36
Q ss_pred EEEEEecCCCchhhhhhc-cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeeccccc
Q 003288 585 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 662 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla 662 (834)
++||||+++ +|...+.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 45444432 234457999999999999999999999998 9999999999999965 56899999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc----ccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH----AWDLW 735 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~----~~~~~ 735 (834)
+.+.... ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||........ .++.. ....+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9764432 12335789999999998765 799999999999999999999999865432110 00000 00000
Q ss_pred c--ccccccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 K--DDRVHDLIDPVIMQD----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~--~~~~~~li~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. .....+...+.+... .+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000000000100000 0111224578899999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.79 Aligned_cols=272 Identities=19% Similarity=0.231 Sum_probs=191.3
Q ss_pred HHHHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe--
Q 003288 507 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-- 583 (834)
Q Consensus 507 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 583 (834)
......++|++.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999875 58999999985542 233456788889999999999999999976543
Q ss_pred -----eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH--hcCCCceeeCCCCCCcEEecC-CCCce
Q 003288 584 -----KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--QYSRFRIIHRDLKASNILLDK-DMNPK 655 (834)
Q Consensus 584 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dikp~NILl~~-~~~~k 655 (834)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987544333322345567899999999999999999999 887 999999999999997 89999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccccc--
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA-- 731 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~-- 731 (834)
|+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .+...
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 99999998765432 22345789999999998765 4899999999999999999999998654321110 00000
Q ss_pred ------ccccccc-cccccccc-cc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 732 ------WDLWKDD-RVHDLIDP-VI----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 732 ------~~~~~~~-~~~~li~~-~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+...... ........ .. ............+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 00000000 00 0011122245678999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.72 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=192.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE---------- 580 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 580 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 568999999999999999999875 689999999964 34456789999999999999999999998865
Q ss_pred ---cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 581 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 581 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
....++||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 4578999999999999999954 3345788999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCcc------------cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 658 DFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 658 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
|||++........ ........||+.|+|||.+.+. .++.++||||||+++|||++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999987643210 1122345789999999999864 78999999999999999998 3321100 0
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ..... .... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~----~~~~~------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILK----KLRSV------SIEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHH----HHHST------TCCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHH----hcccc------cccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00000 00000 0001 112233344567899999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=360.50 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=203.5
Q ss_pred HhcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
..++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 35789999999999999999998743 467999998754 3445678999999999999999999999985 46789
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999532 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ... ......
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~----~i~~~~----- 609 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----RIENGE----- 609 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHHTC-----
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH----HHHcCC-----
Confidence 443221 2223456789999999999999999999999999999997 888876432211 000 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||.+||++.||++.|+.+
T Consensus 610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.14 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=199.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Cee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 584 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999875 58899999996543 34567789999999999999999999988764 678
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888843 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccC--------CcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc-c----cc
Q 003288 665 FGGDELQG--------NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-L----GH 730 (834)
Q Consensus 665 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~-~----~~ 730 (834)
........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... + ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 75322111 1223578999999998765 678999999999999999999999986543211000 0 00
Q ss_pred -----ccccccccccccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 -----AWDLWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 -----~~~~~~~~~~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+.......... ......+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000000000000 1234567899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.93 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=195.1
Q ss_pred HHhcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-------
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------- 581 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 581 (834)
...++|++.++||+|+||.||+|+. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567999999999999999999987 46899999998654322 24799999999999999999998543
Q ss_pred -------------------------------CeeEEEEEecCCCchhhhhhcc-CCCccCCHHHHHHHHHHHHHHHHHHH
Q 003288 582 -------------------------------GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 629 (834)
Q Consensus 582 -------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH 629 (834)
...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5777776432 23456999999999999999999999
Q ss_pred hcCCCceeeCCCCCCcEEec-CCCCceeeccccceecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHH
Q 003288 630 QYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 707 (834)
Q Consensus 630 ~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl 707 (834)
+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 68899999999999764432 22345789999999998875 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCcc-cccccccc------------cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCC
Q 003288 708 LETLSSKKNTGVYNADSF-NLLGHAWD------------LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAA 774 (834)
Q Consensus 708 ~elltg~~p~~~~~~~~~-~~~~~~~~------------~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 774 (834)
|||++|+.||........ ..+..... .+............. ...........+.+++.+||+.||.
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW-RKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH-HhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999875432111 00000000 000000000000000 0001112345688999999999999
Q ss_pred CCCCHHHHHHH
Q 003288 775 DRPTMSDVISM 785 (834)
Q Consensus 775 ~RPt~~evl~~ 785 (834)
+|||+.|+++.
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=325.49 Aligned_cols=267 Identities=24% Similarity=0.361 Sum_probs=199.6
Q ss_pred HhcCccccceeccCCcEeEEEEEe--cCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhc---CCCceeeEeeeee----
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCV---- 579 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 579 (834)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 357899999999999999999997 358899999986432 22233566788777776 8999999999987
Q ss_pred -ecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeec
Q 003288 580 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 658 (834)
Q Consensus 580 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 658 (834)
.....++||||++ ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 6999988543 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc--ccccc----cc
Q 003288 659 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH----AW 732 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~--~~~~~----~~ 732 (834)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .+... ..
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998654322 22345789999999999999999999999999999999999999865432110 00000 00
Q ss_pred cccccc-ccc-cccccc--cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDD-RVH-DLIDPV--IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~-~~~-~li~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+... ... ...... .............+.+++.+||+.||.+||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000 000000 00001112234567899999999999999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.05 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=179.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHH-HHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999885 58999999997643 334455666666 677789999999999999999999999
Q ss_pred EecCCCchhhhhhc--cCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 589 EYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 589 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
||+++ +|.+++.. ......+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77776642 12245689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccccccCcccc----cCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+........... .. .....
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~-~~~~~- 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----QV-VKGDP- 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----CC-CCSCC-
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----HH-hcCCC-
Confidence 4332 12234789999999998 456789999999999999999999999864322111000 00 00000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.+ ...........+.+++.+||+.||.+||++.|+++
T Consensus 248 ----~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ----PQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 01111123456889999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.21 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=196.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK---- 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 584 (834)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999875 5899999999754 344567889999999999999999999999877655
Q ss_pred --EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 585 --ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 585 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 58877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--ccc---c----cc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLG---H----AW 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~~---~----~~ 732 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ... . ..
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 865432 234578999999999987 68899999999999999999999998643321100 000 0 00
Q ss_pred ccccccccccccccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........+......... .......+.+++.+||+.||.+|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000000000000 01124578899999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.01 Aligned_cols=204 Identities=26% Similarity=0.425 Sum_probs=155.4
Q ss_pred hcCccc-cceeccCCcEeEEEEEec---CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeE
Q 003288 512 TENFSM-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKI 585 (834)
Q Consensus 512 ~~~y~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 585 (834)
.+.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345666 458999999999999965 47889999997543 23567899999999999999999999954 66899
Q ss_pred EEEEecCCCchhhhhhcc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe----cCCCCce
Q 003288 586 LILEYMPNKSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPK 655 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl----~~~~~~k 655 (834)
+||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 676666421 12234899999999999999999999998 9999999999999 7788999
Q ss_pred eeccccceecCCCcc-cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 656 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 656 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
|+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999987654321 1223446889999999999874 58999999999999999999999986433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=331.44 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=200.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----------CCceeeEeeeee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCV 579 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 579 (834)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999874 6889999999643 345577889999999886 889999999998
Q ss_pred ecC----eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEec-----
Q 003288 580 EQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLD----- 649 (834)
Q Consensus 580 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~----- 649 (834)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 754 789999999 889999985432 34589999999999999999999998 8 99999999999995
Q ss_pred -CCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--
Q 003288 650 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-- 726 (834)
Q Consensus 650 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-- 726 (834)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999876432 23357899999999999999999999999999999999999998754321110
Q ss_pred --ccccccc------------------cccccccccccc--------c-ccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 727 --LLGHAWD------------------LWKDDRVHDLID--------P-VIMQDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 727 --~~~~~~~------------------~~~~~~~~~li~--------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.+..... .+........+. . ..............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0000000 000000000000 0 0001234456678899999999999999999
Q ss_pred CHHHHHHH
Q 003288 778 TMSDVISM 785 (834)
Q Consensus 778 t~~evl~~ 785 (834)
|++|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.33 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=201.3
Q ss_pred HHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
...++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34678999999999999999999876 6899999998643 23456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC---CCceeeccccce
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLAR 663 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~ 663 (834)
||||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999888533 35899999999999999999999998 9999999999999754 469999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
...... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.|+....... ... ........
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----~~~~~~~~-- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK----RVETGKYA-- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCCCC--
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHcCCCC--
Confidence 764332 2233568999999998875 48999999999999999999999986432211 000 00000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... +........+.+++.+||+.||.+||++.|+++
T Consensus 241 --~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 --FDL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --CCS---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCc---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 000112356889999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=337.78 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=188.2
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEec
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
+.|.+.++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.++...++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776678999999998643 345678999999987 8999999999999999999999999
Q ss_pred CCCchhhhhhccCCCc----cCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-------------CCc
Q 003288 592 PNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-------------MNP 654 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-------------~~~ 654 (834)
+ |+|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999985433211 1234456789999999999999998 9999999999999754 479
Q ss_pred eeeccccceecCCCccc--CCcccccccccccCcccccC-------CCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCc
Q 003288 655 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 724 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~ 724 (834)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987543221 12334689999999999976 678999999999999999999 899986432211
Q ss_pred ccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....... ................++.+++.+||+.||.+||++.||++
T Consensus 248 ~~i~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRGI------------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTC------------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCC------------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111100 00000011123455678999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=328.11 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=196.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe-----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 583 (834)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 5899999999653 33446788999999999999999999999987654
Q ss_pred -eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 584 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 584 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58887762 23899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc--------cc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AW 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~ 732 (834)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+.. ..
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865322 234578999999999887 6789999999999999999999999865332110 00000 00
Q ss_pred ccccccccccccc---ccc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 733 DLWKDDRVHDLID---PVI--MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 733 ~~~~~~~~~~li~---~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........+. ... .-..........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000000 000 0001112335678999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=329.14 Aligned_cols=199 Identities=27% Similarity=0.363 Sum_probs=171.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CC-----ceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 584 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+++..|+.+++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 578999999999999999999875 5789999999743 344677888999999885 55 499999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh--cCCCceeeCCCCCCcEEec--CCCCceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ--YSRFRIIHRDLKASNILLD--KDMNPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~~~~ivH~Dikp~NILl~--~~~~~kl~DFG 660 (834)
++||||++ ++|.+++.... ...+++..+..++.||+.||+|||. .+ |+||||||+|||++ .++.+||+|||
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999996 59999885432 2458999999999999999999995 45 99999999999994 57889999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCC
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 721 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~ 721 (834)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 234578999999999999999999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.61 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=199.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CC-cEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc------eeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+++.. ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999874 34 68999999653 345677889999999998766 8999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe---------------
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--------------- 648 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl--------------- 648 (834)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55665665432 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCc
Q 003288 649 ----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724 (834)
Q Consensus 649 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~ 724 (834)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999865332 234578999999999999999999999999999999999999987543211
Q ss_pred cc-ccccc--------cccccccc------------------cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003288 725 FN-LLGHA--------WDLWKDDR------------------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 777 (834)
Q Consensus 725 ~~-~~~~~--------~~~~~~~~------------------~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.. .+... ........ ..+...+..............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 10 00000 00000000 00000000001112234456889999999999999999
Q ss_pred CHHHHHH
Q 003288 778 TMSDVIS 784 (834)
Q Consensus 778 t~~evl~ 784 (834)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.71 Aligned_cols=253 Identities=18% Similarity=0.204 Sum_probs=173.5
Q ss_pred hcCccccc-eeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeE
Q 003288 512 TENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKI 585 (834)
Q Consensus 512 ~~~y~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 585 (834)
.++|.+.+ +||+|+||.||+|+.. +++.||||++.... . ...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 57899865 6999999999999886 58999999996532 1 11223334566799999999999876 44589
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeeccccc
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLA 662 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla 662 (834)
+||||+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999543 2346899999999999999999999998 999999999999976 455999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...... .....+|+.|+|||++....++.++||||||+++|||++|+.|+........... ....... ..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~---~~ 249 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRL---GQ 249 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhc---cc
Confidence 8764322 2345789999999999988999999999999999999999999864332211000 0000000 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... ...........+.+++.+||+.||.+|||++|+++.
T Consensus 250 ---~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 ---YGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 011112234578899999999999999999999983
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.32 Aligned_cols=244 Identities=22% Similarity=0.376 Sum_probs=191.3
Q ss_pred HHHhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhc----CCCceeeEeee
Q 003288 509 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKL----QHRNLVRLLGC 577 (834)
Q Consensus 509 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~ 577 (834)
....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334678999999999999999999864 588999999965432 1233466799999999 89999999999
Q ss_pred eeecCeeEEEEEe-cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCce
Q 003288 578 CVEQGEKILILEY-MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 655 (834)
Q Consensus 578 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~k 655 (834)
+.+.+..++|||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999854 345899999999999999999999998 99999999999999 889999
Q ss_pred eeccccceecCCCcccCCcccccccccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.|+..... .
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~------- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----I------- 245 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H-------
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----H-------
Confidence 99999998775432 2345689999999999877664 589999999999999999999753210 0
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... ..........+.+++.+||+.||++||+++|+++.
T Consensus 246 ---------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 ---------LEAE---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------HHTC---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------hhhc---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01111233567899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.46 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=187.4
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
..+|++.++||+|+||.|+.....+++.||||++..... +.+.+|+.+|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 457999999999999997655566899999999965432 2356899999999 899999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-----CCCceeeccccceec
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMF 665 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~ 665 (834)
++ |+|.+++... ...+.+.++..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 5999998543 233555667899999999999999998 999999999999943 335789999999876
Q ss_pred CCCcc-cCCcccccccccccCccccc---CCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccc
Q 003288 666 GGDEL-QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |..|++............ ...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG-------ACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT-------CCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc-------cCC
Confidence 54321 12234467999999999997 4567889999999999999999 888875432211111000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ...........+.+++.+||+.||.+||+++||++
T Consensus 247 ~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 01112234556789999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.18 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=198.1
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcC--CCceeeEeeeeeec
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 581 (834)
..++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3678999999999999999999864 588999999865421 12345678999999996 59999999999999
Q ss_pred CeeEEEEEecCC-CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCceeecc
Q 003288 582 GEKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDF 659 (834)
Q Consensus 582 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DF 659 (834)
+..++|||++.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 899999853 346899999999999999999999998 99999999999999 7889999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+...... .
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~---------- 256 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----I---------- 256 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----H----------
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----h----------
Confidence 9998765432 233578999999999987766 68899999999999999999998532110 0
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 739 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 739 ~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... .........+.+++.+||+.||++||+++|+++.
T Consensus 257 ------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ------RGQV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------HCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cccc---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0011123467899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.33 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=179.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-h-hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999985 689999999975432 2 2344555566788889999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+ ++.+..+... ....+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455554422 234689999999999999999999995 7 99999999999999999999999999986643
Q ss_pred CcccCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.. ......+|+.|+|||++. ...++.++||||||+++|||++|+.|+........ ..... .. ..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~---~~-~~--- 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKV---LQ-EE--- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHH---HH-SC---
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHH---hc-cC---
Confidence 32 223357899999999984 55788999999999999999999999864322110 00000 00 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+.+ +........+.+++.+||+.||.+||+++|+++.
T Consensus 247 --~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 --PPLL---PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCC---CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 0011123568899999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=344.32 Aligned_cols=264 Identities=24% Similarity=0.300 Sum_probs=200.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee------cCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 583 (834)
.++|++.++||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999874 5889999998754 45556789999999999999999999998765 667
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCC---ceeeccc
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFG 660 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFG 660 (834)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999998 999999999999997765 8999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc---cccc-cccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN---LLGH-AWDLWK 736 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~---~~~~-~~~~~~ 736 (834)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .... ......
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998765432 223467899999999999999999999999999999999999998643210000 0000 000000
Q ss_pred cccccc--cccccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003288 737 DDRVHD--LIDPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSD 781 (834)
Q Consensus 737 ~~~~~~--li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
...... .....+ ............+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 000110 112334456778999999999999999999866
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=304.57 Aligned_cols=232 Identities=13% Similarity=0.112 Sum_probs=184.1
Q ss_pred hcCccccceeccCCcEeEEEEEecC-CcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.++|++.+.||+|+||.||+|+... ++.||||.+.... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4689999999999999999999864 8999999997542 34567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. . ....++.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 355678899999999999999998 9999999999999999999998543
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
|++| ++.++|||||||++|||++|+.||......... .......... .....
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~----~~~~~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQ----PIEPA 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSC----BCCHH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccC----CCChh
Confidence 3333 688999999999999999999998754332110 0000000000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.........+.+++.+||+.||.+| |+.|+++.|++...
T Consensus 227 ----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 227 ----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0011123468899999999999999 99999999988643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.39 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=193.5
Q ss_pred hcCccccceeccCCcEeEEEEEec--CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCe-----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 583 (834)
.++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 5899999998654 34556788999999999999999999999988765
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++.. .+++.+++.++.||++||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999998 9999999999999986 89999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
..... ....||+.|+|||++.+.. +.++|||||||+++||++|.+|+...... .+
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GL 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SC
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------cc
Confidence 76432 3457999999999987654 88999999999999999998775421000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhcc
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVISMINNE 789 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~~ 789 (834)
. ...........+.+++.+||+.||.+||+ ++++.+.|.+.
T Consensus 285 ~-----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 P-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp C-----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c-----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00011122357889999999999999994 66666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.45 Aligned_cols=228 Identities=19% Similarity=0.253 Sum_probs=178.7
Q ss_pred hcCcccc-ceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHH-HhcCCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 584 (834)
.++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4677777 78999999999999874 5889999999643 4567888888 55599999999999987 6788
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeecccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGl 661 (834)
++||||+++++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999653 2346899999999999999999999998 999999999999998 78899999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+.... +..++.++|||||||++|||++|+.||......... .. ..
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~---------~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG---------MK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CC---------SC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HH---------HH
Confidence 87532 244678999999999999999999998643321110 00 00
Q ss_pred cccccccccCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVIMQDEIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+... ..... ......+.+++.+||+.||.+||++.|+++.
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 00111 1124578899999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=319.10 Aligned_cols=241 Identities=15% Similarity=0.169 Sum_probs=179.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh---hhHHHHHHHHHHHHhcCC-Ccee--------------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQH-RNLV-------------- 572 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv-------------- 572 (834)
...|.+.++||+|+||.||+|++. +|+.||||++..... ...+.|.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 456888899999999999999964 589999999874332 336789999999999987 2211
Q ss_pred -eE------eeeeee-----cCeeEEEEEecCCCchhhhhhc----cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003288 573 -RL------LGCCVE-----QGEKILILEYMPNKSLNVFLFD----STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 573 -~l------~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 636 (834)
.+ +.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 111111 12346666655 6899888731 223456889999999999999999999998 9
Q ss_pred eeCCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccc----------cCCCCCccCcchhhHHH
Q 003288 637 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGIL 706 (834)
Q Consensus 637 vH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDVwslGvv 706 (834)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 334567 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003288 707 MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 707 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
+|||++|+.||........ . ..++.. ... ....+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~--~------------~~~~~~---~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG--S------------EWIFRS---CKN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC--S------------GGGGSS---CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh--H------------HHHHhh---ccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999864322110 0 000100 011 125688999999999999999966653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.64 Aligned_cols=238 Identities=16% Similarity=0.187 Sum_probs=182.1
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcC---------CCceeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL 574 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 574 (834)
.++|++.++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 78999999996542 234578899999999986 6666655
Q ss_pred eee-----------------eee-------------cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHH
Q 003288 575 LGC-----------------CVE-------------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 624 (834)
Q Consensus 575 ~~~-----------------~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 624 (834)
.++ +.+ ....++||||+++|++.+.+. +..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 554 333 678999999999997666652 2458999999999999999
Q ss_pred HHHHH-hcCCCceeeCCCCCCcEEecCCC--------------------CceeeccccceecCCCcccCCcccccccccc
Q 003288 625 LLYLH-QYSRFRIIHRDLKASNILLDKDM--------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGY 683 (834)
Q Consensus 625 L~~LH-~~~~~~ivH~Dikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 683 (834)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876432 35899999
Q ss_pred cCcccccCCCCCccCcchhhHHH-HHHHHhCCCCCCCCCCCcccccccccccccccccccccc----cccccCCCCHHHH
Q 003288 684 MSPEYALDGLFSIKSDVFSFGIL-MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID----PVIMQDEISLPML 758 (834)
Q Consensus 684 ~aPE~~~~~~~s~~sDVwslGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~----~~~~~~~~~~~~~ 758 (834)
+|||++.+.. +.++|||||+++ .+++++|..|+.... | .......+.. .............
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----------W---LHYLTDKMLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----------H---HHHHHHHHHHTCCCSSCCCSHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----------h---hhHHHHhhhhhhccCcccchhhhhhcC
Confidence 9999998766 899999998777 777888888863100 0 0000000000 0000111123456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHH
Q 003288 759 MRYINVALLCVQENAADRPTMSDVI 783 (834)
Q Consensus 759 ~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
.++.+|+.+||+.| |++|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 78999999999966 899887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=280.93 Aligned_cols=185 Identities=16% Similarity=0.160 Sum_probs=131.7
Q ss_pred eeccCCcEeEEEEE-ecCCcEEEEEEecCCC----------hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEE
Q 003288 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 520 ~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 587 (834)
..+.|++|.+..++ ...|+.+|+|.+.... +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46777777776654 3458899999986431 23457799999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||++|++|.++|.. .+.++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 3456554 58899999999999999 99999999999999999999999999987654
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p 716 (834)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 23445789999999999875 467789999999999888765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-25 Score=254.66 Aligned_cols=184 Identities=18% Similarity=0.205 Sum_probs=145.9
Q ss_pred cccceeccCCcEeEEEEEecCCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
...++||+|+||.||+++. .++.+++|+..... ....+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3356899999999999954 67889999864321 11245689999999999999999777777788888999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4589999999999999998 999999999999999 999999999998754
Q ss_pred CcccC-----CcccccccccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCC
Q 003288 668 DELQG-----NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKN 716 (834)
Q Consensus 668 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDVwslGvvl~elltg~~p 716 (834)
..... ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.+
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 32211 1245789999999999987 5688889999999988888776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=214.16 Aligned_cols=165 Identities=18% Similarity=0.150 Sum_probs=130.8
Q ss_pred HHHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhc
Q 003288 505 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKL 566 (834)
Q Consensus 505 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 566 (834)
+..+......|++.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 4445555677888899999999999999997799999999964321 2356789999999999
Q ss_pred CCCceeeEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcE
Q 003288 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 646 (834)
Q Consensus 567 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NI 646 (834)
+ | +++.+++. .+..++||||+++++|.+ +. ..+...++.|+++||+|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 66666543 456799999999999988 41 1234579999999999999998 99999999999
Q ss_pred EecCCCCceeeccccceecCCCcccCCcccccccccccCcccccC----------CCCCccCcchh
Q 003288 647 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD----------GLFSIKSDVFS 702 (834)
Q Consensus 647 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~~sDVws 702 (834)
|++ ++.+||+|||+++. +..++|||++.. ..|...+|+|.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999 99999999999974 345788998753 34555566654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=175.21 Aligned_cols=108 Identities=19% Similarity=0.367 Sum_probs=94.7
Q ss_pred ccccccCCCcccCCCCeEE--eCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEE
Q 003288 23 LAADTVTPASFIRDGEKLV--SSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100 (834)
Q Consensus 23 ~~~d~~~~~~~l~~~~~l~--S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl 100 (834)
++.|+|++||+|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+||++.| +.++.|+|..||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5689999999999999999 999999999999885 2 57876 799999999877 3357899999999999
Q ss_pred EcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 101 ~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
.|.++.++|+|++........++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999997655455678999999999997 269997
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=170.41 Aligned_cols=104 Identities=16% Similarity=0.364 Sum_probs=92.4
Q ss_pred cccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCC
Q 003288 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (834)
Q Consensus 26 d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~ 105 (834)
|+|.+||.|.+|+.|+| |.|.|.|...|+ |.++. ..++||+|||+.|... .+.|+|+.||||||.|+++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCc
Confidence 78999999999999998 889999998876 77765 3589999999999865 6789999999999999999
Q ss_pred CeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 106 ~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
.+||+|+++......+|+|+|+|||||++. .||||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 999999987666667899999999999963 59998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.7e-21 Score=169.60 Aligned_cols=110 Identities=25% Similarity=0.432 Sum_probs=95.3
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
+|+|.+||.|.+|++|+ ++|.|+|+|+..|+ + ++|+ ..++||.||++.|. .++.|+|..||||||.|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999998886 3 6676 47999999998763 3578999999999999999
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCC
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPT 153 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PT 153 (834)
|.++|+|++........++|+|+|||||++. .+||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999987554556789999999999862 5999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=167.36 Aligned_cols=110 Identities=21% Similarity=0.383 Sum_probs=93.9
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||+||++.|. .++.|+|..||||||.|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58999999999999998 7999999998775 32 355 47999999999884 3678999999999999999
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCCh
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTD 154 (834)
+.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999976444556789999999999852 69999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=163.18 Aligned_cols=110 Identities=24% Similarity=0.462 Sum_probs=93.1
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
+|||.+||+|.+|++| ++|.|+|+|+.+|+ + +||+. .++||+||++.+ +.++.|+|..||||||.| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 5899999999999999 58999999999886 3 35765 699999999863 345789999999999999 8
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCC
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~P 152 (834)
+.++|+|++........++|+++|||||++.. +.++||||+|.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 88999998765545567899999999999743 36899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.3e-19 Score=156.83 Aligned_cols=105 Identities=26% Similarity=0.439 Sum_probs=88.9
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
.+||.|||.|.+|++|+ +|.|+|+|...|+ +.+ |+. .++||+||++.+ +..+.|+|..||||||.|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 36899999999999997 7999999998875 433 554 689999999876 33578999999999999999
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeec
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSF 149 (834)
+.++|+|++.+.....+|+|+|+|||||++. .+|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 9999999987554456899999999999973 599973
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=179.70 Aligned_cols=138 Identities=16% Similarity=0.192 Sum_probs=108.4
Q ss_pred cCccccceeccCCcEeEEEEEe-cCCcE--EEEEEecCCChh------------------------hHHHHHHHHHHHHh
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLKEFKNEMMLIAK 565 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~ 565 (834)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999988 67889 999987543111 12368899999999
Q ss_pred cCCCce--eeEeeeeeecCeeEEEEEecCC-C----chhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCcee
Q 003288 566 LQHRNL--VRLLGCCVEQGEKILILEYMPN-K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRII 637 (834)
Q Consensus 566 l~h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iv 637 (834)
++|+++ +.+++. ...++||||+.+ | +|.++... .++.++..++.|++.+|.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 344432 367899999942 4 56655421 235567899999999999999 887 99
Q ss_pred eCCCCCCcEEecCCCCceeeccccceec
Q 003288 638 HRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 638 H~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999865
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=148.89 Aligned_cols=106 Identities=20% Similarity=0.345 Sum_probs=87.2
Q ss_pred hccccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEE
Q 003288 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLL 101 (834)
Q Consensus 22 ~~~~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~ 101 (834)
.+|.|||.|||.|.+|+.|+| |.|.|-|-..|+ |.+ |.. ++||.+|++.. +..+.|+|..||||||.
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 468899999999999999998 458887666554 655 544 58999999862 33578999999999999
Q ss_pred cCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 102 NQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 102 ~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
|.++.++|++++.......+|+|+|+|||||++. .+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 9999999999986544457899999999999972 59987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-16 Score=142.78 Aligned_cols=108 Identities=14% Similarity=0.282 Sum_probs=90.3
Q ss_pred ccccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEc
Q 003288 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (834)
Q Consensus 23 ~~~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~ 102 (834)
.+.|+|.+||.|.+|+.|.+ |.|.|-|...|+ |.++.. -..++||.+|+..+- ..+.|.|..||||||.|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGRG--QHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccCC--cCEEEEEeCCCcEEEEC
Confidence 46799999999999999975 889999987775 777532 246899999998763 35789999999999999
Q ss_pred CCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 103 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
.++.++|+|++.......+|+|+|+|||||++ ..+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99999999998654445789999999999996 369997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=140.43 Aligned_cols=97 Identities=23% Similarity=0.432 Sum_probs=79.2
Q ss_pred CCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhc
Q 003288 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDM 160 (834)
Q Consensus 81 ~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~ 160 (834)
.|+.+...+|.|..||+|+|.+. +.+||++++.+......|+|+++|||||++ ++ .++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~---------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNT---------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCC----------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCc----------
Confidence 34444467899999999999987 789999998655455789999999999998 43 68999993
Q ss_pred ccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEc-CCeeeeecCCCCC
Q 003288 161 KLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFN-GSVKFTCSGHWDG 217 (834)
Q Consensus 161 ~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~-~~~~~~~~g~w~g 217 (834)
+|++|.|++.++++|. ++++. ++.+||+++.|+|
T Consensus 77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999997 44454 5789999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-16 Score=171.65 Aligned_cols=144 Identities=14% Similarity=0.182 Sum_probs=103.7
Q ss_pred HHHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh--------------hhHHH--------HHHHHHHH
Q 003288 506 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLKE--------FKNEMMLI 563 (834)
Q Consensus 506 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l 563 (834)
..+.....-|++.++||+|+||.||+|...+|+.||||+++.... ..... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344443445999999999999999999998999999998753210 01111 13455566
Q ss_pred HhcCCCcee--eEeeeeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCC
Q 003288 564 AKLQHRNLV--RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 641 (834)
Q Consensus 564 ~~l~h~niv--~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di 641 (834)
.++.+.++. ..++ ....+|||||+++++|..+.. .+....++.||+.+|.+||+.+ ||||||
T Consensus 168 ~rL~~~gv~vp~p~~----~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIA----QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEE----EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHhcCCCCCeeee----ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 666443332 2221 123479999999998866541 2234578899999999999998 999999
Q ss_pred CCCcEEecCCCC----------ceeeccccceec
Q 003288 642 KASNILLDKDMN----------PKISDFGLARMF 665 (834)
Q Consensus 642 kp~NILl~~~~~----------~kl~DFGla~~~ 665 (834)
||.|||+++++. +.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999988773 889999987754
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.1e-16 Score=137.46 Aligned_cols=103 Identities=21% Similarity=0.384 Sum_probs=85.9
Q ss_pred ccccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEc
Q 003288 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (834)
Q Consensus 23 ~~~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~ 102 (834)
+|.|||.|||.|.+|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ +.++.|+|..||||||.|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 57999999987775 443 332 699998865 336789999999999999
Q ss_pred CCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 103 ~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
.++.++|+|++.+.....+|+|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 99999999998654445689999999999996 369997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=136.44 Aligned_cols=88 Identities=20% Similarity=0.362 Sum_probs=73.8
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
..+|.|..||||||.| .+.+||++|+.+......|+|+|+|||||++.++ .++||||
T Consensus 21 ~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~-----~~~W~S~----------------- 77 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSN-----RVIWQTK----------------- 77 (110)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECC-----------------
T ss_pred CEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCC-----cEEEecC-----------------
Confidence 5789999999999998 5899999998755556789999999999998643 7899999
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCCC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHW 215 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (834)
+++++|.|++.++++|. ++++++ .||+++.+
T Consensus 78 --------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 --------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp --------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred --------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35678999999999987 455665 79999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=130.71 Aligned_cols=86 Identities=24% Similarity=0.348 Sum_probs=71.9
Q ss_pred ceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhcccccccc
Q 003288 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFK 167 (834)
Q Consensus 88 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~ 167 (834)
.+|.|..||||+|++. +++||++|+........|+|+|+|||||+|.++ .++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~-----~~lW~S~------------------ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP------------------ 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCC-----cEEEcCC------------------
Confidence 4699999999999987 899999998655556789999999999998643 7899999
Q ss_pred cccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 168 NRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 168 t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999997 44555 38999985
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-14 Score=128.30 Aligned_cols=91 Identities=25% Similarity=0.333 Sum_probs=75.3
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
...|.|..||||+|.+ .+.+||++|+........++|+++|||||+|.++ .++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~-----~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNN-----NDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCc-----eEEEEcCCC---------------
Confidence 5679999999999998 5889999998655445788999999999998643 689999998
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCCCCCc
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHWDGA 218 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w~g~ 218 (834)
|++|.|++.++++|. +++++. .||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 555654 89999999753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.49 E-value=8.7e-14 Score=124.32 Aligned_cols=103 Identities=16% Similarity=0.275 Sum_probs=82.8
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
.|+|.+||.|.+|+.|. +|.|.|.|...|+ |.+ |.. .. ||.+|+..+ ...+.|+|..||||||.|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 48999999999999994 7899999987775 555 432 23 999999876 23578999999999999988
Q ss_pred CC-eEEEEecCC--CCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 105 NG-TIWSTNVSS--EVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 105 ~~-~vWst~~~~--~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
+. ++|+|++.. .....+++|+++|||||++ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2234678999999999996 369997
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8e-12 Score=130.38 Aligned_cols=113 Identities=19% Similarity=0.389 Sum_probs=88.6
Q ss_pred ccccccCCCcc----cCCCCeEEeCCCeEEEEEeCCC--CCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCC
Q 003288 23 LAADTVTPASF----IRDGEKLVSSSQRFELGFFSPG--KSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNG 96 (834)
Q Consensus 23 ~~~d~~~~~~~----l~~~~~l~S~~g~F~lgF~~~~--~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G 96 (834)
..+||+.|||. |..|+.|+|+ ..++.|+|... ...+.+ + |++ ..+++|.+++..+- ...|.+..||
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~-~~~~yW~Sgt~~~~---~~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP-NGAATWNAGTQGKG---AVRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT-TSSEEEECCCTTTT---CCEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC-CCeEEEECCCCCCc---cEEEEEcCCC
Confidence 57899999999 8899999664 57777776542 222333 3 322 35899999998763 2689999999
Q ss_pred cEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCC
Q 003288 97 NLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (834)
Q Consensus 97 ~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~ 151 (834)
+|++.|.++.++|++++... ...+|+|+++|||||++. +++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 99999998899999997644 357899999999999974 479999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.8e-11 Score=127.96 Aligned_cols=145 Identities=17% Similarity=0.115 Sum_probs=115.2
Q ss_pred HHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEE
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 588 (834)
..-+.|++...++.|+.+.||++.. .++.+++|............+.+|+.+++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3456798888999999999999976 47899999986532222346889999999994 677889999998888999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 632 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 632 (834)
||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999977641 12234578899999999999821
Q ss_pred --------------------CCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 633 --------------------RFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 633 --------------------~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876666799999875
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.4e-11 Score=107.90 Aligned_cols=95 Identities=17% Similarity=0.285 Sum_probs=72.0
Q ss_pred CCCCCCCCceEEEeeCCcEEEEcC-CCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhh
Q 003288 80 DRPISDNNAVLTISNNGNLVLLNQ-TNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQ 158 (834)
Q Consensus 80 ~~p~~~~~~~l~~~~~G~Lvl~~~-~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLp 158 (834)
+.|+.+...+|.+..||||||.+. .+.++|++++.+......++|+++|||||++.++ .++|||=.+-
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~-----~~iW~S~t~~------ 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRL-----NTVFVSNTVG------ 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECSCCC------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCC-----CEEEECCCcC------
Confidence 455555567899999999999998 5899999998755456788999999999998643 6799963210
Q ss_pred hcccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 159 DMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 159 g~~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
..|.|.+.++.+|...++ + .+.|.+|+
T Consensus 87 -------------------------~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 87 -------------------------QEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 124578889888877665 2 57888764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.15 E-value=9.2e-11 Score=104.64 Aligned_cols=95 Identities=19% Similarity=0.239 Sum_probs=71.0
Q ss_pred CCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhc
Q 003288 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDM 160 (834)
Q Consensus 81 ~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~ 160 (834)
.++......|.+..||||||.+.++ +|++++.+......++|+++|||||++.++ +.++|||.-+
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~--------- 79 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS--------- 79 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS---------
T ss_pred CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc---------
Confidence 3444445689999999999999877 999998765555788999999999998653 2359998721
Q ss_pred ccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 161 KLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 161 ~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.....|.|.+.++.+|...++- .++|.++.
T Consensus 80 --------------------~~~~~~~~~l~Lq~dGNlvly~----~~~W~s~t 109 (111)
T 3mez_A 80 --------------------VNTVRGNYAATLGPDQHVTIYG----PAIWSTPA 109 (111)
T ss_dssp --------------------CCCCSSCCEEEECTTSCEEEEC----SEEEECCC
T ss_pred --------------------cCCCCcCEEEEECCCCeEEEec----cCEEccCC
Confidence 0113477899999999777652 67887763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.6e-10 Score=120.31 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=103.2
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~ 590 (834)
.++.+..+.+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+++.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554343456669999998777888999997654 2245788999999996544 56688888877789999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-------------------------------------- 632 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 632 (834)
+++.+|. .. . .+ ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~-~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS-H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS-C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC-c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 21 1 11 2357788888888888753
Q ss_pred -----------------CCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 633 -----------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 633 -----------------~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
...++|+|++|.|||++++..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.01 E-value=7.6e-10 Score=98.49 Aligned_cols=85 Identities=21% Similarity=0.331 Sum_probs=64.5
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
+..|.+..||||||.+. .++|++++.+......++|+++|||||++.++ .++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~-----~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF-----KTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTC-----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCC-----CEEEEcCCcC--------------
Confidence 56799999999999886 59999998765555688999999999998643 6899975321
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
..|.|.+.++.+|...++ + .+.|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 124577888888876655 2 3678765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1.3e-09 Score=96.88 Aligned_cols=86 Identities=24% Similarity=0.343 Sum_probs=64.9
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
...|.|..||||||.+. +.++|++++.+......++|+++|||||++.++ .++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~-----~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRN-----NPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTS-----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCC-----CEEEECCCCC--------------
Confidence 56799999999999987 789999998755455788999999999998643 6899975321
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
..+.|.+.++.+|...++- . +.|.+|
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly~--~--~~W~s~ 105 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIYG--T--ARWATG 105 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEEE--S--CCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEEC--C--CEEeCC
Confidence 1245778888888766552 2 566654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.9e-09 Score=116.56 Aligned_cols=142 Identities=15% Similarity=0.249 Sum_probs=107.8
Q ss_pred ccceeccCCcEeEEEEEecCCcEEEEEEec--CCC-hhhHHHHHHHHHHHHhcC--CCceeeEeeeeeec---CeeEEEE
Q 003288 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ---GEKILIL 588 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 588 (834)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.++ +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999874 4688899875 322 122356788999999997 45578899888776 4589999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 632 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 632 (834)
||+++..+.+.. -..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998875422 123678888899999999999999731
Q ss_pred -------------------CCceeeCCCCCCcEEecCCCC--ceeecccccee
Q 003288 633 -------------------RFRIIHRDLKASNILLDKDMN--PKISDFGLARM 664 (834)
Q Consensus 633 -------------------~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~ 664 (834)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987754 68999998874
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.4e-09 Score=95.06 Aligned_cols=92 Identities=22% Similarity=0.356 Sum_probs=68.6
Q ss_pred CCCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhh
Q 003288 80 DRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQD 159 (834)
Q Consensus 80 ~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg 159 (834)
+.|+......|.+..||||||.++ +|+|++.+......++|.++|||||+|.++ .++|+|-..
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~-----~~vWss~t~-------- 77 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDG-----STVWKSGAQ-------- 77 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECCCC--------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCC-----CEEEcCCCc--------
Confidence 344444466899999999999985 799998765556788999999999998643 678975210
Q ss_pred cccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCCC
Q 003288 160 MKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGHW 215 (834)
Q Consensus 160 ~~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (834)
...+.|.+.++.+|...++ . .+.|.++.|
T Consensus 78 -----------------------~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 -----------------------SVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp -----------------------CSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred -----------------------CCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 1235678889988876655 2 578999876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=3.8e-09 Score=112.82 Aligned_cols=187 Identities=18% Similarity=0.200 Sum_probs=123.6
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCc--eeeEeeeeeecC---eeEEEEEec
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCVEQG---EKILILEYM 591 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 591 (834)
.+.++.|....||+.. +.+++|..... .....+.+|+.+|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3569999999999863 56889986532 44577899999999884 333 345555443333 347899999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--------------------------------------- 632 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 632 (834)
+|.+|..... ..++..++..++.++++.|+.||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 23677788888999999999988621
Q ss_pred ----------------CCceeeCCCCCCcEEecC--CCCceeeccccceecCCCccc-CCcc-----------ccccccc
Q 003288 633 ----------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGDELQ-GNTK-----------QIVGTYG 682 (834)
Q Consensus 633 ----------------~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~~-~~~~-----------~~~gt~~ 682 (834)
...++|+|++|.||++++ ...+.|+||+.+..-.....- .... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 235899999999999998 456889999998754321100 0000 0000011
Q ss_pred ccC-cccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 003288 683 YMS-PEYALDGLFSIKSDVFSFGILMLETLSSKKNT 717 (834)
Q Consensus 683 y~a-PE~~~~~~~s~~sDVwslGvvl~elltg~~p~ 717 (834)
... |+.... .....+.|+++.++|++.+|+.++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221111 112358999999999999997664
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.53 E-value=3.8e-07 Score=80.17 Aligned_cols=77 Identities=27% Similarity=0.415 Sum_probs=57.7
Q ss_pred ceEEEeeCCcEEEEcCCCCeEEEEecCCCC-ccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 88 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
-+|.+..||||||.+. +.+||++|+.... ....++|.++|||||+|.++ +++|+|-
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~-----~~vWss~----------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG-----RSLWASH----------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC-----CEEEECC-----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCc-----EEEEEec-----------------
Confidence 4589999999999974 6899999976433 34678899999999998754 6788851
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEE
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKIC 201 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~ 201 (834)
+....+.+.+.++.+|...++
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 --------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp --------------CCCCSSCEEEEECTTSCEEEE
T ss_pred --------------CCCCCCCEEEEEeCCCeEEEE
Confidence 112345678888888866554
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=3e-07 Score=93.96 Aligned_cols=86 Identities=23% Similarity=0.362 Sum_probs=66.1
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
.-+|.++.||+|+|.+.+ .++|++++.+......++|.++||||+++.+ +..+||||.+.
T Consensus 151 ~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-----~~~vw~s~~~~-------------- 210 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-----NIAVWTSGNSR-------------- 210 (236)
T ss_dssp SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----TEEEEECCCCC--------------
T ss_pred cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCC-----CcEEEEeCCCC--------------
Confidence 457999999999999865 6899999765444567899999999999854 36899999431
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
++|.|.+.+|++|..+++ . ..||.+|
T Consensus 211 -----------------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 211 -----------------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp -----------------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred -----------------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 236789999999987765 2 2688765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.4e-06 Score=89.84 Aligned_cols=136 Identities=22% Similarity=0.198 Sum_probs=97.3
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC---ceeeEeeeee-ecCeeEEEEEecCC
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCV-EQGEKILILEYMPN 593 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~ 593 (834)
.+.++.|....||+. ++.+++|+-. .......+.+|+.+|..+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357888999999987 5678889853 234457889999999999652 3556666664 34567899999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY------------------------------------------ 631 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 631 (834)
..|...... .++..+...++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988763211 134555556666666666666643
Q ss_pred ---------------CCCceeeCCCCCCcEEecC---CCC-ceeecccccee
Q 003288 632 ---------------SRFRIIHRDLKASNILLDK---DMN-PKISDFGLARM 664 (834)
Q Consensus 632 ---------------~~~~ivH~Dikp~NILl~~---~~~-~kl~DFGla~~ 664 (834)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=5e-06 Score=86.66 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=102.0
Q ss_pred cCccccceeccCCcE-eEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 589 (834)
..|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|+.+|+.+. +--+.++++++.+.+..++|||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 345556655 68987654 4667999986533 3456788999999884 4446788999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-------------------------------------- 631 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 631 (834)
++++.++.+.... .......+..++++.|+.||..
T Consensus 101 ~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 101 AIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999888765421 1233445667777777777742
Q ss_pred -----------------CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 632 -----------------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 -----------------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.7e-06 Score=92.71 Aligned_cols=81 Identities=7% Similarity=0.013 Sum_probs=57.3
Q ss_pred ccee-ccCCcEeEEEEEec-------CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCC---CceeeEeeeeeec--
Q 003288 518 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQ-- 581 (834)
Q Consensus 518 ~~~L-G~G~fg~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 581 (834)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88889999998764 26789999865432 0012456789999988843 3567788877655
Q ss_pred -CeeEEEEEecCCCchhh
Q 003288 582 -GEKILILEYMPNKSLNV 598 (834)
Q Consensus 582 -~~~~lv~E~~~~gsL~~ 598 (834)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3.8e-05 Score=84.88 Aligned_cols=75 Identities=9% Similarity=0.156 Sum_probs=50.7
Q ss_pred cceeccCCcEeEEEEEec-CCcEEEEEEecCCCh-------hhHHHHHHHHHHHHhcCC--Cc-eeeEeeeeeecCeeEE
Q 003288 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RN-LVRLLGCCVEQGEKIL 586 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 586 (834)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899998653221 123456789999988842 33 4455543 4456789
Q ss_pred EEEecCCC
Q 003288 587 ILEYMPNK 594 (834)
Q Consensus 587 v~E~~~~g 594 (834)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=8.5e-05 Score=79.98 Aligned_cols=141 Identities=16% Similarity=0.175 Sum_probs=81.5
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeEee------eeeecCeeEEEEEe
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E~ 590 (834)
+.|+.|..+.||+....+| .+++|+.... . ..+..|+.++..+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5899998752 2 334456666666532 12344443 12345678999999
Q ss_pred cCCCchhh--------------hhhccCC----C-------ccCCHHHH-------------------------------
Q 003288 591 MPNKSLNV--------------FLFDSTK----K-------RLLNWQAR------------------------------- 614 (834)
Q Consensus 591 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~------------------------------- 614 (834)
++|..+.. .++.... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865530 0111000 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 615 VRIIEGIAQGLLYLHQ----------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 615 ~~i~~~ia~~L~~LH~----------~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
..+...+.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666763 1234699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=8.5e-05 Score=78.10 Aligned_cols=81 Identities=16% Similarity=0.240 Sum_probs=60.6
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC---ceeeEeeeeeecCeeEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 588 (834)
.....-.+.+|.|..+.||+.++.+|+.+++|+...........|..|+..|+.|... -+.+++++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 3456667889999999999999999999999987655444445688999999988532 24455543 2347899
Q ss_pred EecCCCch
Q 003288 589 EYMPNKSL 596 (834)
Q Consensus 589 E~~~~gsL 596 (834)
||++.+..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00021 Score=75.74 Aligned_cols=138 Identities=22% Similarity=0.139 Sum_probs=92.8
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC---CCceeeEeeeeeecCeeEEEEEecCCC
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g 594 (834)
.+.|+.|....+|+... +++.+++|+.... ....|..|+..|+.|. ...+++++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46799999999999876 5778999987532 3567889999999884 356788888888778899999999988
Q ss_pred chhh-----------hhhccCC-C-------------c-----cCCHHHHH---HHHH----------------HHHH-H
Q 003288 595 SLNV-----------FLFDSTK-K-------------R-----LLNWQARV---RIIE----------------GIAQ-G 624 (834)
Q Consensus 595 sL~~-----------~l~~~~~-~-------------~-----~l~~~~~~---~i~~----------------~ia~-~ 624 (834)
.+.. .|+.... . . .-+|.+.. ++.. .++. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6531 1121111 0 0 11343321 1111 1111 1
Q ss_pred HHHHHh-cCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 625 LLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 625 L~~LH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
...|.. ..++.++|+|+.+.||+++.++ +.|+|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2356799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00038 Score=77.41 Aligned_cols=73 Identities=11% Similarity=0.154 Sum_probs=46.5
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCC----Ch-----hhHHHHHHHHHHHHh-cCCCceeeEeeeeeecCeeEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SG-----QGLKEFKNEMMLIAK-LQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~-----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.||.|....||++.. +++.++||..... .. .....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46899999999999965 5678999953221 01 123344444443332 2234566777664 5677999
Q ss_pred EEec-CC
Q 003288 588 LEYM-PN 593 (834)
Q Consensus 588 ~E~~-~~ 593 (834)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0012 Score=70.39 Aligned_cols=158 Identities=14% Similarity=0.132 Sum_probs=87.8
Q ss_pred cHHHHHHHhcCccc-----cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc--eeeEee
Q 003288 504 SLASITAATENFSM-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG 576 (834)
Q Consensus 504 ~~~~i~~~~~~y~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 576 (834)
+...+...-.+|.+ .+.|+.|....+|+....+| .+++|...... ..+.+..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34444444455544 34577788899999987555 68899886521 1234566888887774222 334432
Q ss_pred e------eeecCeeEEEEEecCCCchhhh--------------hhccCC----C-----ccCCHHHHHH-----------
Q 003288 577 C------CVEQGEKILILEYMPNKSLNVF--------------LFDSTK----K-----RLLNWQARVR----------- 616 (834)
Q Consensus 577 ~------~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~~----------- 616 (834)
. ....+..+++|||++|..+... ++.... . ....|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1234567899999998654210 111000 0 0011222110
Q ss_pred -HHHHHHHHHHHHHhc----CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 617 -IIEGIAQGLLYLHQY----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 617 -i~~~ia~~L~~LH~~----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+...+.+.++.++.. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 134599999999999999876568999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00091 Score=74.43 Aligned_cols=73 Identities=21% Similarity=0.295 Sum_probs=51.0
Q ss_pred cceeccCCcEeEEEEEecC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILIL 588 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 588 (834)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578889889999998753 5789999884421 11455679999998853344 567765542 3899
Q ss_pred EecCCCch
Q 003288 589 EYMPNKSL 596 (834)
Q Consensus 589 E~~~~gsL 596 (834)
||+++..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0016 Score=71.03 Aligned_cols=141 Identities=20% Similarity=0.231 Sum_probs=83.9
Q ss_pred ceeccCCcEeEEEEEec--------CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeEeeeeeecCeeEEEEE
Q 003288 519 CKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 589 (834)
+.|..|....+|+.... +++.+++|+.... ......+.+|..+++.+...+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888889998764 2478999986432 223456678999999884322 3567766544 29999
Q ss_pred ecCCCchhhhh-----------------hccC--CCccC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 003288 590 YMPNKSLNVFL-----------------FDST--KKRLL--NWQARVRIIEGIAQ-------------------GLLYL- 628 (834)
Q Consensus 590 ~~~~gsL~~~l-----------------~~~~--~~~~l--~~~~~~~i~~~ia~-------------------~L~~L- 628 (834)
|+++..|..-- +... -.+.. -+.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99987664210 1100 01111 13444445443321 22333
Q ss_pred ---Hhc-CCCceeeCCCCCCcEEecCC----CCceeecccccee
Q 003288 629 ---HQY-SRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 664 (834)
Q Consensus 629 ---H~~-~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~~ 664 (834)
... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23469999999999999876 7899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0021 Score=71.83 Aligned_cols=75 Identities=12% Similarity=0.104 Sum_probs=49.8
Q ss_pred cceeccCCcEeEEEEEecC-CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEecCCCc
Q 003288 518 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
.+.|+.|-...+|+....+ ++.+++|+......... .-.+|..++..+...++ .++++.+. + .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3678889889999998755 47889998754322211 12579999999965555 56777663 2 25999999865
Q ss_pred hh
Q 003288 596 LN 597 (834)
Q Consensus 596 L~ 597 (834)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0019 Score=68.90 Aligned_cols=142 Identities=14% Similarity=0.153 Sum_probs=82.9
Q ss_pred ceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCC--ceeeEeee-----eeecCeeEEEEEec
Q 003288 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGC-----CVEQGEKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~E~~ 591 (834)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877677789999986331 1235667788888887422 24445443 12245667899999
Q ss_pred CCCchhh-----h---------hhcc------CCCccCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 003288 592 PNKSLNV-----F---------LFDS------TKKRLLNWQAR----VRI---------------IEGIAQGLLYLHQY- 631 (834)
Q Consensus 592 ~~gsL~~-----~---------l~~~------~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~- 631 (834)
++..+.. . ++.. ......++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 0 1100 00111222111 000 11111223333221
Q ss_pred ---CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 632 ---SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 ---~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0013 Score=69.42 Aligned_cols=128 Identities=14% Similarity=0.145 Sum_probs=76.8
Q ss_pred cceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCeeEEEEEec-CCCc
Q 003288 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYM-PNKS 595 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs 595 (834)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .+++++. .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578999999999998 568899876532221 123568888887743333 4555543 33457899999 6655
Q ss_pred hhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 003288 596 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ--------------------------------------------- 630 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------------------------------------------- 630 (834)
|....... +..++.++++.|+-||.
T Consensus 95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 53210000 00011222222222221
Q ss_pred -----cCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 631 -----YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
.....++|+|+.+.||+ ..++.+.|+||+.+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345899999999999 6667889999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0037 Score=66.87 Aligned_cols=142 Identities=13% Similarity=0.123 Sum_probs=73.7
Q ss_pred ceeccCCcEe-EEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeEeeeeeecCeeEEEEEecCCCc
Q 003288 519 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs 595 (834)
+.|+.|+... +|+....+++.+++|....... ..+..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6677654467788886543321 234557777777742 2355666654333 378999998766
Q ss_pred hhhhhhccC---------------------C--CccCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003288 596 LNVFLFDST---------------------K--KRLLNWQARV-------R-------------IIEGIAQGLLYLH--- 629 (834)
Q Consensus 596 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~L~~LH--- 629 (834)
+.+.+.... . ...++..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 644331100 0 0111111100 0 0001112222221
Q ss_pred hcCCCceeeCCCCCCcEEecCC----CCceeeccccceec
Q 003288 630 QYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARMF 665 (834)
Q Consensus 630 ~~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~~~ 665 (834)
......++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999874 67899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0032 Score=68.47 Aligned_cols=73 Identities=14% Similarity=0.129 Sum_probs=45.2
Q ss_pred ceeccCCcEeEEEEEecC---------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeEeeeeeecCeeEEEE
Q 003288 519 CKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 588 (834)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 578888888999987653 268888887543222 122467888888885333 34666543 2 36899
Q ss_pred EecCCCch
Q 003288 589 EYMPNKSL 596 (834)
Q Consensus 589 E~~~~gsL 596 (834)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.013 Score=62.84 Aligned_cols=67 Identities=9% Similarity=0.043 Sum_probs=43.8
Q ss_pred cCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC---CceeeEeee------eeecCeeEEEEEecCC
Q 003288 523 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGC------CVEQGEKILILEYMPN 593 (834)
Q Consensus 523 ~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~E~~~~ 593 (834)
.|....||+....+| .+++|+...... ..|+.++..|.. +.+++.+.. ....+..+++|||++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333678999987667 899998765432 356666666632 224454432 2335677999999998
Q ss_pred Cch
Q 003288 594 KSL 596 (834)
Q Consensus 594 gsL 596 (834)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0076 Score=59.14 Aligned_cols=99 Identities=15% Similarity=0.065 Sum_probs=64.8
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcccCC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
-+|.++|. ..+.++++++++.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 37888884 34567999999999999999987763211 1 12333457899999999888764 1110
Q ss_pred cccccccccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 003288 674 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt 712 (834)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123566888653 345678889999999999985
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.083 Score=58.16 Aligned_cols=141 Identities=16% Similarity=0.167 Sum_probs=84.9
Q ss_pred cceeccCCcEeEEEEEecC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCc-eeeEeeeeeecCeeEEEE
Q 003288 518 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 588 (834)
.+.|..|-...+|+....+ ++.+++|+......... .-.+|..+++.+...+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3577778888999998753 57899998754432221 2357888888885333 345565332 37899
Q ss_pred EecCCCchhhh-h----------------hc--c-----C---CCccCCHHHHHHHHHHH-------------------H
Q 003288 589 EYMPNKSLNVF-L----------------FD--S-----T---KKRLLNWQARVRIIEGI-------------------A 622 (834)
Q Consensus 589 E~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a 622 (834)
||+++..|..- + +. . . ......+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 0 00 0 0 11111234444443322 1
Q ss_pred HHHHHHH---------------------hcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 623 QGLLYLH---------------------QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 623 ~~L~~LH---------------------~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
+.+..|. ......++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223322 112346999999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.29 E-value=0.17 Score=55.48 Aligned_cols=30 Identities=27% Similarity=0.401 Sum_probs=25.4
Q ss_pred ceeeCCCCCCcEEe------cCCCCceeecccccee
Q 003288 635 RIIHRDLKASNILL------DKDMNPKISDFGLARM 664 (834)
Q Consensus 635 ~ivH~Dikp~NILl------~~~~~~kl~DFGla~~ 664 (834)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=91.45 E-value=6.9 Score=39.80 Aligned_cols=73 Identities=12% Similarity=0.274 Sum_probs=44.9
Q ss_pred EEEEeecCCCeeEEeecCCCC--CCC----CCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeC
Q 003288 62 LGIRFQQIPDAVVWVANRDRP--ISD----NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135 (834)
Q Consensus 62 ~giw~~~~~~t~vW~ANr~~p--~~~----~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~ 135 (834)
+.+| +.-...++|...+..+ +.+ +++.+-++.++.+...|.+|..+|............+..+.+||+++-+.
T Consensus 17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 5555 2225578898887542 111 23444445555666778889999998864222333456778888888764
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=83.38 E-value=0.94 Score=36.77 Aligned_cols=35 Identities=26% Similarity=0.540 Sum_probs=29.8
Q ss_pred cCChHHHHHHHhhcCCceeeecccccCCcceeeeccc
Q 003288 361 RMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 397 (834)
Q Consensus 361 ~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~~~ 397 (834)
..++++|+..|+.+=.|.||.|. .....|++..+.
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN--~~s~~CflKs~~ 63 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYN--VKSGLCYPKRGK 63 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEE--TTTTEEEEEESS
T ss_pred CCCHHHHHHHhhccCCCCeEEec--cCCCceEcccCC
Confidence 46899999999999999999996 356689988764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.75 E-value=9.9 Score=38.61 Aligned_cols=65 Identities=15% Similarity=0.070 Sum_probs=40.2
Q ss_pred CeeEEeecCCCCCCC----CCce-EEEeeC-CcEEEEcCC-CCeEEEEecCCC-----CccceEEEecCCcEEEEeC
Q 003288 71 DAVVWVANRDRPISD----NNAV-LTISNN-GNLVLLNQT-NGTIWSTNVSSE-----VKNPVAQLRDDGNLVIRDN 135 (834)
Q Consensus 71 ~t~vW~ANr~~p~~~----~~~~-l~~~~~-G~Lvl~~~~-~~~vWst~~~~~-----~~~~~a~LldsGNlVl~~~ 135 (834)
..++|.-.+..+... .++. |-...+ +.++.+|.. |.++|+.....- .....+.++.+||+++.+.
T Consensus 155 G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~~ 231 (276)
T 3no2_A 155 GQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICNW 231 (276)
T ss_dssp SCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEEE
T ss_pred CCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEec
Confidence 578898886532211 2333 333333 347777887 999999864311 1134457889999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 834 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 5e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-09 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 9e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 7e-70
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 20/285 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+G + ++ ++ SL L + + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-- 690
IIHRDLK++NI L +D+ KI DFGLA + +Q+ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 691 -DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
+S +SDV++FGI++ E + TG + N + + P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELM-----TGQLPYSNINNRDQIIFMVGRGYL----SPDLS 232
Query: 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 794
+ + P M+ + C+++ +RP +++ I +LP
Sbjct: 233 KVRSNCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-65
Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 26/276 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L + T++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + SPE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 693 LFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
+S KSDV+SFG+LM E S K N++ + + L+ P +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------KPRLAS 228
Query: 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ + C +E DRP S ++ +
Sbjct: 229 THV--------YQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-65
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
RL Q +I EYM N SL FL + +L + + IA+G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 693 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
F+IKSDV+SFGIL+ E ++ + + + + + +R + ++ P +E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 753 ISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ + LC +E DRPT + S++ +
Sbjct: 239 L--------YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-65
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 28/291 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579
+G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 580 EQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ----- 630
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 688
+ I HRDLK+ NIL+ K+ I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 689 ALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSF-----NLLGHAWDLWKD 737
D + ++D+++ G++ E G++ + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 738 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ P I S L + C N A R T + ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-63
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 693 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 752
FS KSD+++FG+LM E S K + ++ + L P + ++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 753 ISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
+ + C E A +RPT ++S I
Sbjct: 230 V--------YTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-63
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 26/290 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 573 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+L + ++ EYM SL FL T K L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 633 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 692
+HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 693 LFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
F+IKSDV+SFGIL+ E + + G+ N + + + + + + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL------ 243
Query: 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 800
++ C ++ +RPT + + + + + +P
Sbjct: 244 -----------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-61
Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 43/319 (13%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 568
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
+V G GE + +E+M SL+ L K + Q ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK------------------------KNTGVYNADS 724
+S++SD++S G+ ++E + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLM---RYINVALLCVQENAADRPTMSD 781
L + D + +L+D ++ + LP + + + C+ +N A+R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 782 V-----ISMINNEHLNLPS 795
+ I + E ++
Sbjct: 295 LMVHAFIKRSDAEEVDFAG 313
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-61
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 32/279 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 573 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L + +L ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
+HRDL A N+L+ +D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
FS KSDV+SFGIL+ E S + + + D++ V
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP-----------------YPRIPLKDVVPRVEKGY 217
Query: 752 EISLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 788
++ P V C +AA RP+ + + +
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 31/299 (10%)
Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L + +VRL+G C + +L++E L+ FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYM 684
YL + +HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
+PE FS +SDV+S+G+ M E LS + +K + +++
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYKKMKGPEVM 222
Query: 745 DPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAF 801
+ + P + C DRP V + + +L S E
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 2e-60
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 41/304 (13%)
Query: 503 FSLASITAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 548
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL 608
+ + ++F +E ++ + H N++ L G + ++I E+M N SL+ FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 609 LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 669 ELQGNTKQIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF 725
+G + +PE F+ SDV+S+GI+M E
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE---------------- 225
Query: 726 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVI 783
++ + + D D+I+ + + PM + L C Q++ RP ++
Sbjct: 226 -VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 784 SMIN 787
+ ++
Sbjct: 285 NTLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (513), Expect = 2e-59
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 22/277 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 632 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IHRDL A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
FSIKSDV++FG+L+ E + + + +V++L++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDY-RM 235
Query: 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
E + + C Q N +DRP+ +++
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 2e-59
Identities = 72/311 (23%), Positives = 129/311 (41%), Gaps = 46/311 (14%)
Query: 504 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEF 556
L S+ N +GEG FG V++ R VAVK L ++ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 557 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------- 608
+ E L+A+ + N+V+LLG C L+ EYM LN FL + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 609 -------------LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 655
L+ ++ I +A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 656 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 715
I+DFGL+R + +M PE ++ +SDV+++G+++ E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 716 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD 775
+ + ++ ++ + D I+ + P + N+ LC + AD
Sbjct: 241 Q-------------PYYGMAHEEVIYYVRDGNILACPENCP--LELYNLMRLCWSKLPAD 285
Query: 776 RPTMSDVISMI 786
RP+ + ++
Sbjct: 286 RPSFCSIHRIL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 570 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLL 626
N+VR +++ L ++EY L + TK+R L+ + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 627 YLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
H+ S ++HRDLK +N+ LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
SPE ++ KSD++S G L+ E L + +L
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYE------------------LCALMPPFTAFSQKELA 223
Query: 745 DPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVI 783
+ +P + + RP++ +++
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 23/275 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 570
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 691 DGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
F + DV+S GI++ L G D + + WK+ + + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
++L L + + EN + R T+ D+
Sbjct: 234 SAPLAL--LHK-------ILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 520 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRL 574
+LG G FG V KG + VAVK L N++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+G C E +L++E LN +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 635 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYMSPEYALDGL 693
+HRDL A N+LL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 694 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 753
FS KSDV+SFG+LM E S + ++ + ++ + + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAMLEKGERM 229
Query: 754 SLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 788
P ++ LC + +RP + V + N
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-58
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG 576
++G G F VYKG EVA L ++ + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 577 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 633 RFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
+ DV++FG+ MLE +S+ ++ +A +++ RV + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYR--RVTSGVKPASFDK 236
Query: 752 EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
+ + C+++N +R ++ D+++
Sbjct: 237 VAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 3e-58
Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H N ++ GC + + L++EY + ++ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH + +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 688 YAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
L +G + K DV+S GI +E + N + + + +++
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPLFNMNAMSALYHIAQNES----- 231
Query: 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
P + S N C+Q+ DRPT ++
Sbjct: 232 -PALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 520 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 574
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 575 LGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LG C+ +G +++L YM + L F + + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ--IVGTYGYMSPEYALD 691
+ +HRDL A N +LD+ K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
F+ KSDV+SFG+L+ E ++ N L + R L+ P D
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRR---LLQPEYCPD 261
Query: 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+ V L C A RP+ S+++S I+
Sbjct: 262 PL--------YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-58
Identities = 62/283 (21%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+LL + +++E+ +++ + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
+IIHRDLKA NIL D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 691 -----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
D + K+DV+S GI ++E + + ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLL 225
Query: 746 PVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVIS 784
+ + +L R+ + C+++N R T S ++
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-57
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 45/305 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK------------------ 606
L H N+V LLG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 --RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664
+L ++ + +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 665 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 724
D +M+PE +G+++IKSDV+S+GIL+ E S GV
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----LGVNPYPG 269
Query: 725 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
+ + + L ++ D P +EI + C ++ RP+ ++ S
Sbjct: 270 IPVDANFYKLIQNGFKMDQ--PFYATEEI--------YIIMQSCWAFDSRKRPSFPNLTS 319
Query: 785 MINNE 789
+ +
Sbjct: 320 FLGCQ 324
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 71/300 (23%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 565
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---------------L 609
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ + + +A+G+ +L IHRDL A NILL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729
+M+PE + +++ +SDV+S+GI + E S G +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDS 255
Query: 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789
+ + K+ ++ P E+ ++ C + RPT ++ +I +
Sbjct: 256 KFYKMIKEG--FRMLSPEHAPAEM--------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
H N++RL G + ++I EYM N +L+ FL + K + V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMS 685
YL +HRDL A NIL++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745
PE F+ SDV+SFGI+M E ++ + W+L + + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAIND 228
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
+ + P + + + C Q+ A RP +D++S+++
Sbjct: 229 GFRLPTPMDCPSAIY--QLMMQCWQQERARRPKFADIVSILD 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-56
Identities = 75/312 (24%), Positives = 134/312 (42%), Gaps = 43/312 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 567 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
+ ++ RLLG C+ LI + MP L + K + Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 627 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 686
YL R++HRDL A N+L+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID- 745
E L +++ +SDV+S+G+ + E ++ +D + +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228
Query: 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--------------NNEHL 791
+ + + + + C +A RP ++I +E +
Sbjct: 229 GERLPQPPICTIDVY--MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 792 NLPSPKEPAFTK 803
+LPSP + F +
Sbjct: 287 HLPSPTDSNFYR 298
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 8e-56
Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 568
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
N++RL G + LILEY P ++ L K + Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
+ K D++S G+L E L K ++ + + I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYK-RI 216
Query: 749 MQDEISLPMLM--RYINVALLCVQENAADRPTMSDVIS 784
+ E + P + ++ ++ N + RP + +V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 614
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 615 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 675 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734
+M+ E +++ SDV+S+G+L+ E +S + + A
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------TPYCGMTCAELY 236
Query: 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787
K + + L P+ DE+ ++ C +E +RP+ + ++ +N
Sbjct: 237 EKLPQGYRLEKPLNCDDEV--------YDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-55
Identities = 59/286 (20%), Positives = 122/286 (42%), Gaps = 32/286 (11%)
Query: 504 SLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 562
S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 622
+ + ++ N+V L + E +++EY+ S L D + ++ +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 623 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 682
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742
+M+PE + K D++S GI+ +E + + + ++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PYLNENPLR 223
Query: 743 LIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVIS 784
+ + L + + C+ + R + +++
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-55
Identities = 68/282 (24%), Positives = 103/282 (36%), Gaps = 28/282 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L HRNL+RL G ++ E P SL + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYM 684
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744
+PE FS SD + FG+ + E + + W ++ I
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILHKI 227
Query: 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 786
D + NV + C DRPT + +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-54
Identities = 74/304 (24%), Positives = 134/304 (44%), Gaps = 36/304 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 565
E +M +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRII 618
++VRLLG + ++I+E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 678
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 738
+MSPE DG+F+ SDV+SFG+++ E + + + ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242
Query: 739 RVHDLI-DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 797
+V + + ++ + P ++ + +C Q N RP+ ++IS I E P +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFR 298
Query: 798 EPAF 801
E +F
Sbjct: 299 EVSF 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 60/283 (21%), Positives = 117/283 (41%), Gaps = 31/283 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 567
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H ++V+L+G E +I+E L F +K L+ + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
L R +HRD+ A N+L+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
F+ SDV+ FG+ M E L ++ + +D+I +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRI 222
Query: 748 IMQDEISLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ + +P ++ C + + RP +++ + ++
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-51
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 564
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 565 KLQHRNLVRLLGCCVEQGEKILIL-EYMPNKSLNVFLF-------------DSTKKRLLN 610
H N+V LLG C + G ++++ E+ +L+ +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 611 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670
+ + +A+G+ +L + IHRDL A NILL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 730
+M+PE D +++I+SDV+SFG+L+ E S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245
Query: 731 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
K+ D + L C + RPT S+++ + N
Sbjct: 246 FCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 564 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 610 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669
+ + V +A+G+ YL + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 729
T +M+PE D +++ +SDV+SFG+L+ E + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMIN 787
+ V +L + + P + C + RPT ++ ++
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 788 N 788
Sbjct: 293 R 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 39/300 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
V+L + + L Y N L + R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748
+ SD+++ G ++ + ++ ++ + + I
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQK-I 222
Query: 749 MQDEISLP--MLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGIN 806
++ E P + ++ + +A R ++ K F + +
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM--------EGYGPLKAHPFFESVT 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 9e-50
Identities = 59/311 (18%), Positives = 110/311 (35%), Gaps = 35/311 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+++ + +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
V L + E ++I E+M L + D + ++ V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+H DLK NI+ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI--DPV 747
+D++S G+L LS + DD +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL---------------SPFGGENDDETLRNVKSCDW 242
Query: 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDV-----ISMIN--NEHLNLPSPKEPA 800
M D + + + + R T+ ++ N +PS +
Sbjct: 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 801 FTKGINVKNSS 811
I K +
Sbjct: 303 IRDSIKTKYDA 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 2e-48
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 36/294 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ L ++ E +LILE++ L F + + ++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I+H D+K NI+ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
+D+++ G+L LS + + + + V
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 750 QDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--INNEHLNLPSP 796
D ++ +Q+ R T+ D + + +H NL S
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-45
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 21/291 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N++ + + + Y+ + L+ K + L+ + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEY 688
++HRDLK SN+LL+ + KI DFGLAR+ D + V T Y +PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 689 ALDGLFSIKS-DVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
L+ KS D++S G ++ E LS++ G + D N + + ++ +I+
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 747 VIMQDEISLPMLMRY-------------INVALLCVQENAADRPTMSDVIS 784
+SLP + +++ + N R + ++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (401), Expect = 4e-44
Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 567
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 568 HRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
H +V + + +++EY+ +L + + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYG 682
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742
Y+SPE A +SDV+S G ++ E L TG + + A+ ++D +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVL-----TGEPPFTGDSPVSVAYQHVREDPIPP 234
Query: 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMI 786
+ ++ V L + +N +R T +++ + +
Sbjct: 235 SARHEGLSADL--------DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ L E ++I E++ + + +T LN + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 632 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
+ S +D++S G L+ LS + + +I+ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMN 217
Query: 750 QDEISLPMLMRYINVALL-----CVQENAADRPTMSDV 782
+ + I++ + + + R T S+
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 9e-44
Identities = 53/281 (18%), Positives = 101/281 (35%), Gaps = 33/281 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 569
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V L G LI++ + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
+ LD+D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749
+S D +S G++ L + D+ L + I+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFE-QIL 222
Query: 750 QDEISLPMLMR------YINVALLCVQENAADRPTMSDVIS 784
+ E + ++++ R T +
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 70/313 (22%), Positives = 110/313 (35%), Gaps = 43/313 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 567
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 627
H L + + ++EY+ L + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 628 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
LH I++RDLK NILLDKD + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
L ++ D +SFG+L+ E L + + +L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHS- 214
Query: 748 IMQDEISLPMLMRYINVALL--CVQENAADRPTMSDVI------SMINNEHLN---LPSP 796
I D P + LL R + I IN E L + P
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 274
Query: 797 KEPAFTKGINVKN 809
P + N
Sbjct: 275 FRPKVKSPFDCSN 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 6e-43
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 562
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 563 IAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
+ K+ H N+++L L+ + M L +L T+K L+ + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 681
+ + LH + I+HRDLK NILLD DMN K++DFG + E +++ GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 682 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 735
Y++PE + + + D++S G++M L+ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PF 215
Query: 736 KDDRVHDLIDPVIMQD-EISLPMLMRY----INVALLCVQENAADRPTMSDVIS 784
+ ++ ++ + + P Y ++ + R T + ++
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (399), Expect = 6e-43
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 565
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
+V + + IL+ M L+ L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSK 714
PE G+ + +D FS G ++ + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-43
Identities = 73/300 (24%), Positives = 114/300 (38%), Gaps = 28/300 (9%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 573
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 633
LL + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 634 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-G 692
I+HRDLK +N+LLD++ K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 693 LFSIKSDVFSFGILMLETLS------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746
++ + D+++ G ++ E L + L + W D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 747 VIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--INNEHLNLPSPKEP 799
I L + LL N R T + + M +N P + P
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 8e-43
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
++F + LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++R+ G + + +I++Y+ L F +R N A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKK 715
++ D +SFGIL+ E L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 5e-42
Identities = 44/287 (15%), Positives = 101/287 (35%), Gaps = 27/287 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 571
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 572 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 631
+ + ++G +++ + SL L R + + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 632 SRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN-----TKQIVGTY 681
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741
YMS L S + D+ + G + + L G + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFL-----RGSLPWQGLKAATNKQKYERIGEKK 232
Query: 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
+ +Y++ P + + +
Sbjct: 233 QSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-41
Identities = 53/278 (19%), Positives = 97/278 (34%), Gaps = 25/278 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638
+G+ +++ + SL + R + + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 639 RDLKASNIL---LDKDMNPKISDFGLARMFGGDELQGN-----TKQIVGTYGYMSPEYAL 690
RD+K N L K I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 691 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750
S + D+ S G +++ G + ++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFN-----LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788
Y+N C D+P S + + N
Sbjct: 242 KGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 26/294 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 563
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 564 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRIIEG 620
+H N+VRL C + + ++ D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 680
+ +GL +LH R++HRDLK NIL+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSF-NLLGHAWDLWKDD 738
Y +PE L ++ D++S G + E K G + D +L ++D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 739 RVHDLIDPVIMQDEISLPMLMRY--------INVALLCVQENAADRPTMSDVIS 784
D+ P S + ++ ++ L C+ N A R + +S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 4e-41
Identities = 59/287 (20%), Positives = 113/287 (39%), Gaps = 23/287 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 570
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 630
+V+L + +L+ E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 690
R++HRDLK N+L++++ KI+DFGLAR FG + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLS------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743
+S D++S G + E ++ L W +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 744 IDPVIMQDE-ISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 784
DP E + ++ ++ + + ++ + R T +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 29/291 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+V+LL + + L+ E++ D++ + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-Y 688
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS--------FNLLG----HAWDLWK 736
+S D++S G + E ++ + ++ DS F LG W
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 737 DDRVHDLIDPVIMQDEISL---PMLMRYINVALLCVQENAADRPTMSDVIS 784
+ P + + S P+ ++ + + R + ++
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 36/311 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 572
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 573 RLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 626
RL GEK L+L+Y+P V S K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 627 YLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 685
Y+H + I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLGHAWDLWKDDR 739
PE ++ DV+S G ++ E L + + + +LG +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 740 VHDLIDPVIMQDEISLPMLMRYINV-----ALL--CVQENAADRPTMSDV-----ISMIN 787
+ + Q + + AL ++ R T + +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 788 NEHLNLPSPKE 798
+ ++ LP+ ++
Sbjct: 311 DPNVKLPNGRD 321
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 43/288 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 565
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 566 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
+QH N++ L + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQILNG- 125
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFGGDELQGNTKQIVGTY 681
++ +I H DLK NI+L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741
+++PE +++D++S G++ LS + D
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQ 222
Query: 742 DLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 784
+ + V + + + ++ R T+ D +
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 51/300 (17%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 567
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 568 --HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
++RLL +LILE T++ L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 685 SPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743
PE+ + V+S GIL+ + + ++ D +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDE-EII 217
Query: 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH---LNLPSPKEPA 800
V + +S ++ C+ +DRPT ++ H ++ P+E A
Sbjct: 218 RGQVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEIQ-----NHPWMQDVLLPQETA 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 69/319 (21%), Positives = 124/319 (38%), Gaps = 43/319 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
+ K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 570 NLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 621
N+V L+ C + L+ ++ + + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT--KQIVG 679
GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG---- 729
T Y PE L + + D++ G +M E + A L G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 730 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL------CVQENAADRPTMSDVI 783
W + +++ ++ V Q L Y+ + + A R D +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 784 SMINNEH---LNLPSPKEP 799
H + P P +
Sbjct: 304 -----NHDFFWSDPMPSDL 317
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-37
Identities = 50/273 (18%), Positives = 102/273 (37%), Gaps = 30/273 (10%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 578
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 579 ----VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 634
+ ++++E + L + D + + I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSI--- 130
Query: 635 RIIHRDLKASNILLDKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 691
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 692 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751
+ D++S G++M G S + L + + R+ P
Sbjct: 188 EKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 752 EISLPMLMRYINVALLCVQENAADRPTMSDVIS 784
E+S + + ++ R T+++ ++
Sbjct: 243 EVSEEV----KMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-37
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
L L ++EY LF + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
+++RD+K N++LDKD + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
D + D + G++M E + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 57/288 (19%), Positives = 113/288 (39%), Gaps = 23/288 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 569
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 570 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 629
N+VRL + L+ E+ F + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 630 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 689
++HRDLK N+L++++ K+++FGLAR F G ++ + ++V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 690 LDGLFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747
L+S D++S G + E ++ + G D + +++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 748 IMQDEISLPMLMRYINVA---------LL--CVQENAADRPTMSDVIS 784
+ P +NV LL ++ N R + + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 62/315 (19%), Positives = 120/315 (38%), Gaps = 39/315 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 569
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL + L++ +M + K L ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG----HAWD 733
+PE L+ + ++ D++S G +M E ++ K + + + G
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--I 786
+ D + + + ++ ++ + + + +A R T + ++
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 787 NNEHLNLPSPKEPAF 801
+ H P+ +
Sbjct: 305 ESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 2e-34
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 568
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
LV+L + +++EY+ + L + + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 629 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 688
H +I+RDLK N+L+D+ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSK 714
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 564
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 565 KLQHR-NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
++ LV L + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
+L L + II+RD+K NILLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 684 MSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741
M+P+ G D +S G+LM E L+ + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---------------SPFTVDGEKNSQ 241
Query: 742 DLIDPVIMQDEISLPMLMRYINVALL--CVQENAADRPTMS 780
I I++ E P M + L+ + ++ R
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (314), Expect = 5e-32
Identities = 52/299 (17%), Positives = 113/299 (37%), Gaps = 42/299 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 570
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 571 LVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 628
++ L + + L+ E++ N + L ++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 629 HQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 687
H I+HRD+K N+++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSSK------KNTGVYNADSFNLLGHAWDLWKDDRV 740
+D ++ D++S G ++ + K + +LG D+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 741 HDLIDPVIMQ----------DEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 784
+ +DP + ++ L ++ + R T + +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 569
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 570 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL Q + L++E M V + L+ + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
G+ +LH IIHRDLK SNI++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 714
+PE L + D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-30
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 35/296 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 568
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 569 RNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 623
N++ LL + ++ ++ L + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLTDDHVQFLIYQILR 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 683
GL Y+H IIHRDLK SN+ +++D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG----HAWD 733
+PE L+ + ++ D++S G +M E L+ + + L+G
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 784
+ + I + +++ + N + + ++ R T + ++
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 5e-28
Identities = 41/210 (19%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 578
KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 579 VEQGEKIL-------------ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 626 LYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 684
Y+H+ R IIH D+K N+L++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSK 714
SPE L + +D++S L+ E ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 3e-25
Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAKLQHR 569
+GEG V+ E VK ++ + S + +K F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 NLVRLLGCCV----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 625
L +L G V +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 626 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663
+ I+H DL N+L+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 89.6 bits (222), Expect = 5e-22
Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ +GE L + Q ++ + + L + VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++GN V+ + ++W+++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 38.4 bits (89), Expect = 4e-04
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNP-VAQLRDDGNLVIRDNSSGNAT 141
+ + + NLVL + + ++W++N K A L+ DGN V+ D +
Sbjct: 16 LDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLW 74
Query: 142 ESYLWQSFDYPTDTLLQD 159
S+ + L +D
Sbjct: 75 ASHSVRGNGNYVLVLQED 92
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.7 bits (167), Expect = 1e-14
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
VL + N+GNLV+ + + IW++N + + N L+ D N+VI DNS+ +
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDYPTD 154
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 68.5 bits (167), Expect = 1e-14
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 20/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L + F L + D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ L++ +GNLV+ N +N IW++N + N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDY 151
W + +
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.4 bits (94), Expect = 9e-05
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
++ + V + + NLVL + + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDYPTDTLLQDMKL 162
S L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.0 bits (166), Expect = 3e-14
Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D + + + + L++ + NLVL ++ + +WSTN + + A L+ +G +
Sbjct: 20 DNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRM 78
Query: 131 VIRDNSSGNATESYLWQSFD--YPTDTLL 157
+ N + +W S + +
Sbjct: 79 DVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.3 bits (133), Expect = 7e-10
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 41 VSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100
+ ++Q +L + L + + D VW N + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDV 80
Query: 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
L N +W++ S V L+ D NL I +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.4 bits (159), Expect = 2e-13
Identities = 19/112 (16%), Positives = 41/112 (36%), Gaps = 18/112 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLV 99
++ + + + L + + +W N N + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLYD---NNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++ N T+W + V+ + + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.4 bits (128), Expect = 3e-09
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 23/134 (17%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
+++F LS T+ A + F S L + D
Sbjct: 2 NILFGLS-HEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SD 44
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 45 VRVWASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVT 101
Query: 132 IRDN---SSGNATE 142
I SG + +
Sbjct: 102 IYGPGLWDSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.2 bits (117), Expect = 9e-08
Identities = 20/128 (15%), Positives = 39/128 (30%), Gaps = 38/128 (29%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
+ + + + ++ T+ ++ NLVL + + +W++N + A L+
Sbjct: 6 GLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQ 63
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
DG LVI + + W S S
Sbjct: 64 SDGLLVILTAQN-----TIRWSSGT-------------------------------KGSI 87
Query: 186 GNFTYRLD 193
GN+ L
Sbjct: 88 GNYVLVLQ 95
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 834 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.65 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.57 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.06 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.84 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.73 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.25 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.38 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=418.06 Aligned_cols=264 Identities=28% Similarity=0.442 Sum_probs=205.7
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 568999999999999999999863 46999998643 45567899999999999999999999998754 56899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999853 3345999999999999999999999998 9999999999999999999999999998775544
Q ss_pred ccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.........||+.|||||++.+ ..|+.++|||||||+||||++|+.||........ +.. ....+ ...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~----~~~~~----~~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIF----MVGRG----YLSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH----HHHHT----SCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHH----HHhcC----CCCC
Confidence 4444456789999999999864 3589999999999999999999999864332111 000 00000 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 794 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 794 (834)
.+ ..........+.+++.+||+.||++|||++||++.|+.+...+|
T Consensus 230 ~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11122234578899999999999999999999999998755554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=412.97 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=199.9
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3578999999999999999999988999999999754 334578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++.. ....+++..++.++.|||+||+|||+.+ |+||||||+|||+++++++||+|||+++........
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999853 3456899999999999999999999998 999999999999999999999999999876543322
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC-CCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......||+.|+|||++.+..++.++|||||||++|||+++..| +...... .+... +.... .
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~-------------i~~~~-~ 220 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED-------------ISTGF-R 220 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHH-------------HHHTC-C
T ss_pred -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHH-------------HHhcC-C
Confidence 22345789999999999999999999999999999999996554 3321111 11110 00000 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+.....++.+++.+||+.||++||||+||+++|+++
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111122345788999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=411.22 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=205.2
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|+.. +|+.||||++.... .+..+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999875 58999999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++. +...+++.++..++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999983 4457999999999999999999999998 9999999999999999999999999999875444
Q ss_pred ccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
........+||+.|||||++.+..+ +.++|||||||+||||++|+.||............. ... ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~--------~~ 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEK--------KT 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTT--------CT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcC--------CC
Confidence 3444556789999999999988876 578999999999999999999986443221111100 000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++|||++|+++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111122456789999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=409.04 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=207.4
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 56899999999999999999999888999999997543 345789999999999999999999998754 5679999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++... ....+++.++++|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987432 2335899999999999999999999998 999999999999999999999999999987544322
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......||+.|+|||++.+..++.++|||||||++|||+||..|+....... .... ....+ . ..
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----~i~~~-----~-----~~ 229 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----NLERG-----Y-----RM 229 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHTT-----C-----CC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHhc-----C-----CC
Confidence 2334578999999999999999999999999999999999766543222110 1110 00000 0 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....++.+++.+||+.||++||||+||+++|+..
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11222345688999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=409.19 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=208.0
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999864 5999999999766555678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999998743 35899999999999999999999998 99999999999999999999999999998754322
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+. . .+......
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~---~---------~~~~~~~~ 235 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY---L---------IATNGTPE 235 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---H---------HHHHCSCC
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHH---H---------HHhCCCCC
Confidence 2344689999999999999999999999999999999999999986432211 000 0 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111223457889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-48 Score=412.99 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=199.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC-C---cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.+.|++.++||+|+||+||+|++.. + ..||||.+... .....++|.+|+++|++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998753 3 35899998654 45566789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998853 3446999999999999999999999998 9999999999999999999999999999775
Q ss_pred CCcccC---CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccc
Q 003288 667 GDELQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 667 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... ......||+.|||||.+.+..++.++|||||||+||||+| |++|+....... +..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~------------- 244 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VIN------------- 244 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH-------------
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHH-------------
Confidence 432221 1223467999999999999999999999999999999998 888976433211 110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ..+........+.+++.+||+.||++||||.||++.|+++
T Consensus 245 ~i~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 245 AIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCC-CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 010000 1112233456788999999999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=401.29 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=211.8
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.++||+|+||.||+|++++++.||||+++... ...++|++|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36899999999999999999999888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|..++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999743 3456899999999999999999999998 999999999999999999999999999876544332
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccccccccc
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~ 750 (834)
......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||........ ... .... . .
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~----i~~~---------~-~ 219 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEH----IAQG---------L-R 219 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHH----HHTT---------C-C
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHH----HHhC---------C-C
Confidence 2334578999999999999999999999999999999998 7888865433211 100 0000 0 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003288 751 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...+.....++.+++.+||+.||++|||++|+++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11122233578899999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=402.98 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=205.3
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5889999998643 2334677899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999999865432
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
......||+.|||||++.+..++.++|||||||+||||++|+.||....... ... ... ..
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~----~i~--------~~-- 219 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYK----RIS--------RV-- 219 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH----HHH--------TT--
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHH----HHH--------cC--
Confidence 2345689999999999999999999999999999999999999986433211 100 000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.||++|||++|+++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00111223457889999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-48 Score=410.16 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=211.9
Q ss_pred HhcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
..++|++.++||+|+||.||+|++. +++.||||+++... ...++|.+|+.+|++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3568999999999999999999886 48899999996543 346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998543 3457899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.|+....... . +.+.+....
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~-------------~~~~i~~~~- 233 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q-------------VYELLEKDY- 233 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H-------------HHHHHHTTC-
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-H-------------HHHHHhcCC-
Confidence 22 2233568899999999999999999999999999999999877653222110 0 011111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.......++.+++.+||+.||++|||++||++.|+.+
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122223345789999999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=408.04 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=206.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+.|+++++||+|+||.||+|+.. +++.||||+++.......+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357899999999999999999875 5889999999877777778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999987532 346999999999999999999999998 9999999999999999999999999998653221
Q ss_pred cCCcccccccccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.......||+.|+|||++. ...|+.++|||||||++|||++|+.||........ .. .+..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~------------~i~~ 229 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LL------------KIAK 229 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH------------HHHH
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HH------------HHHc
Confidence 1223468999999999984 45689999999999999999999999864332211 00 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
............+.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001111233457889999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=403.16 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=208.2
Q ss_pred hcCccccc-eeccCCcEeEEEEEec---CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+ +||+|+||.||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45777777 4999999999999764 3557999999765 34456889999999999999999999999865 56899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. .+..+++.++.+++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccccc
Q 003288 667 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 667 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.... ........||+.|+|||++....++.++|||||||++|||++ |+.||....... +. .....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~----~~i~~~~----- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGK----- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH----HHHHTTC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcCC-----
Confidence 5432 223334578999999999999999999999999999999998 899986433211 11 0111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.+...+.++.+++.+||+.||++||||.+|++.|+..
T Consensus 230 -----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112223346788999999999999999999999999765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=413.54 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=207.4
Q ss_pred hcCccccceeccCCcEeEEEEEecC------CcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||+||+|+... ...||||.+... .....+.|.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999998643 236999998654 334456799999999998 89999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCC
Q 003288 584 KILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp 643 (834)
.++||||+++|+|.++|..... ...+++.+++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965432 245899999999999999999999998 99999999
Q ss_pred CcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCC
Q 003288 644 SNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNA 722 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~ 722 (834)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333345678999999999999999999999999999999998 8999864332
Q ss_pred CcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003288 723 DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 787 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
... + .+++.... +.+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~-~-------------~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-F-------------YKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-H-------------HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-H-------------HHHHhcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 0 01111110 11122233457889999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=403.86 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=195.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--cCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||.+... .+...+.|.+|+++|++++|||||++++++.+ ....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999875 5899999998654 34556789999999999999999999999865 456899
Q ss_pred EEEecCCCchhhhhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 587 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999985432 3456999999999999999999999875 2359999999999999999999999999999
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 743 (834)
.+.... .......||+.|||||++.+..|+.++|||||||++|||++|++||....... +.. .......
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~----~i~~~~~--- 231 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG----KIREGKF--- 231 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH----HHHHTCC---
T ss_pred ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHH----HHHcCCC---
Confidence 865432 22345689999999999999999999999999999999999999986433211 100 0011100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 744 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 744 i~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+...+.++.+++.+||+.||++|||++|+++
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112223457889999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=403.86 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=205.4
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 591 (834)
.++|++.+.||+|+||.||+|++.++++||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46899999999999999999999888899999996543 345789999999999999999999999854 5688999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|..++... ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999888543 2345999999999999999999999998 99999999999999999999999999987654332
Q ss_pred CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 672 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
.......||+.|+|||++..+.++.++|||||||+||||++|+.|+....... ..... +.... ..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~-------------i~~~~-~~ 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ-------------VERGY-RM 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH-------------HHTTC-CC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH-------------HHhcC-CC
Confidence 22334578999999999999999999999999999999999776654322211 01110 00000 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 793 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 793 (834)
+.......++.+++.+||+.||++||+|++|+++|+......
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 222334457889999999999999999999999999874443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=403.05 Aligned_cols=258 Identities=29% Similarity=0.443 Sum_probs=201.5
Q ss_pred hcCccccceeccCCcEeEEEEEecCC-----cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
.+.|++.++||+|+||.||+|++... ..||||+++.. .....++|.+|+.++++++|||||+++|++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688999999999999999987542 36999999654 3445668999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+.+++|.+++.. ....+++.++++++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988743 3356999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
..... ........||+.|||||++.+..++.++|||||||++|||+++..|+....... .+. +.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~-------------~~i 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVM-------------KAI 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH-------------HHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHH-------------HHH
Confidence 54322 122334578999999999999999999999999999999999766643222110 111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... +.+.......++.+++.+||+.||++||||.||+++|+++
T Consensus 227 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 227 NDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HTTC-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hccC-CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1111 1122223446789999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=402.69 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=198.3
Q ss_pred ceeccCCcEeEEEEEecC---CcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEecCC
Q 003288 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 593 (834)
++||+|+||.||+|.+.+ ++.||||+++.. +....++|.+|+++|++++|||||+++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999999653 33446789999999999999999999999864 567899999999
Q ss_pred CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc-cC
Q 003288 594 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 672 (834)
|+|.+++.. ...+++.++++++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999843 346999999999999999999999998 99999999999999999999999999998754322 22
Q ss_pred CcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccccC
Q 003288 673 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~ 751 (834)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||....... +.. ....+. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~----~i~~~~----------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA----MLEKGE----------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTTC----------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHH----HHHcCC----------CC
Confidence 2334678999999999999999999999999999999998 899986433211 110 001110 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 752 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+...+.++.+++.+||+.||++|||+++|+++|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 12223345788999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=405.83 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=203.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999875 6899999998643 2334578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. .+.+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998843 346999999999999999999999998 999999999999999999999999999987655
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ... .+....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~------------~i~~~~- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQ------------KIIKLE- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHTTC-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHH------------HHHcCC-
Confidence 44444455689999999999999999999999999999999999999986432211 000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......++.+++.+||+.||++|||++|+++
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0111223456889999999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=409.37 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=206.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 5899999999654 34456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||++ + |+||||||+||||+.++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999953 34589999999999999999999975 7 999999999999999999999999999876322
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccc------ccc-------
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW------DLW------- 735 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~------~~~------- 735 (834)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+........... ...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 234568999999999999999999999999999999999999999654432211100000 000
Q ss_pred -------cc----cccccccccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 -------KD----DRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 -------~~----~~~~~li~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ....+.++.... ........+.++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 000000000000 000011123568899999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-47 Score=405.77 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=213.3
Q ss_pred HHHHHhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeee
Q 003288 507 SITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 579 (834)
Q Consensus 507 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 579 (834)
+++.+.++|++.++||+|+||.||+|+.. +++.||||+++... .+..++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445788999999999999999999864 35789999997543 345678999999999999999999999999
Q ss_pred ecCeeEEEEEecCCCchhhhhhccC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 003288 580 EQGEKILILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 638 (834)
Q Consensus 580 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 638 (834)
+....++||||+++|+|.++++... ....+++.+++.++.||++||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996432 1234899999999999999999999998 999
Q ss_pred CCCCCCcEEecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCC
Q 003288 639 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNT 717 (834)
Q Consensus 639 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~-~p~ 717 (834)
|||||+||||+.++++||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++|. +|+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998775544444445567899999999999999999999999999999999986 455
Q ss_pred CCCCCCcccccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 718 GVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... +.. ....+.. .+.....+.++.+|+.+||+.||++||||.||+++|+++
T Consensus 244 ~~~~~~e--~~~----~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEE--VIY----YVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHH--HHH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHH--HHH----HHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4332211 111 0111110 111222345788999999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=394.35 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=196.3
Q ss_pred ccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee----cCeeEEE
Q 003288 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 587 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 587 (834)
|++.++||+|+||+||+|++. +++.||+|.+... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999875 5889999998643 44556789999999999999999999999875 3457999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec-CCCCceeeccccceecC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~ 666 (834)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999843 346899999999999999999999875 3499999999999996 57899999999998643
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||....... .+. .....+. .+
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~----~~i~~~~-----~~ 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIY----RRVTSGV-----KP 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHH----HHHTTTC-----CC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHH----HHHHcCC-----CC
Confidence 32 2345689999999998865 59999999999999999999999986332211 000 0000000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........++.+++.+||+.||++|||++|+++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111112346789999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-46 Score=400.62 Aligned_cols=246 Identities=31% Similarity=0.436 Sum_probs=201.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
.+.|+++++||+|+||.||+|+.. +++.||||+++... ....+.|.+|+.+|++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 346999999999999999999865 58899999986543 34457799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++. ....+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987763 2346999999999999999999999998 99999999999999999999999999986532
Q ss_pred CcccCCcccccccccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... ... .+.
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~------------~i~ 227 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY------------HIA 227 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH------------HHH
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HHH------------HHH
Confidence 234579999999999864 468999999999999999999999985332111 000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... ........+..+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 228 QNES-PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HSCC-CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hCCC-CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0000 01111223457889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=398.51 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=190.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999875 58999999996543 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec---CCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~ 666 (834)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999994 3456999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 746 (834)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ ... ......
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~----i~~~~~------ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FEQ----ILKAEY------ 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH----HHTTCC------
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HHH----HhccCC------
Confidence 332 23346899999999999999999999999999999999999999864322110 000 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 747 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..+.....+..+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 111112234578899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-46 Score=403.09 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=212.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|+++++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999874 6999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec--CCCCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++. .....+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988773 23446999999999999999999999998 99999999999997 6789999999999987543
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ..... ...
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~----i~~~~------~~~ 247 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQN----VKRCD------WEF 247 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH----HHHCC------CCC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhCC------CCC
Confidence 2 2344689999999999999999999999999999999999999986433211 1000 00000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCC
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNEHLNL 793 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~ 793 (834)
..........++.+|+.+||+.||++|||++|+++. +.+....+
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~ 293 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchh
Confidence 111112234568899999999999999999999875 55443333
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-45 Score=400.97 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=209.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
-++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999875 5899999999877777778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec--CCCCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999843 3346999999999999999999999998 99999999999995 4678999999999987543
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||....... .... ...... . .
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~----i~~~~~-~-~---- 244 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRN----VKSCDW-N-M---- 244 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHTCC-C-S----
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHH----HHhCCC-C-C----
Confidence 2 2344689999999999999999999999999999999999999986433211 1100 000000 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...........+.+++.+||+.||++|||++|+++.
T Consensus 245 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111223568899999999999999999999885
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=399.36 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=202.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
++|+++++||+|+||+||+|++. +|+ +||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 6899998654 345678899999999999999999999999864 5678
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++||+.+++|.+++.. ....+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988754 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
............||+.|+|||++.++.++.++|||||||+||||+| |++|+........ ...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---------------~~~i~ 227 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---------------SSILE 227 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---------------HHHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---------------HHHHH
Confidence 5544444455678999999999999999999999999999999998 7778754332211 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... +.+.+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 228 ~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 228 KGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC-CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 100 1112223446788999999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=395.64 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=201.5
Q ss_pred HHhcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
...++|++.++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999863 2468999999754 344567788898888887 689999999998765
Q ss_pred C-eeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEE
Q 003288 582 G-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 647 (834)
Q Consensus 582 ~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NIL 647 (834)
+ ..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4 68999999999999999964322 345899999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCCCCCCccc
Q 003288 648 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~-~p~~~~~~~~~~ 726 (834)
|++++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +|+....... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence 9999999999999998775554444455678999999999999999999999999999999999975 4554322211 0
Q ss_pred ccccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 727 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+. .....+. ..........++.+++.+||+.||++|||++||+++|+++
T Consensus 246 ~~----~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 FC----RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HH----HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 0001010 1111222345688999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=387.62 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=198.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-CeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 590 (834)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46789999999999999999998 5789999999754 3457899999999999999999999998654 568999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.++|... ....+++..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999543 2335899999999999999999999998 999999999999999999999999999865432
Q ss_pred cCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.....+|..|+|||++.+..++.++|||||||++|||++ |++|+....... +... ...+ .
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~----i~~~---------~- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR----VEKG---------Y- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHH----HTTT---------C-
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcC---------C-
Confidence 233567899999999999999999999999999999998 677665332211 1110 0100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.......++.+++.+||+.||++||||.||+++|+++
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122233346788999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=387.98 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=196.9
Q ss_pred hcCccccceeccCCcEeEEEEEecC----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998743 356999998654 3445678999999999999999999999986 467899
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecC
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998743 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccccccccccccccccccccc
Q 003288 667 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 745 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+|+........ .. ....+.
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~----~i~~~~------ 226 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE------ 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTC------
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC------
Confidence 4322 22334678999999999999999999999999999999998 7888764332211 10 001110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 746 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....+..+.+++.+||+.||++|||++||++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112223345788999999999999999999999999765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=388.02 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=204.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC------hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 68999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC----Cceeeccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFG 660 (834)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999853 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ......
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~----i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----VSAVNY 233 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH----HHTTCC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHH----HHhcCC
Confidence 998875432 23345789999999999999999999999999999999999999864332110 000 000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 741 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 741 ~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ------EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000112346789999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=390.66 Aligned_cols=272 Identities=24% Similarity=0.287 Sum_probs=202.2
Q ss_pred hcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----eeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 587 (834)
.+.|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+++ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35788899999999999999997 789999999964422 1222334555556789999999999998765 57999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
|||+++|+|.++|.. ..++|..+++++.|++.||+|||+.. +.+|+||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999953 35899999999999999999999741 235999999999999999999999999999
Q ss_pred eecCCCcc--cCCcccccccccccCcccccCCC------CCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 663 RMFGGDEL--QGNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 663 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
+....... ........||+.|+|||++.+.. ++.++|||||||+||||++|..|+.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 98754322 22334578999999999987643 57789999999999999999988765443222111110000
Q ss_pred cc-----ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 735 WK-----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 735 ~~-----~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. ........++.+.......+....+.+++.+||+.||++|||+.||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00 00011112222211112334556789999999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=391.48 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=209.2
Q ss_pred hcCccccceeccCCcEeEEEEEecC--------CcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeec
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 581 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 581 (834)
.++|++.++||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 5789999999999999999998532 2479999997653 44567899999999998 899999999999999
Q ss_pred CeeEEEEEecCCCchhhhhhccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 582 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 582 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
...++||||+++|+|.++|..... ...+++.++++++.||++||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |.+|+.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999998766554455566789999999999999999999999999999999998 677765333211
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+..+. ..+.......++.+++.+||+.||++|||+.||+++|+++
T Consensus 246 ---~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 ---LFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111110 1111222345789999999999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=388.43 Aligned_cols=257 Identities=27% Similarity=0.365 Sum_probs=197.6
Q ss_pred hcCccccceeccCCcEeEEEEEecC--C--cEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|++.. + ..||||++... ..+..++|.+|+.+|++++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998642 2 36899998653 34456789999999999999999999999976 467
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999887543 345999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCCCCCCccccccccccccccccccc
Q 003288 665 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...... .......||..|+|||.+.+..++.++|||||||++|||++ |+.||....... .... ..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~---i~~~~---- 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHK---IDKEG---- 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---HHTSC----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHH---HHhCC----
Confidence 7554322 22334567889999999999999999999999999999998 899986433221 1100 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ..+.....+..+.+++.+||+.||++|||++||++.|++.
T Consensus 232 -----~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -----E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 1111222335688999999999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=392.07 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=212.4
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 578999999999999999999852 35789999997643 44566899999999999 69999999999999999
Q ss_pred eEEEEEecCCCchhhhhhccC---------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEe
Q 003288 584 KILILEYMPNKSLNVFLFDST---------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 648 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl 648 (834)
.++||||+++|+|.+++.... ....+++.++..++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986533 2235899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC-CCCCCCCcccc
Q 003288 649 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p-~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++++.| +........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999999999987654433444557899999999999999999999999999999999995544 432222110
Q ss_pred cccccccccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 728 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+++.... ...........+.+|+.+||+.||++||||+||+++|++.
T Consensus 257 ------------~~~~i~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ------------FYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ------------HHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------HHHHHhcCC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111111 1122223346789999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=393.32 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=206.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 587 (834)
-++|+++++||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.++...++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999874 6899999999643 233467789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999843 456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.... .. .....
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~i~~~--------- 220 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILME--------- 220 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC---------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH----HHhcC---------
Confidence 22 223457899999999999999999999999999999999999999865432211 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 785 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 785 (834)
...++...+.++.+|+.+||+.||++||+ ++|++++
T Consensus 221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 01112223456889999999999999995 8888763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=386.36 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=202.6
Q ss_pred cceeccCCcEeEEEEEecCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-CeeEEEEEec
Q 003288 518 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEYM 591 (834)
Q Consensus 518 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~ 591 (834)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899999753 555678899999999999999999999998764 5889999999
Q ss_pred CCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCccc
Q 003288 592 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999853 3445788899999999999999999998 999999999999999999999999999987544322
Q ss_pred --CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccccc
Q 003288 672 --GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 749 (834)
Q Consensus 672 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~ 749 (834)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+....... ..... ...+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~----i~~g~---------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY----LLQGR---------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTC----------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHcCC----------
Confidence 22334578999999999999999999999999999999999888765322111 11110 00010
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003288 750 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+.....++.+++.+||+.||++||+|.||++.|+++.
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01111123356889999999999999999999999998873
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-44 Score=381.70 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=201.7
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----e
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----E 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 583 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. +....+.|.+|++++++++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999874 6899999999754 3445678999999999999999999999998764 3
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|..++.. .+.+++.++..++.||++||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCc-ccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccc
Q 003288 664 MFGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 742 (834)
Q Consensus 664 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... .........||+.|+|||++.+..++.++|||||||++|||++|++||........ . .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~---~~~~~~~~~-- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--A---YQHVREDPI-- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H---HHHHHCCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--H---HHHHhcCCC--
Confidence 764332 22234456899999999999999999999999999999999999999864332111 0 000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 003288 743 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 789 (834)
Q Consensus 743 li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 789 (834)
. ........+.++.+++.+||+.||.+|| |++++++.|.++
T Consensus 233 --~----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --P----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --C----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --C----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 0011112335688999999999999999 899999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=389.79 Aligned_cols=257 Identities=29% Similarity=0.434 Sum_probs=204.8
Q ss_pred cCccccceeccCCcEeEEEEEecC-Cc--EEEEEEecCC-ChhhHHHHHHHHHHHHhc-CCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 587 (834)
++|++.++||+|+||.||+|++.+ +. .||||+++.. .....+.|.+|+++|.++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999998754 43 5788988644 344567899999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhhcc-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCc
Q 003288 588 LEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 654 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~ 654 (834)
|||+++|+|.++|+.. .....+++.++.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23467999999999999999999999998 9999999999999999999
Q ss_pred eeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCC-CCCCCCCCcccccccccc
Q 003288 655 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~-p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+....... +...
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~--- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHH---
Confidence 999999998653322 2234578999999999999999999999999999999999765 554322111 1100
Q ss_pred cccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003288 734 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 791 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
+.... ..+.......++.+++.+||+.||++||||+||++.|+++..
T Consensus 239 ----------i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 ----------LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----------GGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------HHhcC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00000 112222334678999999999999999999999999988743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-44 Score=388.18 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=204.3
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 5899999999643 2334678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999884 3445788999999999999999999998 999999999999999999999999999976432
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||...+... .. ..+....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~------------~~i~~~~- 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY------------EKILNAE- 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH------------HHHHHCC-
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HH------------HHHHcCC-
Confidence 334689999999999999999999999999999999999999986432211 00 0000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
.........++.+++.+||+.||.+|| +++|++++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111122345688999999999999996 89999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=388.29 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=211.6
Q ss_pred hcCccccceeccCCcEeEEEEEec------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 584 (834)
.++|++.++||+|+||.||+|.+. +++.||||+++.. .......|.+|+.++++++||||+++++++..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478999999999999999999763 2578999999754 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhccC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceee
Q 003288 585 ILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 657 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 657 (834)
++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999985422 2234789999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCCCCCCccccccccccccc
Q 003288 658 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++|. +|+....... ... .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~----~-- 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLR----F-- 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHH----H--
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHH----H--
Confidence 999998775544444445567899999999999999999999999999999999985 5554322111 000 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 737 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 737 ~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+... ..........+.+++.+||+.+|++||||+||+++|++.
T Consensus 248 ------i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 248 ------VMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ------HHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ------HHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 011111 111222345789999999999999999999999999886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-44 Score=375.71 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=204.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh---------hhHHHHHHHHHHHHhcC-CCceeeEeeeeee
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE 580 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 580 (834)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 689999999865421 22456889999999997 9999999999999
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
++..++||||+++|+|.++|.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999953 346999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccC------CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 734 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 734 (834)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||........ . ..
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~----~~ 226 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--L----RM 226 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HH
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--H----HH
Confidence 999875432 2334689999999999853 3568899999999999999999999864332110 0 00
Q ss_pred ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+.. . . ........+.++.+++.+||+.||++|||++||++.
T Consensus 227 i~~~~~-~-----~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNY-Q-----F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCC-C-----C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCC-C-----C-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000 0 0 111112344678999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-44 Score=389.16 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=204.5
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 588 (834)
++|+++++||+|+||.||+|++. +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999875 6999999998643 2234577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+|+|..++.. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999999976432
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
.....||+.|||||++.+..++.++|||||||++|||++|+.||....... ... .+....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~------------~i~~~~- 254 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYE------------KIVSGK- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHHCC-
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHH------------HHhcCC-
Confidence 334689999999999999999999999999999999999999986432211 100 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003288 749 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.........++.+++.+||+.||.+|+ |++|+++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011122345688999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=379.84 Aligned_cols=260 Identities=25% Similarity=0.297 Sum_probs=195.4
Q ss_pred ccceeccCCcEeEEEEEec-CCcEEEEEEecCCChh-----hHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 517 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.+++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4579999999999999975 5899999998643221 234688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+.++++..++ .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998877665 34556899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc-----cccccccc-cccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH-----AWDLWKDD-RVHD 742 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~-----~~~~~~~~-~~~~ 742 (834)
......||+.|+|||++... .++.++|||||||++|||++|++||........ ..+.. ....+... ....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22345799999999998754 679999999999999999999999864332110 00000 00000000 0000
Q ss_pred ccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 743 LIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 743 li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...... ..... ......+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKS-FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCC-CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhcc-CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 00011 1123578899999999999999999999873
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=379.48 Aligned_cols=248 Identities=19% Similarity=0.274 Sum_probs=204.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
.++|++.++||+|+||+||+|+.. +++.||||.++.... ....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 588999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC--CCceeeccccceecCCC
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 2346899999999999999999999998 9999999999999854 57999999999876443
Q ss_pred cccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccccccc
Q 003288 669 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~ 748 (834)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. .+....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~------------~i~~~~- 219 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE------------NIMNAE- 219 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH------------HHHHTC-
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHhCC-
Confidence 2 23446789999999999999999999999999999999999999864332110 00 000000
Q ss_pred ccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 749 MQDEISL----PMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 749 ~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..... ....++.+++.+||+.||++|||+.|++++
T Consensus 220 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 --YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111 123467899999999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=377.50 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=202.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|+++++||+|+||+||+|+.. +|+.||||+++... +...+++.+|+++|++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999874 68999999996442 2345789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.++.+..... .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765544432 23456999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-c-ccc---c-cccccccc-ccc
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLG---H-AWDLWKDD-RVH 741 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~-~~~---~-~~~~~~~~-~~~ 741 (834)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||........ . ... . ....+... ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2233458999999999887765 57899999999999999999999864332110 0 000 0 00000000 000
Q ss_pred cccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003288 742 DLIDPVIMQDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 789 (834)
Q Consensus 742 ~li~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 789 (834)
+.......... .......++.+++.+||+.||++|||++|+++. ++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000000000 011223578899999999999999999999985 5544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-43 Score=386.92 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=198.1
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCC---hhhHHHHHH---HHHHHHhcCCCceeeEeeeeeecCeeE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKN---EMMLIAKLQHRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 585 (834)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 58999999985321 122233444 466677778999999999999999999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999843 346889999999999999999999998 999999999999999999999999999977
Q ss_pred CCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccccccccccccccccc
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li 744 (834)
.... .....||+.|+|||++.. ..|+.++|||||||+||||++|+.||..........+.. ...
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-----------~~~ 222 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MTL 222 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----------HSS
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------hcc
Confidence 5432 334689999999999975 568999999999999999999999986543322110000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003288 745 DPVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVIS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
.. ..........++.+++.+||+.||++||| ++|+++
T Consensus 223 ~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 TM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SC---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cC---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 01111223456889999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=380.17 Aligned_cols=252 Identities=17% Similarity=0.213 Sum_probs=198.3
Q ss_pred hcCccccc-eeccCCcEeEEEEEe-cCCcEEEEEEecCCChhhHHHHHHHHHHHHhc-CCCceeeEeeeeee----cCee
Q 003288 512 TENFSMQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 584 (834)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999987 46899999999643 4567899987665 89999999999876 4578
Q ss_pred EEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC---CCCceeecccc
Q 003288 585 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 661 (834)
Q Consensus 585 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGl 661 (834)
++|||||++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2346999999999999999999999998 999999999999975 55799999999
Q ss_pred ceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 662 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
|+...... ......||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ......
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~-------- 227 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKT-------- 227 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHH--------
Confidence 99775433 23446899999999999999999999999999999999999999864332111 000000
Q ss_pred ccccccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 742 DLIDPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 742 ~li~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+..... .........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 0001111234578999999999999999999999883
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=383.92 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=202.0
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC---ChhhHHHHHHHHHHHH-hcCCCceeeEeeeeeecCeeEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 587 (834)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5899999999643 2334566777777765 67999999999999999999999
Q ss_pred EEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCC
Q 003288 588 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999953 345899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccccccccc
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 747 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~i~~~--------- 218 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----SIRMD--------- 218 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHC---------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHH----HHHcC---------
Confidence 32 22344689999999999999999999999999999999999999986433211 100 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003288 748 IMQDEISLPMLMRYINVALLCVQENAADRPTMS-DVIS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 784 (834)
....+.....++.+|+.+||+.||++||++. |+++
T Consensus 219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0111122345688999999999999999996 6753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.5e-43 Score=370.97 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=201.3
Q ss_pred cCccccceeccCCcEeEEEEEecCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEEe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 590 (834)
++|+++++||+|+||+||+|++.+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996543 33467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCcc
Q 003288 591 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+.++.+..+. .....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988887776 34467999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cc-c----cccccccccc-cccc
Q 003288 671 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NL-L----GHAWDLWKDD-RVHD 742 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~-~----~~~~~~~~~~-~~~~ 742 (834)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ .- . ......+... ....
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334689999999998764 568999999999999999999999864332110 00 0 0000000000 0000
Q ss_pred c---cc--cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 743 L---ID--PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 743 l---i~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .. ...............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 000001111223356889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=370.62 Aligned_cols=241 Identities=22% Similarity=0.341 Sum_probs=195.4
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCCh------hhHHHHHHHHHHHHhcC--CCceeeEeeeeeecC
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQG 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 582 (834)
.++|++.++||+|+||.||+|+.. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999875 689999999864311 12234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCC-CCceeeccc
Q 003288 583 EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFG 660 (834)
Q Consensus 583 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFG 660 (834)
..++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777733 346899999999999999999999998 9999999999999854 789999999
Q ss_pred cceecCCCcccCCcccccccccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 661 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~~---------- 218 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIR---------- 218 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHH----------
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hhh----------
Confidence 99875433 2334689999999999987765 5779999999999999999999853211 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. .......+.++.+++.+||+.||++|||++|+++.
T Consensus 219 ------~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 ------GQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cc---cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 00111123568899999999999999999999763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=368.52 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=197.5
Q ss_pred hcCccccceeccCCcEeEEEEEec-C-CcEEEEEEecCC--ChhhHHHHHHHHHHHHhc---CCCceeeEeeeeee----
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE---- 580 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 580 (834)
.++|+++++||+|+||+||+|++. + ++.||||+++.. .......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 4 567999998543 222233566777777766 79999999999863
Q ss_pred -cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeecc
Q 003288 581 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 659 (834)
Q Consensus 581 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 659 (834)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346899999999988765542 34456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc-c----cccc
Q 003288 660 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G----HAWD 733 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~-~----~~~~ 733 (834)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|++||........ ..+ . ....
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 998865332 233456899999999999999999999999999999999999999865432110 000 0 0000
Q ss_pred ccccc-ccc-ccccccc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LWKDD-RVH-DLIDPVI--MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~~~~-~~~-~li~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+... ... ....... ............+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000 0000000 0001111233567889999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=363.44 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=198.1
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee--------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 580 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 580 (834)
.++|+++++||+|+||+||+|+.. +|+.||||++... .+...+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 6999999998543 33445778999999999999999999998865
Q ss_pred cCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccc
Q 003288 581 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 660 (834)
+...++||||++++.+..+. .....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34679999999988877655 34456889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc--CCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccccc------
Q 003288 661 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH------ 730 (834)
Q Consensus 661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~------ 730 (834)
+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+... ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99877543322 223345799999999998765 689999999999999999999999864332111 00000
Q ss_pred --ccccccccccccccccccccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 731 --AWDLWKDDRVHDLIDPVIMQDEISLP-------MLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 731 --~~~~~~~~~~~~li~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+...........+.... ....... ....+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000011110000 0011111 13366789999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=366.53 Aligned_cols=261 Identities=22% Similarity=0.269 Sum_probs=195.7
Q ss_pred CccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec------CeeEE
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKIL 586 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 586 (834)
+|+.+++||+|+||+||+|++. +|+.||||++..... .+.+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999985 589999999975432 234799999999999999999998643 24789
Q ss_pred EEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-Cceeeccccceec
Q 003288 587 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 665 (834)
Q Consensus 587 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~ 665 (834)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443445567999999999999999999999998 99999999999999775 8999999999877
Q ss_pred CCCcccCCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-ccc-c-------ccccc-
Q 003288 666 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G-------HAWDL- 734 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~-~-------~~~~~- 734 (834)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..+ . ..+..
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 54332 234579999999998875 5689999999999999999999999865432110 000 0 00000
Q ss_pred ---ccccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 735 ---WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 735 ---~~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.............. ...........+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCG-GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCch-hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 001112234568899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=364.50 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=195.6
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC------
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 582 (834)
.++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999875 5999999999753 3445678899999999999999999999998655
Q ss_pred eeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccc
Q 003288 583 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 662 (834)
..++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 567777663 345999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccc--------ccc
Q 003288 663 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLG--------HAW 732 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~--------~~~ 732 (834)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.|+......... ... ..+
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876432 2346799999999998764 5689999999999999999999998654321100 000 000
Q ss_pred ccccccc-------cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003288 733 DLWKDDR-------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 789 (834)
Q Consensus 733 ~~~~~~~-------~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 789 (834)
....... ..+...... ..........+.+|+.+||+.||++|||++|+++. ++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 000000000 00111223467899999999999999999999985 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=356.07 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=196.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCcee-eEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|++. +|+.||||++..... .+++..|++++++++|+|++ .+.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 467999999999999999999874 589999999865432 24578899999999877655 55555677788899999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEec---CCCCceeeccccceecC
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~ 666 (834)
|+. ++|...+.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 995 455555432 3456899999999999999999999998 99999999999975 45679999999999875
Q ss_pred CCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 667 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~---~~~---~ 231 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER---ISE---K 231 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH---HHH---H
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH---hhc---c
Confidence 43221 223456899999999999999999999999999999999999999865433221110000 000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+ ........+.++.+++..||+.+|++||+++++.+.|+..
T Consensus 232 ~~~~~---~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 232 KMSTP---IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHSC---HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cCCCC---hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000 0000111235688999999999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=356.33 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=197.4
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeec--CeeEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 588 (834)
++|+++++||+|+||+||+|+.. +|+.||||+++... .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999974 68999999997543 467889999999995 99999999998754 4689999
Q ss_pred EecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCC-CceeeccccceecCC
Q 003288 589 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGG 667 (834)
Q Consensus 589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~ 667 (834)
||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 34899999999999999999999998 99999999999998655 599999999997754
Q ss_pred CcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCccccccc--------cc------
Q 003288 668 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH--------AW------ 732 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~--------~~------ 732 (834)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+............. ..
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 23446789999999998765 47999999999999999999999986544321100000 00
Q ss_pred cccccccccccc-------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003288 733 DLWKDDRVHDLI-------DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 784 (834)
Q Consensus 733 ~~~~~~~~~~li-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
............ ...............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 0001011112223457889999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=364.95 Aligned_cols=267 Identities=20% Similarity=0.274 Sum_probs=197.7
Q ss_pred hcCccccceeccCCcEeEEEEEe-cCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhcCCCceeeEeeeeeecC----eeE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKI 585 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 585 (834)
+++|+++++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999986 469999999997543 445678999999999999999999999987654 345
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceec
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999999843 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-CCcccccccccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-ccccccccccccc---
Q 003288 666 GGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDR--- 739 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~--- 739 (834)
...... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||......... .............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 543222 22345679999999999854 46789999999999999999999998643321100 0000000000000
Q ss_pred -----cccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 740 -----VHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 740 -----~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
............... .....++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000111 1123468899999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=351.69 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=203.7
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeecCeeEEEEE
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 589 (834)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 6889999998543 34457889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccceecCCCc
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
++.+++|..++. ..+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988873 3456889999999999999999999998 9999999999999999999999999999875433
Q ss_pred ccCCcccccccccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCCCCCCcccc--cccccc-----cc------
Q 003288 670 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--LGHAWD-----LW------ 735 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~--~~~~~~-----~~------ 735 (834)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+.......... +..... .+
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 222346788999999987665 6899999999999999999999864322211000 000000 00
Q ss_pred cccccccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 736 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 736 ~~~~~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........................+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000111222334568899999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-40 Score=351.99 Aligned_cols=261 Identities=17% Similarity=0.214 Sum_probs=203.9
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC-CceeeEeeeeeecCeeEEEEE
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 589 (834)
.++|++.++||+|+||.||+|++. +|+.||||.++.... .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 588999999865432 2456789999999965 899999999999999999999
Q ss_pred ecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecC-----CCCceeecccccee
Q 003288 590 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARM 664 (834)
Q Consensus 590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~ 664 (834)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899888743 3346899999999999999999999998 999999999999974 56799999999998
Q ss_pred cCCCccc-----CCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccc
Q 003288 665 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 739 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~---~~i~~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH---HHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH---HHHHhcc
Confidence 7543211 2234568999999999999999999999999999999999999999754332111000 0000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003288 740 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 789 (834)
Q Consensus 740 ~~~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. ...+.+ ....+.++.+++..|++.+|++||+++.+.+.|++.
T Consensus 233 ~~-~~~~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 QS-TPLREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HH-SCHHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CC-CChHHh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 000000 011224688899999999999999999998888765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=356.61 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=200.6
Q ss_pred cCccccceeccCCcEeEEEEEec----CCcEEEEEEecCC----ChhhHHHHHHHHHHHHhcCC-CceeeEeeeeeecCe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGE 583 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 583 (834)
++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 4789999998643 22345678899999999966 899999999999999
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998433 35678899999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccCCcccccccccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcccccccccccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||.......... ... .
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~--------~ 246 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EIS--------R 246 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHH--------H
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH--------H
Confidence 76543322 23346899999999999764 46889999999999999999999986543321100 000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003288 742 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 784 (834)
Q Consensus 742 ~li~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
..... ..........++.+++.+||+.||.+|| |++|+++
T Consensus 247 ~~~~~---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 247 RILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred hcccC---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00000 1122233456789999999999999999 5889876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=350.39 Aligned_cols=261 Identities=23% Similarity=0.258 Sum_probs=191.2
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeee------cCe
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 583 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 583 (834)
++|+++++||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 5999999999654 34456678999999999999999999999864 367
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.|+||||+.++.+..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876665442 34899999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc--cc----ccccccccc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LL----GHAWDLWKD 737 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~--~~----~~~~~~~~~ 737 (834)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+..... .. ....+.+..
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 764432 334467899999999999999999999999999999999999998643321100 00 000000000
Q ss_pred -----------------cccccccccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 738 -----------------DRVHDLIDPVIMQDE--ISLPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 738 -----------------~~~~~li~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
............... ........+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000011111110001 112345678999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=349.59 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=195.3
Q ss_pred hcCccccceeccCCcEeEEEEEec-CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhcCCCceeeEeeeeeec-----Ce
Q 003288 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 583 (834)
.++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999864 6999999999754 334556789999999999999999999998643 34
Q ss_pred eEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCceeeccccce
Q 003288 584 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 663 (834)
.++++||+.+|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999983 235999999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCcccCCcccccccccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCCCCCCcc-cccccc--------cc
Q 003288 664 MFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------WD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~~ 733 (834)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.... ..+... ..
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6432 23346789999999987765 468999999999999999999999864332110 000000 00
Q ss_pred cccccccccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003288 734 LWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 785 (834)
Q Consensus 734 ~~~~~~~~~li~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..................... ......+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000000111 1123567899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-35 Score=324.02 Aligned_cols=264 Identities=19% Similarity=0.250 Sum_probs=194.8
Q ss_pred cCccccceeccCCcEeEEEEEec-CCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-----------CCceeeEeeeeee
Q 003288 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCVE 580 (834)
Q Consensus 513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 580 (834)
.+|+++++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 6899999999754 334567889999998885 4789999998865
Q ss_pred c--CeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeCCCCCCcEEecCCCC----
Q 003288 581 Q--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMN---- 653 (834)
Q Consensus 581 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dikp~NILl~~~~~---- 653 (834)
. ...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4567777777666554444444556678999999999999999999998 66 999999999999986654
Q ss_pred --ceeeccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCCCCCCccc-c---
Q 003288 654 --PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-L--- 727 (834)
Q Consensus 654 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~elltg~~p~~~~~~~~~~-~--- 727 (834)
+|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||......... .
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865322 23467999999999999999999999999999999999999998643321100 0
Q ss_pred c-------cc-ccccc----------ccccccccccc---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003288 728 L-------GH-AWDLW----------KDDRVHDLIDP---------VIMQDEISLPMLMRYINVALLCVQENAADRPTMS 780 (834)
Q Consensus 728 ~-------~~-~~~~~----------~~~~~~~li~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
. .. ..... ........+.. ..............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0 00 00000 00000000000 0012233456677899999999999999999999
Q ss_pred HHHHH
Q 003288 781 DVISM 785 (834)
Q Consensus 781 evl~~ 785 (834)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.7e-22 Score=199.21 Aligned_cols=171 Identities=17% Similarity=0.169 Sum_probs=123.6
Q ss_pred ccccceeccCCcEeEEEEEecCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhcCCCceeeEee
Q 003288 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLG 576 (834)
Q Consensus 515 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~ 576 (834)
+.+.++||+|+||.||+|+..+|+.||||+++.... .....+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999998999999998753210 11234567889999999999998876
Q ss_pred eeeecCeeEEEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeeCCCCCCcEEecCCCCcee
Q 003288 577 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 656 (834)
Q Consensus 577 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dikp~NILl~~~~~~kl 656 (834)
+. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 53 2379999998866533 344556789999999999999998 9999999999999965 4899
Q ss_pred eccccceecCCCcccCCcccccccccccCcccccCCCCCccCcchhhHHHHH
Q 003288 657 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDVwslGvvl~ 708 (834)
+|||+|.....+........ .... -.| +..+.|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~~-~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVRN-IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHHH-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHHH-HHH-HHcCCCCCcccHHHHHHHHh
Confidence 99999987643321100000 0000 011 12366889999999765443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=4.6e-21 Score=170.26 Aligned_cols=112 Identities=24% Similarity=0.411 Sum_probs=96.2
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
+|||.|||.|.+|+.|+| |.|+|+|...|+ |.++. ..++||.||++.|.. .+.|.|+.||+|+|.|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 599999999999999985 999999999886 77765 358999999998854 46899999999999996
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCCh
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTD 154 (834)
+.++|++++.......+|+|+|+|||||++.++ .++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~-----~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTS-----CEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCCC-----cEEecCCCccCC
Confidence 578888887666566789999999999998654 689999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=1.6e-20 Score=165.06 Aligned_cols=107 Identities=24% Similarity=0.356 Sum_probs=93.4
Q ss_pred ccccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003288 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (834)
Q Consensus 25 ~d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~ 104 (834)
.|+|.+||.|.+|+.|. +|.|.|+|..+|+ |.|+. ..++||.||++.|. +.+.|.|..||+|+|.|++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCC--CccEEEEeccceEEEECCC
Confidence 47899999999999995 6999999999987 78875 35899999999884 3467999999999999999
Q ss_pred CCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCC
Q 003288 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (834)
Q Consensus 105 ~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~ 151 (834)
|.+||+|++.......+|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987665666789999999999963 38999988
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=3e-20 Score=163.26 Aligned_cols=107 Identities=20% Similarity=0.347 Sum_probs=92.7
Q ss_pred cccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCC
Q 003288 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (834)
Q Consensus 26 d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~ 105 (834)
|+|.|||.|.+|+.|.+ |.|.|+|...|+ |.++. ..++||+||++.|+.. .+.|.|+.||+|||.|++|
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCC
Confidence 78999999999999975 889999998776 66654 3589999999999865 6789999999999999999
Q ss_pred CeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCC
Q 003288 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (834)
Q Consensus 106 ~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~ 151 (834)
.+||+|+++.......|+|+|+|||||+++ .+|||+-|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 999999987555667889999999999963 49999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=9.9e-17 Score=142.87 Aligned_cols=102 Identities=21% Similarity=0.324 Sum_probs=86.7
Q ss_pred EEEeecC-CCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCC
Q 003288 63 GIRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141 (834)
Q Consensus 63 giw~~~~-~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~ 141 (834)
-|||..+ .++.+|++|++.|+.....+|.|..||||+|.+. +.++|++++.+.+....|+|+++|||||++.++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~---- 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN---- 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC----
Confidence 4889887 6799999999999988777899999999999986 678999998877677789999999999999754
Q ss_pred CceeeeecCCCChhhhhhcccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEE
Q 003288 142 ESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKIC 201 (834)
Q Consensus 142 ~~~lWqSFd~PTDtlLpg~~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~ 201 (834)
++|||||. +.++|.|.+.++++|...++
T Consensus 86 -~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 86 -IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 78999983 34678899999999987654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.57 E-value=3.1e-15 Score=132.56 Aligned_cols=103 Identities=17% Similarity=0.340 Sum_probs=83.6
Q ss_pred cccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCC
Q 003288 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (834)
Q Consensus 26 d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~ 105 (834)
++|.++|+| .+.+..|.|.|.|...|+ |.++ + ..++||.||+..|.. .+.|.|..||+|+|.|++|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCC
Confidence 556666655 246779999999999997 6553 3 368999999987753 4789999999999999999
Q ss_pred CeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecC
Q 003288 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (834)
Q Consensus 106 ~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd 150 (834)
.+||++++.+.....+|+|+|+|||||++ ..+|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 99999998766566678999999999995 35999864
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=7.8e-15 Score=128.97 Aligned_cols=109 Identities=23% Similarity=0.290 Sum_probs=87.7
Q ss_pred EEeecC-CCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCC
Q 003288 64 IRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142 (834)
Q Consensus 64 iw~~~~-~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~ 142 (834)
|||.-. ..+..|+.+.+.++.....+|.|..||||||.+ .+.++|++++.+. .+..|.|+++|||||++.++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~~~----- 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQN----- 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTTT-----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEccCC-----
Confidence 566543 567779999999998877789999999999988 5789999998654 46778999999999998754
Q ss_pred ceeeeecCCCChhhhhhcccccccccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 143 SYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 143 ~~lWqSFd~PTDtlLpg~~l~~~~~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+||||+- +.++|.|.+.|+++|...++ +.++|.+|-
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 78999763 34689999999999986544 346888763
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=2.2e-13 Score=119.58 Aligned_cols=98 Identities=23% Similarity=0.352 Sum_probs=76.8
Q ss_pred cccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCCCeEEEE
Q 003288 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWst 111 (834)
|.|.+++.| .+|.|.|.|...|+ |.++. ..++||.+|... ...+.+.|..||||||.|.++.+||++
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEEc
Confidence 344444444 35779999999887 77754 357899999754 235789999999999999999999999
Q ss_pred ecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecC
Q 003288 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (834)
Q Consensus 112 ~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd 150 (834)
++.......+++|.++|||||++ ..+|+|-.
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred CCCCCCCCEEEEECCCCcEEEeC--------CCeecCCC
Confidence 98766666678999999999995 35999753
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=2.3e-10 Score=101.11 Aligned_cols=97 Identities=22% Similarity=0.326 Sum_probs=71.2
Q ss_pred cccCCCcccCCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEeecCCCeeEEeecCCCCCCCCCceEEEeeCCcEEEEcCCC
Q 003288 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (834)
Q Consensus 26 d~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~G~Lvl~~~~~ 105 (834)
+++.++|+|.. |.|.|.|=..|+ |.++. ...+||.+|-. ..+..+.+.|..+|||||.|.++
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~ 85 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD---RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQN 85 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB---TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec---CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCC
Confidence 34555555544 556666666654 55543 24678998843 34445689999999999999999
Q ss_pred CeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeee
Q 003288 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (834)
Q Consensus 106 ~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqS 148 (834)
.++|++++.......+++|.++|||||++. .+|.|
T Consensus 86 ~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 86 IAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp EEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred CEEEEeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 999999987665666789999999999952 48875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.84 E-value=5.3e-09 Score=90.48 Aligned_cols=85 Identities=26% Similarity=0.420 Sum_probs=64.6
Q ss_pred ceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhcccccccc
Q 003288 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFK 167 (834)
Q Consensus 88 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~ 167 (834)
-+|.+..||||||.+ .+.+||++++.+.+....++|.++|||||++.++ .++|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g-----~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSN-----KPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCc-----cceEEc-------------------
Confidence 358899999999987 4679999998777666788999999999998754 788875
Q ss_pred cccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 168 NRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 168 t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
.+....+.|.+.++.+|...++ . .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1222456788889888877655 2 2456654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.73 E-value=2e-08 Score=88.03 Aligned_cols=84 Identities=26% Similarity=0.336 Sum_probs=65.2
Q ss_pred eEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccccc
Q 003288 89 VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKN 168 (834)
Q Consensus 89 ~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~t 168 (834)
.|.+..||||||.+. +.++|++++.+......+.|.++|||||++.++ .++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g-----~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCC-----cEEEECC-------------------
Confidence 588999999999875 568999998776667789999999999998754 6788742
Q ss_pred ccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecC
Q 003288 169 RLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSG 213 (834)
Q Consensus 169 ~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
+.-+.|.|.+.++.+|...++ ..+.|.++
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~ 116 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVIY----GDALWATQ 116 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEEE----ESEEEECC
T ss_pred ------------CcCCCCceEEEEcCCCCEEEE----CCCEeccC
Confidence 112456788999999887764 23578765
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.62 E-value=1.2e-07 Score=81.78 Aligned_cols=86 Identities=26% Similarity=0.376 Sum_probs=63.0
Q ss_pred ceEEEeeCCcEEEEcCCCCeEEEEecCCCC-ccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 88 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
-.|.|..||||||.+ .+.+||++++.... ....+.|.++|||||++.++ .++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~s------------------ 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-----RSLWAS------------------ 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS-----CEEEEC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC-----cEEEEE------------------
Confidence 458889999999987 56899999976433 34678899999999998754 778885
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+..+.|.|.+.++.+|...++ + .+.|.++-
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 1112346788889888877654 3 35776653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.5e-07 Score=95.35 Aligned_cols=149 Identities=17% Similarity=0.120 Sum_probs=106.9
Q ss_pred HHHHHhcCccccceeccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcC-CCceeeEeeeeeecCeeE
Q 003288 507 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 585 (834)
Q Consensus 507 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 585 (834)
++...-++|++.+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555567888877655555678998865 56778899887654444456788998888874 444678888888888999
Q ss_pred EEEEecCCCchhhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 003288 586 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------------------------------- 631 (834)
Q Consensus 586 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------- 631 (834)
+|||++++..+...... ......++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888655421 112334566666667777642
Q ss_pred ----------------------CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 632 ----------------------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 ----------------------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112389999999999999877677999998753
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.43 E-value=5.1e-07 Score=78.33 Aligned_cols=89 Identities=26% Similarity=0.434 Sum_probs=65.3
Q ss_pred CceEEEeeCCcEEEEcCCCCeEEEEecCCCCccceEEEecCCcEEEEeCCCCCCCCceeeeecCCCChhhhhhccccccc
Q 003288 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~ 166 (834)
.-.|.|..||||||.+ .+.+||++++.+......+.|..+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 3469999999999987 568999999876666678899999999999853 345543
Q ss_pred ccccceeeEEecCCCCCCCcceEEeeccCCCceEEEEcCCeeeeecCC
Q 003288 167 KNRLERYLSSWRSADDPSPGNFTYRLDIHVLPKICTFNGSVKFTCSGH 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+.-..|.+.+.++.+|...++- ....+.|.++-
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 22224467888999998776553 23456787763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=4.4e-05 Score=76.05 Aligned_cols=131 Identities=18% Similarity=0.176 Sum_probs=88.8
Q ss_pred eeccCCc-EeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCC--CceeeEeeeeeecCeeEEEEEecCCCch
Q 003288 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 520 ~LG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL 596 (834)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 578999887788899998765433 345678888887743 3467788888888889999999998776
Q ss_pred hhhhhccCCCccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 003288 597 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ---------------------------------------------- 630 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------------- 630 (834)
.... +.. ..++.++++.|+-||.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 111 1122333333444442
Q ss_pred -----c----CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 631 -----Y----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----~----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122389999999999999877678999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00021 Score=76.08 Aligned_cols=75 Identities=11% Similarity=0.157 Sum_probs=49.3
Q ss_pred ceeccCCcEeEEEEEecC-CcEEEEEEecCC-------ChhhHHHHHHHHHHHHhcC-C--CceeeEeeeeeecCeeEEE
Q 003288 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 587 (834)
+.||.|....||+....+ ++.++||.-... .+...++...|++.|+.+. + ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 579999999999998654 678999975421 1112334556888887763 3 345566654 55567899
Q ss_pred EEecCCCc
Q 003288 588 LEYMPNKS 595 (834)
Q Consensus 588 ~E~~~~gs 595 (834)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.0022 Score=67.82 Aligned_cols=77 Identities=19% Similarity=0.311 Sum_probs=52.2
Q ss_pred CccccceeccCCcEeEEEEEecC--------CcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce-eeEeeeeeecCee
Q 003288 514 NFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEK 584 (834)
Q Consensus 514 ~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~ 584 (834)
.+++ +.|+.|--=.+|+....+ .+.|.+++.... . ......+|..+++.+.-.++ .++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4444 678888888999998754 346777776532 2 22345689999998853344 577777643
Q ss_pred EEEEEecCCCchh
Q 003288 585 ILILEYMPNKSLN 597 (834)
Q Consensus 585 ~lv~E~~~~gsL~ 597 (834)
.+|+||+++..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 5899999876553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0016 Score=66.92 Aligned_cols=135 Identities=13% Similarity=0.122 Sum_probs=78.9
Q ss_pred EeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce--eeEe-----eeeeecCeeEEEEEecCCCchhhh
Q 003288 527 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL-----GCCVEQGEKILILEYMPNKSLNVF 599 (834)
Q Consensus 527 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~gsL~~~ 599 (834)
-.||+++..+|+.+++|..+... ...+++..|...+..|....+ +..+ .....++..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999899999999986542 234667789888888853322 1111 122345567889999987543210
Q ss_pred ----h----------hc------cCCCccCC-------------------HHHHHHHHHHHHHHHHHHHh----cCCCce
Q 003288 600 ----L----------FD------STKKRLLN-------------------WQARVRIIEGIAQGLLYLHQ----YSRFRI 636 (834)
Q Consensus 600 ----l----------~~------~~~~~~l~-------------------~~~~~~i~~~ia~~L~~LH~----~~~~~i 636 (834)
+ +. ......++ ......+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 00 00011111 11111222223333333332 223458
Q ss_pred eeCCCCCCcEEecCCCCceeecccccee
Q 003288 637 IHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 637 vH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.25 E-value=0.087 Score=52.92 Aligned_cols=158 Identities=12% Similarity=0.024 Sum_probs=82.0
Q ss_pred cHHHHHHHhcCccccce-----eccCCcEeEEEEEecCCcEEEEEEecCCChhhHHHHHHHHHHHHhcCCCce--eeEee
Q 003288 504 SLASITAATENFSMQCK-----LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLG 576 (834)
Q Consensus 504 ~~~~i~~~~~~y~~~~~-----LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~ 576 (834)
+..++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..+++..|+.++..+.+.++ ...+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 44566666677766433 44666677899887655 58999986532 12344556777777743222 11111
Q ss_pred ------eeeecCeeEEEEEecCCCchhhhh--------------hc------cCCC------------------ccCCHH
Q 003288 577 ------CCVEQGEKILILEYMPNKSLNVFL--------------FD------STKK------------------RLLNWQ 612 (834)
Q Consensus 577 ------~~~~~~~~~lv~E~~~~gsL~~~l--------------~~------~~~~------------------~~l~~~ 612 (834)
+.........++.+..+......- +. .... ......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112234556677777654331110 00 0000 000011
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCceeeCCCCCCcEEecCCCCceeecccccee
Q 003288 613 ARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 664 (834)
Q Consensus 613 ~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 664 (834)
.....+..+...+.-.+.. -+..+||+|+.++||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1112222222222222221 133599999999999999887778999998763
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.38 E-value=0.036 Score=34.70 Aligned_cols=32 Identities=31% Similarity=0.579 Sum_probs=25.6
Q ss_pred CCCCCCCCCCCCcccCCC-CCCccccccCcccCC
Q 003288 286 QYCGKYGYCGANTICSLD-QKPMCECLEGFKLES 318 (834)
Q Consensus 286 ~~Cd~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 318 (834)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6799999998 6889753 445799999999853
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.82 E-value=0.19 Score=33.61 Aligned_cols=32 Identities=22% Similarity=0.463 Sum_probs=25.1
Q ss_pred CCCCCC-CCCCCCCcccCCC-CCCccccccCccc
Q 003288 285 DQYCGK-YGYCGANTICSLD-QKPMCECLEGFKL 316 (834)
Q Consensus 285 ~~~Cd~-~~~CG~~g~C~~~-~~~~C~C~~Gf~~ 316 (834)
.|+|.. ...|..+|.|... ..-.|.|++||+-
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 467875 5789999999754 4568999999974
|